
<html lang="en"     class="pb-page"  data-request-id="0102c768-be8c-4414-a2a4-983289ed0255"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2015.58.issue-5;pageGroup:string:Publication Pages;article:article:10.1021/jm500907a;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Targeting Aldose Reductase for the Treatment of Diabetes Complications and Inflammatory Diseases: New Insights and Future Directions" /></meta><meta name="dc.Creator" content="Rosanna  Maccari" /></meta><meta name="dc.Creator" content="Rosaria  Ottanà" /></meta><meta name="dc.Description" content="Aldose reductase (AR) is an aldo–keto reductase that has been widely investigated as an enzyme crucially involved in the pathogenesis of chronic complications associated with diabetes mellitus. Rec..." /></meta><meta name="Description" content="Aldose reductase (AR) is an aldo–keto reductase that has been widely investigated as an enzyme crucially involved in the pathogenesis of chronic complications associated with diabetes mellitus. Rec..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 17, 2014" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm500907a" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm500907a" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm500907a" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm500907a" /></link>
        
    
    

<title>Targeting Aldose Reductase for the Treatment of Diabetes Complications and Inflammatory Diseases: New Insights and Future Directions | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm500907a" /></meta><meta property="og:title" content="Targeting Aldose Reductase for the Treatment of Diabetes Complications and Inflammatory Diseases: New Insights and Future Directions" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0012.jpeg" /></meta><meta property="og:description" content="Aldose reductase (AR) is an aldo–keto reductase that has been widely investigated as an enzyme crucially involved in the pathogenesis of chronic complications associated with diabetes mellitus. Recently it was established that AR also acts as a key mediator of certain oxidative and inflammatory signaling pathways that are involved in the development of different human pathologies, such as cardiovascular disorders, sepsis, and cancer. These findings have renewed interest in the search for new AR inhibitors (ARIs) with improved profiles as potential therapeutic agents. In this review, recent advances in the field and promising future directions for developing ARIs are discussed." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm500907a"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm500907a">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm500907a&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm500907a&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm500907a&amp;href=/doi/10.1021/jm500907a" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2047-2067</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm5011308" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Targeting Aldose Reductase for the Treatment of Diabetes Complications and Inflammatory Diseases: New Insights and Future Directions</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rosanna++Maccari">Rosanna Maccari</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"> and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rosaria++Ottan%C3%A0">Rosaria Ottanà</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Dipartimento di Scienze del Farmaco e dei Prodotti per la Salute, Università degli Studi di Messina, Polo Universitario dell’Annunziata, 98168 Messina, Italy</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#1e6c737f7d7d7f6c775e6b7077737b30776a"><span class="__cf_email__" data-cfemail="e99b84888a8a889b80a99c8780848cc7809d">[email protected]</span></a>. Telephone +39906766406.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm500907a&amp;href=/doi/10.1021%2Fjm500907a" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2047–2067</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 6, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 June 2014</li><li><span class="item_label"><b>Published</b> online</span>17 November 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 March 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm500907a" title="DOI URL">https://doi.org/10.1021/jm500907a</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2047%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRosanna%2BMaccari%252C%2BRosaria%2BOttan%25C3%25A0%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D5%26contentID%3Djm500907a%26title%3DTargeting%2BAldose%2BReductase%2Bfor%2Bthe%2BTreatment%2Bof%2BDiabetes%2BComplications%2Band%2BInflammatory%2BDiseases%253A%2BNew%2BInsights%2Band%2BFuture%2BDirections%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2067%26publicationDate%3DMarch%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm500907a"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2461</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">83</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm500907a" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Targeting Aldose Reductase for the Treatment of Diabetes Complications and Inflammatory Diseases: New Insights and Future Directions&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Rosanna&quot;,&quot;last_name&quot;:&quot;Maccari&quot;},{&quot;first_name&quot;:&quot;Rosaria&quot;,&quot;last_name&quot;:&quot;Ottanà&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;2047-2067&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm500907a&quot;},&quot;abstract&quot;:&quot;Aldose reductase (AR) is an aldo–keto reductase that has been widely investigated as an enzyme crucially involved in the pathogenesis of chronic complications associated with diabetes mellitus. Recently it was established that AR also acts as a key mediator of certain oxidative and inflammatory signaling pathways that are involved in the development of different human pathologies, such as cardiovascular disorders, sepsis, and cancer. These findings have renewed interest in the search for new AR inhibitors (ARIs) with improved profiles as potential therapeutic agents. In this review, recent advances in the field and promising future directions for developing ARIs are discussed.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500907a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500907a" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500907a&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500907a" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500907a&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500907a" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm500907a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500907a&amp;href=/doi/10.1021/jm500907a" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm500907a" /></input><a href="/doi/pdf/10.1021/jm500907a" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm500907a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm500907a%26sid%3Dliteratum%253Aachs%26pmid%3D25375908%26genre%3Darticle%26aulast%3DMaccari%26date%3D2015%26atitle%3DTargeting%2BAldose%2BReductase%2Bfor%2Bthe%2BTreatment%2Bof%2BDiabetes%2BComplications%2Band%2BInflammatory%2BDiseases%253A%2BNew%2BInsights%2Band%2BFuture%2BDirections%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D5%26spage%3D2047%26epage%3D2067%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292169" title="Antioxidants">Antioxidants</a>,</li><li><a href="/action/doSearch?ConceptID=291831" title="Chemical specificity">Chemical specificity</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291161" title="Inflammation">Inflammation</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jmcmar.2015.58.issue-5/20150312/jmcmar.2015.58.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0012.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Aldose reductase (AR) is an aldo–keto reductase that has been widely investigated as an enzyme crucially involved in the pathogenesis of chronic complications associated with diabetes mellitus. Recently it was established that AR also acts as a key mediator of certain oxidative and inflammatory signaling pathways that are involved in the development of different human pathologies, such as cardiovascular disorders, sepsis, and cancer. These findings have renewed interest in the search for new AR inhibitors (ARIs) with improved profiles as potential therapeutic agents. In this review, recent advances in the field and promising future directions for developing ARIs are discussed.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63786" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63786" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Aldose reductase (AR; AKR1B1, human enzyme) is a cytoplasmatic aldo–keto reductase (AKR) that is present in most human cells. During the past 4 decades, it has been widely investigated as an enzyme critically involved in the onset and progression of various pathologies associated with diabetes mellitus (DM).<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6 ref7 ref8">(1-8)</a></div><div class="NLM_p">Under normal conditions, the major physiological function of AR appears to be the degradation of toxic aldehydes originated from lipid peroxidation, such as 4-hydroxy-<i>trans</i>-2-nonenal (HNE) and its glutathione adduct GS-HNE. However, in DM, this enzyme plays a pivotal role in mediating hyperglycemia-induced oxidative stress and consequent tissue and vascular damage, through the NADPH-dependent reduction of glucose to sorbitol and consequent modifications of both cellular osmolarity and redox status. Accordingly, AR inhibitors (ARIs) have been shown to prevent or slow the progression of DM-associated pathologies, such as neuropathy, retinopathy, cataracts, and nephropathy, both in animal models and humans.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18">(9-18)</a> Therefore, AR has received a great deal of attention as an attractive therapeutic target for designing drugs able to counteract the development of long-term diabetic complications.</div><div class="NLM_p">On this basis, up to now, a large variety of small molecule ARIs have been discovered and many of them have been evaluated in preclinical and clinical trials.<a onclick="showRef(event, 'ref4 ref5 ref6 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref19 ref20 ref21">(4-6, 19-21)</a> However, their development was often hampered by pharmacokinetic drawbacks, low in vivo efficacy, or adverse side effects. Currently, only epalrestat (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is commercially available as ARI approved for the management of diabetic neuropathy.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Several clinical trials confirmed that this drug can slow the progression of diabetic neuropathy and can provide a significant improvement in the associated symptoms, without any severe side effects after long-term administration.<a onclick="showRef(event, 'ref14 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref14 ref23 ref24">(14, 23, 24)</a> Nevertheless, epalrestat is currently used only in few Asian countries (such as Japan and India) and it was suggested that its efficacy should be elucidated by further long-term comparative studies in different patient populations.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of some known ARIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Among ARIs that entered clinical trials, a few molecules showed clinically suitable profiles. In fact, sorbinil (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which was the first extensively tested ARI with good acivity both in vitro and in vivo, was withdrawn from clinical trials because of hypersensitivity reactions that were related to its hydantoin ring.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> Imirestat (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), a fluorene analog of sorbinil, also showed appreciable in vivo activity but was discontinued because of its toxicity.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Tolrestat (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), a carboxylic acid derivative that was launched on the market in 1989, was withdrawn worldwide in 1996 because of its severe liver toxicity versus poor in vivo efficacy.<a onclick="showRef(event, 'ref6 ref27'); return false;" href="javascript:void(0);" class="ref ref6 ref27">(6, 27)</a> Zopolrestat<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and zenarestat (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) were also withdrawn from clinical trials because of liver and/or renal toxicity. On the other hand, fidarestat (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) exhibited higher efficacy and selectivity than its parent sorbinil and it was shown to provide beneficial clinical effects in the treatment of diabetic neuropathy, with no significant adverse effects. Therefore, currently fidarestat is one of the most promising drug candidates among ARIs.<a onclick="showRef(event, 'ref10 ref18 ref29'); return false;" href="javascript:void(0);" class="ref ref10 ref18 ref29">(10, 18, 29)</a> Analogous spirosuccinimides minalrestat and ranirestat as well as carboxylic acid ponalrestat (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) also showed appreciable activity and safety profiles in clinical trials.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30-32)</a> However, ponalrestat showed limited efficacy in improving diabetic neuropathy, whereas clinical trials conducted for ranirestat provided encouraging results in the treatment of this serious DM complication.<a onclick="showRef(event, 'ref18 ref31'); return false;" href="javascript:void(0);" class="ref ref18 ref31">(18, 31)</a></div><div class="NLM_p">Therefore, despite the difficulties in developing effective ARIs, the inhibition of AR has continued to be considered an attractive route to prevent or manage diabetic complications.</div><div class="NLM_p">Moreover, in recent years, important advances in understanding the physiological and pathological roles of AR have prompted a renewed interest in designing and evaluating ARIs. In particular, it was demonstrated that this enzyme is overexpressed under various oxidative conditions and is involved in inflammatory signaling under both hyperglycemic and normoglycemic conditions. Accordingly, known ARIs, such as sorbinil, tolrestat, zopolrestat, fidarestat, were shown to prevent cellular inflammatory events.<a onclick="showRef(event, 'ref33 ref34 ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35 ref36 ref37">(33-37)</a> These findings suggested that AR inhibition could be a useful strategy not only in the management of DM and its chronic complications but also in the treatment of other serious human diseases that are associated with increased tissue inflammation, such as rheumatoid arthritis, sepsis, atherosclerosis, and cancer.</div><div class="NLM_p">Thus, today AR can be considered an emerging target for therapeutic interventions in different pathologies, and consequently the development of effective ARIs with improved therapeutic potential is demanded.</div><div class="NLM_p last">Several reviews described these recent advances from a biochemical/biological standpoint.<a onclick="showRef(event, 'ref7 ref38 ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref7 ref38 ref39 ref40 ref41">(7, 38-41)</a> In this review, we will focus on the main challenges that medicinal chemists must tackle to identify new, safer, and more efficacious ARIs as drug candidates and will highlight advances in the design and optimization of these agents in the past decade. In this context, the selectivity toward AR over other highly homologous AKRs as well as the differential inhibition of AR depending on the nature of the substrate may be considered as major requirements. Main aspects of the current knowledge about the involvement of AR in pathogenic events that underlie the onset of human diseases are also reported.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Implications of Aldose Reductase in the Development of Diabetes Complications</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41135" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41135" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">DM is a chronic disease characterized by impaired response of target tissues to insulin (insulin resistance) and/or progressively reduced function of pancreatic β-cells, with consequent hyperglycemia and metabolic dysfunctions. This serious pathology currently affects almost 400 million people worldwide, and especially as a consequence of the soaring rates of type 2 DM and obesity in both developed and developing countries, its prevalence is predicted to rise to about 10% of total world population by 2030.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><div class="NLM_p">In DM, both prolonged hyperglycemia and insulin resistance can induce blood vessel and nerve damage as well as cell signaling alterations, finally resulting in the onset of long-term complications, such as retinopathy, cataracts, neuropathy, nephropathy, accelerated atherosclerosis, and increased risk of cardiovascular diseases, which are the main causes of morbidity and mortality in diabetic patients. Normalizing glycemia by means of prompt intensive antihyperglycemic treatments can delay the development of long-term diabetic complications that are caused by microvascular damage, without reducing the increased cardiovascular risk derived from macrovascular injury.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> Consequently, the emergence of these debilitating pathologies appears to be unavoidable in the majority of diabetic patients.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> This makes the identification of new drugs for the treatment of diabetic complications a still urgent therapeutic need.</div><div class="NLM_p">Hyperglycemia-induced tissue injury was shown to be mediated by several intracellular mechanisms. Out of them, the increased flux of glucose through the polyol pathway plays a pivotal role. AR is the first and rate-limiting enzyme of this metabolic pathway in which it catalyzes the NADPH-dependent reduction of glucose to sorbitol. This latter is subsequently oxidized to fructose by sorbitol dehydrogenase (SD), with concomitant reduction of NAD<sup>+</sup> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Role of AR in the development of diabetic complications. Abbreviations are defined as follows: AGE, advanced glycation end product; AR, aldose reductase; DAG, diacylglycerol; DHAP, dihydroxyacetone phosphate; DHN, 1,4-dihydroxynonene; GS-DHN, glutathione-1,4-dihydroxynonene; GSH, glutathione; GS-HNE, glutathione-4-hydroxy-<i>trans</i>-2-nonenal; HNE, 4-hydroxy-<i>trans</i>-2-nonenal; iNOS, inducible nitric oxide synthase; NF-κB, nuclear factor κB; PKC, protein kinase C; PLC, phospholipase C; ROS, radical oxygen species; SD, sorbitol dehydrogenase; TNF-α, tumor necrosis factor α.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Under euglycemic conditions, the reduction of glucose is a minor function of AR which regards less than 3% of the metabolized amount of this aldose because AR has a relatively low affinity toward this substrate. Instead, glucose mainly enters the glycolytic pathway, following its conversion to glucose 6-phosphate by hexokinase. Indeed, AR can catalyze the NADPH-dependent reduction of a wide variety of aromatic and aliphatic carbonyl substrates, and its catalytic effectiveness is markedly higher toward several hydrophobic saturated and unsaturated aldehydes than toward aldoses, particularly glucose.<a onclick="showRef(event, 'ref3 ref8'); return false;" href="javascript:void(0);" class="ref ref3 ref8">(3, 8)</a> On this basis, the main physiological role of AR appears to be the reduction of several toxic medium or long-chain aldehydes originated during lipid peroxidation, such as HNE and their glutathione adducts.<a onclick="showRef(event, 'ref8 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref8 ref45 ref46">(8, 45, 46)</a> Modulation of cell osmolarity, through the production of osmotically active compounds, such as sorbitol in the kidneys, was proposed as another function of AR.<a onclick="showRef(event, 'ref3 ref7'); return false;" href="javascript:void(0);" class="ref ref3 ref7">(3, 7)</a> In addition, the recently emerged involvement of AR in cell growth and signaling reveals other physiological roles of the enzyme.<a onclick="showRef(event, 'ref7 ref8 ref33 ref35'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref33 ref35">(7, 8, 33, 35)</a></div><div class="NLM_p">In contrast, under hyperglycemic conditions, AR converts the excess of intracellular glucose (which can vary up to one-third of total glucose amount depending on organ and tissue) to sorbitol, after hexokinase saturation, in tissues possessing insulin-independent glucose uptake, such as lens, retina, peripheral nerves, kidney, and erythrocytes.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">The significantly increased flux of glucose through the polyol pathway originates a complex cascade of multiple downstream events that can culminate in tissue and vascular damage, reduced nerve blood flow, and decreased nerve conduction velocity, thus critically contributing to the etiology of chronic complications associated with DM (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref1 ref2 ref3 ref8 ref15 ref21'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref8 ref15 ref21">(1-3, 8, 15, 21)</a></div><div class="NLM_p">In particular, in the lens, intracellular accumulation of the osmotically active sorbitol gives rise to osmotic stress, swelling, and membrane permeability changes, thus promoting cataractogenesis (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). However, in other sites, such as in blood vessels, nerves, and retina, intracellular sorbitol concentration generally appears to be too low to cause a serious osmotic imbalance.<a onclick="showRef(event, 'ref1 ref16'); return false;" href="javascript:void(0);" class="ref ref1 ref16">(1, 16)</a></div><div class="NLM_p">Indeed, in most tissues, hyperglycemia-induced damage is prevalently mediated by substantially increased cellular susceptibility to oxidative stress. In fact, NADPH depletion, due to the activation of the polyol pathway in hyperglycemic conditions, impairs the activity of other NADPH-dependent enzymes, particularly glutathione reductase, and gives rise to an imbalance between the generation of intracellular reactive oxygen species (ROS) and cellular antioxidant defense (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref8 ref47'); return false;" href="javascript:void(0);" class="ref ref8 ref47">(8, 47)</a> Concomitantly, the altered NADH/NAD<sup>+</sup> ratio, described as “pseudohypoxia”, which results from the NAD<sup>+</sup> consumption during the oxidation of sorbitol to fructose by SD, brings about further metabolic and signaling changes by exacerbating redox imbalance (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p">The increased catabolism of glucose through the polyol pathway also produces glycative stress by promoting the intracellular formation of advanced glycation end products (AGEs) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The end product of the polyol pathway, fructose, is more reactive as glycating agent than glucose and is capable of reacting with amino groups of proteins to form Schiff bases that, in turn, undergo rearrangement and oxidative reactions to give AGEs.<a onclick="showRef(event, 'ref21 ref50'); return false;" href="javascript:void(0);" class="ref ref21 ref50">(21, 50)</a> These latter can cause alterations of the functions of proteins as well as impair cellular signaling and, at the same time, contribute to the intracellular production of ROS.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Fructose may also be converted to reactive carbonyl compounds, such as dihydroxyacetone phosphate (DHAP), glyceraldehyde 3-phosphate, and methylglyoxal, which further contribute to the formation of AGEs.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p">In addition, DHAP can be reduced to glycerol 3-phosphate which is a precursor of diacylglycerol (DAG). DAG, in turn, activates protein kinase C (PKC) which also promotes the intracellular ROS production (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref35 ref51'); return false;" href="javascript:void(0);" class="ref ref35 ref51">(35, 51)</a></div><div class="NLM_p">Under hyperglycemic conditions, ROS-induced lipid peroxidation with formation of cytotoxic aldehydes, such as HNE, is one of the most important consequences of increased oxidative stress. HNE can cause AR up-regulation, thus originating a positive feedback that amplifies hyperglycemia-induced oxidative stress.<a onclick="showRef(event, 'ref8 ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref8 ref52 ref53 ref54">(8, 52-54)</a> Moreover, HNE can propagate oxidative signaling by acting as a cytotoxic second messenger. In fact, it is a particularly reactive aldehyde, which at high concentrations is able to react with various cellular nucleophiles, such as amino acid residues of proteins, producing cellular damage. HNE-modified proteins were found to be present in several pathological conditions, such as atherosclerosis and neurodegenerative and autoimmune diseases, and they were also used as oxidative stress markers.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><div class="NLM_p">HNE and its glutathione adduct GS-HNE are converted by AR to 1,4-dihydroxynonene (DHN) and GS-DHN, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). However, in the presence of intracellular glutathione, GS-HNE is the predominant metabolite derived from HNE which prevails over DHN, likely due to the high reactivity of the aldehyde with glutathione. GS-HNE, in turn, is the only parent molecule that can be converted to GS-DHN, since free DHN is unable to react with nucleophiles such as glutathione. Therefore, AR-catalyzed reduction of GS-HNE is the major pathway that generates GS-DHN and, accordingly, inhibition of AR was shown to reduce cellular levels of GS-DHN.<a onclick="showRef(event, 'ref45 ref54'); return false;" href="javascript:void(0);" class="ref ref45 ref54">(45, 54)</a></div><div class="NLM_p">On the basis of recent studies, GS-DHN was recognized as a potent mediator of oxidative stress-induced cellular signaling pathways via activation of phospholipase C (PLC)/DAG/PKC/nuclear transcription factor κB (NF-κB) pathway (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref8 ref39'); return false;" href="javascript:void(0);" class="ref ref8 ref39">(8, 39)</a> It was demonstrated that the hyperglycemia-induced activation of the polyol pathway can control the activation of PLC/DAG/PKC/NF-κB cascade and, in fact, upstream AR inhibition can extinguish these signaling events.<a onclick="showRef(event, 'ref8 ref33 ref34 ref38 ref47 ref51'); return false;" href="javascript:void(0);" class="ref ref8 ref33 ref34 ref38 ref47 ref51">(8, 33, 34, 38, 47, 51)</a></div><div class="NLM_p">The activation of NF-κB is a key step in the inflammatory response, since it regulates the transcription of numerous genes involved in inflammation, apoptosis, cell growth, and adhesion, thus determining the expression of proinflammatory cytokines, growth factors, adhesion molecules, tumor necrosis factor α (TNF-α), and inducible NO synthase (iNOS) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref47 ref55'); return false;" href="javascript:void(0);" class="ref ref47 ref55">(47, 55)</a></div><div class="NLM_p">Inflammation and oxidative stress can promote endothelial cell apoptosis, vascular hyperplasia, infiltration, and adhesion of inflammatory cells to vascular walls, which are events involved in the formation of atherosclerotic lesions as well as in diabetic nephropathy and myocardial ischemia reperfusion injury.<a onclick="showRef(event, 'ref15 ref34 ref38 ref40 ref43 ref52 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref15 ref34 ref38 ref40 ref43 ref52 ref56 ref57">(15, 34, 38, 40, 43, 52, 56, 57)</a></div><div class="NLM_p">Furthermore, cellular production of interleukin 6 (IL-6), IL-1β, and TNF-α consequent to NF-κB activation can mediate inflammatory mechanisms leading to pancreatic β-cell apoptosis and decreased insulin secretion. Inflammatory cytokines also induce iNOS expression which results in impaired insulin signaling in target tissues.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><div class="NLM_p">Accordingly, in mice, inflammation and insulin resistance were shown to be associated with the upstream production of HNE and its metabolites GS-HNE and GS-DHN induced in adipocytes by high glucose and oxidative stress.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div><div class="NLM_p">Recently, a novel AR-mediated mechanism that supports inflammatory signaling pathways was demonstrated in diabetic mice. In fact, the increased flux of glucose through the polyol pathway also decreases NAD<sup>+</sup>/NADH ratio, thus impairing the activity of sirtuins and other NAD<sup>+</sup>-dependent deacetylases. This, in turn, prevents the sirtuin-1-dependent deacetylation of Egr-1 (“immediate early response gene”) and maintains this latter in its acetylated form that triggers prothrombotic and proinflammatory events and subsequent endothelial dysfunction, vascular injury, and atherosclerosis.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div><div class="NLM_p">On the basis of all these findings, hyperglycemia-induced oxidative stress and inflammation can be recognized as unifying pathogenetic mechanisms involved in the development of both insulin resistance/deficiency and long-term complications of DM.<a onclick="showRef(event, 'ref8 ref47 ref58 ref61'); return false;" href="javascript:void(0);" class="ref ref8 ref47 ref58 ref61">(8, 47, 58, 61)</a> Therefore, AR implication in oxidative and inflammatory signaling further validates this enzyme as a crucial target in the development of new agents for the therapy of DM-associated pathologies and stimulates the search for new and safer ARIs. In view of this, as suggested by several authors, new and old ARIs could be evaluated with redesigned screening procedures that allow the assessment of their effectiveness in interrupting inflammatory signaling and preventing consequent vascular damage in diabetic patients.</div><div class="NLM_p last">Finally, much evidence supports the hypothesis that AR gene polymorphisms may modulate the susceptibility to diabetic microvascular complications, although contrasting findings have also been reported. In certain populations of diabetic patients, the Z-2 allele of the AR gene promoter region was found to be associated with increased risk of diabetic nephropathy and retinopathy as well as with increased AR expression, whereas the <i>Z</i> + 2 allele appeared to determine reduced susceptibility to diabetic complications. The C-106T polymorphism of the AR gene was also found to be involved in the development of nephropathy and neuropathy in certain diabetic patients.<a onclick="showRef(event, 'ref62 ref63 ref64 ref65 ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref62 ref63 ref64 ref65 ref66 ref67">(62-67)</a></div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Aldose Reductase as an Emerging Therapeutic Target for Inflammatory Pathologies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01360" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01360" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Recent studies in both cell cultures and animal models demonstrated a critical implication of AR in inflammatory signaling pathways, not only in DM but also under normoglycemic conditions.<a onclick="showRef(event, 'ref53 ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref53 ref68 ref69">(53, 68, 69)</a></div><div class="NLM_p">Besides hyperglycemia, several other factors, such as lipopolysaccharides, proinflammatory cytokines, growth factors, and allergens, can stimulate intracellular ROS production.<a onclick="showRef(event, 'ref39 ref53 ref70'); return false;" href="javascript:void(0);" class="ref ref39 ref53 ref70">(39, 53, 70)</a> In many inflammatory cell types, such as phagocytes, monocytes, and macrophages, these factors can activate NADPH oxidase, which catalyzes the formation of superoxide anions from the reduction of oxygen, using NADPH as electron donor. Superoxide anions further generate ROS, thus substaining cellular oxidative stress.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div><div class="NLM_p">As mentioned above, ROS, in turn, can induce both lipid peroxidation and AR expression. Therefore, in the presence of oxidative stress, even under normoglycemic conditions, AR-catalyzed reduction of glutathione adducts of lipid-derived aldehydes, such as GS-HNE, is a key upstream event which is able to propagate the oxidative/inflammatory signaling through the activation of the PLC/PKC/NF-κB cascade (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The subsequent transcription of numerous proinflammatory genes regulated by NF-κB amplifies and sustains inflammation and cytotoxicity. In fact, the treatment of lipopolysaccharide-stimulated macrophages with different known ARIs (sorbinil, tolrestat, zopolrestat) prevented both the activation of NF-κB and the production of proinflammatory cytokines and inflammatory molecules, such as NO, prostaglandin E<sub>2</sub> (PGE<sub>2</sub>), and cyclooxygenase 2 (COX-2).<a onclick="showRef(event, 'ref35 ref53'); return false;" href="javascript:void(0);" class="ref ref35 ref53">(35, 53)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Implication of AR in inflammatory signaling under normoglycemic conditions. Abbreviations are defined as follows: AR, aldose reductase; COX-2, cyclooxygenase 2; DAG, diacylglycerol; GS-DHN, glutathione-1,4-dihydroxynonene; GS-HNE, glutathione-4-hydroxy-<i>trans</i>-2-nonenal; HNE, 4-hydroxy-<i>trans</i>-2-nonenal; iNOS, inducible nitric oxide synthase; NF-κB, nuclear factor κB; PGE<sub>2</sub>, prostaglandin E<sub>2</sub>; PKC, protein kinase C; PLC, phospholipase C; ROS, radical oxygen species; TNF-α, tumor necrosis factor α.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the whole, AR gives a substantial contribution to the pathogenic course of several inflammatory pathologies, such as rheumatoid arthritis, sepsis, asthma, cardiovascular diseases, and cancer, besides DM and its complications.</div><div class="NLM_p">In animal models of systemic inflammation induced by bacterial endotoxins, the treatment with sorbinil, fidarestat, tolrestat, or zopolrestat prevented ROS generation and attenuated both NF-κB activation and release of proinflammatory cytokines, chemokines, PGE<sub>2</sub>, and NO, thus indicating that ARIs could be considered as potential drugs to treat endotoxin-related inflammatory diseases, such as sepsis, asthma, and uveitis.<a onclick="showRef(event, 'ref33 ref34 ref36 ref37 ref41 ref53'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref36 ref37 ref41 ref53">(33, 34, 36, 37, 41, 53)</a></div><div class="NLM_p">Recently, several new ARIs (compounds <b>1</b>–<b>4</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) were also shown to possess promising properties as potential agents for treating inflammatory diseases (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).<a onclick="showRef(event, 'ref71 ref72 ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref71 ref72 ref73 ref74">(71-74)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of ARIs recently reported as potential anti-inflammatory agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition, growing evidence supports the involvement of AR-mediated oxidative and inflammatory signaling pathways in the pathophysiology of cardiovascular diseases, such as atherosclerosis, vasculopathy, hypertension, endothelial dysfunction, and myocardial ischemia, in normoglycemic individuals. In endothelial cells, the inhibition of AR was shown both to reduce NF-κB activation and to attenuate TNF-α-induced up-regulation of adhesion molecules.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Moreover, ARIs significantly reduced cardiac ischemic injury in human AR-expressing transgenic mice by attenuating oxidative stress and apoptosis.<a onclick="showRef(event, 'ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref75 ref76">(75, 76)</a> All these data support the hypothesis that targeting AR may be a new effective approach to the treatment or prevention of vascular and myocardial dysfunctions in both diabetic and nondiabetic patients and have prompted preclinical and clinical evaluation of ARIs in this area.<a onclick="showRef(event, 'ref38 ref40'); return false;" href="javascript:void(0);" class="ref ref38 ref40">(38, 40)</a></div><div class="NLM_p">Furthermore, recent studies demonstrated that AR is overexpressed and up-regulated in a broad variety of solid tumors and leukemias.<a onclick="showRef(event, 'ref68 ref77'); return false;" href="javascript:void(0);" class="ref ref68 ref77">(68, 77)</a> AR was found to be an essential component of carcinogenic inflammatory signaling pathways and, in addition, to be implicated in the development of drug resistance in different cancer cells.<a onclick="showRef(event, 'ref21 ref68 ref78'); return false;" href="javascript:void(0);" class="ref ref21 ref68 ref78">(21, 68, 78)</a> The central AR-catalyzed event in oxidative stress-mediated carcinogenesis once again appears to be the reduction of GS-HNE to GS-DHN which promotes the propagation of cytotoxic signaling. The subsequent activation of NF-κB was shown to be involved in cancer cell survival, proliferation, adhesion, invasion, and angiogenesis.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div><div class="NLM_p">Increased oxidative stress and NF-κB activation are also predominant aspects in cancer cachexia.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> AR inhibition by ponalrestat was found to provide benefit by reducing cancer-induced cachexia symptoms through the control of certain inflammatory pathways.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div><div class="NLM_p">In human colon tumor cells, AR inhibition by means of sorbinil or tolrestat prevented the activation of NF-κB and PKC as well as the overexpression of COX-2 and the consequent PGE<sub>2</sub> production induced by TNF-α, HNE, and GS-HNE but did not counteract the cytotoxic effects of already formed GS-DHN.<a onclick="showRef(event, 'ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref81 ref82">(81, 82)</a></div><div class="NLM_p">ARIs also induced tumor cell apoptosis by up-regulating death receptors and proapoptotic proteins and down-regulating cell survival proteins.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Moreover, they were shown to prevent growth and invasiveness of tumors by suppressing the production of growth factors, matrix metalloproteinases, and adhesion molecules which promote angiogenesis.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></div><div class="NLM_p last">All these findings strongly suggest that AR could be a promising novel target for chemotherapeutic and chemopreventive agents capable to treat cancer as well as to improve the effectiveness of certain antitumor drugs. However, since the available data on ARI efficacy regard mainly colon cancer, additional investigations on different tumor types would be desirable to further validate ARIs as potential chemotherapeutic agents.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div></div><div id="sec1_3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Structure of Aldose Reductase</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62235" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62235" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The first AR structures to be solved by means of X-ray crystallography, in 1992, were those of the recombinant human placenta and pig lens enzymes.<a onclick="showRef(event, 'ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref85 ref86">(85, 86)</a> Afterward, X-ray crystallographic studies solved several other structures of AR cocrystallized with various substrates and inhibitors, thus giving important insights into the binding sites and interaction modes of substrates and inhibitors.<a onclick="showRef(event, 'ref4 ref5 ref19 ref87 ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref19 ref87 ref88 ref89">(4, 5, 19, 87-89)</a></div><div class="NLM_p">The human enzyme consists of a single peptide chain of 316 amino acid residues that folds as an eight-stranded β/α-barrel with a small β-sheet capping at the N-terminal of the barrel and a C-terminal extension comprising residues 275–315 (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). The substrate-binding site is located in a large and deep cleft at the C-terminal of the barrel, with the pyridine cofactor NADP<sup>+</sup> bound at the bottom, and it is delimited by loops connecting the central β-strands with the external α-helices.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structure of human AR complexed with zopolrestat (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MAR">1MAR</a>)<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> with a schematic representation of the AR active site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The cofactor is held within the cleft by a flexible loop (residues Gly213-Ser226) named “safety-belt” loop.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Conformational motions of the safety-belt are responsible for the binding or release of the cofactor. A “closed” conformation of the safety-belt, with the cofactor partially covered by the loop and thus locked into the pocket, is present in most holoenzyme structures. A partially opened conformation of this loop was also observed only in a small number of AR holoenzyme molecules.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Instead, in the absence of NADP<sup>+</sup>, the safety-belt loop of the apoenzyme assumes a significantly different “open” conformation.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Gly213, Ser214, and Ser226 act as hinges allowing the loop to interconvert its conformation. Another amino acid residue of the loop, Trp219, plays a key role by establishing interactions with Cys298 and Arg293 that stabilize the “closed” and “open“ conformations, respectively.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> In addition, in the closed conformation of the safety-belt loop, Trp219 can engage effective interactions with ligands.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></div><div class="NLM_p">The conformational changes that accompany the binding and release of NADP(H) are strictly associated with the catalytic mechanism of AR. The binding of the substrate to the enzyme is subsequent to the binding of NADPH, and at the end of the reaction, the reduced product is released from the enzyme before the oxidized cofactor. Therefore, the motion from the “closed” to the “open” conformation of the safety-belt loop represents the rate-limiting step of the AR-catalyzed reduction of carbonyl substrates.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">The AR active site is delimitated by prevalently hydrophobic amino acid residues, with the exception of few hydrophilic residues, consequently favoring the binding of lipophilic ligands over monosaccharides. In particular, in the active site cleft, certain polar amino acid residues, i.e., Asp43, Tyr48, Lys77, His110, Ser159, Asn160, Gln183, and Tyr209, form a rigid subsite in which a network of hydrogen bonds keeps the nicotinamide ring of the cofactor tightly bound and positioned for the transfer of the 4-<i>pro</i>-R hydride from NADPH to the carbon atom of the carbonyl group of the substrate during the catalytic reaction.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Among these residues, Tyr48 serves as proton donor to the carbonyl oxygen atom of the substrate during the second step of the reduction, whereas His110 maintains the proper orientation of the substrate in the active site. This subsite can serve as a polar recognition region able to anchor anionic and/or hydrogen bond acceptor groups of various substrates and inhibitors (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</div><div class="NLM_p">In the AR active site, a second contiguous region is detectable, which is situated above the coenzyme and consists of a pocket lined with hydrophobic amino acid residues, such as Trp20, Trp79, Trp111 (this latter residue demarcates an edge between the two main regions of the AR active site), Phe122, Pro218, Trp219, Cys298, and Leu300. This hydrophobic zone includes a “specificity” pocket, also named “induced cavity region”, which is localized among Trp111, Thr113, Phe122, Ala299, Leu300, Ser302, and Cys303 (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>)<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> and shows a high degree of flexibility in contrast with the rigid polar subsite around the cofactor. This pocket, in fact, can adopt different conformations depending on the size and nature of the ligand.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> It was also proposed that the enzyme may exist in different conformational states and each ligand binds the most suitable conformation by stabilizing it and thus changing the conformational distribution of the protein.<a onclick="showRef(event, 'ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref92 ref93">(92, 93)</a></div><div class="NLM_p">The binding of certain ARIs, such as tolrestat, zopolrestat, and minalrestat (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), to the enzyme induces a conformational change in two loops containing Phe122 and Leu300, respectively. As a consequence, the specificity pocket, which is closed in the apoenzyme crystal structure, becomes accessible to inhibitors, and thus, aromatic portions present in these ARIs, such as naphthalene, benzothiazole or 4-bromo-2-fluorophenyl moieties, can fit efficaciously this cavity (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).<a onclick="showRef(event, 'ref87 ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref87 ref88 ref89">(87-89)</a> Leu300 appears to act crucially as a gate-keeper which controls the access to the specificity pocket and can also affect the position of proximal residues, such as Phe122, Trp219, and Cys303.<a onclick="showRef(event, 'ref92 ref94'); return false;" href="javascript:void(0);" class="ref ref92 ref94">(92, 94)</a></div><div class="NLM_p">On the contrary, sorbinil (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which possesses a compact structure lacking of a suitable hydrophobic portion, is not able to open the specificity pocket and, in fact, binds to an AR conformation with the specificity pocket in the closed state.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></div><div class="NLM_p">Therefore, induced-fit adaptation is not necessary for the binding to AR, but it can remarkably influence the effects of ligand-enzyme interaction. Indeed, among the members of the AKR superfamily, the amino acid residues present in the AR specificity pocket are less conserved than the hydrophilic residues of the active site, such as Tyr48 and His110, thus providing a structural basis for selective inhibition of AR. However, given the pronounced induced-fit adaptations and the number of possible binding-competent conformations that have been observed, even in AR crystals under varying cocrystallization conditions, AR remains a challenging target for structure-based drug design.<a onclick="showRef(event, 'ref92 ref95'); return false;" href="javascript:void(0);" class="ref ref92 ref95">(92, 95)</a></div><div class="NLM_p">The high flexibility of the binding site of AR may explain the wide variety of small molecule ligands (both substrates and inhibitors) that it can accommodate, though being able to discriminate among similar ligands.<a onclick="showRef(event, 'ref87 ref92'); return false;" href="javascript:void(0);" class="ref ref87 ref92">(87, 92)</a> In fact, AR can recognize different substrates with either hydrophilic (such as glyceraldheyde and aldoses) or hydrophobic (such as HNE) structures, although it greatly prefers the latter, and it can accommodate inhibitors with different size and shape.</div><div class="NLM_p">In addition, AR reduces glutathione conjugates of aldehydes, such as GS-HNE, more efficiently than the corresponding free aldehydes. The enhanced catalytic efficiency of the enzyme toward glutathiolated substrates is mainly due to a selective recognition of the glutathione backbone within the AR binding site which shows a flexible glutathione-binding domain distinct from the aldehyde-binding region and largely coincident with the specificity pocket.<a onclick="showRef(event, 'ref96 ref97'); return false;" href="javascript:void(0);" class="ref ref96 ref97">(96, 97)</a> In particular, the N-terminal glutamate and C-terminal glycine of glutathione may provide specific interactions particularly with Trp20, Leu301, and Ser302. Accordingly, substitutions at these positions in both glutathione-conjugated substrates and enzyme reduced the catalytic efficiency of AR.<a onclick="showRef(event, 'ref96 ref97 ref98'); return false;" href="javascript:void(0);" class="ref ref96 ref97 ref98">(96-98)</a></div><div class="NLM_p">A further feature that can influence AR activity is its high sensitivity to oxidants, which can inactivate the enzyme by modifying the reactive residue Cys298 present in the active site.<a onclick="showRef(event, 'ref8 ref99'); return false;" href="javascript:void(0);" class="ref ref8 ref99">(8, 99)</a> In fact, in oxidative conditions, cellular glutathione is oxidized to glutathione disulfide, which may readily react with the thiol group of Cys298 to give a mixed disulfide that exhibits altered kinetic parameters with respect to the native enzyme, showing lower affinity toward substrates.<a onclick="showRef(event, 'ref7 ref100 ref101 ref102'); return false;" href="javascript:void(0);" class="ref ref7 ref100 ref101 ref102">(7, 100-102)</a> It was proposed that the thiol/disulfide exchange may be a regulatory process that modulates AR activity providing a reversible modification capable of protecting the enzyme from irreversible damage caused by oxidative conditions.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> It might also serve to prevent the consumption of the reducing cofactor NADPH in conditions of oxidative stress.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a></div><div class="NLM_p last">S-thiolated forms of the enzyme also show altered sensitivity to inhibitors. Modified forms of AR, which are less sensitive to ARIs, were found in patients with hyperglycemia, likely due to the oxidative stress condition associated with DM. This aspect appears to be particularly significant in view of the therapeutic use of ARIs, since it might explain, at least in part, the limited efficacy shown by certain inhibitors in long-term treatments of diabetic individuals,<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> and it should be taken into account in developing ARIs as drugs.</div></div><div id="sec1_4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Challenges and Recent Advances in Developing Aldose Reductase Inhibitors as Drug Candidates</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38322" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38322" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The great number of ARIs discovered in the past 40 years show a wide variety of different chemical structures that, however, share certain molecular features. In fact, most ARIs bear an acidic group, which is capable of effectively anchoring the inhibitor to the polar positively charged recognition region of the AR catalytic site through ionic and/or hydrogen bonds. In addition, one or more aromatic moieties may contribute to ligand/enzyme binding by efficiently fitting the lipophilic region of the AR active site including the specificity pocket. These latter interactions may significantly affect the stability of inhibitor/enzyme complex as well as determine a proper orientation of the ligand into the cavity of the enzyme, which is prevalently lined by lipophilic amino acid residues. Moreover, hydrophobic moieties of ARIs involved in effective interactions with nonconserved amino acid residues in the specificity pocket can function as important selectivity determinants.</div><div class="NLM_p">Most known ARIs belong to the chemical classes of (i) cyclic imides, mostly spirohydantoins (such as sorbinil and fidarestat, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) or spirosuccinimides (such as minalrestat and ranirestat, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), and (ii) carboxylic acids (such as epalrestat, tolrestat, zopolrestat, ponalrestat, and zenarestat, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Besides them, numerous structurally diverse ARIs were reported, including phenolic compounds (flavonoids, chalcones, curcumin, and other related natural and synthetic compounds), benfotiamine, sulfonylpyridazinone, and 4-thiazolidinone derivatives.<a onclick="showRef(event, 'ref2 ref4 ref5 ref19 ref20 ref21 ref22 ref39 ref103 ref104'); return false;" href="javascript:void(0);" class="ref ref2 ref4 ref5 ref19 ref20 ref21 ref22 ref39 ref103 ref104">(2, 4, 5, 19-22, 39, 103, 104)</a></div><div class="NLM_p">Cyclic imides were shown to be effective ARIs both in vitro and in vivo. In an attempt to avoid the phenytoin-like hypersensitivity reactions provoked by some of them, such as sorbinil, and attributed to the hydantoin moiety, safer bioisosters were designed and tested as ARIs, such as succinimides, 2,4-thiazolidinediones, and 2-thioxo-4-thiazolidinones, which include several efficacious ARIs with clinically suitable profiles.<a onclick="showRef(event, 'ref4 ref5 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref19 ref20 ref21 ref22">(4, 5, 19-22)</a></div><div class="NLM_p">Carboxylic acid derivatives emerged as potent ARIs, often remarkably more active than imides, because they are prevalently ionized at physiological pH values and therefore capable of establishing strong interactions with the positively charged recognition region of the AR active site. Although these features are favorable in order to enhance affinity for the target and inhibitory potency, in vivo they may determine a limited capability to cross biomembranes and consequently poor tissue penetration. However, certain carboxylic acid derivatives display favorable pharmacological properties, depending on the overall physicochemical features of molecules, and several of them, including epalrestat, proved to be effective in cell cultures or in vivo.<a onclick="showRef(event, 'ref14 ref22 ref23 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref14 ref22 ref23 ref27 ref28">(14, 22, 23, 27, 28)</a></div><div class="NLM_p">Capability of penetrating well into key target tissues, such as peripheral nerves, is a crucial property required for ARIs, and thus, although the reasons of the disappointing results of certain clinical trials are still debated, cellular permeability remains a major goal in the development of ARIs as drugs.</div><div class="NLM_p">Limiting unwanted effects is another unavoidable aim in the design of new ARIs and their optimization, especially considering that the prevention and management of diabetic complications require effective and safe drugs that have to be used in long-term therapies. In this view, the capability of discriminating between AR and other related AKRs is a desirable feature of ARIs as drug candidates.</div><div class="NLM_p">A novel approach in the search for ARIs is the design of molecules that are able to differentially block the activity of the enzyme toward glucose and glutathione-conjugated aldehydes without affecting the capability of AR to reduce free toxic aldehydes so that the cytotoxic role of AR in inflammatory signaling as well as in glucose metabolism can be prevented while its detoxifying function remains unaltered.</div><div id="sec1_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> (a) Design of Selective Aldose Reductase Inhibitors</h3><div class="NLM_p">The scarcely selective inhibition of different AKRs related to AR, in particular aldehyde reductase (ALR1, AKR1A1), might be responsible for unwanted effects or inadequate therapeutic indexes observed during clinical investigation of several ARIs. ALR1 catalyzes the reduction of highly reactive toxic 2-oxoaldeydes, such as 3-deoxyglucosone and methylglyoxal, which participate in AGE formation and protein cross-linking. These aldehydes are formed in high amounts under hyperglycemic conditions and contribute to the tissue and vascular damage induced by prolonged exposure to high glucose concentrations.<a onclick="showRef(event, 'ref105 ref106'); return false;" href="javascript:void(0);" class="ref ref105 ref106">(105, 106)</a> Therefore, the simultaneous inhibition of both AR and ALR1 may reduce the benefits provided by ARIs, by preventing the detoxifying function of ALR1.</div><div class="NLM_p">The significant similarity of sequence (more than 85% sequence homology) and overall architecture at the active sites of AR and ALR1 may be a challenge in identifying selective ARIs. However, the two enzymes show crucial differences in the substrate-binding site which can be exploited for designing selective inhibitors. In particular, Thr113, Ala299, and Leu300, which are present in the C-terminal loop flanking the AR specificity pocket, are replaced by Tyr116, Ile299, and Pro301, respectively, in ALR1, whereas Ser302 is replaced by an extra loop from Pro301 to Arg312. In addition, in the ALR1 active site, the nonconserved Arg312 and Asp313 appear to play critical roles in determining the binding to ligands.<a onclick="showRef(event, 'ref94 ref107 ref108'); return false;" href="javascript:void(0);" class="ref ref94 ref107 ref108">(94, 107, 108)</a></div><div class="NLM_p">Ligands able to open and occupy the specificity pocket of AR, such as tolrestat and zopolrestat, are generally unable to bind efficiently the corresponding amino acid residues of ALR1, thus inhibiting selectively AR. Accordingly, the absence of structural portions suitable to gain access to the specificity pocket can explain the nonselective action of some ARIs, such as sorbinil.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Diversely, the selective ARI fidarestat does not induce AR conformational changes but possesses an exocyclic amide group that can bind Leu300 and Trp219 of the target. In ALR1, Leu300 is replaced by a proline, which is unable to form H-bonds with the inhibitor. Thus, the amide chain of fidarestat appears to be the main feature of this compound which is responsible for the selective inhibition of AR over ALR1.<a onclick="showRef(event, 'ref109 ref110 ref111'); return false;" href="javascript:void(0);" class="ref ref109 ref110 ref111">(109-111)</a></div><div class="NLM_p">The high flexibility of the AR specificity pocket can be exploited in drug design to explore structural diversity, thus favoring the identification of novel chemotypes as potential selective ARIs, although the above-mentioned unpredictable conformational adaptation of AR induced by ligands may complicate the task of medicinal chemists.</div><div class="NLM_p">On this basis, in the past decade new potent and selective ARIs were identified by exploring molecules endowed with a hydrophobic moiety, generally a substituted heteroaromatic system, which is able to effectively interact with the AR specificity pocket by inducing a proper conformational adaptation of this region. In most cases, high affinity for the target was achieved by means of an acetic acid residue as hydrophilic head capable of anchoring the inhibitor to the polar recognition region of the AR active site.</div><div class="NLM_p">An interesting example of acetic acid based selective ARIs is a series of (2-arylcarbamoyl)phenoxyacetic acids and their carbamothioyl analogues which include the potent inhibitor (2-{[(4-bromo-2-fluorophenyl)methyl]carbamothioyl}-5-fluorophenoxy)acetic acid (<b>5</b>) (IDD594) (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> X-ray crystallographic analysis highlighted that compound <b>5</b> is firmly bound within the AR active site through the carboxylate head which forms tight hydrogen bonds with Tyr48, His110, and Trp111 and a strong electrostatic interaction with NADP<sup>+</sup>. The binding of <b>5</b> to the enzyme induces a conformational change that opens the specificity pocket. This allows the 4-bromo-2-fluorobenzyl portion to fit this cavity and effectively interact with Ala299, Leu300, and Thr113, by assuming an orientation which can be superimposed to the same moiety of minalrestat.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> The short contact between the bromine atom of <b>5</b> and the amino acid residue Thr113 of the enzyme appeared to be crucial in determining the high affinity of the inhibitor toward AR (more than 1000-fold higher than toward ALR1). In fact, Thr113 is replaced by a bulkier tyrosine in ALR1, thus causing steric hindrance and preventing interaction with the bromine atom.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> Interestingly, compound <b>5</b> was shown to be active in vivo, determining reduced sorbitol accumulation in diabetic rat nerve.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of selective ARIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Investigation of a different series of acetic acid derivatives led to the identification of a promising clinical candidate, 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-<i>N</i>-acetic acid (<b>6</b>) (lidorestat) (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), which was 5400-fold more active against AR than against ALR1.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> The presence of fluorine substituents in positions 4, 5, and 7 of the benzothiazole system proved to be optimal for an effective binding to the target enzyme.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Furthermore, the replacement of the indole nucleus with the pyrrolo[2,3-<i>b</i>]pyridine isoster provided a significant gain in AR selectivity up to more than 14 000-fold over ALR1 (compound <b>7</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Once again, X-ray crystallography revealed that lidorestat and its pyrrolopyridine analogue <b>7</b> are strongly anchored within the AR active site by means of electrostatic interactions and hydrogen bonds of the carboxylate head with the polar recognition region of the target. The opened specificity pocket can accommodate the benzothiazole moiety which interacts with Trp111 and Leu300.<a onclick="showRef(event, 'ref115 ref116'); return false;" href="javascript:void(0);" class="ref ref115 ref116">(115, 116)</a></div><div class="NLM_p">Lidorestat exhibited a favorable pharmacokinetic profile, with good capability of penetrating tissues in which diabetic complications occur, such as nerve and lens. In fact, in diabetic rats, it was able to normalize sorbitol and fructose levels in nerve, to prevent cataracts and to reduce plasma triglyceride levels. In clinical trials, lidorestat administration also led to normalization of nerve sorbitol levels.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></div><div class="NLM_p">Acetic acid derivatives of 3,4-dihydro-2<i>H</i>-1,2,4-benzothiadiazine 1,1-dioxide (<b>8</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) were also reported as potent ARIs endowed with in vivo activity.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Compound <b>8a</b> was one of the most potent and selective in vitro inhibitors among these ARIs and showed appreciable ability to reduce sorbitol levels in diabetic rat nerve after oral administration.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> SAR studies highlighted that the carboxylic group of the acetic chain is an important structural feature to determine AR inhibition. The substituted benzyl moiety played a central role in determining AR inhibitory effects, the 2,4,5-trifluorobenzyl ring being the most advantageous, while the insertion of a halogen in position 7 of the benzothiadiazine 1,1-dioxide scaffold was beneficial but not essential for activity. In a subsequent study, hydrophobic and bulky substituents (such as dialkylcarbamoyl moieties) in this position were found to be beneficial for both AR inhibitory activity and selectivity.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Similar SARs were observed in analogous (3,4-dihydro-2<i>H</i>-pyrido[2,3-<i>e</i>]-1,2,4-thiadiazine 1,1-dioxide)acetic acids (<b>9</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Docking studies indicated that the benzothiadiazine moiety of compound <b>8a</b> could fit the specificity pocket in the tolrestat-bound conformation of AR, positioning between Leu300 and Phe122, and it also appeared to control the orientation of the substituted benzyl ring in a near hydrophobic cavity delimited by Phe121, Phe122, Trp20, Val47, Tyr48.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a></div><div class="NLM_p">In contrast, 3,3-dioxide-1,2-dihydronaphtho[1,2-<i>d</i>]-isothiazol-1-one acetic acid derivatives <b>10</b> and <b>11</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>),<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> initially designed as rigid analogues of tolrestat, were shown to bind an AR conformer with the specificity pocket in the closed state, similar to the sorbinil-bound conformation. However, compound <b>10</b>, which acts as potent and selective ARI, was able to induce a displacement of Trp20 which determined the opening of a novel subpocket within the catalytic cavity of the enzyme. This subpocket can accommodate the naphthyl system, whereas the carboxylic group in position 4 of the scaffold points toward the polar region of the active site.<a onclick="showRef(event, 'ref121 ref122'); return false;" href="javascript:void(0);" class="ref ref121 ref122">(121, 122)</a> Subsequent molecular simplification, by removing the central benzene ring from the naphto[1,2-<i>d</i>]isothiazole system, led to ARIs with a five-membered heterocyclic core, such as (1,2,4-oxadiazol-5-yl)acetic acid analogues <b>12</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), most of which act as selective ARIs with IC<sub>50</sub> values ranging from 0.27 to 28.4 μM toward AR and IC<sub>50</sub> > 10 μM toward ALR1.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> The most effective inhibitor of the series (compound <b>12a</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) possesses a 4-methoxyphenyl ring in position 3 of the oxadiazole core which can fit the AR specificity pocket in the <b>5</b>-bound conformation, being trapped in the hydrophobic cavity formed by Trp79, Phe115, Phe122, and Leu300.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a></div><div class="NLM_p">Recently, the selective AR inhibitory effects of certain (5-arylidene-2,4-dioxothiazolidin-3-yl)acetic acids were rationalized by means of X-ray crystallographic and computational studies.<a onclick="showRef(event, 'ref124 ref125'); return false;" href="javascript:void(0);" class="ref ref124 ref125">(124, 125)</a> The carboxymethoxy group in position 3 of the benzylidene ring of compound <b>13</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) can tightly bind the polar recognition region of both AR and ALR1, mainly by means of hydrogen bonds, whereas the (2,4-dioxothiazolidin-3-yl)acetic acid portion can reach the AR specificity pocket by interacting with Leu300 and Trp219. A more selective analogue (<b>14</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) assumed a 180° flipped orientation, thus interacting with the backbone nitrogen atom of Leu300 through the 3-hydroxy group of the benzylidene portion, whereas the carboxylic group of the acetic chain on N-3 was bound to the polar recognition region. In ALR1 the amino acid residue Pro301 (Leu300 in AR) was incapable of producing efficacious interactions with the inhibitors; thus, the hydrogen bond contact with Leu300 appeared to be of particular importance for the selectivity of these ARIs. In addition, π-stacking interactions with Trp219 of AR contributed to affinity for the target, whereas the corresponding Trp220 of ALR1 adopted a different rotamer conformation which was less favorable for interaction with these inhibitors.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a></div><div class="NLM_p">Compounds <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) and <b>15</b>–<b>19</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) are other examples of recently reported selective ARIs.<a onclick="showRef(event, 'ref126 ref127 ref128 ref129 ref130'); return false;" href="javascript:void(0);" class="ref ref126 ref127 ref128 ref129 ref130">(126-130)</a> (1-Thioxo-1,2,3,4-tetrahydro-β-carbolin-9-yl)acetic acid <b>18</b><a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> as well as β-glucogallin (<b>3</b>) and analogous amide <b>19</b><a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> showed selectivity toward AR over both related ALR1 and AKR1B10. It was proposed that the benzyl group of <b>18</b> can fit the hydrophobic pocket of the AR active site by establishing effective interactions with Trp219, whereas the carboxylic group of the acetic chain in position 9 can bind Ser302. The benzyl moiety appeared to assume a different and less favorable orientation in AKR1B10.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a></div><div class="NLM_p">Selectivity toward AR over AKR1B10 recently emerged as an additional aspect which could be evaluated in developing ARIs as potentially safe drugs, since simultaneous AKR1B10 inhibition might be related to the onset of unwanted effects. AKR1B10 is an AKR enzyme mainly expressed in human small intestine and adrenal gland. It shows 71% sequence identity and similar folding with human AR. AKR1B10 and AR also show almost overlapping substrate specificity, since AKR1B10 reduces a variety of substrates, such as HNE, glyceraldehyde, methylglyoxal, retinals, and aromatic aldehydes, which are also substrates for AR. Thus, this enzyme may contribute to the metabolization of toxic aldehydes by cooperating with AR.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> In contrast, AKR1B10 is unable to reduce aldoses. The preference of AKR1B10 toward retinals, farnesal, geranylgeranial, and 20α-hydroxysteroids suggested that its main physiological role may be the metabolism of retinoids, isoprenoids, and steroids.<a onclick="showRef(event, 'ref132 ref133'); return false;" href="javascript:void(0);" class="ref ref132 ref133">(132, 133)</a></div><div class="NLM_p">On the other hand, AKR1B10 was found to be considerably overexpressed in liver, lung, and pancreatic tumors and adenocarcinomas, whereas AR overexpression is generally more marked in other human tumor types and leukemias.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> In addition, analogous to AR, AKR1B10 was found to be linked to the development of drug resistance in cancer cells by catalyzing carbonyl reduction of certain anticancer drugs, such as anthracyclines,<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> and, thus, it is also considered as a potential novel target for antitumor chemotherapeutics. In this view, selectivity toward AR or AKR1B10 might be desirable in order to achieve specific management of tumor types which express different levels of these AKRs, whereas on the other hand, the nonselective inhibition of both enzymes might contribute to counteract drug resistance onset in cancer cells.</div><div class="NLM_p">Tolrestat and other known ARIs exhibited appreciable AKR1B10 inhibitory properties; however, they were found to be markedly more active against AR than against AKR1B10.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a></div><div class="NLM_p">In contrast, certain nonsteroidal anti-inflammatory drugs were shown to inhibit selectively AKR1B10 over AR, particularly <i>N</i>-phenylanthranilic acid derivatives (<b>20</b>, <b>21</b>) and diclofenac (<b>22</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Other compounds (<b>23</b>–<b>30</b>) endowed with selective AKR1B10 inhibitory properties are depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>.<a onclick="showRef(event, 'ref136 ref137 ref138 ref139 ref140'); return false;" href="javascript:void(0);" class="ref ref136 ref137 ref138 ref139 ref140">(136-140)</a> Among them, oleanolic acid (<b>23</b>)<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> and 3-(4-hydroxy-2-methoxyphenyl)acrylic acid 3-(3-hydroxyphenyl)propyl ester (<b>24</b>)<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> exhibited the highest selectivity levels toward AKR1B10 versus AR.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structures of selective AKR1B10 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Crystallographic analysis, molecular docking, and site-directed mutagenesis studies allowed the identification of selectivity determinants for AKR1B10. Amino acid residues in the active site of the enzyme, such as Lys125, Val301, Gln303, Gln114, Trp220, and Ser304, were shown to be critically involved in interactions with selective AKR1B10 inhibitors, by delimiting a cavity that, in analogy to AR, is named “specificity pocket”. In particular, a pivotal role of Val301 was recognized in determining inhibitor selectivity. This also provided an explanation of the high selectivity of fidarestat for AR versus AKR1B10. In fact, in AKR1B10 the interaction of the exocyclic amide group of fidarestat with Val301 (Leu300 in AR) is prevented by unfavorable steric contacts.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a></div><div class="NLM_p last">The orientation of the side chain of Trp112, a conserved residue (Trp111 in AR), was shown to be a further key feature for the binding of inhibitors to AKR1B10. In fact, this residue exists in a native “B10-position” in the holoenzyme, but it assumes a “AKR1B1-like” orientation in several complexes with ARIs. It is likely that ARIs, capable of inducing the opening of the AR specificity pocket, can produce a similar conformational change in AKR1B10, causing a flip of the Trp112 side chain to a position similar to that of Trp111 in AR. This could explain the limited selectivity of several ARIs, such as tolrestat and zopolrestat, relative to AKR1B10. In complexes of the enzyme with inhibitors unable to induce conformational changes in Trp112, this residue remains in the native AKR1B10 orientation which leaves a wide entrance to the anionic region, thus allowing the accommodation of inhibitors with wide structures, generally more bulky and rigid than those of ARIs.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a></div></div><div id="sec1_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> (b) Design of Differential Aldose Reductase Inhibitors</h3><div class="NLM_p">Compelling evidence indicates that unwanted or toxic effects of ARIs can be ascribed, at least in part, to the capability of inhibitors to block the detoxifying function of AR toward lipid-derived aldehydes.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a></div><div class="NLM_p">As described above, the reduction of highly reactive carbonyl metabolites derived from lipid peroxidation, such as HNE, is a prominent physiological function of AR. On the other hand, the AR-catalyzed conversion of the glutathione-conjugated aldehyde GS-HNE to GS-DHN is a crucial step in the propagation of oxidative stress, capable of sustaining oxidative and inflammatory signaling events and produce tissue injury.<a onclick="showRef(event, 'ref7 ref8 ref39 ref45'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref39 ref45">(7, 8, 39, 45)</a></div><div class="NLM_p">Therefore, it is desirable to design AR differential inhibitors (ARDIs), which could be developed as a novel generation of agents able to prevent the AR-catalyzed production of both GS-DHN and sorbitol and the consequent tissue injury, without affecting the detoxifying function of the enzyme.</div><div class="NLM_p">The antiprotozoal drug nitazoxanide (<b>31</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>), which proved to inhibit human AR with an IC<sub>50</sub> value of 8.22 μM, was reported as a partial inhibitor of AR which might allow the enzyme to bind and reduce only certain substrates.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> In fact, in the AR–NADP<sup>+</sup>–nitazoxanide ternary complex, the inhibitor was positioned into the hydrophobic pocket of the active site, whereas a cocrystallized molecule of dimethylformamide occupied the catalytic polar region in the same position that <span class="smallcaps smallerCapital">d</span>-glyceraldehyde assumed in the active site of the enzyme. This suggested that nitazoxanide could leave an empty space, delimited by Trp219, Cys298, and Leu300, that might allow small molecule substrates, such as aldehydes, to enter the catalytic site, whereas the interaction with bulkier substrates, such as glucose or glutathione-conjugated aldehydes, might be prevented.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of partial or differential AR inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Indeed, the design of ARDIs can be mainly based on the possibility of occupying the hydrophobic region of the AR active site, which includes the specificity pocket, by means of small molecule inhibitors, in particular by establishing effective interactions with amino acid residues involved in the selective recognition of glutathione-conjugated aldehydes (such as Leu301 and Ser302). At the same time, the anion-binding site should be only partially occupied and, thus, accessible for the binding of free toxic aldehydes and their consequent reduction. This guideline could lead to the design of inhibitors which are unable to reach the anion-binding region at the bottom of the active site cavity but able to efficiently fit the upper hydrophobic pocket. Moreover, interactions with poorly conserved amino acid residues, such as Leu301 and Ser302, which line the specificity pocket, could simultaneously favor the selective inhibition of AR over other related enzymes.</div><div class="NLM_p">Starting from the crystal structures of AR cocrystallized with selective ARIs, such as zopolrestat and tolrestat, a recent computational study led to the rational design of potential ARDIs.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> In these molecules (structures <b>32</b>–<b>36</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>), two heteroaromatic moieties linked via a carbonyl group are present in order to maintain the capability of effectively fitting the specificity pocket and tightly interacting with amino acid residues, such as Trp111, Thr113, Leu300, and Cys303, through H-bonds and hydrophobic interactions, whereas acidic portions able to bind the anion-binding subsite were removed in order to leave this latter region partially unoccupied. When three substrates (glyceraldehyde 3-phosphate, methylglyoxal, and glucose) were docked into the complex of AR–NADP<sup>+</sup> with the potentially most active inhibitor (<b>32</b>, PI-1, Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>), glyceraldehyde 3-phosphate and methylglyoxal were shown to occupy the anion-binding region of the AR catalytic site, whereas glucose was unable to gain access to the active site and remained on the surface of the enzyme, thus suggesting that compound <b>32</b> might act as an ARDI.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a></div><div class="NLM_p last">More recently, a series of structurally different ARIs were tested by using <span class="smallcaps smallerCapital">l</span>-glyceraldehyde (GAL) and HNE as substrates, and the differences in AR inhibition depending on the nature of the substrate were evaluated.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Out of the tested compounds, <span class="smallcaps smallerCapital">d</span>-glyceramide (<b>37</b>) and <span class="smallcaps smallerCapital">d</span>-gluconamide (<b>38</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) showed the highest differential inhibitory capability, by inhibiting the enzyme activity toward GAL more efficiently than toward HNE. <span class="smallcaps smallerCapital">d</span>-Glyceramide also inhibited the AR-catalyzed conversion of GS-HNE to GS-DHN. However, the differential intrasite specificity was not associated with high inhibitory potency, since these compounds exerted AR inhibition at millimolar concentrations. Among ARIs with high affinity for the target, epalrestat and sorbinil were found to inhibit the reduction of both GAL and HNE almost to the same extent, whereas quercetin (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) exerted a moderate differential inhibition toward GAL reduction.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Instead, compounds <b>39</b> and <b>40</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) were shown to inhibit the activity of AR at micromolar concentrations by blocking the AR-catalyzed reduction of both <span class="smallcaps smallerCapital">d</span>-glucose and GS-HNE more efficiently than that of HNE. Therefore, they can be considerd lead compounds with a potential to be developed as effective ARDIs.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a></div></div><div id="sec1_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> (c) Aldose Reductase Inhibitors Endowed with Antioxidant Properties</h3><div class="NLM_p">The limited in vivo effectiveness observed with certain ARIs during clinical trials might be related, besides to poor capability of penetrating target tissues, to the post-translational modifications of AR that occur under oxidative conditions. In fact, in both DM and different inflammatory pathologies, increased cellular oxidative stress induces oxidation of the critical amino acid residue Cys298 in the active site of AR as well as promotes the generation of S-thiolated forms of the enzyme with reduced sensitivity to inhibitors.<a onclick="showRef(event, 'ref7 ref8 ref100 ref101 ref102'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref100 ref101 ref102">(7, 8, 100-102)</a></div><div class="NLM_p">On this basis, therapeutic treatments with ARIs combined with antioxidants could be a useful strategy in order to prevent the oxidative modifications of the enzyme that may be responsible for drug resistance, thus keeping the target in its ARI-sensitive reduced form. In addition, antioxidants could act synergistically with ARIs by contributing to counteract oxidative stress derived from hyperglycemia and/or inflammation.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">In view of this, compounds endowed with dual activity as ARIs and antioxidants were identified in the past decade. Previously, flavonoids (such as quercetin, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) were described in the literature as compounds endowed with both AR inhibitory and antioxidant effects, but none of them showed clinically suitable profiles, especially because of their high hydrophilicity and low oral bioavailability.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> However, both flavones and isoflavones remain attractive molecules, since they possess structural features corresponding to certain pharmacophoric requirements for AR inhibition, such as acidic phenol groups, which could effectively interact with the anion-binding region of the AR active site, and the benzopyranone nucleus, which is potentially able to bind the enzyme through both hydrogen bonds and hydrophobic interactions.</div><div class="NLM_p">Among these natural compounds, genistein (<b>41</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>), which is an isoflavinoid found in soy beans, appears to be a promising agent, showing both AR inhibitory activity and remarkable antioxidant effectiveness. It was able to increase the cellular levels of glutathione in high glucose-treated lens epithelial cells and to prevent xylose-induced cataractogenesis in an ex vivo assay.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures of ARIs endowed with antioxidant properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, the pyrido[1,2-<i>a</i>]pyrimidin-4-one scaffold was reported as a bioisoster of the flavone system.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> The presence of a hydroxy substituent in position 6 of this scaffold was beneficial for AR inhibitory activity and, along with the insertion of a 3,4-dihydroxyphenyl moiety in position 2, led to the most potent and selective ARI of this series endowed with significant antioxidant activity (compound <b>42</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>).<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> Docking and molecular dynamics simulations into the AR active site suggested that, as expected, the dissociated hydroxy groups present on the phenyl ring in position 2 could simulate the interactions between a carboxylic group and the anion-binding region of the enzyme, whereas the pyridopyrimidine nucleus could fit the specificity pocket, thus accounting for the observed AR selectivity over ALR1.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a></div><div class="NLM_p">Another example of compounds with dual activity was given by structural analogues of the potent antioxidant stobadine (<b>43</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). Tetrahydropyridoindoles (<b>44</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>) were found to be more effective and selective ARIs than their hexahydropyridoindole congeners <b>45</b>, whereas these latter showed better radical scavenging and antioxidant properties.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a></div><div class="NLM_p">Novel benzofuroxane derivatives, based on a parent compound previously identified by means of a virtual screening (compound <b>63</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>), showed AR inhibitory and antioxidant properties, besides an additional NO donor activity. Among them, compounds <b>46a</b>,<b>b</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>) displayed promising profiles as both ARI and radical scavenger agents, being significantly more effective than α-tocopherol in reducing hydroxyl radical-dependent lipoperoxidation induced in rat brain homogenate.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> 5-Arylidene-4-thiazolidinone-based ARIs <b>47</b>, <b>48</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>) were also shown to act as excellent antioxidant agents which were more effective than the reference α-tocopherol in the same assay.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of non-carboxylic non-hydantoin ARIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> (d) Improving Bioavailability of Aldose Reductase Inhibitors</h3><div class="NLM_p">Different approaches may be applied in order to improve cell permeability and bioavailability of ARIs.</div><div class="NLM_p">The presence of large hydrophobic moieties in the structure of numerous compounds, described above as selective ARIs, is beneficial for their AR affinity and selectivity, by means of effective interactions with the specificity pocket of the enzyme, and at the same time can influence activity by enhancing hydrophobicity of molecules and consequently improving their capability to cross biomembranes. This gain in lipophilicity can account for the bioavailability of many carboxylic acid containing ARIs (e.g., epalrestat, zopolrestat, ponalrestat, <b>5</b>, and lidorestat, Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> and <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) that, although highly ionized at physiological pH values, exhibit excellent in vivo activity. The insertion of small lipophilic substituents, such as fluorine or bromine atoms, on the aromatic systems of these ARIs was also shown to improve both their affinity for the target and cell permeability.<a onclick="showRef(event, 'ref112 ref114 ref115'); return false;" href="javascript:void(0);" class="ref ref112 ref114 ref115">(112, 114, 115)</a></div><div class="NLM_p">It was also proposed that zwitterionic forms of amphoteric agents might be interesting in order to achieve acceptable in vivo distribution, due to their lipophilicity profile. In certain ampholytes, lipophilicity reaches a maximum value at the isoelectric point, thus giving potentially enhanced partitioning for the doubly charged zwitterionic species compared to the single charged ions. Therefore, it was suggested that the design of amphoteric agents with isoelectric point at physiological pH values might be exploited to obtain ARIs with improved pharmacokinetics.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> However, the poor water solubility of amphoteric compounds at their isoelectric point should be taken into consideration as a possible drawback.</div><div class="NLM_p">Non-carboxylic acid containing molecules with low ionization potential at physiological pH values may be designed and explored as ARIs potentially endowed with good cellular permeability.</div><div class="NLM_p">An excellent example of low molecular weight, selective, and potent non-carboxylic acid, non-hydantoin ARIs reported in the past decade was provided by a class of arylsulfonylpyridazinone derivatives, out of which 6-(5-chloro-3-methylbenzofuran-2-sulfonyl)-2<i>H</i>-pyridazin-3-one (<b>49</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) was shown to be the best inhibitor exhibiting significant in vitro effectiveness (IC<sub>50</sub> = 1 nM) and remarkable selectivity (930-fold) toward human AR over ALR1.<a onclick="showRef(event, 'ref151 ref152'); return false;" href="javascript:void(0);" class="ref ref151 ref152">(151, 152)</a> It also displayed favorable pharmacokinetic properties, with high oral bioavailability, and was able to block the flux of glucose through the polyol pathway in nerve, retina, and lens of diabetic rats, with greater efficacy than both zopolrestat and sorbinil.<a onclick="showRef(event, 'ref152 ref153'); return false;" href="javascript:void(0);" class="ref ref152 ref153">(152, 153)</a> X-ray crystallographic analysis revealed that the pyridazinone headgroup of compound <b>49</b> binds the polar anion-binding region of the AR active site by establishing an H bond with Trp111 and a charge-assisted interaction with the positively charged nicotinamide moiety of NADP<sup>+</sup> through the deprotonated and negatively charged N-2 atom of the pyridazinone ring as well as H-bonds with His110 and Tyr48 through the carbonyl oxygen in position 3. The chloro-substituted benzofuran system can occupy the specificity pocket of the enzyme, thus allowing a rationalization of the marked selectivity of this ARI.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a></div><div class="NLM_p">2,4-Thiazolidinedione and 2-thioxo-4-thiazolidinone rings were also exploited as scaffolds for the design of non-carboxylic acid containing ARIs, being considered as safer bioisosters of the hydantoin ring. 2-Thioxo-4-thiazolidinone derivatives generally exhibited greater AR inhibitory potency than their 2,4-thiazolidinedione analogues.<a onclick="showRef(event, 'ref22 ref155'); return false;" href="javascript:void(0);" class="ref ref22 ref155">(22, 155)</a> These findings could be ascribed to additional favorable interactions of the ligands within the AR active site, as recently reported for compounds <b>50</b>, <b>51</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>).<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> In fact, N-unsubstituted 2-thioxo-4-thiazolidinones <b>51</b> were shown to be from twice to more than 30-fold more effective inhibitors than their 2,4-thiazolidinedione counterparts <b>50</b>, by exhibiting IC<sub>50</sub> values in the range from 1.08 to 11.6 μM.<a onclick="showRef(event, 'ref72 ref156'); return false;" href="javascript:void(0);" class="ref ref72 ref156">(72, 156)</a></div><div class="NLM_p">Non-carboxylic acid containing 4-thiazolidinone-based ARIs with a different substitution pattern on the heterocyclic scaffold (compounds <b>52</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) also displayed AR inhibitory activity at micromolar concentrations (IC<sub>50</sub> = 2.54–36.1 μM), with selectivity over ALR1 likely related to interactions of the aromatic ring in position 3 of the thiazolidinone ring with amino acid residues lining the specificity pocket of AR.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a></div><div class="NLM_p">Starting from carboxylic acid containing lead compounds that exhibit molecular features appropriate for binding AR, the replacement of the highly ionized carboxylic heads with less ionized bioisosters is a straightforward strategy often used to achieve inhibitors with potentially improved capability to cross cell membrane. Recently, this approach led to the discovery of effective ARIs, although in some cases they displayed lower affinity for the target enzyme than the carboxylic acid containing parents.</div><div class="NLM_p">A prominent example of lipophilic bioisoster of carboxylic acid containing portions is the 2,6-difluorophenol moiety, which was inserted in <i>N</i>-(3,5-difluoro-4-hydroxyphenyl)benzenesulfonamides (compounds <b>53</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) recently investigated as non carboxylic acid-containing ARIs.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> Although their activity levels were in a wide micromolar range, they showed improved potency in comparison to the corresponding <i>N</i>-benzenesulfonylglycine analogues. Both the presence of an electron-releasing group in the para position of the benzene ring and the insertion of a 4-bromo-2-fluoromethylbenzyl moiety on the sulfonamide nitrogen atom were found to be favorable for the activity (e.g., compound <b>53a</b>, IC<sub>50</sub> = 0.397 μM, Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>).<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> In addition, some of these 2,6-difluorophenol substituted ARIs exhibited significant antioxidant potential.<a onclick="showRef(event, 'ref158 ref159'); return false;" href="javascript:void(0);" class="ref ref158 ref159">(158, 159)</a> When the 2,6-difluorophenol portion was replaced by other possible biososters of the carboxylic group, such as a sulfonamide functionality, a tetrazole, or a isoxazolidin-3-one ring, a reduction of the inhibitory potency was observed versus an increase in selectivity toward AR over ALR1.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a></div><div class="NLM_p">The 2,6-difluorophenol moiety was also used for bioisosteric replacement of the acetic acid chain of benzoylpyrrol-1-ylacetic acids to give compounds <b>54</b>, <b>55</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>), most of which were endowed with AR inhibitory activity in the low micromolar/submicromolar range (IC<sub>50</sub> = 0.19–9.93 μM) and generally appreciable selectivity over ALR1.<a onclick="showRef(event, 'ref160 ref161'); return false;" href="javascript:void(0);" class="ref ref160 ref161">(160, 161)</a> Compound <b>55a</b> also exhibited antioxidant properties and was able to reduce sorbitol accumulation in isolated rat lenses incubated in the presence of high glucose concentrations.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> The carboxylic acid head of benzoylpyrrol-1-ylacetic acid derivatives was also replaced by a tetrazole ring, a commonly used bioisoster of carboxylic acids which is more lipophilic than the carboxylic group, despite that it is also ionized at physiological pH values. However, although the tetrazole ring appeared to mimic the carboxylate in anchoring the molecules to the anion-binding region of the AR active site, these bioisosters displayed reduced AR inhibitory activity compared to the carboxylic acid-containing analogues.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> Subsequently, the 1-hydroxypyrazole ring was introduced on the same scaffold as a new acetic acid bioisoster endowed with a higher p<i>K</i><sub>a</sub> value than both carboxylic acid and tetrazole. Among the synthesized compounds, biphenyl substituted derivative <b>56</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) was proposed as a lead compound, being endowed with an IC<sub>50</sub> value of 0.698 μM and appreciable selectivity related to ALR1.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a></div><div class="NLM_p">More recently, benzoylpyrrole analogues were obtained by inserting a 2-fluorophenol moiety on the pyrrole nitrogen atom, out of which compounds <b>57a</b>,<b>b</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) emerged as promising ARIs, with IC<sub>50</sub> values of 1.04 and 0.443 μM, respectively. Compounds <b>57a</b>,<b>b</b> were also able to reduce sorbitol accumulation in isolated rat lenses incubated with glucose, and <b>57b</b> displayed an appreciable ability to permeate rat jejunum.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a></div><div class="NLM_p">Other bioisosters of carboxylic acid containing ARIs were obtained by replacing the acetic chain of (5-arylidene-2,4-dioxothiazolidin-3-yl)acetic acids (<b>58</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) with different isosteric groups. The insertion of an acetamide, <i>N</i>-hydroxyacetamide, or 3,3,3-trifluoro-2-oxopropyl chain on N-3 of the thiazolidinedione ring (compounds <b>59</b>–<b>61</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) produced a general decrease in the AR inhibitory effect compared to the parent carboxylic acids, particularly for amide derivatives <b>59</b>. However, among compounds <b>59</b>–<b>61</b>, which are mainly nonionized at physiological pH values, inhibitors active at low micromolar concentrations (IC<sub>50</sub> = 1.79–8.3 μM) were identified.<a onclick="showRef(event, 'ref165 ref166'); return false;" href="javascript:void(0);" class="ref ref165 ref166">(165, 166)</a> These inhibition data prompt further evaluation of selected compounds on cell cultures and/or in vivo.</div><div class="NLM_p">Structurally diverse non-carboxylic acid containing ARIs were identified by means of a virtual screening.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> Out of them, compounds <b>62</b>, <b>63</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) were shown to be active in vitro with IC<sub>50</sub> values of 31.08 and 35.61 μM, respectively. The sulfonate group present in both of them might interact differently with the AR active site, as suggested by docking simulations, since the SO<sub>2</sub> group of compound <b>62</b> was positioned in the anion-binding pocket, whereas compound <b>63</b> inserted its benzoxadiazole ring in the same subsite.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a></div><div class="NLM_p last">Finally, the common presence of a carboxylic group in the structure of many potent ARIs offers the opportunity to synthesize esters as prodrugs more lipophilic than parent acids. An example was provided by compound <b>10</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>)<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> that was converted to the corresponding isopropyl diester. This latter provided appreciable reduction of cataract incidence when topically administered as ophthalmic solution in galactosemic rats, contrary to the parent compound.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Concluding Remarks and Future Prospectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67758" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67758" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">It is definitely established that AR plays pivotal roles in mediating oxidative and inflammatory signaling events which are crucially involved in the pathogenic course of DM and its chronic complications as well as in the development of different pathologies not associated with DM.</div><div class="NLM_p">The recent findings regarding the pathophysiological functions of AR have encouraged the search for new effective and safe ARIs, thus prompting medicinal chemists to find new strategies to tackle old challenges in targeting this apparently evasive enzyme. Despite the difficulties encountered during investigation of ARIs as potential therapeutic agents, it can be expected that the current enhanced knowledge of structural and functional features of AR will allow the identification of new inhibitors with improved properties for drug development in the near future.</div><div class="NLM_p">In the search for new ARIs as potential drug candidates, identifying inhibitors endowed with good capability to cross biomembranes as well as devoid of serious unwanted effects is the main challenge for medicinal chemists. Modulating the capability of molecules to act as selective and/or differential inhibitors appears to be a pivotal approach to obtain ARIs with improved safety profiles.</div><div class="NLM_p">Certain structural features introduced in a template of potential ARIs could be useful to optimize more than one property of the molecule. For example, the presence of appropriate hydrophobic moieties able to open and fit the specificity pocket can achieve the goal of a selective interaction with AR over related enzymes and at the same time it can favor the differential inhibition of AR, in order to retain its detoxifying function and block the AR-catalyzed production of cytotoxic metabolites. Moreover, it can facilitate the partitioning of compounds to target tissues.</div><div class="NLM_p">In this context, we believe that the search for ARDIs is a challenging future direction that could be considered as a priority goal. In our opinion, the discovery of ARDIs with proper druglike features could represent a crucial turning point in the difficult route to develop inhibitors of AR useful as therapeutic agents, likely leading to a new generation of safer ARIs. This might facilitate the selection of new candidates with suitable safety profiles to be submitted to clinical trials. However, this is a recent approach that, up to now, has been reported in very few investigations and needs to be further developed.</div><div class="NLM_p">In addition, considering that the increased oxidative stress associated with DM and inflammation could interfere with the effectiveness of ARIs in vivo, the search for dual agents endowed with both AR inhibitory and antioxidant properties is considered as another promising strategy.</div><div class="NLM_p last">At the same time, as suggested by several authors, a desirable advance in the development of ARIs could be to perform further biological screenings and clinical trials aimed at the treatment of inflammation and cancer, possibly starting from known ARIs with good pharmacokinetic and safety profiles, such as epalrestat, fidarestat, and ranirestat. This would allow the assessment of the efficacy of these agents in preventing or suppressing oxidative stress and chronic inflammation, which are closely related critical events in the onset and progression of different pathologies associated or not with DM, thus providing findings useful for developing novel agents targeted to the treatment of inflammation-based diseases.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm500907a" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25385" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25385" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rosanna Maccari</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienze del
Farmaco e dei Prodotti per la Salute, Università
degli Studi di Messina, Polo Universitario dell’Annunziata, 98168 Messina, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9eecf3fffdfdffecf7deebf0f7f3fbb0f7ea"><span class="__cf_email__" data-cfemail="fd8f909c9e9e9c8f94bd8893949098d39489">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rosaria Ottanà</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienze del
Farmaco e dei Prodotti per la Salute, Università
degli Studi di Messina, Polo Universitario dell’Annunziata, 98168 Messina, Italy</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16181" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16181" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Rosanna Maccari</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=BIO-d1910e1691-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Rosanna Maccari</b> graduated with a degree in Medicinal Chemistry (1992) and earned her Ph.D. degree in Pharmaceutical Sciences (1997) at the University of Messina, Italy. She has been a researcher in medicinal chemistry at the Faculty of Pharmacy, now Dipartimento di Scienze del Farmaco e dei Prodotti per la Salute, of the University of Messina since 1999. Her main research interests concern drug design, lead discovery and optimization, and chemical synthesis in medicinal chemistry. For the past few years she has dealt with the design, synthesis, and SAR studies of aldose reductase inhibitors and phosphotyrosine protein phosphatase inhibitors. In recent years she was also engaged in the search for the identification of new antitubercular, anti-inflammatory, antitumoral, and antiviral agents.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Rosaria Ottanà</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=BIO-d1910e1696-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Rosaria Ottanà</b> received a degree in Industrial Chemistry (1980) and specialized in “Chemistry and Technology of Catalysis” (1982) at the University of Messina, Italy. She has been Associate Professor in Medicinal Chemistry since 2001 and was university researcher from 1983 to 2001 at the Faculty of Pharmacy, now Dipartimento di Scienze del Farmaco e dei Prodotti per la Salute, of the University of Messina. Her research interests have included the design and synthesis of bisthiazolidinones as antiinflammatory, analgesic agents and lipophilic analogues of isoniazid active against AIDS-associated infections and tumors. Currently, her research targets the design, synthesis, SARs, and molecular modeling of 2-oxo/2-arylimino-4-thiazolidinones as inhibitors of (a) aldose reductase for the treatment of diabetic complications and (b) phosphotyrosine protein phosphatases as agents to fight diabetes, obesity, and cancer.</p></figure></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i14" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i14"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i15" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i15"> Abbreviations Used</h2><tr><td class="NLM_term">AGE</td><td class="NLM_def"><p class="first last">advanced glycation end product</p></td></tr><tr><td class="NLM_term">ALR1, AKR1A1</td><td class="NLM_def"><p class="first last">aldehyde reductase</p></td></tr><tr><td class="NLM_term">AR, AKR1B1</td><td class="NLM_def"><p class="first last">aldose reductase</p></td></tr><tr><td class="NLM_term">ARDI</td><td class="NLM_def"><p class="first last">aldose reductase differential inhibitor</p></td></tr><tr><td class="NLM_term">ARI</td><td class="NLM_def"><p class="first last">aldose reductase inhibitor</p></td></tr><tr><td class="NLM_term">COX-2</td><td class="NLM_def"><p class="first last">cyclooxygenase 2</p></td></tr><tr><td class="NLM_term">DAG</td><td class="NLM_def"><p class="first last">diacylglycerol</p></td></tr><tr><td class="NLM_term">DHAP</td><td class="NLM_def"><p class="first last">dihydroxyacetone phosphate</p></td></tr><tr><td class="NLM_term">DHN</td><td class="NLM_def"><p class="first last">1,4-dihydroxynonene</p></td></tr><tr><td class="NLM_term">DM</td><td class="NLM_def"><p class="first last">diabetes mellitus</p></td></tr><tr><td class="NLM_term">GAL</td><td class="NLM_def"><p class="first last"><span class="smallcaps smallerCapital">l</span>-glyceraldehyde</p></td></tr><tr><td class="NLM_term">GS-DHN</td><td class="NLM_def"><p class="first last">glutathione-1,4-dihydroxynonene</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">GS-HNE</td><td class="NLM_def"><p class="first last">glutathione-4-hydroxy-<i>trans</i>-2-nonenal</p></td></tr><tr><td class="NLM_term">HNE</td><td class="NLM_def"><p class="first last">4-hydroxy-<i>trans</i>-2-nonenal</p></td></tr><tr><td class="NLM_term">IL</td><td class="NLM_def"><p class="first last">interleukin</p></td></tr><tr><td class="NLM_term">iNOS</td><td class="NLM_def"><p class="first last">inducible nitric oxide synthase</p></td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor κB</p></td></tr><tr><td class="NLM_term">PGE<sub>2</sub></td><td class="NLM_def"><p class="first last">prostaglandin E<sub>2</sub></p></td></tr><tr><td class="NLM_term">PKC</td><td class="NLM_def"><p class="first last">protein kinase C</p></td></tr><tr><td class="NLM_term">PLC</td><td class="NLM_def"><p class="first last">phospholipase C</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">radical oxygen species</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">sorbitol dehydrogenase</p></td></tr><tr><td class="NLM_term">TNF-α</td><td class="NLM_def"><p class="first last">tumor necrosis factor α</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35122" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35122" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 167 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Brownlee, M.</span><span> </span><span class="NLM_article-title">Biochemistry and Molecular Cell Biology of Diabetic Complications</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">414</span><span class="NLM_x">, </span> <span class="NLM_fpage">813</span><span class="NLM_x">–</span> <span class="NLM_lpage">820</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1038%2F414813a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=11742414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD38Xhtlyltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2001&pages=813-820&author=M.+Brownlee&title=Biochemistry+and+Molecular+Cell+Biology+of+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemistry and molecular cell biology of diabetic complications</span></div><div class="casAuthors">Brownlee, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">414</span>
        (<span class="NLM_cas:issue">6865</span>),
    <span class="NLM_cas:pages">813-820</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Diabetes-specific microvascular disease is a leading cause of blindness, renal failure and nerve damage, and diabetes-accelerated atherosclerosis leads to increased risk of myocardial infarction, stroke and limb amputation.  Four main mol. mechanisms have been implicated in glucose-mediated vascular damage.  All seem to reflect a single hyperglycemia-induced process of overprodn. of superoxide by the mitochondrial electron-transport chain.  This integrating paradigm provides a new conceptual framework for future research and drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU6OQEmAUWmLVg90H21EOLACvtfcHk0lgbXUaI5Q1IYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xhtlyltg%253D%253D&md5=b229af6b6bc93ada1888c24d7a82ca3b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F414813a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F414813a%26sid%3Dliteratum%253Aachs%26aulast%3DBrownlee%26aufirst%3DM.%26atitle%3DBiochemistry%2520and%2520Molecular%2520Cell%2520Biology%2520of%2520Diabetic%2520Complications%26jtitle%3DNature%26date%3D2001%26volume%3D414%26spage%3D813%26epage%3D820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Brownlee, M.</span><span> </span><span class="NLM_article-title">The Pathobiology of Diabetic Complications. A Unifying Mechanism</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1615</span><span class="NLM_x">–</span> <span class="NLM_lpage">1625</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=1615-1625&author=M.+Brownlee&title=The+Pathobiology+of+Diabetic+Complications.+A+Unifying+Mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrownlee%26aufirst%3DM.%26atitle%3DThe%2520Pathobiology%2520of%2520Diabetic%2520Complications.%2520A%2520Unifying%2520Mechanism%26jtitle%3DDiabetes%26date%3D2005%26volume%3D54%26spage%3D1615%26epage%3D1625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Yabe-Nishimura, C.</span><span> </span><span class="NLM_article-title">Aldose Reductase in Glucose Toxicity: A Potential Target for the Prevention of Diabetic Complications</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1998&pages=21-33&author=C.+Yabe-Nishimura&title=Aldose+Reductase+in+Glucose+Toxicity%3A+A+Potential+Target+for+the+Prevention+of+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYabe-Nishimura%26aufirst%3DC.%26atitle%3DAldose%2520Reductase%2520in%2520Glucose%2520Toxicity%253A%2520A%2520Potential%2520Target%2520for%2520the%2520Prevention%2520of%2520Diabetic%2520Complications%26jtitle%3DPharmacol.%2520Rev.%26date%3D1998%26volume%3D50%26spage%3D21%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Costantino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rastelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cignarella, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlocco, D.</span><span> </span><span class="NLM_article-title">New Aldose Reductase Inhibitors as Potential Agents for the Prevention of Long-Term Diabetic Complications</span> <span class="citation_source-journal">Exp. Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">843</span><span class="NLM_x">–</span> <span class="NLM_lpage">858</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1517%2F13543776.7.8.843" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADyaK2sXlt12ls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=843-858&author=L.+Costantinoauthor=G.+Rastelliauthor=G.+Cignarellaauthor=P.+Vianelloauthor=D.+Barlocco&title=New+Aldose+Reductase+Inhibitors+as+Potential+Agents+for+the+Prevention+of+Long-Term+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">New aldose reductase inhibitors as potential agents for the prevention of long-term diabetic complications</span></div><div class="casAuthors">Costantino, Luca; Rastelli, Giulio; Cignarella, Giorgio; Vianello, Paola; Barlocco, Daniela</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">843-858</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications</span>)
        </div><div class="casAbstract">A review with 189 refs.  The results of recent clin. trials emphasize the importance of an improved glycemic control in diabetic patients to prevent or at least to delay long-term complications.  The difficulty in obtaining normalization of blood glucose values has underlined the importance of the search for new and effective aldose reductase inhibitors (ARIs) to control the consequences of elevated glucose levels, therefore delaying the onset and retarding the progression of diabetic complications such as neuropathy, nephropathy, retinopathy and cataract.  Although the physiol. role of aldose reductase (ALR2) has not been clearly elucidated yet, it has been shown that this enzyme, the first of the polyol pathway, is responsible for the prodn. of sorbitol from glucose.  There are several pieces of evidence which link this process to the occurrence of diabetic complications.  Orally active aldose reductase inhibitors can be grouped into two chem. classes: cyclic imide and carboxylic acid derivs.  This review describes the recent insights into these two classes of inhibitors, and the further development of ARIs provided with antidiabetic and antihyperlipidemic properties.  The most recent developments in understanding of the structure, catalytic mechanism and biochem. behavior of ALR2 are also reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8dM0Nsjrm3LVg90H21EOLACvtfcHk0lgbXUaI5Q1IYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlt12ls7s%253D&md5=f2601af33b510dac509b9ab093194f4a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F13543776.7.8.843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.7.8.843%26sid%3Dliteratum%253Aachs%26aulast%3DCostantino%26aufirst%3DL.%26aulast%3DRastelli%26aufirst%3DG.%26aulast%3DCignarella%26aufirst%3DG.%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DBarlocco%26aufirst%3DD.%26atitle%3DNew%2520Aldose%2520Reductase%2520Inhibitors%2520as%2520Potential%2520Agents%2520for%2520the%2520Prevention%2520of%2520Long-Term%2520Diabetic%2520Complications%26jtitle%3DExp.%2520Opin.%2520Ther.%2520Pat.%26date%3D1997%26volume%3D7%26spage%3D843%26epage%3D858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Costantino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rastelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cignarella, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlocco, D.</span><span> </span><span class="NLM_article-title">Diabetes Complications and Their Potential Prevention: Aldose Reductase Inhibition and Other Approaches</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1002%2F%28SICI%291098-1128%28199901%2919%3A1%3C3%3A%3AAID-MED2%3E3.0.CO%3B2-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=9918192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADyaK1MXjs1ygtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=3-23&author=L.+Costantinoauthor=G.+Rastelliauthor=P.+Vianelloauthor=G.+Cignarellaauthor=D.+Barlocco&title=Diabetes+Complications+and+Their+Potential+Prevention%3A+Aldose+Reductase+Inhibition+and+Other+Approaches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Diabetes complications and their potential prevention: aldose reductase inhibition and other approaches</span></div><div class="casAuthors">Costantino, Luca; Rastelli, Giulio; Vianello, Paola; Cignarella, Giorgio; Barlocco, Daniela</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-23</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review with 153 refs.  Despite recent advances both in the chem. and mol. pharmacol. of antidiabetic drugs, diabetes still remains a life-threatening disease, which tends to spread all over the world.  The clin. profile of diabetic subjects is often worsened by the presence of several long-term complications, namely neuropathy, nephropathy, retinopathy, and cataract.  Several attempts have been made to prevent or at least to delay them.  The most relevant are reported in this review, including the development of compds. acting as aldose reductase inhibitors, anti-advanced glycation end-product drugs, free radical scavengers, vasoactive agents, essential fatty acid supplementation, and neurotropic growth factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQa1u-NjUMUrVg90H21EOLACvtfcHk0lgbXUaI5Q1IYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjs1ygtA%253D%253D&md5=4bb0a6c86b0f030ad67bb05009ae115e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28199901%2919%3A1%3C3%3A%3AAID-MED2%3E3.0.CO%3B2-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528199901%252919%253A1%253C3%253A%253AAID-MED2%253E3.0.CO%253B2-7%26sid%3Dliteratum%253Aachs%26aulast%3DCostantino%26aufirst%3DL.%26aulast%3DRastelli%26aufirst%3DG.%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DCignarella%26aufirst%3DG.%26aulast%3DBarlocco%26aufirst%3DD.%26atitle%3DDiabetes%2520Complications%2520and%2520Their%2520Potential%2520Prevention%253A%2520Aldose%2520Reductase%2520Inhibition%2520and%2520Other%2520Approaches%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1999%26volume%3D19%26spage%3D3%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Costantino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rastelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamberini, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlocco, D.</span><span> </span><span class="NLM_article-title">Pharmacological Approaches to the Treatment of Diabetic Complications</span> <span class="citation_source-journal">Exp. Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1245</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1517%2F13543776.10.8.1245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvFWqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1245-1262&author=L.+Costantinoauthor=G.+Rastelliauthor=M.+C.+Gamberiniauthor=D.+Barlocco&title=Pharmacological+Approaches+to+the+Treatment+of+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological approaches to the treatment of diabetic complications</span></div><div class="casAuthors">Costantino, Luca; Rastelli, Giulio; Gamberini, Maria Cristina; Barlocco, Daniela</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1245-1262</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 153 refs.  Diabetes is often accompanied by several long-term complications such as neuropathy, nephropathy, retinopathy, cataract and angiopathy; their occurrence has been linked to the modification of the physiol. levels of glycemia.  Several interrelated metabolic pathways have been implicated in the toxic effects of glucose; the polyol pathway was one of the first considered.  However, while in diabetic animal models the inhibitors of aldose reductase (ALR2, the first enzyme of this pathway) seem to be active, 16 yr of clin. trials, based mainly on neuropathy, have been inconclusive; only one drug currently being marketed.  Newer potent and selective aldose reductase inhibitors have been discovered in the last few years, but the lack of com. success has probably led to the very rapid decrease in the no. of patents relating to newer aldose reductase inhibitors.  Inhibition of the second enzyme of this pathway, sorbitol dehydrogenase (SDH), has been shown to be detrimental.  Other approaches for the prevention and the delay of progression of diabetic complications seem to be more promising, namely, the inhibition of the formation of advanced glycated end products (AGEs) or protein kinase C (PKC) β2 inhibition; compds. acting on these two pathways have proved effective in retarding the development of diabetic complications in animal models and some products are in clin. trials at the moment.  Renewed attention has been paid to vascular involvement in the pathogenesis of diabetic neuropathy; the biol. activity of C-peptide and the role of endothelin-1 (ET-1) in diabetic vascular disease are emerging as a new research area for the treatment of diabetic complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC9eUSGnqqF7Vg90H21EOLACvtfcHk0lj9guWc7bdHCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvFWqu7s%253D&md5=4848a865cf01793a83f66281134f4a7d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1517%2F13543776.10.8.1245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.10.8.1245%26sid%3Dliteratum%253Aachs%26aulast%3DCostantino%26aufirst%3DL.%26aulast%3DRastelli%26aufirst%3DG.%26aulast%3DGamberini%26aufirst%3DM.%2BC.%26aulast%3DBarlocco%26aufirst%3DD.%26atitle%3DPharmacological%2520Approaches%2520to%2520the%2520Treatment%2520of%2520Diabetic%2520Complications%26jtitle%3DExp.%2520Opin.%2520Ther.%2520Pat.%26date%3D2000%26volume%3D10%26spage%3D1245%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Del Corso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappiello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mura, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">From, A.</span><span> </span><span class="NLM_article-title">Dull Enzyme to Something Else: Facts and Perspectives Regarding Aldose Reductase</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1452</span><span class="NLM_x">–</span> <span class="NLM_lpage">1461</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.2174%2F092986708784638870" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=18537622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVyhs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=1452-1461&author=A.+Del+Corsoauthor=M.+Cappielloauthor=U.+Muraauthor=A.+From&title=Dull+Enzyme+to+Something+Else%3A+Facts+and+Perspectives+Regarding+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">From a dull enzyme to something else: facts and perspectives regarding aldose reductase</span></div><div class="casAuthors">Del Corso, A.; Cappiello, M.; Mura, U.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1452-1461</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Aldose Reductase (ALR2) is defined as the first enzyme of the "polyol pathway".  As such, ALR2 would convert glucose to sorbitol through an NADPH dependent reaction.  Considered a promoter of osmotic imbalance under hyperglycemic conditions, the enzyme has been under intense investigation as a crit. target to prevent and control diabetic complications through the inhibition of its activity.  Further characterization of ALR2 suggests its participation in cell detoxification mechanisms through the redn. of toxic aldehydes.  Moreover, intriguing is the apparent involvement of the enzyme in the signaling machinery of inflammatory cell response.  Here, the structural and functional assessment of ALR2 as an aldose/aldehyde reducing enzyme, and its involvement in various aspects of cell function from sugar metab. to redox homeostasis and cell signaling are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6V1lpOaJTyLVg90H21EOLACvtfcHk0lj9guWc7bdHCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVyhs7Y%253D&md5=7f3fa8415b040c8c2fc08f3ef64fdecf</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F092986708784638870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708784638870%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BCorso%26aufirst%3DA.%26aulast%3DCappiello%26aufirst%3DM.%26aulast%3DMura%26aufirst%3DU.%26aulast%3DFrom%26aufirst%3DA.%26atitle%3DDull%2520Enzyme%2520to%2520Something%2520Else%253A%2520Facts%2520and%2520Perspectives%2520Regarding%2520Aldose%2520Reductase%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26spage%3D1452%26epage%3D1461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Srivastava, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span> </span><span class="NLM_article-title">Role of Aldose Reductase and Oxidative Damage in Diabetes and the Consequent Potential for Therapeutic Options</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1210%2Fer.2004-0028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=15814847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVWru7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=380-392&author=S.+K.+Srivastavaauthor=K.+V.+Ramanaauthor=A.+Bhatnagar&title=Role+of+Aldose+Reductase+and+Oxidative+Damage+in+Diabetes+and+the+Consequent+Potential+for+Therapeutic+Options"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options</span></div><div class="casAuthors">Srivastava, Satish K.; Ramana, Kota V.; Bhatnagar, Aruni</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">380-392</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Aldose reductase (AR) is widely expressed aldehyde-metabolizing enzyme.  The redn. of glucose by the AR-catalyzed polyol pathway has been linked to the development of secondary diabetic complications.  Although treatment with AR inhibitors has been shown to prevent tissue injury in animal models of diabetes, the clin. efficacy of these drugs remains to be established.  Recent studies suggest that glucose may be an incidental substrate of AR, which appears to be more adept in catalyzing the redn. of a wide range of aldehydes generated from lipid peroxidn.  Moreover, inhibition of the enzyme has been shown to increase inflammation-induced vascular oxidative stress and prevent myocardial protection assocd. with the late phase of ischemic preconditioning.  On the basis of these studies, several investigators have ascribed an important antioxidant role to the enzyme.  Addnl., ongoing work indicates that AR is a crit. component of intracellular signaling, and inhibition of the enzyme prevents high glucose-, cytokine-, or growth factor-induced activation of protein kinase C and nuclear factor-κ-binding protein.  Thus, treatment with AR inhibitors prevents vascular smooth muscle cell growth and endothelial cell apoptosis in culture and inflammation and restenosis in vivo.  Addnl. studies indicate that the antioxidant and signaling roles of AR are interlinked and that AR regulates protein kinase C and nuclear factor-κB via redox-sensitive mechanisms.  These data underscore the need for reevaluating anti-AR interventions for the treatment of diabetic complications.  Potentially, the development of newer drugs that selectively inhibit AR-mediated glucose metab. and signaling, without affecting aldehyde detoxification, may be useful in preventing inflammation assocd. with the development of diabetic complications, particularly micro- and macrovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOtJ6RgWVDzrVg90H21EOLACvtfcHk0lj9guWc7bdHCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVWru7s%253D&md5=21c5b244909e660d240a1600ffd6e938</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1210%2Fer.2004-0028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2004-0028%26sid%3Dliteratum%253Aachs%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DBhatnagar%26aufirst%3DA.%26atitle%3DRole%2520of%2520Aldose%2520Reductase%2520and%2520Oxidative%2520Damage%2520in%2520Diabetes%2520and%2520the%2520Consequent%2520Potential%2520for%2520Therapeutic%2520Options%26jtitle%3DEndocr.%2520Rev.%26date%3D2005%26volume%3D26%26spage%3D380%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Banditelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boldrini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardo, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecconi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappiello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Monte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Corso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mura, U.</span><span> </span><span class="NLM_article-title">A New Approach against Sugar Cataract through Aldose Reductase Inhibitors</span> <span class="citation_source-journal">Exp. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">538</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1006%2Fexer.1999.0729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=10548473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADyaK1MXntVCntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1999&pages=533-538&author=S.+Banditelliauthor=E.+Boldriniauthor=P.+G.+Vilardoauthor=I.+Cecconiauthor=M.+Cappielloauthor=M.+Dal+Monteauthor=I.+Mariniauthor=A.+Del+Corsoauthor=U.+Mura&title=A+New+Approach+against+Sugar+Cataract+through+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A new approach against sugar cataract through aldose reductase inhibitors</span></div><div class="casAuthors">Banditelli, Stefania; Boldrini, Enrico; Vilardo, Pier Giuseppe; Cecconi, Ilaria; Cappiello, Mario; Dal Monte, Massimo; Marini, Isabella; Del Corso, Antonella; Mura, Umberto</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">533-538</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Aldose reductase inhibition is one of the therapeutic strategies that has been proposed to prevent or ameliorate long term diabetic complications including retinopathy and sugar cataract.  Rats were fed with a galactose rich diet and the aldose reductase inhibitor Tolrestat was topically delivered by ocular instillation.  The levels of lens aldose reductase activity, galactitol and the onset of cataract were evaluated during and after treatment with the inhibitor. Topical application of 1-3% Tolrestat (10 μl) four times daily resulted, after 9 days, in a significant decrease in the enzyme activity.  Well after interrupting treatment with the drug, the enzyme activity remained impaired and galactose induced cataract was prevented.  Our findings may represent the basis for therapeutic plans to prevent sugar cataract by long term cyclic treatments with aldose reductase inhibitors, with redn. in drug doses and side effects.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8HwXqhqinobVg90H21EOLACvtfcHk0lj9guWc7bdHCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntVCntbo%253D&md5=91b63bf9326d7ee40f9c75f05703715a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1006%2Fexer.1999.0729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexer.1999.0729%26sid%3Dliteratum%253Aachs%26aulast%3DBanditelli%26aufirst%3DS.%26aulast%3DBoldrini%26aufirst%3DE.%26aulast%3DVilardo%26aufirst%3DP.%2BG.%26aulast%3DCecconi%26aufirst%3DI.%26aulast%3DCappiello%26aufirst%3DM.%26aulast%3DDal%2BMonte%26aufirst%3DM.%26aulast%3DMarini%26aufirst%3DI.%26aulast%3DDel%2BCorso%26aufirst%3DA.%26aulast%3DMura%26aufirst%3DU.%26atitle%3DA%2520New%2520Approach%2520against%2520Sugar%2520Cataract%2520through%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D1999%26volume%3D69%26spage%3D533%26epage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Hotta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigeta, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikkawa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, N.</span><span> </span><span class="NLM_article-title">Clinical Efficacy of Fidarestat, a Novel Aldose Reductase Inhibitor, for Diabetic Peripheral Neuropathy</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1776</span><span class="NLM_x">–</span> <span class="NLM_lpage">1782</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2001&pages=1776-1782&author=N.+Hottaauthor=T.+Toyotaauthor=K.+Matsuokaauthor=Y.+Shigetaauthor=R.+Kikkawaauthor=T.+Kanekoauthor=A.+Takahashiauthor=K.+Sugimuraauthor=Y.+Koikeauthor=J.+Ishiiauthor=N.+Sakamoto&title=Clinical+Efficacy+of+Fidarestat%2C+a+Novel+Aldose+Reductase+Inhibitor%2C+for+Diabetic+Peripheral+Neuropathy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHotta%26aufirst%3DN.%26aulast%3DToyota%26aufirst%3DT.%26aulast%3DMatsuoka%26aufirst%3DK.%26aulast%3DShigeta%26aufirst%3DY.%26aulast%3DKikkawa%26aufirst%3DR.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DSugimura%26aufirst%3DK.%26aulast%3DKoike%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DJ.%26aulast%3DSakamoto%26aufirst%3DN.%26atitle%3DClinical%2520Efficacy%2520of%2520Fidarestat%252C%2520a%2520Novel%2520Aldose%2520Reductase%2520Inhibitor%252C%2520for%2520Diabetic%2520Peripheral%2520Neuropathy%26jtitle%3DDiabetes%2520Care%26date%3D2001%26volume%3D24%26spage%3D1776%26epage%3D1782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Asano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, N.</span><span> </span><span class="NLM_article-title">Fidarestat (SNK-860), a Potent Aldose Reductase Inhibitor, Normalizes the Elevated Sorbitol Accumulation in Erythrocytes of Diabetic Patients</span> <span class="citation_source-journal">J. Diabetes Complications</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2FS1056-8727%2801%2900175-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=12039395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A280%3ADC%252BD383pslCmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=133-138&author=T.+Asanoauthor=Y.+Saitoauthor=M.+Kawakamiauthor=N.+Yamada&title=Fidarestat+%28SNK-860%29%2C+a+Potent+Aldose+Reductase+Inhibitor%2C+Normalizes+the+Elevated+Sorbitol+Accumulation+in+Erythrocytes+of+Diabetic+Patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Fidarestat (SNK-860), a potent aldose reductase inhibitor, normalizes the elevated sorbitol accumulation in erythrocytes of diabetic patients</span></div><div class="casAuthors">Asano Tomoichiro; Saito Yasushi; Kawakami Masanobu; Yamada Nobuhiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of diabetes and its complications</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-8</span>
        ISSN:<span class="NLM_cas:issn">1056-8727</span>.
    </div><div class="casAbstract">Sorbitol accumulation in nerves has been regarded as one of the major causes of diabetic neuropathy.  In this study, fidarestat (SNK-860; 1 mg daily), a potent new aldose reductase inhibitor (ARI), or the commercially available ARI epalrestat (150 mg daily), was administered for 4 weeks to 58 Type 2 diabetic patients.  Treatment with these drugs had no effect on glycemic control, judging from plasma glucose and HbA(1c) levels.  However, fidarestat treatment normalized the elevated sorbitol content of erythrocytes under fasting as well as postprandial conditions.  In contrast, the effect of epalrestat was minimal.  There were no major side effects with fidarestat.  Thus, fidarestat is considered to be a potent and promising ARI, possibly useful for both preventing and treating diabetic neuropathy.  Further studies are needed to clarify how much the occurrence and progression of diabetic neuropathy are inhibited by normalizing sorbitol elevation with fidarestat treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQY67nKm4kYoMK3uFsUIZtkfW6udTcc2ebevi4WOONVHbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD383pslCmsw%253D%253D&md5=4018c38d0dca96a3f3a7296cc6ebd7e5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS1056-8727%2801%2900175-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1056-8727%252801%252900175-1%26sid%3Dliteratum%253Aachs%26aulast%3DAsano%26aufirst%3DT.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DKawakami%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DN.%26atitle%3DFidarestat%2520%2528SNK-860%2529%252C%2520a%2520Potent%2520Aldose%2520Reductase%2520Inhibitor%252C%2520Normalizes%2520the%2520Elevated%2520Sorbitol%2520Accumulation%2520in%2520Erythrocytes%2520of%2520Diabetic%2520Patients%26jtitle%3DJ.%2520Diabetes%2520Complications%26date%3D2002%26volume%3D16%26spage%3D133%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Okayama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okouchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imaeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukutomi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, M.</span><span> </span><span class="NLM_article-title">Mechanisms of Inhibitory Activity of the Aldose Reductase Inhibitor, Epalrestat, on High Glucose-Mediated Endothelial Injury: Neutrophil-Endothelial Cell Adhesion and Surface Expression of Endothelial Adhesion Molecules</span> <span class="citation_source-journal">J. Diabetes Complications</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2FS1056-8727%2802%2900178-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=12200074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A280%3ADC%252BD38votVKmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=321-326&author=N.+Okayamaauthor=H.+Omiauthor=M.+Okouchiauthor=K.+Imaedaauthor=T.+Katoauthor=M.+Akaoauthor=S.+Imaiauthor=M.+Shimizuauthor=T.+Fukutomiauthor=M.+Itoh&title=Mechanisms+of+Inhibitory+Activity+of+the+Aldose+Reductase+Inhibitor%2C+Epalrestat%2C+on+High+Glucose-Mediated+Endothelial+Injury%3A+Neutrophil-Endothelial+Cell+Adhesion+and+Surface+Expression+of+Endothelial+Adhesion+Molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of inhibitory activity of the aldose reductase inhibitor, epalrestat, on high glucose-mediated endothelial injury: neutrophil-endothelial cell adhesion and surface expression of endothelial adhesion molecules</span></div><div class="casAuthors">Okayama Naotsuka; Omi Hitoshi; Okouchi Masahiro; Imaeda Kenro; Kato Takashi; Akao Masaya; Imai Seiji; Shimizu Manabu; Fukutomi Tatsuya; Itoh Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of diabetes and its complications</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">321-6</span>
        ISSN:<span class="NLM_cas:issn">1056-8727</span>.
    </div><div class="casAbstract">BACKGROUND:  We have previously reported that endothelial cells cultured in the presence of high concentrations of glucose (27.8 and 55.5 mM) exhibited enhanced neutrophil adhesion through increased expression of endothelial adhesion molecules via the activation of a protein kinase C (PKC)-dependent pathway.  We also found that the aldose reductase inhibitor, epalrestat, inhibited these events, but the mechanisms for this inhibition remained unclear.  In this study, we further investigated the inhibitory mechanisms of epalrestat with reference to PKC activation and nitric oxide (NO) production.  METHODS:  Human umbilical vein endothelial cells (HUVECs) were cultured for 48 h in glucose-rich medium and neutrophils from healthy volunteers were then added and allowed to adhere for 30 min.  Adhered neutrophils were quantified by measuring myeloperoxidase (MPO) activity and surface expression of endothelial adhesion molecules was determined by enzyme immunoassay.  RESULTS:  Culture in the presence of a high concentration of glucose (27.8 mM for 48 h) increased neutrophil-endothelial cell adhesion and surface expression of intercellular adhesion molecule-1 (ICAM-1), P-selectin, and E-selectin on endothelial cells.  These phenomena were significantly inhibited by epalrestat (10 microM), while NO synthase (NOS) inhibitors reduced the inhibitory effects of this compound.  In contrast, 10 nM phorbol 12-myristate 13-acetate (PMA), a PKC activator, showed similar effects as high glucose, and these effects were also inhibited by epalrestat.  CONCLUSIONS:  Our data suggested that epalrestat inhibited high glucose-mediated neutrophil-endothelial cell adhesion and expression of endothelial adhesion molecules not only through inhibition of a PKC-dependent pathway, but also through increased endothelial NO production.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKGJV6B1R8mGGmni0r9GoKfW6udTcc2ebevi4WOONVHbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38votVKmug%253D%253D&md5=247cac5ec15041960174b06f7a241f59</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS1056-8727%2802%2900178-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1056-8727%252802%252900178-2%26sid%3Dliteratum%253Aachs%26aulast%3DOkayama%26aufirst%3DN.%26aulast%3DOmi%26aufirst%3DH.%26aulast%3DOkouchi%26aufirst%3DM.%26aulast%3DImaeda%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DAkao%26aufirst%3DM.%26aulast%3DImai%26aufirst%3DS.%26aulast%3DShimizu%26aufirst%3DM.%26aulast%3DFukutomi%26aufirst%3DT.%26aulast%3DItoh%26aufirst%3DM.%26atitle%3DMechanisms%2520of%2520Inhibitory%2520Activity%2520of%2520the%2520Aldose%2520Reductase%2520Inhibitor%252C%2520Epalrestat%252C%2520on%2520High%2520Glucose-Mediated%2520Endothelial%2520Injury%253A%2520Neutrophil-Endothelial%2520Cell%2520Adhesion%2520and%2520Surface%2520Expression%2520of%2520Endothelial%2520Adhesion%2520Molecules%26jtitle%3DJ.%2520Diabetes%2520Complications%26date%3D2002%26volume%3D16%26spage%3D321%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Nakahara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nejima, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamagami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amano, S.</span><span> </span><span class="NLM_article-title">A Randomised, Placebo Controlled Clinical Trial of the Aldose Reductse Inhibitor CT-112 as Management of Corneal Epithelial Disorders in Diabetic Patients</span> <span class="citation_source-journal">Br. J. Ophthalmol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">268</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1136%2Fbjo.2004.049841" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=15722300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A280%3ADC%252BD2M%252FptV2jsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2005&pages=266-268&author=M.+Nakaharaauthor=K.+Miyataauthor=S.+Otaniauthor=T.+Miyaiauthor=R.+Nejimaauthor=S.+Yamagamiauthor=S.+Amano&title=A+Randomised%2C+Placebo+Controlled+Clinical+Trial+of+the+Aldose+Reductse+Inhibitor+CT-112+as+Management+of+Corneal+Epithelial+Disorders+in+Diabetic+Patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients</span></div><div class="casAuthors">Nakahara M; Miyata K; Otani S; Miyai T; Nejima R; Yamagami S; Amano S</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of ophthalmology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">266-8</span>
        ISSN:<span class="NLM_cas:issn">0007-1161</span>.
    </div><div class="casAbstract">AIM:  To evaluate the efficacy of topical aldose reductase inhibitor CT-112 (5-[3-ethoxy-4-pentyloxyphenyl]-2,4-thiazolidinedione) on corneal epithelial barrier function in diabetic patients.  METHODS:  This was a prospective, randomised, double masked placebo controlled study. 34 eyes of 34 diabetic patients were randomly assigned treatment with 0.25% eye drops of CT-112 (n = 22) or a placebo (n = 12) four times a day for 8 weeks.  Corneal fluorescein staining and corneal sensation were examined before treatment as well as 4 and 8 weeks after administration.  Corneal epithelial permeability to fluorescence was measured with an anterior fluorophotometer.  RESULTS:  Average scores of superficial punctate keratopathy and corneal sensitivity did not differ significantly between the two groups at any time.  Whereas average fluorescein concentrations did not differ significantly for the CT-112 and placebo groups before treatment, they did differ significantly 4 and 8 weeks after treatment (4 weeks, p = 0.0327; 8 weeks, p = 0.0143).  CONCLUSION:  The topical aldose reductase inhibitor, CT-112 improves the corneal epithelial barrier function in diabetic patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTdVHiDU6CHZckU0YCbOU3EfW6udTcc2eZtflQK_Nx_ALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M%252FptV2jsw%253D%253D&md5=60c13679d2054555c7205de50dffacf4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1136%2Fbjo.2004.049841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbjo.2004.049841%26sid%3Dliteratum%253Aachs%26aulast%3DNakahara%26aufirst%3DM.%26aulast%3DMiyata%26aufirst%3DK.%26aulast%3DOtani%26aufirst%3DS.%26aulast%3DMiyai%26aufirst%3DT.%26aulast%3DNejima%26aufirst%3DR.%26aulast%3DYamagami%26aufirst%3DS.%26aulast%3DAmano%26aufirst%3DS.%26atitle%3DA%2520Randomised%252C%2520Placebo%2520Controlled%2520Clinical%2520Trial%2520of%2520the%2520Aldose%2520Reductse%2520Inhibitor%2520CT-112%2520as%2520Management%2520of%2520Corneal%2520Epithelial%2520Disorders%2520in%2520Diabetic%2520Patients%26jtitle%3DBr.%2520J.%2520Ophthalmol.%26date%3D2005%26volume%3D89%26spage%3D266%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Hotta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akanuma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamori, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shichiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigeta, Y.</span><span> </span><span class="NLM_article-title">Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1538</span><span class="NLM_x">–</span> <span class="NLM_lpage">1544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=1538-1544&author=N.+Hottaauthor=Y.+Akanumaauthor=R.+Kawamoriauthor=K.+Matsuokaauthor=Y.+Okaauthor=M.+Shichiriauthor=T.+Toyotaauthor=M.+Nakashimaauthor=I.+Yoshimuraauthor=N.+Sakamotoauthor=Y.+Shigeta&title=Long-Term+Clinical+Effects+of+Epalrestat%2C+an+Aldose+Reductase+Inhibitor%2C+on+Diabetic+Peripheral+Neuropathy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHotta%26aufirst%3DN.%26aulast%3DAkanuma%26aufirst%3DY.%26aulast%3DKawamori%26aufirst%3DR.%26aulast%3DMatsuoka%26aufirst%3DK.%26aulast%3DOka%26aufirst%3DY.%26aulast%3DShichiri%26aufirst%3DM.%26aulast%3DToyota%26aufirst%3DT.%26aulast%3DNakashima%26aufirst%3DM.%26aulast%3DYoshimura%26aufirst%3DI.%26aulast%3DSakamoto%26aufirst%3DN.%26aulast%3DShigeta%26aufirst%3DY.%26atitle%3DLong-Term%2520Clinical%2520Effects%2520of%2520Epalrestat%252C%2520an%2520Aldose%2520Reductase%2520Inhibitor%252C%2520on%2520Diabetic%2520Peripheral%2520Neuropathy%26jtitle%3DDiabetes%2520Care%26date%3D2006%26volume%3D29%26spage%3D1538%26epage%3D1544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Oyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyasita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirai, K.</span><span> </span><span class="NLM_article-title">The Role of Polyol Pathway in High Glucose-Induced Endothelial Cell Damages</span> <span class="citation_source-journal">Diabetes Res. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.diabres.2006.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=16624439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1Sltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2006&pages=227-234&author=T.+Oyamaauthor=Y.+Miyasitaauthor=H.+Watanabeauthor=K.+Shirai&title=The+Role+of+Polyol+Pathway+in+High+Glucose-Induced+Endothelial+Cell+Damages"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The role of polyol pathway in high glucose-induced endothelial cell damages</span></div><div class="casAuthors">Oyama, Tomokazu; Miyasita, Yoh; Watanabe, Husako; Shirai, Kohji</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes Research and Clinical Practice</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-234</span>CODEN:
                <span class="NLM_cas:coden">DRCPE9</span>;
        ISSN:<span class="NLM_cas:issn">0168-8227</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">To clarify the mechanism by which hyperglycemia in diabetes mellitus causes endothelial cell damages, the effects of high glucose on DNA fragmentation and caspase-3 activity of cultured endothelial cells and on the generation of 8-hydroxy-2'-deoxyguanosine (8-OHdG) were studied.  Furthermore, the involvement of the polyol pathway in this process was investigated using aldose reductase inhibitor (SNK-860).  Human umbilical vein endothelial cells (HUVECs) were incubated with 5.5 mmol/L (low glucose medium) or 28 mmol/L (high glucose medium) of glucose.  The amts. of fragmented DNA, caspase-3 activity and 8-OHdG in the medium increased in significantly greater extent in high glucose-incubated HUVECs than in low glucose-incubated HUVECs.  No significant increase in fragmented DNA or 8-OHdG was obsd. when HUVECs were incubated with mannitol (500 mg/mL).  The concn. of intracellular sorbitol was significantly higher in HUVECs incubated in high glucose medium than that in low glucose medium.  Addn. of the aldose reductase inhibitor SNK-860 dose-dependently decreased the intracellular sorbitol concn. in HUVECs incubated in high glucose medium, and also significantly suppressed the increases in fragmented DNA, caspase-3 activity and 8-OHdG by conditioning with high glucose medium.  These results suggest that high glucose-induced endothelial cell damages may be mediated by activation of the polyol pathway accompanied by augmented oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2QQzvSyT1ubVg90H21EOLACvtfcHk0lieIzCVr0FtNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1Sltrc%253D&md5=c7de29a2eb061126eba68042d83f984e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.diabres.2006.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.diabres.2006.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DOyama%26aufirst%3DT.%26aulast%3DMiyasita%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DShirai%26aufirst%3DK.%26atitle%3DThe%2520Role%2520of%2520Polyol%2520Pathway%2520in%2520High%2520Glucose-Induced%2520Endothelial%2520Cell%2520Damages%26jtitle%3DDiabetes%2520Res.%2520Clin.%2520Pract.%26date%3D2006%26volume%3D73%26spage%3D227%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Lorenzi, M.</span><span> </span><span class="NLM_article-title">The Polyol Pathway as a Mechanism for Diabetic Retinopathy: Attractive, Elusive, and Resilient</span> <span class="citation_source-journal">Exp. Diabetes Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">61038</span><span class="refDoi"> DOI: 10.1155/2007/61038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1155%2F2007%2F61038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=18224243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FmvVOjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=61038&author=M.+Lorenzi&title=The+Polyol+Pathway+as+a+Mechanism+for+Diabetic+Retinopathy%3A+Attractive%2C+Elusive%2C+and+Resilient&doi=10.1155%2F2007%2F61038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient</span></div><div class="casAuthors">Lorenzi Mara</div><div class="citationInfo"><span class="NLM_cas:title">Experimental diabetes research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2007</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61038</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The polyol pathway is a two-step metabolic pathway in which glucose is reduced to sorbitol, which is then converted to fructose.  It is one of the most attractive candidate mechanisms to explain, at least in part, the cellular toxicity of diabetic hyperglycemia because (i) it becomes active when intracellular glucose concentrations are elevated, (ii) the two enzymes are present in human tissues and organs that are sites of diabetic complications, and (iii) the products of the pathway and the altered balance of cofactors generate the types of cellular stress that occur at the sites of diabetic complications.  Inhibition (or ablation) of aldose reductase, the first and rate-limiting enzyme in the pathway, reproducibly prevents diabetic retinopathy in diabetic rodent models, but the results of a major clinical trial have been disappointing.  Since then, it has become evident that truly informative indicators of polyol pathway activity and/or inhibition are elusive, but are likely to be other than sorbitol levels if meant to predict accurately tissue consequences.  The spectrum of abnormalities known to occur in human diabetic retinopathy has enlarged to include glial and neuronal abnormalities, which in experimental animals are mediated by the polyol pathway.  The endothelial cells of human retinal vessels have been noted to have aldose reductase.  Specific polymorphisms in the promoter region of the aldose reductase gene have been found associated with susceptibility or progression of diabetic retinopathy.  This new knowledge has rekindled interest in a possible role of the polyol pathway in diabetic retinopathy and in methodological investigation that may prepare new clinical trials.  Only new drugs that inhibit aldose reductase with higher efficacy and safety than older drugs will make possible to learn if the resilience of the polyol pathway means that it has a role in human diabetic retinopathy that should not have gone undiscovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtb9gFve5I2-IHSmpohpd0fW6udTcc2eZtflQK_Nx_ALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FmvVOjtQ%253D%253D&md5=dad10f3003f34edbcae39108b3631d74</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1155%2F2007%2F61038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2007%252F61038%26sid%3Dliteratum%253Aachs%26aulast%3DLorenzi%26aufirst%3DM.%26atitle%3DThe%2520Polyol%2520Pathway%2520as%2520a%2520Mechanism%2520for%2520Diabetic%2520Retinopathy%253A%2520Attractive%252C%2520Elusive%252C%2520and%2520Resilient%26jtitle%3DExp.%2520Diabetes%2520Res.%26date%3D2007%26spage%3D61038%26doi%3D10.1155%2F2007%2F61038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Matsumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuromiya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bril, V.</span><span> </span><span class="NLM_article-title">Ranirestat (AS-3201), a Potent Aldose Reductase Inhibitor, Reduces Sorbinil Levels and Improves Motor Nerve Conduction Velocity in Streptozotocin-Diabetes Rats</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1254%2Fjphs.08061FP" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=18635918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpt12mtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2008&pages=231-237&author=T.+Matsumotoauthor=Y.+Onoauthor=M.+Kuronoauthor=A.+Kuromiyaauthor=K.+Nakamuraauthor=V.+Bril&title=Ranirestat+%28AS-3201%29%2C+a+Potent+Aldose+Reductase+Inhibitor%2C+Reduces+Sorbinil+Levels+and+Improves+Motor+Nerve+Conduction+Velocity+in+Streptozotocin-Diabetes+Rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Ranirestat (AS-3201), a potent aldose reductase inhibitor, reduces sorbitol levels and improves motor nerve conduction velocity in streptozotocin-diabetic rats</span></div><div class="casAuthors">Matsumoto, Takafumi; Ono, Yoshiyuki; Kurono, Masuo; Kuromiya, Akemi; Nakamura, Keiji; Bril, Vera</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">231-237</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">Ranirestat (AS-3201) is a novel aldose reductase (AR) inhibitor with potentially beneficial effects on diabetic sensorimotor polyneuropathy.  In this study, we performed a kinetic anal. to det. the mode of inhibition of ranirestat on AR and investigated the effects of ranirestat on sorbitol levels in the sciatic nerves and lens of streptozotocin (STZ)-diabetic rats.  We also evaluated the effects on motor nerve conduction velocity (MNCV) in STZ-diabetic rats.  Kinetic analyses revealed that the ranirestat inhibition of AR is uncompetitive and reversible.  In the sciatic nerve and lens of STZ-diabetic rats, single oral administration of ranirestat slightly reduced sorbitol levels.  However, repeated oral administration of ranirestat for 5, 21, or 60 days enhanced the reducing effect of the ranirestat on sorbitol levels in the sciatic nerves and lens of STZ-diabetic rats with max. effects after 21 days of treatment.  Finally, repeated oral administration of ranirestat for 21 or 42 days dose-dependently improved the STZ-induced decrease in MNCV in STZ-diabetic rats.  These findings demonstrate that repeated oral administration of ranirestat reduces sorbitol accumulation and improves MNCV in STZ-diabetic rats, indicating that ranirestat is an agent for the management of diabetic sensorimotor polyneuropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQk1kpbKc2NLVg90H21EOLACvtfcHk0lgKsMlHO4F4KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpt12mtrs%253D&md5=53f4c68da0d7c990a5b981592e597fa9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1254%2Fjphs.08061FP&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.08061FP%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DT.%26aulast%3DOno%26aufirst%3DY.%26aulast%3DKurono%26aufirst%3DM.%26aulast%3DKuromiya%26aufirst%3DA.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DBril%26aufirst%3DV.%26atitle%3DRanirestat%2520%2528AS-3201%2529%252C%2520a%2520Potent%2520Aldose%2520Reductase%2520Inhibitor%252C%2520Reduces%2520Sorbinil%2520Levels%2520and%2520Improves%2520Motor%2520Nerve%2520Conduction%2520Velocity%2520in%2520Streptozotocin-Diabetes%2520Rats%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2008%26volume%3D107%26spage%3D231%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Schemmel, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padiyara, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Souza, J. J.</span><span> </span><span class="NLM_article-title">Aldose Reductase Inhibitors in the Treatment of Diabetic Peripheral Neuropathy: A Review</span> <span class="citation_source-journal">J. Diabetes Complications</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">354</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.jdiacomp.2009.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=19748287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A280%3ADC%252BC3cfgsFyisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=354-360&author=K.+E.+Schemmelauthor=R.+S.+Padiyaraauthor=J.+J.+D%E2%80%99Souza&title=Aldose+Reductase+Inhibitors+in+the+Treatment+of+Diabetic+Peripheral+Neuropathy%3A+A+Review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review</span></div><div class="casAuthors">Schemmel Kate E; Padiyara Rosalyn S; D'Souza Jennifer J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of diabetes and its complications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">354-60</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  The purpose of this article was to examine how aldose reductase (AR) inhibitors are used in the prevention and treatment of peripheral neuropathy in diabetes, specifically focusing on efficacy.  METHODS:  Medline searches were used to identify clinical trials investigating AR inhibitors and their proposed mechanism of action, efficacy, and adverse effects.  Additionally, the references of the articles returned by the Medline search were examined for pertinent publications.  RESULTS:  Three AR inhibitors were selected for review.  Modest improvements in the preservation and restoration of nerve conduction velocities were reported in the studies.  Additionally, patients reported improvements in the subjective symptoms associated with diabetic peripheral neuropathy.  Adverse effects for the studied agents were minimal or not reported.  CONCLUSIONS:  Given the mechanism by which diabetic peripheral neuropathy can result, targeting the polyol pathway as a method of treatment appears promising, yet the efficacy of newer AR inhibitors is still to be proven.  Currently, these agents are not marketed in the United States.  As newer studies emerge, diabetes educators will learn more about their efficacy and safety in preventing and treating diabetic peripheral neuropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRS8EHgBzm8mGPgL4LrC-0VfW6udTcc2eZ79OrhrElTGbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfgsFyisw%253D%253D&md5=64a85cc489cd45120d17ab35bd459f88</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.jdiacomp.2009.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jdiacomp.2009.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DSchemmel%26aufirst%3DK.%2BE.%26aulast%3DPadiyara%26aufirst%3DR.%2BS.%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DJ.%2BJ.%26atitle%3DAldose%2520Reductase%2520Inhibitors%2520in%2520the%2520Treatment%2520of%2520Diabetic%2520Peripheral%2520Neuropathy%253A%2520A%2520Review%26jtitle%3DJ.%2520Diabetes%2520Complications%26date%3D2010%26volume%3D24%26spage%3D354%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Miyamoto, S.</span><span> </span><span class="NLM_article-title">Molecular Modeling and Structure-Based Drug Discovery Studies of Aldose Reductase Inhibitors</span> <span class="citation_source-journal">Chem-Bio Inf. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=74-85&author=S.+Miyamoto&title=Molecular+Modeling+and+Structure-Based+Drug+Discovery+Studies+of+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DS.%26atitle%3DMolecular%2520Modeling%2520and%2520Structure-Based%2520Drug%2520Discovery%2520Studies%2520of%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DChem-Bio%2520Inf.%2520J.%26date%3D2002%26volume%3D2%26spage%3D74%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Suzen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buyukbingol, E.</span><span> </span><span class="NLM_article-title">Recent Studies of Aldose Reductase Enzyme Inhibition for Diabetic Complications</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1329</span><span class="NLM_x">–</span> <span class="NLM_lpage">1352</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.2174%2F0929867033457377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=12871133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD3sXls1Wrtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=1329-1352&author=S.+Suzenauthor=E.+Buyukbingol&title=Recent+Studies+of+Aldose+Reductase+Enzyme+Inhibition+for+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Recent studies of aldose reductase enzyme inhibition for diabetic complications</span></div><div class="casAuthors">Suzen, Sibel; Buyukbingol, Erdem</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1329-1352</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Aldose reductase [ALR2; EC 1.1.1.21], a key enzyme of polyol pathway, catalyzes NADPH-dependent redn. of glucose to sorbitol (Sorbitol pathway), and an excessive accumulation of intracellular sorbitol found in various tissues of diabetic animals and in cells cultured under high glucose conditions has been proposed to be an important factor for the pathogenesis of diabetic complications.  The only strategy shown to be consistently beneficial in the treatment of diabetic complications is meticulous control of blood glucose.  However, aldose reductase (AR) enzyme inhibition is becoming one of the therapeutic strategies that have been proposed to prevent or ameliorate long-term diabetic complications.  Therefore, AR inhibitors (ARIs) hold promise for reducing metabolic nerve injury, but further study is needed.  On the other hand, there is strong evidence to show that diabetes is assocd. with increased oxidative stress.  However, the source of this oxidative stress remains unclear.  This relationship between diabetic complications and free radical prodn. was also under investigation.  The studies suggest that hydroxyl radical is indirectly inhibited by ARIs resulting from decreasing polyol levels and hydroxyl radical formation is related to the early stages of diabetic complications, possibly via the Fenton reaction involving H2O2 produced from the activated polyol pathway.  Therefore, it is proposed that hydroxyl radical may accelerate damage to the cell membranes resulting from polyol accumulation.  The search for specific inhibitors of AR enzyme has still become a major pharmaceutic challenge, though a no. of AR inhibitors have so far been assessed for diabetic complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVxwqI7nZRXrVg90H21EOLACvtfcHk0lgKsMlHO4F4KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXls1Wrtb0%253D&md5=3039c410e8129e2ededf14fff77035ad</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F0929867033457377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867033457377%26sid%3Dliteratum%253Aachs%26aulast%3DSuzen%26aufirst%3DS.%26aulast%3DBuyukbingol%26aufirst%3DE.%26atitle%3DRecent%2520Studies%2520of%2520Aldose%2520Reductase%2520Enzyme%2520Inhibition%2520for%2520Diabetic%2520Complications%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2003%26volume%3D10%26spage%3D1329%26epage%3D1352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Alexiou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegklidou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatzopoulou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolaou, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demopoulos, V. J.</span><span> </span><span class="NLM_article-title">Aldose Reductase Enzyme and Its Implication to Major Health Problems of the 21st Century</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">734</span><span class="NLM_x">–</span> <span class="NLM_lpage">752</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.2174%2F092986709787458362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=19199934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFGqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=734-752&author=P.+Alexiouauthor=K.+Pegklidouauthor=M.+Chatzopoulouauthor=I.+Nicolaouauthor=V.+J.+Demopoulos&title=Aldose+Reductase+Enzyme+and+Its+Implication+to+Major+Health+Problems+of+the+21st+Century"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Aldose reductase enzyme and its implication to major health problems of the 21st century</span></div><div class="casAuthors">Alexiou, Polyxeni; Pegklidou, Kyriaki; Chatzopoulou, Maria; Nicolaou, Ioannis; Demopoulos, Vassilis J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">734-752</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Aldose reductase enzyme (ALR2) of the polyol metabolic pathway, apart from its role as detoxifying enzyme towards toxic aldehydes, osmoregulator in the kidney and regulator of sperm maturation, was first found to be implicated in the etiol. of the long term diabetic complications.  However, to date, emerging reports have suggested that under normal glucose concn., ALR2 may be up-regulated by factors other than hyperglycemia and therefore be involved also in other pathol. processes that have become major threats to human health in the 21st century.  Such pathologies are a no. of cardiac disorders, inflammation, mood disorders, renal insufficiency and ovarian abnormalities.  In addn., ALR2 was found to be over-expressed in different human cancers such as liver, breast, ovarian, cervical and rectal cancers.  Although several aldose reductase inhibitors (ARIs) have progressed to the clin. level, only one is currently on the market.  Thus, attention is currently targeted to discover ARIs of distinct chem. structures, being neither hydantoin nor carboxylic acid derivs.  The present review focuses on the mol. mechanisms by which ALR2 is implicated in a no. of pathologies, on various aspects concerning its catalytic mechanism and its active site, and on the main classes of ARIs that have been developed to date, as well as on reported (quant.) structure-activity relationships.  The presented data aim to support the notion that ARIs are of pharmacotherapeutic interest for the pharmaceutical community and highlight essential aspects for the development of efficient and potent ARIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEzbMxWaT45bVg90H21EOLACvtfcHk0lg2o9Usay04XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFGqtr0%253D&md5=b84b7cfab09e7c63dc78ac8f2d729411</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F092986709787458362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986709787458362%26sid%3Dliteratum%253Aachs%26aulast%3DAlexiou%26aufirst%3DP.%26aulast%3DPegklidou%26aufirst%3DK.%26aulast%3DChatzopoulou%26aufirst%3DM.%26aulast%3DNicolaou%26aufirst%3DI.%26aulast%3DDemopoulos%26aufirst%3DV.%2BJ.%26atitle%3DAldose%2520Reductase%2520Enzyme%2520and%2520Its%2520Implication%2520to%2520Major%2520Health%2520Problems%2520of%2520the%252021st%2520Century%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2009%26volume%3D16%26spage%3D734%26epage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Maccari, R.; Ottanà, R.</span><span> </span><span class="NLM_article-title">2,4-Thiazolidinedione and 2-Thioxo-4-thiazolidinone Derivatives as Aldose Reductase Inhibitors in the Search for Drugs To Prevent Long-Term Diabetes Complications</span>. In  <span class="citation_source-book">Advances in Molecular Mechanisms and Pharmacology of Diabetic Complications</span>; <span class="NLM_contrib-group">Stefek, M.</span> Ed.; <span class="NLM_publisher-name">Transworld Research Network</span>: <span class="NLM_publisher-loc">Kerala, India</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=219-245&author=R.+Maccari&author=R.+Ottan%C3%A0author=M.+Stefek&title=Advances+in+Molecular+Mechanisms+and+Pharmacology+of+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMaccari%26aufirst%3DR.%26atitle%3D2%252C4-Thiazolidinedione%2520and%25202-Thioxo-4-thiazolidinone%2520Derivatives%2520as%2520Aldose%2520Reductase%2520Inhibitors%2520in%2520the%2520Search%2520for%2520Drugs%2520To%2520Prevent%2520Long-Term%2520Diabetes%2520Complications%26btitle%3DAdvances%2520in%2520Molecular%2520Mechanisms%2520and%2520Pharmacology%2520of%2520Diabetic%2520Complications%26aulast%3DStefek%26aufirst%3DM.%26pub%3DTransworld%2520Research%2520Network%26date%3D2010%26spage%3D219%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Hotta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamori, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atsumi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigeta, Y.</span><span> </span><span class="NLM_article-title">Stratified Analyses for Selecting Appropriate Target Patients with Diabetic Peripheral Neuropathy for Long-Term Treatment with an Aldose Reductase Inhibitor, Epalrestat</span> <span class="citation_source-journal">Diabetic Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">818</span><span class="NLM_x">–</span> <span class="NLM_lpage">825</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1111%2Fj.1464-5491.2008.02490.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=18644069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvFyiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2008&pages=818-825&author=N.+Hottaauthor=R.+Kawamoriauthor=Y.+Atsumiauthor=M.+Babaauthor=H.+Kishikawaauthor=J.+Nakamuraauthor=S.+Oikawaauthor=N.+Yamadaauthor=H.+Yasudaauthor=Y.+Shigeta&title=Stratified+Analyses+for+Selecting+Appropriate+Target+Patients+with+Diabetic+Peripheral+Neuropathy+for+Long-Term+Treatment+with+an+Aldose+Reductase+Inhibitor%2C+Epalrestat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat</span></div><div class="casAuthors">Hotta, N.; Kawamori, R.; Atsumi, Y.; Baba, M.; Kishikawa, H.; Nakamura, J.; Oikawa, S.; Yamada, N.; Yasuda, H.; Shigeta, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetic Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">818-825</span>CODEN:
                <span class="NLM_cas:coden">DIMEEV</span>;
        ISSN:<span class="NLM_cas:issn">0742-3071</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The long-term efficacy of epalrestat, an aldose reductase inhibitor, in improving subjective symptoms and nerve function was comprehensively assessed to identify patients with diabetic peripheral neuropathy who responded to epalrestat treatment.  Stratified analyses were conducted on data from patients in the Aldose Reductase Inhibitor-Diabetes Complications Trial (ADCT).  The ADCT included patients with diabetic peripheral neuropathy, median motor nerve conduction velocity ≥ 40 m/s and with glycated Hb (HbA1c) ≤9.0%.  Longitudinal data on HbA1c and subjective symptoms of the patients for 3 years were analyzed (epalrestat n = 231, control subjects n = 273).  Stratified analyses based on background variables (glycemic control, grades of retinopathy or proteinuria) were performed to examine the relationship between subjective symptoms and nerve function.  Multiple logistic regression analyses were conducted.  Stratified subgroup analyses revealed significantly better efficacy of epalrestat in patients with good glycemic control and less severe diabetic complications.  In the control group, no improvement in nerve function was seen regardless of whether symptomatic benefit was obtained.  In the epalrestat group, nerve function deteriorated less or improved in patients whose symptoms improved.  The odds ratio of the efficacy of epalrestat vs. control subjects was approx. 2:1 (4:1 in patients with HbA1c ≤7.0%).  Our results suggest that epalrestat, an aldose reductase inhibitor, will provide a clin. significant means of preventing and treating diabetic neuropathy if used in appropriate patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoELGO2L0SGxLVg90H21EOLACvtfcHk0lg2o9Usay04XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvFyiuro%253D&md5=e70778d565ff6534db82c1b35bd81102</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1111%2Fj.1464-5491.2008.02490.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1464-5491.2008.02490.x%26sid%3Dliteratum%253Aachs%26aulast%3DHotta%26aufirst%3DN.%26aulast%3DKawamori%26aufirst%3DR.%26aulast%3DAtsumi%26aufirst%3DY.%26aulast%3DBaba%26aufirst%3DM.%26aulast%3DKishikawa%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DJ.%26aulast%3DOikawa%26aufirst%3DS.%26aulast%3DYamada%26aufirst%3DN.%26aulast%3DYasuda%26aufirst%3DH.%26aulast%3DShigeta%26aufirst%3DY.%26atitle%3DStratified%2520Analyses%2520for%2520Selecting%2520Appropriate%2520Target%2520Patients%2520with%2520Diabetic%2520Peripheral%2520Neuropathy%2520for%2520Long-Term%2520Treatment%2520with%2520an%2520Aldose%2520Reductase%2520Inhibitor%252C%2520Epalrestat%26jtitle%3DDiabetic%2520Med.%26date%3D2008%26volume%3D25%26spage%3D818%26epage%3D825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Ramirez, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borja, N. L.</span><span> </span><span class="NLM_article-title">Epalrestat: An Aldose Reductase Inhibitor for the Treatment of Diabetic Neuropathy</span> <span class="citation_source-journal">Pharmacotherapy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">646</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1592%2Fphco.28.5.646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=18447661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVyku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=646-655&author=M.+A.+Ramirezauthor=N.+L.+Borja&title=Epalrestat%3A+An+Aldose+Reductase+Inhibitor+for+the+Treatment+of+Diabetic+Neuropathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy</span></div><div class="casAuthors">Ramirez, Mary Ann; Borja, Nancy L.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-655</span>CODEN:
                <span class="NLM_cas:coden">PHPYDQ</span>;
        ISSN:<span class="NLM_cas:issn">0277-0008</span>.
    
            (<span class="NLM_cas:orgname">Pharmacotherapy Publications</span>)
        </div><div class="casAbstract">A review.  Diabetic neuropathy is one of the most common long-term complications in patients with diabetes mellitus, with a prevalence of 60-70% in the United States.  Treatment options include antidepressants, anticonvulsants, tramadol, and capsaicin.  These agents are modestly effective for symptomatic relief, but they do not affect the underlying pathol. nor do they slow progression of the disease.  Epalrestat is an aldose reductase inhibitor that is approved in Japan for the improvement of subjective neuropathy symptoms, abnormality of vibration sense, and abnormal changes in heart beat assocd. with diabetic peripheral neuropathy.  Unlike the current treatment options for diabetic neuropathy, epalrestat may affect or delay progression of the underlying disease process.  Data from exptl. studies indicate that epalrestat reduces sorbitol accumulation in the sciatic nerve, erythrocytes, and ocular tissues in animals, and in erythrocytes in humans.  Data from six clin. trials were evaluated, and it was detd. that epalrestat 50 mg 3 times/day may improve motor and sensory nerve conduction velocity and subjective neuropathy symptoms as compared with baseline and placebo.  Epalrestat is well tolerated, and the most frequently reported adverse effects include elevations in liver enzyme levels and gastrointestinal-related events such as nausea and vomiting.  Epalrestat may serve as a new therapeutic option to prevent or slow the progression of diabetic neuropathy.  Long-term, comparative studies in diverse patient populations are needed for clin. application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowdga4NOt42rVg90H21EOLACvtfcHk0lg2o9Usay04XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVyku7c%253D&md5=f0db682380b3aa9f9eaa8d19165a77ee</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1592%2Fphco.28.5.646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1592%252Fphco.28.5.646%26sid%3Dliteratum%253Aachs%26aulast%3DRamirez%26aufirst%3DM.%2BA.%26aulast%3DBorja%26aufirst%3DN.%2BL.%26atitle%3DEpalrestat%253A%2520An%2520Aldose%2520Reductase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Diabetic%2520Neuropathy%26jtitle%3DPharmacotherapy%26date%3D2008%26volume%3D28%26spage%3D646%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Sarges, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnur, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belletire, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. J.</span><span> </span><span class="NLM_article-title">Spiro Hydantoin Aldose Reductase Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00396a037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=230-243&author=R.+Sargesauthor=R.+C.+Schnurauthor=J.+L.+Belletireauthor=M.+J.+Peterson&title=Spiro+Hydantoin+Aldose+Reductase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00396a037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00396a037%26sid%3Dliteratum%253Aachs%26aulast%3DSarges%26aufirst%3DR.%26aulast%3DSchnur%26aufirst%3DR.%2BC.%26aulast%3DBelletire%26aufirst%3DJ.%2BL.%26aulast%3DPeterson%26aufirst%3DM.%2BJ.%26atitle%3DSpiro%2520Hydantoin%2520Aldose%2520Reductase%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D230%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldinger, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdi, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussolotti, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inskeep, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, T. W.</span><span> </span><span class="NLM_article-title">Hydantoin Bioisosteres. In Vivo Active Spiro Hydroxy Acetic Acid Aldose Reductase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2169</span><span class="NLM_x">–</span> <span class="NLM_lpage">2177</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00090a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADyaK38Xkt1Kht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=2169-2177&author=C.+A.+Lipinskiauthor=C.+E.+Aldingerauthor=T.+A.+Beyerauthor=J.+Bordnerauthor=D.+F.+Burdiauthor=D.+L.+Bussolottiauthor=P.+B.+Inskeepauthor=T.+W.+Siegel&title=Hydantoin+Bioisosteres.+In+Vivo+Active+Spiro+Hydroxy+Acetic+Acid+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Hydantoin bioisosteres.  In vivo active spiro hydroxy acetic acid aldose reductase inhibitors</span></div><div class="casAuthors">Lipinski, Christopher A.; Aldinger, Charles E.; Beyer, Thomas A.; Bordner, Jon; Burdi, Douglas F.; Bussolotti, Donald L.; Inskeep, Philip B.; Siegel, Todd W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2169-77</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The hypothesis that clin. side effects of the aldose reductase inhibitor (ARI) sorbinil were related to its hydantoin ring led to a bioisosteric anal. and replacement of the hydantoin by a spiro hydroxy acetic acid moiety as in chromans I ( R = H, Me; R1 = H, F, Cl; R2 = H, Cl).  These hydroxy acids, compared to hydantoins, showed a similar potency increase on chroman 2-Me substitution, a similar orthogonal relationship of acidic to arom. moieties, and similar ARI enantioselectivity.  In this series the six-membered spiro hydroxy acetic acid anion array is a bioisostere for a spiro hydantoin anion and leads to ARIs with excellent in vivo activity.  In vitro and in vivo activity was improved over I ( R-R2 = H) by chroman cis-2-methylation and by arom. 6,7-halogen substitution.  Compds. with the best acute in vivo activity in rats were compared for chronic in vivo activity.  The highest tissue levels and best chronic in vivo activities were found in the racemic I [ R = Me, R1 = R2= Cl(II); R = Me, R1 = F, R2 = Cl(III)].  ARI activity was enantioselective for the (2R,4R)-enantiomers of II and III.  (2R,4R)-III was selected for phase 1 clin. trials and did not exhibit sorbinil-like hypersensitivity side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnUzTAoGxO-bVg90H21EOLACvtfcHk0lh_B0OdeEGB2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xkt1Kht7k%253D&md5=8fe16309a1efc184e11e90fa17829eb5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm00090a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00090a004%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DAldinger%26aufirst%3DC.%2BE.%26aulast%3DBeyer%26aufirst%3DT.%2BA.%26aulast%3DBordner%26aufirst%3DJ.%26aulast%3DBurdi%26aufirst%3DD.%2BF.%26aulast%3DBussolotti%26aufirst%3DD.%2BL.%26aulast%3DInskeep%26aufirst%3DP.%2BB.%26aulast%3DSiegel%26aufirst%3DT.%2BW.%26atitle%3DHydantoin%2520Bioisosteres.%2520In%2520Vivo%2520Active%2520Spiro%2520Hydroxy%2520Acetic%2520Acid%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D2169%26epage%3D2177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Sestanj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treasurywala, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humber, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simard-Duquesne, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvornik, D.</span><span> </span><span class="NLM_article-title"><i>N</i>-[[5-(Trifluoromethyl)-6-methoxy-1-naphthalenyl]thioxomethyl]-<i>N</i>-methylglycine (Tolrestat), a Potent, Orally Active Aldose Reductase Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00369a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1984&pages=255-256&author=K.+Sestanjauthor=F.+Belliniauthor=S.+Fungauthor=N.+Abrahamauthor=A.+Treasurywalaauthor=L.+Humberauthor=N.+Simard-Duquesneauthor=D.+Dvornik&title=N-%5B%5B5-%28Trifluoromethyl%29-6-methoxy-1-naphthalenyl%5Dthioxomethyl%5D-N-methylglycine+%28Tolrestat%29%2C+a+Potent%2C+Orally+Active+Aldose+Reductase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm00369a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00369a003%26sid%3Dliteratum%253Aachs%26aulast%3DSestanj%26aufirst%3DK.%26aulast%3DBellini%26aufirst%3DF.%26aulast%3DFung%26aufirst%3DS.%26aulast%3DAbraham%26aufirst%3DN.%26aulast%3DTreasurywala%26aufirst%3DA.%26aulast%3DHumber%26aufirst%3DL.%26aulast%3DSimard-Duquesne%26aufirst%3DN.%26aulast%3DDvornik%26aufirst%3DD.%26atitle%3DN-%255B%255B5-%2528Trifluoromethyl%2529-6-methoxy-1-naphthalenyl%255Dthioxomethyl%255D-N-methylglycine%2520%2528Tolrestat%2529%252C%2520a%2520Potent%252C%2520Orally%2520Active%2520Aldose%2520Reductase%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1984%26volume%3D27%26spage%3D255%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Mylari, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zembrowski, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldinger, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dee, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, D. H.</span><span> </span><span class="NLM_article-title">Novel, Potent Aldose Reductase Inhibitors: 3,4-Dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-1-phthalazine-acetic Acid (Zopolrestat) and Congeners</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">108</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00105a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=108-122&author=B.+L.+Mylariauthor=E.+R.+Larsonauthor=T.+A.+Beyerauthor=W.+J.+Zembrowskiauthor=C.+E.+Aldingerauthor=M.+F.+Deeauthor=T.+W.+Siegelauthor=D.+H.+Singleton&title=Novel%2C+Potent+Aldose+Reductase+Inhibitors%3A+3%2C4-Dihydro-4-oxo-3-%5B%5B5-%28trifluoromethyl%29-2-benzothiazolyl%5Dmethyl%5D-1-phthalazine-acetic+Acid+%28Zopolrestat%29+and+Congeners"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm00105a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00105a018%26sid%3Dliteratum%253Aachs%26aulast%3DMylari%26aufirst%3DB.%2BL.%26aulast%3DLarson%26aufirst%3DE.%2BR.%26aulast%3DBeyer%26aufirst%3DT.%2BA.%26aulast%3DZembrowski%26aufirst%3DW.%2BJ.%26aulast%3DAldinger%26aufirst%3DC.%2BE.%26aulast%3DDee%26aufirst%3DM.%2BF.%26aulast%3DSiegel%26aufirst%3DT.%2BW.%26aulast%3DSingleton%26aufirst%3DD.%2BH.%26atitle%3DNovel%252C%2520Potent%2520Aldose%2520Reductase%2520Inhibitors%253A%25203%252C4-Dihydro-4-oxo-3-%255B%255B5-%2528trifluoromethyl%2529-2-benzothiazolyl%255Dmethyl%255D-1-phthalazine-acetic%2520Acid%2520%2528Zopolrestat%2529%2520and%2520Congeners%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D108%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Hotta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakuta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span> </span><span class="NLM_article-title">Effects of a Novel Aldose Reductase Inhibitor, Fidarestat (SNK-860), on Vibration Perception Threshold and Subjective Symptoms in Patients with Diabetic Polyneuropathy</span> <span class="citation_source-journal">Clin. Drug Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">680</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.2165%2F00044011-200424110-00006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=17523730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsV2juw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=671-680&author=N.+Hottaauthor=K.+Yasudaauthor=Y.+Sumitaauthor=T.+Sanoauthor=H.+Kakutaauthor=M.+Nagashimaauthor=Y.+Hayashiauthor=M.+Yamamotoauthor=T.+Wakaoauthor=M.+Okuyamaauthor=M.+Kobayashiauthor=K.+Mori&title=Effects+of+a+Novel+Aldose+Reductase+Inhibitor%2C+Fidarestat+%28SNK-860%29%2C+on+Vibration+Perception+Threshold+and+Subjective+Symptoms+in+Patients+with+Diabetic+Polyneuropathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of a novel aldose reductase inhibitor, fidarestat (SNK-860), on vibration perception threshold and subjective symptoms in patients with diabetic polyneuropathy: An open-label pilot study</span></div><div class="casAuthors">Hotta, Nigishi; Yasuda, Keigo; Sumita, Yasuhiro; Sano, Takahisa; Kakuta, Hironobu; Nagashima, Makoto; Hayashi, Yoshinari; Yamamoto, Masahiro; Wakao, Takaaki; Okuyama, Makio; Kobayashi, Masato; Mori, Kouichi</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Drug Investigation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">671-680</span>CODEN:
                <span class="NLM_cas:coden">CDINFR</span>;
        ISSN:<span class="NLM_cas:issn">1173-2563</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">Objective: To evaluate the effects of fidarestat (SNK-860) on vibration perception threshold, as measured by C64 quant. tuning fork (64Hz) anal., as well as its effects on subjective symptoms in patients with diabetic polyneuropathy.  Design and setting: Open-label, prospective study conducted at 12 hospitals in the central area of Honshu, Japan.  Interventions: Fidarestat was administered at a dosage of 1mg once daily after breakfast for 28 wk.  Main outcome measures: Vibration perception threshold of upper and lower extremities was detd. using a C64 quant. tuning fork, and measured at baseline and after 12 and 28 wk of treatment.  Subjective symptoms, including numbness, spontaneous pain and hypoaesthesia, were evaluated every 4 wk.  Results: Subjective symptoms were evaluated in 22 patients, and vibration perception threshold data were available for 19 patients.  Vibration perception threshold at baseline was neg. correlated with the severity of the following subjective symptoms: numbness in the upper limbs, and numbness, coldness and hot flushes, smarting pain causing difficulty walking and hypoaesthesia in the lower limbs.  During treatment with fidarestat, vibration perception threshold increased significantly in the upper (p = 0.0017) and lower (p = 0.0001) limbs.  The following symptoms were also significantly improved: severity of numbness in the lower limbs, heaviness in the foot, coldness and hot flushes in the lower limbs, smarting pain causing difficulty walking, sensation as if walking on sand, sensation as if walking on an uneven road, spontaneous pain in the lower limbs, and dizziness.  Adverse events occurred in four patients.  Conclusions: Administration of fidarestat after breakfast was effective in significantly alleviating some symptoms of diabetic polyneuropathy.  The C64 quant. tuning fork anal. is useful in the diagnosis of diabetic polyneuropathy, and as a measure of the severity of the neuropathol. symptoms of this condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGLmvqhe1tubVg90H21EOLACvtfcHk0li5VjfGxpvfyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsV2juw%253D%253D&md5=01cc072bd94487b75ad2424e0b5ad463</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2165%2F00044011-200424110-00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00044011-200424110-00006%26sid%3Dliteratum%253Aachs%26aulast%3DHotta%26aufirst%3DN.%26aulast%3DYasuda%26aufirst%3DK.%26aulast%3DSumita%26aufirst%3DY.%26aulast%3DSano%26aufirst%3DT.%26aulast%3DKakuta%26aufirst%3DH.%26aulast%3DNagashima%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DWakao%26aufirst%3DT.%26aulast%3DOkuyama%26aufirst%3DM.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DK.%26atitle%3DEffects%2520of%2520a%2520Novel%2520Aldose%2520Reductase%2520Inhibitor%252C%2520Fidarestat%2520%2528SNK-860%2529%252C%2520on%2520Vibration%2520Perception%2520Threshold%2520and%2520Subjective%2520Symptoms%2520in%2520Patients%2520with%2520Diabetic%2520Polyneuropathy%26jtitle%3DClin.%2520Drug%2520Invest.%26date%3D2004%26volume%3D24%26spage%3D671%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohman, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millen, J.</span><span> </span><span class="NLM_article-title">Novel Spirosuccinimide Aldose Reductase Inhibitors Derived from Isoquinoline-1,3-diones: 2-[(4-Bromo-2-fluorophenyl)methyl]-6-fluorospiro[isoquinoline-4(1<i>H</i>),3′-pyrrolidine]-1,2′,3,5′(2<i>H</i>)-tetrone and Congeners. I</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2043</span><span class="NLM_x">–</span> <span class="NLM_lpage">2058</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00039a017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2043-2058&author=M.+S.+Malamasauthor=T.+C.+Hohmanauthor=J.+Millen&title=Novel+Spirosuccinimide+Aldose+Reductase+Inhibitors+Derived+from+Isoquinoline-1%2C3-diones%3A+2-%5B%284-Bromo-2-fluorophenyl%29methyl%5D-6-fluorospiro%5Bisoquinoline-4%281H%29%2C3%E2%80%B2-pyrrolidine%5D-1%2C2%E2%80%B2%2C3%2C5%E2%80%B2%282H%29-tetrone+and+Congeners.+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm00039a017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00039a017%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DHohman%26aufirst%3DT.%2BC.%26aulast%3DMillen%26aufirst%3DJ.%26atitle%3DNovel%2520Spirosuccinimide%2520Aldose%2520Reductase%2520Inhibitors%2520Derived%2520from%2520Isoquinoline-1%252C3-diones%253A%25202-%255B%25284-Bromo-2-fluorophenyl%2529methyl%255D-6-fluorospiro%255Bisoquinoline-4%25281H%2529%252C3%25E2%2580%25B2-pyrrolidine%255D-1%252C2%25E2%2580%25B2%252C3%252C5%25E2%2580%25B2%25282H%2529-tetrone%2520and%2520Congeners.%2520I%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2043%26epage%3D2058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Bril, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirose, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamioka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, R.</span><span> </span><span class="NLM_article-title">Ranirestat for the Management of Diabetic Sensorimotor Polyneuropathy</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1256</span><span class="NLM_x">–</span> <span class="NLM_lpage">1260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2009&pages=1256-1260&author=V.+Brilauthor=T.+Hiroseauthor=S.+Tamiokaauthor=R.+Buchanan&title=Ranirestat+for+the+Management+of+Diabetic+Sensorimotor+Polyneuropathy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBril%26aufirst%3DV.%26aulast%3DHirose%26aufirst%3DT.%26aulast%3DTamioka%26aufirst%3DS.%26aulast%3DBuchanan%26aufirst%3DR.%26atitle%3DRanirestat%2520for%2520the%2520Management%2520of%2520Diabetic%2520Sensorimotor%2520Polyneuropathy%26jtitle%3DDiabetes%2520Care%26date%3D2009%26volume%3D32%26spage%3D1256%26epage%3D1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Ward, W. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sennitt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timms, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirrlees, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuffin, D. P.</span><span> </span><span class="NLM_article-title">Ponalrestat: A Potent and Specific Inhibitor of Aldose Reductase</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">346</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1990&pages=337-346&author=W.+H.+J.+Wardauthor=C.+A.+Sennittauthor=H.+Rossauthor=A.+Dingleauthor=D.+Timmsauthor=D.+J.+Mirrleesauthor=D.+P.+Tuffin&title=Ponalrestat%3A+A+Potent+and+Specific+Inhibitor+of+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DW.%2BH.%2BJ.%26aulast%3DSennitt%26aufirst%3DC.%2BA.%26aulast%3DRoss%26aufirst%3DH.%26aulast%3DDingle%26aufirst%3DA.%26aulast%3DTimms%26aufirst%3DD.%26aulast%3DMirrlees%26aufirst%3DD.%2BJ.%26aulast%3DTuffin%26aufirst%3DD.%2BP.%26atitle%3DPonalrestat%253A%2520A%2520Potent%2520and%2520Specific%2520Inhibitor%2520of%2520Aldose%2520Reductase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1990%26volume%3D39%26spage%3D337%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Activation of Nuclear Factor-κB by Hyperglycemia in Vascular Smooth Muscle Cells Is Regulated by Aldose Reductase</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2910</span><span class="NLM_x">–</span> <span class="NLM_lpage">2920</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2004&pages=2910-2920&author=K.+V.+Ramanaauthor=B.+Friedrichauthor=S.+Srivastavaauthor=A.+Bhatnagarauthor=S.+K.+Srivastava&title=Activation+of+Nuclear+Factor-%CE%BAB+by+Hyperglycemia+in+Vascular+Smooth+Muscle+Cells+Is+Regulated+by+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DFriedrich%26aufirst%3DB.%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DBhatnagar%26aufirst%3DA.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DActivation%2520of%2520Nuclear%2520Factor-%25CE%25BAB%2520by%2520Hyperglycemia%2520in%2520Vascular%2520Smooth%2520Muscle%2520Cells%2520Is%2520Regulated%2520by%2520Aldose%2520Reductase%26jtitle%3DDiabetes%26date%3D2004%26volume%3D53%26spage%3D2910%26epage%3D2920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Inhibition of Aldose Reductase Attenuates TNF-α-Induced Expression of Adhesion Molecules in Endothelial Cells</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1209</span><span class="NLM_x">–</span> <span class="NLM_lpage">1218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=1209-1218&author=K.+V.+Ramanaauthor=A.+Bhatnagarauthor=S.+K.+Srivastava&title=Inhibition+of+Aldose+Reductase+Attenuates+TNF-%CE%B1-Induced+Expression+of+Adhesion+Molecules+in+Endothelial+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DBhatnagar%26aufirst%3DA.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DInhibition%2520of%2520Aldose%2520Reductase%2520Attenuates%2520TNF-%25CE%25B1-Induced%2520Expression%2520of%2520Adhesion%2520Molecules%2520in%2520Endothelial%2520Cells%26jtitle%3DFASEB%2520J.%26date%3D2004%26volume%3D18%26spage%3D1209%26epage%3D1218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Mediation of Aldose Reductase in Lipopolysaccharide-Induced Inflammatory Signals in Mouse Peritoneal Macrophages</span> <span class="citation_source-journal">Cytokine</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2006&pages=115-122&author=K.+V.+Ramanaauthor=S.+K.+Srivastava&title=Mediation+of+Aldose+Reductase+in+Lipopolysaccharide-Induced+Inflammatory+Signals+in+Mouse+Peritoneal+Macrophages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DMediation%2520of%2520Aldose%2520Reductase%2520in%2520Lipopolysaccharide-Induced%2520Inflammatory%2520Signals%2520in%2520Mouse%2520Peritoneal%2520Macrophages%26jtitle%3DCytokine%26date%3D2006%26volume%3D36%26spage%3D115%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Yadav, U. C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span> </span><span class="NLM_article-title">Aldose Reductase Inhibition Prevents Endotoxin-Induced Uveitis in Rats</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4634</span><span class="NLM_x">–</span> <span class="NLM_lpage">4642</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=4634-4642&author=U.+C.+S.+Yadavauthor=S.+K.+Srivastavaauthor=K.+V.+Ramana&title=Aldose+Reductase+Inhibition+Prevents+Endotoxin-Induced+Uveitis+in+Rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYadav%26aufirst%3DU.%2BC.%2BS.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26atitle%3DAldose%2520Reductase%2520Inhibition%2520Prevents%2520Endotoxin-Induced%2520Uveitis%2520in%2520Rats%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2007%26volume%3D48%26spage%3D4634%26epage%3D4642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Yadav, U. C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilera-Aguirre, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boldogh, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulares, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Inhibition of Aldose Reductase Prevents Experimental Allergic Airway Inflammation in Mice</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e6535</span><span class="refDoi"> DOI: 10.1371/journal.pone.0006535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1371%2Fjournal.pone.0006535" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e6535&author=U.+C.+S.+Yadavauthor=K.+V.+Ramanaauthor=L.+Aguilera-Aguirreauthor=I.+Boldoghauthor=H.+A.+Boularesauthor=S.+K.+Srivastava&title=Inhibition+of+Aldose+Reductase+Prevents+Experimental+Allergic+Airway+Inflammation+in+Mice&doi=10.1371%2Fjournal.pone.0006535"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0006535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0006535%26sid%3Dliteratum%253Aachs%26aulast%3DYadav%26aufirst%3DU.%2BC.%2BS.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DAguilera-Aguirre%26aufirst%3DL.%26aulast%3DBoldogh%26aufirst%3DI.%26aulast%3DBoulares%26aufirst%3DH.%2BA.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DInhibition%2520of%2520Aldose%2520Reductase%2520Prevents%2520Experimental%2520Allergic%2520Airway%2520Inflammation%2520in%2520Mice%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26spage%3De6535%26doi%3D10.1371%2Fjournal.pone.0006535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Reddy, A. B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span> </span><span class="NLM_article-title">Aldose Reductase Inhibition: Emerging Drug Target for the Treatment of Cardiovascular Complications</span> <span class="citation_source-journal">Recent Pat. Cardiovasc. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.2174%2F157489010790192683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=19886861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVCiur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=25-32&author=A.+B.+M.+Reddyauthor=K.+V.+Ramana&title=Aldose+Reductase+Inhibition%3A+Emerging+Drug+Target+for+the+Treatment+of+Cardiovascular+Complications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Aldose reductase inhibition: emerging drug target for the treatment of cardiovascular complications</span></div><div class="casAuthors">Reddy, Aramati B. M.; Ramana, Kota V.</div><div class="citationInfo"><span class="NLM_cas:title">Recent Patents on Cardiovascular Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-32</span>CODEN:
                <span class="NLM_cas:coden">RPCDFC</span>;
        ISSN:<span class="NLM_cas:issn">1574-8901</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Diabetes is a major metabolic disorder and leading cause of morbidity and mortality in the developed world.  Indeed, vascular complications are the major cause of mortality in diabetics.  Impaired glucose metab. has been implicated as a cause for the obsd. cardiac dysfunction in diabetics.  Dramatic increase in polyol pathway flux during hyperglycemia could cause damage to blood vessels that leads to heart failure.  Recent investigations and patent applications suggest the interesting and important role of polyol pathway enzyme, aldose reductase (AR) in mediating oxidative stress-induced inflammatory signals.  AR inhibitors have been shown to prevent or delay the onset of cardiovascular complications such as ischemic injury, restenosis and atherosclerosis.  In this review, we have focused on describing the pivotal role of AR in the pathogenesis of cardiovascular complications and use of AR inhibitors as emerging therapeutic strategies in preventing cardiovascular complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY9mnSCT6gAbVg90H21EOLACvtfcHk0lhtjXHSNdfwcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVCiur8%253D&md5=ad62d6613594dced2aa9701f1030eba2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2174%2F157489010790192683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157489010790192683%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DA.%2BB.%2BM.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26atitle%3DAldose%2520Reductase%2520Inhibition%253A%2520Emerging%2520Drug%2520Target%2520for%2520the%2520Treatment%2520of%2520Cardiovascular%2520Complications%26jtitle%3DRecent%2520Pat.%2520Cardiovasc.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26spage%3D25%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Ramana, K. V.</span><span> </span><span class="NLM_article-title">Aldose Reductase: New Insights for an Old Enzyme</span> <span class="citation_source-journal">Biomol. Concepts</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1515%2Fbmc.2011.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejsbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=103-114&author=K.+V.+Ramana&title=Aldose+Reductase%3A+New+Insights+for+an+Old+Enzyme"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Aldose reductase: new insights for an old enzyme</span></div><div class="casAuthors">Ramana, Kota V.</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecular Concepts</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">103-114</span>CODEN:
                <span class="NLM_cas:coden">BCIOB8</span>;
        ISSN:<span class="NLM_cas:issn">1868-5021</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review.  In the past years aldose reductase (AKR1B1; AR) is thought to be involved in the pathogenesis of secondary diabetic complications such as retinopathy, neuropathy, nephropathy and cataractogenesis.  Subsequently, several AR inhibitors have been developed and tested for diabetic complications.  Although these inhibitors have found to be safe for human use, they have not been successful in clin. studies because of limited efficacy.  Recently, the potential physiol. role of AR has been reassessed from a different point of view.  Diverse groups suggested that AR, in addn. to reducing glucose, also efficiently reduces oxidative stress-generated lipid peroxidn.-derived aldehydes and their glutathione conjugates.  Because lipid aldehydes alter cellular signals by regulating the activation of transcription factors such as NF-κB and AP1, inhibition of AR could inhibit such events.  Indeed, a wide array of recent exptl. evidence indicates that the inhibition of AR prevents oxidative stress-induced activation of NF-κB and AP1 signals that lead to cell death or growth.  Furthermore, AR inhibitors have been shown to prevent inflammatory complications such as sepsis, asthma, colon cancer and uveitis in rodent animal models.  The new exptl. in vitro and in vivo data has provided a basis for investigating the clin. efficacy of AR inhibitors in preventing other inflammatory complications than diabetes.  This review describes how recent studies have identified novel plethoric physiol. and pathophysiol. significance of AR in mediating inflammatory complications, and how the discovery of such new insights for this old enzyme could have considerable importance in envisioning potential new therapeutic strategies for the prevention or treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBBjQ7Gvv8drVg90H21EOLACvtfcHk0lhtjXHSNdfwcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejsbfJ&md5=41eabcb1adc38247121caf1b9fff87be</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1515%2Fbmc.2011.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fbmc.2011.002%26sid%3Dliteratum%253Aachs%26aulast%3DRamana%26aufirst%3DK.%2BV.%26atitle%3DAldose%2520Reductase%253A%2520New%2520Insights%2520for%2520an%2520Old%2520Enzyme%26jtitle%3DBiomol.%2520Concepts%26date%3D2011%26volume%3D2%26spage%3D103%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Tang, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwa, J.</span><span> </span><span class="NLM_article-title">Aldose Reductase, Oxidative Stress, and Diabetic Mellitus</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="refDoi"> DOI: 10.3389/fphar.2012.00087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.3389%2Ffphar.2012.00087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms12qtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=87&author=W.+H.+Tangauthor=K.+A.+Martinauthor=J.+Hwa&title=Aldose+Reductase%2C+Oxidative+Stress%2C+and+Diabetic+Mellitus&doi=10.3389%2Ffphar.2012.00087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Aldose reductase, oxidative stress and diabetic mellitus</span></div><div class="casAuthors">Tang, Wai Ho; Martin, Kathleen A.; Hwa, John</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Experimental Pharmacology and Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">May</span>),
    <span class="NLM_cas:pages">87</span>CODEN:
                <span class="NLM_cas:coden">FEPDAX</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Diabetes mellitus (DM) is a complex metabolic disorder arising from lack of insulin prodn. or insulin resistance.  DM is a leading cause of morbidity and mortality in the developed world, particularly from vascular complications such as atherothrombosis in the coronary vessels.  Aldose reductase (AR; ALR2), a key enzyme in the polyol pathway, catalyzes nicotinamide adenosine dinucleotide phosphate-dependent redn. of glucose to sorbitol, leading to excessive accumulation of intracellular reactive oxygen species (ROS) in various tissues of DM including the heart, vasculature, neurons, eyes and kidneys.  As an example, hyperglycemia through such polyol pathway induced oxidative stress, may have dual heart actions, on coronary blood vessel (atherothrombosis) and myocardium (heart failure) leading to severe morbidity and mortality.  In cells cultured under high glucose conditions, many studies have demonstrated similar AR-dependent increases in ROS prodn., confirming AR as an important factor for the pathogenesis of many diabetic complications.  Moreover, recent studies have shown that AR inhibitors may be able to prevent or delay the onset of cardiovascular complications such as ischemia/reperfusion injury, atherosclerosis and atherothrombosis.  In this review, we will focus on describing pivotal roles of AR in the pathogenesis of cardiovascular diseases as well as other diabetic complications and the potential use of AR inhibitors as an emerging therapeutic strategy in preventing DM complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuTqdIi_lUS7Vg90H21EOLACvtfcHk0lhtjXHSNdfwcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms12qtrg%253D&md5=910cb046de1f2c5dc1013e8167f559f0</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2012.00087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2012.00087%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DW.%2BH.%26aulast%3DMartin%26aufirst%3DK.%2BA.%26aulast%3DHwa%26aufirst%3DJ.%26atitle%3DAldose%2520Reductase%252C%2520Oxidative%2520Stress%252C%2520and%2520Diabetic%2520Mellitus%26jtitle%3DFront.%2520Pharmacol.%26date%3D2012%26volume%3D3%26spage%3D87%26doi%3D10.3389%2Ffphar.2012.00087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Pandey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span> </span><span class="NLM_article-title">A Potential Therapeutic Role for Aldose Reductase Inhibitors in the Treatment of Endotoxin-Related Inflammatory Diseases</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=329-339&author=S.+Pandeyauthor=S.+K.+Srivastavaauthor=K.+V.+Ramana&title=A+Potential+Therapeutic+Role+for+Aldose+Reductase+Inhibitors+in+the+Treatment+of+Endotoxin-Related+Inflammatory+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26atitle%3DA%2520Potential%2520Therapeutic%2520Role%2520for%2520Aldose%2520Reductase%2520Inhibitors%2520in%2520the%2520Treatment%2520of%2520Endotoxin-Related%2520Inflammatory%2520Diseases%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2012%26volume%3D21%26spage%3D329%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saraf, S.</span><span> </span><span class="NLM_article-title">Type 2 Diabetes Mellitus—Its Global Prevalence and Therapeutic Strategies</span> <span class="citation_source-journal">Diabetes Metab. Syndr.: Clin. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.dsx.2008.04.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2010&pages=48-56&author=S.+Jainauthor=S.+Saraf&title=Type+2+Diabetes+Mellitus%E2%80%94Its+Global+Prevalence+and+Therapeutic+Strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.dsx.2008.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dsx.2008.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DS.%26aulast%3DSaraf%26aufirst%3DS.%26atitle%3DType%25202%2520Diabetes%2520Mellitus%25E2%2580%2594Its%2520Global%2520Prevalence%2520and%2520Therapeutic%2520Strategies%26jtitle%3DDiabetes%2520Metab.%2520Syndr.%253A%2520Clin.%2520Res.%2520Rev.%26date%3D2010%26volume%3D4%26spage%3D48%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Gleissner, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galkina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadler, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, K.</span><span> </span><span class="NLM_article-title">Mechanisms by Which Diabetes Increases Cardiovascular Disease</span> <span class="citation_source-journal">Drug Discovery Today: Dis. Mech.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.ddmec.2007.12.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=131-140&author=C.+A.+Gleissnerauthor=E.+Galkinaauthor=J.+L.+Nadlerauthor=K.+Ley&title=Mechanisms+by+Which+Diabetes+Increases+Cardiovascular+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ddmec.2007.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddmec.2007.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DGleissner%26aufirst%3DC.%2BA.%26aulast%3DGalkina%26aufirst%3DE.%26aulast%3DNadler%26aufirst%3DJ.%2BL.%26aulast%3DLey%26aufirst%3DK.%26atitle%3DMechanisms%2520by%2520Which%2520Diabetes%2520Increases%2520Cardiovascular%2520Disease%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Dis.%2520Mech.%26date%3D2007%26volume%3D4%26spage%3D131%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Turner, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cull, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratton, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frighi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manley, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neil, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElroy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadden, D.</span><span> </span><span class="NLM_article-title">Intensive Blood-Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS 33)</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=1998&pages=837-853&author=R.+C.+Turnerauthor=R.+R.+Holmanauthor=C.+A.+Cullauthor=I.+M.+Strattonauthor=D.+R.+Matthewsauthor=V.+Frighiauthor=S.+E.+Manleyauthor=A.+Neilauthor=H.+McElroyauthor=D.+Wrightauthor=E.+Kohnerauthor=C.+Foxauthor=D.+Hadden&title=Intensive+Blood-Glucose+Control+with+Sulphonylureas+or+Insulin+Compared+with+Conventional+Treatment+and+Risk+of+Complications+in+Patients+with+Type+2+Diabetes+%28UKPDS+33%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DR.%2BC.%26aulast%3DHolman%26aufirst%3DR.%2BR.%26aulast%3DCull%26aufirst%3DC.%2BA.%26aulast%3DStratton%26aufirst%3DI.%2BM.%26aulast%3DMatthews%26aufirst%3DD.%2BR.%26aulast%3DFrighi%26aufirst%3DV.%26aulast%3DManley%26aufirst%3DS.%2BE.%26aulast%3DNeil%26aufirst%3DA.%26aulast%3DMcElroy%26aufirst%3DH.%26aulast%3DWright%26aufirst%3DD.%26aulast%3DKohner%26aufirst%3DE.%26aulast%3DFox%26aufirst%3DC.%26aulast%3DHadden%26aufirst%3DD.%26atitle%3DIntensive%2520Blood-Glucose%2520Control%2520with%2520Sulphonylureas%2520or%2520Insulin%2520Compared%2520with%2520Conventional%2520Treatment%2520and%2520Risk%2520of%2520Complications%2520in%2520Patients%2520with%2520Type%25202%2520Diabetes%2520%2528UKPDS%252033%2529%26jtitle%3DLancet%26date%3D1998%26volume%3D352%26spage%3D837%26epage%3D853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Srivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Metabolism of Lipid Peroxidation Product, 4-Hydroxynonenal (HNE) in Rat Erythrocytes: Role of Aldose Reductase</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">642</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2FS0891-5849%2800%2900351-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=11033416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1Sis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=642-651&author=S.+Srivastavaauthor=B.+L.+Dixitauthor=J.+Caiauthor=S.+Sharmaauthor=H.+E.+Hurstauthor=A.+Bhatnagarauthor=S.+K.+Srivastava&title=Metabolism+of+Lipid+Peroxidation+Product%2C+4-Hydroxynonenal+%28HNE%29+in+Rat+Erythrocytes%3A+Role+of+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of lipid peroxidation product, 4-hydroxynonenal (HNE) in rat erythrocytes: role of aldose reductase</span></div><div class="casAuthors">Srivastava, S.; Dixit, B. L.; Cai, J.; Sharma, S.; Hurst, H. E.; Bhatnagar, A.; Srivastava, S. K.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">642-651</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Lipid peroxidn. represents a significant source of erythrocyte dysfunction and aging.  Because the toxicity of lipid peroxidn. appears to be in part due to aldehydic end products, the authors examd., in rat erythrocytes, the metab. of 4-hydroxy-trans-2-nonenal (HNE), one of the most abundant and toxic lipid-derived aldehydes.  Packed erythrocytes, 0.1 mL, completely metabolized 20 nmoles of HNE in 20 min.  The glutathione conjugate of HNE and 4-hydroxynonanoic acid (HNA) represented 70 and 25% of the total metab., resp.  Approx. 70% of the metabolites were extruded to the medium.  Upon electrospray ionization mass spectrometry, the glutathione conjugate resolved into two distinct species corresponding to glutathionyl HNE (GS-HNE) and glutathionyl 1,4-dihydroxynonene (GS-DHN).  The concn. of GS-DHN formed was twice that of GS-HNE.  Inhibition of aldose reductase by sorbinil and tolrestat led to a selective decrease in the formation of GS-DHN, although the extent of HNE glutathiolation was unaffected.  Inhibitors of aldehyde or alc. dehydrogenase, i.e., cyanamide and 4-Me pyrazole, had no effect on the formation of HNA and GS-DHN, indicating that these enzymes are not significant participants in the erythrocyte HNE metab.  Thus, oxidn. to HNA, conjugation with glutathione, and further redn. of the conjugate by aldose reductase appear to be the major pathways of HNE metab. in erythrocytes.  These pathways may be crit. determinants of erythrocyte toxicity due to lipid peroxidn.-derived aldehydes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7GYWFuB9gZbVg90H21EOLACvtfcHk0lhPoubWfrQe6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1Sis7w%253D&md5=7dd80721320da401eaec82c14e62b956</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2800%2900351-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252800%252900351-8%26sid%3Dliteratum%253Aachs%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DDixit%26aufirst%3DB.%2BL.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DHurst%26aufirst%3DH.%2BE.%26aulast%3DBhatnagar%26aufirst%3DA.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DMetabolism%2520of%2520Lipid%2520Peroxidation%2520Product%252C%25204-Hydroxynonenal%2520%2528HNE%2529%2520in%2520Rat%2520Erythrocytes%253A%2520Role%2520of%2520Aldose%2520Reductase%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2000%26volume%3D29%26spage%3D642%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Vander Jagt, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vander Jagt, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunsaker, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Royer, R. E.</span><span> </span><span class="NLM_article-title">Substrate Specificity of Human Aldose Reductase: Identification of 4-Hydroxynonenal as an Endogenous Substrate</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1249</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1249&publication_year=1995&pages=117-126&author=D.+L.+Vander+Jagtauthor=N.+S.+Kolbauthor=T.+J.+Vander+Jagtauthor=J.+Chinoauthor=F.+J.+Martinezauthor=L.+A.+Hunsakerauthor=R.+E.+Royer&title=Substrate+Specificity+of+Human+Aldose+Reductase%3A+Identification+of+4-Hydroxynonenal+as+an+Endogenous+Substrate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVander%2BJagt%26aufirst%3DD.%2BL.%26aulast%3DKolb%26aufirst%3DN.%2BS.%26aulast%3DVander%2BJagt%26aufirst%3DT.%2BJ.%26aulast%3DChino%26aufirst%3DJ.%26aulast%3DMartinez%26aufirst%3DF.%2BJ.%26aulast%3DHunsaker%26aufirst%3DL.%2BA.%26aulast%3DRoyer%26aufirst%3DR.%2BE.%26atitle%3DSubstrate%2520Specificity%2520of%2520Human%2520Aldose%2520Reductase%253A%2520Identification%2520of%25204-Hydroxynonenal%2520as%2520an%2520Endogenous%2520Substrate%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1995%26volume%3D1249%26spage%3D117%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Evans, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldfine, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddux, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grodsky, G. M.</span><span> </span><span class="NLM_article-title">Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1210%2Fer.2001-0039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=12372842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD38XosVejsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=599-622&author=J.+L.+Evansauthor=I.+D.+Goldfineauthor=B.+A.+Madduxauthor=G.+M.+Grodsky&title=Oxidative+Stress+and+Stress-Activated+Signaling+Pathways%3A+A+Unifying+Hypothesis+of+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes</span></div><div class="casAuthors">Evans, Joseph L.; Goldfine, Ira D.; Maddux, Betty A.; Grodsky, Gerold M.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">599-622</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  In both type 1 and type 2 diabetes, the late diabetic complications in nerve, vascular endothelium, and kidney arise from chronic elevations of glucose and possibly other metabolites including free fatty acids (FFA).  Recent evidence suggests that common stress-activated signaling pathways such as nuclear factor-κB, p38 MAPK, and NH2-terminal Jun kinases/stress-activated protein kinases underlie the development of these late diabetic complications.  In addn., in type 2 diabetes, there is evidence that the activation of these same stress pathways by glucose and possibly FFA leads to both insulin resistance and impaired insulin secretion.  Thus, we propose a unifying hypothesis whereby hyperglycemia and FFA-induced activation of the nuclear factor-κB, p38 MAPK, and NH2-terminal Jun kinases/stress-activated protein kinases stress pathways, along with the activation of the advanced glycosylation end-products/receptor for advanced glycosylation end-products, protein kinase C, and sorbitol stress pathways, plays a key role in causing late complications in type 1 and type 2 diabetes, along with insulin resistance and impaired insulin secretion in type 2 diabetes.  Studies with antioxidants such as vitamin E, α-lipoic acid, and N-acetylcysteine suggest that new strategies may become available to treat these conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgexQPyQ6ffLVg90H21EOLACvtfcHk0lhPoubWfrQe6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosVejsbg%253D&md5=97a6da9c7cebd3ace6498a6525838472</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1210%2Fer.2001-0039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2001-0039%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DJ.%2BL.%26aulast%3DGoldfine%26aufirst%3DI.%2BD.%26aulast%3DMaddux%26aufirst%3DB.%2BA.%26aulast%3DGrodsky%26aufirst%3DG.%2BM.%26atitle%3DOxidative%2520Stress%2520and%2520Stress-Activated%2520Signaling%2520Pathways%253A%2520A%2520Unifying%2520Hypothesis%2520of%2520Type%25202%2520Diabetes%26jtitle%3DEndocr.%2520Rev.%26date%3D2002%26volume%3D23%26spage%3D599%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Williamson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frangos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasan, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ido, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyengaard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Enden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilton, R. G.</span><span> </span><span class="NLM_article-title">Hyperglycemic Pseudohypoxia and Diabetic Complications</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1993&pages=801-813&author=J.+R.+Williamsonauthor=K.+Changauthor=M.+Frangosauthor=K.+S.+Hasanauthor=Y.+Idoauthor=T.+Kawamuraauthor=J.+R.+Nyengaardauthor=M.+Van+den+Endenauthor=C.+Kiloauthor=R.+G.+Tilton&title=Hyperglycemic+Pseudohypoxia+and+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliamson%26aufirst%3DJ.%2BR.%26aulast%3DChang%26aufirst%3DK.%26aulast%3DFrangos%26aufirst%3DM.%26aulast%3DHasan%26aufirst%3DK.%2BS.%26aulast%3DIdo%26aufirst%3DY.%26aulast%3DKawamura%26aufirst%3DT.%26aulast%3DNyengaard%26aufirst%3DJ.%2BR.%26aulast%3DVan%2Bden%2BEnden%26aufirst%3DM.%26aulast%3DKilo%26aufirst%3DC.%26aulast%3DTilton%26aufirst%3DR.%2BG.%26atitle%3DHyperglycemic%2520Pseudohypoxia%2520and%2520Diabetic%2520Complications%26jtitle%3DDiabetes%26date%3D1993%26volume%3D42%26spage%3D801%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Hamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naruse, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasuya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiuchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotta, N.</span><span> </span><span class="NLM_article-title">Epalrestat, an Aldose Reductase Inhibitor, Reduces the Levels of <i>N</i>-(Carboxymethyl)lysine Protein Adducts and Their Precursors in Erythrocytes from Diabetic Patients</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1539</span><span class="NLM_x">–</span> <span class="NLM_lpage">1544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2000&pages=1539-1544&author=Y.+Hamadaauthor=J.+Nakamuraauthor=K.+Naruseauthor=T.+Komoriauthor=K.+Katoauthor=Y.+Kasuyaauthor=R.+Nagaiauthor=S.+Horiuchiauthor=N.+Hotta&title=Epalrestat%2C+an+Aldose+Reductase+Inhibitor%2C+Reduces+the+Levels+of+N-%28Carboxymethyl%29lysine+Protein+Adducts+and+Their+Precursors+in+Erythrocytes+from+Diabetic+Patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHamada%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DJ.%26aulast%3DNaruse%26aufirst%3DK.%26aulast%3DKomori%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DKasuya%26aufirst%3DY.%26aulast%3DNagai%26aufirst%3DR.%26aulast%3DHoriuchi%26aufirst%3DS.%26aulast%3DHotta%26aufirst%3DN.%26atitle%3DEpalrestat%252C%2520an%2520Aldose%2520Reductase%2520Inhibitor%252C%2520Reduces%2520the%2520Levels%2520of%2520N-%2528Carboxymethyl%2529lysine%2520Protein%2520Adducts%2520and%2520Their%2520Precursors%2520in%2520Erythrocytes%2520from%2520Diabetic%2520Patients%26jtitle%3DDiabetes%2520Care%26date%3D2000%26volume%3D23%26spage%3D1539%26epage%3D1544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Roscic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvat, S.</span><span> </span><span class="NLM_article-title">Transformations of Bioactive Peptides in the Presence of Sugars—Characterization and Stability Studies of the Adducts Generated via the Maillard Reaction</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4933</span><span class="NLM_x">–</span> <span class="NLM_lpage">4943</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=4933-4943&author=M.+Roscicauthor=S.+Horvat&title=Transformations+of+Bioactive+Peptides+in+the+Presence+of+Sugars%E2%80%94Characterization+and+Stability+Studies+of+the+Adducts+Generated+via+the+Maillard+Reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoscic%26aufirst%3DM.%26aulast%3DHorvat%26aufirst%3DS.%26atitle%3DTransformations%2520of%2520Bioactive%2520Peptides%2520in%2520the%2520Presence%2520of%2520Sugars%25E2%2580%2594Characterization%2520and%2520Stability%2520Studies%2520of%2520the%2520Adducts%2520Generated%2520via%2520the%2520Maillard%2520Reaction%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D4933%26epage%3D4943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tammali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Requirement of Aldose Reductse for the Hyperglycemic Activation of Protein Kinase C and Formation of Diacylglycerol in Vascular Smooth Muscle Cells</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">818</span><span class="NLM_x">–</span> <span class="NLM_lpage">829</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=818-829&author=K.+V.+Ramanaauthor=B.+Friedrichauthor=R.+Tammaliauthor=M.+B.+Westauthor=A.+Bhatnagarauthor=S.+K.+Srivastava&title=Requirement+of+Aldose+Reductse+for+the+Hyperglycemic+Activation+of+Protein+Kinase+C+and+Formation+of+Diacylglycerol+in+Vascular+Smooth+Muscle+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DFriedrich%26aufirst%3DB.%26aulast%3DTammali%26aufirst%3DR.%26aulast%3DWest%26aufirst%3DM.%2BB.%26aulast%3DBhatnagar%26aufirst%3DA.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DRequirement%2520of%2520Aldose%2520Reductse%2520for%2520the%2520Hyperglycemic%2520Activation%2520of%2520Protein%2520Kinase%2520C%2520and%2520Formation%2520of%2520Diacylglycerol%2520in%2520Vascular%2520Smooth%2520Muscle%2520Cells%26jtitle%3DDiabetes%26date%3D2005%26volume%3D54%26spage%3D818%26epage%3D829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Gleissner, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J.M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, K.</span><span> </span><span class="NLM_article-title">Upregulation of Aldose Reductase During Foam Cell Formation as Possible Link Among Diabetes, Hyperlipidemia, and Atherosclerosis</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1137</span><span class="NLM_x">–</span> <span class="NLM_lpage">1143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1161%2FATVBAHA.107.158295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=18451330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsFOjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=1137-1143&author=C.+A.+Gleissnerauthor=J.M.+Sandersauthor=J.+Nadlerauthor=K.+Ley&title=Upregulation+of+Aldose+Reductase+During+Foam+Cell+Formation+as+Possible+Link+Among+Diabetes%2C+Hyperlipidemia%2C+and+Atherosclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Upregulation of aldose reductase during foam cell formation as possible link among diabetes, hyperlipidemia, and atherosclerosis</span></div><div class="casAuthors">Gleissner, Christian A.; Sanders, John M.; Nadler, Jerry; Ley, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1137-1143</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective- Aldose reductase (AR) is the rate-limiting enzyme of the polyol pathway.  In diabetes, it is related to microvascular complications.  We discovered AR expression in foam cells by gene chip screening and hypothesized that it may be relevant in atherosclerosis.  Methods and Results- AR gene expression and activity were found to be increased in human blood monocyte-derived macrophages during foam cell formation induced by oxidized LDL (oxLDL, 100 μg/mL).  AR activity as photometrically detd. by NADPH consumption was effectively inhibited by the AR inhibitor epalrestat. oxLDL-dependent AR upregulation was further increased under hyperglycemic conditions (30 mmol/L D-glucose) as compared to osmotic control, suggesting a synergistic effect of hyperlipidemia and hyperglycemia.  AR was also upregulated by 4-hydroxynonenal, a constituent of oxLDL.  Upregulation was blocked by an antibody to CD36.  AR inhibition resulted in redn. of oxLDL-induced intracellular oxidative stress as detd. by 2'7'-dichlorofluoresceine diacetate (H2DCFDA) fluorescence, indicating that proinflammatory effects of oxLDL are partly mediated by AR.  Immunohistochem. showed AR expression in CD68+ human atherosclerotic plaque macrophages.  Conclusions- These data show that oxLDL-induced upregulation of AR in human macrophages is proinflammatory in foam cells and may represent a potential link among hyperlipidemia, atherosclerosis, and diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQs9JpPOkYjrVg90H21EOLACvtfcHk0lict1JEMcIMcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsFOjurg%253D&md5=33d4fef567d0c9ed7d0334ffc08ed6d5</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.107.158295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.107.158295%26sid%3Dliteratum%253Aachs%26aulast%3DGleissner%26aufirst%3DC.%2BA.%26aulast%3DSanders%26aufirst%3DJ.M.%26aulast%3DNadler%26aufirst%3DJ.%26aulast%3DLey%26aufirst%3DK.%26atitle%3DUpregulation%2520of%2520Aldose%2520Reductase%2520During%2520Foam%2520Cell%2520Formation%2520as%2520Possible%2520Link%2520Among%2520Diabetes%252C%2520Hyperlipidemia%252C%2520and%2520Atherosclerosis%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D1137%26epage%3D1143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Srivastava, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, U. C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, A. B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tammali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoeb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansari, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span> </span><span class="NLM_article-title">Aldose Reductase Inhibition Suppresses Oxidative Stress-Induced Inflammatory Disorders</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">330</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.cbi.2011.02.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=21354119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFaisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2011&pages=330-338&author=S.+K.+Srivastavaauthor=U.+C.+S.+Yadavauthor=A.+B.+M.+Reddyauthor=A.+Saxenaauthor=R.+Tammaliauthor=M.+Shoebauthor=N.+H.+Ansariauthor=A.+Bhatnagarauthor=M.+J.+Petrashauthor=S.+Srivastavaauthor=K.+V.+Ramana&title=Aldose+Reductase+Inhibition+Suppresses+Oxidative+Stress-Induced+Inflammatory+Disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders</span></div><div class="casAuthors">Srivastava, Satish K.; Yadav, Umesh C. S.; Reddy, Aramati B. M.; Mishra, Rakesh; Saxena, Ashish; Tammali, Ravinder; Shoeb, Mohammad; Ansari, Naseem H.; Bhatnagar, Aruni; Petrash, Mark J.; Srivastava, Sanjay; Ramana, Kota V.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">330-338</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress-induced inflammation is a major contributor to several disease conditions including sepsis, carcinogenesis and metastasis, diabetic complications, allergic asthma, uveitis and after cataract surgery posterior capsular opacification.  Since reactive oxygen species (ROS)-mediated activation of redox-sensitive transcription factors and subsequent expression of inflammatory cytokines, chemokines and growth factors are characteristics of inflammatory disorders, we envisioned that by blocking the mol. signals of ROS that activate redox-sensitive transcription factors, various inflammatory diseases could be ameliorated.  We have indeed demonstrated that ROS-induced lipid peroxidn.-derived lipid aldehydes such as 4-hydroxy-trans-2-nonenal (HNE) and their glutathione-conjugates (e.g. GS-HNE) are efficiently reduced by aldose reductase to corresponding alcs. which mediate the inflammatory signals.  These results showed that inhibition of aldose reductase (AKR1B1) significantly prevented the inflammatory signals induced by cytokines, growth factors, endotoxins, high glucose, allergens and auto-immune reactions in cellular as well as animal models.  We have demonstrated that AKR1B1 inhibitor, fidarestat, significantly prevents tumor necrosis factor-alpha (TNF-α)-, growth factors-, lipopolysachharide (LPS)-, and environmental allergens-induced inflammatory signals that cause various inflammatory diseases.  In animal models of inflammatory diseases such as diabetes, cardiovascular, uveitis, asthma, and cancer (colon, breast, prostate and lung) and metastasis, inhibition of AKR1B1 significantly ameliorated the disease.  These results from various cellular and animal models representing a no. of inflammatory conditions suggest that ROS-induced inflammatory response could be reduced by inhibition of AKR1B1, thereby decreasing the progression of the disease and if the therapy is initiated early, the disease could be eliminated.  Since fidarestat has already undergone phase III clin. trial for diabetic neuropathy and found to be safe, though clin. not very effective,these results indicate that it can be developed for the therapy of a no. of inflammation-related diseases.  These results thus offer a novel therapeutic approach to treat a wide array of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9l50Gk-U_xLVg90H21EOLACvtfcHk0lict1JEMcIMcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFaisrg%253D&md5=926a39f300f8b2537f9fc6603d3e76f8</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2011.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2011.02.023%26sid%3Dliteratum%253Aachs%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26aulast%3DYadav%26aufirst%3DU.%2BC.%2BS.%26aulast%3DReddy%26aufirst%3DA.%2BB.%2BM.%26aulast%3DSaxena%26aufirst%3DA.%26aulast%3DTammali%26aufirst%3DR.%26aulast%3DShoeb%26aufirst%3DM.%26aulast%3DAnsari%26aufirst%3DN.%2BH.%26aulast%3DBhatnagar%26aufirst%3DA.%26aulast%3DPetrash%26aufirst%3DM.%2BJ.%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26atitle%3DAldose%2520Reductase%2520Inhibition%2520Suppresses%2520Oxidative%2520Stress-Induced%2520Inflammatory%2520Disorders%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2011%26volume%3D191%26spage%3D330%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Shoeb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansari, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span> </span><span class="NLM_article-title">4-Hydroxynonenal in the Pathogenesis and Progression of Human Diseases</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.2174%2F09298673113209990181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=23848536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=230-237&author=M.+Shoebauthor=N.+H.+Ansariauthor=S.+K.+Srivastavaauthor=K.+V.+Ramana&title=4-Hydroxynonenal+in+the+Pathogenesis+and+Progression+of+Human+Diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">4-Hydroxynonenal in the Pathogenesis and Progression of Human Diseases</span></div><div class="casAuthors">Shoeb, Mohammad; Ansari, Naseem H.; Srivastava, Satish K.; Ramana, Kota V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">230-237</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Metastable aldehydes produced by lipid peroxidn. act as 'toxic second messengers' that extend the injurious potential of free radicals. 4-hydroxy 2-nonenal (HNE), a highly toxic and most abundant stable end product of lipid peroxidn., has been implicated in the tissue damage, dysfunction, injury assocd. with aging and other pathol. states such as cancer, Alzheimer, diabetes, cardiovascular and inflammatory complications.  Further, HNE has been considered as a oxidative stress marker and it act as a secondary signaling mol. to regulates a no. of cell signaling pathways.  Biol. activity of HNE depends on its intracellular concn., which can differentially modulate cell death, growth and differentiation.  Therefore, the mechanisms responsible for maintaining the intracellular levels of HNE are most important, not only in the defense against oxidative stress but also in the pathophysiol. of a no. of disease processes.  In this review, we discussed the significance of HNE in mediating various disease processes and how regulation of its metab. could be therapeutically effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouDoR-ApnydbVg90H21EOLACvtfcHk0lhtsaHd6s7pRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOqtb0%253D&md5=1b8f7bdcaaa873f78e65543a15e7f0f9</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.2174%2F09298673113209990181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F09298673113209990181%26sid%3Dliteratum%253Aachs%26aulast%3DShoeb%26aufirst%3DM.%26aulast%3DAnsari%26aufirst%3DN.%2BH.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26atitle%3D4-Hydroxynonenal%2520in%2520the%2520Pathogenesis%2520and%2520Progression%2520of%2520Human%2520Diseases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D230%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Gupta, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaram, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aggarwal, B. B.</span><span> </span><span class="NLM_article-title">Inhibiting NF-κB Activation by Small Molecules as a Therapeutic Strategy</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1799</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">787</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1799&publication_year=2010&pages=775-787&author=S.+C.+Guptaauthor=C.+Sundaramauthor=S.+Reuterauthor=B.+B.+Aggarwal&title=Inhibiting+NF-%CE%BAB+Activation+by+Small+Molecules+as+a+Therapeutic+Strategy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%2BC.%26aulast%3DSundaram%26aufirst%3DC.%26aulast%3DReuter%26aufirst%3DS.%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DInhibiting%2520NF-%25CE%25BAB%2520Activation%2520by%2520Small%2520Molecules%2520as%2520a%2520Therapeutic%2520Strategy%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2010%26volume%3D1799%26spage%3D775%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Luis-Rodriguez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Castelao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorriz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Alvaro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro-Gonzalez, J. F.</span><span> </span><span class="NLM_article-title">Pathophysiological Role and Therapeutic Implications of Inflammation in Diabetic Nephropathy</span> <span class="citation_source-journal">World J. Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.4239%2Fwjd.v3.i1.7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A280%3ADC%252BC387lsVWnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=7-18&author=D.+Luis-Rodriguezauthor=A.+Martinez-Castelaoauthor=J.+L.+Gorrizauthor=F.+de+Alvaroauthor=J.+F.+Navarro-Gonzalez&title=Pathophysiological+Role+and+Therapeutic+Implications+of+Inflammation+in+Diabetic+Nephropathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy</span></div><div class="casAuthors">Luis-Rodriguez Desiree; Martinez-Castelao Alberto; Gorriz Jose Luis; De-Alvaro Fernando; Navarro-Gonzalez Juan F</div><div class="citationInfo"><span class="NLM_cas:title">World journal of diabetes</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-18</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Diabetes mellitus and its complications are becoming one of the most important health problems in the world.  Diabetic nephropathy is now the main cause of end-stage renal disease.  The mechanisms leading to the development and progression of renal injury are not well known.  Therefore, it is very important to find new pathogenic pathways to provide opportunities for early diagnosis and targets for novel treatments.  At the present time, we know that activation of innate immunity with development of a chronic low grade inflammatory response is a recognized factor in the pathogenesis of diabetic nephropathy.  Numerous experimental and clinical studies have shown the participation of different inflammatory molecules and pathways in the pathophysiology of this complication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzX6Povz2h7HWEEzDrymxmfW6udTcc2ea7n48rFsufQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC387lsVWnsw%253D%253D&md5=f844fee875385aea24c2b9f87a92c06a</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.4239%2Fwjd.v3.i1.7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4239%252Fwjd.v3.i1.7%26sid%3Dliteratum%253Aachs%26aulast%3DLuis-Rodriguez%26aufirst%3DD.%26aulast%3DMartinez-Castelao%26aufirst%3DA.%26aulast%3DGorriz%26aufirst%3DJ.%2BL.%26aulast%3Dde%2BAlvaro%26aufirst%3DF.%26aulast%3DNavarro-Gonzalez%26aufirst%3DJ.%2BF.%26atitle%3DPathophysiological%2520Role%2520and%2520Therapeutic%2520Implications%2520of%2520Inflammation%2520in%2520Diabetic%2520Nephropathy%26jtitle%3DWorld%2520J.%2520Diabetes%26date%3D2012%26volume%3D3%26spage%3D7%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Plutzky, J.</span><span> </span><span class="NLM_article-title">Inflammation in Atherosclerosis and Diabetes Mellitus</span> <span class="citation_source-journal">Rev. Endocr. Metab. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1023%2FB%3AREMD.0000032414.17672.5c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=15211097" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=255-259&author=J.+Plutzky&title=Inflammation+in+Atherosclerosis+and+Diabetes+Mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1023%2FB%3AREMD.0000032414.17672.5c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FB%253AREMD.0000032414.17672.5c%26sid%3Dliteratum%253Aachs%26aulast%3DPlutzky%26aufirst%3DJ.%26atitle%3DInflammation%2520in%2520Atherosclerosis%2520and%2520Diabetes%2520Mellitus%26jtitle%3DRev.%2520Endocr.%2520Metab.%2520Dis.%26date%3D2004%26volume%3D5%26spage%3D255%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Schmidt, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saad, M. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, B. B.</span><span> </span><span class="NLM_article-title">Subclinical Inflammation and Obesity, Diabetes and Related Disorders</span> <span class="citation_source-journal">Drug Discovery Today: Dis. Mech.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.ddmec.2005.08.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=307-312&author=M.+I.+Schmidtauthor=M.+J.+A.+Saadauthor=B.+B.+Duncan&title=Subclinical+Inflammation+and+Obesity%2C+Diabetes+and+Related+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.ddmec.2005.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddmec.2005.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DM.%2BI.%26aulast%3DSaad%26aufirst%3DM.%2BJ.%2BA.%26aulast%3DDuncan%26aufirst%3DB.%2BB.%26atitle%3DSubclinical%2520Inflammation%2520and%2520Obesity%252C%2520Diabetes%2520and%2520Related%2520Disorders%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Dis.%2520Mech.%26date%3D2005%26volume%3D2%26spage%3D307%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Frohnert, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernlohr, D. A.</span><span> </span><span class="NLM_article-title">Glutathionylated Lipid Aldehydes Are Products of Adipocyte Oxidative Stress and Activators of Macrophage Inflammation</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=89-100&author=B.+I.+Frohnertauthor=E.+K.+Longauthor=W.+S.+Hahnauthor=D.+A.+Bernlohr&title=Glutathionylated+Lipid+Aldehydes+Are+Products+of+Adipocyte+Oxidative+Stress+and+Activators+of+Macrophage+Inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrohnert%26aufirst%3DB.%2BI.%26aulast%3DLong%26aufirst%3DE.%2BK.%26aulast%3DHahn%26aufirst%3DW.%2BS.%26aulast%3DBernlohr%26aufirst%3DD.%2BA.%26atitle%3DGlutathionylated%2520Lipid%2520Aldehydes%2520Are%2520Products%2520of%2520Adipocyte%2520Oxidative%2520Stress%2520and%2520Activators%2520of%2520Macrophage%2520Inflammation%26jtitle%3DDiabetes%26date%3D2014%26volume%3D63%26spage%3D89%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Vedantham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiagarajan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ananthakrishnan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosario, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramasamy, R.</span><span> </span><span class="NLM_article-title">Aldose Reductase Drives Hyperacetylation of Erg-1 in Hyperglycemia and Consequent Upregulation of Proinflammatory and Prothrombotic Signals</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=761-774&author=S.+Vedanthamauthor=D.+Thiagarajanauthor=R.+Ananthakrishnanauthor=L.+Wangauthor=R.+Rosarioauthor=Y.+S.+Zouauthor=I.+Goldbergauthor=S.+F.+Yanauthor=A.+M.+Schmidtauthor=R.+Ramasamy&title=Aldose+Reductase+Drives+Hyperacetylation+of+Erg-1+in+Hyperglycemia+and+Consequent+Upregulation+of+Proinflammatory+and+Prothrombotic+Signals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVedantham%26aufirst%3DS.%26aulast%3DThiagarajan%26aufirst%3DD.%26aulast%3DAnanthakrishnan%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DRosario%26aufirst%3DR.%26aulast%3DZou%26aufirst%3DY.%2BS.%26aulast%3DGoldberg%26aufirst%3DI.%26aulast%3DYan%26aufirst%3DS.%2BF.%26aulast%3DSchmidt%26aufirst%3DA.%2BM.%26aulast%3DRamasamy%26aufirst%3DR.%26atitle%3DAldose%2520Reductase%2520Drives%2520Hyperacetylation%2520of%2520Erg-1%2520in%2520Hyperglycemia%2520and%2520Consequent%2520Upregulation%2520of%2520Proinflammatory%2520and%2520Prothrombotic%2520Signals%26jtitle%3DDiabetes%26date%3D2014%26volume%3D63%26spage%3D761%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Zozulinska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wierusz-Wysocka, B.</span><span> </span><span class="NLM_article-title">Type 2 Diabetes Mellitus as Inflammatory Disease</span> <span class="citation_source-journal">Diabetes Res. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">74S</span><span class="NLM_x">, </span> <span class="NLM_fpage">S12</span><span class="NLM_x">–</span> <span class="NLM_lpage">S16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74S&publication_year=2006&pages=S12-S16&author=D.+Zozulinskaauthor=B.+Wierusz-Wysocka&title=Type+2+Diabetes+Mellitus+as+Inflammatory+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZozulinska%26aufirst%3DD.%26aulast%3DWierusz-Wysocka%26aufirst%3DB.%26atitle%3DType%25202%2520Diabetes%2520Mellitus%2520as%2520Inflammatory%2520Disease%26jtitle%3DDiabetes%2520Res.%2520Clin.%2520Pract.%26date%3D2006%26volume%3D74S%26spage%3DS12%26epage%3DS16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Oates, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mylari, B. L.</span><span> </span><span class="NLM_article-title">Aldose Reductase Inhibitors: Therapeutic Implications for Diabetic Complications</span> <span class="citation_source-journal">Expert. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2095</span><span class="NLM_x">–</span> <span class="NLM_lpage">2119</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1999&pages=2095-2119&author=P.+J.+Oatesauthor=B.+L.+Mylari&title=Aldose+Reductase+Inhibitors%3A+Therapeutic+Implications+for+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOates%26aufirst%3DP.%2BJ.%26aulast%3DMylari%26aufirst%3DB.%2BL.%26atitle%3DAldose%2520Reductase%2520Inhibitors%253A%2520Therapeutic%2520Implications%2520for%2520Diabetic%2520Complications%26jtitle%3DExpert.%2520Opin.%2520Invest.%2520Drugs%26date%3D1999%26volume%3D8%26spage%3D2095%26epage%3D2119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Heesom, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibberd, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millward, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demaine, A. G.</span><span> </span><span class="NLM_article-title">Polymorphism in the 5′-End of the Aldose Reductase Gene Is Strongly Associated with the Development of Diabetic Nephopathy in Type 1 Diabetes</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1997&pages=287-291&author=A.+E.+Heesomauthor=M.+L.+Hibberdauthor=A.+Millwardauthor=A.+G.+Demaine&title=Polymorphism+in+the+5%E2%80%B2-End+of+the+Aldose+Reductase+Gene+Is+Strongly+Associated+with+the+Development+of+Diabetic+Nephopathy+in+Type+1+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeesom%26aufirst%3DA.%2BE.%26aulast%3DHibberd%26aufirst%3DM.%2BL.%26aulast%3DMillward%26aufirst%3DA.%26aulast%3DDemaine%26aufirst%3DA.%2BG.%26atitle%3DPolymorphism%2520in%2520the%25205%25E2%2580%25B2-End%2520of%2520the%2520Aldose%2520Reductase%2520Gene%2520Is%2520Strongly%2520Associated%2520with%2520the%2520Development%2520of%2520Diabetic%2520Nephopathy%2520in%2520Type%25201%2520Diabetes%26jtitle%3DDiabetes%26date%3D1997%26volume%3D46%26spage%3D287%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Kao, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donaghue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silink, M.</span><span> </span><span class="NLM_article-title">A Novel Polymorphism in the Aldose Reductase Gene Promoter Region Is Strongly Associated with Diabetic Retinopathy in Adolescents with Type 1 Diabetes</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1338</span><span class="NLM_x">–</span> <span class="NLM_lpage">1340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1999&pages=1338-1340&author=Y.+L.+Kaoauthor=K.+Donaghueauthor=A.+Chanauthor=J.+Knightauthor=M.+Silink&title=A+Novel+Polymorphism+in+the+Aldose+Reductase+Gene+Promoter+Region+Is+Strongly+Associated+with+Diabetic+Retinopathy+in+Adolescents+with+Type+1+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKao%26aufirst%3DY.%2BL.%26aulast%3DDonaghue%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DKnight%26aufirst%3DJ.%26aulast%3DSilink%26aufirst%3DM.%26atitle%3DA%2520Novel%2520Polymorphism%2520in%2520the%2520Aldose%2520Reductase%2520Gene%2520Promoter%2520Region%2520Is%2520Strongly%2520Associated%2520with%2520Diabetic%2520Retinopathy%2520in%2520Adolescents%2520with%2520Type%25201%2520Diabetes%26jtitle%3DDiabetes%26date%3D1999%26volume%3D48%26spage%3D1338%26epage%3D1340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Lajer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarnow, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleckner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parving, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boel, E.</span><span> </span><span class="NLM_article-title">Association of Aldose Reductase Gene Z+2 Polymorphism with Reduced Susceptibility to Diabetic Nephropathy in Caucasian Type 1 Diabetic Patients</span> <span class="citation_source-journal">Diabetic Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">873</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1111%2Fj.1464-5491.2004.01259.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=15270790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt1Onsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2004&pages=867-873&author=M.+Lajerauthor=L.+Tarnowauthor=J.+Flecknerauthor=B.+V.+Hansenauthor=D.+G.+Edwardsauthor=H.+H.+Parvingauthor=E.+Boel&title=Association+of+Aldose+Reductase+Gene+Z%2B2+Polymorphism+with+Reduced+Susceptibility+to+Diabetic+Nephropathy+in+Caucasian+Type+1+Diabetic+Patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patients</span></div><div class="casAuthors">Lajer, M.; Tarnow, L.; Fleckner, J.; Hansen, B. V.; Edwards, D. G.; Parving, H.-H.; Boel, E.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetic Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">867-873</span>CODEN:
                <span class="NLM_cas:coden">DIMEEV</span>;
        ISSN:<span class="NLM_cas:issn">0742-3071</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Aims The Z-2 allele of the (AC)n polymorphism in the aldose reductase gene (ALR2) confers increased risk of microvascular diabetic complications, whereas the Z+2 allele has been proposed to be a marker of protection.  However data are conflicting.  Therefore, we investigated whether this polymorphism is assocd. with diabetic nephropathy and retinopathy in Type 1 diabetes mellitus in a large case-control study and a family-based anal.  Methods A total of 431 Type 1 diabetic patients with diabetic nephropathy and 468 patients with longstanding Type 1 diabetes and persistent normoalbuminuria were genotyped for the case-control study.  In addn., 102 case trios and 98 control trios were genotyped for a family-based study.  Results Thirteen different alleles were identified.  In the case-control study, the Z+2 allele frequency was significantly higher in the normoalbuminuric diabetic than in patients with diabetic nephropathy (0.17 vs. 0.11, P = 0.008), suggesting a protective function of the Z+2 allele.  No significant increase in the frequency of the putative risk allele Z-2 was found in patients with diabetic nephropathy vs. controls (0.39 vs. 0.36).  No assocn. with diabetic retinopathy was found.  Although the results of the transmission of the Z-2 and Z+2 alleles in the independent family-based study were consistent with the assocn. study, the no. of informative families was limited and thus differences were not statistically significant.  Conclusions The Z+2 allele of the ALR2 promoter polymorphism is assocd. with a reduced susceptibility to diabetic nephropathy in Danish Type 1 diabetic patients, suggesting a minor role for the polyol pathway in the pathogenesis of diabetic kidney disease.  No assocn. of the ALR2 polymorphism with diabetic retinopathy was found.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUIgPNcjFYJ7Vg90H21EOLACvtfcHk0liuixOX54OmKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt1Onsbg%253D&md5=724874d6537cb63fa8158228fe0c927e</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1111%2Fj.1464-5491.2004.01259.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1464-5491.2004.01259.x%26sid%3Dliteratum%253Aachs%26aulast%3DLajer%26aufirst%3DM.%26aulast%3DTarnow%26aufirst%3DL.%26aulast%3DFleckner%26aufirst%3DJ.%26aulast%3DHansen%26aufirst%3DB.%2BV.%26aulast%3DEdwards%26aufirst%3DD.%2BG.%26aulast%3DParving%26aufirst%3DH.%2BH.%26aulast%3DBoel%26aufirst%3DE.%26atitle%3DAssociation%2520of%2520Aldose%2520Reductase%2520Gene%2520Z%252B2%2520Polymorphism%2520with%2520Reduced%2520Susceptibility%2520to%2520Diabetic%2520Nephropathy%2520in%2520Caucasian%2520Type%25201%2520Diabetic%2520Patients%26jtitle%3DDiabetic%2520Med.%26date%3D2004%26volume%3D21%26spage%3D867%26epage%3D873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Sivenius, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niskanen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voutilainen-Kaunisto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laakso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uusitupa, M.</span><span> </span><span class="NLM_article-title">Aldose Reductase Gene Polymorphisms and Susceptibility to Microvascular Complications in Type 2 Diabetes</span> <span class="citation_source-journal">Diabetic Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1325</span><span class="NLM_x">–</span> <span class="NLM_lpage">1333</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1111%2Fj.1464-5491.2004.01345.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=15569136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjt1KitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2004&pages=1325-1333&author=K.+Siveniusauthor=L.+Niskanenauthor=R.+Voutilainen-Kaunistoauthor=M.+Laaksoauthor=M.+Uusitupa&title=Aldose+Reductase+Gene+Polymorphisms+and+Susceptibility+to+Microvascular+Complications+in+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Aldose reductase gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes</span></div><div class="casAuthors">Sivenius, K.; Niskanen, L.; Voutilainen-Kaunisto, R.; Laakso, M.; Uusitupa, M.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetic Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1325-1333</span>CODEN:
                <span class="NLM_cas:coden">DIMEEV</span>;
        ISSN:<span class="NLM_cas:issn">0742-3071</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Aims: The gene encoding the human aldose reductase, the first and rate-limiting enzyme of the polyol pathway of glucose metab., is a promising candidate gene which may contribute to diabetic microvascular complications.  We investigated the assocn. of two previously reported DNA sequence variants of this gene, the C-106T polymorphism and the (CA)n dinucleotide repeat marker, with the risk of albuminuria and retinopathy in Finnish Type 2 diabetic patients and non-diabetic control subjects.  Methods: The study population included 85 Finnish, middle-aged, newly diagnosed Type 2 diabetic patients and 126 non-diabetic control subjects.  Genetic analyses were performed using the polymerase chain reaction, restriction fragment length polymorphism, and automated laser fluorescence scanning analyses.  Microvascular complications were detd. using 10-yr follow-up data of urinary albumin excretion measurements and ophthalmol. examns.  Results: The C and Z-2 alleles of the C-106T polymorphism and the (CA)n repeat marker, resp., were found to be more frequent in Type 2 diabetic subjects than in non-diabetic subjects.  The C and Z-2 alleles were in 60% linkage disequil. in diabetic subjects.  At the time of diagnosis, diabetic subjects with the T allele of the C-106T polymorphism had significantly higher urinary albumin excretion rate and prevalence of albuminuria than subjects with the C-106C genotype (prevalence of albuminuria: 33.3 vs. 13.8%, P = 0.036, odds ratio = 3.9, 95% confidence interval 1.1, 14.7).  The Z-2 allele of the (CA)n repeat marker was not consistently assocd. with the prevalence of albuminuria.  No assocns. were obsd. between the polymorphisms examd. and the prevalence of retinopathy at any point of the follow-up.  Conclusions: The present study suggests that the C-106T polymorphism of the aldose reductase gene could be involved in the early development of microalbuminuria in Finnish Type 2 diabetic patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQZu0UcEUxDbVg90H21EOLACvtfcHk0liuixOX54OmKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjt1KitQ%253D%253D&md5=461efc4309b66d16775b1caa3c6f8cba</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1111%2Fj.1464-5491.2004.01345.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1464-5491.2004.01345.x%26sid%3Dliteratum%253Aachs%26aulast%3DSivenius%26aufirst%3DK.%26aulast%3DNiskanen%26aufirst%3DL.%26aulast%3DVoutilainen-Kaunisto%26aufirst%3DR.%26aulast%3DLaakso%26aufirst%3DM.%26aulast%3DUusitupa%26aufirst%3DM.%26atitle%3DAldose%2520Reductase%2520Gene%2520Polymorphisms%2520and%2520Susceptibility%2520to%2520Microvascular%2520Complications%2520in%2520Type%25202%2520Diabetes%26jtitle%3DDiabetic%2520Med.%26date%3D2004%26volume%3D21%26spage%3D1325%26epage%3D1333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Sivenius, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pihlajamaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partanen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niskanen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laakso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uusitupa, M.</span><span> </span><span class="NLM_article-title">Aldose Reductase Gene Polymorphisms and Peripheral Nerve Function in Patients with Type 2 Diabetes</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">2021</span><span class="NLM_x">–</span> <span class="NLM_lpage">2026</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=2021-2026&author=K.+Siveniusauthor=J.+Pihlajamakiauthor=J.+Partanenauthor=L.+Niskanenauthor=M.+Laaksoauthor=M.+Uusitupa&title=Aldose+Reductase+Gene+Polymorphisms+and+Peripheral+Nerve+Function+in+Patients+with+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSivenius%26aufirst%3DK.%26aulast%3DPihlajamaki%26aufirst%3DJ.%26aulast%3DPartanen%26aufirst%3DJ.%26aulast%3DNiskanen%26aufirst%3DL.%26aulast%3DLaakso%26aufirst%3DM.%26aulast%3DUusitupa%26aufirst%3DM.%26atitle%3DAldose%2520Reductase%2520Gene%2520Polymorphisms%2520and%2520Peripheral%2520Nerve%2520Function%2520in%2520Patients%2520with%2520Type%25202%2520Diabetes%26jtitle%3DDiabetes%2520Care%26date%3D2004%26volume%3D27%26spage%3D2021%26epage%3D2026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Tammali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span> </span><span class="NLM_article-title">Targeting Aldose Reductase for the Treatment of Cancer</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">571</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.2174%2F156800911795655958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=21486217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFegsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=560-571&author=R.+Tammaliauthor=S.+K.+Srivastavaauthor=K.+V.+Ramana&title=Targeting+Aldose+Reductase+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting aldose reductase for the treatment of cancer</span></div><div class="casAuthors">Tammali, R.; Srivastava, S. K.; Ramana, K. V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">560-571</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  It is strongly established by numerous studies that oxidative stress-induced inflammation is one of the major causative agents in a variety of cancers.  Various factors such as bacterial, viral, parasitic infections, chem. irritants, carcinogens are involved in the initiation of oxidative stress-mediated inflammation.  Chronic and persistent inflammation promotes the formation of cancerous tumors.  Recent investigations strongly suggest that aldose reductase [AR; AKR1B1], a member of aldo-keto reductase superfamily of proteins, is the mediator of inflammatory signals induced by growth factors, cytokines, chemokines, carcinogens etc.  Further, AR reduced product(s) of lipid derived aldehydes and their metabolites such as glutathionyl 1,4-dihydroxynonanol (GS-DHN) have been shown to be involved in the activation of transcription factors such as NF-κB and AP-1 which transcribe the genes of inflammatory cytokines.  The increased inflammatory cytokines and growth factors promote cell proliferation, a main feature involved in the tumorigenesis process.  Inhibition of AR has been shown to prevent cancer cell growth in vitro and in vivo models.  In this review, we have described the possible assocn. between AR with oxidative stress- and inflammation- initiated carcinogenesis.  A thorough understanding of the role of AR in the inflammation - assocd. cancers could lead to the use of AR inhibitors as novel chemotherapeutic agents against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRDrHmZBYv1bVg90H21EOLACvtfcHk0lhgO8dG8xFdvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFegsrw%253D&md5=fbfd97875e888631928c77b50b0614b1</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.2174%2F156800911795655958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800911795655958%26sid%3Dliteratum%253Aachs%26aulast%3DTammali%26aufirst%3DR.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26atitle%3DTargeting%2520Aldose%2520Reductase%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2011%26volume%3D11%26spage%3D560%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Aldose Reductase: A Novel Therapeutic Target for Inflammatory Pathologies</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.biocel.2009.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=19778627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsV2mt7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2010&pages=17-20&author=K.+V.+Ramanaauthor=S.+K.+Srivastava&title=Aldose+Reductase%3A+A+Novel+Therapeutic+Target+for+Inflammatory+Pathologies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Aldose reductase: A novel therapeutic target for inflammatory pathologies</span></div><div class="casAuthors">Ramana, Kota V.; Srivastava, Satish K.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-20</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Aldose reductase (AR), that catalyzes the rate limiting step of the polyol pathway of glucose metab., besides reducing glucose to sorbitol, reduces a no. of lipid peroxidn. - derived aldehydes and their glutathione conjugates.  Recent studies suggest that apart from its involvement in diabetic complications, AR's catalytic activity plays a key role in a no. of inflammatory diseases such as atherosclerosis, sepsis, asthma, uveitis, and colon cancer.  Furthermore, AR is overexpressed in human cancers such as liver, colon, breast, cervical and ovarian.  Since AR inhibitors have already undergone up to phase-iii clin. trials for diabetic complications, they could be safe anti-inflammatory drugs.  Therefore the future use of AR inhibitors in down-regulating major inflammatory pathologies such as cancer and cardiovascular diseases could relieve some of the major health concerns of worldwide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIPbxyf8RUyrVg90H21EOLACvtfcHk0lhgO8dG8xFdvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsV2mt7zP&md5=10b486d07849c5512a8cd3f3a6d67bfd</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2009.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2009.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DAldose%2520Reductase%253A%2520A%2520Novel%2520Therapeutic%2520Target%2520for%2520Inflammatory%2520Pathologies%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2010%26volume%3D42%26spage%3D17%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Reuter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aggarwal, B. B.</span><span> </span><span class="NLM_article-title">Oxidative Stress, Inflammation, and Cancer: How Are They Linked?</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1603</span><span class="NLM_x">–</span> <span class="NLM_lpage">1616</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.freeradbiomed.2010.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=20840865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKktLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=1603-1616&author=S.+Reuterauthor=S.+C.+Guptaauthor=M.+M.+Chaturvediauthor=B.+B.+Aggarwal&title=Oxidative+Stress%2C+Inflammation%2C+and+Cancer%3A+How+Are+They+Linked%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress, inflammation, and cancer: How are they linked?</span></div><div class="casAuthors">Reuter, Simone; Gupta, Subash C.; Chaturvedi, Madan M.; Aggarwal, Bharat B.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1603-1616</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Extensive research during the past 2 decades has revealed the mechanism by which continued oxidative stress can lead to chronic inflammation, which in turn could mediate most chronic diseases including cancer, diabetes, and cardiovascular, neurol., and pulmonary diseases.  Oxidative stress can activate a variety of transcription factors including NF-κB, AP-1, p53, HIF-1α, PPAR-γ, β-catenin/Wnt, and Nrf2.  Activation of these transcription factors can lead to the expression of over 500 different genes, including those for growth factors, inflammatory cytokines, chemokines, cell cycle regulatory mols., and anti-inflammatory mols.  How oxidative stress activates inflammatory pathways leading to transformation of a normal cell to tumor cell, tumor cell survival, proliferation, chemoresistance, radioresistance, invasion, angiogenesis, and stem cell survival is the focus of this review.  Overall, observations to date suggest that oxidative stress, chronic inflammation, and cancer are closely linked.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNUO29xqkZYrVg90H21EOLACvtfcHk0lhgO8dG8xFdvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKktLjF&md5=711e87493285f8d1167063aa0357324a</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2010.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2010.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DReuter%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DS.%2BC.%26aulast%3DChaturvedi%26aufirst%3DM.%2BM.%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DOxidative%2520Stress%252C%2520Inflammation%252C%2520and%2520Cancer%253A%2520How%2520Are%2520They%2520Linked%253F%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2010%26volume%3D49%26spage%3D1603%26epage%3D1616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Panico, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardile, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crascì, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronsisvalle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottanà, R.</span><span> </span><span class="NLM_article-title">5-Arylidene-4-thiazolidinone Derivatives Active as Antidegenerative Agents on Human Chondrocyte Cultures</span> <span class="citation_source-journal">Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.2174%2F157340613804488378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=22762165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktF2mtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=84-90&author=A.+Panicoauthor=R.+Maccariauthor=V.+Cardileauthor=L.+Crasc%C3%ACauthor=S.+Ronsisvalleauthor=R.+Ottan%C3%A0&title=5-Arylidene-4-thiazolidinone+Derivatives+Active+as+Antidegenerative+Agents+on+Human+Chondrocyte+Cultures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">5-arylidene-4-thiazolidinone derivatives active as antidegenerative agents on human chondrocyte cultures</span></div><div class="casAuthors">Panico, Annamaria; Maccari, Rosanna; Cardile, Venera; Crasci, Lucia; Ronsisvalle, Simone; Ottana, Rosaria</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-90</span>CODEN:
                <span class="NLM_cas:coden">MCEHAJ</span>;
        ISSN:<span class="NLM_cas:issn">1573-4064</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">5-Arylidene-2-oxo-4-thiazolidinones and 2-phenylimino analogs were evaluated for their antidegenerative activity on human chondrocyte cultures stimulated by IL-1β and for their inhibitory capability against matrix metalloproteinase-13.  Our results indicated that 5-arylidene-4-thiazolidinone derivs. 1-9 exhibit antidegenerative activity and could block multiple cartilage destruction during the osteoarthritic process.  Out of the selected compds., (5-arylidene-2,4-dioxothiazolidin-3-yl)acetic acids 7-9 showed significant effectiveness in reducing NO release and restoring normal levels of GAGs in chondrocytes treated with IL-1β.  Moreover, benzoic acids 1, 5 and 6 proved to be effective MMP-13 inhibitors and were able to restore normal levels of GAGs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplfUQ7EiPKjbVg90H21EOLACvtfcHk0liNTKX74x35Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktF2mtbY%253D&md5=157970f44597e670bee1fe376cfceee0</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.2174%2F157340613804488378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157340613804488378%26sid%3Dliteratum%253Aachs%26aulast%3DPanico%26aufirst%3DA.%26aulast%3DMaccari%26aufirst%3DR.%26aulast%3DCardile%26aufirst%3DV.%26aulast%3DCrasc%25C3%25AC%26aufirst%3DL.%26aulast%3DRonsisvalle%26aufirst%3DS.%26aulast%3DOttan%25C3%25A0%26aufirst%3DR.%26atitle%3D5-Arylidene-4-thiazolidinone%2520Derivatives%2520Active%2520as%2520Antidegenerative%2520Agents%2520on%2520Human%2520Chondrocyte%2520Cultures%26jtitle%3DMed.%2520Chem.%26date%3D2013%26volume%3D9%26spage%3D84%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Maccari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitale, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottanà, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocchiccioli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrazzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardile, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graziano, A. C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amodeo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mura, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Corso, A.</span><span> </span><span class="NLM_article-title">Structure–Activity Relationships and Molecular Modelling of New 5-Arylidene-4-thiazolidinone Derivatives as Aldose Reductase Inhibitors and Potential Anti-Inflammatory Agents</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2014&pages=1-14&author=R.+Maccariauthor=R.+M.+Vitaleauthor=R.+Ottan%C3%A0author=M.+Rocchiccioliauthor=A.+Marrazzoauthor=V.+Cardileauthor=A.+C.+E.+Grazianoauthor=P.+Amodeoauthor=U.+Muraauthor=A.+Del+Corso&title=Structure%E2%80%93Activity+Relationships+and+Molecular+Modelling+of+New+5-Arylidene-4-thiazolidinone+Derivatives+as+Aldose+Reductase+Inhibitors+and+Potential+Anti-Inflammatory+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaccari%26aufirst%3DR.%26aulast%3DVitale%26aufirst%3DR.%2BM.%26aulast%3DOttan%25C3%25A0%26aufirst%3DR.%26aulast%3DRocchiccioli%26aufirst%3DM.%26aulast%3DMarrazzo%26aufirst%3DA.%26aulast%3DCardile%26aufirst%3DV.%26aulast%3DGraziano%26aufirst%3DA.%2BC.%2BE.%26aulast%3DAmodeo%26aufirst%3DP.%26aulast%3DMura%26aufirst%3DU.%26aulast%3DDel%2BCorso%26aufirst%3DA.%26atitle%3DStructure%25E2%2580%2593Activity%2520Relationships%2520and%2520Molecular%2520Modelling%2520of%2520New%25205-Arylidene-4-thiazolidinone%2520Derivatives%2520as%2520Aldose%2520Reductase%2520Inhibitors%2520and%2520Potential%2520Anti-Inflammatory%2520Agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D81%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Chang, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laffin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Énzsöly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Németh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBarbera, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, J. M.</span><span> </span><span class="NLM_article-title">Beta-Glucogallin Reduces the Expression of Lipopolysaccharide-Induced Inflammatory Markers by Inhibition of Aldose Reductase in Murine Macrophages and Ocular Tissues</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">287</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.cbi.2012.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=23247009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFaqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2013&pages=283-287&author=K.-C.+Changauthor=B.+Laffinauthor=J.+Ponderauthor=A.+%C3%89nzs%C3%B6lyauthor=J.+N%C3%A9methauthor=D.+V.+LaBarberaauthor=J.+M.+Petrash&title=Beta-Glucogallin+Reduces+the+Expression+of+Lipopolysaccharide-Induced+Inflammatory+Markers+by+Inhibition+of+Aldose+Reductase+in+Murine+Macrophages+and+Ocular+Tissues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Beta-glucogallin reduces the expression of lipopolysaccharide-induced inflammatory markers by inhibition of aldose reductase in murine macrophages and ocular tissues</span></div><div class="casAuthors">Chang, Kun-Che; Laffin, Brian; Ponder, Jessica; Enzsoly, Anna; Nemeth, Janos; LaBarbera, Daniel V.; Petrash, J. Mark</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">283-287</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Aldose reductase (AR) catalyzes the redn. of toxic lipid aldehydes to their alc. products and mediates inflammatory signals triggered by lipopolysaccharide (LPS).  Beta-glucogallin (BGG), a recently described AR inhibitor, was purified from exts. of the Indian gooseberry (Emblica officinalis).  In this study, we found that BGG showed low cytotoxicity in Raw264.7 murine macrophages and effectively inhibited AR activity as measured by a decrease in sorbitol accumulation.  In addn., BGG-mediated inhibition of AR prevented LPS-induced activation of JNK and p38 and lowered ROS levels, which could inhibit LPS-induced apoptosis.  Uveitis is a disease of the eye assocd. with chronic inflammation.  In this study, we also demonstrated that treatment with BGG decreased the no. of inflammatory cells that infiltrate the ocular media of mice with exptl. uveitis.  Accordingly, these results suggest BGG is a potential therapy for inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqk_VWCpvDtrVg90H21EOLACvtfcHk0liNTKX74x35Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFaqsw%253D%253D&md5=01672c72c826fc6d83e3e3c39ab8d83c</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2012.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2012.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DK.-C.%26aulast%3DLaffin%26aufirst%3DB.%26aulast%3DPonder%26aufirst%3DJ.%26aulast%3D%25C3%2589nzs%25C3%25B6ly%26aufirst%3DA.%26aulast%3DN%25C3%25A9meth%26aufirst%3DJ.%26aulast%3DLaBarbera%26aufirst%3DD.%2BV.%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26atitle%3DBeta-Glucogallin%2520Reduces%2520the%2520Expression%2520of%2520Lipopolysaccharide-Induced%2520Inflammatory%2520Markers%2520by%2520Inhibition%2520of%2520Aldose%2520Reductase%2520in%2520Murine%2520Macrophages%2520and%2520Ocular%2520Tissues%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2013%26volume%3D202%26spage%3D283%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Zeng, K.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, P.-F.</span><span> </span><span class="NLM_article-title">Anti-Neuroinflammatory Efficacy of the Aldose Reductase Inhibitor FMHM via Phospholipase C/Protein Kinase C-Dependent NF-κB and MAPK Pathways</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.taap.2013.08.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=24021941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslKqt7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=2013&pages=159-171&author=K.-W.+Zengauthor=J.+Liauthor=X.+Dongauthor=Y.-H.+Wangauthor=Z.-Z.+Maauthor=Y.+Jiangauthor=H.-W.+Jinauthor=P.-F.+Tu&title=Anti-Neuroinflammatory+Efficacy+of+the+Aldose+Reductase+Inhibitor+FMHM+via+Phospholipase+C%2FProtein+Kinase+C-Dependent+NF-%CE%BAB+and+MAPK+Pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-neuroinflammatory efficacy of the aldose reductase inhibitor FMHM via phospholipase C/protein kinase C-dependent NF-κB and MAPK pathways</span></div><div class="casAuthors">Zeng, Ke-Wu; Li, Jun; Dong, Xin; Wang, Ying-Hong; Ma, Zhi-Zhong; Jiang, Yong; Jin, Hong-Wei; Tu, Peng-Fei</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">159-171</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Aldose reductase (AR) has a key role in several inflammatory diseases: diabetes, cancer and cardiovascular diseases.  Therefore, AR inhibition seems to be a useful strategy for anti-inflammation therapy.  In the central nervous system (CNS), microglial over-activation is considered to be a central event in neuroinflammation.  However, the effects of AR inhibition in CNS inflammation and its underlying mechanism of action remain unknown.  In the present study, we found that FMHM (a naturally derived AR inhibitor from the roots of Polygala tricornis Gagnep.) showed potent anti-neuroinflammatory effects in vivo and in vitro by inhibiting microglial activation and expression of inflammatory mediators.  Mechanistic studies showed that FMHM suppressed the activity of AR-dependent phospholipase C/protein kinase C signaling, which further resulted in downstream inactivation of the IκB kinase/IκB/nuclear factor-kappa B (NF-κB) inflammatory pathway.  Therefore, AR inhibition-dependent NF-κB inactivation neg. regulated the transcription and expression of various inflammatory genes.  AR inhibition by FMHM exerted neuroprotective effects in lipopolysaccharide-induced neuron-microglia co-cultures.  These findings suggested that AR is a potential target for neuroinflammation inhibition and that FMHM could be an effective agent for treating or preventing neuroinflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG2kWQVggzY7Vg90H21EOLACvtfcHk0liNTKX74x35Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslKqt7jE&md5=1cddf94e77cb068bb4b80e996fac607a</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2013.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2013.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DK.-W.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.-H.%26aulast%3DMa%26aufirst%3DZ.-Z.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DH.-W.%26aulast%3DTu%26aufirst%3DP.-F.%26atitle%3DAnti-Neuroinflammatory%2520Efficacy%2520of%2520the%2520Aldose%2520Reductase%2520Inhibitor%2520FMHM%2520via%2520Phospholipase%2520C%252FProtein%2520Kinase%2520C-Dependent%2520NF-%25CE%25BAB%2520and%2520MAPK%2520Pathways%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2013%26volume%3D273%26spage%3D159%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Hwang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakr, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itakura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rui, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skopicki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oates, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabolcs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramasamy, R.</span><span> </span><span class="NLM_article-title">Central Role for Aldose Reductase Pathway in Myocardial Ischemic Injury</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1192</span><span class="NLM_x">–</span> <span class="NLM_lpage">1199</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=1192-1199&author=Y.+C.+Hwangauthor=M.+Kanekoauthor=S.+Bakrauthor=H.+Liaoauthor=Y.+Luauthor=E.+R.+Lewisauthor=S.+Yanauthor=S.+Iiauthor=M.+Itakuraauthor=L.+Ruiauthor=H.+Skopickiauthor=S.+Hommaauthor=A.+M.+Schmidtauthor=P.+J.+Oatesauthor=M.+Szabolcsauthor=R.+Ramasamy&title=Central+Role+for+Aldose+Reductase+Pathway+in+Myocardial+Ischemic+Injury"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DY.%2BC.%26aulast%3DKaneko%26aufirst%3DM.%26aulast%3DBakr%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLewis%26aufirst%3DE.%2BR.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DIi%26aufirst%3DS.%26aulast%3DItakura%26aufirst%3DM.%26aulast%3DRui%26aufirst%3DL.%26aulast%3DSkopicki%26aufirst%3DH.%26aulast%3DHomma%26aufirst%3DS.%26aulast%3DSchmidt%26aufirst%3DA.%2BM.%26aulast%3DOates%26aufirst%3DP.%2BJ.%26aulast%3DSzabolcs%26aufirst%3DM.%26aulast%3DRamasamy%26aufirst%3DR.%26atitle%3DCentral%2520Role%2520for%2520Aldose%2520Reductase%2520Pathway%2520in%2520Myocardial%2520Ischemic%2520Injury%26jtitle%3DFASEB%2520J.%26date%3D2004%26volume%3D18%26spage%3D1192%26epage%3D1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Son, N.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ananthakrishnan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramasamy, R.</span><span> </span><span class="NLM_article-title">Cardiomyocyte Aldose Reductase Causes Heart Failure and Impairs Recovery from Ischemia</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e46549</span><span class="refDoi"> DOI: 10.1371/journal.pone.0046549</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1371%2Fjournal.pone.0046549" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e46549&author=N.-H.+Sonauthor=R.+Ananthakrishnanauthor=S.+Yuauthor=R.+S.+Khanauthor=H.+Jiangauthor=R.+Jiauthor=H.+Akashiauthor=Q.+Liauthor=K.+O%E2%80%99Sheaauthor=S.+Hommaauthor=I.+J.+Goldbergauthor=R.+Ramasamy&title=Cardiomyocyte+Aldose+Reductase+Causes+Heart+Failure+and+Impairs+Recovery+from+Ischemia&doi=10.1371%2Fjournal.pone.0046549"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0046549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0046549%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DN.-H.%26aulast%3DAnanthakrishnan%26aufirst%3DR.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DR.%2BS.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DR.%26aulast%3DAkashi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DK.%26aulast%3DHomma%26aufirst%3DS.%26aulast%3DGoldberg%26aufirst%3DI.%2BJ.%26aulast%3DRamasamy%26aufirst%3DR.%26atitle%3DCardiomyocyte%2520Aldose%2520Reductase%2520Causes%2520Heart%2520Failure%2520and%2520Impairs%2520Recovery%2520from%2520Ischemia%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De46549%26doi%3D10.1371%2Fjournal.pone.0046549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Laffin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, J. M.</span><span> </span><span class="NLM_article-title">Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="refDoi"> DOI: 10.3389/fphar.2012.00104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.3389%2Ffphar.2012.00104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=22685431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms12qtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=104&author=B.+Laffinauthor=J.+M.+Petrash&title=Expression+of+the+Aldo-Ketoreductases+AKR1B1+and+AKR1B10+in+Human+Cancers&doi=10.3389%2Ffphar.2012.00104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of the aldo-ketoreductases AKR1B1 and AKR1B10 in human cancers</span></div><div class="casAuthors">Laffin, Brian; Petrash, J. Mark</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Experimental Pharmacology and Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">June</span>),
    <span class="NLM_cas:pages">104</span>CODEN:
                <span class="NLM_cas:coden">FEPDAX</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The American Cancer Society ests. that there will be more than 1.5 million new cases of cancer in 2011, underscoring the need for identification of new therapeutic targets and development of novel cancer therapies.  Previous studies have implicated the human aldo-ketoreductases AKR1B1 and AKR1B10 in cancer and therefore we examd. AKR1B1 and AKR1B10 expression across all major human cancer types using the Oncomine cancer gene expression database (Compendia Biosciences).  Using this database, we found that expression of AKR1B1 and AKR1B10 varies greatly by cancer type and tissue of origin, including agreement with previous reports that AKR1B10 is significantly over-expressed in cancers of the lungs and liver.  AKR1B1 is more broadly over-expressed in human cancers than AKR1B10, albeit at a generally lower magnitude.  AKR1B1 over-expression was found to be assocd. with shortened patient survival in acute myelogenous leukemias and multiple myelomas.  High AKR1B10 expression tends to predict less aggressive clin. course generally, notably within lung cancers, where it tends to be highly over-expressed compared to normal tissue.  These findings suggest that AKR1B1 inhibitors in particular hold great potential as novel cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYNF9NNpr1X7Vg90H21EOLACvtfcHk0liCKes4bgxnCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms12qtr0%253D&md5=3bd8b0daadb669454fb8b9c95906b9cd</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2012.00104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2012.00104%26sid%3Dliteratum%253Aachs%26aulast%3DLaffin%26aufirst%3DB.%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26atitle%3DExpression%2520of%2520the%2520Aldo-Ketoreductases%2520AKR1B1%2520and%2520AKR1B10%2520in%2520Human%2520Cancers%26jtitle%3DFront.%2520Pharmacol.%26date%3D2012%26volume%3D3%26spage%3D104%26doi%3D10.3389%2Ffphar.2012.00104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Plebuch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soldan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungerer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maser, E.</span><span> </span><span class="NLM_article-title">Increased Resistance of Tumor Cells to Daunorubicin after Transfection of cDNAs Coding for Anthracycline Inactivating Enzymes</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.canlet.2007.03.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=17482758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFGmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=2007&pages=49-56&author=M.+Plebuchauthor=M.+Soldanauthor=C.+Hungererauthor=L.+Kochauthor=E.+Maser&title=Increased+Resistance+of+Tumor+Cells+to+Daunorubicin+after+Transfection+of+cDNAs+Coding+for+Anthracycline+Inactivating+Enzymes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Increased resistance of tumor cells to daunorubicin after transfection of cDNAs coding for anthracycline inactivating enzymes</span></div><div class="casAuthors">Plebuch, Mariann; Soldan, Michael; Hungerer, Christoph; Koch, Lutz; Maser, Edmund</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">255</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-56</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Carbonyl redn. is a main but undesired metabolic pathway of the anti-cancer drug daunorubicin (DRC).  The resulting alc. metabolite daunorubicinol has a far less anti-tumor potency and, in addn., is responsible for the life-threatening cardiac toxicity that limits the clin. use of DRC.  Elevated levels of carbonyl-reducing enzymes in cancer cells may therefore contribute to the development of DRC chemoresistance and affect the clin. outcome.  In the present investigation, human pancreas carcinoma cells were transfected with three important DRC reductases, namely carbonyl reductase (CBR1), aldehyde reductase (AKR1A1) and aldose reductase (AKR1B1), and levels of resistance towards DCR detd.  Overexpression of all three reductases lead to a higher DRC inactivation and to an elevation of chemoresistance (7-fold for CBR1, 4.5-fold for AKR1A1 and 3.7-fold for AKR1B1), when IC50-values were considered.  Coadministration of DRC reductase inhibitors in DRC chemotherapy may be desirable since this would reduce the formation of the cardiotoxic alc. metabolite and prevent drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9gnZXHCVnM7Vg90H21EOLACvtfcHk0liCKes4bgxnCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFGmsLo%253D&md5=8acda29f3ff2eb769de1ae44fbd5c584</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2007.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2007.03.018%26sid%3Dliteratum%253Aachs%26aulast%3DPlebuch%26aufirst%3DM.%26aulast%3DSoldan%26aufirst%3DM.%26aulast%3DHungerer%26aufirst%3DC.%26aulast%3DKoch%26aufirst%3DL.%26aulast%3DMaser%26aufirst%3DE.%26atitle%3DIncreased%2520Resistance%2520of%2520Tumor%2520Cells%2520to%2520Daunorubicin%2520after%2520Transfection%2520of%2520cDNAs%2520Coding%2520for%2520Anthracycline%2520Inactivating%2520Enzymes%26jtitle%3DCancer%2520Lett.%26date%3D2007%26volume%3D255%26spage%3D49%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Der-Torossian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wysong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shadfar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDunn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couch, M. E.</span><span> </span><span class="NLM_article-title">Metabolic Derangements in the Gastrocnemius and the Effect of Compound A Therapy in a Murine Model of Cancer Cachexia</span> <span class="citation_source-journal">J. Cachexia Sarcopenia Muscle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1007%2Fs13539-012-0101-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=23344889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A280%3ADC%252BC3szhslSktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=145-155&author=H.+Der-Torossianauthor=A.+Wysongauthor=S.+Shadfarauthor=M.+S.+Willisauthor=J.+McDunnauthor=M.+E.+Couch&title=Metabolic+Derangements+in+the+Gastrocnemius+and+the+Effect+of+Compound+A+Therapy+in+a+Murine+Model+of+Cancer+Cachexia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic derangements in the gastrocnemius and the effect of Compound A therapy in a murine model of cancer cachexia</span></div><div class="casAuthors">Der-Torossian Hirak; Wysong Ashley; Shadfar Scott; Willis Monte S; McDunn Jonathan; Couch Marion E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cachexia, sarcopenia and muscle</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-55</span>
        ISSN:<span class="NLM_cas:issn">2190-5991</span>.
    </div><div class="casAbstract">BACKGROUND:  Cancer cachexia is a severe wasting syndrome characterized by the progressive loss of lean body mass and systemic inflammation.  Inhibiting the signaling of the transcription factor nuclear factor kappa B (NF-κB) largely prevents cancer-induced muscle wasting in murine models.  We have previously shown the utility of Compound A, a highly selective novel NF-κB inhibitor that targets the IκB kinase complex, to provide clinical benefit in cancer-induced skeletal muscle and cardiac atrophy.  METHODS:  Using a metabolomics approach, we describe the changes found between cachectic and noncachectic gastrocnemius muscles before and after Compound A treatment at various doses.  RESULTS:  Of the 234 metabolites in the gastrocnemius, cachexia-induced changes in gastrocnemius metabolism reset the steady-state abundances of 42 metabolites (p < 0.05).  These changes, not evenly distributed across biochemical categories, are concentrated in amino acids, peptides, carbohydrates and energetics intermediates, and lipids.  The gastrocnemius glycolytic pathway is markedly altered-changes consistent with tumor Warburg physiology.  This is the first account of a Warburg effect that is not exclusively restricted to cancer cells or rapidly proliferating nonmalignant cells.  Cachectic gastrocnemius also displays tricarboxylic acid cycle disruptions, signs of oxidative stress, and impaired redox homeostasis.  Compound A only partially rescues the phenotype of the cachectic gastrocnemius, failing to restore the gastrocnemius' baseline metabolic profile.  CONCLUSIONS:  The findings in the present manuscript enumerate the metabolic consequences of cachexia in the gastrocnemius and demonstrate that NF-kB targeted treatment only partly rescues the cachectic metabolic phenotype.  These data strengthen the previous findings from metabolomic characterization of serum in cachectic animals, suggesting that many of the metabolic alterations observed in the blood originate in the diseased muscle.  These findings provide significant insight into the complex pathophysiology of cancer cachexia and provide objective criteria for evaluating future therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRoTDtAPL-NkzAyhZbj3lKdfW6udTcc2eYOWOB6UR4gYLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szhslSktA%253D%253D&md5=d5d85abf9016bd994f3deb8543608dd0</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1007%2Fs13539-012-0101-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13539-012-0101-7%26sid%3Dliteratum%253Aachs%26aulast%3DDer-Torossian%26aufirst%3DH.%26aulast%3DWysong%26aufirst%3DA.%26aulast%3DShadfar%26aufirst%3DS.%26aulast%3DWillis%26aufirst%3DM.%2BS.%26aulast%3DMcDunn%26aufirst%3DJ.%26aulast%3DCouch%26aufirst%3DM.%2BE.%26atitle%3DMetabolic%2520Derangements%2520in%2520the%2520Gastrocnemius%2520and%2520the%2520Effect%2520of%2520Compound%2520A%2520Therapy%2520in%2520a%2520Murine%2520Model%2520of%2520Cancer%2520Cachexia%26jtitle%3DJ.%2520Cachexia%2520Sarcopenia%2520Muscle%26date%3D2013%26volume%3D4%26spage%3D145%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Kawamura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeshita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishigaki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimomura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, T.</span><span> </span><span class="NLM_article-title">Ponalrestat, an Aldose Reductase Inhibitor, Inhibits Cachexia Syndrome Induced by Colon26 Adenocarcinoma in Mice</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4105</span><span class="NLM_x">–</span> <span class="NLM_lpage">4111</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=10628361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt12k" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=4105-4111&author=I.+Kawamuraauthor=E.+Laceyauthor=N.+Yamamotoauthor=F.+Sakaiauthor=S.+Takeshitaauthor=M.+Inamiauthor=F.+Nishigakiauthor=Y.+Naoeauthor=S.+Tsujimotoauthor=T.+Mandaauthor=K.+Shimomuraauthor=T.+Goto&title=Ponalrestat%2C+an+Aldose+Reductase+Inhibitor%2C+Inhibits+Cachexia+Syndrome+Induced+by+Colon26+Adenocarcinoma+in+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon26 adenocarcinoma in mice</span></div><div class="casAuthors">Kawamura, Ikuo; Lacey, Elizabeth; Yamamoto, Nobuchika; Sakai, Fumihiko; Takeshita, Shigeru; Inami, Masamichi; Nishigaki, Fusako; Naoe, Yoshinori; Tsujimoto, Susumu; Manda, Toshitaka; Shimomura, Kyoichi; Goto, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5B</span>),
    <span class="NLM_cas:pages">4105-4111</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Our recent study has demonstrated that ponalrestat, an aldose reductase inhibitor, activates lipoprotein lipase activity and alleviates B16 melanoma-induced cachexia in mice.  In this study, the effect of ponalrestat on murine adenocarcinoma colon26-induced cachexia was investigated in mice.  Mice bearing colon26 s.c. lost wt. and became cachectic, assocd. with the tumor growth.  Although tumor growth was slightly stimulated when tumor bearing mice were treated with ponalrestat; nevertheless, the drug attenuated the redn. in the wt. of body mass, epididymal fat, gastrocnemius muscle and carcass induced by colon26, as well as significantly prolonged the survival of the colon26 bearing mice.  Ponalrestat inhibited the prodn. of interleukin-1 (IL-1) from human monocytes stimulated by Lipopolysaccharide (LPS) in vitro, and also suppressed LPS-induced increase of IL-1 in the blood in mice.  Overall, this study showed that ponalrestat suppresses IL-1 prodn. both in vitro and in vivo, and inhibits the cachectic symptoms induced by colon26 adenocarcinoma in mice, suggesting that ponalrestat has a therapeutic potential for the treatment of cancer cachexia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAE9s69ApIs7Vg90H21EOLACvtfcHk0lgb9b3DHIuQgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt12k&md5=1de4fa208dfa9909dbc119f708e6d093</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKawamura%26aufirst%3DI.%26aulast%3DLacey%26aufirst%3DE.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DSakai%26aufirst%3DF.%26aulast%3DTakeshita%26aufirst%3DS.%26aulast%3DInami%26aufirst%3DM.%26aulast%3DNishigaki%26aufirst%3DF.%26aulast%3DNaoe%26aufirst%3DY.%26aulast%3DTsujimoto%26aufirst%3DS.%26aulast%3DManda%26aufirst%3DT.%26aulast%3DShimomura%26aufirst%3DK.%26aulast%3DGoto%26aufirst%3DT.%26atitle%3DPonalrestat%252C%2520an%2520Aldose%2520Reductase%2520Inhibitor%252C%2520Inhibits%2520Cachexia%2520Syndrome%2520Induced%2520by%2520Colon26%2520Adenocarcinoma%2520in%2520Mice%26jtitle%3DAnticancer%2520Res.%26date%3D1999%26volume%3D19%26spage%3D4105%26epage%3D4111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Tammali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singhal, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awasthi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Aldose Reductase Regulates Growth Factor-Induced Cyclooxygenase-2 Expression and Prostaglandin E2 Production in Human Colon Cancer Cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">9705</span><span class="NLM_x">–</span> <span class="NLM_lpage">9713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=9705-9713&author=R.+Tammaliauthor=K.+V.+Ramanaauthor=S.+S.+Singhalauthor=S.+Awasthiauthor=S.+K.+Srivastava&title=Aldose+Reductase+Regulates+Growth+Factor-Induced+Cyclooxygenase-2+Expression+and+Prostaglandin+E2+Production+in+Human+Colon+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTammali%26aufirst%3DR.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DSinghal%26aufirst%3DS.%2BS.%26aulast%3DAwasthi%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DAldose%2520Reductase%2520Regulates%2520Growth%2520Factor-Induced%2520Cyclooxygenase-2%2520Expression%2520and%2520Prostaglandin%2520E2%2520Production%2520in%2520Human%2520Colon%2520Cancer%2520Cells%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D9705%26epage%3D9713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Tammali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Aldose Reductase Regulates TNF-α-Induced PGE<sub>2</sub> Production in Human Colon Cancer Cells</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">252</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">306</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.canlet.2007.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=17300864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlvVyitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=252&publication_year=2007&pages=299-306&author=R.+Tammaliauthor=K.+V.+Ramanaauthor=S.+K.+Srivastava&title=Aldose+Reductase+Regulates+TNF-%CE%B1-Induced+PGE2+Production+in+Human+Colon+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Aldose reductase regulates TNF-α-induced PGE2 production in human colon cancer cells</span></div><div class="casAuthors">Tammali, Ravinder; Ramana, Kota V.; Srivastava, Satish K.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">252</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">299-306</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pro-inflammatory cytokines such as TNF-α play an important role in the pathophysiol. of diseases such as Crohn's and ulcerative colitis which cause increased risk of colorectal cancer.  However, the mechanisms underlying colon carcinogenesis are not well understood.  Herein the authors report that inhibition/antisense abolition of polyol pathway enzyme, aldose reductase (AR) inhibited the TNF-α-induced synthesis of prostaglandin E2 and the activity of cyclooxygenase (Cox) in human colon cancer cells, Caco-2.  Inhibition of AR prevented TNF-α-induced activation of PKC and NF-κB which resulted in the abrogation of Cox-2 mRNA and protein expression.  These results suggest that inhibition of AR could be a novel chemopreventive approach to colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWSeMmxCM0bLVg90H21EOLACvtfcHk0lgb9b3DHIuQgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlvVyitbk%253D&md5=b671824fa0147ac1f5a9b72a0ecdfc6a</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2007.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2007.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DTammali%26aufirst%3DR.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DAldose%2520Reductase%2520Regulates%2520TNF-%25CE%25B1-Induced%2520PGE2%2520Production%2520in%2520Human%2520Colon%2520Cancer%2520Cells%26jtitle%3DCancer%2520Lett.%26date%3D2007%26volume%3D252%26spage%3D299%26epage%3D306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Shoeb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Aldose Reductase Inhibition Enhances TRAIL-Induced Human Colon Cancer Cell Apoptosis through AKT/FOXO3a-dependent Upregulation of Death Receptors</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.freeradbiomed.2013.05.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=23732517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFyjt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2013&pages=280-290&author=M.+Shoebauthor=K.+V.+Ramanaauthor=S.+K.+Srivastava&title=Aldose+Reductase+Inhibition+Enhances+TRAIL-Induced+Human+Colon+Cancer+Cell+Apoptosis+through+AKT%2FFOXO3a-dependent+Upregulation+of+Death+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Aldose reductase inhibition enhances TRAIL-induced human colon cancer cell apoptosis through AKT/FOXO3a-dependent upregulation of death receptors</span></div><div class="casAuthors">Shoeb, Mohammad; Ramana, Kota V.; Srivastava, Satish K.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">280-290</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">One of the major problems assocd. with the chemotherapy of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) that selectively kills tumor cells is decreased drug resistance.  This warranted the development of safe novel pharmacol. agents that could sensitize the tumor cells to TRAIL.  Herein, we examd. the role of aldose reductase (AR) in sensitizing cancer cells to TRAIL and potentiating TRAIL-induced apoptosis of human colon cancer cells.  We demonstrate that AR inhibition potentiates TRAIL-induced cytotoxicity in cancer cells by upregulation of both death receptor (DR)-5 and DR4.  Knockdown of DR5 and DR4 significantly (>85%) reduced the sensitizing effect of the AR inhibitor fidarestat on TRAIL-induced apoptosis.  Further, AR inhibition also downregulates cell survival proteins (Bcl-xL, Bcl-2, survivin, XIAP, and FLIP) and upregulates the expression of proapoptotic proteins such as Bax and alters mitochondrial membrane potential, leading to cytochrome c release, caspases-3 activation, and PARP cleavage.  We found that AR inhibition regulates AKT/PI3K-dependent activation of forkhead transcription factor FOXO3a.  Knockdown of FOXO3a significantly (>80%) abolished AR inhibition-induced upregulation of DR5 and DR4 and apoptosis in colon cancer cells.  Overall, our results show that fidarestat potentiates TRAIL-induced apoptosis through downregulation of cell survival proteins and upregulation of death receptors via activation of the AKT/FOXO3a pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqmOjBKim4WbVg90H21EOLACvtfcHk0lgkMZSQrbAHqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFyjt7vE&md5=4d3f3cdbf3aba47bc5ed35c9a475744b</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2013.05.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2013.05.039%26sid%3Dliteratum%253Aachs%26aulast%3DShoeb%26aufirst%3DM.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DAldose%2520Reductase%2520Inhibition%2520Enhances%2520TRAIL-Induced%2520Human%2520Colon%2520Cancer%2520Cell%2520Apoptosis%2520through%2520AKT%252FFOXO3a-dependent%2520Upregulation%2520of%2520Death%2520Receptors%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2013%26volume%3D63%26spage%3D280%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Tammali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, A. B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span> </span><span class="NLM_article-title">Inhibition of Aldose Reductase Prevents Angiogenesis in Vitro and in Vivo</span> <span class="citation_source-journal">Angiogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=209-221&author=R.+Tammaliauthor=A.+B.+M.+Reddyauthor=S.+K.+Srivastavaauthor=K.+V.+Ramana&title=Inhibition+of+Aldose+Reductase+Prevents+Angiogenesis+in+Vitro+and+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTammali%26aufirst%3DR.%26aulast%3DReddy%26aufirst%3DA.%2BB.%2BM.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26atitle%3DInhibition%2520of%2520Aldose%2520Reductase%2520Prevents%2520Angiogenesis%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DAngiogenesis%26date%3D2011%26volume%3D14%26spage%3D209%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Wilson, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohren, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabbay, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiocho, F. A.</span><span> </span><span class="NLM_article-title">An Unlikely Sugar Substrate Site in the 1.65 Å Structure of the Human Aldose Reductase Holoenzyme Implicated in Diabetic Complications</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1992&pages=81-84&author=D.+K.+Wilsonauthor=K.+M.+Bohrenauthor=K.+H.+Gabbayauthor=F.+A.+Quiocho&title=An+Unlikely+Sugar+Substrate+Site+in+the+1.65+%C3%85+Structure+of+the+Human+Aldose+Reductase+Holoenzyme+Implicated+in+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DD.%2BK.%26aulast%3DBohren%26aufirst%3DK.%2BM.%26aulast%3DGabbay%26aufirst%3DK.%2BH.%26aulast%3DQuiocho%26aufirst%3DF.%2BA.%26atitle%3DAn%2520Unlikely%2520Sugar%2520Substrate%2520Site%2520in%2520the%25201.65%2520%25C3%2585%2520Structure%2520of%2520the%2520Human%2520Aldose%2520Reductase%2520Holoenzyme%2520Implicated%2520in%2520Diabetic%2520Complications%26jtitle%3DScience%26date%3D1992%26volume%3D257%26spage%3D81%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Rondeau, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tête-Favier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reymann, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biellmann, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moras, D.</span><span> </span><span class="NLM_article-title">Novel NADPH-Binding Domain Revealed by the Crystal Structure of Aldose Reductase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=1992&pages=469-472&author=J.+M.+Rondeauauthor=F.+T%C3%AAte-Favierauthor=A.+Podjarnyauthor=J.+M.+Reymannauthor=P.+Barthauthor=J.+F.+Biellmannauthor=D.+Moras&title=Novel+NADPH-Binding+Domain+Revealed+by+the+Crystal+Structure+of+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRondeau%26aufirst%3DJ.%2BM.%26aulast%3DT%25C3%25AAte-Favier%26aufirst%3DF.%26aulast%3DPodjarny%26aufirst%3DA.%26aulast%3DReymann%26aufirst%3DJ.%2BM.%26aulast%3DBarth%26aufirst%3DP.%26aulast%3DBiellmann%26aufirst%3DJ.%2BF.%26aulast%3DMoras%26aufirst%3DD.%26atitle%3DNovel%2520NADPH-Binding%2520Domain%2520Revealed%2520by%2520the%2520Crystal%2520Structure%2520of%2520Aldose%2520Reductase%26jtitle%3DNature%26date%3D1992%26volume%3D355%26spage%3D469%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Urzhumtsev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tête-Favier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbanton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urzhumtseva, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biellmann, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moras, D.</span><span> </span><span class="NLM_article-title">A “Specificity” Pocket Inferred from the Crystal Structures of the Complexes of Aldose Reductase with the Pharmaceutically Important Inhibitors Tolrestat and Sorbinil</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1997&pages=601-612&author=A.+Urzhumtsevauthor=F.+T%C3%AAte-Favierauthor=A.+Mitschlerauthor=J.+Barbantonauthor=P.+Barthauthor=L.+Urzhumtsevaauthor=J.-F.+Biellmannauthor=A.+D.+Podjarnyauthor=D.+Moras&title=A+%E2%80%9CSpecificity%E2%80%9D+Pocket+Inferred+from+the+Crystal+Structures+of+the+Complexes+of+Aldose+Reductase+with+the+Pharmaceutically+Important+Inhibitors+Tolrestat+and+Sorbinil"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUrzhumtsev%26aufirst%3DA.%26aulast%3DT%25C3%25AAte-Favier%26aufirst%3DF.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DBarbanton%26aufirst%3DJ.%26aulast%3DBarth%26aufirst%3DP.%26aulast%3DUrzhumtseva%26aufirst%3DL.%26aulast%3DBiellmann%26aufirst%3DJ.-F.%26aulast%3DPodjarny%26aufirst%3DA.%2BD.%26aulast%3DMoras%26aufirst%3DD.%26atitle%3DA%2520%25E2%2580%259CSpecificity%25E2%2580%259D%2520Pocket%2520Inferred%2520from%2520the%2520Crystal%2520Structures%2520of%2520the%2520Complexes%2520of%2520Aldose%2520Reductase%2520with%2520the%2520Pharmaceutically%2520Important%2520Inhibitors%2520Tolrestat%2520and%2520Sorbinil%26jtitle%3DStructure%26date%3D1997%26volume%3D5%26spage%3D601%26epage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darmanin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazemann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze-Briese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomizaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A.</span><span> </span><span class="NLM_article-title">Ultrahigh Resolution Drug Design. II. Atomic Resolution Structures of Human Aldose Reductase Holoenzyme Complexed with Fidarestat and Minalrestat: Implications for the Binding of Cyclic Imide Inhibitors</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">805</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=805-813&author=O.+El-Kabbaniauthor=C.+Darmaninauthor=T.+R.+Schneiderauthor=I.+Hazemannauthor=F.+Ruizauthor=M.+Okaauthor=A.+Joachimiakauthor=C.+Schulze-Brieseauthor=T.+Tomizakiauthor=A.+Mitschlerauthor=A.+Podjarny&title=Ultrahigh+Resolution+Drug+Design.+II.+Atomic+Resolution+Structures+of+Human+Aldose+Reductase+Holoenzyme+Complexed+with+Fidarestat+and+Minalrestat%3A+Implications+for+the+Binding+of+Cyclic+Imide+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DDarmanin%26aufirst%3DC.%26aulast%3DSchneider%26aufirst%3DT.%2BR.%26aulast%3DHazemann%26aufirst%3DI.%26aulast%3DRuiz%26aufirst%3DF.%26aulast%3DOka%26aufirst%3DM.%26aulast%3DJoachimiak%26aufirst%3DA.%26aulast%3DSchulze-Briese%26aufirst%3DC.%26aulast%3DTomizaki%26aufirst%3DT.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DPodjarny%26aufirst%3DA.%26atitle%3DUltrahigh%2520Resolution%2520Drug%2520Design.%2520II.%2520Atomic%2520Resolution%2520Structures%2520of%2520Human%2520Aldose%2520Reductase%2520Holoenzyme%2520Complexed%2520with%2520Fidarestat%2520and%2520Minalrestat%253A%2520Implications%2520for%2520the%2520Binding%2520of%2520Cyclic%2520Imide%2520Inhibitors%26jtitle%3DProteins%26date%3D2004%26volume%3D55%26spage%3D805%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Wilson, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarle, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiocho, F. A.</span><span> </span><span class="NLM_article-title">Refined 1.8 Å Structure of Human Aldose Reductase Complexed with the Potent Inhibitor Zopolrestat</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">9847</span><span class="NLM_x">–</span> <span class="NLM_lpage">9851</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=9847-9851&author=D.+K.+Wilsonauthor=I.+Tarleauthor=J.+M.+Petrashauthor=F.+A.+Quiocho&title=Refined+1.8+%C3%85+Structure+of+Human+Aldose+Reductase+Complexed+with+the+Potent+Inhibitor+Zopolrestat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DD.%2BK.%26aulast%3DTarle%26aufirst%3DI.%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26aulast%3DQuiocho%26aufirst%3DF.%2BA.%26atitle%3DRefined%25201.8%2520%25C3%2585%2520Structure%2520of%2520Human%2520Aldose%2520Reductase%2520Complexed%2520with%2520the%2520Potent%2520Inhibitor%2520Zopolrestat%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1993%26volume%3D90%26spage%3D9847%26epage%3D9851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Biadene, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazemann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cousido, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheldrick, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, T. R.</span><span> </span><span class="NLM_article-title">The Atomic Resolution Structure of Human Aldose Reductase Reveals That Rearrangement of a Bound Ligand Allows the Opening of the Safety-Belt Loop</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">D63</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D63&publication_year=2007&pages=665-672&author=M.+Biadeneauthor=I.+Hazemannauthor=A.+Cousidoauthor=S.+Ginellauthor=A.+Joachimiakauthor=G.+M.+Sheldrickauthor=A.+Podjarnyauthor=T.+R.+Schneider&title=The+Atomic+Resolution+Structure+of+Human+Aldose+Reductase+Reveals+That+Rearrangement+of+a+Bound+Ligand+Allows+the+Opening+of+the+Safety-Belt+Loop"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBiadene%26aufirst%3DM.%26aulast%3DHazemann%26aufirst%3DI.%26aulast%3DCousido%26aufirst%3DA.%26aulast%3DGinell%26aufirst%3DS.%26aulast%3DJoachimiak%26aufirst%3DA.%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26aulast%3DPodjarny%26aufirst%3DA.%26aulast%3DSchneider%26aufirst%3DT.%2BR.%26atitle%3DThe%2520Atomic%2520Resolution%2520Structure%2520of%2520Human%2520Aldose%2520Reductase%2520Reveals%2520That%2520Rearrangement%2520of%2520a%2520Bound%2520Ligand%2520Allows%2520the%2520Opening%2520of%2520the%2520Safety-Belt%2520Loop%26jtitle%3DActa%2520Crystallogr.%26date%3D2007%26volume%3DD63%26spage%3D665%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Bohren, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brownlee, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milne, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabbay, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, D. H.T.</span><span> </span><span class="NLM_article-title">The Structure of Apo R268A Human Aldose Reductase: Hinges and Latches That Control the Kinetic Mechanism</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1748</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1748&publication_year=2005&pages=201-212&author=K.+M.+Bohrenauthor=J.+M.+Brownleeauthor=A.+C.+Milneauthor=K.+H.+Gabbayauthor=D.+H.T.+Harrison&title=The+Structure+of+Apo+R268A+Human+Aldose+Reductase%3A+Hinges+and+Latches+That+Control+the+Kinetic+Mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBohren%26aufirst%3DK.%2BM.%26aulast%3DBrownlee%26aufirst%3DJ.%2BM.%26aulast%3DMilne%26aufirst%3DA.%2BC.%26aulast%3DGabbay%26aufirst%3DK.%2BH.%26aulast%3DHarrison%26aufirst%3DD.%2BH.T.%26atitle%3DThe%2520Structure%2520of%2520Apo%2520R268A%2520Human%2520Aldose%2520Reductase%253A%2520Hinges%2520and%2520Latches%2520That%2520Control%2520the%2520Kinetic%2520Mechanism%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2005%26volume%3D1748%26spage%3D201%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Sotriffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krämer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">Probing Flexibility and “Induced-Fit” Phenomena in Aldose Reductase by Comparative Crystal Structure Analysis and Molecular Dynamics Simulations</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=52-66&author=C.+A.+Sotrifferauthor=O.+Kr%C3%A4merauthor=G.+Klebe&title=Probing+Flexibility+and+%E2%80%9CInduced-Fit%E2%80%9D+Phenomena+in+Aldose+Reductase+by+Comparative+Crystal+Structure+Analysis+and+Molecular+Dynamics+Simulations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DKr%25C3%25A4mer%26aufirst%3DO.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DProbing%2520Flexibility%2520and%2520%25E2%2580%259CInduced-Fit%25E2%2580%259D%2520Phenomena%2520in%2520Aldose%2520Reductase%2520by%2520Comparative%2520Crystal%2520Structure%2520Analysis%2520and%2520Molecular%2520Dynamics%2520Simulations%26jtitle%3DProteins%26date%3D2004%26volume%3D56%26spage%3D52%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Krämer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazemann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">Virtual Screening for Inhibitors of Human Aldose Reductase</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">814</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=814-23&author=O.+Kr%C3%A4merauthor=I.+Hazemannauthor=A.+D.+Podjarnyauthor=G.+Klebe&title=Virtual+Screening+for+Inhibitors+of+Human+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKr%25C3%25A4mer%26aufirst%3DO.%26aulast%3DHazemann%26aufirst%3DI.%26aulast%3DPodjarny%26aufirst%3DA.%2BD.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DVirtual%2520Screening%2520for%2520Inhibitors%2520of%2520Human%2520Aldose%2520Reductase%26jtitle%3DProteins%26date%3D2004%26volume%3D55%26spage%3D814%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Steuber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">Merging the Binding Sites of Aldose and Aldehyde Reductase for Detection of Inhibitor Selectivity-Determining Features</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">379</span><span class="NLM_x">, </span> <span class="NLM_fpage">991</span><span class="NLM_x">–</span> <span class="NLM_lpage">1016</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.jmb.2008.03.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=18495158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFKqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2008&pages=991-1016&author=H.+Steuberauthor=A.+Heineauthor=A.+Podjarnyauthor=G.+Klebe&title=Merging+the+Binding+Sites+of+Aldose+and+Aldehyde+Reductase+for+Detection+of+Inhibitor+Selectivity-Determining+Features"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Merging the Binding Sites of Aldose and Aldehyde Reductase for Detection of Inhibitor Selectivity-determining Features</span></div><div class="casAuthors">Steuber, Holger; Heine, Andreas; Podjarny, Alberto; Klebe, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">991-1016</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Inhibition of human aldose reductase (ALR2) evolved as a promising therapeutic concept to prevent late complications of diabetes.  As well as appropriate affinity and bioavailability, putative inhibitors should possess a high level of selectivity for ALR2 over the related aldehyde reductase (ALR1).  We investigated the selectivity-detg. features by gradually mapping the residues deviating between the binding pockets of ALR1 and ALR2 into the ALR2 binding pocket.  The resulting mutational constructs of ALR2 (eight point mutations and one double mutant) were probed for their influence towards ligand selectivity by x-ray structure anal. of the corresponding complexes and isothermal titrn. calorimetry (ITC).  The binding properties of these mutants were evaluated using a ligand set of zopolrestat, a related uracil deriv., IDD388, IDD393, sorbinil, fidarestat and tolrestat.  Our study revealed induced-fit adaptations within the mutated binding site as an essential prerequisite for ligand accommodation related to the selectivity discrimination of the ligands.  However, our study also highlights the limits of the present understanding of protein-ligand interactions.  Interestingly, binding site mutations not involved in any direct interaction to the ligands in various cases show significant effects towards their binding thermodn.  Furthermore, our results suggest the binding site residues deviating between ALR1 and ALR2 influence ligand affinity in a complex interplay, presumably involving changes of dynamic properties and differences of the solvation/desolvation balance upon ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXEFEh9rqZDLVg90H21EOLACvtfcHk0ljmpMa2UMbyHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFKqtLw%253D&md5=5be0f213751356e837ee03fe7bee4fed</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.03.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.03.063%26sid%3Dliteratum%253Aachs%26aulast%3DSteuber%26aufirst%3DH.%26aulast%3DHeine%26aufirst%3DA.%26aulast%3DPodjarny%26aufirst%3DA.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DMerging%2520the%2520Binding%2520Sites%2520of%2520Aldose%2520and%2520Aldehyde%2520Reductase%2520for%2520Detection%2520of%2520Inhibitor%2520Selectivity-Determining%2520Features%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D379%26spage%3D991%26epage%3D1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Steuber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zentgraf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotriffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">Expect the Unexpected or Caveat for Drug Designers: Multiple Structure Determinations Using Aldose Reductase Crystals Treated under Varying Soaking and Co-Crystallisation Conditions</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2006&pages=174-187&author=H.+Steuberauthor=M.+Zentgrafauthor=C.+Gerlachauthor=C.+A.+Sotrifferauthor=A.+Heineauthor=G.+Klebe&title=Expect+the+Unexpected+or+Caveat+for+Drug+Designers%3A+Multiple+Structure+Determinations+Using+Aldose+Reductase+Crystals+Treated+under+Varying+Soaking+and+Co-Crystallisation+Conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSteuber%26aufirst%3DH.%26aulast%3DZentgraf%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DC.%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DHeine%26aufirst%3DA.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DExpect%2520the%2520Unexpected%2520or%2520Caveat%2520for%2520Drug%2520Designers%253A%2520Multiple%2520Structure%2520Determinations%2520Using%2520Aldose%2520Reductase%2520Crystals%2520Treated%2520under%2520Varying%2520Soaking%2520and%2520Co-Crystallisation%2520Conditions%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D363%26spage%3D174%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Dixit, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balendiran, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watowich, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Kinetic and Structural Characterization of the Glutathione-Binding Site of Aldose Reductase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">21587</span><span class="NLM_x">–</span> <span class="NLM_lpage">21595</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=21587-21595&author=B.+L.+Dixitauthor=G.+K.+Balendiranauthor=S.+J.+Watowichauthor=S.+Srivastavaauthor=K.+V.+Ramanaauthor=J.+M.+Petrashauthor=A.+Bhatnagarauthor=S.+K.+Srivastava&title=Kinetic+and+Structural+Characterization+of+the+Glutathione-Binding+Site+of+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDixit%26aufirst%3DB.%2BL.%26aulast%3DBalendiran%26aufirst%3DG.%2BK.%26aulast%3DWatowich%26aufirst%3DS.%2BJ.%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26aulast%3DBhatnagar%26aufirst%3DA.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DKinetic%2520and%2520Structural%2520Characterization%2520of%2520the%2520Glutathione-Binding%2520Site%2520of%2520Aldose%2520Reductase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D21587%26epage%3D21595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watowich, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Structure of a Glutathione Conjugate Bound to the Active Site of Aldose Reductase</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2006&pages=101-110&author=R.+Singhauthor=M.+A.+Whiteauthor=K.+V.+Ramanaauthor=J.+M.+Petrashauthor=S.+J.+Watowichauthor=A.+Bhatnagarauthor=S.+K.+Srivastava&title=Structure+of+a+Glutathione+Conjugate+Bound+to+the+Active+Site+of+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DWhite%26aufirst%3DM.%2BA.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26aulast%3DWatowich%26aufirst%3DS.%2BJ.%26aulast%3DBhatnagar%26aufirst%3DA.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DStructure%2520of%2520a%2520Glutathione%2520Conjugate%2520Bound%2520to%2520the%2520Active%2520Site%2520of%2520Aldose%2520Reductase%26jtitle%3DProteins%26date%3D2006%26volume%3D64%26spage%3D101%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balendiran, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span> </span><span class="NLM_article-title">Selective Recognition of Glutathiolated Aldehydes by Aldose Reductase</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">12172</span><span class="NLM_x">–</span> <span class="NLM_lpage">12180</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi000796e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=12172-12180&author=K.+V.+Ramanaauthor=B.+L.+Dixitauthor=S.+Srivastavaauthor=G.+K.+Balendiranauthor=S.+K.+Srivastavaauthor=A.+Bhatnagar&title=Selective+Recognition+of+Glutathiolated+Aldehydes+by+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fbi000796e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi000796e%26sid%3Dliteratum%253Aachs%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DDixit%26aufirst%3DB.%2BL.%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DBalendiran%26aufirst%3DG.%2BK.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26aulast%3DBhatnagar%26aufirst%3DA.%26atitle%3DSelective%2520Recognition%2520of%2520Glutathiolated%2520Aldehydes%2520by%2520Aldose%2520Reductase%26jtitle%3DBiochemistry%26date%3D2000%26volume%3D39%26spage%3D12172%26epage%3D12180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Petrash, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harter, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olins, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Involvement of Cysteine Residues in Catalysis and Inhibition of Human Aldose Reductase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">24833</span><span class="NLM_x">–</span> <span class="NLM_lpage">24840</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=24833-24840&author=J.+M.+Petrashauthor=T.+M.+Harterauthor=C.+S.+Devineauthor=P.+O.+Olinsauthor=A.+Bhatnagarauthor=S.+Liuauthor=S.+K.+Srivastava&title=Involvement+of+Cysteine+Residues+in+Catalysis+and+Inhibition+of+Human+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26aulast%3DHarter%26aufirst%3DT.%2BM.%26aulast%3DDevine%26aufirst%3DC.%2BS.%26aulast%3DOlins%26aufirst%3DP.%2BO.%26aulast%3DBhatnagar%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DInvolvement%2520of%2520Cysteine%2520Residues%2520in%2520Catalysis%2520and%2520Inhibition%2520of%2520Human%2520Aldose%2520Reductase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D24833%26epage%3D24840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Cappiello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardo, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micheli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacomelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banditelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverenz, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giblin, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Corso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mura, U.</span><span> </span><span class="NLM_article-title">Thiol Disulfide Exchange Modulates the Activity of Aldose Reductase in Intact Bovine Lens as a Response to Oxidative Stress</span> <span class="citation_source-journal">Exp. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">795</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1006%2Fexer.2000.0838" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=10843784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjvVSktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2000&pages=795-803&author=M.+Cappielloauthor=P.+G.+Vilardoauthor=V.+Micheliauthor=G.+Jacomelliauthor=S.+Banditelliauthor=V.+Leverenzauthor=F.+J.+Giblinauthor=A.+Del+Corsoauthor=U.+Mura&title=Thiol+Disulfide+Exchange+Modulates+the+Activity+of+Aldose+Reductase+in+Intact+Bovine+Lens+as+a+Response+to+Oxidative+Stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Thiol Disulfide Exchange Modulates the Activity of Aldose Reductase in Intact Bovine Lens as a Response to Oxidative Stress</span></div><div class="casAuthors">Cappiello, Mario; Vilardo, Pier Giuseppe; Micheli, Vanna; Jacomelli, Gabriella; Banditelli, Stefania; Leverenz, Victor; Giblin, Frank J.; Corso, Antonella Del; Mura, Umberto</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">795-803</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The reversibility of S-thiolation of aldose reductase was shown in intact bovine lens subjected to oxidative stress.  The glutathione modified aldose reductase generated in the lens as a consequence of hyperbaric oxygen treatment was recovered in its reduced form following culturing in normobaric air conditions.  Nucleus and cortex were differently affected by both oxidative treatment and normobaric air recovery.  The extent of S-thiolation of aldose reductase appeared to be higher in the nucleus than in the cortex.  Moreover, the nucleus, but not the cortex, was unable to completely recover from the protein S-thiolation process.  The ratios of GSH/GSSG and NADPH/NADP+as well as the Energy Charge values were detd. in the cortex and nucleus both after oxidative stress and recovery.  The results are consistent with the existence of a quite well-defined boundary between the two lens regions.  Moreover, they are supportive of the hypothesis that thiol/disulfide exchange has the potential to be a regulatory mechanism for certain enzymes which can modulate the flux of NADPH inside the cell.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJnDbBZSnet7Vg90H21EOLACvtfcHk0lh841tr10fKYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjvVSktLs%253D&md5=520dd368757102d97aeb6893a21db4aa</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1006%2Fexer.2000.0838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexer.2000.0838%26sid%3Dliteratum%253Aachs%26aulast%3DCappiello%26aufirst%3DM.%26aulast%3DVilardo%26aufirst%3DP.%2BG.%26aulast%3DMicheli%26aufirst%3DV.%26aulast%3DJacomelli%26aufirst%3DG.%26aulast%3DBanditelli%26aufirst%3DS.%26aulast%3DLeverenz%26aufirst%3DV.%26aulast%3DGiblin%26aufirst%3DF.%2BJ.%26aulast%3DDel%2BCorso%26aufirst%3DA.%26aulast%3DMura%26aufirst%3DU.%26atitle%3DThiol%2520Disulfide%2520Exchange%2520Modulates%2520the%2520Activity%2520of%2520Aldose%2520Reductase%2520in%2520Intact%2520Bovine%2520Lens%2520as%2520a%2520Response%2520to%2520Oxidative%2520Stress%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D2000%26volume%3D70%26spage%3D795%26epage%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Cappiello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voltarelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannessi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecconi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camici, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Corso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mura, U.</span><span> </span><span class="NLM_article-title">Glutathione Dependent Modification of Bovine Lens Aldose Reductase</span> <span class="citation_source-journal">Exp. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1006%2Fexer.1994.1042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=7925685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADyaK2cXltVaqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1994&pages=491-501&author=M.+Cappielloauthor=M.+Voltarelliauthor=M.+Giannessiauthor=I.+Cecconiauthor=G.+Camiciauthor=G.+Manaoauthor=A.+Del+Corsoauthor=U.+Mura&title=Glutathione+Dependent+Modification+of+Bovine+Lens+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Glutathione dependent modification of bovine lens aldose reductase</span></div><div class="casAuthors">Cappiello, Mario; Voltarelli, Margaret; Giannessi, Maggiorana; Cecconi, Ilaria; Camici, Guido; Manao, Gianpaolo; Del Corso, Antonella; Mura, Umberto</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">491-501</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    </div><div class="casAbstract">Bovine lens aldose reductase (ALR2) is readily modified by glutathione disulfide (GSSG) to an enzyme form (GS-ALR2) exhibiting a reduced catalytic efficiency with all the substrates tested and a reduced susceptibility to inhibition.  The modification, which is completely reversed by reduced glutathione (GSH) or dithiothreitol occurs by a pseudo-1st-order process with respect to the enzyme and a 2nd-order rate const. of 30 mol-1 at 25° was detd.  By measuring the residual activity of ALR2 incubated in different glutathione redox buffers at 25°, an apparent redox equil. const. of 1.4 was evaluated.  Thus, the rate and the maximal extent of ALR2 inactivation are proportional to the redox ratio of the thiol used as modifying agent (i.e., [GSH]/[GSSG]).  The stoichiometric reversibility of the enzyme modification may be impaired by a reduced soly. of GS-ALR2 with respect to ALR2 and by an increased susceptibility of the modified enzyme to proteolysis.  Whereas the native enzyme form was rather insensitive to proteolytic breakdown, GS-ALR2 was easily degraded by chymotrypsin with the generation of a peptide of 26 kDa with an amino acid sequence at the N-terminal side compatible with proteolysis at Tyr-7 of aldose reductase.  A reduced efficiency in enzyme-cofactor binding following the GSSG-dependent modification of ALR2 appeared to be assocd. to the thiol accessibility of GS-ALR2 measured at different temps.  GS-ALR2 was characterized by the presence of 1 glutathione residue, linked through a mixed disulfide bond.  This was sustained by: (1) the pI for the modified enzyme of 4.75, which was 0.1 pH units lower than that obsd. for the native enzyme, which indicated the contribution of an acidic residue to the pI of GS-ALR2; (2) the incorporation of radioactivity coming from [3H]GSSG accounting for the presence of 1 equiv of glutathione per mol of enzyme.  Besides being a general feature of protein reactivity in oxidative conditions, the glutathione-mediated ALR2 modification may be part of a cell strategy to preserve reducing power in conditions of oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-3jCUj_RL-7Vg90H21EOLACvtfcHk0lgwANBjSQqXng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXltVaqsLk%253D&md5=cb55083f0e51dc0ddf0ca77a4a5a4b31</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1006%2Fexer.1994.1042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexer.1994.1042%26sid%3Dliteratum%253Aachs%26aulast%3DCappiello%26aufirst%3DM.%26aulast%3DVoltarelli%26aufirst%3DM.%26aulast%3DGiannessi%26aufirst%3DM.%26aulast%3DCecconi%26aufirst%3DI.%26aulast%3DCamici%26aufirst%3DG.%26aulast%3DManao%26aufirst%3DG.%26aulast%3DDel%2BCorso%26aufirst%3DA.%26aulast%3DMura%26aufirst%3DU.%26atitle%3DGlutathione%2520Dependent%2520Modification%2520of%2520Bovine%2520Lens%2520Aldose%2520Reductase%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D1994%26volume%3D58%26spage%3D491%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Cappiello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardo, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecconi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverenz, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giblin, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Corso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mura, U.</span><span> </span><span class="NLM_article-title">Occurrence of Glutathione-Modified Aldose Reductase in Oxidatively Stressed Bovine Lens</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">207</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">782</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=1995&pages=775-782&author=M.+Cappielloauthor=P.+G.+Vilardoauthor=I.+Cecconiauthor=V.+Leverenzauthor=F.+J.+Giblinauthor=A.+Del+Corsoauthor=U.+Mura&title=Occurrence+of+Glutathione-Modified+Aldose+Reductase+in+Oxidatively+Stressed+Bovine+Lens"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCappiello%26aufirst%3DM.%26aulast%3DVilardo%26aufirst%3DP.%2BG.%26aulast%3DCecconi%26aufirst%3DI.%26aulast%3DLeverenz%26aufirst%3DV.%26aulast%3DGiblin%26aufirst%3DF.%2BJ.%26aulast%3DDel%2BCorso%26aufirst%3DA.%26aulast%3DMura%26aufirst%3DU.%26atitle%3DOccurrence%2520of%2520Glutathione-Modified%2520Aldose%2520Reductase%2520in%2520Oxidatively%2520Stressed%2520Bovine%2520Lens%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1995%26volume%3D207%26spage%3D775%26epage%3D782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Muthenna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suryanarayana, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunda, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, G. B.</span><span> </span><span class="NLM_article-title">Inhibition of Aldose Reductase by Dietary Antioxidant Curcumin: Mechanism of Inhibition, Specificity and Significance</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">583</span><span class="NLM_x">, </span> <span class="NLM_fpage">3637</span><span class="NLM_x">–</span> <span class="NLM_lpage">3642</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=583&publication_year=2009&pages=3637-3642&author=P.+Muthennaauthor=P.+Suryanarayanaauthor=S.+K.+Gundaauthor=J.+M.+Petrashauthor=G.+B.+Reddy&title=Inhibition+of+Aldose+Reductase+by+Dietary+Antioxidant+Curcumin%3A+Mechanism+of+Inhibition%2C+Specificity+and+Significance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuthenna%26aufirst%3DP.%26aulast%3DSuryanarayana%26aufirst%3DP.%26aulast%3DGunda%26aufirst%3DS.%2BK.%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26aulast%3DReddy%26aufirst%3DG.%2BB.%26atitle%3DInhibition%2520of%2520Aldose%2520Reductase%2520by%2520Dietary%2520Antioxidant%2520Curcumin%253A%2520Mechanism%2520of%2520Inhibition%252C%2520Specificity%2520and%2520Significance%26jtitle%3DFEBS%2520Lett.%26date%3D2009%26volume%3D583%26spage%3D3637%26epage%3D3642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Berrone, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beltramo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solimine, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubertalli Ape, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porta, M.</span><span> </span><span class="NLM_article-title">Regulation of Intracellular Glucose and Polyol Pathway by Thiamine and Benfotiamine in Vascular Cells Cultured in High Glucose</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">9307</span><span class="NLM_x">–</span> <span class="NLM_lpage">9313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=9307-9313&author=E.+Berroneauthor=E.+Beltramoauthor=C.+Solimineauthor=A.+Ubertalli+Apeauthor=M.+Porta&title=Regulation+of+Intracellular+Glucose+and+Polyol+Pathway+by+Thiamine+and+Benfotiamine+in+Vascular+Cells+Cultured+in+High+Glucose"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerrone%26aufirst%3DE.%26aulast%3DBeltramo%26aufirst%3DE.%26aulast%3DSolimine%26aufirst%3DC.%26aulast%3DUbertalli%2BApe%26aufirst%3DA.%26aulast%3DPorta%26aufirst%3DM.%26atitle%3DRegulation%2520of%2520Intracellular%2520Glucose%2520and%2520Polyol%2520Pathway%2520by%2520Thiamine%2520and%2520Benfotiamine%2520in%2520Vascular%2520Cells%2520Cultured%2520in%2520High%2520Glucose%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D9307%26epage%3D9313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Kanazu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinoda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deyashiki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, H.</span><span> </span><span class="NLM_article-title">Aldehyde Reductase Is a Major Protein Associated with 3-Deoxyglucosone Reductase Activity in Rat, Pig, and Human Livers</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">903</span><span class="NLM_x">–</span> <span class="NLM_lpage">906</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1991&pages=903-906&author=T.+Kanazuauthor=M.+Shinodaauthor=T.+Nakayamaauthor=Y.+Deyashikiauthor=A.+Haraauthor=H.+Sawada&title=Aldehyde+Reductase+Is+a+Major+Protein+Associated+with+3-Deoxyglucosone+Reductase+Activity+in+Rat%2C+Pig%2C+and+Human+Livers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKanazu%26aufirst%3DT.%26aulast%3DShinoda%26aufirst%3DM.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DDeyashiki%26aufirst%3DY.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DSawada%26aufirst%3DH.%26atitle%3DAldehyde%2520Reductase%2520Is%2520a%2520Major%2520Protein%2520Associated%2520with%25203-Deoxyglucosone%2520Reductase%2520Activity%2520in%2520Rat%252C%2520Pig%252C%2520and%2520Human%2520Livers%26jtitle%3DBiochem.%2520J.%26date%3D1991%26volume%3D279%26spage%3D903%26epage%3D906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Oya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchida, K.</span><span> </span><span class="NLM_article-title">Methylglyoxal Modification of Protein. Chemical and Immunochemical Characterization of Methylglyoxal-Arginine Adducts</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">18492</span><span class="NLM_x">–</span> <span class="NLM_lpage">18502</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=18492-18502&author=T.+Oyaauthor=N.+Hattoriauthor=Y.+Mizunoauthor=S.+Miyataauthor=S.+Maedaauthor=T.+Osawaauthor=K.+Uchida&title=Methylglyoxal+Modification+of+Protein.+Chemical+and+Immunochemical+Characterization+of+Methylglyoxal-Arginine+Adducts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOya%26aufirst%3DT.%26aulast%3DHattori%26aufirst%3DN.%26aulast%3DMizuno%26aufirst%3DY.%26aulast%3DMiyata%26aufirst%3DS.%26aulast%3DMaeda%26aufirst%3DS.%26aulast%3DOsawa%26aufirst%3DT.%26aulast%3DUchida%26aufirst%3DK.%26atitle%3DMethylglyoxal%2520Modification%2520of%2520Protein.%2520Chemical%2520and%2520Immunochemical%2520Characterization%2520of%2520Methylglyoxal-Arginine%2520Adducts%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D18492%26epage%3D18502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiocho, F. A.</span><span> </span><span class="NLM_article-title">Structural Features of the Aldose Reductase and Aldehyde Reductase Inhibitor-Binding Sites</span> <span class="citation_source-journal">Mol. Vision</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=9756955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A280%3ADyaK1M%252FjtVOmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=19-25&author=O.+El-Kabbaniauthor=D.+K.+Wilsonauthor=J.+M.+Petrashauthor=F.+A.+Quiocho&title=Structural+Features+of+the+Aldose+Reductase+and+Aldehyde+Reductase+Inhibitor-Binding+Sites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites</span></div><div class="casAuthors">El-Kabbani O; Wilson D K; Petrash M; Quiocho F A</div><div class="citationInfo"><span class="NLM_cas:title">Molecular vision</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The three-dimensional structures of aldose reductase and aldehyde reductase, members of the aldo-keto reductase superfamily, are composed of similar alpha/beta TIM-barrels.  However, examination of the structures reveals that the inhibitor-binding site of aldose reductase differs from that of aldehyde reductase due to the participation of non-conserved residues in its formation.  This information will be useful in the design of inhibitors to prevent or delay diabetic retinopathy.  A review of the structures of the inhibitor-binding sites is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRq_Yqq-8NVw4HWj6b1v8uTfW6udTcc2ebh5AXTLiapY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M%252FjtVOmsA%253D%253D&md5=04fd4b982cbe945e8ca1b6130a1c138e</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DWilson%26aufirst%3DD.%2BK.%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26aulast%3DQuiocho%26aufirst%3DF.%2BA.%26atitle%3DStructural%2520Features%2520of%2520the%2520Aldose%2520Reductase%2520and%2520Aldehyde%2520Reductase%2520Inhibitor-Binding%2520Sites%26jtitle%3DMol.%2520Vision%26date%3D1998%26volume%3D4%26spage%3D19%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A.</span><span> </span><span class="NLM_article-title">Selectivity Determinants of the Aldose and Aldehyde Reductase Inhibitor-Binding Sites</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1970</span><span class="NLM_x">–</span> <span class="NLM_lpage">1978</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1007%2Fs00018-007-6514-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=17497245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptFKht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2007&pages=1970-1978&author=O.+El-Kabbaniauthor=A.+Podjarny&title=Selectivity+Determinants+of+the+Aldose+and+Aldehyde+Reductase+Inhibitor-Binding+Sites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity determinants of the aldose and aldehyde reductase inhibitor-binding sites</span></div><div class="casAuthors">El-Kabbani, O.; Podjarny, A.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1970-1978</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Aldose reductase (EC 1.1.1.21) (I) and aldehyde reductase (EC 1.1.1.2) (II) belong to the aldo-keto reductase superfamily of enzymes whose members are responsible for a wide variety of biol. functions.  I has been identified as the 1st enzyme involved in the polyol pathway of glucose metab. which converts glucose into sorbitol.  Glucose overutilization through the polyol pathway has been linked to tissue-based pathologies assocd. with diabetes complications, which make the development of a potent I inhibitor an obvious and attractive strategy to prevent or delay the onset and progression of the complications.  Structural studies of I and the homologous II in complex with inhibitors have been carried out to explain the difference in the potency of enzyme inhibition.  Here, the authors aim to provide a comprehensive summary of previous studies to aid the development of I inhibitors that may have less toxicity problems than the currently available ones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlP-qrjnEJTLVg90H21EOLACvtfcHk0lhUw5zTZ7oN6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptFKht7Y%253D&md5=cca5d328edb68ab38e09dd03ea26e8c5</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1007%2Fs00018-007-6514-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-007-6514-3%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DPodjarny%26aufirst%3DA.%26atitle%3DSelectivity%2520Determinants%2520of%2520the%2520Aldose%2520and%2520Aldehyde%2520Reductase%2520Inhibitor-Binding%2520Sites%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2007%26volume%3D64%26spage%3D1970%26epage%3D1978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darmanin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze-Briese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomizaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazemann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A.</span><span> </span><span class="NLM_article-title">High-Resolution Structures of Human Aldose Reductase Holoenzyme in Complex with Stereoisomers of the Potent Inhibitor Fidarestat: Stereospecific Interaction between the Enzyme and a Cyclic Imide Type Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4530</span><span class="NLM_x">–</span> <span class="NLM_lpage">4537</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0497794" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4530-4537&author=O.+El-Kabbaniauthor=C.+Darmaninauthor=M.+Okaauthor=C.+Schulze-Brieseauthor=T.+Tomizakiauthor=I.+Hazemannauthor=A.+Mitschlerauthor=A.+Podjarny&title=High-Resolution+Structures+of+Human+Aldose+Reductase+Holoenzyme+in+Complex+with+Stereoisomers+of+the+Potent+Inhibitor+Fidarestat%3A+Stereospecific+Interaction+between+the+Enzyme+and+a+Cyclic+Imide+Type+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fjm0497794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0497794%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DDarmanin%26aufirst%3DC.%26aulast%3DOka%26aufirst%3DM.%26aulast%3DSchulze-Briese%26aufirst%3DC.%26aulast%3DTomizaki%26aufirst%3DT.%26aulast%3DHazemann%26aufirst%3DI.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DPodjarny%26aufirst%3DA.%26atitle%3DHigh-Resolution%2520Structures%2520of%2520Human%2520Aldose%2520Reductase%2520Holoenzyme%2520in%2520Complex%2520with%2520Stereoisomers%2520of%2520the%2520Potent%2520Inhibitor%2520Fidarestat%253A%2520Stereospecific%2520Interaction%2520between%2520the%2520Enzyme%2520and%2520a%2520Cyclic%2520Imide%2520Type%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4530%26epage%3D4537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbone, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darmanin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze-Briese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, R. P.-T.</span><span> </span><span class="NLM_article-title">Structure of Aldehyde Reductase Holoenzyme in Complex with the Potent Aldose Reductase Inhibitor Fidarestat: Implications for Inhibitor Binding and Selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5536</span><span class="NLM_x">–</span> <span class="NLM_lpage">5542</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050412o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5536-5542&author=O.+El-Kabbaniauthor=V.+Carboneauthor=C.+Darmaninauthor=M.+Okaauthor=A.+Mitschlerauthor=A.+Podjarnyauthor=C.+Schulze-Brieseauthor=R.+P.-T.+Chung&title=Structure+of+Aldehyde+Reductase+Holoenzyme+in+Complex+with+the+Potent+Aldose+Reductase+Inhibitor+Fidarestat%3A+Implications+for+Inhibitor+Binding+and+Selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fjm050412o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050412o%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DCarbone%26aufirst%3DV.%26aulast%3DDarmanin%26aufirst%3DC.%26aulast%3DOka%26aufirst%3DM.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DPodjarny%26aufirst%3DA.%26aulast%3DSchulze-Briese%26aufirst%3DC.%26aulast%3DChung%26aufirst%3DR.%2BP.-T.%26atitle%3DStructure%2520of%2520Aldehyde%2520Reductase%2520Holoenzyme%2520in%2520Complex%2520with%2520the%2520Potent%2520Aldose%2520Reductase%2520Inhibitor%2520Fidarestat%253A%2520Implications%2520for%2520Inhibitor%2520Binding%2520and%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5536%26epage%3D5542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Petrova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steuber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazemann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cousido-Siah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A.</span><span> </span><span class="NLM_article-title">Factorizing Selectivity Determinants of Inhibitor Binding toward Aldose and Aldehyde Reductases: Structural and Thermodynamic Properties of the Aldose Reductase Mutant Leu300Pro–Fidarestat Complex</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5659</span><span class="NLM_x">–</span> <span class="NLM_lpage">5665</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050424%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5659-5665&author=T.+Petrovaauthor=H.+Steuberauthor=I.+Hazemannauthor=A.+Cousido-Siahauthor=A.+Mitschlerauthor=R.+Chungauthor=M.+Okaauthor=G.+Klebeauthor=O.+El-Kabbaniauthor=A.+Joachimiakauthor=A.+Podjarny&title=Factorizing+Selectivity+Determinants+of+Inhibitor+Binding+toward+Aldose+and+Aldehyde+Reductases%3A+Structural+and+Thermodynamic+Properties+of+the+Aldose+Reductase+Mutant+Leu300Pro%E2%80%93Fidarestat+Complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1021%2Fjm050424%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050424%252B%26sid%3Dliteratum%253Aachs%26aulast%3DPetrova%26aufirst%3DT.%26aulast%3DSteuber%26aufirst%3DH.%26aulast%3DHazemann%26aufirst%3DI.%26aulast%3DCousido-Siah%26aufirst%3DA.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DChung%26aufirst%3DR.%26aulast%3DOka%26aufirst%3DM.%26aulast%3DKlebe%26aufirst%3DG.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DJoachimiak%26aufirst%3DA.%26aulast%3DPodjarny%26aufirst%3DA.%26atitle%3DFactorizing%2520Selectivity%2520Determinants%2520of%2520Inhibitor%2520Binding%2520toward%2520Aldose%2520and%2520Aldehyde%2520Reductases%253A%2520Structural%2520and%2520Thermodynamic%2520Properties%2520of%2520the%2520Aldose%2520Reductase%2520Mutant%2520Leu300Pro%25E2%2580%2593Fidarestat%2520Complex%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5659%26epage%3D5665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Van Zandt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawicki, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabetta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrington, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sredy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A. D.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Highly Potent and Selective (2-Arylcarbamoyl-phenoxy)-acetic Acid Inhibitors of Aldose Reductase for Treatment of Chronic Diabetic Complications</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5661</span><span class="NLM_x">–</span> <span class="NLM_lpage">5675</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=5661-5675&author=M.+C.+Van+Zandtauthor=E.+O.+Sibleyauthor=E.+E.+McCannauthor=K.+J.+Combsauthor=B.+Flamauthor=D.+R.+Sawickiauthor=A.+Sabettaauthor=A.+Carringtonauthor=J.+Sredyauthor=E.+Howardauthor=A.+Mitschlerauthor=A.+D.+Podjarny&title=Design+and+Synthesis+of+Highly+Potent+and+Selective+%282-Arylcarbamoyl-phenoxy%29-acetic+Acid+Inhibitors+of+Aldose+Reductase+for+Treatment+of+Chronic+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BZandt%26aufirst%3DM.%2BC.%26aulast%3DSibley%26aufirst%3DE.%2BO.%26aulast%3DMcCann%26aufirst%3DE.%2BE.%26aulast%3DCombs%26aufirst%3DK.%2BJ.%26aulast%3DFlam%26aufirst%3DB.%26aulast%3DSawicki%26aufirst%3DD.%2BR.%26aulast%3DSabetta%26aufirst%3DA.%26aulast%3DCarrington%26aufirst%3DA.%26aulast%3DSredy%26aufirst%3DJ.%26aulast%3DHoward%26aufirst%3DE.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DPodjarny%26aufirst%3DA.%2BD.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Highly%2520Potent%2520and%2520Selective%2520%25282-Arylcarbamoyl-phenoxy%2529-acetic%2520Acid%2520Inhibitors%2520of%2520Aldose%2520Reductase%2520for%2520Treatment%2520of%2520Chronic%2520Diabetic%2520Complications%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D5661%26epage%3D5675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Podjarny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cachau, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Zandt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, A.</span><span> </span><span class="NLM_article-title">Subatomic and Atomic Crystallographic Studies of Aldose Reductase: Implications for Inhibitor Binding</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">763</span><span class="NLM_x">–</span> <span class="NLM_lpage">773</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1007%2Fs00018-003-3404-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=15095001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD2cXls1Grt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2004&pages=763-773&author=A.+Podjarnyauthor=R.+E.+Cachauauthor=T.+Schneiderauthor=M.+Van+Zandtauthor=A.+Joachimiak&title=Subatomic+and+Atomic+Crystallographic+Studies+of+Aldose+Reductase%3A+Implications+for+Inhibitor+Binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Subatomic and atomic crystallographic studies of aldose reductase: Implications for inhibitor binding</span></div><div class="casAuthors">Podjarny, A.; Cachau, R. E.; Schneider, T.; Van Zandt, M.; Joachimiak, A.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">763-773</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review and discussion.  The detn. of several aldose reductase (ALR)·inhibitor complexes at subat. resoln. has revealed new structural details, including the specific interat. contacts involved in inhibitor binding.  Here, the authors review the structures of the complexes of ALR2 with IDD 594 (resoln., 0.66 Å; IC50, 30 nM; space group, P21), IDD 393 (resoln., 0.90 Å; IC50, 6 nM; space group, P1), fidarestat (resoln., 0.92 Å; IC50, 9 nM; space group, P21), and minalrestat (resoln., 1.10 Å; IC50, 73 nM; space group: P1).  The structures have been compared and have been found to be highly reproducible within the same space group (root mean square (RMS) deviations: 0.15-0.3 Å).  The mode of binding of the carboxylate inhibitors, IDD 594 and IDD 393 has been analyzed.  The binding of the carboxylate head have been accurately detd. by the subat. resoln. structures, since both the protonation states and the positions of the atoms are very precisely known.  The differences appear in the binding in the specificity pocket.  The high-resoln. structures explain the differences in IC50 values, which have been confirmed both exptl. by mass spectrometry measures of VC50 and theor. by free energy perturbation calcns.  The binding of the cyclic imide inhibitors, fidarestat and minalrestat, is also described, focusing on the observation of a Cl- ion which binds simultaneously with fidarestat.  The presence of this anion, binding also to active site residue His-110, leads to a mechanism in which the inhibitor can bind in a neutral state and then become charged inside the active site pocket.  This mechanism helps explain the excellent in vivo properties of cyclic imide inhibitors.  Thus, the complete and detailed information supplied by the subat. resoln. structures can explain the differences in binding energy of the different inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUJ45XOnna3bVg90H21EOLACvtfcHk0lhUw5zTZ7oN6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXls1Grt74%253D&md5=559fdc56712e340c49edc73e2b1264af</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1007%2Fs00018-003-3404-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-003-3404-1%26sid%3Dliteratum%253Aachs%26aulast%3DPodjarny%26aufirst%3DA.%26aulast%3DCachau%26aufirst%3DR.%2BE.%26aulast%3DSchneider%26aufirst%3DT.%26aulast%3DVan%2BZandt%26aufirst%3DM.%26aulast%3DJoachimiak%26aufirst%3DA.%26atitle%3DSubatomic%2520and%2520Atomic%2520Crystallographic%2520Studies%2520of%2520Aldose%2520Reductase%253A%2520Implications%2520for%2520Inhibitor%2520Binding%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2004%26volume%3D61%26spage%3D763%26epage%3D773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Howard, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanishvili, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cachau, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevrier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamour, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Zandt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moras, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A.</span><span> </span><span class="NLM_article-title">Ultrahigh Resolution Drug Design I: Details of Interactions in Human Aldose Reductase–Inhibitor Complex at 0.66 Å</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span><span class="NLM_x">–</span> <span class="NLM_lpage">804</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=792-804&author=E.+I.+Howardauthor=R.+Sanishviliauthor=R.+E.+Cachauauthor=A.+Mitschlerauthor=B.+Chevrierauthor=P.+Barthauthor=V.+Lamourauthor=M.+Van+Zandtauthor=E.+Sibleyauthor=C.+Bonauthor=D.+Morasauthor=T.+R.+Schneiderauthor=A.+Joachimiakauthor=A.+Podjarny&title=Ultrahigh+Resolution+Drug+Design+I%3A+Details+of+Interactions+in+Human+Aldose+Reductase%E2%80%93Inhibitor+Complex+at+0.66+%C3%85"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoward%26aufirst%3DE.%2BI.%26aulast%3DSanishvili%26aufirst%3DR.%26aulast%3DCachau%26aufirst%3DR.%2BE.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DChevrier%26aufirst%3DB.%26aulast%3DBarth%26aufirst%3DP.%26aulast%3DLamour%26aufirst%3DV.%26aulast%3DVan%2BZandt%26aufirst%3DM.%26aulast%3DSibley%26aufirst%3DE.%26aulast%3DBon%26aufirst%3DC.%26aulast%3DMoras%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DT.%2BR.%26aulast%3DJoachimiak%26aufirst%3DA.%26aulast%3DPodjarny%26aufirst%3DA.%26atitle%3DUltrahigh%2520Resolution%2520Drug%2520Design%2520I%253A%2520Details%2520of%2520Interactions%2520in%2520Human%2520Aldose%2520Reductase%25E2%2580%2593Inhibitor%2520Complex%2520at%25200.66%2520%25C3%2585%26jtitle%3DProteins%26date%3D2004%26volume%3D55%26spage%3D792%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Van Zandt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geraci, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawicki, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sredy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacot, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiCioccio, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A. D.</span><span> </span><span class="NLM_article-title">Discovery of 3-[(4,5,7-Trifluorobenzothiazol-2-yl)methyl]indole-<i>N</i>-acetic Acid (Lidorestat) and Congeners as Highly Potent and Selective Inhibitors of Aldose Reductase for Treatment of Chronic Diabetic Complications</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3141</span><span class="NLM_x">–</span> <span class="NLM_lpage">3152</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0492094" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3141-3152&author=M.+C.+Van+Zandtauthor=M.+L.+Jonesauthor=D.+E.+Gunnauthor=L.+S.+Geraciauthor=J.+H.+Jonesauthor=D.+R.+Sawickiauthor=J.+Sredyauthor=J.+L.+Jacotauthor=A.+T.+DiCioccioauthor=T.+Petrovaauthor=A.+Mitschlerauthor=A.+D.+Podjarny&title=Discovery+of+3-%5B%284%2C5%2C7-Trifluorobenzothiazol-2-yl%29methyl%5Dindole-N-acetic+Acid+%28Lidorestat%29+and+Congeners+as+Highly+Potent+and+Selective+Inhibitors+of+Aldose+Reductase+for+Treatment+of+Chronic+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Fjm0492094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0492094%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BZandt%26aufirst%3DM.%2BC.%26aulast%3DJones%26aufirst%3DM.%2BL.%26aulast%3DGunn%26aufirst%3DD.%2BE.%26aulast%3DGeraci%26aufirst%3DL.%2BS.%26aulast%3DJones%26aufirst%3DJ.%2BH.%26aulast%3DSawicki%26aufirst%3DD.%2BR.%26aulast%3DSredy%26aufirst%3DJ.%26aulast%3DJacot%26aufirst%3DJ.%2BL.%26aulast%3DDiCioccio%26aufirst%3DA.%2BT.%26aulast%3DPetrova%26aufirst%3DT.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DPodjarny%26aufirst%3DA.%2BD.%26atitle%3DDiscovery%2520of%25203-%255B%25284%252C5%252C7-Trifluorobenzothiazol-2-yl%2529methyl%255Dindole-N-acetic%2520Acid%2520%2528Lidorestat%2529%2520and%2520Congeners%2520as%2520Highly%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Aldose%2520Reductase%2520for%2520Treatment%2520of%2520Chronic%2520Diabetic%2520Complications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3141%26epage%3D3152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Van Zandt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawicki, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sredy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A. D.</span><span> </span><span class="NLM_article-title">Discovery of [3-(4,5,7-Trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-<i>b</i>]pyridin-1-yl]acetic Acids as Highly Potent and Selective Inhibitors of Aldose Reductase for Treatment of Chronic Diabetic Complications</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2006</span><span class="NLM_x">–</span> <span class="NLM_lpage">2008</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2006-2008&author=M.+C.+Van+Zandtauthor=B.+Doanauthor=D.+R.+Sawickiauthor=J.+Sredyauthor=A.+D.+Podjarny&title=Discovery+of+%5B3-%284%2C5%2C7-Trifluoro-benzothiazol-2-ylmethyl%29-pyrrolo%5B2%2C3-b%5Dpyridin-1-yl%5Dacetic+Acids+as+Highly+Potent+and+Selective+Inhibitors+of+Aldose+Reductase+for+Treatment+of+Chronic+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BZandt%26aufirst%3DM.%2BC.%26aulast%3DDoan%26aufirst%3DB.%26aulast%3DSawicki%26aufirst%3DD.%2BR.%26aulast%3DSredy%26aufirst%3DJ.%26aulast%3DPodjarny%26aufirst%3DA.%2BD.%26atitle%3DDiscovery%2520of%2520%255B3-%25284%252C5%252C7-Trifluoro-benzothiazol-2-ylmethyl%2529-pyrrolo%255B2%252C3-b%255Dpyridin-1-yl%255Dacetic%2520Acids%2520as%2520Highly%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Aldose%2520Reductase%2520for%2520Treatment%2520of%2520Chronic%2520Diabetic%2520Complications%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2006%26epage%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parveen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, B.</span><span> </span><span class="NLM_article-title">Acetic Acid Derivatives of 3,4-Dihydro-2<i>H</i>-1,2,4-benzothiadiazine 1,1-Dioxide as a Novel Class of Potent Aldose Reductase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8330</span><span class="NLM_x">–</span> <span class="NLM_lpage">8344</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100962a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8330-8344&author=X.+Chenauthor=C.+Zhuauthor=F.+Guoauthor=X.+Qiuauthor=Y.+Yangauthor=S.+Zhangauthor=M.+Heauthor=S.+Parveenauthor=C.+Jingauthor=Y.+Liauthor=B.+Ma&title=Acetic+Acid+Derivatives+of+3%2C4-Dihydro-2H-1%2C2%2C4-benzothiadiazine+1%2C1-Dioxide+as+a+Novel+Class+of+Potent+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fjm100962a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100962a%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DParveen%26aufirst%3DS.%26aulast%3DJing%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DB.%26atitle%3DAcetic%2520Acid%2520Derivatives%2520of%25203%252C4-Dihydro-2H-1%252C2%252C4-benzothiadiazine%25201%252C1-Dioxide%2520as%2520a%2520Novel%2520Class%2520of%2520Potent%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8330%26epage%3D8344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parveen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C.</span><span> </span><span class="NLM_article-title">Effect of C7 Modifications on Benzothiadiazine-1,1-dioxide Derivatives on Their Inhibitory Activity and Selectivity toward Aldose Reductase</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">613</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1002%2Fcmdc.201200386" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=23136050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1eiu77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=603-613&author=S.+Zhangauthor=X.+Chenauthor=S.+Parveenauthor=S.+Hussainauthor=Y.+Yangauthor=C.+Jingauthor=C.+Zhu&title=Effect+of+C7+Modifications+on+Benzothiadiazine-1%2C1-dioxide+Derivatives+on+Their+Inhibitory+Activity+and+Selectivity+toward+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of C7 modifications on benzothiadiazine-1,1-dioxide derivatives on their inhibitory activity and selectivity toward aldose reductase</span></div><div class="casAuthors">Zhang, Shuzhen; Chen, Xin; Parveen, Shagufta; Hussain, Saghir; Yang, Yanchun; Jing, Chaojun; Zhu, Changjin</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">603-613</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The development and progression of chronic complications in diabetic patients, such as retinopathy, nephropathy, neuropathy, cataracts, and stroke, are related to the activation and/or overexpression of aldose reductase (ALR2), which is a member of the aldo-keto reductase superfamily.  A structure-activity relationship study focused on the C7 position of 1,2,4-benzothiadiazine-1,1-dioxide derivs. was pursued in an attempt to discover ALR2 inhibitors with enhanced potency and selectivity.  These studies led to a series of new C7-substituted compds., which were evaluated for their inhibitory activity against ALR2; they exhibited IC50 values in the range of 2.80-45.13 nM.  Two compds. with a C7-dimethylcarbamoyl and a C7-diethylcarbamoyl substituent, resp., were found to be the most active and presented excellent selectivity for ALR2 over aldehyde reductase (ALR1).  The structure-activity relationship analyses and mol. modeling studies presented herein highlight the importance of hydrophobic and bulky groups at the C7 position for inhibitory activity and selectivity toward ALR2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN53qA8uAsfbVg90H21EOLACvtfcHk0lhZon3OIA5Hgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1eiu77K&md5=23eac78354d6bca12c8487211edc7d50</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200386%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DParveen%26aufirst%3DS.%26aulast%3DHussain%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DJing%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DC.%26atitle%3DEffect%2520of%2520C7%2520Modifications%2520on%2520Benzothiadiazine-1%252C1-dioxide%2520Derivatives%2520on%2520Their%2520Inhibitory%2520Activity%2520and%2520Selectivity%2520toward%2520Aldose%2520Reductase%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D603%26epage%3D613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gui, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Potent and Selective Aldose Reductase Inhibitors Based on Pyridylthiadiazine Scaffold</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1536</span><span class="NLM_x">–</span> <span class="NLM_lpage">1544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=1536-1544&author=X.+Chenauthor=Y.+Yangauthor=B.+Maauthor=S.+Zhangauthor=M.+Heauthor=D.+Guiauthor=S.+Hussainauthor=C.+Jingauthor=C.+Zhuauthor=Q.+Yuauthor=Y.+Liu&title=Design+and+Synthesis+of+Potent+and+Selective+Aldose+Reductase+Inhibitors+Based+on+Pyridylthiadiazine+Scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DGui%26aufirst%3DD.%26aulast%3DHussain%26aufirst%3DS.%26aulast%3DJing%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Potent%2520and%2520Selective%2520Aldose%2520Reductase%2520Inhibitors%2520Based%2520on%2520Pyridylthiadiazine%2520Scaffold%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D1536%26epage%3D1544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Primofiore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simorini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavecchia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boldrini, E.</span><span> </span><span class="NLM_article-title">Naphtho[1,2-<i>d</i>]isothiazole Acetic Acid Derivatives as a Novel Class of Selective Aldose Reductase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6897</span><span class="NLM_x">–</span> <span class="NLM_lpage">6907</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050382p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6897-6907&author=F.+Da+Settimoauthor=G.+Primofioreauthor=C.+La+Mottaauthor=S.+Sartiniauthor=S.+Talianiauthor=F.+Simoriniauthor=A.+M.+Mariniauthor=A.+Lavecchiaauthor=E.+Novellinoauthor=E.+Boldrini&title=Naphtho%5B1%2C2-d%5Disothiazole+Acetic+Acid+Derivatives+as+a+Novel+Class+of+Selective+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Fjm050382p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050382p%26sid%3Dliteratum%253Aachs%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DPrimofiore%26aufirst%3DG.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DTaliani%26aufirst%3DS.%26aulast%3DSimorini%26aufirst%3DF.%26aulast%3DMarini%26aufirst%3DA.%2BM.%26aulast%3DLavecchia%26aufirst%3DA.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DBoldrini%26aufirst%3DE.%26atitle%3DNaphtho%255B1%252C2-d%255Disothiazole%2520Acetic%2520Acid%2520Derivatives%2520as%2520a%2520Novel%2520Class%2520of%2520Selective%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6897%26epage%3D6907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Steuber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zentgraf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">Evidence for a Novel Binding Site Conformer of Aldose Reductase in Ligand-Bound State</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2007&pages=186-197&author=H.+Steuberauthor=M.+Zentgrafauthor=C.+La+Mottaauthor=S.+Sartiniauthor=A.+Heineauthor=G.+Klebe&title=Evidence+for+a+Novel+Binding+Site+Conformer+of+Aldose+Reductase+in+Ligand-Bound+State"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSteuber%26aufirst%3DH.%26aulast%3DZentgraf%26aufirst%3DM.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DHeine%26aufirst%3DA.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DEvidence%2520for%2520a%2520Novel%2520Binding%2520Site%2520Conformer%2520of%2520Aldose%2520Reductase%2520in%2520Ligand-Bound%2520State%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2007%26volume%3D369%26spage%3D186%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Zentgraf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steuber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotriffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">How Reliable Are Current Docking Approaches for Structure-Based Drug Design? Lessons from Aldose Reductase</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3575</span><span class="NLM_x">–</span> <span class="NLM_lpage">3578</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=3575-3578&author=M.+Zentgrafauthor=H.+Steuberauthor=C.+Kochauthor=C.+La+Mottaauthor=S.+Sartiniauthor=C.+A.+Sotrifferauthor=G.+Klebe&title=How+Reliable+Are+Current+Docking+Approaches+for+Structure-Based+Drug+Design%3F+Lessons+from+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZentgraf%26aufirst%3DM.%26aulast%3DSteuber%26aufirst%3DH.%26aulast%3DKoch%26aufirst%3DC.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DHow%2520Reliable%2520Are%2520Current%2520Docking%2520Approaches%2520for%2520Structure-Based%2520Drug%2520Design%253F%2520Lessons%2520from%2520Aldose%2520Reductase%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D3575%26epage%3D3578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simorini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limongelli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span> </span><span class="NLM_article-title">Acetic Acid Aldose Reductase Inhibitors Bearing a Five-Membered Heterocyclic Core with Potent Topical Activity in a Visual Impairment Rat Model</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3182</span><span class="NLM_x">–</span> <span class="NLM_lpage">3193</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701613h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3182-3193&author=C.+La+Mottaauthor=S.+Sartiniauthor=S.+Salernoauthor=F.+Simoriniauthor=S.+Talianiauthor=A.+M.+Mariniauthor=F.+Da+Settimoauthor=L.+Marinelliauthor=V.+Limongelliauthor=E.+Novellino&title=Acetic+Acid+Aldose+Reductase+Inhibitors+Bearing+a+Five-Membered+Heterocyclic+Core+with+Potent+Topical+Activity+in+a+Visual+Impairment+Rat+Model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fjm701613h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701613h%26sid%3Dliteratum%253Aachs%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DSalerno%26aufirst%3DS.%26aulast%3DSimorini%26aufirst%3DF.%26aulast%3DTaliani%26aufirst%3DS.%26aulast%3DMarini%26aufirst%3DA.%2BM.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DLimongelli%26aufirst%3DV.%26aulast%3DNovellino%26aufirst%3DE.%26atitle%3DAcetic%2520Acid%2520Aldose%2520Reductase%2520Inhibitors%2520Bearing%2520a%2520Five-Membered%2520Heterocyclic%2520Core%2520with%2520Potent%2520Topical%2520Activity%2520in%2520a%2520Visual%2520Impairment%2520Rat%2520Model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3182%26epage%3D3193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Maccari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottanà, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciurleo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigorita, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakowitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steindl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, T.</span><span> </span><span class="NLM_article-title">Evaluation of In Vitro Aldose Reductase Inhibitory Activity of 5-Arylidene-2,4-thiazolidinediones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3886</span><span class="NLM_x">–</span> <span class="NLM_lpage">3893</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3886-3893&author=R.+Maccariauthor=R.+Ottan%C3%A0author=R.+Ciurleoauthor=M.+G.+Vigoritaauthor=D.+Rakowitzauthor=T.+Steindlauthor=T.+Langer&title=Evaluation+of+In+Vitro+Aldose+Reductase+Inhibitory+Activity+of+5-Arylidene-2%2C4-thiazolidinediones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaccari%26aufirst%3DR.%26aulast%3DOttan%25C3%25A0%26aufirst%3DR.%26aulast%3DCiurleo%26aufirst%3DR.%26aulast%3DVigorita%26aufirst%3DM.%2BG.%26aulast%3DRakowitz%26aufirst%3DD.%26aulast%3DSteindl%26aufirst%3DT.%26aulast%3DLanger%26aufirst%3DT.%26atitle%3DEvaluation%2520of%2520In%2520Vitro%2520Aldose%2520Reductase%2520Inhibitory%2520Activity%2520of%25205-Arylidene-2%252C4-thiazolidinediones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3886%26epage%3D3893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Carbone, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giglio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huyton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottanà, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span> </span><span class="NLM_article-title">Structure of Aldehyde Reductase in Ternary Complex with a 5-Arylidene-2,4-thiazolidinedione Aldose Reductase Inhibitor</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1140</span><span class="NLM_x">–</span> <span class="NLM_lpage">1145</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=1140-1145&author=V.+Carboneauthor=M.+Giglioauthor=R.+Chungauthor=T.+Huytonauthor=J.+Adamsauthor=R.+Maccariauthor=R.+Ottan%C3%A0author=A.+Haraauthor=O.+El-Kabbani&title=Structure+of+Aldehyde+Reductase+in+Ternary+Complex+with+a+5-Arylidene-2%2C4-thiazolidinedione+Aldose+Reductase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarbone%26aufirst%3DV.%26aulast%3DGiglio%26aufirst%3DM.%26aulast%3DChung%26aufirst%3DR.%26aulast%3DHuyton%26aufirst%3DT.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DMaccari%26aufirst%3DR.%26aulast%3DOttan%25C3%25A0%26aufirst%3DR.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26atitle%3DStructure%2520of%2520Aldehyde%2520Reductase%2520in%2520Ternary%2520Complex%2520with%2520a%25205-Arylidene-2%252C4-thiazolidinedione%2520Aldose%2520Reductase%2520Inhibitor%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D1140%26epage%3D1145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Puppala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suryanarayana, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBarbera, D. V.</span><span> </span><span class="NLM_article-title">The Isolation and Characterization of β-Glucogallin as a Novel Aldose Reductase Inhibitor from <i>Emblica officinalis</i></span> <span class="citation_source-journal">PLoS ONE</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e31399</span><span class="refDoi"> DOI: 10.1371/journal.pone.0031399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1371%2Fjournal.pone.0031399" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e31399&author=M.+Puppalaauthor=J.+Ponderauthor=P.+Suryanarayanaauthor=G.+B.+Reddyauthor=J.+M.+Petrashauthor=D.+V.+LaBarbera&title=The+Isolation+and+Characterization+of+%CE%B2-Glucogallin+as+a+Novel+Aldose+Reductase+Inhibitor+from+Emblica+officinalis&doi=10.1371%2Fjournal.pone.0031399"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0031399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0031399%26sid%3Dliteratum%253Aachs%26aulast%3DPuppala%26aufirst%3DM.%26aulast%3DPonder%26aufirst%3DJ.%26aulast%3DSuryanarayana%26aufirst%3DP.%26aulast%3DReddy%26aufirst%3DG.%2BB.%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26aulast%3DLaBarbera%26aufirst%3DD.%2BV.%26atitle%3DThe%2520Isolation%2520and%2520Characterization%2520of%2520%25CE%25B2-Glucogallin%2520as%2520a%2520Novel%2520Aldose%2520Reductase%2520Inhibitor%2520from%2520Emblica%2520officinalis%26jtitle%3DPLoS%2520ONE%26date%3D2012%26volume%3D7%26spage%3De31399%26doi%3D10.1371%2Fjournal.pone.0031399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span> </span><span class="NLM_article-title">Discovery of New Selective Human Aldose Reductase Inhibitors through Virtual Screening Multiple Binding Pocket Conformations</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2409</span><span class="NLM_x">–</span> <span class="NLM_lpage">2422</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci400322j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFyhsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=2409-2422&author=L.+Wangauthor=Q.+Guauthor=X.+Zhengauthor=J.+Yeauthor=Z.+Liuauthor=J.+Liauthor=X.+Huauthor=A.+Haglerauthor=J.+Xu&title=Discovery+of+New+Selective+Human+Aldose+Reductase+Inhibitors+through+Virtual+Screening+Multiple+Binding+Pocket+Conformations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of New Selective Human Aldose Reductase Inhibitors through Virtual Screening Multiple Binding Pocket Conformations</span></div><div class="casAuthors">Wang, Ling; Gu, Qiong; Zheng, Xuehua; Ye, Jiming; Liu, Zhihong; Li, Jiabo; Hu, Xiaopeng; Hagler, Arnold; Xu, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2409-2422</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aldose reductase reduces glucose to sorbitol.  It plays a key role in many of the complications arising from diabetes.  Thus, aldose reductase inhibitors (ARI) have been identified as promising therapeutic agents for treating such complications of diabetes, as neuropathy, nephropathy, retinopathy, and cataracts.  In this paper, a virtual screening protocol applied to a library of compds. in house has been utilized to discover novel ARIs.  IC50's were detd. for 15 hits that inhibited ALR2 to greater than 50% at 50 μM, and ten of these have an IC50 of 10 μM or less, corresponding to a rather substantial hit rate of 14% at this level.  The specificity of these compds. relative to their cross-reactivity with human ALR1 was also assessed by inhibition assays.  This resulted in identification of novel inhibitors with IC50's comparable to the com. available drug, epalrestat, and greater than an order of magnitude better selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHO9l6GEzpULVg90H21EOLACvtfcHk0ligi60gMmtBEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFyhsbvE&md5=6bd1ea2c57f7199bb31ea9c167fba020</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fci400322j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci400322j%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DGu%26aufirst%3DQ.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DHagler%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520New%2520Selective%2520Human%2520Aldose%2520Reductase%2520Inhibitors%2520through%2520Virtual%2520Screening%2520Multiple%2520Binding%2520Pocket%2520Conformations%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26spage%3D2409%26epage%3D2422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Ramunno, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maglio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angiuoli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Pietra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Maro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giustiniano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span> </span><span class="NLM_article-title">Progresses in the Pursuit of Aldose Reductase Inhibitors: The Structure-Based Lead Optimization Step</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=216-226&author=A.+Ramunnoauthor=S.+Cosconatiauthor=S.+Sartiniauthor=V.+Maglioauthor=S.+Angiuoliauthor=V.+La+Pietraauthor=S.+Di+Maroauthor=M.+Giustinianoauthor=C.+La+Mottaauthor=F.+Da+Settimoauthor=L.+Marinelliauthor=E.+Novellino&title=Progresses+in+the+Pursuit+of+Aldose+Reductase+Inhibitors%3A+The+Structure-Based+Lead+Optimization+Step"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamunno%26aufirst%3DA.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DMaglio%26aufirst%3DV.%26aulast%3DAngiuoli%26aufirst%3DS.%26aulast%3DLa%2BPietra%26aufirst%3DV.%26aulast%3DDi%2BMaro%26aufirst%3DS.%26aulast%3DGiustiniano%26aufirst%3DM.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DNovellino%26aufirst%3DE.%26atitle%3DProgresses%2520in%2520the%2520Pursuit%2520of%2520Aldose%2520Reductase%2520Inhibitors%253A%2520The%2520Structure-Based%2520Lead%2520Optimization%2520Step%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D51%26spage%3D216%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Minehira, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koseki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirono, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyooka, N.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Novel (1-Thioxo-1,2,3,4-tetrahydro-β-carbolin-9-yl)acetic Acids as Selective Inhibitors for AKR1B1</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=356-367&author=D.+Minehiraauthor=D.+Takedaauthor=H.+Urataauthor=A.+Katoauthor=I.+Adachiauthor=X.+Wangauthor=Y.+Matsuyaauthor=K.+Sugimotoauthor=M.+Takemuraauthor=S.+Endoauthor=T.+Matsunagaauthor=A.+Haraauthor=J.+Kosekiauthor=K.+Narukawaauthor=S.+Hironoauthor=N.+Toyooka&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Novel+%281-Thioxo-1%2C2%2C3%2C4-tetrahydro-%CE%B2-carbolin-9-yl%29acetic+Acids+as+Selective+Inhibitors+for+AKR1B1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMinehira%26aufirst%3DD.%26aulast%3DTakeda%26aufirst%3DD.%26aulast%3DUrata%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DA.%26aulast%3DAdachi%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMatsuya%26aufirst%3DY.%26aulast%3DSugimoto%26aufirst%3DK.%26aulast%3DTakemura%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DKoseki%26aufirst%3DJ.%26aulast%3DNarukawa%26aufirst%3DK.%26aulast%3DHirono%26aufirst%3DS.%26aulast%3DToyooka%26aufirst%3DN.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Novel%2520%25281-Thioxo-1%252C2%252C3%252C4-tetrahydro-%25CE%25B2-carbolin-9-yl%2529acetic%2520Acids%2520as%2520Selective%2520Inhibitors%2520for%2520AKR1B1%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D356%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBarbera, D. V.</span><span> </span><span class="NLM_article-title">Design of an Amide <i>N</i>-Glycoside Derivative of β-Glucogallin: A Stable, Potent, and Specific Inhibitor of Aldose Reductase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401311d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=71-77&author=L.+Liauthor=K.-C.+Changauthor=Y.+Zhouauthor=B.+Shiehauthor=J.+Ponderauthor=A.+D.+Abrahamauthor=H.+Aliauthor=A.+Snowauthor=J.+M.+Petrashauthor=D.+V.+LaBarbera&title=Design+of+an+Amide+N-Glycoside+Derivative+of+%CE%B2-Glucogallin%3A+A+Stable%2C+Potent%2C+and+Specific+Inhibitor+of+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Fjm401311d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401311d%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DChang%26aufirst%3DK.-C.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DShieh%26aufirst%3DB.%26aulast%3DPonder%26aufirst%3DJ.%26aulast%3DAbraham%26aufirst%3DA.%2BD.%26aulast%3DAli%26aufirst%3DH.%26aulast%3DSnow%26aufirst%3DA.%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26aulast%3DLaBarbera%26aufirst%3DD.%2BV.%26atitle%3DDesign%2520of%2520an%2520Amide%2520N-Glycoside%2520Derivative%2520of%2520%25CE%25B2-Glucogallin%253A%2520A%2520Stable%252C%2520Potent%252C%2520and%2520Specific%2520Inhibitor%2520of%2520Aldose%2520Reductase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D71%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Martin, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maser, E.</span><span> </span><span class="NLM_article-title">Role of Human Aldo-Keto-Reductase AKR1B10 in the Protection against Toxic Aldehydes</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.cbi.2008.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=19013440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFOjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2009&pages=145-150&author=H.+J.+Martinauthor=E.+Maser&title=Role+of+Human+Aldo-Keto-Reductase+AKR1B10+in+the+Protection+against+Toxic+Aldehydes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes</span></div><div class="casAuthors">Martin, Hans-Joerg; Maser, Edmund</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">145-150</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Damage of cell membranes by reactive oxygen species results in the formation of toxic lipid peroxides which may ultimately lead to cell death.  Among the best characterized intermediates of oxidative stress are the unsatd. aldehydes 4-hydroxynon-2-enal (4-HNE) and its oxidized counterpart 4-oxonon-2-enal (4-ONE).  4-HNE has been linked to various pathol. conditions including atherosclerosis, Parkinson's and Alzheimer's disease. 4-Methylpentanal (4-MP) is a side-chain cleavage product formed endogenously during steroidogenesis from cholesterol.  Like 4-HNE and 4-ONE, 4-MP is capable of binding covalently to and crosslinking of proteins.  These aldehydes are also damaging DNA by the formation of adducts.  We found that AKR1B10, a cytosolic member of the aldo-keto reductase superfamily, efficiently catalyzes the redn. of 4-HNE (Km = 0.3 mM, k cat = 43 min-1), 4-ONE (Km = 0.3 mM, k cat = 40 min-1) and 4-MP (Km = 0.05 mM, k cat = 25 min-1).  AKR1B10 catalyzed 4-MP redn. with a 30-fold increase in activity using NADPH as cofactor compared with NADH.  As was obsd. for aldose reductase (AKR1B1) 4-ONE rapidly inactivates AKR1B10, while this inactivation is not obsd. when the enzyme is preincubated with NADPH.  It was shown that cysteine 298 of aldose reductase was protected by NADPH from the α,β-unsatd. carbonyls of 4-ONE thus rendering resistance towards inactivation.  We generated a mutant AKR1B10, changing the resp. cysteine on position 299 of AKR1B10 into a serine.  This C299S mutant is still active towards 4-HNE and 4-ONE, albeit at a somewhat lower catalytic efficiency.  However, it is still inactivated by 4-ONE in the absence of NADPH.  While the best substrates for AKR1B10 are retinals, the high catalytic efficiency together with the protection from inactivation by NADPH suggests a role of AKR1B10 in the detoxification of biogenic aldehydes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsHuid09FnKLVg90H21EOLACvtfcHk0ligi60gMmtBEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFOjt7c%253D&md5=cf098515950a42eba5b68e6e6d43a1cb</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2008.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2008.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DH.%2BJ.%26aulast%3DMaser%26aufirst%3DE.%26atitle%3DRole%2520of%2520Human%2520Aldo-Keto-Reductase%2520AKR1B10%2520in%2520the%2520Protection%2520against%2520Toxic%2520Aldehydes%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2009%26volume%3D178%26spage%3D145%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Crosas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyndman, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallego, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martras, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parés, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrés, J.</span><span> </span><span class="NLM_article-title">Human Aldose Reductase and Human Small Intestine Aldose Reductase Are Efficient Retinal Reductases: Consequences for Retinoid Metabolism</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">979</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2003&pages=973-979&author=B.+Crosasauthor=D.+J.+Hyndmanauthor=O.+Gallegoauthor=S.+Martrasauthor=X.+Par%C3%A9sauthor=T.+G.+Flynnauthor=J.+Farr%C3%A9s&title=Human+Aldose+Reductase+and+Human+Small+Intestine+Aldose+Reductase+Are+Efficient+Retinal+Reductases%3A+Consequences+for+Retinoid+Metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrosas%26aufirst%3DB.%26aulast%3DHyndman%26aufirst%3DD.%2BJ.%26aulast%3DGallego%26aufirst%3DO.%26aulast%3DMartras%26aufirst%3DS.%26aulast%3DPar%25C3%25A9s%26aufirst%3DX.%26aulast%3DFlynn%26aufirst%3DT.%2BG.%26aulast%3DFarr%25C3%25A9s%26aufirst%3DJ.%26atitle%3DHuman%2520Aldose%2520Reductase%2520and%2520Human%2520Small%2520Intestine%2520Aldose%2520Reductase%2520Are%2520Efficient%2520Retinal%2520Reductases%253A%2520Consequences%2520for%2520Retinoid%2520Metabolism%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D373%26spage%3D973%26epage%3D979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitade, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Kinetic Studies of AKR1B10, Human Aldose Reductase-like Protein: Endogenous Substrates and Inhibition by Steroids</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">487</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2009&pages=1-9&author=S.+Endoauthor=T.+Matsunagaauthor=H.+Mamiyaauthor=C.+Ohtaauthor=M.+Sodaauthor=Y.+Kitadeauthor=K.+Tajimaauthor=H.-T.+Zhaoauthor=O.+El-Kabbaniauthor=A.+Hara&title=Kinetic+Studies+of+AKR1B10%2C+Human+Aldose+Reductase-like+Protein%3A+Endogenous+Substrates+and+Inhibition+by+Steroids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DMamiya%26aufirst%3DH.%26aulast%3DOhta%26aufirst%3DC.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DKitade%26aufirst%3DY.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DH.-T.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DKinetic%2520Studies%2520of%2520AKR1B10%252C%2520Human%2520Aldose%2520Reductase-like%2520Protein%253A%2520Endogenous%2520Substrates%2520and%2520Inhibition%2520by%2520Steroids%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2009%26volume%3D487%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Zhong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span> </span><span class="NLM_article-title">AKR1B10 Induces Cell Resistance to Daunorubicin and Idarubicin by Reducing C13 Ketonic Group</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.taap.2011.05.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=21640744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFKgsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=2011&pages=40-47&author=L.+Zhongauthor=H.+Shenauthor=C.+Huangauthor=H.+Jingauthor=D.+Cao&title=AKR1B10+Induces+Cell+Resistance+to+Daunorubicin+and+Idarubicin+by+Reducing+C13+Ketonic+Group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group</span></div><div class="casAuthors">Zhong, Linlin; Shen, Honglin; Huang, Chenfei; Jing, Hongwu; Cao, Deliang</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">255</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-47</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Daunorubicin, idarubicin, doxorubicin and epirubicin are anthracyclines widely used for the treatment of lymphoma, leukemia, and breast, lung, and liver cancers, but tumor resistance limits their clin. success.  Aldo-keto reductase family 1 B10 (AKR1B10) is an NADPH-dependent enzyme overexpressed in liver and lung carcinomas.  This study was aimed to det. the role of AKR1B10 in tumor resistance to anthracyclines.  AKR1B10 activity toward anthracyclines was measured using recombinant protein.  Cell resistance to anthracycline was detd. by ectopic expression of AKR1B10 or inhibition by epalrestat.  Results showed that AKR1B10 reduces C13-ketonic group on side chain of daunorubicin and idarubicin to hydroxyl forms.  In vitro, AKR1B10 converted daunorubicin to daunorubicinol at V max of 837.42 ± 81.39 nmol/mg/min, K m of 9.317 ± 2.25 mM and k cat/K m of 3.24.  AKR1B10 showed better catalytic efficiency toward idarubicin with V max at 460.23 ± 28.12 nmol/mg/min, K m at 0.461 ± 0.09 mM and k cat/K m at 35.94.  AKR1B10 was less active toward doxorubicin and epirubicin with a C14-hydroxyl group.  In living cells, AKR1B10 efficiently catalyzed redn. of daunorubicin (50 nM) and idarubicin (30 nM) to corresponding alcs.  Within 24 h, approx. 20 ± 2.7% of daunorubicin (1 μM) or 23 ± 2.3% of idarubicin (1 μM) was converted to daunorubicinol or idarubicinol in AKR1B10 expression cells compared to 7 ± 0.9% and 5 ± 1.5% in vector control.  AKR1B10 expression led to cell resistance to daunorubicin and idarubicin, but inhibitor epalrestat showed a synergistic role with these agents.  Together our data suggest that AKR1B10 participates in cellular metab. of daunorubicin and idarubicin, resulting in drug resistance.  These data are informative for the clin. use of idarubicin and daunorubicin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCCKYVvdAb7rVg90H21EOLACvtfcHk0lhlrstSEW6s9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFKgsbw%253D&md5=bacf54c3a864c7f868f597ca5a0b0d2e</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2011.05.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2011.05.014%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DJing%26aufirst%3DH.%26aulast%3DCao%26aufirst%3DD.%26atitle%3DAKR1B10%2520Induces%2520Cell%2520Resistance%2520to%2520Daunorubicin%2520and%2520Idarubicin%2520by%2520Reducing%2520C13%2520Ketonic%2520Group%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2011%26volume%3D255%26spage%3D40%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Selective Inhibition of the Tumor Marker AKR1B10 by Antiinflammatory <i>N</i>-Phenylanthranilic Acids and Glycyrrhetic Acid</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">886</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1248%2Fbpb.33.886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=20460771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1Oht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=886-890&author=S.+Endoauthor=T.+Matsunagaauthor=M.+Sodaauthor=K.+Tajimaauthor=H.+T.+Zhaoauthor=O.+El-Kabbaniauthor=A.+Hara&title=Selective+Inhibition+of+the+Tumor+Marker+AKR1B10+by+Antiinflammatory+N-Phenylanthranilic+Acids+and+Glycyrrhetic+Acid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of the tumor marker AKR1B10 by antiinflammatory N-phenylanthranilic acids and glycyrrhetic acid</span></div><div class="casAuthors">Endo, Satoshi; Matsunaga, Toshiyuki; Soda, Midori; Tajima, Kazuo; Zhao, Hi-Tai; El-Kabbani, Ossama; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">886-890</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A human aldose reductase-like protein, AKR1B10 in the aldo-keto reductase (AKR) superfamily, was recently identified as a tumor marker of several types of cancer.  Tolrestat, an aldose reductase inhibitor (ARI), is known to be the most potent inhibitor of the enzyme.  In this study, we compared the inhibitory effects of other ARIs including flavonoids on AKR1B10 and aldose reductase to evaluate their specificity.  However, ARIs showed lower inhibitory potency for AKR1B10 than for aldose reductase.  In the search for potent and selective inhibitors of AKR1B10 from other drugs used clin., we found that non-steroidal antiinflammatory N-phenylanthranilic acids, diclofenac and glycyrrhetic acid competitively inhibited AKR1B10, showing Ki values of 0.35-2.9 μM and high selectivity to this enzyme (43-57 fold vs. aldose reductase).  Mol. docking studies of mefenamic acid and glycyrrhetic acid in the AKR1B10-NADP (NADP+) complex and site-directed mutagenesis of the putative binding residues suggest that the side chain of Val301 and a hydrogen-bonding network among residues Val301, Gln114 and Ser304 are important for detg. the inhibitory potency and selectivity of the non-steroidal antiinflammatory drugs.  Thus, the potent and selective inhibition may be related to the cancer chemopreventive roles of the drugs, and their structural features may facilitate the design of new anti-cancer agents targeting AKR1B10.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDHEPGYUtiEbVg90H21EOLACvtfcHk0lhlrstSEW6s9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1Oht7Y%253D&md5=89b4e78d049e6bccaab07c410f541a0c</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1248%2Fbpb.33.886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.33.886%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DH.%2BT.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DSelective%2520Inhibition%2520of%2520the%2520Tumor%2520Marker%2520AKR1B10%2520by%2520Antiinflammatory%2520N-Phenylanthranilic%2520Acids%2520and%2520Glycyrrhetic%2520Acid%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2010%26volume%3D33%26spage%3D886%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Potent and Selective Inhibition of the Tumor Marker AKR1B10 by Bisdemethoxycurcumin: Probing the Active Site of the Enzyme with Molecular Modeling and Site-Directed Mutagenesis</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">389</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2009&pages=128-132&author=T.+Matsunagaauthor=S.+Endoauthor=M.+Sodaauthor=H.-T.+Zhaoauthor=O.+El-Kabbaniauthor=K.+Tajimaauthor=A.+Hara&title=Potent+and+Selective+Inhibition+of+the+Tumor+Marker+AKR1B10+by+Bisdemethoxycurcumin%3A+Probing+the+Active+Site+of+the+Enzyme+with+Molecular+Modeling+and+Site-Directed+Mutagenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DH.-T.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DPotent%2520and%2520Selective%2520Inhibition%2520of%2520the%2520Tumor%2520Marker%2520AKR1B10%2520by%2520Bisdemethoxycurcumin%253A%2520Probing%2520the%2520Active%2520Site%2520of%2520the%2520Enzyme%2520with%2520Molecular%2520Modeling%2520and%2520Site-Directed%2520Mutagenesis%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D389%26spage%3D128%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Zhao, H.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span> </span><span class="NLM_article-title">Selectivity Determinants of Inhibitor Binding to the Tumour Marker Human Aldose Reductase-like Protein (AKR1B10) Discovered from Molecular Docking and Database Screening</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4354</span><span class="NLM_x">–</span> <span class="NLM_lpage">4357</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=4354-4357&author=H.-T.+Zhaoauthor=M.+Sodaauthor=S.+Endoauthor=A.+Haraauthor=O.+El-Kabbani&title=Selectivity+Determinants+of+Inhibitor+Binding+to+the+Tumour+Marker+Human+Aldose+Reductase-like+Protein+%28AKR1B10%29+Discovered+from+Molecular+Docking+and+Database+Screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.-T.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26atitle%3DSelectivity%2520Determinants%2520of%2520Inhibitor%2520Binding%2520to%2520the%2520Tumour%2520Marker%2520Human%2520Aldose%2520Reductase-like%2520Protein%2520%2528AKR1B10%2529%2520Discovered%2520from%2520Molecular%2520Docking%2520and%2520Database%2520Screening%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D4354%26epage%3D4357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitade, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Chromene-3-carboxamide Derivatives Discovered from Virtual Screening as Potent Inhibitors of the Tumour Maker, AKR1B10</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2485</span><span class="NLM_x">–</span> <span class="NLM_lpage">2490</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=2485-2490&author=S.+Endoauthor=T.+Matsunagaauthor=K.+Kuwataauthor=H.-T.+Zhaoauthor=O.+El-Kabbaniauthor=Y.+Kitadeauthor=A.+Hara&title=Chromene-3-carboxamide+Derivatives+Discovered+from+Virtual+Screening+as+Potent+Inhibitors+of+the+Tumour+Maker%2C+AKR1B10"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DKuwata%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DH.-T.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DKitade%26aufirst%3DY.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DChromene-3-carboxamide%2520Derivatives%2520Discovered%2520from%2520Virtual%2520Screening%2520as%2520Potent%2520Inhibitors%2520of%2520the%2520Tumour%2520Maker%252C%2520AKR1B10%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D2485%26epage%3D2490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Takemura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iinuma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Selective Inhibition of the Tumor Marker Aldo-Keto Reductase Family Member 1B10 by Oleanolic Acid</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1201</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span></span><div class="citationLinks">[<a href="/doi/10.1021/np200118q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2011&pages=1201-1206&author=M.+Takemuraauthor=S.+Endoauthor=T.+Matsunagaauthor=M.+Sodaauthor=H.-T.+Zhaoauthor=O.+El-Kabbaniauthor=K.+Tajimaauthor=M.+Iinumaauthor=A.+Hara&title=Selective+Inhibition+of+the+Tumor+Marker+Aldo-Keto+Reductase+Family+Member+1B10+by+Oleanolic+Acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1021%2Fnp200118q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp200118q%26sid%3Dliteratum%253Aachs%26aulast%3DTakemura%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DH.-T.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DIinuma%26aufirst%3DM.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DSelective%2520Inhibition%2520of%2520the%2520Tumor%2520Marker%2520Aldo-Keto%2520Reductase%2520Family%2520Member%25201B10%2520by%2520Oleanolic%2520Acid%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2011%26volume%3D74%26spage%3D1201%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ifuku, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyooka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Evaluation of Caffeic Acid Phenethyl Ester-Based Inhibitors Targeting a Selectivity Pocket in the Active Site of Human Aldo-Keto Reductase 1B10</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=321-329&author=M.+Sodaauthor=D.+Huauthor=S.+Endoauthor=M.+Takemuraauthor=J.+Liauthor=R.+Wadaauthor=S.+Ifukuauthor=H.-T.+Zhaoauthor=O.+El-Kabbaniauthor=S.+Ohtaauthor=K.+Yamamuraauthor=N.+Toyookaauthor=A.+Haraauthor=T.+Matsunaga&title=Design%2C+Synthesis+and+Evaluation+of+Caffeic+Acid+Phenethyl+Ester-Based+Inhibitors+Targeting+a+Selectivity+Pocket+in+the+Active+Site+of+Human+Aldo-Keto+Reductase+1B10"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DTakemura%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWada%26aufirst%3DR.%26aulast%3DIfuku%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DH.-T.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DOhta%26aufirst%3DS.%26aulast%3DYamamura%26aufirst%3DK.%26aulast%3DToyooka%26aufirst%3DN.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DMatsunaga%26aufirst%3DT.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Evaluation%2520of%2520Caffeic%2520Acid%2520Phenethyl%2520Ester-Based%2520Inhibitors%2520Targeting%2520a%2520Selectivity%2520Pocket%2520in%2520the%2520Active%2520Site%2520of%2520Human%2520Aldo-Keto%2520Reductase%25201B10%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D48%26spage%3D321%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Ruiz, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cousido-Siah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrés, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parés, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A.</span><span> </span><span class="NLM_article-title">X-ray Structure of the V301L Aldo-Keto Reductase 1B10 Complexed with NADP<sup>+</sup> and the Potent Aldose Reductase Inhibitor Fidarestat: Implications for Inhibitor Binding and Selectivity</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.cbi.2012.12.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=23295227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1GitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2013&pages=178-185&author=F.+X.+Ruizauthor=A.+Cousido-Siahauthor=A.+Mitschlerauthor=J.+Farr%C3%A9sauthor=X.+Par%C3%A9sauthor=A.+Podjarny&title=X-ray+Structure+of+the+V301L+Aldo-Keto+Reductase+1B10+Complexed+with+NADP%2B+and+the+Potent+Aldose+Reductase+Inhibitor+Fidarestat%3A+Implications+for+Inhibitor+Binding+and+Selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP+ and the potent aldose reductase inhibitor fidarestat: Implications for inhibitor binding and selectivity</span></div><div class="casAuthors">Ruiz, Francesc Xavier; Cousido-Siah, Alexandra; Mitschler, Andre; Farres, Jaume; Pares, Xavier; Podjarny, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">178-185</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Only one crystal structure is currently available for tumor marker AKR1B10, complexed with NADP+ and tolrestat, which is an aldose reductase inhibitor (ARI) of the carboxylic acid type.  Here, the X-ray structure of the complex of the V301L substituted AKR1B10 holoenzyme with fidarestat, an ARI of the cyclic imide type, was obtained at 1.60 Å resoln. by replacement soaking of crystals contg. tolrestat.  Previously, fidarestat was found to be safe in phase III trials for diabetic neuropathy and, consistent with its low in vivo side effects, was highly selective for aldose reductase (AR or AKR1B1) vs. aldehyde reductase (AKR1A1).  Now, inhibition studies showed that fidarestat was indeed 1300-fold more selective for AR as compared to AKR1B10, while the change of Val to Leu (found in AR) caused a 20-fold decrease in the IC50 value with fidarestat.  Structural anal. of the V301L AKR1B10-fidarestat complex displayed enzyme-inhibitor interactions similar to those of the AR-fidarestat complex.  However, a close inspection of both the new crystal structure and a computer model of the wild-type AKR1B10 complex with fidarestat revealed subtle changes that could affect fidarestat binding.  In the crystal structure, a significant motion of loop A was obsd. between AR and V301L AKR1B10, linked to a Phe-122/Phe-123 side chain displacement.  This was due to the presence of the more voluminous Gln-303 side chain (Ser-302 in AR) and of a water mol. buried in a subpocket located at the base of flexible loop A.  In the wild-type AKR1B10 model, a short contact was predicted between the Val-301 side chain and fidarestat, but would not be present in AR or in V301L AKR1B10.  Overall, these changes could contribute to the difference in inhibitory potency of fidarestat between AR and AKR1B10.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpADvm7S94DbVg90H21EOLACvtfcHk0ljM00CotFx0YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1GitL4%253D&md5=d50a893844c69c1330fdab1b3e7181ee</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2012.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2012.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DRuiz%26aufirst%3DF.%2BX.%26aulast%3DCousido-Siah%26aufirst%3DA.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DFarr%25C3%25A9s%26aufirst%3DJ.%26aulast%3DPar%25C3%25A9s%26aufirst%3DX.%26aulast%3DPodjarny%26aufirst%3DA.%26atitle%3DX-ray%2520Structure%2520of%2520the%2520V301L%2520Aldo-Keto%2520Reductase%25201B10%2520Complexed%2520with%2520NADP%252B%2520and%2520the%2520Potent%2520Aldose%2520Reductase%2520Inhibitor%2520Fidarestat%253A%2520Implications%2520for%2520Inhibitor%2520Binding%2520and%2520Selectivity%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2013%26volume%3D202%26spage%3D178%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span> </span><span class="NLM_article-title">Inhibitor Selectivity between Aldo-Keto Reductase Superfamily Members AKR1B10 and AKR1B1: Role of Trp112 (Trp111)</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">587</span><span class="NLM_x">, </span> <span class="NLM_fpage">3681</span><span class="NLM_x">–</span> <span class="NLM_lpage">3686</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.febslet.2013.09.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=24100137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Wksr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=587&publication_year=2013&pages=3681-3686&author=L.+Zhangauthor=H.+Zhangauthor=Y.+Zhaoauthor=Z.+Liauthor=S.+Chenauthor=J.+Zhaiauthor=Y.+Chenauthor=W.+Xieauthor=Z.+Wangauthor=Q.+Liauthor=X.+Zhengauthor=X.+Hu&title=Inhibitor+Selectivity+between+Aldo-Keto+Reductase+Superfamily+Members+AKR1B10+and+AKR1B1%3A+Role+of+Trp112+%28Trp111%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor selectivity between aldo-keto reductase superfamily members AKR1B10 and AKR1B1: Role of Trp112 (Trp111)</span></div><div class="casAuthors">Zhang, Liping; Zhang, Hong; Zhao, Yining; Li, Zhe; Chen, Shangke; Zhai, Jing; Chen, Yunyun; Xie, Wei; Wang, Zhong; Li, Qing; Zheng, Xuehua; Hu, Xiaopeng</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">587</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3681-3686</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The antineoplastic target aldo-keto reductase family member 1B10 (AKR1B10) and the crit. polyol pathway enzyme aldose reductase (AKR1B1) share high structural similarity.  Crystal structures reported here reveal a surprising Trp112 native conformation stabilized by a specific Gln114-centered hydrogen bond network in the AKR1B10 holoenzyme, and suggest that AKR1B1 inhibitors could retain their binding affinities toward AKR1B10 by inducing Trp112 flip to result in an "AKR1B1-like" active site in AKR1B10, while selective AKR1B10 inhibitors can take advantage of the broader active site of AKR1B10 provided by the native Trp112 side-chain orientation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-ks8rD0RTSrVg90H21EOLACvtfcHk0lhXbrS8KerkcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Wksr3K&md5=a6faf542117ed3192029261dd69b514c</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2013.09.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2013.09.031%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DZhai%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DX.%26atitle%3DInhibitor%2520Selectivity%2520between%2520Aldo-Keto%2520Reductase%2520Superfamily%2520Members%2520AKR1B10%2520and%2520AKR1B1%253A%2520Role%2520of%2520Trp112%2520%2528Trp111%2529%26jtitle%3DFEBS%2520Lett.%26date%3D2013%26volume%3D587%26spage%3D3681%26epage%3D3686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span> </span><span class="NLM_article-title">Partial Inhibition of Aldose Reductase by Nitazoxanide and Its Molecular Basis</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1921</span><span class="NLM_x">–</span> <span class="NLM_lpage">1923</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1921-1923&author=X.+Zhengauthor=L.+Zhangauthor=W.+Chenauthor=Y.+Chenauthor=W.+Xieauthor=X.+Hu&title=Partial+Inhibition+of+Aldose+Reductase+by+Nitazoxanide+and+Its+Molecular+Basis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DX.%26atitle%3DPartial%2520Inhibition%2520of%2520Aldose%2520Reductase%2520by%2520Nitazoxanide%2520and%2520Its%2520Molecular%2520Basis%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1921%26epage%3D1923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Kumar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobhia, M. E.</span><span> </span><span class="NLM_article-title">Novel Insights into the Structural Requirements for the Design of Selective and Specific Aldose Reductase Inhibitors</span> <span class="citation_source-journal">J. Mol. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1791</span><span class="NLM_x">–</span> <span class="NLM_lpage">1799</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1007%2Fs00894-011-1195-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=21833829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVais7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1791-1799&author=H.+Kumarauthor=A.+Shahauthor=M.+E.+Sobhia&title=Novel+Insights+into+the+Structural+Requirements+for+the+Design+of+Selective+and+Specific+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Novel insights into the structural requirements for the design of selective and specific aldose reductase inhibitors</span></div><div class="casAuthors">Kumar, Hirdesh; Shah, Anup; Sobhia, M. Elizabeth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1791-1799</span>CODEN:
                <span class="NLM_cas:coden">JMMOFK</span>;
        ISSN:<span class="NLM_cas:issn">0948-5023</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aldose reductase (ALR2) plays a vital role in the etiol. of long-term diabetic microvascular complications (DMCs) such as retinopathy, nephropathy and neuropathy.  It initializes the polyol pathway and under hyperglycemic conditions, catalyzes the conversion of glucose into sorbitol in the presence of NADPH.  Many ALR2 inhibitors have been withdrawn from clin. trial studies due to their cross reactivity with other analogs enzymes or due to impairment with detoxification role of ALR2.  To address these issues we characterized the possible rationalities behind the selectivity problem assocd. with the enzyme-inhibitor interactions.  Novel mols. were designed for the induce fit cavity region of ALR2.  Docking studies were carried out using Glide to analyze the binding affinity of the designed mols. for ALR2.  The anal. showed that the designed ALR2 inhibitors are selective for ALR2 over its close analogs.  These inhibitors are also specific for the induced cavity region of ALR2 and do not interfere with the detoxification role of ALR2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPHa6bXbXzZLVg90H21EOLACvtfcHk0lhXbrS8KerkcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVais7s%253D&md5=555968a098bc581691ac141bc7682276</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1007%2Fs00894-011-1195-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00894-011-1195-0%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DH.%26aulast%3DShah%26aufirst%3DA.%26aulast%3DSobhia%26aufirst%3DM.%2BE.%26atitle%3DNovel%2520Insights%2520into%2520the%2520Structural%2520Requirements%2520for%2520the%2520Design%2520of%2520Selective%2520and%2520Specific%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DJ.%2520Mol.%2520Model.%26date%3D2012%26volume%3D18%26spage%3D1791%26epage%3D1799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Del Corso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balestri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Bugno, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappiello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mura, U.</span><span> </span><span class="NLM_article-title">A New Approach To Control the Enigmatic Activity of Aldose Reductase</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e74076</span><span class="refDoi"> DOI: 10.1371/journal.pone.0074076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1371%2Fjournal.pone.0074076" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e74076&author=A.+Del+Corsoauthor=F.+Balestriauthor=E.+Di+Bugnoauthor=R.+Moschiniauthor=M.+Cappielloauthor=S.+Sartiniauthor=C.+La+Mottaauthor=F.+Da+Settimoauthor=U.+Mura&title=A+New+Approach+To+Control+the+Enigmatic+Activity+of+Aldose+Reductase&doi=10.1371%2Fjournal.pone.0074076"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0074076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0074076%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BCorso%26aufirst%3DA.%26aulast%3DBalestri%26aufirst%3DF.%26aulast%3DDi%2BBugno%26aufirst%3DE.%26aulast%3DMoschini%26aufirst%3DR.%26aulast%3DCappiello%26aufirst%3DM.%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DMura%26aufirst%3DU.%26atitle%3DA%2520New%2520Approach%2520To%2520Control%2520the%2520Enigmatic%2520Activity%2520of%2520Aldose%2520Reductase%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De74076%26doi%3D10.1371%2Fjournal.pone.0074076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Kim, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. S.</span><span> </span><span class="NLM_article-title">Genistein Inhibits Aldose Reductase Activity and High Glucose-Induced TGF-β2 Expression in Human Lens Epithelial Cells</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">594</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.ejphar.2008.07.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=18692043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVynurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=594&publication_year=2008&pages=18-25&author=Y.+S.+Kimauthor=N.+H.+Kimauthor=D.+H.+Jungauthor=D.+S.+Jangauthor=Y.+M.+Leeauthor=J.+M.+Kimauthor=J.+S.+Kim&title=Genistein+Inhibits+Aldose+Reductase+Activity+and+High+Glucose-Induced+TGF-%CE%B22+Expression+in+Human+Lens+Epithelial+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Genistein inhibits aldose reductase activity and high glucose-induced TGF-β2 expression in human lens epithelial cells</span></div><div class="casAuthors">Kim, Young Sook; Kim, Nan Hee; Jung, Dong Ho; Jang, Dae Sik; Lee, Yun Mi; Kim, Jong Min; Kim, Jin Sook</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">594</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">18-25</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aldose reductase (AR) and TGF-β have been implicated in the development of diabetic complications, such as cataracts.  In an attempt to obtain potential agents for the prevention of diabetic cataracts from natural products, we purified genistein from the roots of Pueraria lobata and investigated its inhibitory effects upon AR activity and its antioxidant effects on rat lenses.  The inhibition of AR activity by genistein increased in a dose-dependent manner and the opacities of lenses were significantly improved when treated with genistein.  In addn., we detd. the effects of genistein on mechanisms induced by exposure to high glucose in human lens epithelial (HLE-B3) cells.  We found that genistein was able to reduce the expression of TGF-β2, αB-crystallin, and fibronectin mRNAs in HLE-B3 cells that were cultured in high glucose conditions.  In addn., a redn. in glutathione (GSH) levels and thiobarbituratic acid-reactive substances was obsd.  These results show that genistein is protective against lens opacity and also inhibits high glucose-mediated toxic effects in HLE-B3 cells.  These effects are likely achieved by preventing AR and cellular oxidn.; therefore, genistein may be a potential therapeutic agent for preventing and treating complications assocd. with diabetes mellitus, such as diabetic cataracts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH434wfZMbybVg90H21EOLACvtfcHk0lhXbrS8KerkcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVynurrI&md5=3aaece05c30cfa59e17bd2478ce76b5f</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.07.033%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DKim%26aufirst%3DN.%2BH.%26aulast%3DJung%26aufirst%3DD.%2BH.%26aulast%3DJang%26aufirst%3DD.%2BS.%26aulast%3DLee%26aufirst%3DY.%2BM.%26aulast%3DKim%26aufirst%3DJ.%2BM.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26atitle%3DGenistein%2520Inhibits%2520Aldose%2520Reductase%2520Activity%2520and%2520High%2520Glucose-Induced%2520TGF-%25CE%25B22%2520Expression%2520in%2520Human%2520Lens%2520Epithelial%2520Cells%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D594%26spage%3D18%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mugnaini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simorini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavecchia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Failli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciuffi, M.</span><span> </span><span class="NLM_article-title">Pyrido[1,2-<i>a</i>]pyrimidin-4-one Derivatives as a Novel Class of Selective Aldose Reductase. Inhibitors Exhibiting Antioxidant Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4917</span><span class="NLM_x">–</span> <span class="NLM_lpage">4927</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070398a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4917-4927&author=C.+La+Mottaauthor=S.+Sartiniauthor=L.+Mugnainiauthor=F.+Simoriniauthor=S.+Talianiauthor=S.+Salernoauthor=A.+M.+Mariniauthor=F.+Da+Settimoauthor=A.+Lavecchiaauthor=E.+Novellinoauthor=M.+Cantoreauthor=P.+Failliauthor=M.+Ciuffi&title=Pyrido%5B1%2C2-a%5Dpyrimidin-4-one+Derivatives+as+a+Novel+Class+of+Selective+Aldose+Reductase.+Inhibitors+Exhibiting+Antioxidant+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fjm070398a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070398a%26sid%3Dliteratum%253Aachs%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DMugnaini%26aufirst%3DL.%26aulast%3DSimorini%26aufirst%3DF.%26aulast%3DTaliani%26aufirst%3DS.%26aulast%3DSalerno%26aufirst%3DS.%26aulast%3DMarini%26aufirst%3DA.%2BM.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DLavecchia%26aufirst%3DA.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCantore%26aufirst%3DM.%26aulast%3DFailli%26aufirst%3DP.%26aulast%3DCiuffi%26aufirst%3DM.%26atitle%3DPyrido%255B1%252C2-a%255Dpyrimidin-4-one%2520Derivatives%2520as%2520a%2520Novel%2520Class%2520of%2520Selective%2520Aldose%2520Reductase.%2520Inhibitors%2520Exhibiting%2520Antioxidant%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4917%26epage%3D4927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Stefek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snirc, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djoubissie, P.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majekova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demopoulos, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rackova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezakova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karasu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbone, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span> </span><span class="NLM_article-title">Carboxymethylated Pyridoindole Antioxidants as Aldose Reductase Inhibitors: Synthesis, Activity, Partitioning, and Molecular Modeling</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4908</span><span class="NLM_x">–</span> <span class="NLM_lpage">4920</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=4908-4920&author=M.+Stefekauthor=V.+Snircauthor=P.-O.+Djoubissieauthor=M.+Majekovaauthor=V.+Demopoulosauthor=L.+Rackovaauthor=Z.+Bezakovaauthor=C.+Karasuauthor=V.+Carboneauthor=O.+El-Kabbani&title=Carboxymethylated+Pyridoindole+Antioxidants+as+Aldose+Reductase+Inhibitors%3A+Synthesis%2C+Activity%2C+Partitioning%2C+and+Molecular+Modeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStefek%26aufirst%3DM.%26aulast%3DSnirc%26aufirst%3DV.%26aulast%3DDjoubissie%26aufirst%3DP.-O.%26aulast%3DMajekova%26aufirst%3DM.%26aulast%3DDemopoulos%26aufirst%3DV.%26aulast%3DRackova%26aufirst%3DL.%26aulast%3DBezakova%26aufirst%3DZ.%26aulast%3DKarasu%26aufirst%3DC.%26aulast%3DCarbone%26aufirst%3DV.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26atitle%3DCarboxymethylated%2520Pyridoindole%2520Antioxidants%2520as%2520Aldose%2520Reductase%2520Inhibitors%253A%2520Synthesis%252C%2520Activity%252C%2520Partitioning%252C%2520and%2520Molecular%2520Modeling%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D4908%26epage%3D4920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Sartini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barresi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Maro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simorini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span> </span><span class="NLM_article-title">Benzofuroxane Derivatives as Multi-Effective Agents for the Treatment of Cardiovascular Diabetic Complications. Synthesis, Functional Evaluation, and Molecular Modeling Studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10523</span><span class="NLM_x">–</span> <span class="NLM_lpage">10531</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301124s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10523-10531&author=S.+Sartiniauthor=S.+Cosconatiauthor=L.+Marinelliauthor=E.+Barresiauthor=S.+Di+Maroauthor=F.+Simoriniauthor=S.+Talianiauthor=S.+Salernoauthor=A.+M.+Mariniauthor=F.+Da+Settimoauthor=E.+Novellinoauthor=C.+La+Motta&title=Benzofuroxane+Derivatives+as+Multi-Effective+Agents+for+the+Treatment+of+Cardiovascular+Diabetic+Complications.+Synthesis%2C+Functional+Evaluation%2C+and+Molecular+Modeling+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1021%2Fjm301124s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301124s%26sid%3Dliteratum%253Aachs%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DBarresi%26aufirst%3DE.%26aulast%3DDi%2BMaro%26aufirst%3DS.%26aulast%3DSimorini%26aufirst%3DF.%26aulast%3DTaliani%26aufirst%3DS.%26aulast%3DSalerno%26aufirst%3DS.%26aulast%3DMarini%26aufirst%3DA.%2BM.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26atitle%3DBenzofuroxane%2520Derivatives%2520as%2520Multi-Effective%2520Agents%2520for%2520the%2520Treatment%2520of%2520Cardiovascular%2520Diabetic%2520Complications.%2520Synthesis%252C%2520Functional%2520Evaluation%252C%2520and%2520Molecular%2520Modeling%2520Studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10523%26epage%3D10531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Ottanà, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giglio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Corso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappiello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mura, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span> </span><span class="NLM_article-title">Identification of 5-Arylidene-4-thiazolidinone Derivatives Endowed with Dual Activity as Aldose Reductase Inhibitors and Antioxidant Agents for the Treatment of Diabetic Complications</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2797</span><span class="NLM_x">–</span> <span class="NLM_lpage">2806</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=2797-2806&author=R.+Ottan%C3%A0author=R.+Maccariauthor=M.+Giglioauthor=A.+Del+Corsoauthor=M.+Cappielloauthor=U.+Muraauthor=S.+Cosconatiauthor=L.+Marinelliauthor=E.+Novellinoauthor=S.+Sartiniauthor=C.+La+Mottaauthor=F.+Da+Settimo&title=Identification+of+5-Arylidene-4-thiazolidinone+Derivatives+Endowed+with+Dual+Activity+as+Aldose+Reductase+Inhibitors+and+Antioxidant+Agents+for+the+Treatment+of+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOttan%25C3%25A0%26aufirst%3DR.%26aulast%3DMaccari%26aufirst%3DR.%26aulast%3DGiglio%26aufirst%3DM.%26aulast%3DDel%2BCorso%26aufirst%3DA.%26aulast%3DCappiello%26aufirst%3DM.%26aulast%3DMura%26aufirst%3DU.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26atitle%3DIdentification%2520of%25205-Arylidene-4-thiazolidinone%2520Derivatives%2520Endowed%2520with%2520Dual%2520Activity%2520as%2520Aldose%2520Reductase%2520Inhibitors%2520and%2520Antioxidant%2520Agents%2520for%2520the%2520Treatment%2520of%2520Diabetic%2520Complications%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D2797%26epage%3D2806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Mylari, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armento, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beebe, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coutcher, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dina, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Gorman, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhares, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oates, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tess, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withbroe, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zembrowski, W. J.</span><span> </span><span class="NLM_article-title">A Highly Selective, Non-Hydantoin, Non-Carboxylic Acid Inhibitor of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models: 6-(5-Chloro-3-methylbenzofuran-2-sulfonyl)-2-<i>H</i>-pyridazin-3-one</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2283</span><span class="NLM_x">–</span> <span class="NLM_lpage">2286</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm034065z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2283-2286&author=B.+L.+Mylariauthor=S.+J.+Armentoauthor=D.+A.+Beebeauthor=E.+L.+Connauthor=J.+B.+Coutcherauthor=M.+S.+Dinaauthor=M.+T.+O%E2%80%99Gormanauthor=M.+C.+Linharesauthor=W.+H.+Martinauthor=P.+J.+Oatesauthor=D.+A.+Tessauthor=G.+J.+Withbroeauthor=W.+J.+Zembrowski&title=A+Highly+Selective%2C+Non-Hydantoin%2C+Non-Carboxylic+Acid+Inhibitor+of+Aldose+Reductase+with+Potent+Oral+Activity+in+Diabetic+Rat+Models%3A+6-%285-Chloro-3-methylbenzofuran-2-sulfonyl%29-2-H-pyridazin-3-one"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1021%2Fjm034065z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034065z%26sid%3Dliteratum%253Aachs%26aulast%3DMylari%26aufirst%3DB.%2BL.%26aulast%3DArmento%26aufirst%3DS.%2BJ.%26aulast%3DBeebe%26aufirst%3DD.%2BA.%26aulast%3DConn%26aufirst%3DE.%2BL.%26aulast%3DCoutcher%26aufirst%3DJ.%2BB.%26aulast%3DDina%26aufirst%3DM.%2BS.%26aulast%3DO%25E2%2580%2599Gorman%26aufirst%3DM.%2BT.%26aulast%3DLinhares%26aufirst%3DM.%2BC.%26aulast%3DMartin%26aufirst%3DW.%2BH.%26aulast%3DOates%26aufirst%3DP.%2BJ.%26aulast%3DTess%26aufirst%3DD.%2BA.%26aulast%3DWithbroe%26aufirst%3DG.%2BJ.%26aulast%3DZembrowski%26aufirst%3DW.%2BJ.%26atitle%3DA%2520Highly%2520Selective%252C%2520Non-Hydantoin%252C%2520Non-Carboxylic%2520Acid%2520Inhibitor%2520of%2520Aldose%2520Reductase%2520with%2520Potent%2520Oral%2520Activity%2520in%2520Diabetic%2520Rat%2520Models%253A%25206-%25285-Chloro-3-methylbenzofuran-2-sulfonyl%2529-2-H-pyridazin-3-one%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2283%26epage%3D2286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Mylari, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armento, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beebe, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coutcher, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dina, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Gorman, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhares, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oates, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tess, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withbroe, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zembrowski, W. J.</span><span> </span><span class="NLM_article-title">A Novel Series of Non-Carboxylic Acid, Non-Hydantoin Inhibitors of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models: 6-(5-Chloro-3-methylbenzofuran-2-sulfonyl)-2<i>H</i>-pyridazin-3-one and Congeners</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6326</span><span class="NLM_x">–</span> <span class="NLM_lpage">6339</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050462t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6326-6339&author=B.+L.+Mylariauthor=S.+J.+Armentoauthor=D.+A.+Beebeauthor=E.+L.+Connauthor=J.+B.+Coutcherauthor=M.+S.+Dinaauthor=M.+T.+O%E2%80%99Gormanauthor=M.+C.+Linharesauthor=W.+H.+Martinauthor=P.+J.+Oatesauthor=D.+A.+Tessauthor=G.+J.+Withbroeauthor=W.+J.+Zembrowski&title=A+Novel+Series+of+Non-Carboxylic+Acid%2C+Non-Hydantoin+Inhibitors+of+Aldose+Reductase+with+Potent+Oral+Activity+in+Diabetic+Rat+Models%3A+6-%285-Chloro-3-methylbenzofuran-2-sulfonyl%29-2H-pyridazin-3-one+and+Congeners"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1021%2Fjm050462t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050462t%26sid%3Dliteratum%253Aachs%26aulast%3DMylari%26aufirst%3DB.%2BL.%26aulast%3DArmento%26aufirst%3DS.%2BJ.%26aulast%3DBeebe%26aufirst%3DD.%2BA.%26aulast%3DConn%26aufirst%3DE.%2BL.%26aulast%3DCoutcher%26aufirst%3DJ.%2BB.%26aulast%3DDina%26aufirst%3DM.%2BS.%26aulast%3DO%25E2%2580%2599Gorman%26aufirst%3DM.%2BT.%26aulast%3DLinhares%26aufirst%3DM.%2BC.%26aulast%3DMartin%26aufirst%3DW.%2BH.%26aulast%3DOates%26aufirst%3DP.%2BJ.%26aulast%3DTess%26aufirst%3DD.%2BA.%26aulast%3DWithbroe%26aufirst%3DG.%2BJ.%26aulast%3DZembrowski%26aufirst%3DW.%2BJ.%26atitle%3DA%2520Novel%2520Series%2520of%2520Non-Carboxylic%2520Acid%252C%2520Non-Hydantoin%2520Inhibitors%2520of%2520Aldose%2520Reductase%2520with%2520Potent%2520Oral%2520Activity%2520in%2520Diabetic%2520Rat%2520Models%253A%25206-%25285-Chloro-3-methylbenzofuran-2-sulfonyl%2529-2H-pyridazin-3-one%2520and%2520Congeners%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6326%26epage%3D6339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oates, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coutcher, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhardinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenzi, M.</span><span> </span><span class="NLM_article-title">A Selective Aldose Reductase Inhibitor of a New Structural Class Prevents or Reverses Early Retinal Abnormalities in Experimental Diabetic Retinopathy</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2757</span><span class="NLM_x">–</span> <span class="NLM_lpage">2762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2006&pages=2757-2762&author=W.+Sunauthor=P.+J.+Oatesauthor=J.+B.+Coutcherauthor=C.+Gerhardingerauthor=M.+Lorenzi&title=A+Selective+Aldose+Reductase+Inhibitor+of+a+New+Structural+Class+Prevents+or+Reverses+Early+Retinal+Abnormalities+in+Experimental+Diabetic+Retinopathy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DW.%26aulast%3DOates%26aufirst%3DP.%2BJ.%26aulast%3DCoutcher%26aufirst%3DJ.%2BB.%26aulast%3DGerhardinger%26aufirst%3DC.%26aulast%3DLorenzi%26aufirst%3DM.%26atitle%3DA%2520Selective%2520Aldose%2520Reductase%2520Inhibitor%2520of%2520a%2520New%2520Structural%2520Class%2520Prevents%2520or%2520Reverses%2520Early%2520Retinal%2520Abnormalities%2520in%2520Experimental%2520Diabetic%2520Retinopathy%26jtitle%3DDiabetes%26date%3D2006%26volume%3D55%26spage%3D2757%26epage%3D2762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Steuber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zentgraf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">High-Resolution Crystal Structure of Aldose Reductase with the Novel Sulfonyl-Pyridazinone Inhibitor Exhibiting an Alternative Active Site Anchoring Group</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">356</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2006&pages=45-56&author=H.+Steuberauthor=M.+Zentgrafauthor=S.+Podjarnyauthor=A.+Heineauthor=G.+Klebe&title=High-Resolution+Crystal+Structure+of+Aldose+Reductase+with+the+Novel+Sulfonyl-Pyridazinone+Inhibitor+Exhibiting+an+Alternative+Active+Site+Anchoring+Group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSteuber%26aufirst%3DH.%26aulast%3DZentgraf%26aufirst%3DM.%26aulast%3DPodjarny%26aufirst%3DS.%26aulast%3DHeine%26aufirst%3DA.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DHigh-Resolution%2520Crystal%2520Structure%2520of%2520Aldose%2520Reductase%2520with%2520the%2520Novel%2520Sulfonyl-Pyridazinone%2520Inhibitor%2520Exhibiting%2520an%2520Alternative%2520Active%2520Site%2520Anchoring%2520Group%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D356%26spage%3D45%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Fresneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cussac, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morand, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szymonski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tranqui, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leclerc, G.</span><span> </span><span class="NLM_article-title">Synthesis, Activity, and Molecular Modeling of New 2,4-Dioxo-5-(naphthylmethylene)-3-thiazolidineacetic Acids and 2-Thioxo Analogues as Potent Aldose Reductase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">4706</span><span class="NLM_x">–</span> <span class="NLM_lpage">4715</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9801399" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=4706-4715&author=P.+Fresneauauthor=M.+Cussacauthor=J.+M.+Morandauthor=B.+Szymonskiauthor=D.+Tranquiauthor=G.+Leclerc&title=Synthesis%2C+Activity%2C+and+Molecular+Modeling+of+New+2%2C4-Dioxo-5-%28naphthylmethylene%29-3-thiazolidineacetic+Acids+and+2-Thioxo+Analogues+as+Potent+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1021%2Fjm9801399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9801399%26sid%3Dliteratum%253Aachs%26aulast%3DFresneau%26aufirst%3DP.%26aulast%3DCussac%26aufirst%3DM.%26aulast%3DMorand%26aufirst%3DJ.%2BM.%26aulast%3DSzymonski%26aufirst%3DB.%26aulast%3DTranqui%26aufirst%3DD.%26aulast%3DLeclerc%26aufirst%3DG.%26atitle%3DSynthesis%252C%2520Activity%252C%2520and%2520Molecular%2520Modeling%2520of%2520New%25202%252C4-Dioxo-5-%2528naphthylmethylene%2529-3-thiazolidineacetic%2520Acids%2520and%25202-Thioxo%2520Analogues%2520as%2520Potent%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D4706%26epage%3D4715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Maccari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Corso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giglio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mura, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottanà, R.</span><span> </span><span class="NLM_article-title">In vitro Evaluation of 5-Arylidene-2-thioxo-4-thiazolidinones Active as Aldose Reductase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=200-203&author=R.+Maccariauthor=A.+Del+Corsoauthor=M.+Giglioauthor=R.+Moschiniauthor=U.+Muraauthor=R.+Ottan%C3%A0&title=In+vitro+Evaluation+of+5-Arylidene-2-thioxo-4-thiazolidinones+Active+as+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaccari%26aufirst%3DR.%26aulast%3DDel%2BCorso%26aufirst%3DA.%26aulast%3DGiglio%26aufirst%3DM.%26aulast%3DMoschini%26aufirst%3DR.%26aulast%3DMura%26aufirst%3DU.%26aulast%3DOttan%25C3%25A0%26aufirst%3DR.%26atitle%3DIn%2520vitro%2520Evaluation%2520of%25205-Arylidene-2-thioxo-4-thiazolidinones%2520Active%2520as%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D200%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeed, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbas, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, J.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Molecular Modelling of Novel Methyl[4-oxo-2-(aroylimino)-3-(substituted phenyl)thiazolidin-5-ylidene]acetates as Potent and Selective Aldose Reductase Inhibitors</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1428</span><span class="NLM_x">–</span> <span class="NLM_lpage">1434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1039%2Fc2md20228j" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1428-1434&author=S.+Aliauthor=A.+Saeedauthor=N.+Abbasauthor=M.+Shahidauthor=M.+Bolteauthor=J.+Iqbal&title=Design%2C+Synthesis+and+Molecular+Modelling+of+Novel+Methyl%5B4-oxo-2-%28aroylimino%29-3-%28substituted+phenyl%29thiazolidin-5-ylidene%5Dacetates+as+Potent+and+Selective+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1039%2Fc2md20228j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20228j%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DS.%26aulast%3DSaeed%26aufirst%3DA.%26aulast%3DAbbas%26aufirst%3DN.%26aulast%3DShahid%26aufirst%3DM.%26aulast%3DBolte%26aufirst%3DM.%26aulast%3DIqbal%26aufirst%3DJ.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Molecular%2520Modelling%2520of%2520Novel%2520Methyl%255B4-oxo-2-%2528aroylimino%2529-3-%2528substituted%2520phenyl%2529thiazolidin-5-ylidene%255Dacetates%2520as%2520Potent%2520and%2520Selective%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2012%26volume%3D3%26spage%3D1428%26epage%3D1434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Alexiou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolaou, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demopoulos, V. J.</span><span> </span><span class="NLM_article-title">Design and Synthesis of <i>N</i>-(3,5-Difluoro-4-hydroxyphenyl)benzenesulfonamides as Aldose Reductase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3926</span><span class="NLM_x">–</span> <span class="NLM_lpage">3932</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=3926-3932&author=P.+Alexiouauthor=I.+Nicolaouauthor=M.+Stefekauthor=A.+Kristlauthor=V.+J.+Demopoulos&title=Design+and+Synthesis+of+N-%283%2C5-Difluoro-4-hydroxyphenyl%29benzenesulfonamides+as+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlexiou%26aufirst%3DP.%26aulast%3DNicolaou%26aufirst%3DI.%26aulast%3DStefek%26aufirst%3DM.%26aulast%3DKristl%26aufirst%3DA.%26aulast%3DDemopoulos%26aufirst%3DV.%2BJ.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520N-%25283%252C5-Difluoro-4-hydroxyphenyl%2529benzenesulfonamides%2520as%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D3926%26epage%3D3932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Alexiou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demopoulos, V. J.</span><span> </span><span class="NLM_article-title">A Diverse Series of Substituted Benzenesulfonamides as Aldose Reductase Inhibitors with Antioxidant Activity: Design, Synthesis, and in Vitro Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7756</span><span class="NLM_x">–</span> <span class="NLM_lpage">7766</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101008m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1KrsL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7756-7766&author=P.+Alexiouauthor=V.+J.+Demopoulos&title=A+Diverse+Series+of+Substituted+Benzenesulfonamides+as+Aldose+Reductase+Inhibitors+with+Antioxidant+Activity%3A+Design%2C+Synthesis%2C+and+in+Vitro+Activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">A Diverse Series of Substituted Benzenesulfonamides as Aldose Reductase Inhibitors with Antioxidant Activity: Design, Synthesis, and in Vitro Activity</span></div><div class="casAuthors">Alexiou, Polyxeni; Demopoulos, Vassilis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7756-7766</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Based on bioisosteric principles, 2,6-difluorophenol and tetrazole, methylsulfonylamide, and isoxazolidin-3-one phenylsulfonamide derivs. were synthesized and tested in vitro in protocols primarily related to the long-term diabetic complications.  Most of the compds. were found as aldose reductase inhibitors (ARIs) at IC50 < 100 μM, while the introduction of the 4-bromo-2-fluorobenzyl group in a phenylsulfonamidodifluorophenol structure resulted in I, presenting a submicromolar inhibitory profile.  However, the derivs. of tetrazole, methylsulfonylamine, and the (R)-enantiomer of isoxazolidin-3-one did not exhibit appreciable aldose reductase inhibitors (ARI) activity.  The selectivity of the active ARIs is also discussed.  Furthermore, the synthesized compds. exhibit potent antioxidant potential (homogeneous and heterogeneous systems).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB1NvT6auwjLVg90H21EOLACvtfcHk0lg0rPI05oceZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1KrsL7P&md5=563867cc9b9125eaaa603ac959f399a6</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fjm101008m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101008m%26sid%3Dliteratum%253Aachs%26aulast%3DAlexiou%26aufirst%3DP.%26aulast%3DDemopoulos%26aufirst%3DV.%2BJ.%26atitle%3DA%2520Diverse%2520Series%2520of%2520Substituted%2520Benzenesulfonamides%2520as%2520Aldose%2520Reductase%2520Inhibitors%2520with%2520Antioxidant%2520Activity%253A%2520Design%252C%2520Synthesis%252C%2520and%2520in%2520Vitro%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7756%26epage%3D7766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Chatzopoulou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamadou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juskova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koukoulitsa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolaou, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demopoulos, V. J.</span><span> </span><span class="NLM_article-title">Structure–Activity Relations on [1-(3,5-Difluoro-4-hydroxyphenyl)-1<i>H</i>-pyrrol-3-yl]phenylmethanone. The Effect of Methoxy Substitution on Aldose Reductase Inhibitory Activity and Selectivity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1426</span><span class="NLM_x">–</span> <span class="NLM_lpage">1433</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1426-1433&author=M.+Chatzopoulouauthor=E.+Mamadouauthor=M.+Juskovaauthor=C.+Koukoulitsaauthor=I.+Nicolaouauthor=M.+Stefekauthor=V.+J.+Demopoulos&title=Structure%E2%80%93Activity+Relations+on+%5B1-%283%2C5-Difluoro-4-hydroxyphenyl%29-1H-pyrrol-3-yl%5Dphenylmethanone.+The+Effect+of+Methoxy+Substitution+on+Aldose+Reductase+Inhibitory+Activity+and+Selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChatzopoulou%26aufirst%3DM.%26aulast%3DMamadou%26aufirst%3DE.%26aulast%3DJuskova%26aufirst%3DM.%26aulast%3DKoukoulitsa%26aufirst%3DC.%26aulast%3DNicolaou%26aufirst%3DI.%26aulast%3DStefek%26aufirst%3DM.%26aulast%3DDemopoulos%26aufirst%3DV.%2BJ.%26atitle%3DStructure%25E2%2580%2593Activity%2520Relations%2520on%2520%255B1-%25283%252C5-Difluoro-4-hydroxyphenyl%2529-1H-pyrrol-3-yl%255Dphenylmethanone.%2520The%2520Effect%2520of%2520Methoxy%2520Substitution%2520on%2520Aldose%2520Reductase%2520Inhibitory%2520Activity%2520and%2520Selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D1426%26epage%3D1433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Kotsampasakou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demopoulos, V. J.</span><span> </span><span class="NLM_article-title">Synthesis of Derivatives of the Keto-pyrrolyl-difluorophenol Scaffold: Some Structural Aspects for Aldose Reductase Inhibitory Activity and Selectivity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">–</span> <span class="NLM_lpage">873</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=869-873&author=E.+Kotsampasakouauthor=V.+J.+Demopoulos&title=Synthesis+of+Derivatives+of+the+Keto-pyrrolyl-difluorophenol+Scaffold%3A+Some+Structural+Aspects+for+Aldose+Reductase+Inhibitory+Activity+and+Selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKotsampasakou%26aufirst%3DE.%26aulast%3DDemopoulos%26aufirst%3DV.%2BJ.%26atitle%3DSynthesis%2520of%2520Derivatives%2520of%2520the%2520Keto-pyrrolyl-difluorophenol%2520Scaffold%253A%2520Some%2520Structural%2520Aspects%2520for%2520Aldose%2520Reductase%2520Inhibitory%2520Activity%2520and%2520Selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D869%26epage%3D873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Pegklidou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koukoulitsa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolaou, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demopoulos, V. J.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Novel Series of Pyrrole Based Chemotypes and Their Evaluation as Selective Aldose Reductase Inhibitors. A Case of Bioisosterism between a Carboxylic Acid Moiety and That of a Tetrazole</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2107</span><span class="NLM_x">–</span> <span class="NLM_lpage">2114</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=2107-2114&author=K.+Pegklidouauthor=C.+Koukoulitsaauthor=I.+Nicolaouauthor=V.+J.+Demopoulos&title=Design+and+Synthesis+of+Novel+Series+of+Pyrrole+Based+Chemotypes+and+Their+Evaluation+as+Selective+Aldose+Reductase+Inhibitors.+A+Case+of+Bioisosterism+between+a+Carboxylic+Acid+Moiety+and+That+of+a+Tetrazole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPegklidou%26aufirst%3DK.%26aulast%3DKoukoulitsa%26aufirst%3DC.%26aulast%3DNicolaou%26aufirst%3DI.%26aulast%3DDemopoulos%26aufirst%3DV.%2BJ.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Novel%2520Series%2520of%2520Pyrrole%2520Based%2520Chemotypes%2520and%2520Their%2520Evaluation%2520as%2520Selective%2520Aldose%2520Reductase%2520Inhibitors.%2520A%2520Case%2520of%2520Bioisosterism%2520between%2520a%2520Carboxylic%2520Acid%2520Moiety%2520and%2520That%2520of%2520a%2520Tetrazole%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D2107%26epage%3D2114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Papastavrou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatzopoulou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegklidou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolaou, I.</span><span> </span><span class="NLM_article-title">1-Hydroxypyrazole as a Bioisostere of the Acetic Acid Moiety in a Series of Aldose Reductase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4951</span><span class="NLM_x">–</span> <span class="NLM_lpage">4957</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=4951-4957&author=N.+Papastavrouauthor=M.+Chatzopoulouauthor=K.+Pegklidouauthor=I.+Nicolaou&title=1-Hydroxypyrazole+as+a+Bioisostere+of+the+Acetic+Acid+Moiety+in+a+Series+of+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPapastavrou%26aufirst%3DN.%26aulast%3DChatzopoulou%26aufirst%3DM.%26aulast%3DPegklidou%26aufirst%3DK.%26aulast%3DNicolaou%26aufirst%3DI.%26atitle%3D1-Hydroxypyrazole%2520as%2520a%2520Bioisostere%2520of%2520the%2520Acetic%2520Acid%2520Moiety%2520in%2520a%2520Series%2520of%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D4951%26epage%3D4957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Chatzopoulou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patsilinakos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallianatou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prnova, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zakelj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragno, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantili-Kakoulidou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demopoulos, V. J.</span><span> </span><span class="NLM_article-title">Decreasing Acidity in a Series of Aldose Reductase Inhibitors: 2-Fluoro-4-(1<i>H</i>-pyrrol-1-yl)phenol as a Scaffold for Improved Membrane Permeation</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2194</span><span class="NLM_x">–</span> <span class="NLM_lpage">2207</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=2194-2207&author=M.+Chatzopoulouauthor=A.+Patsilinakosauthor=T.+Vallianatouauthor=M.+S.+Prnovaauthor=S.+Zakeljauthor=R.+Ragnoauthor=M.+Stefekauthor=A.+Kristlauthor=A.+Tsantili-Kakoulidouauthor=V.+J.+Demopoulos&title=Decreasing+Acidity+in+a+Series+of+Aldose+Reductase+Inhibitors%3A+2-Fluoro-4-%281H-pyrrol-1-yl%29phenol+as+a+Scaffold+for+Improved+Membrane+Permeation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChatzopoulou%26aufirst%3DM.%26aulast%3DPatsilinakos%26aufirst%3DA.%26aulast%3DVallianatou%26aufirst%3DT.%26aulast%3DPrnova%26aufirst%3DM.%2BS.%26aulast%3DZakelj%26aufirst%3DS.%26aulast%3DRagno%26aufirst%3DR.%26aulast%3DStefek%26aufirst%3DM.%26aulast%3DKristl%26aufirst%3DA.%26aulast%3DTsantili-Kakoulidou%26aufirst%3DA.%26aulast%3DDemopoulos%26aufirst%3DV.%2BJ.%26atitle%3DDecreasing%2520Acidity%2520in%2520a%2520Series%2520of%2520Aldose%2520Reductase%2520Inhibitors%253A%25202-Fluoro-4-%25281H-pyrrol-1-yl%2529phenol%2520as%2520a%2520Scaffold%2520for%2520Improved%2520Membrane%2520Permeation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D2194%26epage%3D2207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Maccari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottanà, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciurleo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakowitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matuszczak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laggner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, T.</span><span> </span><span class="NLM_article-title">Synthesis, Induced-Fit Docking Investigations, and in Vitro Aldose Reductase Inhibitory Activity of Non-Carboxylic Acid Containing 2,4-Thiazolidinedione Derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5840</span><span class="NLM_x">–</span> <span class="NLM_lpage">5852</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=5840-5852&author=R.+Maccariauthor=R.+Ottan%C3%A0author=R.+Ciurleoauthor=D.+Rakowitzauthor=B.+Matuszczakauthor=C.+Laggnerauthor=T.+Langer&title=Synthesis%2C+Induced-Fit+Docking+Investigations%2C+and+in+Vitro+Aldose+Reductase+Inhibitory+Activity+of+Non-Carboxylic+Acid+Containing+2%2C4-Thiazolidinedione+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaccari%26aufirst%3DR.%26aulast%3DOttan%25C3%25A0%26aufirst%3DR.%26aulast%3DCiurleo%26aufirst%3DR.%26aulast%3DRakowitz%26aufirst%3DD.%26aulast%3DMatuszczak%26aufirst%3DB.%26aulast%3DLaggner%26aufirst%3DC.%26aulast%3DLanger%26aufirst%3DT.%26atitle%3DSynthesis%252C%2520Induced-Fit%2520Docking%2520Investigations%252C%2520and%2520in%2520Vitro%2520Aldose%2520Reductase%2520Inhibitory%2520Activity%2520of%2520Non-Carboxylic%2520Acid%2520Containing%25202%252C4-Thiazolidinedione%2520Derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D5840%26epage%3D5852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">Maccari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciurleo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giglio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappiello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Corso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mura, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottanà, R.</span><span> </span><span class="NLM_article-title">Identification of New Non-Carboxylic Acid Containing Inhibitors of Aldose Reductase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4049</span><span class="NLM_x">–</span> <span class="NLM_lpage">4055</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=4049-4055&author=R.+Maccariauthor=R.+Ciurleoauthor=M.+Giglioauthor=M.+Cappielloauthor=R.+Moschiniauthor=A.+Del+Corsoauthor=U.+Muraauthor=R.+Ottan%C3%A0&title=Identification+of+New+Non-Carboxylic+Acid+Containing+Inhibitors+of+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaccari%26aufirst%3DR.%26aulast%3DCiurleo%26aufirst%3DR.%26aulast%3DGiglio%26aufirst%3DM.%26aulast%3DCappiello%26aufirst%3DM.%26aulast%3DMoschini%26aufirst%3DR.%26aulast%3DDel%2BCorso%26aufirst%3DA.%26aulast%3DMura%26aufirst%3DU.%26aulast%3DOttan%25C3%25A0%26aufirst%3DR.%26atitle%3DIdentification%2520of%2520New%2520Non-Carboxylic%2520Acid%2520Containing%2520Inhibitors%2520of%2520Aldose%2520Reductase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D4049%26epage%3D4055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span> </span><span class="NLM_article-title">Pursuing Aldose Reductase Inhibitors through in Situ Cross-Docking and Similarity-Based Virtual Screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5578</span><span class="NLM_x">–</span> <span class="NLM_lpage">5581</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901045w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5578-5581&author=S.+Cosconatiauthor=L.+Marinelliauthor=C.+La+Mottaauthor=S.+Sartiniauthor=F.+Da+Settimoauthor=A.+J.+Olsonauthor=E.+Novellino&title=Pursuing+Aldose+Reductase+Inhibitors+through+in+Situ+Cross-Docking+and+Similarity-Based+Virtual+Screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Fjm901045w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901045w%26sid%3Dliteratum%253Aachs%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DNovellino%26aufirst%3DE.%26atitle%3DPursuing%2520Aldose%2520Reductase%2520Inhibitors%2520through%2520in%2520Situ%2520Cross-Docking%2520and%2520Similarity-Based%2520Virtual%2520Screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5578%26epage%3D5581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 83 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ying-Chu Chen, Juan A. Oses-Prieto, Lauren E. Pope, Alma L. Burlingame, Scott J. Dixon, <span class="NLM_string-name hlFld-ContribAuthor">Adam R. Renslo</span>. </span><span class="cited-content_cbyCitation_article-title">Reactivity-Based Probe of the Iron(II)-Dependent Interactome Identifies New Cellular Modulators of Ferroptosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2020,</strong> <em>142 </em>
                                    (45)
                                     , 19085-19093. <a href="https://doi.org/10.1021/jacs.0c06709" title="DOI URL">https://doi.org/10.1021/jacs.0c06709</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.0c06709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.0c06709%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DReactivity-Based%252BProbe%252Bof%252Bthe%252BIron%252528II%252529-Dependent%252BInteractome%252BIdentifies%252BNew%252BCellular%252BModulators%252Bof%252BFerroptosis%26aulast%3DChen%26aufirst%3DYing-Chu%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D22062020%26date%3D30102020%26volume%3D142%26issue%3D45%26spage%3D19085%26epage%3D19093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matúš Hlaváč, Lucia Kováčiková, Marta Šoltésová Prnová, Peter Šramel, Gabriela Addová, Magdaléna Májeková, Gilles Hanquet, Andrej Boháč, <span class="NLM_string-name hlFld-ContribAuthor">Milan Štefek</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Novel Oxotriazinoindole Inhibitors of Aldose Reductase: Isosteric Sulfur/Oxygen Replacement in the Thioxotriazinoindole Cemtirestat Markedly Improved Inhibition Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (1)
                                     , 369-381. <a href="https://doi.org/10.1021/acs.jmedchem.9b01747" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01747</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01747%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BNovel%252BOxotriazinoindole%252BInhibitors%252Bof%252BAldose%252BReductase%25253A%252BIsosteric%252BSulfur%25252FOxygen%252BReplacement%252Bin%252Bthe%252BThioxotriazinoindole%252BCemtirestat%252BMarkedly%252BImproved%252BInhibition%252BSelectivity%26aulast%3DHlav%25C3%25A1%25C4%258D%26aufirst%3DMat%25C3%25BA%25C5%25A1%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D22102019%26date%3D30122019%26date%3D10122019%26volume%3D63%26issue%3D1%26spage%3D369%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie-Pierre  Dréanic</span>, <span class="hlFld-ContribAuthor ">Colin M.  Edge</span>, and <span class="hlFld-ContribAuthor ">Tell  Tuttle</span>  . </span><span class="cited-content_cbyCitation_article-title">New Insights into the Catalytic Mechanism of Aldose Reductase: A QM/MM Study. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2017,</strong> <em>2 </em>
                                    (9)
                                     , 5737-5747. <a href="https://doi.org/10.1021/acsomega.7b00815" title="DOI URL">https://doi.org/10.1021/acsomega.7b00815</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.7b00815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.7b00815%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DNew%252BInsights%252Binto%252Bthe%252BCatalytic%252BMechanism%252Bof%252BAldose%252BReductase%25253A%252BA%252BQM%25252FMM%252BStudy%26aulast%3DDr%25C3%25A9anic%26aufirst%3DMarie-Pierre%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D19062017%26date%3D28082017%26date%3D30092017%26volume%3D2%26issue%3D9%26spage%3D5737%26epage%3D5747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunlin  Zhuang</span>, <span class="hlFld-ContribAuthor ">Wen  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chengguo  Xing</span>, and <span class="hlFld-ContribAuthor ">Zhenyuan  Miao</span>  . </span><span class="cited-content_cbyCitation_article-title">Chalcone: A Privileged Structure in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2017,</strong> <em>117 </em>
                                    (12)
                                     , 7762-7810. <a href="https://doi.org/10.1021/acs.chemrev.7b00020" title="DOI URL">https://doi.org/10.1021/acs.chemrev.7b00020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.7b00020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.7b00020%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DChalcone%25253A%252BA%252BPrivileged%252BStructure%252Bin%252BMedicinal%252BChemistry%26aulast%3DZhuang%26aufirst%3DChunlin%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D10012017%26date%3D10052017%26date%3D28062017%26volume%3D117%26issue%3D12%26spage%3D7762%26epage%3D7810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chris  Rechlin</span>, <span class="hlFld-ContribAuthor ">Frithjof  Scheer</span>, <span class="hlFld-ContribAuthor ">Felix  Terwesten</span>, <span class="hlFld-ContribAuthor ">Tobias  Wulsdorf</span>, <span class="hlFld-ContribAuthor ">Ewa  Pol</span>, <span class="hlFld-ContribAuthor ">Veronica  Fridh</span>, <span class="hlFld-ContribAuthor ">Philipp  Toth</span>, <span class="hlFld-ContribAuthor ">Wibke E.  Diederich</span>, <span class="hlFld-ContribAuthor ">Andreas  Heine</span>, and <span class="hlFld-ContribAuthor ">Gerhard  Klebe</span>  . </span><span class="cited-content_cbyCitation_article-title">Price for Opening the Transient Specificity Pocket in Human Aldose Reductase upon Ligand Binding: Structural, Thermodynamic, Kinetic, and Computational Analysis. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2017,</strong> <em>12 </em>
                                    (5)
                                     , 1397-1415. <a href="https://doi.org/10.1021/acschembio.7b00062" title="DOI URL">https://doi.org/10.1021/acschembio.7b00062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.7b00062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.7b00062%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DPrice%252Bfor%252BOpening%252Bthe%252BTransient%252BSpecificity%252BPocket%252Bin%252BHuman%252BAldose%252BReductase%252Bupon%252BLigand%252BBinding%25253A%252BStructural%25252C%252BThermodynamic%25252C%252BKinetic%25252C%252Band%252BComputational%252BAnalysis%26aulast%3DRechlin%26aufirst%3DChris%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23012017%26date%3D13032017%26date%3D05042017%26date%3D19052017%26date%3D13032017%26volume%3D12%26issue%3D5%26spage%3D1397%26epage%3D1415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kun-Che  Chang</span>, <span class="hlFld-ContribAuthor ">Linfeng  Li</span>, <span class="hlFld-ContribAuthor ">Theresa M.  Sanborn</span>, <span class="hlFld-ContribAuthor ">Biehuoy  Shieh</span>, <span class="hlFld-ContribAuthor ">Patricia  Lenhart</span>, <span class="hlFld-ContribAuthor ">David  Ammar</span>, <span class="hlFld-ContribAuthor ">Daniel V.  LaBarbera</span>, and <span class="hlFld-ContribAuthor ">J. Mark  Petrash</span>  . </span><span class="cited-content_cbyCitation_article-title">Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2016,</strong> <em>79 </em>
                                    (5)
                                     , 1439-1444. <a href="https://doi.org/10.1021/acs.jnatprod.6b00185" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.6b00185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.6b00185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.6b00185%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DCharacterization%252Bof%252BEmodin%252Bas%252Ba%252BTherapeutic%252BAgent%252Bfor%252BDiabetic%252BCataract%26aulast%3DChang%26aufirst%3DKun-Che%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D02032016%26date%3D03052016%26date%3D27052016%26volume%3D79%26issue%3D5%26spage%3D1439%26epage%3D1444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Milan  Stefek</span>, <span class="hlFld-ContribAuthor ">Marta  Soltesova Prnova</span>, <span class="hlFld-ContribAuthor ">Magdalena  Majekova</span>, <span class="hlFld-ContribAuthor ">Chris  Rechlin</span>, <span class="hlFld-ContribAuthor ">Andreas  Heine</span>, and <span class="hlFld-ContribAuthor ">Gerhard  Klebe</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Novel Aldose Reductase Inhibitors Based on Carboxymethylated Mercaptotriazinoindole Scaffold. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (6)
                                     , 2649-2657. <a href="https://doi.org/10.1021/jm5015814" title="DOI URL">https://doi.org/10.1021/jm5015814</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5015814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5015814%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BNovel%252BAldose%252BReductase%252BInhibitors%252BBased%252Bon%252BCarboxymethylated%252BMercaptotriazinoindole%252BScaffold%26aulast%3DStefek%26aufirst%3DMilan%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D14102014%26date%3D04032015%26date%3D26032015%26date%3D19022015%26volume%3D58%26issue%3D6%26spage%3D2649%26epage%3D2657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohd Usman  Mohd Siddique</span>, <span class="hlFld-ContribAuthor ">Abhishek  Thakur</span>, <span class="hlFld-ContribAuthor ">Deepak  Shilkar</span>, <span class="hlFld-ContribAuthor ">Sabina  Yasmin</span>, <span class="hlFld-ContribAuthor ">Dominika  Halakova</span>, <span class="hlFld-ContribAuthor ">Lucia  Kovacikova</span>, <span class="hlFld-ContribAuthor ">Marta Soltesova  Prnova</span>, <span class="hlFld-ContribAuthor ">Milan  Stefek</span>, <span class="hlFld-ContribAuthor ">Orlando  Acevedo</span>, <span class="hlFld-ContribAuthor ">Gayathri  Dasararaju</span>, <span class="hlFld-ContribAuthor ">Velmurugan  Devadasan</span>, <span class="hlFld-ContribAuthor ">Susanta Kumar  Mondal</span>, <span class="hlFld-ContribAuthor ">Venkatesan  Jayaprakash</span>. </span><span class="cited-content_cbyCitation_article-title">Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113630. <a href="https://doi.org/10.1016/j.ejmech.2021.113630" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113630</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113630%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNon-carboxylic%252Bacid%252Binhibitors%252Bof%252Baldose%252Breductase%252Bbased%252Bon%252BN-substituted%252Bthiazolidinedione%252Bderivatives%26aulast%3DMohd%2BSiddique%26aufirst%3DMohd%2BUsman%26date%3D2021%26volume%3D223%26spage%3D113630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Belgin  Sever</span>, <span class="hlFld-ContribAuthor ">Mehlika Dilek  Altıntop</span>, <span class="hlFld-ContribAuthor ">Yeliz  Demir</span>, <span class="hlFld-ContribAuthor ">Nalan  Yılmaz</span>, <span class="hlFld-ContribAuthor ">Gülşen  Akalın Çiftçi</span>, <span class="hlFld-ContribAuthor ">Şükrü  Beydemir</span>, <span class="hlFld-ContribAuthor ">Ahmet  Özdemir</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a new class of potent aldose reductase inhibitors: Design, microwave-assisted synthesis, in vitro and in silico evaluation of 2-pyrazolines. </span><span class="cited-content_cbyCitation_journal-name">Chemico-Biological Interactions</span><span> <strong>2021,</strong> <em>345 </em>, 109576. <a href="https://doi.org/10.1016/j.cbi.2021.109576" title="DOI URL">https://doi.org/10.1016/j.cbi.2021.109576</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbi.2021.109576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbi.2021.109576%26sid%3Dliteratum%253Aachs%26jtitle%3DChemico-Biological%2520Interactions%26atitle%3DIdentification%252Bof%252Ba%252Bnew%252Bclass%252Bof%252Bpotent%252Baldose%252Breductase%252Binhibitors%25253A%252BDesign%25252C%252Bmicrowave-assisted%252Bsynthesis%25252C%252Bin%252Bvitro%252Band%252Bin%252Bsilico%252Bevaluation%252Bof%252B2-pyrazolines%26aulast%3DSever%26aufirst%3DBelgin%26date%3D2021%26volume%3D345%26spage%3D109576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad Tariq  Shehzad</span>, <span class="hlFld-ContribAuthor ">Ajmal  Khan</span>, <span class="hlFld-ContribAuthor ">Sobia Ahsan  Halim</span>, <span class="hlFld-ContribAuthor ">Abdul  Hameed</span>, <span class="hlFld-ContribAuthor ">Aqeel  Imran</span>, <span class="hlFld-ContribAuthor ">Jamshed  Iqbal</span>, <span class="hlFld-ContribAuthor ">Aziz  Ullah</span>, <span class="hlFld-ContribAuthor ">Asnuzilawati  Asari</span>, <span class="hlFld-ContribAuthor ">Samra  Khan</span>, <span class="hlFld-ContribAuthor ">Zahid  Shafiq</span>, <span class="hlFld-ContribAuthor ">Ahmed  Al-Harrasi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of indole-substituted thiosemicarbazones as an aldose reductase inhibitor: an 
              in vitro
              , selectivity and
              in silico
              study. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2021,</strong> <em>13 </em>
                                    (14)
                                     , 1185-1201. <a href="https://doi.org/10.4155/fmc-2020-0060" title="DOI URL">https://doi.org/10.4155/fmc-2020-0060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2020-0060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2020-0060%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bindole-substituted%252Bthiosemicarbazones%252Bas%252Ban%252Baldose%252Breductase%252Binhibitor%25253A%252Ban%2525C2%2525A0%252Bin%252Bvitro%252B%25252C%252Bselectivity%252Band%252Bin%252Bsilico%252Bstudy%26aulast%3DShehzad%26aufirst%3DMuhammad%2BTariq%26date%3D2021%26volume%3D13%26issue%3D14%26spage%3D1185%26epage%3D1201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sapna  Thakur</span>, <span class="hlFld-ContribAuthor ">Sonu Kumar  Gupta</span>, <span class="hlFld-ContribAuthor ">Villayat  Ali</span>, <span class="hlFld-ContribAuthor ">Priyanka  Singh</span>, <span class="hlFld-ContribAuthor ">Malkhey  Verma</span>. </span><span class="cited-content_cbyCitation_article-title">Aldose Reductase: a cause and a potential target for the treatment of diabetic complications. </span><span class="cited-content_cbyCitation_journal-name">Archives of Pharmacal Research</span><span> <strong>2021,</strong> <em>44 </em>
                                    (7)
                                     , 655-667. <a href="https://doi.org/10.1007/s12272-021-01343-5" title="DOI URL">https://doi.org/10.1007/s12272-021-01343-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12272-021-01343-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12272-021-01343-5%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Pharmacal%2520Research%26atitle%3DAldose%252BReductase%25253A%252Ba%252Bcause%252Band%252Ba%252Bpotential%252Btarget%252Bfor%252Bthe%252Btreatment%252Bof%252Bdiabetic%252Bcomplications%26aulast%3DThakur%26aufirst%3DSapna%26date%3D2021%26date%3D2021%26volume%3D44%26issue%3D7%26spage%3D655%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenchao  Liu</span>, <span class="hlFld-ContribAuthor ">Huan  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaonan  Zhang</span>, <span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Long  Xu</span>, <span class="hlFld-ContribAuthor ">Yanqi  Lei</span>, <span class="hlFld-ContribAuthor ">Changjin  Zhu</span>, <span class="hlFld-ContribAuthor ">Bing  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Isatin derivatives as a new class of aldose reductase inhibitors with antioxidant activity. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>27 </em><a href="https://doi.org/10.1007/s00044-021-02751-4" title="DOI URL">https://doi.org/10.1007/s00044-021-02751-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-021-02751-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-021-02751-4%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DIsatin%252Bderivatives%252Bas%252Ba%252Bnew%252Bclass%252Bof%252Baldose%252Breductase%252Binhibitors%252Bwith%252Bantioxidant%252Bactivity%26aulast%3DLiu%26aufirst%3DWenchao%26date%3D2021%26date%3D2021%26volume%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanqi  Lei</span>, <span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaonan  Zhang</span>, <span class="hlFld-ContribAuthor ">Long  Xu</span>, <span class="hlFld-ContribAuthor ">Wenchao  Liu</span>, <span class="hlFld-ContribAuthor ">Huan  Chen</span>, <span class="hlFld-ContribAuthor ">Changjin  Zhu</span>, <span class="hlFld-ContribAuthor ">Bing  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Benzothiazolone‐Based Carboxylic Acid Aldose Reductase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (20)
                                     , 4874-4880. <a href="https://doi.org/10.1002/slct.202101443" title="DOI URL">https://doi.org/10.1002/slct.202101443</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202101443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202101443%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DDesign%252Bof%252BBenzothiazolone%2525E2%252580%252590Based%252BCarboxylic%252BAcid%252BAldose%252BReductase%252BInhibitors%26aulast%3DLei%26aufirst%3DYanqi%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D20%26spage%3D4874%26epage%3D4880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucia  Kovacikova</span>, <span class="hlFld-ContribAuthor ">Marta Soltesova  Prnova</span>, <span class="hlFld-ContribAuthor ">Magdalena  Majekova</span>, <span class="hlFld-ContribAuthor ">Andrej  Bohac</span>, <span class="hlFld-ContribAuthor ">Cimen  Karasu</span>, <span class="hlFld-ContribAuthor ">Milan  Stefek</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (10)
                                     , 2867. <a href="https://doi.org/10.3390/molecules26102867" title="DOI URL">https://doi.org/10.3390/molecules26102867</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26102867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26102867%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDevelopment%252Bof%252BNovel%252BIndole-Based%252BBifunctional%252BAldose%252BReductase%252BInhibitors%25252FAntioxidants%252Bas%252BPromising%252BDrugs%252Bfor%252Bthe%252BTreatment%252Bof%252BDiabetic%252BComplications%26aulast%3DKovacikova%26aufirst%3DLucia%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D10%26spage%3D2867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guanglei  Zuo</span>, <span class="hlFld-ContribAuthor ">Hyun-Yong  Kim</span>, <span class="hlFld-ContribAuthor ">Yanymee N.  Guillen Quispe</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Kang-Hyuk  Kim</span>, <span class="hlFld-ContribAuthor ">Paul H.  Gonzales Arce</span>, <span class="hlFld-ContribAuthor ">Soon-Sung  Lim</span>. </span><span class="cited-content_cbyCitation_article-title">Valeriana rigida Ruiz & Pav. Root Extract: A New Source of Caffeoylquinic Acids with Antioxidant and Aldose Reductase Inhibitory Activities. </span><span class="cited-content_cbyCitation_journal-name">Foods</span><span> <strong>2021,</strong> <em>10 </em>
                                    (5)
                                     , 1079. <a href="https://doi.org/10.3390/foods10051079" title="DOI URL">https://doi.org/10.3390/foods10051079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/foods10051079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Ffoods10051079%26sid%3Dliteratum%253Aachs%26jtitle%3DFoods%26atitle%3DValeriana%252Brigida%252BRuiz%252B%252526%252BPav.%252BRoot%252BExtract%25253A%252BA%252BNew%252BSource%252Bof%252BCaffeoylquinic%252BAcids%252Bwith%252BAntioxidant%252Band%252BAldose%252BReductase%252BInhibitory%252BActivities%26aulast%3DZuo%26aufirst%3DGuanglei%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D5%26spage%3D1079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sravya  Jannapureddy</span>, <span class="hlFld-ContribAuthor ">Mira  Sharma</span>, <span class="hlFld-ContribAuthor ">Gautham  Yepuri</span>, <span class="hlFld-ContribAuthor ">Ann Marie  Schmidt</span>, <span class="hlFld-ContribAuthor ">Ravichandran  Ramasamy</span>. </span><span class="cited-content_cbyCitation_article-title">Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Endocrinology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fendo.2021.636267" title="DOI URL">https://doi.org/10.3389/fendo.2021.636267</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fendo.2021.636267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffendo.2021.636267%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Endocrinology%26atitle%3DAldose%252BReductase%25253A%252BAn%252BEmerging%252BTarget%252Bfor%252BDevelopment%252Bof%252BInterventions%252Bfor%252BDiabetic%252BCardiovascular%252BComplications%26aulast%3DJannapureddy%26aufirst%3DSravya%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Belgin  Sever</span>, <span class="hlFld-ContribAuthor ">Mehlika Dilek  Altıntop</span>, <span class="hlFld-ContribAuthor ">Yeliz  Demir</span>, <span class="hlFld-ContribAuthor ">Cüneyt  Türkeş</span>, <span class="hlFld-ContribAuthor ">Kaan  Özbaş</span>, <span class="hlFld-ContribAuthor ">Gülşen Akalın  Çiftçi</span>, <span class="hlFld-ContribAuthor ">Şükrü  Beydemir</span>, <span class="hlFld-ContribAuthor ">Ahmet  Özdemir</span>. </span><span class="cited-content_cbyCitation_article-title">A new series of 2,4-thiazolidinediones endowed with potent aldose reductase inhibitory activity. </span><span class="cited-content_cbyCitation_journal-name">Open Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (1)
                                     , 347-357. <a href="https://doi.org/10.1515/chem-2021-0032" title="DOI URL">https://doi.org/10.1515/chem-2021-0032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/chem-2021-0032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fchem-2021-0032%26sid%3Dliteratum%253Aachs%26jtitle%3DOpen%2520Chemistry%26atitle%3DA%252Bnew%252Bseries%252Bof%252B2%25252C4-thiazolidinediones%252Bendowed%252Bwith%252Bpotent%252Baldose%252Breductase%252Binhibitory%252Bactivity%26aulast%3DSever%26aufirst%3DBelgin%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D1%26spage%3D347%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gurprit  Sekhon</span>, <span class="hlFld-ContribAuthor ">Balvinder  Singh</span>, <span class="hlFld-ContribAuthor ">Ranvir  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Cys-298 in specific recognition of glutathione by aldose reductase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>50 </em>, 1-9. <a href="https://doi.org/10.1080/07391102.2021.1891138" title="DOI URL">https://doi.org/10.1080/07391102.2021.1891138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1891138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1891138%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DRole%252Bof%252BCys-298%252Bin%252Bspecific%252Brecognition%252Bof%252Bglutathione%252Bby%252Baldose%252Breductase%26aulast%3DSekhon%26aufirst%3DGurprit%26date%3D2021%26date%3D2021%26volume%3D50%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elix Alberto  Domínguez-Mendoza</span>, <span class="hlFld-ContribAuthor ">Yelzyn  Galván-Ciprés</span>, <span class="hlFld-ContribAuthor ">Josué  Martínez-Miranda</span>, <span class="hlFld-ContribAuthor ">Cristian  Miranda-González</span>, <span class="hlFld-ContribAuthor ">Blanca  Colín-Lozano</span>, <span class="hlFld-ContribAuthor ">Emanuel  Hernández-Núñez</span>, <span class="hlFld-ContribAuthor ">Gloria I.  Hernández-Bolio</span>, <span class="hlFld-ContribAuthor ">Oscar  Palomino-Hernández</span>, <span class="hlFld-ContribAuthor ">Gabriel  Navarrete-Vazquez</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and In Silico Multitarget Pharmacological Simulations of Acid Bioisosteres with a Validated In Vivo Antihyperglycemic Effect. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (4)
                                     , 799. <a href="https://doi.org/10.3390/molecules26040799" title="DOI URL">https://doi.org/10.3390/molecules26040799</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26040799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26040799%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BIn%252BSilico%252BMultitarget%252BPharmacological%252BSimulations%252Bof%252BAcid%252BBioisosteres%252Bwith%252Ba%252BValidated%252BIn%252BVivo%252BAntihyperglycemic%252BEffect%26aulast%3DDom%25C3%25ADnguez-Mendoza%26aufirst%3DElix%2BAlberto%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D4%26spage%3D799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bahare  Salehi</span>, <span class="hlFld-ContribAuthor ">Cristina  Quispe</span>, <span class="hlFld-ContribAuthor ">Imane  Chamkhi</span>, <span class="hlFld-ContribAuthor ">Nasreddine  El Omari</span>, <span class="hlFld-ContribAuthor ">Abdelaali  Balahbib</span>, <span class="hlFld-ContribAuthor ">Javad  Sharifi-Rad</span>, <span class="hlFld-ContribAuthor ">Abdelhakim  Bouyahya</span>, <span class="hlFld-ContribAuthor ">Muhammad  Akram</span>, <span class="hlFld-ContribAuthor ">Mehwish  Iqbal</span>, <span class="hlFld-ContribAuthor ">Anca Oana  Docea</span>, <span class="hlFld-ContribAuthor ">Constantin  Caruntu</span>, <span class="hlFld-ContribAuthor ">Gerardo  Leyva-Gómez</span>, <span class="hlFld-ContribAuthor ">Abhijit  Dey</span>, <span class="hlFld-ContribAuthor ">Miquel  Martorell</span>, <span class="hlFld-ContribAuthor ">Daniela  Calina</span>, <span class="hlFld-ContribAuthor ">Víctor  López</span>, <span class="hlFld-ContribAuthor ">Francisco  Les</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.592654" title="DOI URL">https://doi.org/10.3389/fphar.2020.592654</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.592654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.592654%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DPharmacological%252BProperties%252Bof%252BChalcones%25253A%252BA%252BReview%252Bof%252BPreclinical%252BIncluding%252BMolecular%252BMechanisms%252Band%252BClinical%252BEvidence%26aulast%3DSalehi%26aufirst%3DBahare%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matúš  Hlaváč</span>, <span class="hlFld-ContribAuthor ">Lucia  Kováčiková</span>, <span class="hlFld-ContribAuthor ">Marta  Šoltésová Prnová</span>, <span class="hlFld-ContribAuthor ">Gabriela  Addová</span>, <span class="hlFld-ContribAuthor ">Gilles  Hanquet</span>, <span class="hlFld-ContribAuthor ">Milan  Štefek</span>, <span class="hlFld-ContribAuthor ">Andrej  Boháč</span>. </span><span class="cited-content_cbyCitation_article-title">Novel substituted N-benzyl(oxotriazinoindole) inhibitors of aldose reductase exploiting ALR2 unoccupied interactive pocket. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>29 </em>, 115885. <a href="https://doi.org/10.1016/j.bmc.2020.115885" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115885</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115885%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bsubstituted%252BN-benzyl%252528oxotriazinoindole%252529%252Binhibitors%252Bof%252Baldose%252Breductase%252Bexploiting%252BALR2%252Bunoccupied%252Binteractive%252Bpocket%26aulast%3DHlav%25C3%25A1%25C4%258D%26aufirst%3DMat%25C3%25BA%25C5%25A1%26date%3D2021%26volume%3D29%26spage%3D115885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kármen  Szabó</span>, <span class="hlFld-ContribAuthor ">Rosanna  Maccari</span>, <span class="hlFld-ContribAuthor ">Rosaria  Ottanà</span>, <span class="hlFld-ContribAuthor ">Gyöngyi  Gyémánt</span>. </span><span class="cited-content_cbyCitation_article-title">Extending the investigation of 4-thiazolidinone derivatives as potential multi-target ligands of enzymes involved in diabetes mellitus and its long-term complications: A study with pancreatic α-amylase. </span><span class="cited-content_cbyCitation_journal-name">Carbohydrate Research</span><span> <strong>2021,</strong> <em>499 </em>, 108220. <a href="https://doi.org/10.1016/j.carres.2020.108220" title="DOI URL">https://doi.org/10.1016/j.carres.2020.108220</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.carres.2020.108220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.carres.2020.108220%26sid%3Dliteratum%253Aachs%26jtitle%3DCarbohydrate%2520Research%26atitle%3DExtending%252Bthe%252Binvestigation%252Bof%252B4-thiazolidinone%252Bderivatives%252Bas%252Bpotential%252Bmulti-target%252Bligands%252Bof%252Benzymes%252Binvolved%252Bin%252Bdiabetes%252Bmellitus%252Band%252Bits%252Blong-term%252Bcomplications%25253A%252BA%252Bstudy%252Bwith%252Bpancreatic%252B%2525CE%2525B1-amylase%26aulast%3DSzab%25C3%25B3%26aufirst%3DK%25C3%25A1rmen%26date%3D2021%26volume%3D499%26spage%3D108220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Belgin  Sever</span>, <span class="hlFld-ContribAuthor ">Mehlika Dilek  Altıntop</span>, <span class="hlFld-ContribAuthor ">Yeliz  Demir</span>, <span class="hlFld-ContribAuthor ">Muhammed  Pekdoğan</span>, <span class="hlFld-ContribAuthor ">Gülşen  Akalın Çiftçi</span>, <span class="hlFld-ContribAuthor ">Şükrü  Beydemir</span>, <span class="hlFld-ContribAuthor ">Ahmet  Özdemir</span>. </span><span class="cited-content_cbyCitation_article-title">An extensive research on aldose reductase inhibitory effects of new 4H-1,2,4-triazole derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1224 </em>, 129446. <a href="https://doi.org/10.1016/j.molstruc.2020.129446" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.129446</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.129446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.129446%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DAn%252Bextensive%252Bresearch%252Bon%252Baldose%252Breductase%252Binhibitory%252Beffects%252Bof%252Bnew%252B4H-1%25252C2%25252C4-triazole%252Bderivatives%26aulast%3DSever%26aufirst%3DBelgin%26date%3D2021%26volume%3D1224%26spage%3D129446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guang-Lei  Zuo</span>, <span class="hlFld-ContribAuthor ">Hyun Yong  Kim</span>, <span class="hlFld-ContribAuthor ">Yanymee N.  Guillen Quispe</span>, <span class="hlFld-ContribAuthor ">Zhi-Qiang  Wang</span>, <span class="hlFld-ContribAuthor ">Seung Hwan  Hwang</span>, <span class="hlFld-ContribAuthor ">Kyong-Oh  Shin</span>, <span class="hlFld-ContribAuthor ">Soon Sung  Lim</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Separation of Phytochemicals from Muehlenbeckia volcanica (Benth.) Endl. by Polarity-Stepwise Elution Counter-Current Chromatography and Their Antioxidant, Antiglycation, and Aldose Reductase Inhibition Potentials. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (1)
                                     , 224. <a href="https://doi.org/10.3390/molecules26010224" title="DOI URL">https://doi.org/10.3390/molecules26010224</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26010224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26010224%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DEfficient%252BSeparation%252Bof%252BPhytochemicals%252Bfrom%252BMuehlenbeckia%252Bvolcanica%252B%252528Benth.%252529%252BEndl.%252Bby%252BPolarity-Stepwise%252BElution%252BCounter-Current%252BChromatography%252Band%252BTheir%252BAntioxidant%25252C%252BAntiglycation%25252C%252Band%252BAldose%252BReductase%252BInhibition%252BPotentials%26aulast%3DZuo%26aufirst%3DGuang-Lei%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D1%26spage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosaria  Ottanà</span>, <span class="hlFld-ContribAuthor ">Paolo  Paoli</span>, <span class="hlFld-ContribAuthor ">Mario  Cappiello</span>, <span class="hlFld-ContribAuthor ">Trung Ngoc  Nguyen</span>, <span class="hlFld-ContribAuthor ">Ilenia  Adornato</span>, <span class="hlFld-ContribAuthor ">Antonella  Del Corso</span>, <span class="hlFld-ContribAuthor ">Massimo  Genovese</span>, <span class="hlFld-ContribAuthor ">Ilaria  Nesi</span>, <span class="hlFld-ContribAuthor ">Roberta  Moschini</span>, <span class="hlFld-ContribAuthor ">Alexandra  Naß</span>, <span class="hlFld-ContribAuthor ">Gerhard  Wolber</span>, <span class="hlFld-ContribAuthor ">Rosanna  Maccari</span>. </span><span class="cited-content_cbyCitation_article-title">In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications—A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (2)
                                     , 330. <a href="https://doi.org/10.3390/molecules26020330" title="DOI URL">https://doi.org/10.3390/molecules26020330</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26020330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26020330%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DIn%252BSearch%252Bfor%252BMulti-Target%252BLigands%252Bas%252BPotential%252BAgents%252Bfor%252BDiabetes%252BMellitus%252Band%252BIts%252BComplications%2525E2%252580%252594A%252BStructure-Activity%252BRelationship%252BStudy%252Bon%252BInhibitors%252Bof%252BAldose%252BReductase%252Band%252BProtein%252BTyrosine%252BPhosphatase%252B1B%26aulast%3DOttan%25C3%25A0%26aufirst%3DRosaria%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D2%26spage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhongfei  Han</span>, <span class="hlFld-ContribAuthor ">Gang  Qi</span>, <span class="hlFld-ContribAuthor ">Junkai  Zhu</span>, <span class="hlFld-ContribAuthor ">Yundong  Zhang</span>, <span class="hlFld-ContribAuthor ">Yin  Xu</span>, <span class="hlFld-ContribAuthor ">Kang  Yan</span>, <span class="hlFld-ContribAuthor ">Changjin  Zhu</span>, <span class="hlFld-ContribAuthor ">Xin  Hao</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 3,4-dihydroquinolin-2(1H)-one derivatives as dual inhibitor targeting AKR1B1/ROS for treatment of diabetic complications: Design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>105 </em>, 104428. <a href="https://doi.org/10.1016/j.bioorg.2020.104428" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104428</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104428%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNovel%252B3%25252C4-dihydroquinolin-2%2525281H%252529-one%252Bderivatives%252Bas%252Bdual%252Binhibitor%252Btargeting%252BAKR1B1%25252FROS%252Bfor%252Btreatment%252Bof%252Bdiabetic%252Bcomplications%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DHan%26aufirst%3DZhongfei%26date%3D2020%26volume%3D105%26spage%3D104428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Wei‐Yang  Chen</span>, <span class="hlFld-ContribAuthor ">Jingwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Leila  Gobejishvili</span>, <span class="hlFld-ContribAuthor ">Shirish S.  Barve</span>, <span class="hlFld-ContribAuthor ">Craig J.  McClain</span>, <span class="hlFld-ContribAuthor ">Swati  Joshi‐Barve</span>. </span><span class="cited-content_cbyCitation_article-title">Elevated Fructose and Uric Acid Through Aldose Reductase Contribute to Experimental and Human Alcoholic Liver Disease. </span><span class="cited-content_cbyCitation_journal-name">Hepatology</span><span> <strong>2020,</strong> <em>72 </em>
                                    (5)
                                     , 1617-1637. <a href="https://doi.org/10.1002/hep.31197" title="DOI URL">https://doi.org/10.1002/hep.31197</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hep.31197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhep.31197%26sid%3Dliteratum%253Aachs%26jtitle%3DHepatology%26atitle%3DElevated%252BFructose%252Band%252BUric%252BAcid%252BThrough%252BAldose%252BReductase%252BContribute%252Bto%252BExperimental%252Band%252BHuman%252BAlcoholic%252BLiver%252BDisease%26aulast%3DWang%26aufirst%3DMin%26date%3D2020%26date%3D2020%26volume%3D72%26issue%3D5%26spage%3D1617%26epage%3D1637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna Maria  Iannuzzi</span>, <span class="hlFld-ContribAuthor ">Roberta  Moschini</span>, <span class="hlFld-ContribAuthor ">Marinella  De Leo</span>, <span class="hlFld-ContribAuthor ">Carlotta  Pineschi</span>, <span class="hlFld-ContribAuthor ">Francesco  Balestri</span>, <span class="hlFld-ContribAuthor ">Mario  Cappiello</span>, <span class="hlFld-ContribAuthor ">Alessandra  Braca</span>, <span class="hlFld-ContribAuthor ">Antonella  Del-Corso</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical profile and nutraceutical features of Salsola soda (agretti): Anti-inflammatory and antidiabetic potential of its flavonoids. </span><span class="cited-content_cbyCitation_journal-name">Food Bioscience</span><span> <strong>2020,</strong> <em>37 </em>, 100713. <a href="https://doi.org/10.1016/j.fbio.2020.100713" title="DOI URL">https://doi.org/10.1016/j.fbio.2020.100713</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.fbio.2020.100713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.fbio.2020.100713%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520Bioscience%26atitle%3DChemical%252Bprofile%252Band%252Bnutraceutical%252Bfeatures%252Bof%252BSalsola%252Bsoda%252B%252528agretti%252529%25253A%252BAnti-inflammatory%252Band%252Bantidiabetic%252Bpotential%252Bof%252Bits%252Bflavonoids%26aulast%3DIannuzzi%26aufirst%3DAnna%2BMaria%26date%3D2020%26volume%3D37%26spage%3D100713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Belgin  Sever</span>, <span class="hlFld-ContribAuthor ">Mehlika Dilek  Altıntop</span>, <span class="hlFld-ContribAuthor ">Yeliz  Demir</span>, <span class="hlFld-ContribAuthor ">Gülşen  Akalın Çiftçi</span>, <span class="hlFld-ContribAuthor ">Şükrü  Beydemir</span>, <span class="hlFld-ContribAuthor ">Ahmet  Özdemir</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>102 </em>, 104110. <a href="https://doi.org/10.1016/j.bioorg.2020.104110" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104110%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bin%252Bvitro%252Band%252Bin%252Bsilico%252Binvestigation%252Bof%252Baldose%252Breductase%252Binhibitory%252Beffects%252Bof%252Bnew%252Bthiazole-based%252Bcompounds%26aulast%3DSever%26aufirst%3DBelgin%26date%3D2020%26volume%3D102%26spage%3D104110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andras  Franko</span>, <span class="hlFld-ContribAuthor ">Lucia  Berti</span>, <span class="hlFld-ContribAuthor ">Jörg  Hennenlotter</span>, <span class="hlFld-ContribAuthor ">Steffen  Rausch</span>, <span class="hlFld-ContribAuthor ">Marcus O.  Scharpf</span>, <span class="hlFld-ContribAuthor ">Martin Hrabĕ  de Angelis</span>, <span class="hlFld-ContribAuthor ">Arnulf  Stenzl</span>, <span class="hlFld-ContribAuthor ">Andreas L.  Birkenfeld</span>, <span class="hlFld-ContribAuthor ">Andreas  Peter</span>, <span class="hlFld-ContribAuthor ">Stefan Z.  Lutz</span>, <span class="hlFld-ContribAuthor ">Hans-Ulrich  Häring</span>, <span class="hlFld-ContribAuthor ">Martin  Heni</span>. </span><span class="cited-content_cbyCitation_article-title">Transcript Levels of Aldo-Keto Reductase Family 1 Subfamily C (AKR1C) Are Increased in Prostate Tissue of Patients with Type 2 Diabetes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Personalized Medicine</span><span> <strong>2020,</strong> <em>10 </em>
                                    (3)
                                     , 124. <a href="https://doi.org/10.3390/jpm10030124" title="DOI URL">https://doi.org/10.3390/jpm10030124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/jpm10030124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fjpm10030124%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Personalized%2520Medicine%26atitle%3DTranscript%252BLevels%252Bof%252BAldo-Keto%252BReductase%252BFamily%252B1%252BSubfamily%252BC%252B%252528AKR1C%252529%252BAre%252BIncreased%252Bin%252BProstate%252BTissue%252Bof%252BPatients%252Bwith%252BType%252B2%252BDiabetes%26aulast%3DFranko%26aufirst%3DAndras%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D3%26spage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noman  Javid</span>, <span class="hlFld-ContribAuthor ">Rubina  Munir</span>, <span class="hlFld-ContribAuthor ">Faryal  Chaudhry</span>, <span class="hlFld-ContribAuthor ">Aqeel  Imran</span>, <span class="hlFld-ContribAuthor ">Sumera  Zaib</span>, <span class="hlFld-ContribAuthor ">Ayesha  Muzaffar</span>, <span class="hlFld-ContribAuthor ">Jamshed  Iqbal</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting oxadiazole-sulfonamide hybrids as new structural leads to combat diabetic complications via aldose reductase inhibition. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>99 </em>, 103852. <a href="https://doi.org/10.1016/j.bioorg.2020.103852" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103852</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103852%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DExploiting%252Boxadiazole-sulfonamide%252Bhybrids%252Bas%252Bnew%252Bstructural%252Bleads%252Bto%252Bcombat%252Bdiabetic%252Bcomplications%252Bvia%252Baldose%252Breductase%252Binhibition%26aulast%3DJavid%26aufirst%3DNoman%26date%3D2020%26volume%3D99%26spage%3D103852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Norman G.  Quilantang</span>, <span class="hlFld-ContribAuthor ">Carlo A.  Limbo</span>, <span class="hlFld-ContribAuthor ">Ju Sung  Lee</span>, <span class="hlFld-ContribAuthor ">Sonia D.  Jacinto</span>, <span class="hlFld-ContribAuthor ">Sung-Kwon  Moon</span>, <span class="hlFld-ContribAuthor ">Sanghyun  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Aldose reductase inhibition of Rosa hybrida petals and its active component, kaempferol. </span><span class="cited-content_cbyCitation_journal-name">Horticulture, Environment, and Biotechnology</span><span> <strong>2020,</strong> <em>61 </em>
                                    (3)
                                     , 601-607. <a href="https://doi.org/10.1007/s13580-020-00232-y" title="DOI URL">https://doi.org/10.1007/s13580-020-00232-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13580-020-00232-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13580-020-00232-y%26sid%3Dliteratum%253Aachs%26jtitle%3DHorticulture%252C%2520Environment%252C%2520and%2520Biotechnology%26atitle%3DAldose%252Breductase%252Binhibition%252Bof%252BRosa%252Bhybrida%252Bpetals%252Band%252Bits%252Bactive%252Bcomponent%25252C%252Bkaempferol%26aulast%3DQuilantang%26aufirst%3DNorman%2BG.%26date%3D2020%26date%3D2020%26volume%3D61%26issue%3D3%26spage%3D601%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta Soltesova  Prnova</span>, <span class="hlFld-ContribAuthor ">Lucia  Kovacikova</span>, <span class="hlFld-ContribAuthor ">Karol  Svik</span>, <span class="hlFld-ContribAuthor ">Stefan  Bezek</span>, <span class="hlFld-ContribAuthor ">Zübeyir  Elmazoğlu</span>, <span class="hlFld-ContribAuthor ">Cimen  Karasu</span>, <span class="hlFld-ContribAuthor ">Milan  Stefek</span>. </span><span class="cited-content_cbyCitation_article-title">Triglyceride-lowering effect of the aldose reductase inhibitor cemtirestat—another factor that may contribute to attenuation of symptoms of peripheral neuropathy in STZ-diabetic rats. </span><span class="cited-content_cbyCitation_journal-name">Naunyn-Schmiedeberg's Archives of Pharmacology</span><span> <strong>2020,</strong> <em>393 </em>
                                    (4)
                                     , 651-661. <a href="https://doi.org/10.1007/s00210-019-01769-1" title="DOI URL">https://doi.org/10.1007/s00210-019-01769-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00210-019-01769-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00210-019-01769-1%26sid%3Dliteratum%253Aachs%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Archives%2520of%2520Pharmacology%26atitle%3DTriglyceride-lowering%252Beffect%252Bof%252Bthe%252Baldose%252Breductase%252Binhibitor%252Bcemtirestat%2525E2%252580%252594another%252Bfactor%252Bthat%252Bmay%252Bcontribute%252Bto%252Battenuation%252Bof%252Bsymptoms%252Bof%252Bperipheral%252Bneuropathy%252Bin%252BSTZ-diabetic%252Brats%26aulast%3DPrnova%26aufirst%3DMarta%2BSoltesova%26date%3D2020%26date%3D2019%26volume%3D393%26issue%3D4%26spage%3D651%26epage%3D661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul W.  Finn</span>. </span><span class="cited-content_cbyCitation_article-title">Cheminformatics in the Identification of Drug Classes for the Treatment of Type 2 Diabetes. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 71-84. <a href="https://doi.org/10.1007/978-1-4939-9882-1_4" title="DOI URL">https://doi.org/10.1007/978-1-4939-9882-1_4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-9882-1_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-9882-1_4%26sid%3Dliteratum%253Aachs%26atitle%3DCheminformatics%252Bin%252Bthe%252BIdentification%252Bof%252BDrug%252BClasses%252Bfor%252Bthe%252BTreatment%252Bof%252BType%252B2%252BDiabetes%26aulast%3DFinn%26aufirst%3DPaul%2BW.%26date%3D2020%26date%3D2019%26spage%3D71%26epage%3D84%26pub%3DSpringer%2520New%2520York%26atitle%3DType%252B2%252BDiabetes%26aulast%3DStocker%26aufirst%3DClaire%2BJ.%26date%3D2020%26volume%3D2076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sant Kumar  Verma</span>, <span class="hlFld-ContribAuthor ">Suresh  Thareja</span>. </span><span class="cited-content_cbyCitation_article-title">An overview on chemistry of natural aldose reductase inhibitors for the management of diabetic complications. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 381-429. <a href="https://doi.org/10.1016/B978-0-12-817905-5.00011-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-817905-5.00011-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-817905-5.00011-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-817905-5.00011-1%26sid%3Dliteratum%253Aachs%26atitle%3DAn%252Boverview%252Bon%252Bchemistry%252Bof%252Bnatural%252Baldose%252Breductase%252Binhibitors%252Bfor%252Bthe%252Bmanagement%252Bof%252Bdiabetic%252Bcomplications%26aulast%3DVerma%26aufirst%3DSant%2BKumar%26date%3D2020%26spage%3D381%26epage%3D429%26pub%3DElsevier%26atitle%3DBioactive%252BNatural%252BProducts%26date%3D2020%26volume%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lara  Azul</span>, <span class="hlFld-ContribAuthor ">Adriana  Leandro</span>, <span class="hlFld-ContribAuthor ">Parastoo  Boroumand</span>, <span class="hlFld-ContribAuthor ">Amira  Klip</span>, <span class="hlFld-ContribAuthor ">Raquel  Seiça</span>, <span class="hlFld-ContribAuthor ">Cristina M.  Sena</span>. </span><span class="cited-content_cbyCitation_article-title">Increased inflammation, oxidative stress and a reduction in antioxidant defense enzymes in perivascular adipose tissue contribute to vascular dysfunction in type 2 diabetes. </span><span class="cited-content_cbyCitation_journal-name">Free Radical Biology and Medicine</span><span> <strong>2020,</strong> <em>146 </em>, 264-274. <a href="https://doi.org/10.1016/j.freeradbiomed.2019.11.002" title="DOI URL">https://doi.org/10.1016/j.freeradbiomed.2019.11.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.freeradbiomed.2019.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.freeradbiomed.2019.11.002%26sid%3Dliteratum%253Aachs%26jtitle%3DFree%2520Radical%2520Biology%2520and%2520Medicine%26atitle%3DIncreased%252Binflammation%25252C%252Boxidative%252Bstress%252Band%252Ba%252Breduction%252Bin%252Bantioxidant%252Bdefense%252Benzymes%252Bin%252Bperivascular%252Badipose%252Btissue%252Bcontribute%252Bto%252Bvascular%252Bdysfunction%252Bin%252Btype%252B2%252Bdiabetes%26aulast%3DAzul%26aufirst%3DLara%26date%3D2020%26volume%3D146%26spage%3D264%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoxia  Gao</span>, <span class="hlFld-ContribAuthor ">Nan  Wang</span>, <span class="hlFld-ContribAuthor ">Jinping  Jia</span>, <span class="hlFld-ContribAuthor ">Peiyi  Wang</span>, <span class="hlFld-ContribAuthor ">Airong  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuemei  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical profliling of Dingkun Dan by ultra High performance liquid chromatography Q exactive orbitrap high resolution mass spectrometry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical and Biomedical Analysis</span><span> <strong>2020,</strong> <em>177 </em>, 112732. <a href="https://doi.org/10.1016/j.jpba.2019.06.029" title="DOI URL">https://doi.org/10.1016/j.jpba.2019.06.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpba.2019.06.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpba.2019.06.029%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520and%2520Biomedical%2520Analysis%26atitle%3DChemical%252Bprofliling%252Bof%252BDingkun%252BDan%252Bby%252Bultra%252BHigh%252Bperformance%252Bliquid%252Bchromatography%252BQ%252Bexactive%252Borbitrap%252Bhigh%252Bresolution%252Bmass%252Bspectrometry%26aulast%3DGao%26aufirst%3DXiaoxia%26date%3D2020%26volume%3D177%26spage%3D112732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ria Purnawian  SULISTIANI</span>, <span class="hlFld-ContribAuthor ">Diana Nur  AFIFAH</span>, <span class="hlFld-ContribAuthor ">Tjokorda Gde Dalem  PEMAYUN</span>, <span class="hlFld-ContribAuthor ">Nyoman Suci  WIDYASTITI</span>, <span class="hlFld-ContribAuthor ">Gemala  ANJANI</span>, <span class="hlFld-ContribAuthor ">Dewi Marfu’ah  KURNIAWATI</span>. </span><span class="cited-content_cbyCitation_article-title">The Effects of Colocasia esculenta Leaf Extract in Inhibition of Erythrocyte Aldose Reductase Activity and Increase of Haemoglobin in Experimental Rats. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nutritional Science and Vitaminology</span><span> <strong>2020,</strong> <em>66 </em>
                                    (Supplement)
                                     , S320-S323. <a href="https://doi.org/10.3177/jnsv.66.S320" title="DOI URL">https://doi.org/10.3177/jnsv.66.S320</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3177/jnsv.66.S320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3177%2Fjnsv.66.S320%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nutritional%2520Science%2520and%2520Vitaminology%26atitle%3DThe%252BEffects%252Bof%252BColocasia%252Besculenta%252BLeaf%252BExtract%252Bin%252BInhibition%252Bof%252BErythrocyte%252BAldose%252BReductase%252BActivity%252Band%252BIncrease%252Bof%252BHaemoglobin%252Bin%252BExperimental%252BRats%26aulast%3DSULISTIANI%26aufirst%3DRia%2BPurnawian%26date%3D2020%26volume%3D66%26issue%3DSupplement%26spage%3DS320%26epage%3DS323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Albert  Castellví</span>, <span class="hlFld-ContribAuthor ">Isidro  Crespo</span>, <span class="hlFld-ContribAuthor ">Eva  Crosas</span>, <span class="hlFld-ContribAuthor ">Ana  Cámara-Artigas</span>, <span class="hlFld-ContribAuthor ">José A.  Gavira</span>, <span class="hlFld-ContribAuthor ">Miguel A. G.  Aranda</span>, <span class="hlFld-ContribAuthor ">Xavier  Parés</span>, <span class="hlFld-ContribAuthor ">Jaume  Farrés</span>, <span class="hlFld-ContribAuthor ">Judith  Juanhuix</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy of aldose reductase inhibitors is affected by oxidative stress induced under X-ray irradiation. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-39722-0" title="DOI URL">https://doi.org/10.1038/s41598-019-39722-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-39722-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-39722-0%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DEfficacy%252Bof%252Baldose%252Breductase%252Binhibitors%252Bis%252Baffected%252Bby%252Boxidative%252Bstress%252Binduced%252Bunder%252BX-ray%252Birradiation%26aulast%3DCastellv%25C3%25AD%26aufirst%3DAlbert%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Hao</span>, <span class="hlFld-ContribAuthor ">Xiangyu  Qin</span>, <span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Bing  Ma</span>, <span class="hlFld-ContribAuthor ">Gang  Qi</span>, <span class="hlFld-ContribAuthor ">Taiming  Yu</span>, <span class="hlFld-ContribAuthor ">Zhongfei  Han</span>, <span class="hlFld-ContribAuthor ">Changjin  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of quinoxalin-2(1
              H
              )-one derivatives as a novel class of multifunctional aldose reductase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (23)
                                     , 2989-3004. <a href="https://doi.org/10.4155/fmc-2019-0194" title="DOI URL">https://doi.org/10.4155/fmc-2019-0194</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2019-0194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2019-0194%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Bquinoxalin-2%2525281%252BH%252B%252529-one%252Bderivatives%252Bas%252Ba%252Bnovel%252Bclass%252Bof%252Bmultifunctional%252Baldose%252Breductase%252Binhibitors%26aulast%3DHao%26aufirst%3DXin%26date%3D2019%26volume%3D11%26issue%3D23%26spage%3D2989%26epage%3D3004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad Tariq  Shehzad</span>, <span class="hlFld-ContribAuthor ">Abdul  Hameed</span>, <span class="hlFld-ContribAuthor ">Mariya  al-Rashida</span>, <span class="hlFld-ContribAuthor ">Aqeel  Imran</span>, <span class="hlFld-ContribAuthor ">Maliha  Uroos</span>, <span class="hlFld-ContribAuthor ">Asnuzilawati  Asari</span>, <span class="hlFld-ContribAuthor ">Habsah  Mohamad</span>, <span class="hlFld-ContribAuthor ">Muhammad  Islam</span>, <span class="hlFld-ContribAuthor ">Shafia  Iftikhar</span>, <span class="hlFld-ContribAuthor ">Zahid  Shafiq</span>, <span class="hlFld-ContribAuthor ">Jamshed  Iqbal</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring antidiabetic potential of adamantyl-thiosemicarbazones via aldose reductase (ALR2) inhibition. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>92 </em>, 103244. <a href="https://doi.org/10.1016/j.bioorg.2019.103244" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103244</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103244%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DExploring%252Bantidiabetic%252Bpotential%252Bof%252Badamantyl-thiosemicarbazones%252Bvia%252Baldose%252Breductase%252B%252528ALR2%252529%252Binhibition%26aulast%3DShehzad%26aufirst%3DMuhammad%2BTariq%26date%3D2019%26volume%3D92%26spage%3D103244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cang  Cheng</span>, <span class="hlFld-ContribAuthor ">Bin  Wan</span>, <span class="hlFld-ContribAuthor ">Bo  Zhou</span>, <span class="hlFld-ContribAuthor ">Yichao  Gu</span>, <span class="hlFld-ContribAuthor ">Yanghui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective synthesis of quaternary 3,4-dihydroisoquinolinones
              via
              Heck carbonylation reactions: development and application to the synthesis of Minalrestat analogues. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2019,</strong> <em>10 </em>
                                    (42)
                                     , 9853-9858. <a href="https://doi.org/10.1039/C9SC03406D" title="DOI URL">https://doi.org/10.1039/C9SC03406D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9SC03406D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9SC03406D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DEnantioselective%252Bsynthesis%252Bof%252Bquaternary%252B3%25252C4-dihydroisoquinolinones%252Bvia%252BHeck%252Bcarbonylation%252Breactions%25253A%252Bdevelopment%252Band%252Bapplication%252Bto%252Bthe%252Bsynthesis%252Bof%252BMinalrestat%252Banalogues%26aulast%3DCheng%26aufirst%3DCang%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D42%26spage%3D9853%26epage%3D9858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhaoxi  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Wang</span>, <span class="hlFld-ContribAuthor ">Qianqian  Zhao</span>, <span class="hlFld-ContribAuthor ">Tong  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding Aldose Reductase-Inhibitors interactions with free energy simulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2019,</strong> <em>91 </em>, 10-21. <a href="https://doi.org/10.1016/j.jmgm.2019.05.011" title="DOI URL">https://doi.org/10.1016/j.jmgm.2019.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2019.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2019.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DUnderstanding%252BAldose%252BReductase-Inhibitors%252Binteractions%252Bwith%252Bfree%252Benergy%252Bsimulation%26aulast%3DSun%26aufirst%3DZhaoxi%26date%3D2019%26volume%3D91%26spage%3D10%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenichi  Goto</span>, <span class="hlFld-ContribAuthor ">Takanari  Kitazono</span>. </span><span class="cited-content_cbyCitation_article-title">Endothelium-Dependent Hyperpolarization (EDH) in Diabetes: Mechanistic Insights and Therapeutic Implications. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (15)
                                     , 3737. <a href="https://doi.org/10.3390/ijms20153737" title="DOI URL">https://doi.org/10.3390/ijms20153737</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20153737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20153737%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DEndothelium-Dependent%252BHyperpolarization%252B%252528EDH%252529%252Bin%252BDiabetes%25253A%252BMechanistic%252BInsights%252Band%252BTherapeutic%252BImplications%26aulast%3DGoto%26aufirst%3DKenichi%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D15%26spage%3D3737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Shigang  Shen</span>, <span class="hlFld-ContribAuthor ">Ze  Cui</span>, <span class="hlFld-ContribAuthor ">Hailiang  Nie</span>, <span class="hlFld-ContribAuthor ">Dandan  Han</span>, <span class="hlFld-ContribAuthor ">Hongyuan  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Screening and Isolating Major Aldose Reductase Inhibitors from the Seeds of Evening Primrose (Oenothera biennis). </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (15)
                                     , 2709. <a href="https://doi.org/10.3390/molecules24152709" title="DOI URL">https://doi.org/10.3390/molecules24152709</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24152709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24152709%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DScreening%252Band%252BIsolating%252BMajor%252BAldose%252BReductase%252BInhibitors%252Bfrom%252Bthe%252BSeeds%252Bof%252BEvening%252BPrimrose%252B%252528Oenothera%252Bbiennis%252529%26aulast%3DWang%26aufirst%3DZhiqiang%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D15%26spage%3D2709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Venkatesh Teja  Banala</span>, <span class="hlFld-ContribAuthor ">Sandeep  Urandur</span>, <span class="hlFld-ContribAuthor ">Shweta  Sharma</span>, <span class="hlFld-ContribAuthor ">Madhu  Sharma</span>, <span class="hlFld-ContribAuthor ">Ravi P.  Shukla</span>, <span class="hlFld-ContribAuthor ">Disha  Marwaha</span>, <span class="hlFld-ContribAuthor ">Shalini  Gautam</span>, <span class="hlFld-ContribAuthor ">Monika  Dwivedi</span>, <span class="hlFld-ContribAuthor ">Prabhat Ranjan  Mishra</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin
              via
              a redox-sensitive prodrug approach promotes synergistic tumor suppression. </span><span class="cited-content_cbyCitation_journal-name">Biomaterials Science</span><span> <strong>2019,</strong> <em>7 </em>
                                    (7)
                                     , 2889-2906. <a href="https://doi.org/10.1039/C9BM00221A" title="DOI URL">https://doi.org/10.1039/C9BM00221A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9BM00221A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9BM00221A%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomaterials%2520Science%26atitle%3DTargeted%252Bco-delivery%252Bof%252Bthe%252Baldose%252Breductase%252Binhibitor%252Bepalrestat%252Band%252Bchemotherapeutic%252Bdoxorubicin%252Bvia%252Ba%252Bredox-sensitive%252Bprodrug%252Bapproach%252Bpromotes%252Bsynergistic%252Btumor%252Bsuppression%26aulast%3DBanala%26aufirst%3DVenkatesh%2BTeja%26date%3D2019%26date%3D2019%26volume%3D7%26issue%3D7%26spage%3D2889%26epage%3D2906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryota  Saito</span>, <span class="hlFld-ContribAuthor ">Kana  Ishibashi</span>, <span class="hlFld-ContribAuthor ">Maiko  Noumi</span>, <span class="hlFld-ContribAuthor ">Sota  Uno</span>, <span class="hlFld-ContribAuthor ">Shoko  Higashi</span>, <span class="hlFld-ContribAuthor ">Masaru  Goto</span>, <span class="hlFld-ContribAuthor ">Shunsuke  Kuwahara</span>, <span class="hlFld-ContribAuthor ">Toshiya  Komatsu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Aldose Reductase Inhibitory Activity of Botryllazine A Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemical and Pharmaceutical Bulletin</span><span> <strong>2019,</strong> <em>67 </em>
                                    (6)
                                     , 556-565. <a href="https://doi.org/10.1248/cpb.c19-00003" title="DOI URL">https://doi.org/10.1248/cpb.c19-00003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c19-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c19-00003%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DSynthesis%252Band%252BAldose%252BReductase%252BInhibitory%252BActivity%252Bof%252BBotryllazine%252BA%252BDerivatives%26aulast%3DSaito%26aufirst%3DRyota%26date%3D2019%26volume%3D67%26issue%3D6%26spage%3D556%26epage%3D565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Soltesova Prnova</span>, <span class="hlFld-ContribAuthor ">Karol  Svik</span>, <span class="hlFld-ContribAuthor ">Stefan  Bezek</span>, <span class="hlFld-ContribAuthor ">Lucia  Kovacikova</span>, <span class="hlFld-ContribAuthor ">Cimen  Karasu</span>, <span class="hlFld-ContribAuthor ">Milan  Stefek</span>. </span><span class="cited-content_cbyCitation_article-title">3-Mercapto-5H-1,2,4-Triazino[5,6-b]Indole-5-Acetic Acid (Cemtirestat) Alleviates Symptoms of Peripheral Diabetic Neuropathy in Zucker Diabetic Fatty (ZDF) Rats: A Role of Aldose Reductase. </span><span class="cited-content_cbyCitation_journal-name">Neurochemical Research</span><span> <strong>2019,</strong> <em>44 </em>
                                    (5)
                                     , 1056-1064. <a href="https://doi.org/10.1007/s11064-019-02736-1" title="DOI URL">https://doi.org/10.1007/s11064-019-02736-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11064-019-02736-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11064-019-02736-1%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurochemical%2520Research%26atitle%3D3-Mercapto-5H-1%25252C2%25252C4-Triazino%25255B5%25252C6-b%25255DIndole-5-Acetic%252BAcid%252B%252528Cemtirestat%252529%252BAlleviates%252BSymptoms%252Bof%252BPeripheral%252BDiabetic%252BNeuropathy%252Bin%252BZucker%252BDiabetic%252BFatty%252B%252528ZDF%252529%252BRats%25253A%252BA%252BRole%252Bof%252BAldose%252BReductase%26aulast%3DSoltesova%2BPrnova%26aufirst%3DMarta%26date%3D2019%26date%3D2019%26volume%3D44%26issue%3D5%26spage%3D1056%26epage%3D1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanwei  Fu</span>, <span class="hlFld-ContribAuthor ">Jiaoyang  Luo</span>, <span class="hlFld-ContribAuthor ">Jiaan  Qin</span>, <span class="hlFld-ContribAuthor ">Meihua  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Screening techniques for the identification of bioactive compounds in natural products. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical and Biomedical Analysis</span><span> <strong>2019,</strong> <em>168 </em>, 189-200. <a href="https://doi.org/10.1016/j.jpba.2019.02.027" title="DOI URL">https://doi.org/10.1016/j.jpba.2019.02.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpba.2019.02.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpba.2019.02.027%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520and%2520Biomedical%2520Analysis%26atitle%3DScreening%252Btechniques%252Bfor%252Bthe%252Bidentification%252Bof%252Bbioactive%252Bcompounds%252Bin%252Bnatural%252Bproducts%26aulast%3DFu%26aufirst%3DYanwei%26date%3D2019%26volume%3D168%26spage%3D189%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bartolo  Ferraro</span>, <span class="hlFld-ContribAuthor ">Maria  Donniacuo</span>, <span class="hlFld-ContribAuthor ">Loredana  Sodano</span>, <span class="hlFld-ContribAuthor ">Franca  Ferraraccio</span>, <span class="hlFld-ContribAuthor ">Rosa  Maisto</span>, <span class="hlFld-ContribAuthor ">Eliana  Gulotta</span>, <span class="hlFld-ContribAuthor ">Gorizio  Pieretti</span>, <span class="hlFld-ContribAuthor ">Michele  D’Amico</span>, <span class="hlFld-ContribAuthor ">Maria Consiglia  Trotta</span>, <span class="hlFld-ContribAuthor ">Barbara  Rinaldi</span>. </span><span class="cited-content_cbyCitation_article-title">Addition of the Aldose Reductase Inhibitor Benzofuroxane Derivative BF-5m to Prolonged and Moderate Exercise Training Enhanced Protection of the Rat Heart From Type-1 Diabetes. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fphar.2019.00392" title="DOI URL">https://doi.org/10.3389/fphar.2019.00392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2019.00392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2019.00392%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DAddition%252Bof%252Bthe%252BAldose%252BReductase%252BInhibitor%252BBenzofuroxane%252BDerivative%252BBF-5m%252Bto%252BProlonged%252Band%252BModerate%252BExercise%252BTraining%252BEnhanced%252BProtection%252Bof%252Bthe%252BRat%252BHeart%252BFrom%252BType-1%252BDiabetes%26aulast%3DFerraro%26aufirst%3DBartolo%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carmen  Alvarez-Lorenzo</span>, <span class="hlFld-ContribAuthor ">Soledad  Anguiano-Igea</span>, <span class="hlFld-ContribAuthor ">Angela  Varela-García</span>, <span class="hlFld-ContribAuthor ">María  Vivero-Lopez</span>, <span class="hlFld-ContribAuthor ">Angel  Concheiro</span>. </span><span class="cited-content_cbyCitation_article-title">Bioinspired hydrogels for drug-eluting contact lenses. </span><span class="cited-content_cbyCitation_journal-name">Acta Biomaterialia</span><span> <strong>2019,</strong> <em>84 </em>, 49-62. <a href="https://doi.org/10.1016/j.actbio.2018.11.020" title="DOI URL">https://doi.org/10.1016/j.actbio.2018.11.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.actbio.2018.11.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.actbio.2018.11.020%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Biomaterialia%26atitle%3DBioinspired%252Bhydrogels%252Bfor%252Bdrug-eluting%252Bcontact%252Blenses%26aulast%3DAlvarez-Lorenzo%26aufirst%3DCarmen%26date%3D2019%26volume%3D84%26spage%3D49%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Hao</span>, <span class="hlFld-ContribAuthor ">Gang  Qi</span>, <span class="hlFld-ContribAuthor ">Hongxing  Ma</span>, <span class="hlFld-ContribAuthor ">Changjin  Zhu</span>, <span class="hlFld-ContribAuthor ">Zhongfei  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 2-phenoxypyrido[3,2-
              b
              ]pyrazin-3(4
              H
              )-one derivatives as potent and selective aldose reductase inhibitors with antioxidant activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2019,</strong> <em>34 </em>
                                    (1)
                                     , 1368-1372. <a href="https://doi.org/10.1080/14756366.2019.1643336" title="DOI URL">https://doi.org/10.1080/14756366.2019.1643336</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2019.1643336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2019.1643336%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DNovel%252B2-phenoxypyrido%25255B3%25252C2-%252Bb%252B%25255Dpyrazin-3%2525284%252BH%252B%252529-one%252Bderivatives%252Bas%252Bpotent%252Band%252Bselective%252Baldose%252Breductase%252Binhibitors%252Bwith%252Bantioxidant%252Bactivity%26aulast%3DHao%26aufirst%3DXin%26date%3D2019%26date%3D2019%26volume%3D34%26issue%3D1%26spage%3D1368%26epage%3D1372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gurprit  Sekhon</span>, <span class="hlFld-ContribAuthor ">Ranvir  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Human aldose reductase unfolds through an intermediate.. </span><span class="cited-content_cbyCitation_journal-name">F1000Research</span><span> <strong>2019,</strong> <em>8 </em>, 564. <a href="https://doi.org/10.12688/f1000research.18963.1" title="DOI URL">https://doi.org/10.12688/f1000research.18963.1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.12688/f1000research.18963.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.12688%2Ff1000research.18963.1%26sid%3Dliteratum%253Aachs%26jtitle%3DF1000Research%26atitle%3DHuman%252Baldose%252Breductase%252Bunfolds%252Bthrough%252Ban%252Bintermediate.%26aulast%3DSekhon%26aufirst%3DGurprit%26date%3D2019%26date%3D2019%26volume%3D8%26spage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yeliz  Demir</span>, <span class="hlFld-ContribAuthor ">Parham  Taslimi</span>, <span class="hlFld-ContribAuthor ">Muhammet Serhat  Ozaslan</span>, <span class="hlFld-ContribAuthor ">Necla  Oztaskin</span>, <span class="hlFld-ContribAuthor ">Yasin  Çetinkaya</span>, <span class="hlFld-ContribAuthor ">İlhami  Gulçin</span>, <span class="hlFld-ContribAuthor ">Şükrü  Beydemir</span>, <span class="hlFld-ContribAuthor ">Suleyman  Goksu</span>. </span><span class="cited-content_cbyCitation_article-title">Antidiabetic potential:
              In vitro
              inhibition effects of bromophenol and diarylmethanones derivatives on metabolic enzymes. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2018,</strong> <em>351 </em>
                                    (12)
                                     , 1800263. <a href="https://doi.org/10.1002/ardp.201800263" title="DOI URL">https://doi.org/10.1002/ardp.201800263</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201800263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201800263%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DAntidiabetic%252Bpotential%25253A%252BIn%252Bvitro%252Binhibition%252Beffects%252Bof%252Bbromophenol%252Band%252Bdiarylmethanones%252Bderivatives%252Bon%252Bmetabolic%252Benzymes%26aulast%3DDemir%26aufirst%3DYeliz%26date%3D2018%26date%3D2018%26volume%3D351%26issue%3D12%26spage%3D1800263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosanna  Maccari</span>, <span class="hlFld-ContribAuthor ">Antonella  Del Corso</span>, <span class="hlFld-ContribAuthor ">Paolo  Paoli</span>, <span class="hlFld-ContribAuthor ">Ilenia  Adornato</span>, <span class="hlFld-ContribAuthor ">Giulia  Lori</span>, <span class="hlFld-ContribAuthor ">Francesco  Balestri</span>, <span class="hlFld-ContribAuthor ">Mario  Cappiello</span>, <span class="hlFld-ContribAuthor ">Alexandra  Naß</span>, <span class="hlFld-ContribAuthor ">Gerhard  Wolber</span>, <span class="hlFld-ContribAuthor ">Rosaria  Ottanà</span>. </span><span class="cited-content_cbyCitation_article-title">An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (23-24)
                                     , 3712-3720. <a href="https://doi.org/10.1016/j.bmcl.2018.10.024" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.10.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.10.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.10.024%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAn%252Binvestigation%252Bon%252B4-thiazolidinone%252Bderivatives%252Bas%252Bdual%252Binhibitors%252Bof%252Baldose%252Breductase%252Band%252Bprotein%252Btyrosine%252Bphosphatase%252B1B%25252C%252Bin%252Bthe%252Bsearch%252Bfor%252Bpotential%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252Btype%252B2%252Bdiabetes%252Bmellitus%252Band%252Bits%252Bcomplications%26aulast%3DMaccari%26aufirst%3DRosanna%26date%3D2018%26volume%3D28%26issue%3D23-24%26spage%3D3712%26epage%3D3720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Magdaléna  Májeková</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand-based drug design of novel aldose reductase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (21)
                                     , 2493-2496. <a href="https://doi.org/10.4155/fmc-2018-0127" title="DOI URL">https://doi.org/10.4155/fmc-2018-0127</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0127%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DLigand-based%252Bdrug%252Bdesign%252Bof%252Bnovel%252Baldose%252Breductase%252Binhibitors%26aulast%3DM%25C3%25A1jekov%25C3%25A1%26aufirst%3DMagdal%25C3%25A9na%26date%3D2018%26volume%3D10%26issue%3D21%26spage%3D2493%26epage%3D2496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chujun  Yuan</span>, <span class="hlFld-ContribAuthor ">Jiyuan  Hu</span>, <span class="hlFld-ContribAuthor ">Saj  Parathath</span>, <span class="hlFld-ContribAuthor ">Lisa  Grauer</span>, <span class="hlFld-ContribAuthor ">Courtney Blachford  Cassella</span>, <span class="hlFld-ContribAuthor ">Svetlana  Bagdasarov</span>, <span class="hlFld-ContribAuthor ">Ira J.  Goldberg</span>, <span class="hlFld-ContribAuthor ">Ravichandran  Ramasamy</span>, <span class="hlFld-ContribAuthor ">Edward A.  Fisher</span>. </span><span class="cited-content_cbyCitation_article-title">Human Aldose Reductase Expression Prevents Atherosclerosis Regression in Diabetic Mice. </span><span class="cited-content_cbyCitation_journal-name">Diabetes</span><span> <strong>2018,</strong> <em>67 </em>
                                    (9)
                                     , 1880-1891. <a href="https://doi.org/10.2337/db18-0156" title="DOI URL">https://doi.org/10.2337/db18-0156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2337/db18-0156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2337%2Fdb18-0156%26sid%3Dliteratum%253Aachs%26jtitle%3DDiabetes%26atitle%3DHuman%252BAldose%252BReductase%252BExpression%252BPrevents%252BAtherosclerosis%252BRegression%252Bin%252BDiabetic%252BMice%26aulast%3DYuan%26aufirst%3DChujun%26date%3D2018%26date%3D2018%26volume%3D67%26issue%3D9%26spage%3D1880%26epage%3D1891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T.  Karthick</span>, <span class="hlFld-ContribAuthor ">Poonam  Tandon</span>, <span class="hlFld-ContribAuthor ">Karnica  Srivastava</span>, <span class="hlFld-ContribAuthor ">Swapnil  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of non-covalent interactions of chlorambucil (monomer and dimer) and its interaction with biological targets: Vibrational frequency shift, electron density topological and automated docking analysis. </span><span class="cited-content_cbyCitation_journal-name">Arabian Journal of Chemistry</span><span> <strong>2018,</strong> <em>11 </em>
                                    (5)
                                     , 591-608. <a href="https://doi.org/10.1016/j.arabjc.2017.10.012" title="DOI URL">https://doi.org/10.1016/j.arabjc.2017.10.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.arabjc.2017.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.arabjc.2017.10.012%26sid%3Dliteratum%253Aachs%26jtitle%3DArabian%2520Journal%2520of%2520Chemistry%26atitle%3DEvaluation%252Bof%252Bnon-covalent%252Binteractions%252Bof%252Bchlorambucil%252B%252528monomer%252Band%252Bdimer%252529%252Band%252Bits%252Binteraction%252Bwith%252Bbiological%252Btargets%25253A%252BVibrational%252Bfrequency%252Bshift%25252C%252Belectron%252Bdensity%252Btopological%252Band%252Bautomated%252Bdocking%252Banalysis%26aulast%3DKarthick%26aufirst%3DT.%26date%3D2018%26volume%3D11%26issue%3D5%26spage%3D591%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aliya  Ibrar</span>, <span class="hlFld-ContribAuthor ">Syeda Aaliya  Shehzadi</span>, <span class="hlFld-ContribAuthor ">Faiq  Saeed</span>, <span class="hlFld-ContribAuthor ">Imtiaz  Khan</span>. </span><span class="cited-content_cbyCitation_article-title">Developing hybrid molecule therapeutics for diverse enzyme inhibitory action: Active role of coumarin-based structural leads in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (13)
                                     , 3731-3762. <a href="https://doi.org/10.1016/j.bmc.2018.05.042" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.05.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.05.042%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDeveloping%252Bhybrid%252Bmolecule%252Btherapeutics%252Bfor%252Bdiverse%252Benzyme%252Binhibitory%252Baction%25253A%252BActive%252Brole%252Bof%252Bcoumarin-based%252Bstructural%252Bleads%252Bin%252Bdrug%252Bdiscovery%26aulast%3DIbrar%26aufirst%3DAliya%26date%3D2018%26volume%3D26%26issue%3D13%26spage%3D3731%26epage%3D3762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isidro  Crespo</span>, <span class="hlFld-ContribAuthor ">Joan  Giménez-Dejoz</span>, <span class="hlFld-ContribAuthor ">Sergio  Porté</span>, <span class="hlFld-ContribAuthor ">Alexandra  Cousido-Siah</span>, <span class="hlFld-ContribAuthor ">André  Mitschler</span>, <span class="hlFld-ContribAuthor ">Alberto  Podjarny</span>, <span class="hlFld-ContribAuthor ">Harris  Pratsinis</span>, <span class="hlFld-ContribAuthor ">Dimitris  Kletsas</span>, <span class="hlFld-ContribAuthor ">Xavier  Parés</span>, <span class="hlFld-ContribAuthor ">Francesc X.  Ruiz</span>, <span class="hlFld-ContribAuthor ">Kamel  Metwally</span>, <span class="hlFld-ContribAuthor ">Jaume  Farrés</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, structure-activity relationships and X-ray structural studies of novel 1-oxopyrimido[4,5-c]quinoline-2-acetic acid derivatives as selective and potent inhibitors of human aldose reductase. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>152 </em>, 160-174. <a href="https://doi.org/10.1016/j.ejmech.2018.04.015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.04.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.04.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bstructure-activity%252Brelationships%252Band%252BX-ray%252Bstructural%252Bstudies%252Bof%252Bnovel%252B1-oxopyrimido%25255B4%25252C5-c%25255Dquinoline-2-acetic%252Bacid%252Bderivatives%252Bas%252Bselective%252Band%252Bpotent%252Binhibitors%252Bof%252Bhuman%252Baldose%252Breductase%26aulast%3DCrespo%26aufirst%3DIsidro%26date%3D2018%26volume%3D152%26spage%3D160%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang-jun  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Redox imbalance stress in diabetes mellitus: Role of the polyol pathway. </span><span class="cited-content_cbyCitation_journal-name">Animal Models and Experimental Medicine</span><span> <strong>2018,</strong> <em>1 </em>
                                    (1)
                                     , 7-13. <a href="https://doi.org/10.1002/ame2.12001" title="DOI URL">https://doi.org/10.1002/ame2.12001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ame2.12001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fame2.12001%26sid%3Dliteratum%253Aachs%26jtitle%3DAnimal%2520Models%2520and%2520Experimental%2520Medicine%26atitle%3DRedox%252Bimbalance%252Bstress%252Bin%252Bdiabetes%252Bmellitus%25253A%252BRole%252Bof%252Bthe%252Bpolyol%252Bpathway%26aulast%3DYan%26aufirst%3DLiang-jun%26date%3D2018%26date%3D2018%26volume%3D1%26issue%3D1%26spage%3D7%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kun-Che  Chang</span>, <span class="hlFld-ContribAuthor ">J. Mark  Petrash</span>. </span><span class="cited-content_cbyCitation_article-title">Aldo-Keto Reductases: Multifunctional Proteins as Therapeutic Targets in Diabetes and Inflammatory Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 173-202. <a href="https://doi.org/10.1007/978-3-319-98788-0_13" title="DOI URL">https://doi.org/10.1007/978-3-319-98788-0_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-98788-0_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-98788-0_13%26sid%3Dliteratum%253Aachs%26atitle%3DAldo-Keto%252BReductases%25253A%252BMultifunctional%252BProteins%252Bas%252BTherapeutic%252BTargets%252Bin%252BDiabetes%252Band%252BInflammatory%252BDisease%26aulast%3DChang%26aufirst%3DKun-Che%26date%3D2018%26date%3D2018%26spage%3D173%26epage%3D202%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DAlcohol%252Band%252BCancer%26aulast%3DVasiliou%26aufirst%3DVasilis%26date%3D2018%26volume%3D1032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fernando  Alvarez-Rivera</span>, <span class="hlFld-ContribAuthor ">Angel  Concheiro</span>, <span class="hlFld-ContribAuthor ">Carmen  Alvarez-Lorenzo</span>. </span><span class="cited-content_cbyCitation_article-title">Epalrestat-loaded silicone hydrogels as contact lenses to address diabetic-eye complications. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutics and Biopharmaceutics</span><span> <strong>2018,</strong> <em>122 </em>, 126-136. <a href="https://doi.org/10.1016/j.ejpb.2017.10.016" title="DOI URL">https://doi.org/10.1016/j.ejpb.2017.10.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejpb.2017.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejpb.2017.10.016%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutics%2520and%2520Biopharmaceutics%26atitle%3DEpalrestat-loaded%252Bsilicone%252Bhydrogels%252Bas%252Bcontact%252Blenses%252Bto%252Baddress%252Bdiabetic-eye%252Bcomplications%26aulast%3DAlvarez-Rivera%26aufirst%3DFernando%26date%3D2018%26volume%3D122%26spage%3D126%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hina  Andleeb</span>, <span class="hlFld-ContribAuthor ">Yildiz  Tehseen</span>, <span class="hlFld-ContribAuthor ">Farrukh  Jabeen</span>, <span class="hlFld-ContribAuthor ">Imtiaz  Khan</span>, <span class="hlFld-ContribAuthor ">Jamshed  Iqbal</span>, <span class="hlFld-ContribAuthor ">Shahid  Hameed</span>. </span><span class="cited-content_cbyCitation_article-title">Exploration of thioxothiazolidinone–sulfonate conjugates as a new class of aldehyde/aldose reductase inhibitors: A synthetic and computational investigation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2017,</strong> <em>75 </em>, 1-15. <a href="https://doi.org/10.1016/j.bioorg.2017.08.009" title="DOI URL">https://doi.org/10.1016/j.bioorg.2017.08.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2017.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2017.08.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DExploration%252Bof%252Bthioxothiazolidinone%2525E2%252580%252593sulfonate%252Bconjugates%252Bas%252Ba%252Bnew%252Bclass%252Bof%252Baldehyde%25252Faldose%252Breductase%252Binhibitors%25253A%252BA%252Bsynthetic%252Band%252Bcomputational%252Binvestigation%26aulast%3DAndleeb%26aufirst%3DHina%26date%3D2017%26volume%3D75%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Magdalena  Majekova</span>, <span class="hlFld-ContribAuthor ">Jana  Ballekova</span>, <span class="hlFld-ContribAuthor ">Marta  Prnova</span>, <span class="hlFld-ContribAuthor ">Milan  Stefek</span>. </span><span class="cited-content_cbyCitation_article-title">Structure optimization of tetrahydropyridoindole-based aldose reductase inhibitors improved their efficacy and selectivity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (24)
                                     , 6353-6360. <a href="https://doi.org/10.1016/j.bmc.2017.10.005" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.10.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.10.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructure%252Boptimization%252Bof%252Btetrahydropyridoindole-based%252Baldose%252Breductase%252Binhibitors%252Bimproved%252Btheir%252Befficacy%252Band%252Bselectivity%26aulast%3DMajekova%26aufirst%3DMagdalena%26date%3D2017%26volume%3D25%26issue%3D24%26spage%3D6353%26epage%3D6360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kamel  Metwally</span>, <span class="hlFld-ContribAuthor ">Harris  Pratsinis</span>, <span class="hlFld-ContribAuthor ">Dimitris  Kletsas</span>, <span class="hlFld-ContribAuthor ">Luca  Quattrini</span>, <span class="hlFld-ContribAuthor ">Vito  Coviello</span>, <span class="hlFld-ContribAuthor ">Concettina La  Motta</span>, <span class="hlFld-ContribAuthor ">Ahmed A  El-Rashedy</span>, <span class="hlFld-ContribAuthor ">Mahmoud ES  Soliman</span>. </span><span class="cited-content_cbyCitation_article-title">Novel quinazolinone-based 2,4-thiazolidinedione-3-acetic acid derivatives as potent aldose reductase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (18)
                                     , 2147-2166. <a href="https://doi.org/10.4155/fmc-2017-0149" title="DOI URL">https://doi.org/10.4155/fmc-2017-0149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0149%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bquinazolinone-based%252B2%25252C4-thiazolidinedione-3-acetic%252Bacid%252Bderivatives%252Bas%252Bpotent%252Baldose%252Breductase%252Binhibitors%26aulast%3DMetwally%26aufirst%3DKamel%26date%3D2017%26volume%3D9%26issue%3D18%26spage%3D2147%26epage%3D2166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sherihan  El-sayed</span>, <span class="hlFld-ContribAuthor ">Kamel  Metwally</span>, <span class="hlFld-ContribAuthor ">Abdalla A.  El-Shanawani</span>, <span class="hlFld-ContribAuthor ">Lobna M.  Abdel-Aziz</span>, <span class="hlFld-ContribAuthor ">Ahmed A.  El-Rashedy</span>, <span class="hlFld-ContribAuthor ">Mahmoud E.S.  Soliman</span>, <span class="hlFld-ContribAuthor ">Luca  Quattrini</span>, <span class="hlFld-ContribAuthor ">Vito  Coviello</span>, <span class="hlFld-ContribAuthor ">Concettina  la Motta</span>. </span><span class="cited-content_cbyCitation_article-title">Quinazolinone-based rhodanine-3-acetic acids as potent aldose reductase inhibitors: Synthesis, functional evaluation and molecular modeling study. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (20)
                                     , 4760-4764. <a href="https://doi.org/10.1016/j.bmcl.2017.08.050" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.08.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.08.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.08.050%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DQuinazolinone-based%252Brhodanine-3-acetic%252Bacids%252Bas%252Bpotent%252Baldose%252Breductase%252Binhibitors%25253A%252BSynthesis%25252C%252Bfunctional%252Bevaluation%252Band%252Bmolecular%252Bmodeling%252Bstudy%26aulast%3DEl-sayed%26aufirst%3DSherihan%26date%3D2017%26volume%3D27%26issue%3D20%26spage%3D4760%26epage%3D4764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Seung Hwan  Hwang</span>, <span class="hlFld-ContribAuthor ">Soon Sung  Lim</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of DHDP, a novel aldose reductase inhibitor isolated from Lysimachia christinae. </span><span class="cited-content_cbyCitation_journal-name">Journal of Functional Foods</span><span> <strong>2017,</strong> <em>37 </em>, 241-248. <a href="https://doi.org/10.1016/j.jff.2017.07.057" title="DOI URL">https://doi.org/10.1016/j.jff.2017.07.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jff.2017.07.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jff.2017.07.057%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Functional%2520Foods%26atitle%3DCharacterization%252Bof%252BDHDP%25252C%252Ba%252Bnovel%252Baldose%252Breductase%252Binhibitor%252Bisolated%252Bfrom%252BLysimachia%252Bchristinae%26aulast%3DWang%26aufirst%3DZhiqiang%26date%3D2017%26volume%3D37%26spage%3D241%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Seung Hwan  Hwang</span>, <span class="hlFld-ContribAuthor ">Yanymee N.  Guillen Quispe</span>, <span class="hlFld-ContribAuthor ">Paul H.  Gonzales Arce</span>, <span class="hlFld-ContribAuthor ">Soon Sung  Lim</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of the antioxidant and aldose reductase inhibitory activities of extracts from Peruvian tea plant infusions. </span><span class="cited-content_cbyCitation_journal-name">Food Chemistry</span><span> <strong>2017,</strong> <em>231 </em>, 222-230. <a href="https://doi.org/10.1016/j.foodchem.2017.03.107" title="DOI URL">https://doi.org/10.1016/j.foodchem.2017.03.107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.foodchem.2017.03.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.foodchem.2017.03.107%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520Chemistry%26atitle%3DInvestigation%252Bof%252Bthe%252Bantioxidant%252Band%252Baldose%252Breductase%252Binhibitory%252Bactivities%252Bof%252Bextracts%252Bfrom%252BPeruvian%252Btea%252Bplant%252Binfusions%26aulast%3DWang%26aufirst%3DZhiqiang%26date%3D2017%26volume%3D231%26spage%3D222%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Min  Song</span>, <span class="hlFld-ContribAuthor ">Qian  Yu</span>, <span class="hlFld-ContribAuthor ">Xin  Dong</span>, <span class="hlFld-ContribAuthor ">Hyun Ok  Yang</span>, <span class="hlFld-ContribAuthor ">Ke-Wu  Zeng</span>, <span class="hlFld-ContribAuthor ">Jun  Li</span>, <span class="hlFld-ContribAuthor ">Peng-Fei  Tu</span>. </span><span class="cited-content_cbyCitation_article-title">Aldose reductase inhibitors attenuate β-amyloid-induced TNF-α production in microlgia via ROS-PKC-mediated NF-κB and MAPK pathways. </span><span class="cited-content_cbyCitation_journal-name">International Immunopharmacology</span><span> <strong>2017,</strong> <em>50 </em>, 30-37. <a href="https://doi.org/10.1016/j.intimp.2017.06.005" title="DOI URL">https://doi.org/10.1016/j.intimp.2017.06.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.intimp.2017.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.intimp.2017.06.005%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Immunopharmacology%26atitle%3DAldose%252Breductase%252Binhibitors%252Battenuate%252B%2525CE%2525B2-amyloid-induced%252BTNF-%2525CE%2525B1%252Bproduction%252Bin%252Bmicrolgia%252Bvia%252BROS-PKC-mediated%252BNF-%2525CE%2525BAB%252Band%252BMAPK%252Bpathways%26aulast%3DSong%26aufirst%3DXiao-Min%26date%3D2017%26volume%3D50%26spage%3D30%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guang-Yue  Hou</span>, <span class="hlFld-ContribAuthor ">Li-Hui  Men</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Zhong  Zheng</span>, <span class="hlFld-ContribAuthor ">Zhi-Qiang  Liu</span>, <span class="hlFld-ContribAuthor ">Feng-Rui  Song</span>, <span class="hlFld-ContribAuthor ">Zhong-Ying  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative analysis of urinary endogenous markers for the treatment effect of Radix Scutellariae on type 2 diabetes rats. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2017,</strong> <em>28 </em>
                                    (6)
                                     , 1214-1219. <a href="https://doi.org/10.1016/j.cclet.2016.12.039" title="DOI URL">https://doi.org/10.1016/j.cclet.2016.12.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2016.12.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2016.12.039%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DQuantitative%252Banalysis%252Bof%252Burinary%252Bendogenous%252Bmarkers%252Bfor%252Bthe%252Btreatment%252Beffect%252Bof%252BRadix%252BScutellariae%252Bon%252Btype%252B2%252Bdiabetes%252Brats%26aulast%3DHou%26aufirst%3DGuang-Yue%26date%3D2017%26volume%3D28%26issue%3D6%26spage%3D1214%26epage%3D1219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolaos  Papastavrou</span>, <span class="hlFld-ContribAuthor ">Maria  Chatzopoulou</span>, <span class="hlFld-ContribAuthor ">Jana  Ballekova</span>, <span class="hlFld-ContribAuthor ">Mario  Cappiello</span>, <span class="hlFld-ContribAuthor ">Roberta  Moschini</span>, <span class="hlFld-ContribAuthor ">Francesco  Balestri</span>, <span class="hlFld-ContribAuthor ">Alexandros  Patsilinakos</span>, <span class="hlFld-ContribAuthor ">Rino  Ragno</span>, <span class="hlFld-ContribAuthor ">Milan  Stefek</span>, <span class="hlFld-ContribAuthor ">Ioannis  Nicolaou</span>. </span><span class="cited-content_cbyCitation_article-title">Enhancing activity and selectivity in a series of pyrrol-1-yl-1-hydroxypyrazole-based aldose reductase inhibitors: The case of trifluoroacetylation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>130 </em>, 328-335. <a href="https://doi.org/10.1016/j.ejmech.2017.02.053" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.02.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.02.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.02.053%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEnhancing%252Bactivity%252Band%252Bselectivity%252Bin%252Ba%252Bseries%252Bof%252Bpyrrol-1-yl-1-hydroxypyrazole-based%252Baldose%252Breductase%252Binhibitors%25253A%252BThe%252Bcase%252Bof%252Btrifluoroacetylation%26aulast%3DPapastavrou%26aufirst%3DNikolaos%26date%3D2017%26volume%3D130%26spage%3D328%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fengchao  Cui</span>, <span class="hlFld-ContribAuthor ">Lunyang  Liu</span>, <span class="hlFld-ContribAuthor ">Haifeng  Tang</span>, <span class="hlFld-ContribAuthor ">Kecheng  Yang</span>, <span class="hlFld-ContribAuthor ">Yunqi  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Construction of explicit models to correlate the structure and the inhibitory activity of aldose reductase: Flavonoids and sulfonyl-pyridazinones as inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2017,</strong> <em>89 </em>
                                    (4)
                                     , 482-491. <a href="https://doi.org/10.1111/cbdd.12868" title="DOI URL">https://doi.org/10.1111/cbdd.12868</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12868%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DConstruction%252Bof%252Bexplicit%252Bmodels%252Bto%252Bcorrelate%252Bthe%252Bstructure%252Band%252Bthe%252Binhibitory%252Bactivity%252Bof%252Baldose%252Breductase%25253A%252BFlavonoids%252Band%252Bsulfonyl-pyridazinones%252Bas%252Binhibitors%26aulast%3DCui%26aufirst%3DFengchao%26date%3D2017%26date%3D2016%26volume%3D89%26issue%3D4%26spage%3D482%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Livia  Misuri</span>, <span class="hlFld-ContribAuthor ">Mario  Cappiello</span>, <span class="hlFld-ContribAuthor ">Francesco  Balestri</span>, <span class="hlFld-ContribAuthor ">Roberta  Moschini</span>, <span class="hlFld-ContribAuthor ">Vito  Barracco</span>, <span class="hlFld-ContribAuthor ">Umberto  Mura</span>, <span class="hlFld-ContribAuthor ">Antonella  Del-Corso</span>. </span><span class="cited-content_cbyCitation_article-title">The use of dimethylsulfoxide as a solvent in enzyme inhibition studies: the case of aldose reductase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2017,</strong> <em>32 </em>
                                    (1)
                                     , 1152-1158. <a href="https://doi.org/10.1080/14756366.2017.1363744" title="DOI URL">https://doi.org/10.1080/14756366.2017.1363744</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2017.1363744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2017.1363744%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DThe%252Buse%252Bof%252Bdimethylsulfoxide%252Bas%252Ba%252Bsolvent%252Bin%252Benzyme%252Binhibition%252Bstudies%25253A%252Bthe%252Bcase%252Bof%252Baldose%252Breductase%26aulast%3DMisuri%26aufirst%3DLivia%26date%3D2017%26date%3D2017%26volume%3D32%26issue%3D1%26spage%3D1152%26epage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minpei  Kuroda</span>, <span class="hlFld-ContribAuthor ">Takumi  Ohshima</span>, <span class="hlFld-ContribAuthor ">Chihiro  Kan</span>, <span class="hlFld-ContribAuthor ">Yoshihiro  Mimaki</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Constituents of the Leaves of
              Tussilago farfara
              and their Aldose Reductase Inhibitory Activity. </span><span class="cited-content_cbyCitation_journal-name">Natural Product Communications</span><span> <strong>2016,</strong> <em>11 </em>
                                    (11)
                                     , 1934578X1601101. <a href="https://doi.org/10.1177/1934578X1601101109" title="DOI URL">https://doi.org/10.1177/1934578X1601101109</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1934578X1601101109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1934578X1601101109%26sid%3Dliteratum%253Aachs%26jtitle%3DNatural%2520Product%2520Communications%26atitle%3DChemical%252BConstituents%252Bof%252Bthe%252BLeaves%252Bof%252BTussilago%252Bfarfara%252Band%252Btheir%252BAldose%252BReductase%252BInhibitory%252BActivity%26aulast%3DKuroda%26aufirst%3DMinpei%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D11%26spage%3D1934578X1601101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yaqin  Wang</span>, <span class="hlFld-ContribAuthor ">Min  Yu</span>, <span class="hlFld-ContribAuthor ">Long  Mo</span>, <span class="hlFld-ContribAuthor ">Zhenyu  Li</span>, <span class="hlFld-ContribAuthor ">Junjie  Wang</span>, <span class="hlFld-ContribAuthor ">Hong-hao  Zhou</span>, <span class="hlFld-ContribAuthor ">Dong-Sheng  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Aldose reductase C-106T polymorphism is associated with the risk of essential hypertension. </span><span class="cited-content_cbyCitation_journal-name">Gene</span><span> <strong>2016,</strong> <em>591 </em>
                                    (1)
                                     , 65-68. <a href="https://doi.org/10.1016/j.gene.2016.06.043" title="DOI URL">https://doi.org/10.1016/j.gene.2016.06.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.gene.2016.06.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.gene.2016.06.043%26sid%3Dliteratum%253Aachs%26jtitle%3DGene%26atitle%3DAldose%252Breductase%252BC-106T%252Bpolymorphism%252Bis%252Bassociated%252Bwith%252Bthe%252Brisk%252Bof%252Bessential%252Bhypertension%26aulast%3DWang%26aufirst%3DYaqin%26date%3D2016%26volume%3D591%26issue%3D1%26spage%3D65%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Shu  Liu</span>, <span class="hlFld-ContribAuthor ">Junpeng  Xing</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Liu</span>, <span class="hlFld-ContribAuthor ">Fengrui  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of interaction property of multi-components in
              Gardenia jasminoides
              with aldose reductase by microdialysis combined with liquid chromatography coupled to mass spectrometry. </span><span class="cited-content_cbyCitation_journal-name">Rapid Communications in Mass Spectrometry</span><span> <strong>2016,</strong> <em>30 </em>, 87-94. <a href="https://doi.org/10.1002/rcm.7620" title="DOI URL">https://doi.org/10.1002/rcm.7620</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/rcm.7620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Frcm.7620%26sid%3Dliteratum%253Aachs%26jtitle%3DRapid%2520Communications%2520in%2520Mass%2520Spectrometry%26atitle%3DCharacterization%252Bof%252Binteraction%252Bproperty%252Bof%252Bmulti-components%252Bin%252BGardenia%252Bjasminoides%252Bwith%252Baldose%252Breductase%252Bby%252Bmicrodialysis%252Bcombined%252Bwith%252Bliquid%252Bchromatography%252Bcoupled%252Bto%252Bmass%252Bspectrometry%26aulast%3DWang%26aufirst%3DLu%26date%3D2016%26date%3D2016%26volume%3D30%26spage%3D87%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Kang</span>, <span class="hlFld-ContribAuthor ">Yanbo  Tang</span>, <span class="hlFld-ContribAuthor ">Quan  Liu</span>, <span class="hlFld-ContribAuthor ">Nan  Guo</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhiyan  Xiao</span>, <span class="hlFld-ContribAuthor ">Ruoyun  Chen</span>, <span class="hlFld-ContribAuthor ">Zhufang  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Isolation, modification, and aldose reductase inhibitory activity of rosmarinic acid derivatives from the roots of Salvia grandifolia. </span><span class="cited-content_cbyCitation_journal-name">Fitoterapia</span><span> <strong>2016,</strong> <em>112 </em>, 197-204. <a href="https://doi.org/10.1016/j.fitote.2016.05.011" title="DOI URL">https://doi.org/10.1016/j.fitote.2016.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.fitote.2016.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.fitote.2016.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DFitoterapia%26atitle%3DIsolation%25252C%252Bmodification%25252C%252Band%252Baldose%252Breductase%252Binhibitory%252Bactivity%252Bof%252Brosmarinic%252Bacid%252Bderivatives%252Bfrom%252Bthe%252Broots%252Bof%252BSalvia%252Bgrandifolia%26aulast%3DKang%26aufirst%3DJie%26date%3D2016%26volume%3D112%26spage%3D197%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.C.  Matias</span>, <span class="hlFld-ContribAuthor ">G.  Biazolla</span>, <span class="hlFld-ContribAuthor ">G.  Cerchiaro</span>, <span class="hlFld-ContribAuthor ">A.F.  Keppler</span>. </span><span class="cited-content_cbyCitation_article-title">α-Aryl-N-aryl nitrones: Synthesis and screening of a new scaffold for cellular protection against an oxidative toxic stimulus. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (2)
                                     , 232-239. <a href="https://doi.org/10.1016/j.bmc.2015.12.007" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.12.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.12.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3D%2525CE%2525B1-Aryl-N-aryl%252Bnitrones%25253A%252BSynthesis%252Band%252Bscreening%252Bof%252Ba%252Bnew%252Bscaffold%252Bfor%252Bcellular%252Bprotection%252Bagainst%252Ban%252Boxidative%252Btoxic%252Bstimulus%26aulast%3DMatias%26aufirst%3DA.C.%26date%3D2016%26volume%3D24%26issue%3D2%26spage%3D232%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesc X.  Ruiz</span>, <span class="hlFld-ContribAuthor ">Alexandra  Cousido-Siah</span>, <span class="hlFld-ContribAuthor ">Sergio  Porté</span>, <span class="hlFld-ContribAuthor ">Marta  Domínguez</span>, <span class="hlFld-ContribAuthor ">Isidro  Crespo</span>, <span class="hlFld-ContribAuthor ">Chris  Rechlin</span>, <span class="hlFld-ContribAuthor ">André  Mitschler</span>, <span class="hlFld-ContribAuthor ">Ángel R.  de Lera</span>, <span class="hlFld-ContribAuthor ">María Jesús  Martín</span>, <span class="hlFld-ContribAuthor ">Jesús Ángel  de la Fuente</span>, <span class="hlFld-ContribAuthor ">Gerhard  Klebe</span>, <span class="hlFld-ContribAuthor ">Xavier  Parés</span>, <span class="hlFld-ContribAuthor ">Jaume  Farrés</span>, <span class="hlFld-ContribAuthor ">Alberto  Podjarny</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Determinants of the Selectivity of 3-Benzyluracil-1-acetic Acids toward Human Enzymes Aldose Reductase and AKR1B10. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2015,</strong> <em>10 </em>
                                    (12)
                                     , 1989-2003. <a href="https://doi.org/10.1002/cmdc.201500393" title="DOI URL">https://doi.org/10.1002/cmdc.201500393</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500393%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DStructural%252BDeterminants%252Bof%252Bthe%252BSelectivity%252Bof%252B3-Benzyluracil-1-acetic%252BAcids%252Btoward%252BHuman%252BEnzymes%252BAldose%252BReductase%252Band%252BAKR1B10%26aulast%3DRuiz%26aufirst%3DFrancesc%2BX.%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D12%26spage%3D1989%26epage%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Soltesova Prnova</span>, <span class="hlFld-ContribAuthor ">Jana  Ballekova</span>, <span class="hlFld-ContribAuthor ">Magdalena  Majekova</span>, <span class="hlFld-ContribAuthor ">Milan  Stefek</span>. </span><span class="cited-content_cbyCitation_article-title">Antioxidant action of 3-mercapto-5
              H
              -1,2,4-triazino[5,6-
              b
              ]indole-5-acetic acid, an efficient aldose reductase inhibitor, in a 1,1′-diphenyl-2-picrylhydrazyl assay and in the cellular system of isolated erythrocytes exposed to
              tert
              -butyl hydroperoxide. </span><span class="cited-content_cbyCitation_journal-name">Redox Report</span><span> <strong>2015,</strong> <em>20 </em>
                                    (6)
                                     , 282-288. <a href="https://doi.org/10.1179/1351000215Y.0000000019" title="DOI URL">https://doi.org/10.1179/1351000215Y.0000000019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1179/1351000215Y.0000000019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1179%2F1351000215Y.0000000019%26sid%3Dliteratum%253Aachs%26jtitle%3DRedox%2520Report%26atitle%3DAntioxidant%252Baction%252Bof%252B3-mercapto-5%252BH%252B-1%25252C2%25252C4-triazino%25255B5%25252C6-%252Bb%252B%25255Dindole-5-acetic%252Bacid%25252C%252Ban%252Befficient%252Baldose%252Breductase%252Binhibitor%25252C%252Bin%252Ba%252B1%25252C1%2525E2%252580%2525B2-diphenyl-2-picrylhydrazyl%252Bassay%252Band%252Bin%252Bthe%252Bcellular%252Bsystem%252Bof%252Bisolated%252Berythrocytes%252Bexposed%252Bto%252Btert%252B-butyl%252Bhydroperoxide%26aulast%3DSoltesova%2BPrnova%26aufirst%3DMarta%26date%3D2015%26date%3D2016%26volume%3D20%26issue%3D6%26spage%3D282%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  SOLTESOVA PRNOVA</span>, <span class="hlFld-ContribAuthor ">J.  BALLEKOVA</span>, <span class="hlFld-ContribAuthor ">A.  GAJDOSIKOVA</span>, <span class="hlFld-ContribAuthor ">A.  GAJDOSIK</span>, <span class="hlFld-ContribAuthor ">M.  STEFEK</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Carboxymethylated Mercaptotriazinoindole Inhibitor of Aldose Reductase Interferes With the Polyol Pathway in Streptozotocin-Induced Diabetic Rats. </span><span class="cited-content_cbyCitation_journal-name">Physiological Research</span><span> <strong>2015,</strong> <em> </em>, 587-591. <a href="https://doi.org/10.33549/physiolres.933034" title="DOI URL">https://doi.org/10.33549/physiolres.933034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.33549/physiolres.933034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.33549%2Fphysiolres.933034%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysiological%2520Research%26atitle%3DA%252BNovel%252BCarboxymethylated%252BMercaptotriazinoindole%252BInhibitor%252Bof%252BAldose%252BReductase%252BInterferes%252BWith%252Bthe%252BPolyol%252BPathway%252Bin%252BStreptozotocin-Induced%252BDiabetic%252BRats%26aulast%3DSOLTESOVA%2BPRNOVA%26aufirst%3DM.%26date%3D2015%26date%3D2015%26spage%3D587%26epage%3D591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abinaya  Manivannan</span>, <span class="hlFld-ContribAuthor ">Prabhakaran  Soundararajan</span>, <span class="hlFld-ContribAuthor ">Yoo Gyeong  Park</span>, <span class="hlFld-ContribAuthor ">Sugunadevi  Sakkiah</span>, <span class="hlFld-ContribAuthor ">Byoung Ryong  Jeong</span>. </span><span class="cited-content_cbyCitation_article-title">Binding Mode Investigation of Polyphenols from
              Scrophularia
              Targeting Human Aldose Reductase Using Molecular Docking and Molecular Dynamics Simulations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemistry</span><span> <strong>2015,</strong> <em>2015 </em>, 1-12. <a href="https://doi.org/10.1155/2015/434256" title="DOI URL">https://doi.org/10.1155/2015/434256</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2015/434256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2015%2F434256%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemistry%26atitle%3DBinding%252BMode%252BInvestigation%252Bof%252BPolyphenols%252Bfrom%252BScrophularia%252BTargeting%252BHuman%252BAldose%252BReductase%252BUsing%252BMolecular%252BDocking%252Band%252BMolecular%252BDynamics%252BSimulations%26aulast%3DManivannan%26aufirst%3DAbinaya%26date%3D2015%26volume%3D2015%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0012.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of some known ARIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Role of AR in the development of diabetic complications. Abbreviations are defined as follows: AGE, advanced glycation end product; AR, aldose reductase; DAG, diacylglycerol; DHAP, dihydroxyacetone phosphate; DHN, 1,4-dihydroxynonene; GS-DHN, glutathione-1,4-dihydroxynonene; GSH, glutathione; GS-HNE, glutathione-4-hydroxy-<i>trans</i>-2-nonenal; HNE, 4-hydroxy-<i>trans</i>-2-nonenal; iNOS, inducible nitric oxide synthase; NF-κB, nuclear factor κB; PKC, protein kinase C; PLC, phospholipase C; ROS, radical oxygen species; SD, sorbitol dehydrogenase; TNF-α, tumor necrosis factor α.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Implication of AR in inflammatory signaling under normoglycemic conditions. Abbreviations are defined as follows: AR, aldose reductase; COX-2, cyclooxygenase 2; DAG, diacylglycerol; GS-DHN, glutathione-1,4-dihydroxynonene; GS-HNE, glutathione-4-hydroxy-<i>trans</i>-2-nonenal; HNE, 4-hydroxy-<i>trans</i>-2-nonenal; iNOS, inducible nitric oxide synthase; NF-κB, nuclear factor κB; PGE<sub>2</sub>, prostaglandin E<sub>2</sub>; PKC, protein kinase C; PLC, phospholipase C; ROS, radical oxygen species; TNF-α, tumor necrosis factor α.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of ARIs recently reported as potential anti-inflammatory agents.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structure of human AR complexed with zopolrestat (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MAR">1MAR</a>)<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> with a schematic representation of the AR active site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of selective ARIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structures of selective AKR1B10 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of partial or differential AR inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures of ARIs endowed with antioxidant properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/medium/jm-2014-00907a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of non-carboxylic non-hydantoin ARIs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm500907a/20150306/images/large/jm-2014-00907a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500907a&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i16">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46541" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46541" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 167 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Brownlee, M.</span><span> </span><span class="NLM_article-title">Biochemistry and Molecular Cell Biology of Diabetic Complications</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">414</span><span class="NLM_x">, </span> <span class="NLM_fpage">813</span><span class="NLM_x">–</span> <span class="NLM_lpage">820</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1038%2F414813a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=11742414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD38Xhtlyltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2001&pages=813-820&author=M.+Brownlee&title=Biochemistry+and+Molecular+Cell+Biology+of+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemistry and molecular cell biology of diabetic complications</span></div><div class="casAuthors">Brownlee, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">414</span>
        (<span class="NLM_cas:issue">6865</span>),
    <span class="NLM_cas:pages">813-820</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Diabetes-specific microvascular disease is a leading cause of blindness, renal failure and nerve damage, and diabetes-accelerated atherosclerosis leads to increased risk of myocardial infarction, stroke and limb amputation.  Four main mol. mechanisms have been implicated in glucose-mediated vascular damage.  All seem to reflect a single hyperglycemia-induced process of overprodn. of superoxide by the mitochondrial electron-transport chain.  This integrating paradigm provides a new conceptual framework for future research and drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU6OQEmAUWmLVg90H21EOLACvtfcHk0lhf9Iu--4ByOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xhtlyltg%253D%253D&md5=b229af6b6bc93ada1888c24d7a82ca3b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F414813a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F414813a%26sid%3Dliteratum%253Aachs%26aulast%3DBrownlee%26aufirst%3DM.%26atitle%3DBiochemistry%2520and%2520Molecular%2520Cell%2520Biology%2520of%2520Diabetic%2520Complications%26jtitle%3DNature%26date%3D2001%26volume%3D414%26spage%3D813%26epage%3D820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Brownlee, M.</span><span> </span><span class="NLM_article-title">The Pathobiology of Diabetic Complications. A Unifying Mechanism</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1615</span><span class="NLM_x">–</span> <span class="NLM_lpage">1625</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=1615-1625&author=M.+Brownlee&title=The+Pathobiology+of+Diabetic+Complications.+A+Unifying+Mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrownlee%26aufirst%3DM.%26atitle%3DThe%2520Pathobiology%2520of%2520Diabetic%2520Complications.%2520A%2520Unifying%2520Mechanism%26jtitle%3DDiabetes%26date%3D2005%26volume%3D54%26spage%3D1615%26epage%3D1625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Yabe-Nishimura, C.</span><span> </span><span class="NLM_article-title">Aldose Reductase in Glucose Toxicity: A Potential Target for the Prevention of Diabetic Complications</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1998&pages=21-33&author=C.+Yabe-Nishimura&title=Aldose+Reductase+in+Glucose+Toxicity%3A+A+Potential+Target+for+the+Prevention+of+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYabe-Nishimura%26aufirst%3DC.%26atitle%3DAldose%2520Reductase%2520in%2520Glucose%2520Toxicity%253A%2520A%2520Potential%2520Target%2520for%2520the%2520Prevention%2520of%2520Diabetic%2520Complications%26jtitle%3DPharmacol.%2520Rev.%26date%3D1998%26volume%3D50%26spage%3D21%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Costantino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rastelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cignarella, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlocco, D.</span><span> </span><span class="NLM_article-title">New Aldose Reductase Inhibitors as Potential Agents for the Prevention of Long-Term Diabetic Complications</span> <span class="citation_source-journal">Exp. Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">843</span><span class="NLM_x">–</span> <span class="NLM_lpage">858</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1517%2F13543776.7.8.843" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADyaK2sXlt12ls7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=843-858&author=L.+Costantinoauthor=G.+Rastelliauthor=G.+Cignarellaauthor=P.+Vianelloauthor=D.+Barlocco&title=New+Aldose+Reductase+Inhibitors+as+Potential+Agents+for+the+Prevention+of+Long-Term+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">New aldose reductase inhibitors as potential agents for the prevention of long-term diabetic complications</span></div><div class="casAuthors">Costantino, Luca; Rastelli, Giulio; Cignarella, Giorgio; Vianello, Paola; Barlocco, Daniela</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">843-858</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications</span>)
        </div><div class="casAbstract">A review with 189 refs.  The results of recent clin. trials emphasize the importance of an improved glycemic control in diabetic patients to prevent or at least to delay long-term complications.  The difficulty in obtaining normalization of blood glucose values has underlined the importance of the search for new and effective aldose reductase inhibitors (ARIs) to control the consequences of elevated glucose levels, therefore delaying the onset and retarding the progression of diabetic complications such as neuropathy, nephropathy, retinopathy and cataract.  Although the physiol. role of aldose reductase (ALR2) has not been clearly elucidated yet, it has been shown that this enzyme, the first of the polyol pathway, is responsible for the prodn. of sorbitol from glucose.  There are several pieces of evidence which link this process to the occurrence of diabetic complications.  Orally active aldose reductase inhibitors can be grouped into two chem. classes: cyclic imide and carboxylic acid derivs.  This review describes the recent insights into these two classes of inhibitors, and the further development of ARIs provided with antidiabetic and antihyperlipidemic properties.  The most recent developments in understanding of the structure, catalytic mechanism and biochem. behavior of ALR2 are also reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8dM0Nsjrm3LVg90H21EOLACvtfcHk0lgVFD6_FbjWaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlt12ls7s%253D&md5=f2601af33b510dac509b9ab093194f4a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F13543776.7.8.843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.7.8.843%26sid%3Dliteratum%253Aachs%26aulast%3DCostantino%26aufirst%3DL.%26aulast%3DRastelli%26aufirst%3DG.%26aulast%3DCignarella%26aufirst%3DG.%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DBarlocco%26aufirst%3DD.%26atitle%3DNew%2520Aldose%2520Reductase%2520Inhibitors%2520as%2520Potential%2520Agents%2520for%2520the%2520Prevention%2520of%2520Long-Term%2520Diabetic%2520Complications%26jtitle%3DExp.%2520Opin.%2520Ther.%2520Pat.%26date%3D1997%26volume%3D7%26spage%3D843%26epage%3D858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Costantino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rastelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianello, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cignarella, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlocco, D.</span><span> </span><span class="NLM_article-title">Diabetes Complications and Their Potential Prevention: Aldose Reductase Inhibition and Other Approaches</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1002%2F%28SICI%291098-1128%28199901%2919%3A1%3C3%3A%3AAID-MED2%3E3.0.CO%3B2-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=9918192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADyaK1MXjs1ygtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=3-23&author=L.+Costantinoauthor=G.+Rastelliauthor=P.+Vianelloauthor=G.+Cignarellaauthor=D.+Barlocco&title=Diabetes+Complications+and+Their+Potential+Prevention%3A+Aldose+Reductase+Inhibition+and+Other+Approaches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Diabetes complications and their potential prevention: aldose reductase inhibition and other approaches</span></div><div class="casAuthors">Costantino, Luca; Rastelli, Giulio; Vianello, Paola; Cignarella, Giorgio; Barlocco, Daniela</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-23</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review with 153 refs.  Despite recent advances both in the chem. and mol. pharmacol. of antidiabetic drugs, diabetes still remains a life-threatening disease, which tends to spread all over the world.  The clin. profile of diabetic subjects is often worsened by the presence of several long-term complications, namely neuropathy, nephropathy, retinopathy, and cataract.  Several attempts have been made to prevent or at least to delay them.  The most relevant are reported in this review, including the development of compds. acting as aldose reductase inhibitors, anti-advanced glycation end-product drugs, free radical scavengers, vasoactive agents, essential fatty acid supplementation, and neurotropic growth factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQa1u-NjUMUrVg90H21EOLACvtfcHk0lgVFD6_FbjWaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjs1ygtA%253D%253D&md5=4bb0a6c86b0f030ad67bb05009ae115e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28199901%2919%3A1%3C3%3A%3AAID-MED2%3E3.0.CO%3B2-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528199901%252919%253A1%253C3%253A%253AAID-MED2%253E3.0.CO%253B2-7%26sid%3Dliteratum%253Aachs%26aulast%3DCostantino%26aufirst%3DL.%26aulast%3DRastelli%26aufirst%3DG.%26aulast%3DVianello%26aufirst%3DP.%26aulast%3DCignarella%26aufirst%3DG.%26aulast%3DBarlocco%26aufirst%3DD.%26atitle%3DDiabetes%2520Complications%2520and%2520Their%2520Potential%2520Prevention%253A%2520Aldose%2520Reductase%2520Inhibition%2520and%2520Other%2520Approaches%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1999%26volume%3D19%26spage%3D3%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Costantino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rastelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamberini, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlocco, D.</span><span> </span><span class="NLM_article-title">Pharmacological Approaches to the Treatment of Diabetic Complications</span> <span class="citation_source-journal">Exp. Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1245</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1517%2F13543776.10.8.1245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvFWqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1245-1262&author=L.+Costantinoauthor=G.+Rastelliauthor=M.+C.+Gamberiniauthor=D.+Barlocco&title=Pharmacological+Approaches+to+the+Treatment+of+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological approaches to the treatment of diabetic complications</span></div><div class="casAuthors">Costantino, Luca; Rastelli, Giulio; Gamberini, Maria Cristina; Barlocco, Daniela</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1245-1262</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 153 refs.  Diabetes is often accompanied by several long-term complications such as neuropathy, nephropathy, retinopathy, cataract and angiopathy; their occurrence has been linked to the modification of the physiol. levels of glycemia.  Several interrelated metabolic pathways have been implicated in the toxic effects of glucose; the polyol pathway was one of the first considered.  However, while in diabetic animal models the inhibitors of aldose reductase (ALR2, the first enzyme of this pathway) seem to be active, 16 yr of clin. trials, based mainly on neuropathy, have been inconclusive; only one drug currently being marketed.  Newer potent and selective aldose reductase inhibitors have been discovered in the last few years, but the lack of com. success has probably led to the very rapid decrease in the no. of patents relating to newer aldose reductase inhibitors.  Inhibition of the second enzyme of this pathway, sorbitol dehydrogenase (SDH), has been shown to be detrimental.  Other approaches for the prevention and the delay of progression of diabetic complications seem to be more promising, namely, the inhibition of the formation of advanced glycated end products (AGEs) or protein kinase C (PKC) β2 inhibition; compds. acting on these two pathways have proved effective in retarding the development of diabetic complications in animal models and some products are in clin. trials at the moment.  Renewed attention has been paid to vascular involvement in the pathogenesis of diabetic neuropathy; the biol. activity of C-peptide and the role of endothelin-1 (ET-1) in diabetic vascular disease are emerging as a new research area for the treatment of diabetic complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC9eUSGnqqF7Vg90H21EOLACvtfcHk0lgVFD6_FbjWaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvFWqu7s%253D&md5=4848a865cf01793a83f66281134f4a7d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1517%2F13543776.10.8.1245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.10.8.1245%26sid%3Dliteratum%253Aachs%26aulast%3DCostantino%26aufirst%3DL.%26aulast%3DRastelli%26aufirst%3DG.%26aulast%3DGamberini%26aufirst%3DM.%2BC.%26aulast%3DBarlocco%26aufirst%3DD.%26atitle%3DPharmacological%2520Approaches%2520to%2520the%2520Treatment%2520of%2520Diabetic%2520Complications%26jtitle%3DExp.%2520Opin.%2520Ther.%2520Pat.%26date%3D2000%26volume%3D10%26spage%3D1245%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Del Corso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappiello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mura, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">From, A.</span><span> </span><span class="NLM_article-title">Dull Enzyme to Something Else: Facts and Perspectives Regarding Aldose Reductase</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1452</span><span class="NLM_x">–</span> <span class="NLM_lpage">1461</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.2174%2F092986708784638870" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=18537622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVyhs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=1452-1461&author=A.+Del+Corsoauthor=M.+Cappielloauthor=U.+Muraauthor=A.+From&title=Dull+Enzyme+to+Something+Else%3A+Facts+and+Perspectives+Regarding+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">From a dull enzyme to something else: facts and perspectives regarding aldose reductase</span></div><div class="casAuthors">Del Corso, A.; Cappiello, M.; Mura, U.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1452-1461</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Aldose Reductase (ALR2) is defined as the first enzyme of the "polyol pathway".  As such, ALR2 would convert glucose to sorbitol through an NADPH dependent reaction.  Considered a promoter of osmotic imbalance under hyperglycemic conditions, the enzyme has been under intense investigation as a crit. target to prevent and control diabetic complications through the inhibition of its activity.  Further characterization of ALR2 suggests its participation in cell detoxification mechanisms through the redn. of toxic aldehydes.  Moreover, intriguing is the apparent involvement of the enzyme in the signaling machinery of inflammatory cell response.  Here, the structural and functional assessment of ALR2 as an aldose/aldehyde reducing enzyme, and its involvement in various aspects of cell function from sugar metab. to redox homeostasis and cell signaling are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6V1lpOaJTyLVg90H21EOLACvtfcHk0lgAiQyzvK2JOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVyhs7Y%253D&md5=7f3fa8415b040c8c2fc08f3ef64fdecf</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F092986708784638870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708784638870%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BCorso%26aufirst%3DA.%26aulast%3DCappiello%26aufirst%3DM.%26aulast%3DMura%26aufirst%3DU.%26aulast%3DFrom%26aufirst%3DA.%26atitle%3DDull%2520Enzyme%2520to%2520Something%2520Else%253A%2520Facts%2520and%2520Perspectives%2520Regarding%2520Aldose%2520Reductase%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26spage%3D1452%26epage%3D1461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Srivastava, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span> </span><span class="NLM_article-title">Role of Aldose Reductase and Oxidative Damage in Diabetes and the Consequent Potential for Therapeutic Options</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1210%2Fer.2004-0028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=15814847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVWru7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=380-392&author=S.+K.+Srivastavaauthor=K.+V.+Ramanaauthor=A.+Bhatnagar&title=Role+of+Aldose+Reductase+and+Oxidative+Damage+in+Diabetes+and+the+Consequent+Potential+for+Therapeutic+Options"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options</span></div><div class="casAuthors">Srivastava, Satish K.; Ramana, Kota V.; Bhatnagar, Aruni</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">380-392</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Aldose reductase (AR) is widely expressed aldehyde-metabolizing enzyme.  The redn. of glucose by the AR-catalyzed polyol pathway has been linked to the development of secondary diabetic complications.  Although treatment with AR inhibitors has been shown to prevent tissue injury in animal models of diabetes, the clin. efficacy of these drugs remains to be established.  Recent studies suggest that glucose may be an incidental substrate of AR, which appears to be more adept in catalyzing the redn. of a wide range of aldehydes generated from lipid peroxidn.  Moreover, inhibition of the enzyme has been shown to increase inflammation-induced vascular oxidative stress and prevent myocardial protection assocd. with the late phase of ischemic preconditioning.  On the basis of these studies, several investigators have ascribed an important antioxidant role to the enzyme.  Addnl., ongoing work indicates that AR is a crit. component of intracellular signaling, and inhibition of the enzyme prevents high glucose-, cytokine-, or growth factor-induced activation of protein kinase C and nuclear factor-κ-binding protein.  Thus, treatment with AR inhibitors prevents vascular smooth muscle cell growth and endothelial cell apoptosis in culture and inflammation and restenosis in vivo.  Addnl. studies indicate that the antioxidant and signaling roles of AR are interlinked and that AR regulates protein kinase C and nuclear factor-κB via redox-sensitive mechanisms.  These data underscore the need for reevaluating anti-AR interventions for the treatment of diabetic complications.  Potentially, the development of newer drugs that selectively inhibit AR-mediated glucose metab. and signaling, without affecting aldehyde detoxification, may be useful in preventing inflammation assocd. with the development of diabetic complications, particularly micro- and macrovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOtJ6RgWVDzrVg90H21EOLACvtfcHk0lgAiQyzvK2JOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVWru7s%253D&md5=21c5b244909e660d240a1600ffd6e938</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1210%2Fer.2004-0028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2004-0028%26sid%3Dliteratum%253Aachs%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DBhatnagar%26aufirst%3DA.%26atitle%3DRole%2520of%2520Aldose%2520Reductase%2520and%2520Oxidative%2520Damage%2520in%2520Diabetes%2520and%2520the%2520Consequent%2520Potential%2520for%2520Therapeutic%2520Options%26jtitle%3DEndocr.%2520Rev.%26date%3D2005%26volume%3D26%26spage%3D380%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Banditelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boldrini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardo, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecconi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappiello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Monte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Corso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mura, U.</span><span> </span><span class="NLM_article-title">A New Approach against Sugar Cataract through Aldose Reductase Inhibitors</span> <span class="citation_source-journal">Exp. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">538</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1006%2Fexer.1999.0729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=10548473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADyaK1MXntVCntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1999&pages=533-538&author=S.+Banditelliauthor=E.+Boldriniauthor=P.+G.+Vilardoauthor=I.+Cecconiauthor=M.+Cappielloauthor=M.+Dal+Monteauthor=I.+Mariniauthor=A.+Del+Corsoauthor=U.+Mura&title=A+New+Approach+against+Sugar+Cataract+through+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A new approach against sugar cataract through aldose reductase inhibitors</span></div><div class="casAuthors">Banditelli, Stefania; Boldrini, Enrico; Vilardo, Pier Giuseppe; Cecconi, Ilaria; Cappiello, Mario; Dal Monte, Massimo; Marini, Isabella; Del Corso, Antonella; Mura, Umberto</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">533-538</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Aldose reductase inhibition is one of the therapeutic strategies that has been proposed to prevent or ameliorate long term diabetic complications including retinopathy and sugar cataract.  Rats were fed with a galactose rich diet and the aldose reductase inhibitor Tolrestat was topically delivered by ocular instillation.  The levels of lens aldose reductase activity, galactitol and the onset of cataract were evaluated during and after treatment with the inhibitor. Topical application of 1-3% Tolrestat (10 μl) four times daily resulted, after 9 days, in a significant decrease in the enzyme activity.  Well after interrupting treatment with the drug, the enzyme activity remained impaired and galactose induced cataract was prevented.  Our findings may represent the basis for therapeutic plans to prevent sugar cataract by long term cyclic treatments with aldose reductase inhibitors, with redn. in drug doses and side effects.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8HwXqhqinobVg90H21EOLACvtfcHk0lgAiQyzvK2JOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntVCntbo%253D&md5=91b63bf9326d7ee40f9c75f05703715a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1006%2Fexer.1999.0729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexer.1999.0729%26sid%3Dliteratum%253Aachs%26aulast%3DBanditelli%26aufirst%3DS.%26aulast%3DBoldrini%26aufirst%3DE.%26aulast%3DVilardo%26aufirst%3DP.%2BG.%26aulast%3DCecconi%26aufirst%3DI.%26aulast%3DCappiello%26aufirst%3DM.%26aulast%3DDal%2BMonte%26aufirst%3DM.%26aulast%3DMarini%26aufirst%3DI.%26aulast%3DDel%2BCorso%26aufirst%3DA.%26aulast%3DMura%26aufirst%3DU.%26atitle%3DA%2520New%2520Approach%2520against%2520Sugar%2520Cataract%2520through%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D1999%26volume%3D69%26spage%3D533%26epage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Hotta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigeta, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikkawa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, N.</span><span> </span><span class="NLM_article-title">Clinical Efficacy of Fidarestat, a Novel Aldose Reductase Inhibitor, for Diabetic Peripheral Neuropathy</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1776</span><span class="NLM_x">–</span> <span class="NLM_lpage">1782</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2001&pages=1776-1782&author=N.+Hottaauthor=T.+Toyotaauthor=K.+Matsuokaauthor=Y.+Shigetaauthor=R.+Kikkawaauthor=T.+Kanekoauthor=A.+Takahashiauthor=K.+Sugimuraauthor=Y.+Koikeauthor=J.+Ishiiauthor=N.+Sakamoto&title=Clinical+Efficacy+of+Fidarestat%2C+a+Novel+Aldose+Reductase+Inhibitor%2C+for+Diabetic+Peripheral+Neuropathy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHotta%26aufirst%3DN.%26aulast%3DToyota%26aufirst%3DT.%26aulast%3DMatsuoka%26aufirst%3DK.%26aulast%3DShigeta%26aufirst%3DY.%26aulast%3DKikkawa%26aufirst%3DR.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DSugimura%26aufirst%3DK.%26aulast%3DKoike%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DJ.%26aulast%3DSakamoto%26aufirst%3DN.%26atitle%3DClinical%2520Efficacy%2520of%2520Fidarestat%252C%2520a%2520Novel%2520Aldose%2520Reductase%2520Inhibitor%252C%2520for%2520Diabetic%2520Peripheral%2520Neuropathy%26jtitle%3DDiabetes%2520Care%26date%3D2001%26volume%3D24%26spage%3D1776%26epage%3D1782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Asano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, N.</span><span> </span><span class="NLM_article-title">Fidarestat (SNK-860), a Potent Aldose Reductase Inhibitor, Normalizes the Elevated Sorbitol Accumulation in Erythrocytes of Diabetic Patients</span> <span class="citation_source-journal">J. Diabetes Complications</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2FS1056-8727%2801%2900175-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=12039395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A280%3ADC%252BD383pslCmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=133-138&author=T.+Asanoauthor=Y.+Saitoauthor=M.+Kawakamiauthor=N.+Yamada&title=Fidarestat+%28SNK-860%29%2C+a+Potent+Aldose+Reductase+Inhibitor%2C+Normalizes+the+Elevated+Sorbitol+Accumulation+in+Erythrocytes+of+Diabetic+Patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Fidarestat (SNK-860), a potent aldose reductase inhibitor, normalizes the elevated sorbitol accumulation in erythrocytes of diabetic patients</span></div><div class="casAuthors">Asano Tomoichiro; Saito Yasushi; Kawakami Masanobu; Yamada Nobuhiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of diabetes and its complications</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-8</span>
        ISSN:<span class="NLM_cas:issn">1056-8727</span>.
    </div><div class="casAbstract">Sorbitol accumulation in nerves has been regarded as one of the major causes of diabetic neuropathy.  In this study, fidarestat (SNK-860; 1 mg daily), a potent new aldose reductase inhibitor (ARI), or the commercially available ARI epalrestat (150 mg daily), was administered for 4 weeks to 58 Type 2 diabetic patients.  Treatment with these drugs had no effect on glycemic control, judging from plasma glucose and HbA(1c) levels.  However, fidarestat treatment normalized the elevated sorbitol content of erythrocytes under fasting as well as postprandial conditions.  In contrast, the effect of epalrestat was minimal.  There were no major side effects with fidarestat.  Thus, fidarestat is considered to be a potent and promising ARI, possibly useful for both preventing and treating diabetic neuropathy.  Further studies are needed to clarify how much the occurrence and progression of diabetic neuropathy are inhibited by normalizing sorbitol elevation with fidarestat treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQY67nKm4kYoMK3uFsUIZtkfW6udTcc2eZw0Zfyenx1pbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD383pslCmsw%253D%253D&md5=4018c38d0dca96a3f3a7296cc6ebd7e5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS1056-8727%2801%2900175-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1056-8727%252801%252900175-1%26sid%3Dliteratum%253Aachs%26aulast%3DAsano%26aufirst%3DT.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DKawakami%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DN.%26atitle%3DFidarestat%2520%2528SNK-860%2529%252C%2520a%2520Potent%2520Aldose%2520Reductase%2520Inhibitor%252C%2520Normalizes%2520the%2520Elevated%2520Sorbitol%2520Accumulation%2520in%2520Erythrocytes%2520of%2520Diabetic%2520Patients%26jtitle%3DJ.%2520Diabetes%2520Complications%26date%3D2002%26volume%3D16%26spage%3D133%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Okayama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okouchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imaeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukutomi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, M.</span><span> </span><span class="NLM_article-title">Mechanisms of Inhibitory Activity of the Aldose Reductase Inhibitor, Epalrestat, on High Glucose-Mediated Endothelial Injury: Neutrophil-Endothelial Cell Adhesion and Surface Expression of Endothelial Adhesion Molecules</span> <span class="citation_source-journal">J. Diabetes Complications</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2FS1056-8727%2802%2900178-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=12200074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A280%3ADC%252BD38votVKmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=321-326&author=N.+Okayamaauthor=H.+Omiauthor=M.+Okouchiauthor=K.+Imaedaauthor=T.+Katoauthor=M.+Akaoauthor=S.+Imaiauthor=M.+Shimizuauthor=T.+Fukutomiauthor=M.+Itoh&title=Mechanisms+of+Inhibitory+Activity+of+the+Aldose+Reductase+Inhibitor%2C+Epalrestat%2C+on+High+Glucose-Mediated+Endothelial+Injury%3A+Neutrophil-Endothelial+Cell+Adhesion+and+Surface+Expression+of+Endothelial+Adhesion+Molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of inhibitory activity of the aldose reductase inhibitor, epalrestat, on high glucose-mediated endothelial injury: neutrophil-endothelial cell adhesion and surface expression of endothelial adhesion molecules</span></div><div class="casAuthors">Okayama Naotsuka; Omi Hitoshi; Okouchi Masahiro; Imaeda Kenro; Kato Takashi; Akao Masaya; Imai Seiji; Shimizu Manabu; Fukutomi Tatsuya; Itoh Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of diabetes and its complications</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">321-6</span>
        ISSN:<span class="NLM_cas:issn">1056-8727</span>.
    </div><div class="casAbstract">BACKGROUND:  We have previously reported that endothelial cells cultured in the presence of high concentrations of glucose (27.8 and 55.5 mM) exhibited enhanced neutrophil adhesion through increased expression of endothelial adhesion molecules via the activation of a protein kinase C (PKC)-dependent pathway.  We also found that the aldose reductase inhibitor, epalrestat, inhibited these events, but the mechanisms for this inhibition remained unclear.  In this study, we further investigated the inhibitory mechanisms of epalrestat with reference to PKC activation and nitric oxide (NO) production.  METHODS:  Human umbilical vein endothelial cells (HUVECs) were cultured for 48 h in glucose-rich medium and neutrophils from healthy volunteers were then added and allowed to adhere for 30 min.  Adhered neutrophils were quantified by measuring myeloperoxidase (MPO) activity and surface expression of endothelial adhesion molecules was determined by enzyme immunoassay.  RESULTS:  Culture in the presence of a high concentration of glucose (27.8 mM for 48 h) increased neutrophil-endothelial cell adhesion and surface expression of intercellular adhesion molecule-1 (ICAM-1), P-selectin, and E-selectin on endothelial cells.  These phenomena were significantly inhibited by epalrestat (10 microM), while NO synthase (NOS) inhibitors reduced the inhibitory effects of this compound.  In contrast, 10 nM phorbol 12-myristate 13-acetate (PMA), a PKC activator, showed similar effects as high glucose, and these effects were also inhibited by epalrestat.  CONCLUSIONS:  Our data suggested that epalrestat inhibited high glucose-mediated neutrophil-endothelial cell adhesion and expression of endothelial adhesion molecules not only through inhibition of a PKC-dependent pathway, but also through increased endothelial NO production.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKGJV6B1R8mGGmni0r9GoKfW6udTcc2eZw0Zfyenx1pbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38votVKmug%253D%253D&md5=247cac5ec15041960174b06f7a241f59</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS1056-8727%2802%2900178-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1056-8727%252802%252900178-2%26sid%3Dliteratum%253Aachs%26aulast%3DOkayama%26aufirst%3DN.%26aulast%3DOmi%26aufirst%3DH.%26aulast%3DOkouchi%26aufirst%3DM.%26aulast%3DImaeda%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DAkao%26aufirst%3DM.%26aulast%3DImai%26aufirst%3DS.%26aulast%3DShimizu%26aufirst%3DM.%26aulast%3DFukutomi%26aufirst%3DT.%26aulast%3DItoh%26aufirst%3DM.%26atitle%3DMechanisms%2520of%2520Inhibitory%2520Activity%2520of%2520the%2520Aldose%2520Reductase%2520Inhibitor%252C%2520Epalrestat%252C%2520on%2520High%2520Glucose-Mediated%2520Endothelial%2520Injury%253A%2520Neutrophil-Endothelial%2520Cell%2520Adhesion%2520and%2520Surface%2520Expression%2520of%2520Endothelial%2520Adhesion%2520Molecules%26jtitle%3DJ.%2520Diabetes%2520Complications%26date%3D2002%26volume%3D16%26spage%3D321%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Nakahara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nejima, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamagami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amano, S.</span><span> </span><span class="NLM_article-title">A Randomised, Placebo Controlled Clinical Trial of the Aldose Reductse Inhibitor CT-112 as Management of Corneal Epithelial Disorders in Diabetic Patients</span> <span class="citation_source-journal">Br. J. Ophthalmol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">268</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1136%2Fbjo.2004.049841" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=15722300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A280%3ADC%252BD2M%252FptV2jsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2005&pages=266-268&author=M.+Nakaharaauthor=K.+Miyataauthor=S.+Otaniauthor=T.+Miyaiauthor=R.+Nejimaauthor=S.+Yamagamiauthor=S.+Amano&title=A+Randomised%2C+Placebo+Controlled+Clinical+Trial+of+the+Aldose+Reductse+Inhibitor+CT-112+as+Management+of+Corneal+Epithelial+Disorders+in+Diabetic+Patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients</span></div><div class="casAuthors">Nakahara M; Miyata K; Otani S; Miyai T; Nejima R; Yamagami S; Amano S</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of ophthalmology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">266-8</span>
        ISSN:<span class="NLM_cas:issn">0007-1161</span>.
    </div><div class="casAbstract">AIM:  To evaluate the efficacy of topical aldose reductase inhibitor CT-112 (5-[3-ethoxy-4-pentyloxyphenyl]-2,4-thiazolidinedione) on corneal epithelial barrier function in diabetic patients.  METHODS:  This was a prospective, randomised, double masked placebo controlled study. 34 eyes of 34 diabetic patients were randomly assigned treatment with 0.25% eye drops of CT-112 (n = 22) or a placebo (n = 12) four times a day for 8 weeks.  Corneal fluorescein staining and corneal sensation were examined before treatment as well as 4 and 8 weeks after administration.  Corneal epithelial permeability to fluorescence was measured with an anterior fluorophotometer.  RESULTS:  Average scores of superficial punctate keratopathy and corneal sensitivity did not differ significantly between the two groups at any time.  Whereas average fluorescein concentrations did not differ significantly for the CT-112 and placebo groups before treatment, they did differ significantly 4 and 8 weeks after treatment (4 weeks, p = 0.0327; 8 weeks, p = 0.0143).  CONCLUSION:  The topical aldose reductase inhibitor, CT-112 improves the corneal epithelial barrier function in diabetic patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTdVHiDU6CHZckU0YCbOU3EfW6udTcc2eZw0Zfyenx1pbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M%252FptV2jsw%253D%253D&md5=60c13679d2054555c7205de50dffacf4</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1136%2Fbjo.2004.049841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbjo.2004.049841%26sid%3Dliteratum%253Aachs%26aulast%3DNakahara%26aufirst%3DM.%26aulast%3DMiyata%26aufirst%3DK.%26aulast%3DOtani%26aufirst%3DS.%26aulast%3DMiyai%26aufirst%3DT.%26aulast%3DNejima%26aufirst%3DR.%26aulast%3DYamagami%26aufirst%3DS.%26aulast%3DAmano%26aufirst%3DS.%26atitle%3DA%2520Randomised%252C%2520Placebo%2520Controlled%2520Clinical%2520Trial%2520of%2520the%2520Aldose%2520Reductse%2520Inhibitor%2520CT-112%2520as%2520Management%2520of%2520Corneal%2520Epithelial%2520Disorders%2520in%2520Diabetic%2520Patients%26jtitle%3DBr.%2520J.%2520Ophthalmol.%26date%3D2005%26volume%3D89%26spage%3D266%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Hotta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akanuma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamori, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shichiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigeta, Y.</span><span> </span><span class="NLM_article-title">Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1538</span><span class="NLM_x">–</span> <span class="NLM_lpage">1544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=1538-1544&author=N.+Hottaauthor=Y.+Akanumaauthor=R.+Kawamoriauthor=K.+Matsuokaauthor=Y.+Okaauthor=M.+Shichiriauthor=T.+Toyotaauthor=M.+Nakashimaauthor=I.+Yoshimuraauthor=N.+Sakamotoauthor=Y.+Shigeta&title=Long-Term+Clinical+Effects+of+Epalrestat%2C+an+Aldose+Reductase+Inhibitor%2C+on+Diabetic+Peripheral+Neuropathy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHotta%26aufirst%3DN.%26aulast%3DAkanuma%26aufirst%3DY.%26aulast%3DKawamori%26aufirst%3DR.%26aulast%3DMatsuoka%26aufirst%3DK.%26aulast%3DOka%26aufirst%3DY.%26aulast%3DShichiri%26aufirst%3DM.%26aulast%3DToyota%26aufirst%3DT.%26aulast%3DNakashima%26aufirst%3DM.%26aulast%3DYoshimura%26aufirst%3DI.%26aulast%3DSakamoto%26aufirst%3DN.%26aulast%3DShigeta%26aufirst%3DY.%26atitle%3DLong-Term%2520Clinical%2520Effects%2520of%2520Epalrestat%252C%2520an%2520Aldose%2520Reductase%2520Inhibitor%252C%2520on%2520Diabetic%2520Peripheral%2520Neuropathy%26jtitle%3DDiabetes%2520Care%26date%3D2006%26volume%3D29%26spage%3D1538%26epage%3D1544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Oyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyasita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirai, K.</span><span> </span><span class="NLM_article-title">The Role of Polyol Pathway in High Glucose-Induced Endothelial Cell Damages</span> <span class="citation_source-journal">Diabetes Res. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.diabres.2006.02.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=16624439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD28Xns1Sltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2006&pages=227-234&author=T.+Oyamaauthor=Y.+Miyasitaauthor=H.+Watanabeauthor=K.+Shirai&title=The+Role+of+Polyol+Pathway+in+High+Glucose-Induced+Endothelial+Cell+Damages"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The role of polyol pathway in high glucose-induced endothelial cell damages</span></div><div class="casAuthors">Oyama, Tomokazu; Miyasita, Yoh; Watanabe, Husako; Shirai, Kohji</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes Research and Clinical Practice</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-234</span>CODEN:
                <span class="NLM_cas:coden">DRCPE9</span>;
        ISSN:<span class="NLM_cas:issn">0168-8227</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">To clarify the mechanism by which hyperglycemia in diabetes mellitus causes endothelial cell damages, the effects of high glucose on DNA fragmentation and caspase-3 activity of cultured endothelial cells and on the generation of 8-hydroxy-2'-deoxyguanosine (8-OHdG) were studied.  Furthermore, the involvement of the polyol pathway in this process was investigated using aldose reductase inhibitor (SNK-860).  Human umbilical vein endothelial cells (HUVECs) were incubated with 5.5 mmol/L (low glucose medium) or 28 mmol/L (high glucose medium) of glucose.  The amts. of fragmented DNA, caspase-3 activity and 8-OHdG in the medium increased in significantly greater extent in high glucose-incubated HUVECs than in low glucose-incubated HUVECs.  No significant increase in fragmented DNA or 8-OHdG was obsd. when HUVECs were incubated with mannitol (500 mg/mL).  The concn. of intracellular sorbitol was significantly higher in HUVECs incubated in high glucose medium than that in low glucose medium.  Addn. of the aldose reductase inhibitor SNK-860 dose-dependently decreased the intracellular sorbitol concn. in HUVECs incubated in high glucose medium, and also significantly suppressed the increases in fragmented DNA, caspase-3 activity and 8-OHdG by conditioning with high glucose medium.  These results suggest that high glucose-induced endothelial cell damages may be mediated by activation of the polyol pathway accompanied by augmented oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2QQzvSyT1ubVg90H21EOLACvtfcHk0lhIa38FDx_elg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xns1Sltrc%253D&md5=c7de29a2eb061126eba68042d83f984e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.diabres.2006.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.diabres.2006.02.010%26sid%3Dliteratum%253Aachs%26aulast%3DOyama%26aufirst%3DT.%26aulast%3DMiyasita%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DShirai%26aufirst%3DK.%26atitle%3DThe%2520Role%2520of%2520Polyol%2520Pathway%2520in%2520High%2520Glucose-Induced%2520Endothelial%2520Cell%2520Damages%26jtitle%3DDiabetes%2520Res.%2520Clin.%2520Pract.%26date%3D2006%26volume%3D73%26spage%3D227%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Lorenzi, M.</span><span> </span><span class="NLM_article-title">The Polyol Pathway as a Mechanism for Diabetic Retinopathy: Attractive, Elusive, and Resilient</span> <span class="citation_source-journal">Exp. Diabetes Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">61038</span><span class="refDoi"> DOI: 10.1155/2007/61038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1155%2F2007%2F61038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=18224243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FmvVOjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=61038&author=M.+Lorenzi&title=The+Polyol+Pathway+as+a+Mechanism+for+Diabetic+Retinopathy%3A+Attractive%2C+Elusive%2C+and+Resilient&doi=10.1155%2F2007%2F61038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient</span></div><div class="casAuthors">Lorenzi Mara</div><div class="citationInfo"><span class="NLM_cas:title">Experimental diabetes research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2007</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">61038</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The polyol pathway is a two-step metabolic pathway in which glucose is reduced to sorbitol, which is then converted to fructose.  It is one of the most attractive candidate mechanisms to explain, at least in part, the cellular toxicity of diabetic hyperglycemia because (i) it becomes active when intracellular glucose concentrations are elevated, (ii) the two enzymes are present in human tissues and organs that are sites of diabetic complications, and (iii) the products of the pathway and the altered balance of cofactors generate the types of cellular stress that occur at the sites of diabetic complications.  Inhibition (or ablation) of aldose reductase, the first and rate-limiting enzyme in the pathway, reproducibly prevents diabetic retinopathy in diabetic rodent models, but the results of a major clinical trial have been disappointing.  Since then, it has become evident that truly informative indicators of polyol pathway activity and/or inhibition are elusive, but are likely to be other than sorbitol levels if meant to predict accurately tissue consequences.  The spectrum of abnormalities known to occur in human diabetic retinopathy has enlarged to include glial and neuronal abnormalities, which in experimental animals are mediated by the polyol pathway.  The endothelial cells of human retinal vessels have been noted to have aldose reductase.  Specific polymorphisms in the promoter region of the aldose reductase gene have been found associated with susceptibility or progression of diabetic retinopathy.  This new knowledge has rekindled interest in a possible role of the polyol pathway in diabetic retinopathy and in methodological investigation that may prepare new clinical trials.  Only new drugs that inhibit aldose reductase with higher efficacy and safety than older drugs will make possible to learn if the resilience of the polyol pathway means that it has a role in human diabetic retinopathy that should not have gone undiscovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtb9gFve5I2-IHSmpohpd0fW6udTcc2eajK1C60ZfXv7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FmvVOjtQ%253D%253D&md5=dad10f3003f34edbcae39108b3631d74</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1155%2F2007%2F61038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2007%252F61038%26sid%3Dliteratum%253Aachs%26aulast%3DLorenzi%26aufirst%3DM.%26atitle%3DThe%2520Polyol%2520Pathway%2520as%2520a%2520Mechanism%2520for%2520Diabetic%2520Retinopathy%253A%2520Attractive%252C%2520Elusive%252C%2520and%2520Resilient%26jtitle%3DExp.%2520Diabetes%2520Res.%26date%3D2007%26spage%3D61038%26doi%3D10.1155%2F2007%2F61038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Matsumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuromiya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bril, V.</span><span> </span><span class="NLM_article-title">Ranirestat (AS-3201), a Potent Aldose Reductase Inhibitor, Reduces Sorbinil Levels and Improves Motor Nerve Conduction Velocity in Streptozotocin-Diabetes Rats</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1254%2Fjphs.08061FP" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=18635918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpt12mtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2008&pages=231-237&author=T.+Matsumotoauthor=Y.+Onoauthor=M.+Kuronoauthor=A.+Kuromiyaauthor=K.+Nakamuraauthor=V.+Bril&title=Ranirestat+%28AS-3201%29%2C+a+Potent+Aldose+Reductase+Inhibitor%2C+Reduces+Sorbinil+Levels+and+Improves+Motor+Nerve+Conduction+Velocity+in+Streptozotocin-Diabetes+Rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Ranirestat (AS-3201), a potent aldose reductase inhibitor, reduces sorbitol levels and improves motor nerve conduction velocity in streptozotocin-diabetic rats</span></div><div class="casAuthors">Matsumoto, Takafumi; Ono, Yoshiyuki; Kurono, Masuo; Kuromiya, Akemi; Nakamura, Keiji; Bril, Vera</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">231-237</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">Ranirestat (AS-3201) is a novel aldose reductase (AR) inhibitor with potentially beneficial effects on diabetic sensorimotor polyneuropathy.  In this study, we performed a kinetic anal. to det. the mode of inhibition of ranirestat on AR and investigated the effects of ranirestat on sorbitol levels in the sciatic nerves and lens of streptozotocin (STZ)-diabetic rats.  We also evaluated the effects on motor nerve conduction velocity (MNCV) in STZ-diabetic rats.  Kinetic analyses revealed that the ranirestat inhibition of AR is uncompetitive and reversible.  In the sciatic nerve and lens of STZ-diabetic rats, single oral administration of ranirestat slightly reduced sorbitol levels.  However, repeated oral administration of ranirestat for 5, 21, or 60 days enhanced the reducing effect of the ranirestat on sorbitol levels in the sciatic nerves and lens of STZ-diabetic rats with max. effects after 21 days of treatment.  Finally, repeated oral administration of ranirestat for 21 or 42 days dose-dependently improved the STZ-induced decrease in MNCV in STZ-diabetic rats.  These findings demonstrate that repeated oral administration of ranirestat reduces sorbitol accumulation and improves MNCV in STZ-diabetic rats, indicating that ranirestat is an agent for the management of diabetic sensorimotor polyneuropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQk1kpbKc2NLVg90H21EOLACvtfcHk0lhIa38FDx_elg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpt12mtrs%253D&md5=53f4c68da0d7c990a5b981592e597fa9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1254%2Fjphs.08061FP&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.08061FP%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DT.%26aulast%3DOno%26aufirst%3DY.%26aulast%3DKurono%26aufirst%3DM.%26aulast%3DKuromiya%26aufirst%3DA.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DBril%26aufirst%3DV.%26atitle%3DRanirestat%2520%2528AS-3201%2529%252C%2520a%2520Potent%2520Aldose%2520Reductase%2520Inhibitor%252C%2520Reduces%2520Sorbinil%2520Levels%2520and%2520Improves%2520Motor%2520Nerve%2520Conduction%2520Velocity%2520in%2520Streptozotocin-Diabetes%2520Rats%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2008%26volume%3D107%26spage%3D231%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Schemmel, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padiyara, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Souza, J. J.</span><span> </span><span class="NLM_article-title">Aldose Reductase Inhibitors in the Treatment of Diabetic Peripheral Neuropathy: A Review</span> <span class="citation_source-journal">J. Diabetes Complications</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">354</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.jdiacomp.2009.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=19748287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A280%3ADC%252BC3cfgsFyisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=354-360&author=K.+E.+Schemmelauthor=R.+S.+Padiyaraauthor=J.+J.+D%E2%80%99Souza&title=Aldose+Reductase+Inhibitors+in+the+Treatment+of+Diabetic+Peripheral+Neuropathy%3A+A+Review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review</span></div><div class="casAuthors">Schemmel Kate E; Padiyara Rosalyn S; D'Souza Jennifer J</div><div class="citationInfo"><span class="NLM_cas:title">Journal of diabetes and its complications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">354-60</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  The purpose of this article was to examine how aldose reductase (AR) inhibitors are used in the prevention and treatment of peripheral neuropathy in diabetes, specifically focusing on efficacy.  METHODS:  Medline searches were used to identify clinical trials investigating AR inhibitors and their proposed mechanism of action, efficacy, and adverse effects.  Additionally, the references of the articles returned by the Medline search were examined for pertinent publications.  RESULTS:  Three AR inhibitors were selected for review.  Modest improvements in the preservation and restoration of nerve conduction velocities were reported in the studies.  Additionally, patients reported improvements in the subjective symptoms associated with diabetic peripheral neuropathy.  Adverse effects for the studied agents were minimal or not reported.  CONCLUSIONS:  Given the mechanism by which diabetic peripheral neuropathy can result, targeting the polyol pathway as a method of treatment appears promising, yet the efficacy of newer AR inhibitors is still to be proven.  Currently, these agents are not marketed in the United States.  As newer studies emerge, diabetes educators will learn more about their efficacy and safety in preventing and treating diabetic peripheral neuropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRS8EHgBzm8mGPgL4LrC-0VfW6udTcc2eY7mJH_TPjAt7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfgsFyisw%253D%253D&md5=64a85cc489cd45120d17ab35bd459f88</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.jdiacomp.2009.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jdiacomp.2009.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DSchemmel%26aufirst%3DK.%2BE.%26aulast%3DPadiyara%26aufirst%3DR.%2BS.%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DJ.%2BJ.%26atitle%3DAldose%2520Reductase%2520Inhibitors%2520in%2520the%2520Treatment%2520of%2520Diabetic%2520Peripheral%2520Neuropathy%253A%2520A%2520Review%26jtitle%3DJ.%2520Diabetes%2520Complications%26date%3D2010%26volume%3D24%26spage%3D354%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Miyamoto, S.</span><span> </span><span class="NLM_article-title">Molecular Modeling and Structure-Based Drug Discovery Studies of Aldose Reductase Inhibitors</span> <span class="citation_source-journal">Chem-Bio Inf. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=74-85&author=S.+Miyamoto&title=Molecular+Modeling+and+Structure-Based+Drug+Discovery+Studies+of+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DS.%26atitle%3DMolecular%2520Modeling%2520and%2520Structure-Based%2520Drug%2520Discovery%2520Studies%2520of%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DChem-Bio%2520Inf.%2520J.%26date%3D2002%26volume%3D2%26spage%3D74%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Suzen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buyukbingol, E.</span><span> </span><span class="NLM_article-title">Recent Studies of Aldose Reductase Enzyme Inhibition for Diabetic Complications</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1329</span><span class="NLM_x">–</span> <span class="NLM_lpage">1352</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.2174%2F0929867033457377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=12871133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD3sXls1Wrtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=1329-1352&author=S.+Suzenauthor=E.+Buyukbingol&title=Recent+Studies+of+Aldose+Reductase+Enzyme+Inhibition+for+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Recent studies of aldose reductase enzyme inhibition for diabetic complications</span></div><div class="casAuthors">Suzen, Sibel; Buyukbingol, Erdem</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1329-1352</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Aldose reductase [ALR2; EC 1.1.1.21], a key enzyme of polyol pathway, catalyzes NADPH-dependent redn. of glucose to sorbitol (Sorbitol pathway), and an excessive accumulation of intracellular sorbitol found in various tissues of diabetic animals and in cells cultured under high glucose conditions has been proposed to be an important factor for the pathogenesis of diabetic complications.  The only strategy shown to be consistently beneficial in the treatment of diabetic complications is meticulous control of blood glucose.  However, aldose reductase (AR) enzyme inhibition is becoming one of the therapeutic strategies that have been proposed to prevent or ameliorate long-term diabetic complications.  Therefore, AR inhibitors (ARIs) hold promise for reducing metabolic nerve injury, but further study is needed.  On the other hand, there is strong evidence to show that diabetes is assocd. with increased oxidative stress.  However, the source of this oxidative stress remains unclear.  This relationship between diabetic complications and free radical prodn. was also under investigation.  The studies suggest that hydroxyl radical is indirectly inhibited by ARIs resulting from decreasing polyol levels and hydroxyl radical formation is related to the early stages of diabetic complications, possibly via the Fenton reaction involving H2O2 produced from the activated polyol pathway.  Therefore, it is proposed that hydroxyl radical may accelerate damage to the cell membranes resulting from polyol accumulation.  The search for specific inhibitors of AR enzyme has still become a major pharmaceutic challenge, though a no. of AR inhibitors have so far been assessed for diabetic complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVxwqI7nZRXrVg90H21EOLACvtfcHk0likcnSO39zlzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXls1Wrtb0%253D&md5=3039c410e8129e2ededf14fff77035ad</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F0929867033457377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867033457377%26sid%3Dliteratum%253Aachs%26aulast%3DSuzen%26aufirst%3DS.%26aulast%3DBuyukbingol%26aufirst%3DE.%26atitle%3DRecent%2520Studies%2520of%2520Aldose%2520Reductase%2520Enzyme%2520Inhibition%2520for%2520Diabetic%2520Complications%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2003%26volume%3D10%26spage%3D1329%26epage%3D1352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Alexiou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegklidou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatzopoulou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolaou, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demopoulos, V. J.</span><span> </span><span class="NLM_article-title">Aldose Reductase Enzyme and Its Implication to Major Health Problems of the 21st Century</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">734</span><span class="NLM_x">–</span> <span class="NLM_lpage">752</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.2174%2F092986709787458362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=19199934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFGqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=734-752&author=P.+Alexiouauthor=K.+Pegklidouauthor=M.+Chatzopoulouauthor=I.+Nicolaouauthor=V.+J.+Demopoulos&title=Aldose+Reductase+Enzyme+and+Its+Implication+to+Major+Health+Problems+of+the+21st+Century"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Aldose reductase enzyme and its implication to major health problems of the 21st century</span></div><div class="casAuthors">Alexiou, Polyxeni; Pegklidou, Kyriaki; Chatzopoulou, Maria; Nicolaou, Ioannis; Demopoulos, Vassilis J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">734-752</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Aldose reductase enzyme (ALR2) of the polyol metabolic pathway, apart from its role as detoxifying enzyme towards toxic aldehydes, osmoregulator in the kidney and regulator of sperm maturation, was first found to be implicated in the etiol. of the long term diabetic complications.  However, to date, emerging reports have suggested that under normal glucose concn., ALR2 may be up-regulated by factors other than hyperglycemia and therefore be involved also in other pathol. processes that have become major threats to human health in the 21st century.  Such pathologies are a no. of cardiac disorders, inflammation, mood disorders, renal insufficiency and ovarian abnormalities.  In addn., ALR2 was found to be over-expressed in different human cancers such as liver, breast, ovarian, cervical and rectal cancers.  Although several aldose reductase inhibitors (ARIs) have progressed to the clin. level, only one is currently on the market.  Thus, attention is currently targeted to discover ARIs of distinct chem. structures, being neither hydantoin nor carboxylic acid derivs.  The present review focuses on the mol. mechanisms by which ALR2 is implicated in a no. of pathologies, on various aspects concerning its catalytic mechanism and its active site, and on the main classes of ARIs that have been developed to date, as well as on reported (quant.) structure-activity relationships.  The presented data aim to support the notion that ARIs are of pharmacotherapeutic interest for the pharmaceutical community and highlight essential aspects for the development of efficient and potent ARIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEzbMxWaT45bVg90H21EOLACvtfcHk0likcnSO39zlzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFGqtr0%253D&md5=b84b7cfab09e7c63dc78ac8f2d729411</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F092986709787458362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986709787458362%26sid%3Dliteratum%253Aachs%26aulast%3DAlexiou%26aufirst%3DP.%26aulast%3DPegklidou%26aufirst%3DK.%26aulast%3DChatzopoulou%26aufirst%3DM.%26aulast%3DNicolaou%26aufirst%3DI.%26aulast%3DDemopoulos%26aufirst%3DV.%2BJ.%26atitle%3DAldose%2520Reductase%2520Enzyme%2520and%2520Its%2520Implication%2520to%2520Major%2520Health%2520Problems%2520of%2520the%252021st%2520Century%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2009%26volume%3D16%26spage%3D734%26epage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Maccari, R.; Ottanà, R.</span><span> </span><span class="NLM_article-title">2,4-Thiazolidinedione and 2-Thioxo-4-thiazolidinone Derivatives as Aldose Reductase Inhibitors in the Search for Drugs To Prevent Long-Term Diabetes Complications</span>. In  <span class="citation_source-book">Advances in Molecular Mechanisms and Pharmacology of Diabetic Complications</span>; <span class="NLM_contrib-group">Stefek, M.</span> Ed.; <span class="NLM_publisher-name">Transworld Research Network</span>: <span class="NLM_publisher-loc">Kerala, India</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=219-245&author=R.+Maccari&author=R.+Ottan%C3%A0author=M.+Stefek&title=Advances+in+Molecular+Mechanisms+and+Pharmacology+of+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMaccari%26aufirst%3DR.%26atitle%3D2%252C4-Thiazolidinedione%2520and%25202-Thioxo-4-thiazolidinone%2520Derivatives%2520as%2520Aldose%2520Reductase%2520Inhibitors%2520in%2520the%2520Search%2520for%2520Drugs%2520To%2520Prevent%2520Long-Term%2520Diabetes%2520Complications%26btitle%3DAdvances%2520in%2520Molecular%2520Mechanisms%2520and%2520Pharmacology%2520of%2520Diabetic%2520Complications%26aulast%3DStefek%26aufirst%3DM.%26pub%3DTransworld%2520Research%2520Network%26date%3D2010%26spage%3D219%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Hotta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamori, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atsumi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigeta, Y.</span><span> </span><span class="NLM_article-title">Stratified Analyses for Selecting Appropriate Target Patients with Diabetic Peripheral Neuropathy for Long-Term Treatment with an Aldose Reductase Inhibitor, Epalrestat</span> <span class="citation_source-journal">Diabetic Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">818</span><span class="NLM_x">–</span> <span class="NLM_lpage">825</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1111%2Fj.1464-5491.2008.02490.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=18644069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvFyiuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2008&pages=818-825&author=N.+Hottaauthor=R.+Kawamoriauthor=Y.+Atsumiauthor=M.+Babaauthor=H.+Kishikawaauthor=J.+Nakamuraauthor=S.+Oikawaauthor=N.+Yamadaauthor=H.+Yasudaauthor=Y.+Shigeta&title=Stratified+Analyses+for+Selecting+Appropriate+Target+Patients+with+Diabetic+Peripheral+Neuropathy+for+Long-Term+Treatment+with+an+Aldose+Reductase+Inhibitor%2C+Epalrestat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat</span></div><div class="casAuthors">Hotta, N.; Kawamori, R.; Atsumi, Y.; Baba, M.; Kishikawa, H.; Nakamura, J.; Oikawa, S.; Yamada, N.; Yasuda, H.; Shigeta, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetic Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">818-825</span>CODEN:
                <span class="NLM_cas:coden">DIMEEV</span>;
        ISSN:<span class="NLM_cas:issn">0742-3071</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The long-term efficacy of epalrestat, an aldose reductase inhibitor, in improving subjective symptoms and nerve function was comprehensively assessed to identify patients with diabetic peripheral neuropathy who responded to epalrestat treatment.  Stratified analyses were conducted on data from patients in the Aldose Reductase Inhibitor-Diabetes Complications Trial (ADCT).  The ADCT included patients with diabetic peripheral neuropathy, median motor nerve conduction velocity ≥ 40 m/s and with glycated Hb (HbA1c) ≤9.0%.  Longitudinal data on HbA1c and subjective symptoms of the patients for 3 years were analyzed (epalrestat n = 231, control subjects n = 273).  Stratified analyses based on background variables (glycemic control, grades of retinopathy or proteinuria) were performed to examine the relationship between subjective symptoms and nerve function.  Multiple logistic regression analyses were conducted.  Stratified subgroup analyses revealed significantly better efficacy of epalrestat in patients with good glycemic control and less severe diabetic complications.  In the control group, no improvement in nerve function was seen regardless of whether symptomatic benefit was obtained.  In the epalrestat group, nerve function deteriorated less or improved in patients whose symptoms improved.  The odds ratio of the efficacy of epalrestat vs. control subjects was approx. 2:1 (4:1 in patients with HbA1c ≤7.0%).  Our results suggest that epalrestat, an aldose reductase inhibitor, will provide a clin. significant means of preventing and treating diabetic neuropathy if used in appropriate patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoELGO2L0SGxLVg90H21EOLACvtfcHk0lhzNNd5v1ITCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvFyiuro%253D&md5=e70778d565ff6534db82c1b35bd81102</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1111%2Fj.1464-5491.2008.02490.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1464-5491.2008.02490.x%26sid%3Dliteratum%253Aachs%26aulast%3DHotta%26aufirst%3DN.%26aulast%3DKawamori%26aufirst%3DR.%26aulast%3DAtsumi%26aufirst%3DY.%26aulast%3DBaba%26aufirst%3DM.%26aulast%3DKishikawa%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DJ.%26aulast%3DOikawa%26aufirst%3DS.%26aulast%3DYamada%26aufirst%3DN.%26aulast%3DYasuda%26aufirst%3DH.%26aulast%3DShigeta%26aufirst%3DY.%26atitle%3DStratified%2520Analyses%2520for%2520Selecting%2520Appropriate%2520Target%2520Patients%2520with%2520Diabetic%2520Peripheral%2520Neuropathy%2520for%2520Long-Term%2520Treatment%2520with%2520an%2520Aldose%2520Reductase%2520Inhibitor%252C%2520Epalrestat%26jtitle%3DDiabetic%2520Med.%26date%3D2008%26volume%3D25%26spage%3D818%26epage%3D825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Ramirez, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borja, N. L.</span><span> </span><span class="NLM_article-title">Epalrestat: An Aldose Reductase Inhibitor for the Treatment of Diabetic Neuropathy</span> <span class="citation_source-journal">Pharmacotherapy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">646</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1592%2Fphco.28.5.646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=18447661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVyku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=646-655&author=M.+A.+Ramirezauthor=N.+L.+Borja&title=Epalrestat%3A+An+Aldose+Reductase+Inhibitor+for+the+Treatment+of+Diabetic+Neuropathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy</span></div><div class="casAuthors">Ramirez, Mary Ann; Borja, Nancy L.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-655</span>CODEN:
                <span class="NLM_cas:coden">PHPYDQ</span>;
        ISSN:<span class="NLM_cas:issn">0277-0008</span>.
    
            (<span class="NLM_cas:orgname">Pharmacotherapy Publications</span>)
        </div><div class="casAbstract">A review.  Diabetic neuropathy is one of the most common long-term complications in patients with diabetes mellitus, with a prevalence of 60-70% in the United States.  Treatment options include antidepressants, anticonvulsants, tramadol, and capsaicin.  These agents are modestly effective for symptomatic relief, but they do not affect the underlying pathol. nor do they slow progression of the disease.  Epalrestat is an aldose reductase inhibitor that is approved in Japan for the improvement of subjective neuropathy symptoms, abnormality of vibration sense, and abnormal changes in heart beat assocd. with diabetic peripheral neuropathy.  Unlike the current treatment options for diabetic neuropathy, epalrestat may affect or delay progression of the underlying disease process.  Data from exptl. studies indicate that epalrestat reduces sorbitol accumulation in the sciatic nerve, erythrocytes, and ocular tissues in animals, and in erythrocytes in humans.  Data from six clin. trials were evaluated, and it was detd. that epalrestat 50 mg 3 times/day may improve motor and sensory nerve conduction velocity and subjective neuropathy symptoms as compared with baseline and placebo.  Epalrestat is well tolerated, and the most frequently reported adverse effects include elevations in liver enzyme levels and gastrointestinal-related events such as nausea and vomiting.  Epalrestat may serve as a new therapeutic option to prevent or slow the progression of diabetic neuropathy.  Long-term, comparative studies in diverse patient populations are needed for clin. application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowdga4NOt42rVg90H21EOLACvtfcHk0lhzNNd5v1ITCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVyku7c%253D&md5=f0db682380b3aa9f9eaa8d19165a77ee</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1592%2Fphco.28.5.646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1592%252Fphco.28.5.646%26sid%3Dliteratum%253Aachs%26aulast%3DRamirez%26aufirst%3DM.%2BA.%26aulast%3DBorja%26aufirst%3DN.%2BL.%26atitle%3DEpalrestat%253A%2520An%2520Aldose%2520Reductase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Diabetic%2520Neuropathy%26jtitle%3DPharmacotherapy%26date%3D2008%26volume%3D28%26spage%3D646%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Sarges, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnur, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belletire, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. J.</span><span> </span><span class="NLM_article-title">Spiro Hydantoin Aldose Reductase Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00396a037" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=230-243&author=R.+Sargesauthor=R.+C.+Schnurauthor=J.+L.+Belletireauthor=M.+J.+Peterson&title=Spiro+Hydantoin+Aldose+Reductase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm00396a037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00396a037%26sid%3Dliteratum%253Aachs%26aulast%3DSarges%26aufirst%3DR.%26aulast%3DSchnur%26aufirst%3DR.%2BC.%26aulast%3DBelletire%26aufirst%3DJ.%2BL.%26aulast%3DPeterson%26aufirst%3DM.%2BJ.%26atitle%3DSpiro%2520Hydantoin%2520Aldose%2520Reductase%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D230%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldinger, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdi, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussolotti, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inskeep, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, T. W.</span><span> </span><span class="NLM_article-title">Hydantoin Bioisosteres. In Vivo Active Spiro Hydroxy Acetic Acid Aldose Reductase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2169</span><span class="NLM_x">–</span> <span class="NLM_lpage">2177</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00090a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADyaK38Xkt1Kht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=2169-2177&author=C.+A.+Lipinskiauthor=C.+E.+Aldingerauthor=T.+A.+Beyerauthor=J.+Bordnerauthor=D.+F.+Burdiauthor=D.+L.+Bussolottiauthor=P.+B.+Inskeepauthor=T.+W.+Siegel&title=Hydantoin+Bioisosteres.+In+Vivo+Active+Spiro+Hydroxy+Acetic+Acid+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Hydantoin bioisosteres.  In vivo active spiro hydroxy acetic acid aldose reductase inhibitors</span></div><div class="casAuthors">Lipinski, Christopher A.; Aldinger, Charles E.; Beyer, Thomas A.; Bordner, Jon; Burdi, Douglas F.; Bussolotti, Donald L.; Inskeep, Philip B.; Siegel, Todd W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2169-77</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The hypothesis that clin. side effects of the aldose reductase inhibitor (ARI) sorbinil were related to its hydantoin ring led to a bioisosteric anal. and replacement of the hydantoin by a spiro hydroxy acetic acid moiety as in chromans I ( R = H, Me; R1 = H, F, Cl; R2 = H, Cl).  These hydroxy acids, compared to hydantoins, showed a similar potency increase on chroman 2-Me substitution, a similar orthogonal relationship of acidic to arom. moieties, and similar ARI enantioselectivity.  In this series the six-membered spiro hydroxy acetic acid anion array is a bioisostere for a spiro hydantoin anion and leads to ARIs with excellent in vivo activity.  In vitro and in vivo activity was improved over I ( R-R2 = H) by chroman cis-2-methylation and by arom. 6,7-halogen substitution.  Compds. with the best acute in vivo activity in rats were compared for chronic in vivo activity.  The highest tissue levels and best chronic in vivo activities were found in the racemic I [ R = Me, R1 = R2= Cl(II); R = Me, R1 = F, R2 = Cl(III)].  ARI activity was enantioselective for the (2R,4R)-enantiomers of II and III.  (2R,4R)-III was selected for phase 1 clin. trials and did not exhibit sorbinil-like hypersensitivity side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnUzTAoGxO-bVg90H21EOLACvtfcHk0lhzNNd5v1ITCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xkt1Kht7k%253D&md5=8fe16309a1efc184e11e90fa17829eb5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm00090a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00090a004%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DAldinger%26aufirst%3DC.%2BE.%26aulast%3DBeyer%26aufirst%3DT.%2BA.%26aulast%3DBordner%26aufirst%3DJ.%26aulast%3DBurdi%26aufirst%3DD.%2BF.%26aulast%3DBussolotti%26aufirst%3DD.%2BL.%26aulast%3DInskeep%26aufirst%3DP.%2BB.%26aulast%3DSiegel%26aufirst%3DT.%2BW.%26atitle%3DHydantoin%2520Bioisosteres.%2520In%2520Vivo%2520Active%2520Spiro%2520Hydroxy%2520Acetic%2520Acid%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D2169%26epage%3D2177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Sestanj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treasurywala, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humber, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simard-Duquesne, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvornik, D.</span><span> </span><span class="NLM_article-title"><i>N</i>-[[5-(Trifluoromethyl)-6-methoxy-1-naphthalenyl]thioxomethyl]-<i>N</i>-methylglycine (Tolrestat), a Potent, Orally Active Aldose Reductase Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00369a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1984&pages=255-256&author=K.+Sestanjauthor=F.+Belliniauthor=S.+Fungauthor=N.+Abrahamauthor=A.+Treasurywalaauthor=L.+Humberauthor=N.+Simard-Duquesneauthor=D.+Dvornik&title=N-%5B%5B5-%28Trifluoromethyl%29-6-methoxy-1-naphthalenyl%5Dthioxomethyl%5D-N-methylglycine+%28Tolrestat%29%2C+a+Potent%2C+Orally+Active+Aldose+Reductase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm00369a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00369a003%26sid%3Dliteratum%253Aachs%26aulast%3DSestanj%26aufirst%3DK.%26aulast%3DBellini%26aufirst%3DF.%26aulast%3DFung%26aufirst%3DS.%26aulast%3DAbraham%26aufirst%3DN.%26aulast%3DTreasurywala%26aufirst%3DA.%26aulast%3DHumber%26aufirst%3DL.%26aulast%3DSimard-Duquesne%26aufirst%3DN.%26aulast%3DDvornik%26aufirst%3DD.%26atitle%3DN-%255B%255B5-%2528Trifluoromethyl%2529-6-methoxy-1-naphthalenyl%255Dthioxomethyl%255D-N-methylglycine%2520%2528Tolrestat%2529%252C%2520a%2520Potent%252C%2520Orally%2520Active%2520Aldose%2520Reductase%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1984%26volume%3D27%26spage%3D255%26epage%3D256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Mylari, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zembrowski, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldinger, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dee, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, D. H.</span><span> </span><span class="NLM_article-title">Novel, Potent Aldose Reductase Inhibitors: 3,4-Dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-1-phthalazine-acetic Acid (Zopolrestat) and Congeners</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">108</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00105a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=108-122&author=B.+L.+Mylariauthor=E.+R.+Larsonauthor=T.+A.+Beyerauthor=W.+J.+Zembrowskiauthor=C.+E.+Aldingerauthor=M.+F.+Deeauthor=T.+W.+Siegelauthor=D.+H.+Singleton&title=Novel%2C+Potent+Aldose+Reductase+Inhibitors%3A+3%2C4-Dihydro-4-oxo-3-%5B%5B5-%28trifluoromethyl%29-2-benzothiazolyl%5Dmethyl%5D-1-phthalazine-acetic+Acid+%28Zopolrestat%29+and+Congeners"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm00105a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00105a018%26sid%3Dliteratum%253Aachs%26aulast%3DMylari%26aufirst%3DB.%2BL.%26aulast%3DLarson%26aufirst%3DE.%2BR.%26aulast%3DBeyer%26aufirst%3DT.%2BA.%26aulast%3DZembrowski%26aufirst%3DW.%2BJ.%26aulast%3DAldinger%26aufirst%3DC.%2BE.%26aulast%3DDee%26aufirst%3DM.%2BF.%26aulast%3DSiegel%26aufirst%3DT.%2BW.%26aulast%3DSingleton%26aufirst%3DD.%2BH.%26atitle%3DNovel%252C%2520Potent%2520Aldose%2520Reductase%2520Inhibitors%253A%25203%252C4-Dihydro-4-oxo-3-%255B%255B5-%2528trifluoromethyl%2529-2-benzothiazolyl%255Dmethyl%255D-1-phthalazine-acetic%2520Acid%2520%2528Zopolrestat%2529%2520and%2520Congeners%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D108%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Hotta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakuta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, K.</span><span> </span><span class="NLM_article-title">Effects of a Novel Aldose Reductase Inhibitor, Fidarestat (SNK-860), on Vibration Perception Threshold and Subjective Symptoms in Patients with Diabetic Polyneuropathy</span> <span class="citation_source-journal">Clin. Drug Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">680</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.2165%2F00044011-200424110-00006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=17523730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsV2juw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=671-680&author=N.+Hottaauthor=K.+Yasudaauthor=Y.+Sumitaauthor=T.+Sanoauthor=H.+Kakutaauthor=M.+Nagashimaauthor=Y.+Hayashiauthor=M.+Yamamotoauthor=T.+Wakaoauthor=M.+Okuyamaauthor=M.+Kobayashiauthor=K.+Mori&title=Effects+of+a+Novel+Aldose+Reductase+Inhibitor%2C+Fidarestat+%28SNK-860%29%2C+on+Vibration+Perception+Threshold+and+Subjective+Symptoms+in+Patients+with+Diabetic+Polyneuropathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of a novel aldose reductase inhibitor, fidarestat (SNK-860), on vibration perception threshold and subjective symptoms in patients with diabetic polyneuropathy: An open-label pilot study</span></div><div class="casAuthors">Hotta, Nigishi; Yasuda, Keigo; Sumita, Yasuhiro; Sano, Takahisa; Kakuta, Hironobu; Nagashima, Makoto; Hayashi, Yoshinari; Yamamoto, Masahiro; Wakao, Takaaki; Okuyama, Makio; Kobayashi, Masato; Mori, Kouichi</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Drug Investigation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">671-680</span>CODEN:
                <span class="NLM_cas:coden">CDINFR</span>;
        ISSN:<span class="NLM_cas:issn">1173-2563</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">Objective: To evaluate the effects of fidarestat (SNK-860) on vibration perception threshold, as measured by C64 quant. tuning fork (64Hz) anal., as well as its effects on subjective symptoms in patients with diabetic polyneuropathy.  Design and setting: Open-label, prospective study conducted at 12 hospitals in the central area of Honshu, Japan.  Interventions: Fidarestat was administered at a dosage of 1mg once daily after breakfast for 28 wk.  Main outcome measures: Vibration perception threshold of upper and lower extremities was detd. using a C64 quant. tuning fork, and measured at baseline and after 12 and 28 wk of treatment.  Subjective symptoms, including numbness, spontaneous pain and hypoaesthesia, were evaluated every 4 wk.  Results: Subjective symptoms were evaluated in 22 patients, and vibration perception threshold data were available for 19 patients.  Vibration perception threshold at baseline was neg. correlated with the severity of the following subjective symptoms: numbness in the upper limbs, and numbness, coldness and hot flushes, smarting pain causing difficulty walking and hypoaesthesia in the lower limbs.  During treatment with fidarestat, vibration perception threshold increased significantly in the upper (p = 0.0017) and lower (p = 0.0001) limbs.  The following symptoms were also significantly improved: severity of numbness in the lower limbs, heaviness in the foot, coldness and hot flushes in the lower limbs, smarting pain causing difficulty walking, sensation as if walking on sand, sensation as if walking on an uneven road, spontaneous pain in the lower limbs, and dizziness.  Adverse events occurred in four patients.  Conclusions: Administration of fidarestat after breakfast was effective in significantly alleviating some symptoms of diabetic polyneuropathy.  The C64 quant. tuning fork anal. is useful in the diagnosis of diabetic polyneuropathy, and as a measure of the severity of the neuropathol. symptoms of this condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGLmvqhe1tubVg90H21EOLACvtfcHk0liuem217ze3Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsV2juw%253D%253D&md5=01cc072bd94487b75ad2424e0b5ad463</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2165%2F00044011-200424110-00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00044011-200424110-00006%26sid%3Dliteratum%253Aachs%26aulast%3DHotta%26aufirst%3DN.%26aulast%3DYasuda%26aufirst%3DK.%26aulast%3DSumita%26aufirst%3DY.%26aulast%3DSano%26aufirst%3DT.%26aulast%3DKakuta%26aufirst%3DH.%26aulast%3DNagashima%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DWakao%26aufirst%3DT.%26aulast%3DOkuyama%26aufirst%3DM.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DK.%26atitle%3DEffects%2520of%2520a%2520Novel%2520Aldose%2520Reductase%2520Inhibitor%252C%2520Fidarestat%2520%2528SNK-860%2529%252C%2520on%2520Vibration%2520Perception%2520Threshold%2520and%2520Subjective%2520Symptoms%2520in%2520Patients%2520with%2520Diabetic%2520Polyneuropathy%26jtitle%3DClin.%2520Drug%2520Invest.%26date%3D2004%26volume%3D24%26spage%3D671%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohman, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millen, J.</span><span> </span><span class="NLM_article-title">Novel Spirosuccinimide Aldose Reductase Inhibitors Derived from Isoquinoline-1,3-diones: 2-[(4-Bromo-2-fluorophenyl)methyl]-6-fluorospiro[isoquinoline-4(1<i>H</i>),3′-pyrrolidine]-1,2′,3,5′(2<i>H</i>)-tetrone and Congeners. I</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2043</span><span class="NLM_x">–</span> <span class="NLM_lpage">2058</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00039a017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=2043-2058&author=M.+S.+Malamasauthor=T.+C.+Hohmanauthor=J.+Millen&title=Novel+Spirosuccinimide+Aldose+Reductase+Inhibitors+Derived+from+Isoquinoline-1%2C3-diones%3A+2-%5B%284-Bromo-2-fluorophenyl%29methyl%5D-6-fluorospiro%5Bisoquinoline-4%281H%29%2C3%E2%80%B2-pyrrolidine%5D-1%2C2%E2%80%B2%2C3%2C5%E2%80%B2%282H%29-tetrone+and+Congeners.+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm00039a017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00039a017%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DHohman%26aufirst%3DT.%2BC.%26aulast%3DMillen%26aufirst%3DJ.%26atitle%3DNovel%2520Spirosuccinimide%2520Aldose%2520Reductase%2520Inhibitors%2520Derived%2520from%2520Isoquinoline-1%252C3-diones%253A%25202-%255B%25284-Bromo-2-fluorophenyl%2529methyl%255D-6-fluorospiro%255Bisoquinoline-4%25281H%2529%252C3%25E2%2580%25B2-pyrrolidine%255D-1%252C2%25E2%2580%25B2%252C3%252C5%25E2%2580%25B2%25282H%2529-tetrone%2520and%2520Congeners.%2520I%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D2043%26epage%3D2058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Bril, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirose, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamioka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, R.</span><span> </span><span class="NLM_article-title">Ranirestat for the Management of Diabetic Sensorimotor Polyneuropathy</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1256</span><span class="NLM_x">–</span> <span class="NLM_lpage">1260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2009&pages=1256-1260&author=V.+Brilauthor=T.+Hiroseauthor=S.+Tamiokaauthor=R.+Buchanan&title=Ranirestat+for+the+Management+of+Diabetic+Sensorimotor+Polyneuropathy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBril%26aufirst%3DV.%26aulast%3DHirose%26aufirst%3DT.%26aulast%3DTamioka%26aufirst%3DS.%26aulast%3DBuchanan%26aufirst%3DR.%26atitle%3DRanirestat%2520for%2520the%2520Management%2520of%2520Diabetic%2520Sensorimotor%2520Polyneuropathy%26jtitle%3DDiabetes%2520Care%26date%3D2009%26volume%3D32%26spage%3D1256%26epage%3D1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Ward, W. H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sennitt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timms, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirrlees, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuffin, D. P.</span><span> </span><span class="NLM_article-title">Ponalrestat: A Potent and Specific Inhibitor of Aldose Reductase</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">346</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1990&pages=337-346&author=W.+H.+J.+Wardauthor=C.+A.+Sennittauthor=H.+Rossauthor=A.+Dingleauthor=D.+Timmsauthor=D.+J.+Mirrleesauthor=D.+P.+Tuffin&title=Ponalrestat%3A+A+Potent+and+Specific+Inhibitor+of+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DW.%2BH.%2BJ.%26aulast%3DSennitt%26aufirst%3DC.%2BA.%26aulast%3DRoss%26aufirst%3DH.%26aulast%3DDingle%26aufirst%3DA.%26aulast%3DTimms%26aufirst%3DD.%26aulast%3DMirrlees%26aufirst%3DD.%2BJ.%26aulast%3DTuffin%26aufirst%3DD.%2BP.%26atitle%3DPonalrestat%253A%2520A%2520Potent%2520and%2520Specific%2520Inhibitor%2520of%2520Aldose%2520Reductase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1990%26volume%3D39%26spage%3D337%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Activation of Nuclear Factor-κB by Hyperglycemia in Vascular Smooth Muscle Cells Is Regulated by Aldose Reductase</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2910</span><span class="NLM_x">–</span> <span class="NLM_lpage">2920</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2004&pages=2910-2920&author=K.+V.+Ramanaauthor=B.+Friedrichauthor=S.+Srivastavaauthor=A.+Bhatnagarauthor=S.+K.+Srivastava&title=Activation+of+Nuclear+Factor-%CE%BAB+by+Hyperglycemia+in+Vascular+Smooth+Muscle+Cells+Is+Regulated+by+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DFriedrich%26aufirst%3DB.%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DBhatnagar%26aufirst%3DA.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DActivation%2520of%2520Nuclear%2520Factor-%25CE%25BAB%2520by%2520Hyperglycemia%2520in%2520Vascular%2520Smooth%2520Muscle%2520Cells%2520Is%2520Regulated%2520by%2520Aldose%2520Reductase%26jtitle%3DDiabetes%26date%3D2004%26volume%3D53%26spage%3D2910%26epage%3D2920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Inhibition of Aldose Reductase Attenuates TNF-α-Induced Expression of Adhesion Molecules in Endothelial Cells</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1209</span><span class="NLM_x">–</span> <span class="NLM_lpage">1218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=1209-1218&author=K.+V.+Ramanaauthor=A.+Bhatnagarauthor=S.+K.+Srivastava&title=Inhibition+of+Aldose+Reductase+Attenuates+TNF-%CE%B1-Induced+Expression+of+Adhesion+Molecules+in+Endothelial+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DBhatnagar%26aufirst%3DA.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DInhibition%2520of%2520Aldose%2520Reductase%2520Attenuates%2520TNF-%25CE%25B1-Induced%2520Expression%2520of%2520Adhesion%2520Molecules%2520in%2520Endothelial%2520Cells%26jtitle%3DFASEB%2520J.%26date%3D2004%26volume%3D18%26spage%3D1209%26epage%3D1218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Mediation of Aldose Reductase in Lipopolysaccharide-Induced Inflammatory Signals in Mouse Peritoneal Macrophages</span> <span class="citation_source-journal">Cytokine</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2006&pages=115-122&author=K.+V.+Ramanaauthor=S.+K.+Srivastava&title=Mediation+of+Aldose+Reductase+in+Lipopolysaccharide-Induced+Inflammatory+Signals+in+Mouse+Peritoneal+Macrophages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DMediation%2520of%2520Aldose%2520Reductase%2520in%2520Lipopolysaccharide-Induced%2520Inflammatory%2520Signals%2520in%2520Mouse%2520Peritoneal%2520Macrophages%26jtitle%3DCytokine%26date%3D2006%26volume%3D36%26spage%3D115%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Yadav, U. C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span> </span><span class="NLM_article-title">Aldose Reductase Inhibition Prevents Endotoxin-Induced Uveitis in Rats</span> <span class="citation_source-journal">Invest. Ophthalmol. Visual Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4634</span><span class="NLM_x">–</span> <span class="NLM_lpage">4642</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=4634-4642&author=U.+C.+S.+Yadavauthor=S.+K.+Srivastavaauthor=K.+V.+Ramana&title=Aldose+Reductase+Inhibition+Prevents+Endotoxin-Induced+Uveitis+in+Rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYadav%26aufirst%3DU.%2BC.%2BS.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26atitle%3DAldose%2520Reductase%2520Inhibition%2520Prevents%2520Endotoxin-Induced%2520Uveitis%2520in%2520Rats%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2007%26volume%3D48%26spage%3D4634%26epage%3D4642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Yadav, U. C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilera-Aguirre, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boldogh, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulares, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Inhibition of Aldose Reductase Prevents Experimental Allergic Airway Inflammation in Mice</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e6535</span><span class="refDoi"> DOI: 10.1371/journal.pone.0006535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1371%2Fjournal.pone.0006535" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e6535&author=U.+C.+S.+Yadavauthor=K.+V.+Ramanaauthor=L.+Aguilera-Aguirreauthor=I.+Boldoghauthor=H.+A.+Boularesauthor=S.+K.+Srivastava&title=Inhibition+of+Aldose+Reductase+Prevents+Experimental+Allergic+Airway+Inflammation+in+Mice&doi=10.1371%2Fjournal.pone.0006535"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0006535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0006535%26sid%3Dliteratum%253Aachs%26aulast%3DYadav%26aufirst%3DU.%2BC.%2BS.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DAguilera-Aguirre%26aufirst%3DL.%26aulast%3DBoldogh%26aufirst%3DI.%26aulast%3DBoulares%26aufirst%3DH.%2BA.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DInhibition%2520of%2520Aldose%2520Reductase%2520Prevents%2520Experimental%2520Allergic%2520Airway%2520Inflammation%2520in%2520Mice%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26spage%3De6535%26doi%3D10.1371%2Fjournal.pone.0006535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Reddy, A. B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span> </span><span class="NLM_article-title">Aldose Reductase Inhibition: Emerging Drug Target for the Treatment of Cardiovascular Complications</span> <span class="citation_source-journal">Recent Pat. Cardiovasc. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.2174%2F157489010790192683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=19886861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVCiur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=25-32&author=A.+B.+M.+Reddyauthor=K.+V.+Ramana&title=Aldose+Reductase+Inhibition%3A+Emerging+Drug+Target+for+the+Treatment+of+Cardiovascular+Complications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Aldose reductase inhibition: emerging drug target for the treatment of cardiovascular complications</span></div><div class="casAuthors">Reddy, Aramati B. M.; Ramana, Kota V.</div><div class="citationInfo"><span class="NLM_cas:title">Recent Patents on Cardiovascular Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-32</span>CODEN:
                <span class="NLM_cas:coden">RPCDFC</span>;
        ISSN:<span class="NLM_cas:issn">1574-8901</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Diabetes is a major metabolic disorder and leading cause of morbidity and mortality in the developed world.  Indeed, vascular complications are the major cause of mortality in diabetics.  Impaired glucose metab. has been implicated as a cause for the obsd. cardiac dysfunction in diabetics.  Dramatic increase in polyol pathway flux during hyperglycemia could cause damage to blood vessels that leads to heart failure.  Recent investigations and patent applications suggest the interesting and important role of polyol pathway enzyme, aldose reductase (AR) in mediating oxidative stress-induced inflammatory signals.  AR inhibitors have been shown to prevent or delay the onset of cardiovascular complications such as ischemic injury, restenosis and atherosclerosis.  In this review, we have focused on describing the pivotal role of AR in the pathogenesis of cardiovascular complications and use of AR inhibitors as emerging therapeutic strategies in preventing cardiovascular complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY9mnSCT6gAbVg90H21EOLACvtfcHk0lhTCvaGXugr1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVCiur8%253D&md5=ad62d6613594dced2aa9701f1030eba2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2174%2F157489010790192683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157489010790192683%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DA.%2BB.%2BM.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26atitle%3DAldose%2520Reductase%2520Inhibition%253A%2520Emerging%2520Drug%2520Target%2520for%2520the%2520Treatment%2520of%2520Cardiovascular%2520Complications%26jtitle%3DRecent%2520Pat.%2520Cardiovasc.%2520Drug%2520Discovery%26date%3D2010%26volume%3D5%26spage%3D25%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Ramana, K. V.</span><span> </span><span class="NLM_article-title">Aldose Reductase: New Insights for an Old Enzyme</span> <span class="citation_source-journal">Biomol. Concepts</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1515%2Fbmc.2011.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejsbfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=103-114&author=K.+V.+Ramana&title=Aldose+Reductase%3A+New+Insights+for+an+Old+Enzyme"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Aldose reductase: new insights for an old enzyme</span></div><div class="casAuthors">Ramana, Kota V.</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecular Concepts</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">103-114</span>CODEN:
                <span class="NLM_cas:coden">BCIOB8</span>;
        ISSN:<span class="NLM_cas:issn">1868-5021</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review.  In the past years aldose reductase (AKR1B1; AR) is thought to be involved in the pathogenesis of secondary diabetic complications such as retinopathy, neuropathy, nephropathy and cataractogenesis.  Subsequently, several AR inhibitors have been developed and tested for diabetic complications.  Although these inhibitors have found to be safe for human use, they have not been successful in clin. studies because of limited efficacy.  Recently, the potential physiol. role of AR has been reassessed from a different point of view.  Diverse groups suggested that AR, in addn. to reducing glucose, also efficiently reduces oxidative stress-generated lipid peroxidn.-derived aldehydes and their glutathione conjugates.  Because lipid aldehydes alter cellular signals by regulating the activation of transcription factors such as NF-κB and AP1, inhibition of AR could inhibit such events.  Indeed, a wide array of recent exptl. evidence indicates that the inhibition of AR prevents oxidative stress-induced activation of NF-κB and AP1 signals that lead to cell death or growth.  Furthermore, AR inhibitors have been shown to prevent inflammatory complications such as sepsis, asthma, colon cancer and uveitis in rodent animal models.  The new exptl. in vitro and in vivo data has provided a basis for investigating the clin. efficacy of AR inhibitors in preventing other inflammatory complications than diabetes.  This review describes how recent studies have identified novel plethoric physiol. and pathophysiol. significance of AR in mediating inflammatory complications, and how the discovery of such new insights for this old enzyme could have considerable importance in envisioning potential new therapeutic strategies for the prevention or treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBBjQ7Gvv8drVg90H21EOLACvtfcHk0lhTCvaGXugr1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejsbfJ&md5=41eabcb1adc38247121caf1b9fff87be</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1515%2Fbmc.2011.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fbmc.2011.002%26sid%3Dliteratum%253Aachs%26aulast%3DRamana%26aufirst%3DK.%2BV.%26atitle%3DAldose%2520Reductase%253A%2520New%2520Insights%2520for%2520an%2520Old%2520Enzyme%26jtitle%3DBiomol.%2520Concepts%26date%3D2011%26volume%3D2%26spage%3D103%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Tang, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwa, J.</span><span> </span><span class="NLM_article-title">Aldose Reductase, Oxidative Stress, and Diabetic Mellitus</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="refDoi"> DOI: 10.3389/fphar.2012.00087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.3389%2Ffphar.2012.00087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms12qtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=87&author=W.+H.+Tangauthor=K.+A.+Martinauthor=J.+Hwa&title=Aldose+Reductase%2C+Oxidative+Stress%2C+and+Diabetic+Mellitus&doi=10.3389%2Ffphar.2012.00087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Aldose reductase, oxidative stress and diabetic mellitus</span></div><div class="casAuthors">Tang, Wai Ho; Martin, Kathleen A.; Hwa, John</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Experimental Pharmacology and Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">May</span>),
    <span class="NLM_cas:pages">87</span>CODEN:
                <span class="NLM_cas:coden">FEPDAX</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Diabetes mellitus (DM) is a complex metabolic disorder arising from lack of insulin prodn. or insulin resistance.  DM is a leading cause of morbidity and mortality in the developed world, particularly from vascular complications such as atherothrombosis in the coronary vessels.  Aldose reductase (AR; ALR2), a key enzyme in the polyol pathway, catalyzes nicotinamide adenosine dinucleotide phosphate-dependent redn. of glucose to sorbitol, leading to excessive accumulation of intracellular reactive oxygen species (ROS) in various tissues of DM including the heart, vasculature, neurons, eyes and kidneys.  As an example, hyperglycemia through such polyol pathway induced oxidative stress, may have dual heart actions, on coronary blood vessel (atherothrombosis) and myocardium (heart failure) leading to severe morbidity and mortality.  In cells cultured under high glucose conditions, many studies have demonstrated similar AR-dependent increases in ROS prodn., confirming AR as an important factor for the pathogenesis of many diabetic complications.  Moreover, recent studies have shown that AR inhibitors may be able to prevent or delay the onset of cardiovascular complications such as ischemia/reperfusion injury, atherosclerosis and atherothrombosis.  In this review, we will focus on describing pivotal roles of AR in the pathogenesis of cardiovascular diseases as well as other diabetic complications and the potential use of AR inhibitors as an emerging therapeutic strategy in preventing DM complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuTqdIi_lUS7Vg90H21EOLACvtfcHk0lhTCvaGXugr1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms12qtrg%253D&md5=910cb046de1f2c5dc1013e8167f559f0</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2012.00087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2012.00087%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DW.%2BH.%26aulast%3DMartin%26aufirst%3DK.%2BA.%26aulast%3DHwa%26aufirst%3DJ.%26atitle%3DAldose%2520Reductase%252C%2520Oxidative%2520Stress%252C%2520and%2520Diabetic%2520Mellitus%26jtitle%3DFront.%2520Pharmacol.%26date%3D2012%26volume%3D3%26spage%3D87%26doi%3D10.3389%2Ffphar.2012.00087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Pandey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span> </span><span class="NLM_article-title">A Potential Therapeutic Role for Aldose Reductase Inhibitors in the Treatment of Endotoxin-Related Inflammatory Diseases</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=329-339&author=S.+Pandeyauthor=S.+K.+Srivastavaauthor=K.+V.+Ramana&title=A+Potential+Therapeutic+Role+for+Aldose+Reductase+Inhibitors+in+the+Treatment+of+Endotoxin-Related+Inflammatory+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26atitle%3DA%2520Potential%2520Therapeutic%2520Role%2520for%2520Aldose%2520Reductase%2520Inhibitors%2520in%2520the%2520Treatment%2520of%2520Endotoxin-Related%2520Inflammatory%2520Diseases%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2012%26volume%3D21%26spage%3D329%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saraf, S.</span><span> </span><span class="NLM_article-title">Type 2 Diabetes Mellitus—Its Global Prevalence and Therapeutic Strategies</span> <span class="citation_source-journal">Diabetes Metab. Syndr.: Clin. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.dsx.2008.04.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2010&pages=48-56&author=S.+Jainauthor=S.+Saraf&title=Type+2+Diabetes+Mellitus%E2%80%94Its+Global+Prevalence+and+Therapeutic+Strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.dsx.2008.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dsx.2008.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DS.%26aulast%3DSaraf%26aufirst%3DS.%26atitle%3DType%25202%2520Diabetes%2520Mellitus%25E2%2580%2594Its%2520Global%2520Prevalence%2520and%2520Therapeutic%2520Strategies%26jtitle%3DDiabetes%2520Metab.%2520Syndr.%253A%2520Clin.%2520Res.%2520Rev.%26date%3D2010%26volume%3D4%26spage%3D48%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Gleissner, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galkina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadler, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, K.</span><span> </span><span class="NLM_article-title">Mechanisms by Which Diabetes Increases Cardiovascular Disease</span> <span class="citation_source-journal">Drug Discovery Today: Dis. Mech.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.ddmec.2007.12.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=131-140&author=C.+A.+Gleissnerauthor=E.+Galkinaauthor=J.+L.+Nadlerauthor=K.+Ley&title=Mechanisms+by+Which+Diabetes+Increases+Cardiovascular+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ddmec.2007.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddmec.2007.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DGleissner%26aufirst%3DC.%2BA.%26aulast%3DGalkina%26aufirst%3DE.%26aulast%3DNadler%26aufirst%3DJ.%2BL.%26aulast%3DLey%26aufirst%3DK.%26atitle%3DMechanisms%2520by%2520Which%2520Diabetes%2520Increases%2520Cardiovascular%2520Disease%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Dis.%2520Mech.%26date%3D2007%26volume%3D4%26spage%3D131%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Turner, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cull, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratton, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frighi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manley, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neil, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElroy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadden, D.</span><span> </span><span class="NLM_article-title">Intensive Blood-Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS 33)</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=1998&pages=837-853&author=R.+C.+Turnerauthor=R.+R.+Holmanauthor=C.+A.+Cullauthor=I.+M.+Strattonauthor=D.+R.+Matthewsauthor=V.+Frighiauthor=S.+E.+Manleyauthor=A.+Neilauthor=H.+McElroyauthor=D.+Wrightauthor=E.+Kohnerauthor=C.+Foxauthor=D.+Hadden&title=Intensive+Blood-Glucose+Control+with+Sulphonylureas+or+Insulin+Compared+with+Conventional+Treatment+and+Risk+of+Complications+in+Patients+with+Type+2+Diabetes+%28UKPDS+33%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DR.%2BC.%26aulast%3DHolman%26aufirst%3DR.%2BR.%26aulast%3DCull%26aufirst%3DC.%2BA.%26aulast%3DStratton%26aufirst%3DI.%2BM.%26aulast%3DMatthews%26aufirst%3DD.%2BR.%26aulast%3DFrighi%26aufirst%3DV.%26aulast%3DManley%26aufirst%3DS.%2BE.%26aulast%3DNeil%26aufirst%3DA.%26aulast%3DMcElroy%26aufirst%3DH.%26aulast%3DWright%26aufirst%3DD.%26aulast%3DKohner%26aufirst%3DE.%26aulast%3DFox%26aufirst%3DC.%26aulast%3DHadden%26aufirst%3DD.%26atitle%3DIntensive%2520Blood-Glucose%2520Control%2520with%2520Sulphonylureas%2520or%2520Insulin%2520Compared%2520with%2520Conventional%2520Treatment%2520and%2520Risk%2520of%2520Complications%2520in%2520Patients%2520with%2520Type%25202%2520Diabetes%2520%2528UKPDS%252033%2529%26jtitle%3DLancet%26date%3D1998%26volume%3D352%26spage%3D837%26epage%3D853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Srivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Metabolism of Lipid Peroxidation Product, 4-Hydroxynonenal (HNE) in Rat Erythrocytes: Role of Aldose Reductase</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">642</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2FS0891-5849%2800%2900351-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=11033416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1Sis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=642-651&author=S.+Srivastavaauthor=B.+L.+Dixitauthor=J.+Caiauthor=S.+Sharmaauthor=H.+E.+Hurstauthor=A.+Bhatnagarauthor=S.+K.+Srivastava&title=Metabolism+of+Lipid+Peroxidation+Product%2C+4-Hydroxynonenal+%28HNE%29+in+Rat+Erythrocytes%3A+Role+of+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism of lipid peroxidation product, 4-hydroxynonenal (HNE) in rat erythrocytes: role of aldose reductase</span></div><div class="casAuthors">Srivastava, S.; Dixit, B. L.; Cai, J.; Sharma, S.; Hurst, H. E.; Bhatnagar, A.; Srivastava, S. K.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">642-651</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Lipid peroxidn. represents a significant source of erythrocyte dysfunction and aging.  Because the toxicity of lipid peroxidn. appears to be in part due to aldehydic end products, the authors examd., in rat erythrocytes, the metab. of 4-hydroxy-trans-2-nonenal (HNE), one of the most abundant and toxic lipid-derived aldehydes.  Packed erythrocytes, 0.1 mL, completely metabolized 20 nmoles of HNE in 20 min.  The glutathione conjugate of HNE and 4-hydroxynonanoic acid (HNA) represented 70 and 25% of the total metab., resp.  Approx. 70% of the metabolites were extruded to the medium.  Upon electrospray ionization mass spectrometry, the glutathione conjugate resolved into two distinct species corresponding to glutathionyl HNE (GS-HNE) and glutathionyl 1,4-dihydroxynonene (GS-DHN).  The concn. of GS-DHN formed was twice that of GS-HNE.  Inhibition of aldose reductase by sorbinil and tolrestat led to a selective decrease in the formation of GS-DHN, although the extent of HNE glutathiolation was unaffected.  Inhibitors of aldehyde or alc. dehydrogenase, i.e., cyanamide and 4-Me pyrazole, had no effect on the formation of HNA and GS-DHN, indicating that these enzymes are not significant participants in the erythrocyte HNE metab.  Thus, oxidn. to HNA, conjugation with glutathione, and further redn. of the conjugate by aldose reductase appear to be the major pathways of HNE metab. in erythrocytes.  These pathways may be crit. determinants of erythrocyte toxicity due to lipid peroxidn.-derived aldehydes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7GYWFuB9gZbVg90H21EOLACvtfcHk0lhY_x76sAX1nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1Sis7w%253D&md5=7dd80721320da401eaec82c14e62b956</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2800%2900351-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252800%252900351-8%26sid%3Dliteratum%253Aachs%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DDixit%26aufirst%3DB.%2BL.%26aulast%3DCai%26aufirst%3DJ.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DHurst%26aufirst%3DH.%2BE.%26aulast%3DBhatnagar%26aufirst%3DA.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DMetabolism%2520of%2520Lipid%2520Peroxidation%2520Product%252C%25204-Hydroxynonenal%2520%2528HNE%2529%2520in%2520Rat%2520Erythrocytes%253A%2520Role%2520of%2520Aldose%2520Reductase%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2000%26volume%3D29%26spage%3D642%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Vander Jagt, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vander Jagt, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunsaker, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Royer, R. E.</span><span> </span><span class="NLM_article-title">Substrate Specificity of Human Aldose Reductase: Identification of 4-Hydroxynonenal as an Endogenous Substrate</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1249</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1249&publication_year=1995&pages=117-126&author=D.+L.+Vander+Jagtauthor=N.+S.+Kolbauthor=T.+J.+Vander+Jagtauthor=J.+Chinoauthor=F.+J.+Martinezauthor=L.+A.+Hunsakerauthor=R.+E.+Royer&title=Substrate+Specificity+of+Human+Aldose+Reductase%3A+Identification+of+4-Hydroxynonenal+as+an+Endogenous+Substrate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVander%2BJagt%26aufirst%3DD.%2BL.%26aulast%3DKolb%26aufirst%3DN.%2BS.%26aulast%3DVander%2BJagt%26aufirst%3DT.%2BJ.%26aulast%3DChino%26aufirst%3DJ.%26aulast%3DMartinez%26aufirst%3DF.%2BJ.%26aulast%3DHunsaker%26aufirst%3DL.%2BA.%26aulast%3DRoyer%26aufirst%3DR.%2BE.%26atitle%3DSubstrate%2520Specificity%2520of%2520Human%2520Aldose%2520Reductase%253A%2520Identification%2520of%25204-Hydroxynonenal%2520as%2520an%2520Endogenous%2520Substrate%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1995%26volume%3D1249%26spage%3D117%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Evans, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldfine, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddux, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grodsky, G. M.</span><span> </span><span class="NLM_article-title">Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1210%2Fer.2001-0039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=12372842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD38XosVejsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=599-622&author=J.+L.+Evansauthor=I.+D.+Goldfineauthor=B.+A.+Madduxauthor=G.+M.+Grodsky&title=Oxidative+Stress+and+Stress-Activated+Signaling+Pathways%3A+A+Unifying+Hypothesis+of+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes</span></div><div class="casAuthors">Evans, Joseph L.; Goldfine, Ira D.; Maddux, Betty A.; Grodsky, Gerold M.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">599-622</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  In both type 1 and type 2 diabetes, the late diabetic complications in nerve, vascular endothelium, and kidney arise from chronic elevations of glucose and possibly other metabolites including free fatty acids (FFA).  Recent evidence suggests that common stress-activated signaling pathways such as nuclear factor-κB, p38 MAPK, and NH2-terminal Jun kinases/stress-activated protein kinases underlie the development of these late diabetic complications.  In addn., in type 2 diabetes, there is evidence that the activation of these same stress pathways by glucose and possibly FFA leads to both insulin resistance and impaired insulin secretion.  Thus, we propose a unifying hypothesis whereby hyperglycemia and FFA-induced activation of the nuclear factor-κB, p38 MAPK, and NH2-terminal Jun kinases/stress-activated protein kinases stress pathways, along with the activation of the advanced glycosylation end-products/receptor for advanced glycosylation end-products, protein kinase C, and sorbitol stress pathways, plays a key role in causing late complications in type 1 and type 2 diabetes, along with insulin resistance and impaired insulin secretion in type 2 diabetes.  Studies with antioxidants such as vitamin E, α-lipoic acid, and N-acetylcysteine suggest that new strategies may become available to treat these conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgexQPyQ6ffLVg90H21EOLACvtfcHk0lhY_x76sAX1nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosVejsbg%253D&md5=97a6da9c7cebd3ace6498a6525838472</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1210%2Fer.2001-0039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2001-0039%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DJ.%2BL.%26aulast%3DGoldfine%26aufirst%3DI.%2BD.%26aulast%3DMaddux%26aufirst%3DB.%2BA.%26aulast%3DGrodsky%26aufirst%3DG.%2BM.%26atitle%3DOxidative%2520Stress%2520and%2520Stress-Activated%2520Signaling%2520Pathways%253A%2520A%2520Unifying%2520Hypothesis%2520of%2520Type%25202%2520Diabetes%26jtitle%3DEndocr.%2520Rev.%26date%3D2002%26volume%3D23%26spage%3D599%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Williamson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frangos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasan, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ido, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyengaard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van den Enden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilton, R. G.</span><span> </span><span class="NLM_article-title">Hyperglycemic Pseudohypoxia and Diabetic Complications</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1993&pages=801-813&author=J.+R.+Williamsonauthor=K.+Changauthor=M.+Frangosauthor=K.+S.+Hasanauthor=Y.+Idoauthor=T.+Kawamuraauthor=J.+R.+Nyengaardauthor=M.+Van+den+Endenauthor=C.+Kiloauthor=R.+G.+Tilton&title=Hyperglycemic+Pseudohypoxia+and+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliamson%26aufirst%3DJ.%2BR.%26aulast%3DChang%26aufirst%3DK.%26aulast%3DFrangos%26aufirst%3DM.%26aulast%3DHasan%26aufirst%3DK.%2BS.%26aulast%3DIdo%26aufirst%3DY.%26aulast%3DKawamura%26aufirst%3DT.%26aulast%3DNyengaard%26aufirst%3DJ.%2BR.%26aulast%3DVan%2Bden%2BEnden%26aufirst%3DM.%26aulast%3DKilo%26aufirst%3DC.%26aulast%3DTilton%26aufirst%3DR.%2BG.%26atitle%3DHyperglycemic%2520Pseudohypoxia%2520and%2520Diabetic%2520Complications%26jtitle%3DDiabetes%26date%3D1993%26volume%3D42%26spage%3D801%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Hamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naruse, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasuya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiuchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotta, N.</span><span> </span><span class="NLM_article-title">Epalrestat, an Aldose Reductase Inhibitor, Reduces the Levels of <i>N</i>-(Carboxymethyl)lysine Protein Adducts and Their Precursors in Erythrocytes from Diabetic Patients</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1539</span><span class="NLM_x">–</span> <span class="NLM_lpage">1544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2000&pages=1539-1544&author=Y.+Hamadaauthor=J.+Nakamuraauthor=K.+Naruseauthor=T.+Komoriauthor=K.+Katoauthor=Y.+Kasuyaauthor=R.+Nagaiauthor=S.+Horiuchiauthor=N.+Hotta&title=Epalrestat%2C+an+Aldose+Reductase+Inhibitor%2C+Reduces+the+Levels+of+N-%28Carboxymethyl%29lysine+Protein+Adducts+and+Their+Precursors+in+Erythrocytes+from+Diabetic+Patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHamada%26aufirst%3DY.%26aulast%3DNakamura%26aufirst%3DJ.%26aulast%3DNaruse%26aufirst%3DK.%26aulast%3DKomori%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DKasuya%26aufirst%3DY.%26aulast%3DNagai%26aufirst%3DR.%26aulast%3DHoriuchi%26aufirst%3DS.%26aulast%3DHotta%26aufirst%3DN.%26atitle%3DEpalrestat%252C%2520an%2520Aldose%2520Reductase%2520Inhibitor%252C%2520Reduces%2520the%2520Levels%2520of%2520N-%2528Carboxymethyl%2529lysine%2520Protein%2520Adducts%2520and%2520Their%2520Precursors%2520in%2520Erythrocytes%2520from%2520Diabetic%2520Patients%26jtitle%3DDiabetes%2520Care%26date%3D2000%26volume%3D23%26spage%3D1539%26epage%3D1544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Roscic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvat, S.</span><span> </span><span class="NLM_article-title">Transformations of Bioactive Peptides in the Presence of Sugars—Characterization and Stability Studies of the Adducts Generated via the Maillard Reaction</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4933</span><span class="NLM_x">–</span> <span class="NLM_lpage">4943</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=4933-4943&author=M.+Roscicauthor=S.+Horvat&title=Transformations+of+Bioactive+Peptides+in+the+Presence+of+Sugars%E2%80%94Characterization+and+Stability+Studies+of+the+Adducts+Generated+via+the+Maillard+Reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoscic%26aufirst%3DM.%26aulast%3DHorvat%26aufirst%3DS.%26atitle%3DTransformations%2520of%2520Bioactive%2520Peptides%2520in%2520the%2520Presence%2520of%2520Sugars%25E2%2580%2594Characterization%2520and%2520Stability%2520Studies%2520of%2520the%2520Adducts%2520Generated%2520via%2520the%2520Maillard%2520Reaction%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D4933%26epage%3D4943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tammali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Requirement of Aldose Reductse for the Hyperglycemic Activation of Protein Kinase C and Formation of Diacylglycerol in Vascular Smooth Muscle Cells</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">818</span><span class="NLM_x">–</span> <span class="NLM_lpage">829</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=818-829&author=K.+V.+Ramanaauthor=B.+Friedrichauthor=R.+Tammaliauthor=M.+B.+Westauthor=A.+Bhatnagarauthor=S.+K.+Srivastava&title=Requirement+of+Aldose+Reductse+for+the+Hyperglycemic+Activation+of+Protein+Kinase+C+and+Formation+of+Diacylglycerol+in+Vascular+Smooth+Muscle+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DFriedrich%26aufirst%3DB.%26aulast%3DTammali%26aufirst%3DR.%26aulast%3DWest%26aufirst%3DM.%2BB.%26aulast%3DBhatnagar%26aufirst%3DA.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DRequirement%2520of%2520Aldose%2520Reductse%2520for%2520the%2520Hyperglycemic%2520Activation%2520of%2520Protein%2520Kinase%2520C%2520and%2520Formation%2520of%2520Diacylglycerol%2520in%2520Vascular%2520Smooth%2520Muscle%2520Cells%26jtitle%3DDiabetes%26date%3D2005%26volume%3D54%26spage%3D818%26epage%3D829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Gleissner, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J.M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, K.</span><span> </span><span class="NLM_article-title">Upregulation of Aldose Reductase During Foam Cell Formation as Possible Link Among Diabetes, Hyperlipidemia, and Atherosclerosis</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1137</span><span class="NLM_x">–</span> <span class="NLM_lpage">1143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1161%2FATVBAHA.107.158295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=18451330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsFOjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=1137-1143&author=C.+A.+Gleissnerauthor=J.M.+Sandersauthor=J.+Nadlerauthor=K.+Ley&title=Upregulation+of+Aldose+Reductase+During+Foam+Cell+Formation+as+Possible+Link+Among+Diabetes%2C+Hyperlipidemia%2C+and+Atherosclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Upregulation of aldose reductase during foam cell formation as possible link among diabetes, hyperlipidemia, and atherosclerosis</span></div><div class="casAuthors">Gleissner, Christian A.; Sanders, John M.; Nadler, Jerry; Ley, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1137-1143</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective- Aldose reductase (AR) is the rate-limiting enzyme of the polyol pathway.  In diabetes, it is related to microvascular complications.  We discovered AR expression in foam cells by gene chip screening and hypothesized that it may be relevant in atherosclerosis.  Methods and Results- AR gene expression and activity were found to be increased in human blood monocyte-derived macrophages during foam cell formation induced by oxidized LDL (oxLDL, 100 μg/mL).  AR activity as photometrically detd. by NADPH consumption was effectively inhibited by the AR inhibitor epalrestat. oxLDL-dependent AR upregulation was further increased under hyperglycemic conditions (30 mmol/L D-glucose) as compared to osmotic control, suggesting a synergistic effect of hyperlipidemia and hyperglycemia.  AR was also upregulated by 4-hydroxynonenal, a constituent of oxLDL.  Upregulation was blocked by an antibody to CD36.  AR inhibition resulted in redn. of oxLDL-induced intracellular oxidative stress as detd. by 2'7'-dichlorofluoresceine diacetate (H2DCFDA) fluorescence, indicating that proinflammatory effects of oxLDL are partly mediated by AR.  Immunohistochem. showed AR expression in CD68+ human atherosclerotic plaque macrophages.  Conclusions- These data show that oxLDL-induced upregulation of AR in human macrophages is proinflammatory in foam cells and may represent a potential link among hyperlipidemia, atherosclerosis, and diabetes mellitus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQs9JpPOkYjrVg90H21EOLACvtfcHk0lgxHKLhzV0hTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsFOjurg%253D&md5=33d4fef567d0c9ed7d0334ffc08ed6d5</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.107.158295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.107.158295%26sid%3Dliteratum%253Aachs%26aulast%3DGleissner%26aufirst%3DC.%2BA.%26aulast%3DSanders%26aufirst%3DJ.M.%26aulast%3DNadler%26aufirst%3DJ.%26aulast%3DLey%26aufirst%3DK.%26atitle%3DUpregulation%2520of%2520Aldose%2520Reductase%2520During%2520Foam%2520Cell%2520Formation%2520as%2520Possible%2520Link%2520Among%2520Diabetes%252C%2520Hyperlipidemia%252C%2520and%2520Atherosclerosis%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D1137%26epage%3D1143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Srivastava, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, U. C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, A. B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tammali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoeb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansari, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span> </span><span class="NLM_article-title">Aldose Reductase Inhibition Suppresses Oxidative Stress-Induced Inflammatory Disorders</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">330</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.cbi.2011.02.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=21354119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFaisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2011&pages=330-338&author=S.+K.+Srivastavaauthor=U.+C.+S.+Yadavauthor=A.+B.+M.+Reddyauthor=A.+Saxenaauthor=R.+Tammaliauthor=M.+Shoebauthor=N.+H.+Ansariauthor=A.+Bhatnagarauthor=M.+J.+Petrashauthor=S.+Srivastavaauthor=K.+V.+Ramana&title=Aldose+Reductase+Inhibition+Suppresses+Oxidative+Stress-Induced+Inflammatory+Disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders</span></div><div class="casAuthors">Srivastava, Satish K.; Yadav, Umesh C. S.; Reddy, Aramati B. M.; Mishra, Rakesh; Saxena, Ashish; Tammali, Ravinder; Shoeb, Mohammad; Ansari, Naseem H.; Bhatnagar, Aruni; Petrash, Mark J.; Srivastava, Sanjay; Ramana, Kota V.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">330-338</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress-induced inflammation is a major contributor to several disease conditions including sepsis, carcinogenesis and metastasis, diabetic complications, allergic asthma, uveitis and after cataract surgery posterior capsular opacification.  Since reactive oxygen species (ROS)-mediated activation of redox-sensitive transcription factors and subsequent expression of inflammatory cytokines, chemokines and growth factors are characteristics of inflammatory disorders, we envisioned that by blocking the mol. signals of ROS that activate redox-sensitive transcription factors, various inflammatory diseases could be ameliorated.  We have indeed demonstrated that ROS-induced lipid peroxidn.-derived lipid aldehydes such as 4-hydroxy-trans-2-nonenal (HNE) and their glutathione-conjugates (e.g. GS-HNE) are efficiently reduced by aldose reductase to corresponding alcs. which mediate the inflammatory signals.  These results showed that inhibition of aldose reductase (AKR1B1) significantly prevented the inflammatory signals induced by cytokines, growth factors, endotoxins, high glucose, allergens and auto-immune reactions in cellular as well as animal models.  We have demonstrated that AKR1B1 inhibitor, fidarestat, significantly prevents tumor necrosis factor-alpha (TNF-α)-, growth factors-, lipopolysachharide (LPS)-, and environmental allergens-induced inflammatory signals that cause various inflammatory diseases.  In animal models of inflammatory diseases such as diabetes, cardiovascular, uveitis, asthma, and cancer (colon, breast, prostate and lung) and metastasis, inhibition of AKR1B1 significantly ameliorated the disease.  These results from various cellular and animal models representing a no. of inflammatory conditions suggest that ROS-induced inflammatory response could be reduced by inhibition of AKR1B1, thereby decreasing the progression of the disease and if the therapy is initiated early, the disease could be eliminated.  Since fidarestat has already undergone phase III clin. trial for diabetic neuropathy and found to be safe, though clin. not very effective,these results indicate that it can be developed for the therapy of a no. of inflammation-related diseases.  These results thus offer a novel therapeutic approach to treat a wide array of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9l50Gk-U_xLVg90H21EOLACvtfcHk0lgxHKLhzV0hTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFaisrg%253D&md5=926a39f300f8b2537f9fc6603d3e76f8</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2011.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2011.02.023%26sid%3Dliteratum%253Aachs%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26aulast%3DYadav%26aufirst%3DU.%2BC.%2BS.%26aulast%3DReddy%26aufirst%3DA.%2BB.%2BM.%26aulast%3DSaxena%26aufirst%3DA.%26aulast%3DTammali%26aufirst%3DR.%26aulast%3DShoeb%26aufirst%3DM.%26aulast%3DAnsari%26aufirst%3DN.%2BH.%26aulast%3DBhatnagar%26aufirst%3DA.%26aulast%3DPetrash%26aufirst%3DM.%2BJ.%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26atitle%3DAldose%2520Reductase%2520Inhibition%2520Suppresses%2520Oxidative%2520Stress-Induced%2520Inflammatory%2520Disorders%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2011%26volume%3D191%26spage%3D330%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Shoeb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansari, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span> </span><span class="NLM_article-title">4-Hydroxynonenal in the Pathogenesis and Progression of Human Diseases</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.2174%2F09298673113209990181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=23848536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=230-237&author=M.+Shoebauthor=N.+H.+Ansariauthor=S.+K.+Srivastavaauthor=K.+V.+Ramana&title=4-Hydroxynonenal+in+the+Pathogenesis+and+Progression+of+Human+Diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">4-Hydroxynonenal in the Pathogenesis and Progression of Human Diseases</span></div><div class="casAuthors">Shoeb, Mohammad; Ansari, Naseem H.; Srivastava, Satish K.; Ramana, Kota V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">230-237</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Metastable aldehydes produced by lipid peroxidn. act as 'toxic second messengers' that extend the injurious potential of free radicals. 4-hydroxy 2-nonenal (HNE), a highly toxic and most abundant stable end product of lipid peroxidn., has been implicated in the tissue damage, dysfunction, injury assocd. with aging and other pathol. states such as cancer, Alzheimer, diabetes, cardiovascular and inflammatory complications.  Further, HNE has been considered as a oxidative stress marker and it act as a secondary signaling mol. to regulates a no. of cell signaling pathways.  Biol. activity of HNE depends on its intracellular concn., which can differentially modulate cell death, growth and differentiation.  Therefore, the mechanisms responsible for maintaining the intracellular levels of HNE are most important, not only in the defense against oxidative stress but also in the pathophysiol. of a no. of disease processes.  In this review, we discussed the significance of HNE in mediating various disease processes and how regulation of its metab. could be therapeutically effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouDoR-ApnydbVg90H21EOLACvtfcHk0liSKF95fXqJrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOqtb0%253D&md5=1b8f7bdcaaa873f78e65543a15e7f0f9</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.2174%2F09298673113209990181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F09298673113209990181%26sid%3Dliteratum%253Aachs%26aulast%3DShoeb%26aufirst%3DM.%26aulast%3DAnsari%26aufirst%3DN.%2BH.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26atitle%3D4-Hydroxynonenal%2520in%2520the%2520Pathogenesis%2520and%2520Progression%2520of%2520Human%2520Diseases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D230%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Gupta, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaram, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aggarwal, B. B.</span><span> </span><span class="NLM_article-title">Inhibiting NF-κB Activation by Small Molecules as a Therapeutic Strategy</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1799</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">787</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1799&publication_year=2010&pages=775-787&author=S.+C.+Guptaauthor=C.+Sundaramauthor=S.+Reuterauthor=B.+B.+Aggarwal&title=Inhibiting+NF-%CE%BAB+Activation+by+Small+Molecules+as+a+Therapeutic+Strategy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%2BC.%26aulast%3DSundaram%26aufirst%3DC.%26aulast%3DReuter%26aufirst%3DS.%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DInhibiting%2520NF-%25CE%25BAB%2520Activation%2520by%2520Small%2520Molecules%2520as%2520a%2520Therapeutic%2520Strategy%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2010%26volume%3D1799%26spage%3D775%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Luis-Rodriguez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Castelao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorriz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Alvaro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro-Gonzalez, J. F.</span><span> </span><span class="NLM_article-title">Pathophysiological Role and Therapeutic Implications of Inflammation in Diabetic Nephropathy</span> <span class="citation_source-journal">World J. Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.4239%2Fwjd.v3.i1.7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A280%3ADC%252BC387lsVWnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=7-18&author=D.+Luis-Rodriguezauthor=A.+Martinez-Castelaoauthor=J.+L.+Gorrizauthor=F.+de+Alvaroauthor=J.+F.+Navarro-Gonzalez&title=Pathophysiological+Role+and+Therapeutic+Implications+of+Inflammation+in+Diabetic+Nephropathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy</span></div><div class="casAuthors">Luis-Rodriguez Desiree; Martinez-Castelao Alberto; Gorriz Jose Luis; De-Alvaro Fernando; Navarro-Gonzalez Juan F</div><div class="citationInfo"><span class="NLM_cas:title">World journal of diabetes</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-18</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Diabetes mellitus and its complications are becoming one of the most important health problems in the world.  Diabetic nephropathy is now the main cause of end-stage renal disease.  The mechanisms leading to the development and progression of renal injury are not well known.  Therefore, it is very important to find new pathogenic pathways to provide opportunities for early diagnosis and targets for novel treatments.  At the present time, we know that activation of innate immunity with development of a chronic low grade inflammatory response is a recognized factor in the pathogenesis of diabetic nephropathy.  Numerous experimental and clinical studies have shown the participation of different inflammatory molecules and pathways in the pathophysiology of this complication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzX6Povz2h7HWEEzDrymxmfW6udTcc2eaOEjr6I9pDQbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC387lsVWnsw%253D%253D&md5=f844fee875385aea24c2b9f87a92c06a</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.4239%2Fwjd.v3.i1.7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4239%252Fwjd.v3.i1.7%26sid%3Dliteratum%253Aachs%26aulast%3DLuis-Rodriguez%26aufirst%3DD.%26aulast%3DMartinez-Castelao%26aufirst%3DA.%26aulast%3DGorriz%26aufirst%3DJ.%2BL.%26aulast%3Dde%2BAlvaro%26aufirst%3DF.%26aulast%3DNavarro-Gonzalez%26aufirst%3DJ.%2BF.%26atitle%3DPathophysiological%2520Role%2520and%2520Therapeutic%2520Implications%2520of%2520Inflammation%2520in%2520Diabetic%2520Nephropathy%26jtitle%3DWorld%2520J.%2520Diabetes%26date%3D2012%26volume%3D3%26spage%3D7%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Plutzky, J.</span><span> </span><span class="NLM_article-title">Inflammation in Atherosclerosis and Diabetes Mellitus</span> <span class="citation_source-journal">Rev. Endocr. Metab. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1023%2FB%3AREMD.0000032414.17672.5c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=15211097" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=255-259&author=J.+Plutzky&title=Inflammation+in+Atherosclerosis+and+Diabetes+Mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1023%2FB%3AREMD.0000032414.17672.5c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FB%253AREMD.0000032414.17672.5c%26sid%3Dliteratum%253Aachs%26aulast%3DPlutzky%26aufirst%3DJ.%26atitle%3DInflammation%2520in%2520Atherosclerosis%2520and%2520Diabetes%2520Mellitus%26jtitle%3DRev.%2520Endocr.%2520Metab.%2520Dis.%26date%3D2004%26volume%3D5%26spage%3D255%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Schmidt, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saad, M. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, B. B.</span><span> </span><span class="NLM_article-title">Subclinical Inflammation and Obesity, Diabetes and Related Disorders</span> <span class="citation_source-journal">Drug Discovery Today: Dis. Mech.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.ddmec.2005.08.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=307-312&author=M.+I.+Schmidtauthor=M.+J.+A.+Saadauthor=B.+B.+Duncan&title=Subclinical+Inflammation+and+Obesity%2C+Diabetes+and+Related+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.ddmec.2005.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddmec.2005.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DM.%2BI.%26aulast%3DSaad%26aufirst%3DM.%2BJ.%2BA.%26aulast%3DDuncan%26aufirst%3DB.%2BB.%26atitle%3DSubclinical%2520Inflammation%2520and%2520Obesity%252C%2520Diabetes%2520and%2520Related%2520Disorders%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Dis.%2520Mech.%26date%3D2005%26volume%3D2%26spage%3D307%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Frohnert, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernlohr, D. A.</span><span> </span><span class="NLM_article-title">Glutathionylated Lipid Aldehydes Are Products of Adipocyte Oxidative Stress and Activators of Macrophage Inflammation</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=89-100&author=B.+I.+Frohnertauthor=E.+K.+Longauthor=W.+S.+Hahnauthor=D.+A.+Bernlohr&title=Glutathionylated+Lipid+Aldehydes+Are+Products+of+Adipocyte+Oxidative+Stress+and+Activators+of+Macrophage+Inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrohnert%26aufirst%3DB.%2BI.%26aulast%3DLong%26aufirst%3DE.%2BK.%26aulast%3DHahn%26aufirst%3DW.%2BS.%26aulast%3DBernlohr%26aufirst%3DD.%2BA.%26atitle%3DGlutathionylated%2520Lipid%2520Aldehydes%2520Are%2520Products%2520of%2520Adipocyte%2520Oxidative%2520Stress%2520and%2520Activators%2520of%2520Macrophage%2520Inflammation%26jtitle%3DDiabetes%26date%3D2014%26volume%3D63%26spage%3D89%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Vedantham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiagarajan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ananthakrishnan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosario, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramasamy, R.</span><span> </span><span class="NLM_article-title">Aldose Reductase Drives Hyperacetylation of Erg-1 in Hyperglycemia and Consequent Upregulation of Proinflammatory and Prothrombotic Signals</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=761-774&author=S.+Vedanthamauthor=D.+Thiagarajanauthor=R.+Ananthakrishnanauthor=L.+Wangauthor=R.+Rosarioauthor=Y.+S.+Zouauthor=I.+Goldbergauthor=S.+F.+Yanauthor=A.+M.+Schmidtauthor=R.+Ramasamy&title=Aldose+Reductase+Drives+Hyperacetylation+of+Erg-1+in+Hyperglycemia+and+Consequent+Upregulation+of+Proinflammatory+and+Prothrombotic+Signals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVedantham%26aufirst%3DS.%26aulast%3DThiagarajan%26aufirst%3DD.%26aulast%3DAnanthakrishnan%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DRosario%26aufirst%3DR.%26aulast%3DZou%26aufirst%3DY.%2BS.%26aulast%3DGoldberg%26aufirst%3DI.%26aulast%3DYan%26aufirst%3DS.%2BF.%26aulast%3DSchmidt%26aufirst%3DA.%2BM.%26aulast%3DRamasamy%26aufirst%3DR.%26atitle%3DAldose%2520Reductase%2520Drives%2520Hyperacetylation%2520of%2520Erg-1%2520in%2520Hyperglycemia%2520and%2520Consequent%2520Upregulation%2520of%2520Proinflammatory%2520and%2520Prothrombotic%2520Signals%26jtitle%3DDiabetes%26date%3D2014%26volume%3D63%26spage%3D761%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Zozulinska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wierusz-Wysocka, B.</span><span> </span><span class="NLM_article-title">Type 2 Diabetes Mellitus as Inflammatory Disease</span> <span class="citation_source-journal">Diabetes Res. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">74S</span><span class="NLM_x">, </span> <span class="NLM_fpage">S12</span><span class="NLM_x">–</span> <span class="NLM_lpage">S16</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74S&publication_year=2006&pages=S12-S16&author=D.+Zozulinskaauthor=B.+Wierusz-Wysocka&title=Type+2+Diabetes+Mellitus+as+Inflammatory+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZozulinska%26aufirst%3DD.%26aulast%3DWierusz-Wysocka%26aufirst%3DB.%26atitle%3DType%25202%2520Diabetes%2520Mellitus%2520as%2520Inflammatory%2520Disease%26jtitle%3DDiabetes%2520Res.%2520Clin.%2520Pract.%26date%3D2006%26volume%3D74S%26spage%3DS12%26epage%3DS16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Oates, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mylari, B. L.</span><span> </span><span class="NLM_article-title">Aldose Reductase Inhibitors: Therapeutic Implications for Diabetic Complications</span> <span class="citation_source-journal">Expert. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2095</span><span class="NLM_x">–</span> <span class="NLM_lpage">2119</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1999&pages=2095-2119&author=P.+J.+Oatesauthor=B.+L.+Mylari&title=Aldose+Reductase+Inhibitors%3A+Therapeutic+Implications+for+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOates%26aufirst%3DP.%2BJ.%26aulast%3DMylari%26aufirst%3DB.%2BL.%26atitle%3DAldose%2520Reductase%2520Inhibitors%253A%2520Therapeutic%2520Implications%2520for%2520Diabetic%2520Complications%26jtitle%3DExpert.%2520Opin.%2520Invest.%2520Drugs%26date%3D1999%26volume%3D8%26spage%3D2095%26epage%3D2119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Heesom, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibberd, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millward, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demaine, A. G.</span><span> </span><span class="NLM_article-title">Polymorphism in the 5′-End of the Aldose Reductase Gene Is Strongly Associated with the Development of Diabetic Nephopathy in Type 1 Diabetes</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">291</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1997&pages=287-291&author=A.+E.+Heesomauthor=M.+L.+Hibberdauthor=A.+Millwardauthor=A.+G.+Demaine&title=Polymorphism+in+the+5%E2%80%B2-End+of+the+Aldose+Reductase+Gene+Is+Strongly+Associated+with+the+Development+of+Diabetic+Nephopathy+in+Type+1+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeesom%26aufirst%3DA.%2BE.%26aulast%3DHibberd%26aufirst%3DM.%2BL.%26aulast%3DMillward%26aufirst%3DA.%26aulast%3DDemaine%26aufirst%3DA.%2BG.%26atitle%3DPolymorphism%2520in%2520the%25205%25E2%2580%25B2-End%2520of%2520the%2520Aldose%2520Reductase%2520Gene%2520Is%2520Strongly%2520Associated%2520with%2520the%2520Development%2520of%2520Diabetic%2520Nephopathy%2520in%2520Type%25201%2520Diabetes%26jtitle%3DDiabetes%26date%3D1997%26volume%3D46%26spage%3D287%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Kao, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donaghue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silink, M.</span><span> </span><span class="NLM_article-title">A Novel Polymorphism in the Aldose Reductase Gene Promoter Region Is Strongly Associated with Diabetic Retinopathy in Adolescents with Type 1 Diabetes</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1338</span><span class="NLM_x">–</span> <span class="NLM_lpage">1340</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1999&pages=1338-1340&author=Y.+L.+Kaoauthor=K.+Donaghueauthor=A.+Chanauthor=J.+Knightauthor=M.+Silink&title=A+Novel+Polymorphism+in+the+Aldose+Reductase+Gene+Promoter+Region+Is+Strongly+Associated+with+Diabetic+Retinopathy+in+Adolescents+with+Type+1+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKao%26aufirst%3DY.%2BL.%26aulast%3DDonaghue%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DKnight%26aufirst%3DJ.%26aulast%3DSilink%26aufirst%3DM.%26atitle%3DA%2520Novel%2520Polymorphism%2520in%2520the%2520Aldose%2520Reductase%2520Gene%2520Promoter%2520Region%2520Is%2520Strongly%2520Associated%2520with%2520Diabetic%2520Retinopathy%2520in%2520Adolescents%2520with%2520Type%25201%2520Diabetes%26jtitle%3DDiabetes%26date%3D1999%26volume%3D48%26spage%3D1338%26epage%3D1340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Lajer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarnow, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleckner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parving, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boel, E.</span><span> </span><span class="NLM_article-title">Association of Aldose Reductase Gene Z+2 Polymorphism with Reduced Susceptibility to Diabetic Nephropathy in Caucasian Type 1 Diabetic Patients</span> <span class="citation_source-journal">Diabetic Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">873</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1111%2Fj.1464-5491.2004.01259.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=15270790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt1Onsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2004&pages=867-873&author=M.+Lajerauthor=L.+Tarnowauthor=J.+Flecknerauthor=B.+V.+Hansenauthor=D.+G.+Edwardsauthor=H.+H.+Parvingauthor=E.+Boel&title=Association+of+Aldose+Reductase+Gene+Z%2B2+Polymorphism+with+Reduced+Susceptibility+to+Diabetic+Nephropathy+in+Caucasian+Type+1+Diabetic+Patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patients</span></div><div class="casAuthors">Lajer, M.; Tarnow, L.; Fleckner, J.; Hansen, B. V.; Edwards, D. G.; Parving, H.-H.; Boel, E.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetic Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">867-873</span>CODEN:
                <span class="NLM_cas:coden">DIMEEV</span>;
        ISSN:<span class="NLM_cas:issn">0742-3071</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Aims The Z-2 allele of the (AC)n polymorphism in the aldose reductase gene (ALR2) confers increased risk of microvascular diabetic complications, whereas the Z+2 allele has been proposed to be a marker of protection.  However data are conflicting.  Therefore, we investigated whether this polymorphism is assocd. with diabetic nephropathy and retinopathy in Type 1 diabetes mellitus in a large case-control study and a family-based anal.  Methods A total of 431 Type 1 diabetic patients with diabetic nephropathy and 468 patients with longstanding Type 1 diabetes and persistent normoalbuminuria were genotyped for the case-control study.  In addn., 102 case trios and 98 control trios were genotyped for a family-based study.  Results Thirteen different alleles were identified.  In the case-control study, the Z+2 allele frequency was significantly higher in the normoalbuminuric diabetic than in patients with diabetic nephropathy (0.17 vs. 0.11, P = 0.008), suggesting a protective function of the Z+2 allele.  No significant increase in the frequency of the putative risk allele Z-2 was found in patients with diabetic nephropathy vs. controls (0.39 vs. 0.36).  No assocn. with diabetic retinopathy was found.  Although the results of the transmission of the Z-2 and Z+2 alleles in the independent family-based study were consistent with the assocn. study, the no. of informative families was limited and thus differences were not statistically significant.  Conclusions The Z+2 allele of the ALR2 promoter polymorphism is assocd. with a reduced susceptibility to diabetic nephropathy in Danish Type 1 diabetic patients, suggesting a minor role for the polyol pathway in the pathogenesis of diabetic kidney disease.  No assocn. of the ALR2 polymorphism with diabetic retinopathy was found.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUIgPNcjFYJ7Vg90H21EOLACvtfcHk0liOqKOmkU3i6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt1Onsbg%253D&md5=724874d6537cb63fa8158228fe0c927e</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1111%2Fj.1464-5491.2004.01259.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1464-5491.2004.01259.x%26sid%3Dliteratum%253Aachs%26aulast%3DLajer%26aufirst%3DM.%26aulast%3DTarnow%26aufirst%3DL.%26aulast%3DFleckner%26aufirst%3DJ.%26aulast%3DHansen%26aufirst%3DB.%2BV.%26aulast%3DEdwards%26aufirst%3DD.%2BG.%26aulast%3DParving%26aufirst%3DH.%2BH.%26aulast%3DBoel%26aufirst%3DE.%26atitle%3DAssociation%2520of%2520Aldose%2520Reductase%2520Gene%2520Z%252B2%2520Polymorphism%2520with%2520Reduced%2520Susceptibility%2520to%2520Diabetic%2520Nephropathy%2520in%2520Caucasian%2520Type%25201%2520Diabetic%2520Patients%26jtitle%3DDiabetic%2520Med.%26date%3D2004%26volume%3D21%26spage%3D867%26epage%3D873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Sivenius, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niskanen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voutilainen-Kaunisto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laakso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uusitupa, M.</span><span> </span><span class="NLM_article-title">Aldose Reductase Gene Polymorphisms and Susceptibility to Microvascular Complications in Type 2 Diabetes</span> <span class="citation_source-journal">Diabetic Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1325</span><span class="NLM_x">–</span> <span class="NLM_lpage">1333</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1111%2Fj.1464-5491.2004.01345.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=15569136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjt1KitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2004&pages=1325-1333&author=K.+Siveniusauthor=L.+Niskanenauthor=R.+Voutilainen-Kaunistoauthor=M.+Laaksoauthor=M.+Uusitupa&title=Aldose+Reductase+Gene+Polymorphisms+and+Susceptibility+to+Microvascular+Complications+in+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Aldose reductase gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes</span></div><div class="casAuthors">Sivenius, K.; Niskanen, L.; Voutilainen-Kaunisto, R.; Laakso, M.; Uusitupa, M.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetic Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1325-1333</span>CODEN:
                <span class="NLM_cas:coden">DIMEEV</span>;
        ISSN:<span class="NLM_cas:issn">0742-3071</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Aims: The gene encoding the human aldose reductase, the first and rate-limiting enzyme of the polyol pathway of glucose metab., is a promising candidate gene which may contribute to diabetic microvascular complications.  We investigated the assocn. of two previously reported DNA sequence variants of this gene, the C-106T polymorphism and the (CA)n dinucleotide repeat marker, with the risk of albuminuria and retinopathy in Finnish Type 2 diabetic patients and non-diabetic control subjects.  Methods: The study population included 85 Finnish, middle-aged, newly diagnosed Type 2 diabetic patients and 126 non-diabetic control subjects.  Genetic analyses were performed using the polymerase chain reaction, restriction fragment length polymorphism, and automated laser fluorescence scanning analyses.  Microvascular complications were detd. using 10-yr follow-up data of urinary albumin excretion measurements and ophthalmol. examns.  Results: The C and Z-2 alleles of the C-106T polymorphism and the (CA)n repeat marker, resp., were found to be more frequent in Type 2 diabetic subjects than in non-diabetic subjects.  The C and Z-2 alleles were in 60% linkage disequil. in diabetic subjects.  At the time of diagnosis, diabetic subjects with the T allele of the C-106T polymorphism had significantly higher urinary albumin excretion rate and prevalence of albuminuria than subjects with the C-106C genotype (prevalence of albuminuria: 33.3 vs. 13.8%, P = 0.036, odds ratio = 3.9, 95% confidence interval 1.1, 14.7).  The Z-2 allele of the (CA)n repeat marker was not consistently assocd. with the prevalence of albuminuria.  No assocns. were obsd. between the polymorphisms examd. and the prevalence of retinopathy at any point of the follow-up.  Conclusions: The present study suggests that the C-106T polymorphism of the aldose reductase gene could be involved in the early development of microalbuminuria in Finnish Type 2 diabetic patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQZu0UcEUxDbVg90H21EOLACvtfcHk0liOqKOmkU3i6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjt1KitQ%253D%253D&md5=461efc4309b66d16775b1caa3c6f8cba</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1111%2Fj.1464-5491.2004.01345.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1464-5491.2004.01345.x%26sid%3Dliteratum%253Aachs%26aulast%3DSivenius%26aufirst%3DK.%26aulast%3DNiskanen%26aufirst%3DL.%26aulast%3DVoutilainen-Kaunisto%26aufirst%3DR.%26aulast%3DLaakso%26aufirst%3DM.%26aulast%3DUusitupa%26aufirst%3DM.%26atitle%3DAldose%2520Reductase%2520Gene%2520Polymorphisms%2520and%2520Susceptibility%2520to%2520Microvascular%2520Complications%2520in%2520Type%25202%2520Diabetes%26jtitle%3DDiabetic%2520Med.%26date%3D2004%26volume%3D21%26spage%3D1325%26epage%3D1333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Sivenius, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pihlajamaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partanen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niskanen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laakso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uusitupa, M.</span><span> </span><span class="NLM_article-title">Aldose Reductase Gene Polymorphisms and Peripheral Nerve Function in Patients with Type 2 Diabetes</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">2021</span><span class="NLM_x">–</span> <span class="NLM_lpage">2026</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=2021-2026&author=K.+Siveniusauthor=J.+Pihlajamakiauthor=J.+Partanenauthor=L.+Niskanenauthor=M.+Laaksoauthor=M.+Uusitupa&title=Aldose+Reductase+Gene+Polymorphisms+and+Peripheral+Nerve+Function+in+Patients+with+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSivenius%26aufirst%3DK.%26aulast%3DPihlajamaki%26aufirst%3DJ.%26aulast%3DPartanen%26aufirst%3DJ.%26aulast%3DNiskanen%26aufirst%3DL.%26aulast%3DLaakso%26aufirst%3DM.%26aulast%3DUusitupa%26aufirst%3DM.%26atitle%3DAldose%2520Reductase%2520Gene%2520Polymorphisms%2520and%2520Peripheral%2520Nerve%2520Function%2520in%2520Patients%2520with%2520Type%25202%2520Diabetes%26jtitle%3DDiabetes%2520Care%26date%3D2004%26volume%3D27%26spage%3D2021%26epage%3D2026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Tammali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span> </span><span class="NLM_article-title">Targeting Aldose Reductase for the Treatment of Cancer</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">571</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.2174%2F156800911795655958" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=21486217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFegsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=560-571&author=R.+Tammaliauthor=S.+K.+Srivastavaauthor=K.+V.+Ramana&title=Targeting+Aldose+Reductase+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting aldose reductase for the treatment of cancer</span></div><div class="casAuthors">Tammali, R.; Srivastava, S. K.; Ramana, K. V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">560-571</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  It is strongly established by numerous studies that oxidative stress-induced inflammation is one of the major causative agents in a variety of cancers.  Various factors such as bacterial, viral, parasitic infections, chem. irritants, carcinogens are involved in the initiation of oxidative stress-mediated inflammation.  Chronic and persistent inflammation promotes the formation of cancerous tumors.  Recent investigations strongly suggest that aldose reductase [AR; AKR1B1], a member of aldo-keto reductase superfamily of proteins, is the mediator of inflammatory signals induced by growth factors, cytokines, chemokines, carcinogens etc.  Further, AR reduced product(s) of lipid derived aldehydes and their metabolites such as glutathionyl 1,4-dihydroxynonanol (GS-DHN) have been shown to be involved in the activation of transcription factors such as NF-κB and AP-1 which transcribe the genes of inflammatory cytokines.  The increased inflammatory cytokines and growth factors promote cell proliferation, a main feature involved in the tumorigenesis process.  Inhibition of AR has been shown to prevent cancer cell growth in vitro and in vivo models.  In this review, we have described the possible assocn. between AR with oxidative stress- and inflammation- initiated carcinogenesis.  A thorough understanding of the role of AR in the inflammation - assocd. cancers could lead to the use of AR inhibitors as novel chemotherapeutic agents against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRDrHmZBYv1bVg90H21EOLACvtfcHk0lhJmoM56ZxaRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFegsrw%253D&md5=fbfd97875e888631928c77b50b0614b1</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.2174%2F156800911795655958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800911795655958%26sid%3Dliteratum%253Aachs%26aulast%3DTammali%26aufirst%3DR.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26atitle%3DTargeting%2520Aldose%2520Reductase%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2011%26volume%3D11%26spage%3D560%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Aldose Reductase: A Novel Therapeutic Target for Inflammatory Pathologies</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.biocel.2009.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=19778627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsV2mt7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2010&pages=17-20&author=K.+V.+Ramanaauthor=S.+K.+Srivastava&title=Aldose+Reductase%3A+A+Novel+Therapeutic+Target+for+Inflammatory+Pathologies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Aldose reductase: A novel therapeutic target for inflammatory pathologies</span></div><div class="casAuthors">Ramana, Kota V.; Srivastava, Satish K.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-20</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Aldose reductase (AR), that catalyzes the rate limiting step of the polyol pathway of glucose metab., besides reducing glucose to sorbitol, reduces a no. of lipid peroxidn. - derived aldehydes and their glutathione conjugates.  Recent studies suggest that apart from its involvement in diabetic complications, AR's catalytic activity plays a key role in a no. of inflammatory diseases such as atherosclerosis, sepsis, asthma, uveitis, and colon cancer.  Furthermore, AR is overexpressed in human cancers such as liver, colon, breast, cervical and ovarian.  Since AR inhibitors have already undergone up to phase-iii clin. trials for diabetic complications, they could be safe anti-inflammatory drugs.  Therefore the future use of AR inhibitors in down-regulating major inflammatory pathologies such as cancer and cardiovascular diseases could relieve some of the major health concerns of worldwide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIPbxyf8RUyrVg90H21EOLACvtfcHk0lhJmoM56ZxaRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsV2mt7zP&md5=10b486d07849c5512a8cd3f3a6d67bfd</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.biocel.2009.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biocel.2009.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DAldose%2520Reductase%253A%2520A%2520Novel%2520Therapeutic%2520Target%2520for%2520Inflammatory%2520Pathologies%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2010%26volume%3D42%26spage%3D17%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Reuter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aggarwal, B. B.</span><span> </span><span class="NLM_article-title">Oxidative Stress, Inflammation, and Cancer: How Are They Linked?</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1603</span><span class="NLM_x">–</span> <span class="NLM_lpage">1616</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.freeradbiomed.2010.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=20840865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKktLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=1603-1616&author=S.+Reuterauthor=S.+C.+Guptaauthor=M.+M.+Chaturvediauthor=B.+B.+Aggarwal&title=Oxidative+Stress%2C+Inflammation%2C+and+Cancer%3A+How+Are+They+Linked%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress, inflammation, and cancer: How are they linked?</span></div><div class="casAuthors">Reuter, Simone; Gupta, Subash C.; Chaturvedi, Madan M.; Aggarwal, Bharat B.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1603-1616</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Extensive research during the past 2 decades has revealed the mechanism by which continued oxidative stress can lead to chronic inflammation, which in turn could mediate most chronic diseases including cancer, diabetes, and cardiovascular, neurol., and pulmonary diseases.  Oxidative stress can activate a variety of transcription factors including NF-κB, AP-1, p53, HIF-1α, PPAR-γ, β-catenin/Wnt, and Nrf2.  Activation of these transcription factors can lead to the expression of over 500 different genes, including those for growth factors, inflammatory cytokines, chemokines, cell cycle regulatory mols., and anti-inflammatory mols.  How oxidative stress activates inflammatory pathways leading to transformation of a normal cell to tumor cell, tumor cell survival, proliferation, chemoresistance, radioresistance, invasion, angiogenesis, and stem cell survival is the focus of this review.  Overall, observations to date suggest that oxidative stress, chronic inflammation, and cancer are closely linked.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNUO29xqkZYrVg90H21EOLACvtfcHk0lhJmoM56ZxaRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKktLjF&md5=711e87493285f8d1167063aa0357324a</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2010.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2010.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DReuter%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DS.%2BC.%26aulast%3DChaturvedi%26aufirst%3DM.%2BM.%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DOxidative%2520Stress%252C%2520Inflammation%252C%2520and%2520Cancer%253A%2520How%2520Are%2520They%2520Linked%253F%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2010%26volume%3D49%26spage%3D1603%26epage%3D1616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Panico, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardile, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crascì, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronsisvalle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottanà, R.</span><span> </span><span class="NLM_article-title">5-Arylidene-4-thiazolidinone Derivatives Active as Antidegenerative Agents on Human Chondrocyte Cultures</span> <span class="citation_source-journal">Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.2174%2F157340613804488378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=22762165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktF2mtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=84-90&author=A.+Panicoauthor=R.+Maccariauthor=V.+Cardileauthor=L.+Crasc%C3%ACauthor=S.+Ronsisvalleauthor=R.+Ottan%C3%A0&title=5-Arylidene-4-thiazolidinone+Derivatives+Active+as+Antidegenerative+Agents+on+Human+Chondrocyte+Cultures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">5-arylidene-4-thiazolidinone derivatives active as antidegenerative agents on human chondrocyte cultures</span></div><div class="casAuthors">Panico, Annamaria; Maccari, Rosanna; Cardile, Venera; Crasci, Lucia; Ronsisvalle, Simone; Ottana, Rosaria</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-90</span>CODEN:
                <span class="NLM_cas:coden">MCEHAJ</span>;
        ISSN:<span class="NLM_cas:issn">1573-4064</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">5-Arylidene-2-oxo-4-thiazolidinones and 2-phenylimino analogs were evaluated for their antidegenerative activity on human chondrocyte cultures stimulated by IL-1β and for their inhibitory capability against matrix metalloproteinase-13.  Our results indicated that 5-arylidene-4-thiazolidinone derivs. 1-9 exhibit antidegenerative activity and could block multiple cartilage destruction during the osteoarthritic process.  Out of the selected compds., (5-arylidene-2,4-dioxothiazolidin-3-yl)acetic acids 7-9 showed significant effectiveness in reducing NO release and restoring normal levels of GAGs in chondrocytes treated with IL-1β.  Moreover, benzoic acids 1, 5 and 6 proved to be effective MMP-13 inhibitors and were able to restore normal levels of GAGs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplfUQ7EiPKjbVg90H21EOLACvtfcHk0lgSgpUs4ugnDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktF2mtbY%253D&md5=157970f44597e670bee1fe376cfceee0</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.2174%2F157340613804488378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157340613804488378%26sid%3Dliteratum%253Aachs%26aulast%3DPanico%26aufirst%3DA.%26aulast%3DMaccari%26aufirst%3DR.%26aulast%3DCardile%26aufirst%3DV.%26aulast%3DCrasc%25C3%25AC%26aufirst%3DL.%26aulast%3DRonsisvalle%26aufirst%3DS.%26aulast%3DOttan%25C3%25A0%26aufirst%3DR.%26atitle%3D5-Arylidene-4-thiazolidinone%2520Derivatives%2520Active%2520as%2520Antidegenerative%2520Agents%2520on%2520Human%2520Chondrocyte%2520Cultures%26jtitle%3DMed.%2520Chem.%26date%3D2013%26volume%3D9%26spage%3D84%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Maccari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitale, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottanà, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocchiccioli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrazzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardile, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graziano, A. C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amodeo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mura, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Corso, A.</span><span> </span><span class="NLM_article-title">Structure–Activity Relationships and Molecular Modelling of New 5-Arylidene-4-thiazolidinone Derivatives as Aldose Reductase Inhibitors and Potential Anti-Inflammatory Agents</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2014&pages=1-14&author=R.+Maccariauthor=R.+M.+Vitaleauthor=R.+Ottan%C3%A0author=M.+Rocchiccioliauthor=A.+Marrazzoauthor=V.+Cardileauthor=A.+C.+E.+Grazianoauthor=P.+Amodeoauthor=U.+Muraauthor=A.+Del+Corso&title=Structure%E2%80%93Activity+Relationships+and+Molecular+Modelling+of+New+5-Arylidene-4-thiazolidinone+Derivatives+as+Aldose+Reductase+Inhibitors+and+Potential+Anti-Inflammatory+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaccari%26aufirst%3DR.%26aulast%3DVitale%26aufirst%3DR.%2BM.%26aulast%3DOttan%25C3%25A0%26aufirst%3DR.%26aulast%3DRocchiccioli%26aufirst%3DM.%26aulast%3DMarrazzo%26aufirst%3DA.%26aulast%3DCardile%26aufirst%3DV.%26aulast%3DGraziano%26aufirst%3DA.%2BC.%2BE.%26aulast%3DAmodeo%26aufirst%3DP.%26aulast%3DMura%26aufirst%3DU.%26aulast%3DDel%2BCorso%26aufirst%3DA.%26atitle%3DStructure%25E2%2580%2593Activity%2520Relationships%2520and%2520Molecular%2520Modelling%2520of%2520New%25205-Arylidene-4-thiazolidinone%2520Derivatives%2520as%2520Aldose%2520Reductase%2520Inhibitors%2520and%2520Potential%2520Anti-Inflammatory%2520Agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D81%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Chang, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laffin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Énzsöly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Németh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBarbera, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, J. M.</span><span> </span><span class="NLM_article-title">Beta-Glucogallin Reduces the Expression of Lipopolysaccharide-Induced Inflammatory Markers by Inhibition of Aldose Reductase in Murine Macrophages and Ocular Tissues</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">287</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.cbi.2012.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=23247009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFaqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2013&pages=283-287&author=K.-C.+Changauthor=B.+Laffinauthor=J.+Ponderauthor=A.+%C3%89nzs%C3%B6lyauthor=J.+N%C3%A9methauthor=D.+V.+LaBarberaauthor=J.+M.+Petrash&title=Beta-Glucogallin+Reduces+the+Expression+of+Lipopolysaccharide-Induced+Inflammatory+Markers+by+Inhibition+of+Aldose+Reductase+in+Murine+Macrophages+and+Ocular+Tissues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Beta-glucogallin reduces the expression of lipopolysaccharide-induced inflammatory markers by inhibition of aldose reductase in murine macrophages and ocular tissues</span></div><div class="casAuthors">Chang, Kun-Che; Laffin, Brian; Ponder, Jessica; Enzsoly, Anna; Nemeth, Janos; LaBarbera, Daniel V.; Petrash, J. Mark</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">283-287</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Aldose reductase (AR) catalyzes the redn. of toxic lipid aldehydes to their alc. products and mediates inflammatory signals triggered by lipopolysaccharide (LPS).  Beta-glucogallin (BGG), a recently described AR inhibitor, was purified from exts. of the Indian gooseberry (Emblica officinalis).  In this study, we found that BGG showed low cytotoxicity in Raw264.7 murine macrophages and effectively inhibited AR activity as measured by a decrease in sorbitol accumulation.  In addn., BGG-mediated inhibition of AR prevented LPS-induced activation of JNK and p38 and lowered ROS levels, which could inhibit LPS-induced apoptosis.  Uveitis is a disease of the eye assocd. with chronic inflammation.  In this study, we also demonstrated that treatment with BGG decreased the no. of inflammatory cells that infiltrate the ocular media of mice with exptl. uveitis.  Accordingly, these results suggest BGG is a potential therapy for inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqk_VWCpvDtrVg90H21EOLACvtfcHk0lgSgpUs4ugnDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFaqsw%253D%253D&md5=01672c72c826fc6d83e3e3c39ab8d83c</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2012.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2012.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DK.-C.%26aulast%3DLaffin%26aufirst%3DB.%26aulast%3DPonder%26aufirst%3DJ.%26aulast%3D%25C3%2589nzs%25C3%25B6ly%26aufirst%3DA.%26aulast%3DN%25C3%25A9meth%26aufirst%3DJ.%26aulast%3DLaBarbera%26aufirst%3DD.%2BV.%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26atitle%3DBeta-Glucogallin%2520Reduces%2520the%2520Expression%2520of%2520Lipopolysaccharide-Induced%2520Inflammatory%2520Markers%2520by%2520Inhibition%2520of%2520Aldose%2520Reductase%2520in%2520Murine%2520Macrophages%2520and%2520Ocular%2520Tissues%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2013%26volume%3D202%26spage%3D283%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Zeng, K.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, P.-F.</span><span> </span><span class="NLM_article-title">Anti-Neuroinflammatory Efficacy of the Aldose Reductase Inhibitor FMHM via Phospholipase C/Protein Kinase C-Dependent NF-κB and MAPK Pathways</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.taap.2013.08.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=24021941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslKqt7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=2013&pages=159-171&author=K.-W.+Zengauthor=J.+Liauthor=X.+Dongauthor=Y.-H.+Wangauthor=Z.-Z.+Maauthor=Y.+Jiangauthor=H.-W.+Jinauthor=P.-F.+Tu&title=Anti-Neuroinflammatory+Efficacy+of+the+Aldose+Reductase+Inhibitor+FMHM+via+Phospholipase+C%2FProtein+Kinase+C-Dependent+NF-%CE%BAB+and+MAPK+Pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-neuroinflammatory efficacy of the aldose reductase inhibitor FMHM via phospholipase C/protein kinase C-dependent NF-κB and MAPK pathways</span></div><div class="casAuthors">Zeng, Ke-Wu; Li, Jun; Dong, Xin; Wang, Ying-Hong; Ma, Zhi-Zhong; Jiang, Yong; Jin, Hong-Wei; Tu, Peng-Fei</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">159-171</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Aldose reductase (AR) has a key role in several inflammatory diseases: diabetes, cancer and cardiovascular diseases.  Therefore, AR inhibition seems to be a useful strategy for anti-inflammation therapy.  In the central nervous system (CNS), microglial over-activation is considered to be a central event in neuroinflammation.  However, the effects of AR inhibition in CNS inflammation and its underlying mechanism of action remain unknown.  In the present study, we found that FMHM (a naturally derived AR inhibitor from the roots of Polygala tricornis Gagnep.) showed potent anti-neuroinflammatory effects in vivo and in vitro by inhibiting microglial activation and expression of inflammatory mediators.  Mechanistic studies showed that FMHM suppressed the activity of AR-dependent phospholipase C/protein kinase C signaling, which further resulted in downstream inactivation of the IκB kinase/IκB/nuclear factor-kappa B (NF-κB) inflammatory pathway.  Therefore, AR inhibition-dependent NF-κB inactivation neg. regulated the transcription and expression of various inflammatory genes.  AR inhibition by FMHM exerted neuroprotective effects in lipopolysaccharide-induced neuron-microglia co-cultures.  These findings suggested that AR is a potential target for neuroinflammation inhibition and that FMHM could be an effective agent for treating or preventing neuroinflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG2kWQVggzY7Vg90H21EOLACvtfcHk0lgSgpUs4ugnDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslKqt7jE&md5=1cddf94e77cb068bb4b80e996fac607a</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2013.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2013.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DK.-W.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.-H.%26aulast%3DMa%26aufirst%3DZ.-Z.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DH.-W.%26aulast%3DTu%26aufirst%3DP.-F.%26atitle%3DAnti-Neuroinflammatory%2520Efficacy%2520of%2520the%2520Aldose%2520Reductase%2520Inhibitor%2520FMHM%2520via%2520Phospholipase%2520C%252FProtein%2520Kinase%2520C-Dependent%2520NF-%25CE%25BAB%2520and%2520MAPK%2520Pathways%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2013%26volume%3D273%26spage%3D159%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Hwang, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakr, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itakura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rui, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skopicki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oates, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabolcs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramasamy, R.</span><span> </span><span class="NLM_article-title">Central Role for Aldose Reductase Pathway in Myocardial Ischemic Injury</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1192</span><span class="NLM_x">–</span> <span class="NLM_lpage">1199</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=1192-1199&author=Y.+C.+Hwangauthor=M.+Kanekoauthor=S.+Bakrauthor=H.+Liaoauthor=Y.+Luauthor=E.+R.+Lewisauthor=S.+Yanauthor=S.+Iiauthor=M.+Itakuraauthor=L.+Ruiauthor=H.+Skopickiauthor=S.+Hommaauthor=A.+M.+Schmidtauthor=P.+J.+Oatesauthor=M.+Szabolcsauthor=R.+Ramasamy&title=Central+Role+for+Aldose+Reductase+Pathway+in+Myocardial+Ischemic+Injury"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DY.%2BC.%26aulast%3DKaneko%26aufirst%3DM.%26aulast%3DBakr%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLewis%26aufirst%3DE.%2BR.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DIi%26aufirst%3DS.%26aulast%3DItakura%26aufirst%3DM.%26aulast%3DRui%26aufirst%3DL.%26aulast%3DSkopicki%26aufirst%3DH.%26aulast%3DHomma%26aufirst%3DS.%26aulast%3DSchmidt%26aufirst%3DA.%2BM.%26aulast%3DOates%26aufirst%3DP.%2BJ.%26aulast%3DSzabolcs%26aufirst%3DM.%26aulast%3DRamasamy%26aufirst%3DR.%26atitle%3DCentral%2520Role%2520for%2520Aldose%2520Reductase%2520Pathway%2520in%2520Myocardial%2520Ischemic%2520Injury%26jtitle%3DFASEB%2520J.%26date%3D2004%26volume%3D18%26spage%3D1192%26epage%3D1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Son, N.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ananthakrishnan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramasamy, R.</span><span> </span><span class="NLM_article-title">Cardiomyocyte Aldose Reductase Causes Heart Failure and Impairs Recovery from Ischemia</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e46549</span><span class="refDoi"> DOI: 10.1371/journal.pone.0046549</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1371%2Fjournal.pone.0046549" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e46549&author=N.-H.+Sonauthor=R.+Ananthakrishnanauthor=S.+Yuauthor=R.+S.+Khanauthor=H.+Jiangauthor=R.+Jiauthor=H.+Akashiauthor=Q.+Liauthor=K.+O%E2%80%99Sheaauthor=S.+Hommaauthor=I.+J.+Goldbergauthor=R.+Ramasamy&title=Cardiomyocyte+Aldose+Reductase+Causes+Heart+Failure+and+Impairs+Recovery+from+Ischemia&doi=10.1371%2Fjournal.pone.0046549"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0046549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0046549%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DN.-H.%26aulast%3DAnanthakrishnan%26aufirst%3DR.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DR.%2BS.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DR.%26aulast%3DAkashi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DK.%26aulast%3DHomma%26aufirst%3DS.%26aulast%3DGoldberg%26aufirst%3DI.%2BJ.%26aulast%3DRamasamy%26aufirst%3DR.%26atitle%3DCardiomyocyte%2520Aldose%2520Reductase%2520Causes%2520Heart%2520Failure%2520and%2520Impairs%2520Recovery%2520from%2520Ischemia%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De46549%26doi%3D10.1371%2Fjournal.pone.0046549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Laffin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, J. M.</span><span> </span><span class="NLM_article-title">Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers</span> <span class="citation_source-journal">Front. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="refDoi"> DOI: 10.3389/fphar.2012.00104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.3389%2Ffphar.2012.00104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=22685431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXms12qtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=104&author=B.+Laffinauthor=J.+M.+Petrash&title=Expression+of+the+Aldo-Ketoreductases+AKR1B1+and+AKR1B10+in+Human+Cancers&doi=10.3389%2Ffphar.2012.00104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of the aldo-ketoreductases AKR1B1 and AKR1B10 in human cancers</span></div><div class="casAuthors">Laffin, Brian; Petrash, J. Mark</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Experimental Pharmacology and Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">June</span>),
    <span class="NLM_cas:pages">104</span>CODEN:
                <span class="NLM_cas:coden">FEPDAX</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The American Cancer Society ests. that there will be more than 1.5 million new cases of cancer in 2011, underscoring the need for identification of new therapeutic targets and development of novel cancer therapies.  Previous studies have implicated the human aldo-ketoreductases AKR1B1 and AKR1B10 in cancer and therefore we examd. AKR1B1 and AKR1B10 expression across all major human cancer types using the Oncomine cancer gene expression database (Compendia Biosciences).  Using this database, we found that expression of AKR1B1 and AKR1B10 varies greatly by cancer type and tissue of origin, including agreement with previous reports that AKR1B10 is significantly over-expressed in cancers of the lungs and liver.  AKR1B1 is more broadly over-expressed in human cancers than AKR1B10, albeit at a generally lower magnitude.  AKR1B1 over-expression was found to be assocd. with shortened patient survival in acute myelogenous leukemias and multiple myelomas.  High AKR1B10 expression tends to predict less aggressive clin. course generally, notably within lung cancers, where it tends to be highly over-expressed compared to normal tissue.  These findings suggest that AKR1B1 inhibitors in particular hold great potential as novel cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYNF9NNpr1X7Vg90H21EOLACvtfcHk0lhnI-Rx8Wm66g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXms12qtr0%253D&md5=3bd8b0daadb669454fb8b9c95906b9cd</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2012.00104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2012.00104%26sid%3Dliteratum%253Aachs%26aulast%3DLaffin%26aufirst%3DB.%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26atitle%3DExpression%2520of%2520the%2520Aldo-Ketoreductases%2520AKR1B1%2520and%2520AKR1B10%2520in%2520Human%2520Cancers%26jtitle%3DFront.%2520Pharmacol.%26date%3D2012%26volume%3D3%26spage%3D104%26doi%3D10.3389%2Ffphar.2012.00104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Plebuch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soldan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungerer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maser, E.</span><span> </span><span class="NLM_article-title">Increased Resistance of Tumor Cells to Daunorubicin after Transfection of cDNAs Coding for Anthracycline Inactivating Enzymes</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.canlet.2007.03.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=17482758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFGmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=2007&pages=49-56&author=M.+Plebuchauthor=M.+Soldanauthor=C.+Hungererauthor=L.+Kochauthor=E.+Maser&title=Increased+Resistance+of+Tumor+Cells+to+Daunorubicin+after+Transfection+of+cDNAs+Coding+for+Anthracycline+Inactivating+Enzymes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Increased resistance of tumor cells to daunorubicin after transfection of cDNAs coding for anthracycline inactivating enzymes</span></div><div class="casAuthors">Plebuch, Mariann; Soldan, Michael; Hungerer, Christoph; Koch, Lutz; Maser, Edmund</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">255</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-56</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Carbonyl redn. is a main but undesired metabolic pathway of the anti-cancer drug daunorubicin (DRC).  The resulting alc. metabolite daunorubicinol has a far less anti-tumor potency and, in addn., is responsible for the life-threatening cardiac toxicity that limits the clin. use of DRC.  Elevated levels of carbonyl-reducing enzymes in cancer cells may therefore contribute to the development of DRC chemoresistance and affect the clin. outcome.  In the present investigation, human pancreas carcinoma cells were transfected with three important DRC reductases, namely carbonyl reductase (CBR1), aldehyde reductase (AKR1A1) and aldose reductase (AKR1B1), and levels of resistance towards DCR detd.  Overexpression of all three reductases lead to a higher DRC inactivation and to an elevation of chemoresistance (7-fold for CBR1, 4.5-fold for AKR1A1 and 3.7-fold for AKR1B1), when IC50-values were considered.  Coadministration of DRC reductase inhibitors in DRC chemotherapy may be desirable since this would reduce the formation of the cardiotoxic alc. metabolite and prevent drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9gnZXHCVnM7Vg90H21EOLACvtfcHk0liSEqO1SiPWvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFGmsLo%253D&md5=8acda29f3ff2eb769de1ae44fbd5c584</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2007.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2007.03.018%26sid%3Dliteratum%253Aachs%26aulast%3DPlebuch%26aufirst%3DM.%26aulast%3DSoldan%26aufirst%3DM.%26aulast%3DHungerer%26aufirst%3DC.%26aulast%3DKoch%26aufirst%3DL.%26aulast%3DMaser%26aufirst%3DE.%26atitle%3DIncreased%2520Resistance%2520of%2520Tumor%2520Cells%2520to%2520Daunorubicin%2520after%2520Transfection%2520of%2520cDNAs%2520Coding%2520for%2520Anthracycline%2520Inactivating%2520Enzymes%26jtitle%3DCancer%2520Lett.%26date%3D2007%26volume%3D255%26spage%3D49%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Der-Torossian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wysong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shadfar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDunn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couch, M. E.</span><span> </span><span class="NLM_article-title">Metabolic Derangements in the Gastrocnemius and the Effect of Compound A Therapy in a Murine Model of Cancer Cachexia</span> <span class="citation_source-journal">J. Cachexia Sarcopenia Muscle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1007%2Fs13539-012-0101-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=23344889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A280%3ADC%252BC3szhslSktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=145-155&author=H.+Der-Torossianauthor=A.+Wysongauthor=S.+Shadfarauthor=M.+S.+Willisauthor=J.+McDunnauthor=M.+E.+Couch&title=Metabolic+Derangements+in+the+Gastrocnemius+and+the+Effect+of+Compound+A+Therapy+in+a+Murine+Model+of+Cancer+Cachexia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic derangements in the gastrocnemius and the effect of Compound A therapy in a murine model of cancer cachexia</span></div><div class="casAuthors">Der-Torossian Hirak; Wysong Ashley; Shadfar Scott; Willis Monte S; McDunn Jonathan; Couch Marion E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cachexia, sarcopenia and muscle</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-55</span>
        ISSN:<span class="NLM_cas:issn">2190-5991</span>.
    </div><div class="casAbstract">BACKGROUND:  Cancer cachexia is a severe wasting syndrome characterized by the progressive loss of lean body mass and systemic inflammation.  Inhibiting the signaling of the transcription factor nuclear factor kappa B (NF-κB) largely prevents cancer-induced muscle wasting in murine models.  We have previously shown the utility of Compound A, a highly selective novel NF-κB inhibitor that targets the IκB kinase complex, to provide clinical benefit in cancer-induced skeletal muscle and cardiac atrophy.  METHODS:  Using a metabolomics approach, we describe the changes found between cachectic and noncachectic gastrocnemius muscles before and after Compound A treatment at various doses.  RESULTS:  Of the 234 metabolites in the gastrocnemius, cachexia-induced changes in gastrocnemius metabolism reset the steady-state abundances of 42 metabolites (p < 0.05).  These changes, not evenly distributed across biochemical categories, are concentrated in amino acids, peptides, carbohydrates and energetics intermediates, and lipids.  The gastrocnemius glycolytic pathway is markedly altered-changes consistent with tumor Warburg physiology.  This is the first account of a Warburg effect that is not exclusively restricted to cancer cells or rapidly proliferating nonmalignant cells.  Cachectic gastrocnemius also displays tricarboxylic acid cycle disruptions, signs of oxidative stress, and impaired redox homeostasis.  Compound A only partially rescues the phenotype of the cachectic gastrocnemius, failing to restore the gastrocnemius' baseline metabolic profile.  CONCLUSIONS:  The findings in the present manuscript enumerate the metabolic consequences of cachexia in the gastrocnemius and demonstrate that NF-kB targeted treatment only partly rescues the cachectic metabolic phenotype.  These data strengthen the previous findings from metabolomic characterization of serum in cachectic animals, suggesting that many of the metabolic alterations observed in the blood originate in the diseased muscle.  These findings provide significant insight into the complex pathophysiology of cancer cachexia and provide objective criteria for evaluating future therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRoTDtAPL-NkzAyhZbj3lKdfW6udTcc2ebPC3rHn5Quq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szhslSktA%253D%253D&md5=d5d85abf9016bd994f3deb8543608dd0</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1007%2Fs13539-012-0101-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13539-012-0101-7%26sid%3Dliteratum%253Aachs%26aulast%3DDer-Torossian%26aufirst%3DH.%26aulast%3DWysong%26aufirst%3DA.%26aulast%3DShadfar%26aufirst%3DS.%26aulast%3DWillis%26aufirst%3DM.%2BS.%26aulast%3DMcDunn%26aufirst%3DJ.%26aulast%3DCouch%26aufirst%3DM.%2BE.%26atitle%3DMetabolic%2520Derangements%2520in%2520the%2520Gastrocnemius%2520and%2520the%2520Effect%2520of%2520Compound%2520A%2520Therapy%2520in%2520a%2520Murine%2520Model%2520of%2520Cancer%2520Cachexia%26jtitle%3DJ.%2520Cachexia%2520Sarcopenia%2520Muscle%26date%3D2013%26volume%3D4%26spage%3D145%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Kawamura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeshita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishigaki, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimomura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, T.</span><span> </span><span class="NLM_article-title">Ponalrestat, an Aldose Reductase Inhibitor, Inhibits Cachexia Syndrome Induced by Colon26 Adenocarcinoma in Mice</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4105</span><span class="NLM_x">–</span> <span class="NLM_lpage">4111</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=10628361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt12k" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=4105-4111&author=I.+Kawamuraauthor=E.+Laceyauthor=N.+Yamamotoauthor=F.+Sakaiauthor=S.+Takeshitaauthor=M.+Inamiauthor=F.+Nishigakiauthor=Y.+Naoeauthor=S.+Tsujimotoauthor=T.+Mandaauthor=K.+Shimomuraauthor=T.+Goto&title=Ponalrestat%2C+an+Aldose+Reductase+Inhibitor%2C+Inhibits+Cachexia+Syndrome+Induced+by+Colon26+Adenocarcinoma+in+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon26 adenocarcinoma in mice</span></div><div class="casAuthors">Kawamura, Ikuo; Lacey, Elizabeth; Yamamoto, Nobuchika; Sakai, Fumihiko; Takeshita, Shigeru; Inami, Masamichi; Nishigaki, Fusako; Naoe, Yoshinori; Tsujimoto, Susumu; Manda, Toshitaka; Shimomura, Kyoichi; Goto, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5B</span>),
    <span class="NLM_cas:pages">4105-4111</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Our recent study has demonstrated that ponalrestat, an aldose reductase inhibitor, activates lipoprotein lipase activity and alleviates B16 melanoma-induced cachexia in mice.  In this study, the effect of ponalrestat on murine adenocarcinoma colon26-induced cachexia was investigated in mice.  Mice bearing colon26 s.c. lost wt. and became cachectic, assocd. with the tumor growth.  Although tumor growth was slightly stimulated when tumor bearing mice were treated with ponalrestat; nevertheless, the drug attenuated the redn. in the wt. of body mass, epididymal fat, gastrocnemius muscle and carcass induced by colon26, as well as significantly prolonged the survival of the colon26 bearing mice.  Ponalrestat inhibited the prodn. of interleukin-1 (IL-1) from human monocytes stimulated by Lipopolysaccharide (LPS) in vitro, and also suppressed LPS-induced increase of IL-1 in the blood in mice.  Overall, this study showed that ponalrestat suppresses IL-1 prodn. both in vitro and in vivo, and inhibits the cachectic symptoms induced by colon26 adenocarcinoma in mice, suggesting that ponalrestat has a therapeutic potential for the treatment of cancer cachexia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAE9s69ApIs7Vg90H21EOLACvtfcHk0liSEqO1SiPWvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt12k&md5=1de4fa208dfa9909dbc119f708e6d093</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKawamura%26aufirst%3DI.%26aulast%3DLacey%26aufirst%3DE.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DSakai%26aufirst%3DF.%26aulast%3DTakeshita%26aufirst%3DS.%26aulast%3DInami%26aufirst%3DM.%26aulast%3DNishigaki%26aufirst%3DF.%26aulast%3DNaoe%26aufirst%3DY.%26aulast%3DTsujimoto%26aufirst%3DS.%26aulast%3DManda%26aufirst%3DT.%26aulast%3DShimomura%26aufirst%3DK.%26aulast%3DGoto%26aufirst%3DT.%26atitle%3DPonalrestat%252C%2520an%2520Aldose%2520Reductase%2520Inhibitor%252C%2520Inhibits%2520Cachexia%2520Syndrome%2520Induced%2520by%2520Colon26%2520Adenocarcinoma%2520in%2520Mice%26jtitle%3DAnticancer%2520Res.%26date%3D1999%26volume%3D19%26spage%3D4105%26epage%3D4111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Tammali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singhal, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awasthi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Aldose Reductase Regulates Growth Factor-Induced Cyclooxygenase-2 Expression and Prostaglandin E2 Production in Human Colon Cancer Cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">9705</span><span class="NLM_x">–</span> <span class="NLM_lpage">9713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=9705-9713&author=R.+Tammaliauthor=K.+V.+Ramanaauthor=S.+S.+Singhalauthor=S.+Awasthiauthor=S.+K.+Srivastava&title=Aldose+Reductase+Regulates+Growth+Factor-Induced+Cyclooxygenase-2+Expression+and+Prostaglandin+E2+Production+in+Human+Colon+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTammali%26aufirst%3DR.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DSinghal%26aufirst%3DS.%2BS.%26aulast%3DAwasthi%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DAldose%2520Reductase%2520Regulates%2520Growth%2520Factor-Induced%2520Cyclooxygenase-2%2520Expression%2520and%2520Prostaglandin%2520E2%2520Production%2520in%2520Human%2520Colon%2520Cancer%2520Cells%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D9705%26epage%3D9713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Tammali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Aldose Reductase Regulates TNF-α-Induced PGE<sub>2</sub> Production in Human Colon Cancer Cells</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">252</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">306</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.canlet.2007.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=17300864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlvVyitbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=252&publication_year=2007&pages=299-306&author=R.+Tammaliauthor=K.+V.+Ramanaauthor=S.+K.+Srivastava&title=Aldose+Reductase+Regulates+TNF-%CE%B1-Induced+PGE2+Production+in+Human+Colon+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Aldose reductase regulates TNF-α-induced PGE2 production in human colon cancer cells</span></div><div class="casAuthors">Tammali, Ravinder; Ramana, Kota V.; Srivastava, Satish K.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">252</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">299-306</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pro-inflammatory cytokines such as TNF-α play an important role in the pathophysiol. of diseases such as Crohn's and ulcerative colitis which cause increased risk of colorectal cancer.  However, the mechanisms underlying colon carcinogenesis are not well understood.  Herein the authors report that inhibition/antisense abolition of polyol pathway enzyme, aldose reductase (AR) inhibited the TNF-α-induced synthesis of prostaglandin E2 and the activity of cyclooxygenase (Cox) in human colon cancer cells, Caco-2.  Inhibition of AR prevented TNF-α-induced activation of PKC and NF-κB which resulted in the abrogation of Cox-2 mRNA and protein expression.  These results suggest that inhibition of AR could be a novel chemopreventive approach to colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWSeMmxCM0bLVg90H21EOLACvtfcHk0li3SoqOHzFAhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlvVyitbk%253D&md5=b671824fa0147ac1f5a9b72a0ecdfc6a</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2007.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2007.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DTammali%26aufirst%3DR.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DAldose%2520Reductase%2520Regulates%2520TNF-%25CE%25B1-Induced%2520PGE2%2520Production%2520in%2520Human%2520Colon%2520Cancer%2520Cells%26jtitle%3DCancer%2520Lett.%26date%3D2007%26volume%3D252%26spage%3D299%26epage%3D306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Shoeb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Aldose Reductase Inhibition Enhances TRAIL-Induced Human Colon Cancer Cell Apoptosis through AKT/FOXO3a-dependent Upregulation of Death Receptors</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.freeradbiomed.2013.05.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=23732517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFyjt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2013&pages=280-290&author=M.+Shoebauthor=K.+V.+Ramanaauthor=S.+K.+Srivastava&title=Aldose+Reductase+Inhibition+Enhances+TRAIL-Induced+Human+Colon+Cancer+Cell+Apoptosis+through+AKT%2FFOXO3a-dependent+Upregulation+of+Death+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Aldose reductase inhibition enhances TRAIL-induced human colon cancer cell apoptosis through AKT/FOXO3a-dependent upregulation of death receptors</span></div><div class="casAuthors">Shoeb, Mohammad; Ramana, Kota V.; Srivastava, Satish K.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">280-290</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">One of the major problems assocd. with the chemotherapy of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) that selectively kills tumor cells is decreased drug resistance.  This warranted the development of safe novel pharmacol. agents that could sensitize the tumor cells to TRAIL.  Herein, we examd. the role of aldose reductase (AR) in sensitizing cancer cells to TRAIL and potentiating TRAIL-induced apoptosis of human colon cancer cells.  We demonstrate that AR inhibition potentiates TRAIL-induced cytotoxicity in cancer cells by upregulation of both death receptor (DR)-5 and DR4.  Knockdown of DR5 and DR4 significantly (>85%) reduced the sensitizing effect of the AR inhibitor fidarestat on TRAIL-induced apoptosis.  Further, AR inhibition also downregulates cell survival proteins (Bcl-xL, Bcl-2, survivin, XIAP, and FLIP) and upregulates the expression of proapoptotic proteins such as Bax and alters mitochondrial membrane potential, leading to cytochrome c release, caspases-3 activation, and PARP cleavage.  We found that AR inhibition regulates AKT/PI3K-dependent activation of forkhead transcription factor FOXO3a.  Knockdown of FOXO3a significantly (>80%) abolished AR inhibition-induced upregulation of DR5 and DR4 and apoptosis in colon cancer cells.  Overall, our results show that fidarestat potentiates TRAIL-induced apoptosis through downregulation of cell survival proteins and upregulation of death receptors via activation of the AKT/FOXO3a pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqmOjBKim4WbVg90H21EOLACvtfcHk0li3SoqOHzFAhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFyjt7vE&md5=4d3f3cdbf3aba47bc5ed35c9a475744b</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2013.05.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2013.05.039%26sid%3Dliteratum%253Aachs%26aulast%3DShoeb%26aufirst%3DM.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DAldose%2520Reductase%2520Inhibition%2520Enhances%2520TRAIL-Induced%2520Human%2520Colon%2520Cancer%2520Cell%2520Apoptosis%2520through%2520AKT%252FFOXO3a-dependent%2520Upregulation%2520of%2520Death%2520Receptors%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2013%26volume%3D63%26spage%3D280%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Tammali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, A. B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span> </span><span class="NLM_article-title">Inhibition of Aldose Reductase Prevents Angiogenesis in Vitro and in Vivo</span> <span class="citation_source-journal">Angiogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=209-221&author=R.+Tammaliauthor=A.+B.+M.+Reddyauthor=S.+K.+Srivastavaauthor=K.+V.+Ramana&title=Inhibition+of+Aldose+Reductase+Prevents+Angiogenesis+in+Vitro+and+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTammali%26aufirst%3DR.%26aulast%3DReddy%26aufirst%3DA.%2BB.%2BM.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26atitle%3DInhibition%2520of%2520Aldose%2520Reductase%2520Prevents%2520Angiogenesis%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DAngiogenesis%26date%3D2011%26volume%3D14%26spage%3D209%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Wilson, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohren, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabbay, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiocho, F. A.</span><span> </span><span class="NLM_article-title">An Unlikely Sugar Substrate Site in the 1.65 Å Structure of the Human Aldose Reductase Holoenzyme Implicated in Diabetic Complications</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1992&pages=81-84&author=D.+K.+Wilsonauthor=K.+M.+Bohrenauthor=K.+H.+Gabbayauthor=F.+A.+Quiocho&title=An+Unlikely+Sugar+Substrate+Site+in+the+1.65+%C3%85+Structure+of+the+Human+Aldose+Reductase+Holoenzyme+Implicated+in+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DD.%2BK.%26aulast%3DBohren%26aufirst%3DK.%2BM.%26aulast%3DGabbay%26aufirst%3DK.%2BH.%26aulast%3DQuiocho%26aufirst%3DF.%2BA.%26atitle%3DAn%2520Unlikely%2520Sugar%2520Substrate%2520Site%2520in%2520the%25201.65%2520%25C3%2585%2520Structure%2520of%2520the%2520Human%2520Aldose%2520Reductase%2520Holoenzyme%2520Implicated%2520in%2520Diabetic%2520Complications%26jtitle%3DScience%26date%3D1992%26volume%3D257%26spage%3D81%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Rondeau, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tête-Favier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reymann, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biellmann, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moras, D.</span><span> </span><span class="NLM_article-title">Novel NADPH-Binding Domain Revealed by the Crystal Structure of Aldose Reductase</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=1992&pages=469-472&author=J.+M.+Rondeauauthor=F.+T%C3%AAte-Favierauthor=A.+Podjarnyauthor=J.+M.+Reymannauthor=P.+Barthauthor=J.+F.+Biellmannauthor=D.+Moras&title=Novel+NADPH-Binding+Domain+Revealed+by+the+Crystal+Structure+of+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRondeau%26aufirst%3DJ.%2BM.%26aulast%3DT%25C3%25AAte-Favier%26aufirst%3DF.%26aulast%3DPodjarny%26aufirst%3DA.%26aulast%3DReymann%26aufirst%3DJ.%2BM.%26aulast%3DBarth%26aufirst%3DP.%26aulast%3DBiellmann%26aufirst%3DJ.%2BF.%26aulast%3DMoras%26aufirst%3DD.%26atitle%3DNovel%2520NADPH-Binding%2520Domain%2520Revealed%2520by%2520the%2520Crystal%2520Structure%2520of%2520Aldose%2520Reductase%26jtitle%3DNature%26date%3D1992%26volume%3D355%26spage%3D469%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Urzhumtsev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tête-Favier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbanton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urzhumtseva, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biellmann, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moras, D.</span><span> </span><span class="NLM_article-title">A “Specificity” Pocket Inferred from the Crystal Structures of the Complexes of Aldose Reductase with the Pharmaceutically Important Inhibitors Tolrestat and Sorbinil</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1997&pages=601-612&author=A.+Urzhumtsevauthor=F.+T%C3%AAte-Favierauthor=A.+Mitschlerauthor=J.+Barbantonauthor=P.+Barthauthor=L.+Urzhumtsevaauthor=J.-F.+Biellmannauthor=A.+D.+Podjarnyauthor=D.+Moras&title=A+%E2%80%9CSpecificity%E2%80%9D+Pocket+Inferred+from+the+Crystal+Structures+of+the+Complexes+of+Aldose+Reductase+with+the+Pharmaceutically+Important+Inhibitors+Tolrestat+and+Sorbinil"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUrzhumtsev%26aufirst%3DA.%26aulast%3DT%25C3%25AAte-Favier%26aufirst%3DF.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DBarbanton%26aufirst%3DJ.%26aulast%3DBarth%26aufirst%3DP.%26aulast%3DUrzhumtseva%26aufirst%3DL.%26aulast%3DBiellmann%26aufirst%3DJ.-F.%26aulast%3DPodjarny%26aufirst%3DA.%2BD.%26aulast%3DMoras%26aufirst%3DD.%26atitle%3DA%2520%25E2%2580%259CSpecificity%25E2%2580%259D%2520Pocket%2520Inferred%2520from%2520the%2520Crystal%2520Structures%2520of%2520the%2520Complexes%2520of%2520Aldose%2520Reductase%2520with%2520the%2520Pharmaceutically%2520Important%2520Inhibitors%2520Tolrestat%2520and%2520Sorbinil%26jtitle%3DStructure%26date%3D1997%26volume%3D5%26spage%3D601%26epage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darmanin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazemann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze-Briese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomizaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A.</span><span> </span><span class="NLM_article-title">Ultrahigh Resolution Drug Design. II. Atomic Resolution Structures of Human Aldose Reductase Holoenzyme Complexed with Fidarestat and Minalrestat: Implications for the Binding of Cyclic Imide Inhibitors</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">805</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=805-813&author=O.+El-Kabbaniauthor=C.+Darmaninauthor=T.+R.+Schneiderauthor=I.+Hazemannauthor=F.+Ruizauthor=M.+Okaauthor=A.+Joachimiakauthor=C.+Schulze-Brieseauthor=T.+Tomizakiauthor=A.+Mitschlerauthor=A.+Podjarny&title=Ultrahigh+Resolution+Drug+Design.+II.+Atomic+Resolution+Structures+of+Human+Aldose+Reductase+Holoenzyme+Complexed+with+Fidarestat+and+Minalrestat%3A+Implications+for+the+Binding+of+Cyclic+Imide+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DDarmanin%26aufirst%3DC.%26aulast%3DSchneider%26aufirst%3DT.%2BR.%26aulast%3DHazemann%26aufirst%3DI.%26aulast%3DRuiz%26aufirst%3DF.%26aulast%3DOka%26aufirst%3DM.%26aulast%3DJoachimiak%26aufirst%3DA.%26aulast%3DSchulze-Briese%26aufirst%3DC.%26aulast%3DTomizaki%26aufirst%3DT.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DPodjarny%26aufirst%3DA.%26atitle%3DUltrahigh%2520Resolution%2520Drug%2520Design.%2520II.%2520Atomic%2520Resolution%2520Structures%2520of%2520Human%2520Aldose%2520Reductase%2520Holoenzyme%2520Complexed%2520with%2520Fidarestat%2520and%2520Minalrestat%253A%2520Implications%2520for%2520the%2520Binding%2520of%2520Cyclic%2520Imide%2520Inhibitors%26jtitle%3DProteins%26date%3D2004%26volume%3D55%26spage%3D805%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Wilson, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarle, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiocho, F. A.</span><span> </span><span class="NLM_article-title">Refined 1.8 Å Structure of Human Aldose Reductase Complexed with the Potent Inhibitor Zopolrestat</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">9847</span><span class="NLM_x">–</span> <span class="NLM_lpage">9851</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=9847-9851&author=D.+K.+Wilsonauthor=I.+Tarleauthor=J.+M.+Petrashauthor=F.+A.+Quiocho&title=Refined+1.8+%C3%85+Structure+of+Human+Aldose+Reductase+Complexed+with+the+Potent+Inhibitor+Zopolrestat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DD.%2BK.%26aulast%3DTarle%26aufirst%3DI.%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26aulast%3DQuiocho%26aufirst%3DF.%2BA.%26atitle%3DRefined%25201.8%2520%25C3%2585%2520Structure%2520of%2520Human%2520Aldose%2520Reductase%2520Complexed%2520with%2520the%2520Potent%2520Inhibitor%2520Zopolrestat%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1993%26volume%3D90%26spage%3D9847%26epage%3D9851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Biadene, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazemann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cousido, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheldrick, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, T. R.</span><span> </span><span class="NLM_article-title">The Atomic Resolution Structure of Human Aldose Reductase Reveals That Rearrangement of a Bound Ligand Allows the Opening of the Safety-Belt Loop</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">D63</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D63&publication_year=2007&pages=665-672&author=M.+Biadeneauthor=I.+Hazemannauthor=A.+Cousidoauthor=S.+Ginellauthor=A.+Joachimiakauthor=G.+M.+Sheldrickauthor=A.+Podjarnyauthor=T.+R.+Schneider&title=The+Atomic+Resolution+Structure+of+Human+Aldose+Reductase+Reveals+That+Rearrangement+of+a+Bound+Ligand+Allows+the+Opening+of+the+Safety-Belt+Loop"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBiadene%26aufirst%3DM.%26aulast%3DHazemann%26aufirst%3DI.%26aulast%3DCousido%26aufirst%3DA.%26aulast%3DGinell%26aufirst%3DS.%26aulast%3DJoachimiak%26aufirst%3DA.%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26aulast%3DPodjarny%26aufirst%3DA.%26aulast%3DSchneider%26aufirst%3DT.%2BR.%26atitle%3DThe%2520Atomic%2520Resolution%2520Structure%2520of%2520Human%2520Aldose%2520Reductase%2520Reveals%2520That%2520Rearrangement%2520of%2520a%2520Bound%2520Ligand%2520Allows%2520the%2520Opening%2520of%2520the%2520Safety-Belt%2520Loop%26jtitle%3DActa%2520Crystallogr.%26date%3D2007%26volume%3DD63%26spage%3D665%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Bohren, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brownlee, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milne, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabbay, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, D. H.T.</span><span> </span><span class="NLM_article-title">The Structure of Apo R268A Human Aldose Reductase: Hinges and Latches That Control the Kinetic Mechanism</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1748</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1748&publication_year=2005&pages=201-212&author=K.+M.+Bohrenauthor=J.+M.+Brownleeauthor=A.+C.+Milneauthor=K.+H.+Gabbayauthor=D.+H.T.+Harrison&title=The+Structure+of+Apo+R268A+Human+Aldose+Reductase%3A+Hinges+and+Latches+That+Control+the+Kinetic+Mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBohren%26aufirst%3DK.%2BM.%26aulast%3DBrownlee%26aufirst%3DJ.%2BM.%26aulast%3DMilne%26aufirst%3DA.%2BC.%26aulast%3DGabbay%26aufirst%3DK.%2BH.%26aulast%3DHarrison%26aufirst%3DD.%2BH.T.%26atitle%3DThe%2520Structure%2520of%2520Apo%2520R268A%2520Human%2520Aldose%2520Reductase%253A%2520Hinges%2520and%2520Latches%2520That%2520Control%2520the%2520Kinetic%2520Mechanism%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2005%26volume%3D1748%26spage%3D201%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Sotriffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krämer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">Probing Flexibility and “Induced-Fit” Phenomena in Aldose Reductase by Comparative Crystal Structure Analysis and Molecular Dynamics Simulations</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=52-66&author=C.+A.+Sotrifferauthor=O.+Kr%C3%A4merauthor=G.+Klebe&title=Probing+Flexibility+and+%E2%80%9CInduced-Fit%E2%80%9D+Phenomena+in+Aldose+Reductase+by+Comparative+Crystal+Structure+Analysis+and+Molecular+Dynamics+Simulations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DKr%25C3%25A4mer%26aufirst%3DO.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DProbing%2520Flexibility%2520and%2520%25E2%2580%259CInduced-Fit%25E2%2580%259D%2520Phenomena%2520in%2520Aldose%2520Reductase%2520by%2520Comparative%2520Crystal%2520Structure%2520Analysis%2520and%2520Molecular%2520Dynamics%2520Simulations%26jtitle%3DProteins%26date%3D2004%26volume%3D56%26spage%3D52%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Krämer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazemann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">Virtual Screening for Inhibitors of Human Aldose Reductase</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">814</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=814-23&author=O.+Kr%C3%A4merauthor=I.+Hazemannauthor=A.+D.+Podjarnyauthor=G.+Klebe&title=Virtual+Screening+for+Inhibitors+of+Human+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKr%25C3%25A4mer%26aufirst%3DO.%26aulast%3DHazemann%26aufirst%3DI.%26aulast%3DPodjarny%26aufirst%3DA.%2BD.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DVirtual%2520Screening%2520for%2520Inhibitors%2520of%2520Human%2520Aldose%2520Reductase%26jtitle%3DProteins%26date%3D2004%26volume%3D55%26spage%3D814%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Steuber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">Merging the Binding Sites of Aldose and Aldehyde Reductase for Detection of Inhibitor Selectivity-Determining Features</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">379</span><span class="NLM_x">, </span> <span class="NLM_fpage">991</span><span class="NLM_x">–</span> <span class="NLM_lpage">1016</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.jmb.2008.03.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=18495158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFKqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2008&pages=991-1016&author=H.+Steuberauthor=A.+Heineauthor=A.+Podjarnyauthor=G.+Klebe&title=Merging+the+Binding+Sites+of+Aldose+and+Aldehyde+Reductase+for+Detection+of+Inhibitor+Selectivity-Determining+Features"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Merging the Binding Sites of Aldose and Aldehyde Reductase for Detection of Inhibitor Selectivity-determining Features</span></div><div class="casAuthors">Steuber, Holger; Heine, Andreas; Podjarny, Alberto; Klebe, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">991-1016</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Inhibition of human aldose reductase (ALR2) evolved as a promising therapeutic concept to prevent late complications of diabetes.  As well as appropriate affinity and bioavailability, putative inhibitors should possess a high level of selectivity for ALR2 over the related aldehyde reductase (ALR1).  We investigated the selectivity-detg. features by gradually mapping the residues deviating between the binding pockets of ALR1 and ALR2 into the ALR2 binding pocket.  The resulting mutational constructs of ALR2 (eight point mutations and one double mutant) were probed for their influence towards ligand selectivity by x-ray structure anal. of the corresponding complexes and isothermal titrn. calorimetry (ITC).  The binding properties of these mutants were evaluated using a ligand set of zopolrestat, a related uracil deriv., IDD388, IDD393, sorbinil, fidarestat and tolrestat.  Our study revealed induced-fit adaptations within the mutated binding site as an essential prerequisite for ligand accommodation related to the selectivity discrimination of the ligands.  However, our study also highlights the limits of the present understanding of protein-ligand interactions.  Interestingly, binding site mutations not involved in any direct interaction to the ligands in various cases show significant effects towards their binding thermodn.  Furthermore, our results suggest the binding site residues deviating between ALR1 and ALR2 influence ligand affinity in a complex interplay, presumably involving changes of dynamic properties and differences of the solvation/desolvation balance upon ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXEFEh9rqZDLVg90H21EOLACvtfcHk0licfj64K6W1Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFKqtLw%253D&md5=5be0f213751356e837ee03fe7bee4fed</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2008.03.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2008.03.063%26sid%3Dliteratum%253Aachs%26aulast%3DSteuber%26aufirst%3DH.%26aulast%3DHeine%26aufirst%3DA.%26aulast%3DPodjarny%26aufirst%3DA.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DMerging%2520the%2520Binding%2520Sites%2520of%2520Aldose%2520and%2520Aldehyde%2520Reductase%2520for%2520Detection%2520of%2520Inhibitor%2520Selectivity-Determining%2520Features%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D379%26spage%3D991%26epage%3D1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Steuber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zentgraf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotriffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">Expect the Unexpected or Caveat for Drug Designers: Multiple Structure Determinations Using Aldose Reductase Crystals Treated under Varying Soaking and Co-Crystallisation Conditions</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2006&pages=174-187&author=H.+Steuberauthor=M.+Zentgrafauthor=C.+Gerlachauthor=C.+A.+Sotrifferauthor=A.+Heineauthor=G.+Klebe&title=Expect+the+Unexpected+or+Caveat+for+Drug+Designers%3A+Multiple+Structure+Determinations+Using+Aldose+Reductase+Crystals+Treated+under+Varying+Soaking+and+Co-Crystallisation+Conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSteuber%26aufirst%3DH.%26aulast%3DZentgraf%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DC.%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DHeine%26aufirst%3DA.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DExpect%2520the%2520Unexpected%2520or%2520Caveat%2520for%2520Drug%2520Designers%253A%2520Multiple%2520Structure%2520Determinations%2520Using%2520Aldose%2520Reductase%2520Crystals%2520Treated%2520under%2520Varying%2520Soaking%2520and%2520Co-Crystallisation%2520Conditions%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D363%26spage%3D174%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Dixit, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balendiran, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watowich, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Kinetic and Structural Characterization of the Glutathione-Binding Site of Aldose Reductase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">21587</span><span class="NLM_x">–</span> <span class="NLM_lpage">21595</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=21587-21595&author=B.+L.+Dixitauthor=G.+K.+Balendiranauthor=S.+J.+Watowichauthor=S.+Srivastavaauthor=K.+V.+Ramanaauthor=J.+M.+Petrashauthor=A.+Bhatnagarauthor=S.+K.+Srivastava&title=Kinetic+and+Structural+Characterization+of+the+Glutathione-Binding+Site+of+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDixit%26aufirst%3DB.%2BL.%26aulast%3DBalendiran%26aufirst%3DG.%2BK.%26aulast%3DWatowich%26aufirst%3DS.%2BJ.%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26aulast%3DBhatnagar%26aufirst%3DA.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DKinetic%2520and%2520Structural%2520Characterization%2520of%2520the%2520Glutathione-Binding%2520Site%2520of%2520Aldose%2520Reductase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D21587%26epage%3D21595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watowich, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Structure of a Glutathione Conjugate Bound to the Active Site of Aldose Reductase</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2006&pages=101-110&author=R.+Singhauthor=M.+A.+Whiteauthor=K.+V.+Ramanaauthor=J.+M.+Petrashauthor=S.+J.+Watowichauthor=A.+Bhatnagarauthor=S.+K.+Srivastava&title=Structure+of+a+Glutathione+Conjugate+Bound+to+the+Active+Site+of+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DWhite%26aufirst%3DM.%2BA.%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26aulast%3DWatowich%26aufirst%3DS.%2BJ.%26aulast%3DBhatnagar%26aufirst%3DA.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DStructure%2520of%2520a%2520Glutathione%2520Conjugate%2520Bound%2520to%2520the%2520Active%2520Site%2520of%2520Aldose%2520Reductase%26jtitle%3DProteins%26date%3D2006%26volume%3D64%26spage%3D101%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Ramana, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balendiran, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span> </span><span class="NLM_article-title">Selective Recognition of Glutathiolated Aldehydes by Aldose Reductase</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">12172</span><span class="NLM_x">–</span> <span class="NLM_lpage">12180</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi000796e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=12172-12180&author=K.+V.+Ramanaauthor=B.+L.+Dixitauthor=S.+Srivastavaauthor=G.+K.+Balendiranauthor=S.+K.+Srivastavaauthor=A.+Bhatnagar&title=Selective+Recognition+of+Glutathiolated+Aldehydes+by+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fbi000796e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi000796e%26sid%3Dliteratum%253Aachs%26aulast%3DRamana%26aufirst%3DK.%2BV.%26aulast%3DDixit%26aufirst%3DB.%2BL.%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DBalendiran%26aufirst%3DG.%2BK.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26aulast%3DBhatnagar%26aufirst%3DA.%26atitle%3DSelective%2520Recognition%2520of%2520Glutathiolated%2520Aldehydes%2520by%2520Aldose%2520Reductase%26jtitle%3DBiochemistry%26date%3D2000%26volume%3D39%26spage%3D12172%26epage%3D12180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Petrash, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harter, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olins, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S. K.</span><span> </span><span class="NLM_article-title">Involvement of Cysteine Residues in Catalysis and Inhibition of Human Aldose Reductase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">24833</span><span class="NLM_x">–</span> <span class="NLM_lpage">24840</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=24833-24840&author=J.+M.+Petrashauthor=T.+M.+Harterauthor=C.+S.+Devineauthor=P.+O.+Olinsauthor=A.+Bhatnagarauthor=S.+Liuauthor=S.+K.+Srivastava&title=Involvement+of+Cysteine+Residues+in+Catalysis+and+Inhibition+of+Human+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26aulast%3DHarter%26aufirst%3DT.%2BM.%26aulast%3DDevine%26aufirst%3DC.%2BS.%26aulast%3DOlins%26aufirst%3DP.%2BO.%26aulast%3DBhatnagar%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DS.%2BK.%26atitle%3DInvolvement%2520of%2520Cysteine%2520Residues%2520in%2520Catalysis%2520and%2520Inhibition%2520of%2520Human%2520Aldose%2520Reductase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D24833%26epage%3D24840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Cappiello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardo, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micheli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacomelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banditelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverenz, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giblin, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Corso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mura, U.</span><span> </span><span class="NLM_article-title">Thiol Disulfide Exchange Modulates the Activity of Aldose Reductase in Intact Bovine Lens as a Response to Oxidative Stress</span> <span class="citation_source-journal">Exp. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">795</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1006%2Fexer.2000.0838" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=10843784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjvVSktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2000&pages=795-803&author=M.+Cappielloauthor=P.+G.+Vilardoauthor=V.+Micheliauthor=G.+Jacomelliauthor=S.+Banditelliauthor=V.+Leverenzauthor=F.+J.+Giblinauthor=A.+Del+Corsoauthor=U.+Mura&title=Thiol+Disulfide+Exchange+Modulates+the+Activity+of+Aldose+Reductase+in+Intact+Bovine+Lens+as+a+Response+to+Oxidative+Stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Thiol Disulfide Exchange Modulates the Activity of Aldose Reductase in Intact Bovine Lens as a Response to Oxidative Stress</span></div><div class="casAuthors">Cappiello, Mario; Vilardo, Pier Giuseppe; Micheli, Vanna; Jacomelli, Gabriella; Banditelli, Stefania; Leverenz, Victor; Giblin, Frank J.; Corso, Antonella Del; Mura, Umberto</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">795-803</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The reversibility of S-thiolation of aldose reductase was shown in intact bovine lens subjected to oxidative stress.  The glutathione modified aldose reductase generated in the lens as a consequence of hyperbaric oxygen treatment was recovered in its reduced form following culturing in normobaric air conditions.  Nucleus and cortex were differently affected by both oxidative treatment and normobaric air recovery.  The extent of S-thiolation of aldose reductase appeared to be higher in the nucleus than in the cortex.  Moreover, the nucleus, but not the cortex, was unable to completely recover from the protein S-thiolation process.  The ratios of GSH/GSSG and NADPH/NADP+as well as the Energy Charge values were detd. in the cortex and nucleus both after oxidative stress and recovery.  The results are consistent with the existence of a quite well-defined boundary between the two lens regions.  Moreover, they are supportive of the hypothesis that thiol/disulfide exchange has the potential to be a regulatory mechanism for certain enzymes which can modulate the flux of NADPH inside the cell.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJnDbBZSnet7Vg90H21EOLACvtfcHk0lgoqhZLkxWbiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjvVSktLs%253D&md5=520dd368757102d97aeb6893a21db4aa</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1006%2Fexer.2000.0838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexer.2000.0838%26sid%3Dliteratum%253Aachs%26aulast%3DCappiello%26aufirst%3DM.%26aulast%3DVilardo%26aufirst%3DP.%2BG.%26aulast%3DMicheli%26aufirst%3DV.%26aulast%3DJacomelli%26aufirst%3DG.%26aulast%3DBanditelli%26aufirst%3DS.%26aulast%3DLeverenz%26aufirst%3DV.%26aulast%3DGiblin%26aufirst%3DF.%2BJ.%26aulast%3DDel%2BCorso%26aufirst%3DA.%26aulast%3DMura%26aufirst%3DU.%26atitle%3DThiol%2520Disulfide%2520Exchange%2520Modulates%2520the%2520Activity%2520of%2520Aldose%2520Reductase%2520in%2520Intact%2520Bovine%2520Lens%2520as%2520a%2520Response%2520to%2520Oxidative%2520Stress%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D2000%26volume%3D70%26spage%3D795%26epage%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Cappiello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voltarelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannessi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecconi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camici, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Corso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mura, U.</span><span> </span><span class="NLM_article-title">Glutathione Dependent Modification of Bovine Lens Aldose Reductase</span> <span class="citation_source-journal">Exp. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1006%2Fexer.1994.1042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=7925685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADyaK2cXltVaqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1994&pages=491-501&author=M.+Cappielloauthor=M.+Voltarelliauthor=M.+Giannessiauthor=I.+Cecconiauthor=G.+Camiciauthor=G.+Manaoauthor=A.+Del+Corsoauthor=U.+Mura&title=Glutathione+Dependent+Modification+of+Bovine+Lens+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Glutathione dependent modification of bovine lens aldose reductase</span></div><div class="casAuthors">Cappiello, Mario; Voltarelli, Margaret; Giannessi, Maggiorana; Cecconi, Ilaria; Camici, Guido; Manao, Gianpaolo; Del Corso, Antonella; Mura, Umberto</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">491-501</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    </div><div class="casAbstract">Bovine lens aldose reductase (ALR2) is readily modified by glutathione disulfide (GSSG) to an enzyme form (GS-ALR2) exhibiting a reduced catalytic efficiency with all the substrates tested and a reduced susceptibility to inhibition.  The modification, which is completely reversed by reduced glutathione (GSH) or dithiothreitol occurs by a pseudo-1st-order process with respect to the enzyme and a 2nd-order rate const. of 30 mol-1 at 25° was detd.  By measuring the residual activity of ALR2 incubated in different glutathione redox buffers at 25°, an apparent redox equil. const. of 1.4 was evaluated.  Thus, the rate and the maximal extent of ALR2 inactivation are proportional to the redox ratio of the thiol used as modifying agent (i.e., [GSH]/[GSSG]).  The stoichiometric reversibility of the enzyme modification may be impaired by a reduced soly. of GS-ALR2 with respect to ALR2 and by an increased susceptibility of the modified enzyme to proteolysis.  Whereas the native enzyme form was rather insensitive to proteolytic breakdown, GS-ALR2 was easily degraded by chymotrypsin with the generation of a peptide of 26 kDa with an amino acid sequence at the N-terminal side compatible with proteolysis at Tyr-7 of aldose reductase.  A reduced efficiency in enzyme-cofactor binding following the GSSG-dependent modification of ALR2 appeared to be assocd. to the thiol accessibility of GS-ALR2 measured at different temps.  GS-ALR2 was characterized by the presence of 1 glutathione residue, linked through a mixed disulfide bond.  This was sustained by: (1) the pI for the modified enzyme of 4.75, which was 0.1 pH units lower than that obsd. for the native enzyme, which indicated the contribution of an acidic residue to the pI of GS-ALR2; (2) the incorporation of radioactivity coming from [3H]GSSG accounting for the presence of 1 equiv of glutathione per mol of enzyme.  Besides being a general feature of protein reactivity in oxidative conditions, the glutathione-mediated ALR2 modification may be part of a cell strategy to preserve reducing power in conditions of oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-3jCUj_RL-7Vg90H21EOLACvtfcHk0lgoqhZLkxWbiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXltVaqsLk%253D&md5=cb55083f0e51dc0ddf0ca77a4a5a4b31</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1006%2Fexer.1994.1042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexer.1994.1042%26sid%3Dliteratum%253Aachs%26aulast%3DCappiello%26aufirst%3DM.%26aulast%3DVoltarelli%26aufirst%3DM.%26aulast%3DGiannessi%26aufirst%3DM.%26aulast%3DCecconi%26aufirst%3DI.%26aulast%3DCamici%26aufirst%3DG.%26aulast%3DManao%26aufirst%3DG.%26aulast%3DDel%2BCorso%26aufirst%3DA.%26aulast%3DMura%26aufirst%3DU.%26atitle%3DGlutathione%2520Dependent%2520Modification%2520of%2520Bovine%2520Lens%2520Aldose%2520Reductase%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D1994%26volume%3D58%26spage%3D491%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Cappiello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilardo, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecconi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverenz, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giblin, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Corso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mura, U.</span><span> </span><span class="NLM_article-title">Occurrence of Glutathione-Modified Aldose Reductase in Oxidatively Stressed Bovine Lens</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">207</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">782</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=1995&pages=775-782&author=M.+Cappielloauthor=P.+G.+Vilardoauthor=I.+Cecconiauthor=V.+Leverenzauthor=F.+J.+Giblinauthor=A.+Del+Corsoauthor=U.+Mura&title=Occurrence+of+Glutathione-Modified+Aldose+Reductase+in+Oxidatively+Stressed+Bovine+Lens"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCappiello%26aufirst%3DM.%26aulast%3DVilardo%26aufirst%3DP.%2BG.%26aulast%3DCecconi%26aufirst%3DI.%26aulast%3DLeverenz%26aufirst%3DV.%26aulast%3DGiblin%26aufirst%3DF.%2BJ.%26aulast%3DDel%2BCorso%26aufirst%3DA.%26aulast%3DMura%26aufirst%3DU.%26atitle%3DOccurrence%2520of%2520Glutathione-Modified%2520Aldose%2520Reductase%2520in%2520Oxidatively%2520Stressed%2520Bovine%2520Lens%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1995%26volume%3D207%26spage%3D775%26epage%3D782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Muthenna, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suryanarayana, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunda, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, G. B.</span><span> </span><span class="NLM_article-title">Inhibition of Aldose Reductase by Dietary Antioxidant Curcumin: Mechanism of Inhibition, Specificity and Significance</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">583</span><span class="NLM_x">, </span> <span class="NLM_fpage">3637</span><span class="NLM_x">–</span> <span class="NLM_lpage">3642</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=583&publication_year=2009&pages=3637-3642&author=P.+Muthennaauthor=P.+Suryanarayanaauthor=S.+K.+Gundaauthor=J.+M.+Petrashauthor=G.+B.+Reddy&title=Inhibition+of+Aldose+Reductase+by+Dietary+Antioxidant+Curcumin%3A+Mechanism+of+Inhibition%2C+Specificity+and+Significance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuthenna%26aufirst%3DP.%26aulast%3DSuryanarayana%26aufirst%3DP.%26aulast%3DGunda%26aufirst%3DS.%2BK.%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26aulast%3DReddy%26aufirst%3DG.%2BB.%26atitle%3DInhibition%2520of%2520Aldose%2520Reductase%2520by%2520Dietary%2520Antioxidant%2520Curcumin%253A%2520Mechanism%2520of%2520Inhibition%252C%2520Specificity%2520and%2520Significance%26jtitle%3DFEBS%2520Lett.%26date%3D2009%26volume%3D583%26spage%3D3637%26epage%3D3642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Berrone, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beltramo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solimine, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubertalli Ape, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porta, M.</span><span> </span><span class="NLM_article-title">Regulation of Intracellular Glucose and Polyol Pathway by Thiamine and Benfotiamine in Vascular Cells Cultured in High Glucose</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">9307</span><span class="NLM_x">–</span> <span class="NLM_lpage">9313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=9307-9313&author=E.+Berroneauthor=E.+Beltramoauthor=C.+Solimineauthor=A.+Ubertalli+Apeauthor=M.+Porta&title=Regulation+of+Intracellular+Glucose+and+Polyol+Pathway+by+Thiamine+and+Benfotiamine+in+Vascular+Cells+Cultured+in+High+Glucose"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerrone%26aufirst%3DE.%26aulast%3DBeltramo%26aufirst%3DE.%26aulast%3DSolimine%26aufirst%3DC.%26aulast%3DUbertalli%2BApe%26aufirst%3DA.%26aulast%3DPorta%26aufirst%3DM.%26atitle%3DRegulation%2520of%2520Intracellular%2520Glucose%2520and%2520Polyol%2520Pathway%2520by%2520Thiamine%2520and%2520Benfotiamine%2520in%2520Vascular%2520Cells%2520Cultured%2520in%2520High%2520Glucose%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D9307%26epage%3D9313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Kanazu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinoda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deyashiki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, H.</span><span> </span><span class="NLM_article-title">Aldehyde Reductase Is a Major Protein Associated with 3-Deoxyglucosone Reductase Activity in Rat, Pig, and Human Livers</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">903</span><span class="NLM_x">–</span> <span class="NLM_lpage">906</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=1991&pages=903-906&author=T.+Kanazuauthor=M.+Shinodaauthor=T.+Nakayamaauthor=Y.+Deyashikiauthor=A.+Haraauthor=H.+Sawada&title=Aldehyde+Reductase+Is+a+Major+Protein+Associated+with+3-Deoxyglucosone+Reductase+Activity+in+Rat%2C+Pig%2C+and+Human+Livers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKanazu%26aufirst%3DT.%26aulast%3DShinoda%26aufirst%3DM.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DDeyashiki%26aufirst%3DY.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DSawada%26aufirst%3DH.%26atitle%3DAldehyde%2520Reductase%2520Is%2520a%2520Major%2520Protein%2520Associated%2520with%25203-Deoxyglucosone%2520Reductase%2520Activity%2520in%2520Rat%252C%2520Pig%252C%2520and%2520Human%2520Livers%26jtitle%3DBiochem.%2520J.%26date%3D1991%26volume%3D279%26spage%3D903%26epage%3D906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Oya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchida, K.</span><span> </span><span class="NLM_article-title">Methylglyoxal Modification of Protein. Chemical and Immunochemical Characterization of Methylglyoxal-Arginine Adducts</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">18492</span><span class="NLM_x">–</span> <span class="NLM_lpage">18502</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=18492-18502&author=T.+Oyaauthor=N.+Hattoriauthor=Y.+Mizunoauthor=S.+Miyataauthor=S.+Maedaauthor=T.+Osawaauthor=K.+Uchida&title=Methylglyoxal+Modification+of+Protein.+Chemical+and+Immunochemical+Characterization+of+Methylglyoxal-Arginine+Adducts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOya%26aufirst%3DT.%26aulast%3DHattori%26aufirst%3DN.%26aulast%3DMizuno%26aufirst%3DY.%26aulast%3DMiyata%26aufirst%3DS.%26aulast%3DMaeda%26aufirst%3DS.%26aulast%3DOsawa%26aufirst%3DT.%26aulast%3DUchida%26aufirst%3DK.%26atitle%3DMethylglyoxal%2520Modification%2520of%2520Protein.%2520Chemical%2520and%2520Immunochemical%2520Characterization%2520of%2520Methylglyoxal-Arginine%2520Adducts%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D18492%26epage%3D18502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiocho, F. A.</span><span> </span><span class="NLM_article-title">Structural Features of the Aldose Reductase and Aldehyde Reductase Inhibitor-Binding Sites</span> <span class="citation_source-journal">Mol. Vision</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=9756955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A280%3ADyaK1M%252FjtVOmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1998&pages=19-25&author=O.+El-Kabbaniauthor=D.+K.+Wilsonauthor=J.+M.+Petrashauthor=F.+A.+Quiocho&title=Structural+Features+of+the+Aldose+Reductase+and+Aldehyde+Reductase+Inhibitor-Binding+Sites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites</span></div><div class="casAuthors">El-Kabbani O; Wilson D K; Petrash M; Quiocho F A</div><div class="citationInfo"><span class="NLM_cas:title">Molecular vision</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The three-dimensional structures of aldose reductase and aldehyde reductase, members of the aldo-keto reductase superfamily, are composed of similar alpha/beta TIM-barrels.  However, examination of the structures reveals that the inhibitor-binding site of aldose reductase differs from that of aldehyde reductase due to the participation of non-conserved residues in its formation.  This information will be useful in the design of inhibitors to prevent or delay diabetic retinopathy.  A review of the structures of the inhibitor-binding sites is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRq_Yqq-8NVw4HWj6b1v8uTfW6udTcc2eZbIwDopYjt-Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M%252FjtVOmsA%253D%253D&md5=04fd4b982cbe945e8ca1b6130a1c138e</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DWilson%26aufirst%3DD.%2BK.%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26aulast%3DQuiocho%26aufirst%3DF.%2BA.%26atitle%3DStructural%2520Features%2520of%2520the%2520Aldose%2520Reductase%2520and%2520Aldehyde%2520Reductase%2520Inhibitor-Binding%2520Sites%26jtitle%3DMol.%2520Vision%26date%3D1998%26volume%3D4%26spage%3D19%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A.</span><span> </span><span class="NLM_article-title">Selectivity Determinants of the Aldose and Aldehyde Reductase Inhibitor-Binding Sites</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1970</span><span class="NLM_x">–</span> <span class="NLM_lpage">1978</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1007%2Fs00018-007-6514-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=17497245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptFKht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2007&pages=1970-1978&author=O.+El-Kabbaniauthor=A.+Podjarny&title=Selectivity+Determinants+of+the+Aldose+and+Aldehyde+Reductase+Inhibitor-Binding+Sites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity determinants of the aldose and aldehyde reductase inhibitor-binding sites</span></div><div class="casAuthors">El-Kabbani, O.; Podjarny, A.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1970-1978</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  Aldose reductase (EC 1.1.1.21) (I) and aldehyde reductase (EC 1.1.1.2) (II) belong to the aldo-keto reductase superfamily of enzymes whose members are responsible for a wide variety of biol. functions.  I has been identified as the 1st enzyme involved in the polyol pathway of glucose metab. which converts glucose into sorbitol.  Glucose overutilization through the polyol pathway has been linked to tissue-based pathologies assocd. with diabetes complications, which make the development of a potent I inhibitor an obvious and attractive strategy to prevent or delay the onset and progression of the complications.  Structural studies of I and the homologous II in complex with inhibitors have been carried out to explain the difference in the potency of enzyme inhibition.  Here, the authors aim to provide a comprehensive summary of previous studies to aid the development of I inhibitors that may have less toxicity problems than the currently available ones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlP-qrjnEJTLVg90H21EOLACvtfcHk0ljRZytrdGJldw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptFKht7Y%253D&md5=cca5d328edb68ab38e09dd03ea26e8c5</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1007%2Fs00018-007-6514-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-007-6514-3%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DPodjarny%26aufirst%3DA.%26atitle%3DSelectivity%2520Determinants%2520of%2520the%2520Aldose%2520and%2520Aldehyde%2520Reductase%2520Inhibitor-Binding%2520Sites%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2007%26volume%3D64%26spage%3D1970%26epage%3D1978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darmanin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze-Briese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomizaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazemann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A.</span><span> </span><span class="NLM_article-title">High-Resolution Structures of Human Aldose Reductase Holoenzyme in Complex with Stereoisomers of the Potent Inhibitor Fidarestat: Stereospecific Interaction between the Enzyme and a Cyclic Imide Type Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4530</span><span class="NLM_x">–</span> <span class="NLM_lpage">4537</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0497794" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4530-4537&author=O.+El-Kabbaniauthor=C.+Darmaninauthor=M.+Okaauthor=C.+Schulze-Brieseauthor=T.+Tomizakiauthor=I.+Hazemannauthor=A.+Mitschlerauthor=A.+Podjarny&title=High-Resolution+Structures+of+Human+Aldose+Reductase+Holoenzyme+in+Complex+with+Stereoisomers+of+the+Potent+Inhibitor+Fidarestat%3A+Stereospecific+Interaction+between+the+Enzyme+and+a+Cyclic+Imide+Type+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fjm0497794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0497794%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DDarmanin%26aufirst%3DC.%26aulast%3DOka%26aufirst%3DM.%26aulast%3DSchulze-Briese%26aufirst%3DC.%26aulast%3DTomizaki%26aufirst%3DT.%26aulast%3DHazemann%26aufirst%3DI.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DPodjarny%26aufirst%3DA.%26atitle%3DHigh-Resolution%2520Structures%2520of%2520Human%2520Aldose%2520Reductase%2520Holoenzyme%2520in%2520Complex%2520with%2520Stereoisomers%2520of%2520the%2520Potent%2520Inhibitor%2520Fidarestat%253A%2520Stereospecific%2520Interaction%2520between%2520the%2520Enzyme%2520and%2520a%2520Cyclic%2520Imide%2520Type%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4530%26epage%3D4537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbone, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darmanin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze-Briese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, R. P.-T.</span><span> </span><span class="NLM_article-title">Structure of Aldehyde Reductase Holoenzyme in Complex with the Potent Aldose Reductase Inhibitor Fidarestat: Implications for Inhibitor Binding and Selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5536</span><span class="NLM_x">–</span> <span class="NLM_lpage">5542</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050412o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5536-5542&author=O.+El-Kabbaniauthor=V.+Carboneauthor=C.+Darmaninauthor=M.+Okaauthor=A.+Mitschlerauthor=A.+Podjarnyauthor=C.+Schulze-Brieseauthor=R.+P.-T.+Chung&title=Structure+of+Aldehyde+Reductase+Holoenzyme+in+Complex+with+the+Potent+Aldose+Reductase+Inhibitor+Fidarestat%3A+Implications+for+Inhibitor+Binding+and+Selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fjm050412o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050412o%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DCarbone%26aufirst%3DV.%26aulast%3DDarmanin%26aufirst%3DC.%26aulast%3DOka%26aufirst%3DM.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DPodjarny%26aufirst%3DA.%26aulast%3DSchulze-Briese%26aufirst%3DC.%26aulast%3DChung%26aufirst%3DR.%2BP.-T.%26atitle%3DStructure%2520of%2520Aldehyde%2520Reductase%2520Holoenzyme%2520in%2520Complex%2520with%2520the%2520Potent%2520Aldose%2520Reductase%2520Inhibitor%2520Fidarestat%253A%2520Implications%2520for%2520Inhibitor%2520Binding%2520and%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5536%26epage%3D5542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Petrova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steuber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazemann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cousido-Siah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A.</span><span> </span><span class="NLM_article-title">Factorizing Selectivity Determinants of Inhibitor Binding toward Aldose and Aldehyde Reductases: Structural and Thermodynamic Properties of the Aldose Reductase Mutant Leu300Pro–Fidarestat Complex</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5659</span><span class="NLM_x">–</span> <span class="NLM_lpage">5665</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050424%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5659-5665&author=T.+Petrovaauthor=H.+Steuberauthor=I.+Hazemannauthor=A.+Cousido-Siahauthor=A.+Mitschlerauthor=R.+Chungauthor=M.+Okaauthor=G.+Klebeauthor=O.+El-Kabbaniauthor=A.+Joachimiakauthor=A.+Podjarny&title=Factorizing+Selectivity+Determinants+of+Inhibitor+Binding+toward+Aldose+and+Aldehyde+Reductases%3A+Structural+and+Thermodynamic+Properties+of+the+Aldose+Reductase+Mutant+Leu300Pro%E2%80%93Fidarestat+Complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1021%2Fjm050424%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050424%252B%26sid%3Dliteratum%253Aachs%26aulast%3DPetrova%26aufirst%3DT.%26aulast%3DSteuber%26aufirst%3DH.%26aulast%3DHazemann%26aufirst%3DI.%26aulast%3DCousido-Siah%26aufirst%3DA.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DChung%26aufirst%3DR.%26aulast%3DOka%26aufirst%3DM.%26aulast%3DKlebe%26aufirst%3DG.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DJoachimiak%26aufirst%3DA.%26aulast%3DPodjarny%26aufirst%3DA.%26atitle%3DFactorizing%2520Selectivity%2520Determinants%2520of%2520Inhibitor%2520Binding%2520toward%2520Aldose%2520and%2520Aldehyde%2520Reductases%253A%2520Structural%2520and%2520Thermodynamic%2520Properties%2520of%2520the%2520Aldose%2520Reductase%2520Mutant%2520Leu300Pro%25E2%2580%2593Fidarestat%2520Complex%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5659%26epage%3D5665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Van Zandt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawicki, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabetta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrington, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sredy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A. D.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Highly Potent and Selective (2-Arylcarbamoyl-phenoxy)-acetic Acid Inhibitors of Aldose Reductase for Treatment of Chronic Diabetic Complications</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5661</span><span class="NLM_x">–</span> <span class="NLM_lpage">5675</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=5661-5675&author=M.+C.+Van+Zandtauthor=E.+O.+Sibleyauthor=E.+E.+McCannauthor=K.+J.+Combsauthor=B.+Flamauthor=D.+R.+Sawickiauthor=A.+Sabettaauthor=A.+Carringtonauthor=J.+Sredyauthor=E.+Howardauthor=A.+Mitschlerauthor=A.+D.+Podjarny&title=Design+and+Synthesis+of+Highly+Potent+and+Selective+%282-Arylcarbamoyl-phenoxy%29-acetic+Acid+Inhibitors+of+Aldose+Reductase+for+Treatment+of+Chronic+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BZandt%26aufirst%3DM.%2BC.%26aulast%3DSibley%26aufirst%3DE.%2BO.%26aulast%3DMcCann%26aufirst%3DE.%2BE.%26aulast%3DCombs%26aufirst%3DK.%2BJ.%26aulast%3DFlam%26aufirst%3DB.%26aulast%3DSawicki%26aufirst%3DD.%2BR.%26aulast%3DSabetta%26aufirst%3DA.%26aulast%3DCarrington%26aufirst%3DA.%26aulast%3DSredy%26aufirst%3DJ.%26aulast%3DHoward%26aufirst%3DE.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DPodjarny%26aufirst%3DA.%2BD.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Highly%2520Potent%2520and%2520Selective%2520%25282-Arylcarbamoyl-phenoxy%2529-acetic%2520Acid%2520Inhibitors%2520of%2520Aldose%2520Reductase%2520for%2520Treatment%2520of%2520Chronic%2520Diabetic%2520Complications%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D5661%26epage%3D5675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Podjarny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cachau, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Zandt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, A.</span><span> </span><span class="NLM_article-title">Subatomic and Atomic Crystallographic Studies of Aldose Reductase: Implications for Inhibitor Binding</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">763</span><span class="NLM_x">–</span> <span class="NLM_lpage">773</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1007%2Fs00018-003-3404-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=15095001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD2cXls1Grt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2004&pages=763-773&author=A.+Podjarnyauthor=R.+E.+Cachauauthor=T.+Schneiderauthor=M.+Van+Zandtauthor=A.+Joachimiak&title=Subatomic+and+Atomic+Crystallographic+Studies+of+Aldose+Reductase%3A+Implications+for+Inhibitor+Binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Subatomic and atomic crystallographic studies of aldose reductase: Implications for inhibitor binding</span></div><div class="casAuthors">Podjarny, A.; Cachau, R. E.; Schneider, T.; Van Zandt, M.; Joachimiak, A.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">763-773</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review and discussion.  The detn. of several aldose reductase (ALR)·inhibitor complexes at subat. resoln. has revealed new structural details, including the specific interat. contacts involved in inhibitor binding.  Here, the authors review the structures of the complexes of ALR2 with IDD 594 (resoln., 0.66 Å; IC50, 30 nM; space group, P21), IDD 393 (resoln., 0.90 Å; IC50, 6 nM; space group, P1), fidarestat (resoln., 0.92 Å; IC50, 9 nM; space group, P21), and minalrestat (resoln., 1.10 Å; IC50, 73 nM; space group: P1).  The structures have been compared and have been found to be highly reproducible within the same space group (root mean square (RMS) deviations: 0.15-0.3 Å).  The mode of binding of the carboxylate inhibitors, IDD 594 and IDD 393 has been analyzed.  The binding of the carboxylate head have been accurately detd. by the subat. resoln. structures, since both the protonation states and the positions of the atoms are very precisely known.  The differences appear in the binding in the specificity pocket.  The high-resoln. structures explain the differences in IC50 values, which have been confirmed both exptl. by mass spectrometry measures of VC50 and theor. by free energy perturbation calcns.  The binding of the cyclic imide inhibitors, fidarestat and minalrestat, is also described, focusing on the observation of a Cl- ion which binds simultaneously with fidarestat.  The presence of this anion, binding also to active site residue His-110, leads to a mechanism in which the inhibitor can bind in a neutral state and then become charged inside the active site pocket.  This mechanism helps explain the excellent in vivo properties of cyclic imide inhibitors.  Thus, the complete and detailed information supplied by the subat. resoln. structures can explain the differences in binding energy of the different inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUJ45XOnna3bVg90H21EOLACvtfcHk0liDyJ2KeDu-cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXls1Grt74%253D&md5=559fdc56712e340c49edc73e2b1264af</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1007%2Fs00018-003-3404-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-003-3404-1%26sid%3Dliteratum%253Aachs%26aulast%3DPodjarny%26aufirst%3DA.%26aulast%3DCachau%26aufirst%3DR.%2BE.%26aulast%3DSchneider%26aufirst%3DT.%26aulast%3DVan%2BZandt%26aufirst%3DM.%26aulast%3DJoachimiak%26aufirst%3DA.%26atitle%3DSubatomic%2520and%2520Atomic%2520Crystallographic%2520Studies%2520of%2520Aldose%2520Reductase%253A%2520Implications%2520for%2520Inhibitor%2520Binding%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2004%26volume%3D61%26spage%3D763%26epage%3D773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Howard, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanishvili, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cachau, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevrier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamour, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Zandt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moras, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A.</span><span> </span><span class="NLM_article-title">Ultrahigh Resolution Drug Design I: Details of Interactions in Human Aldose Reductase–Inhibitor Complex at 0.66 Å</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span><span class="NLM_x">–</span> <span class="NLM_lpage">804</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=792-804&author=E.+I.+Howardauthor=R.+Sanishviliauthor=R.+E.+Cachauauthor=A.+Mitschlerauthor=B.+Chevrierauthor=P.+Barthauthor=V.+Lamourauthor=M.+Van+Zandtauthor=E.+Sibleyauthor=C.+Bonauthor=D.+Morasauthor=T.+R.+Schneiderauthor=A.+Joachimiakauthor=A.+Podjarny&title=Ultrahigh+Resolution+Drug+Design+I%3A+Details+of+Interactions+in+Human+Aldose+Reductase%E2%80%93Inhibitor+Complex+at+0.66+%C3%85"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoward%26aufirst%3DE.%2BI.%26aulast%3DSanishvili%26aufirst%3DR.%26aulast%3DCachau%26aufirst%3DR.%2BE.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DChevrier%26aufirst%3DB.%26aulast%3DBarth%26aufirst%3DP.%26aulast%3DLamour%26aufirst%3DV.%26aulast%3DVan%2BZandt%26aufirst%3DM.%26aulast%3DSibley%26aufirst%3DE.%26aulast%3DBon%26aufirst%3DC.%26aulast%3DMoras%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DT.%2BR.%26aulast%3DJoachimiak%26aufirst%3DA.%26aulast%3DPodjarny%26aufirst%3DA.%26atitle%3DUltrahigh%2520Resolution%2520Drug%2520Design%2520I%253A%2520Details%2520of%2520Interactions%2520in%2520Human%2520Aldose%2520Reductase%25E2%2580%2593Inhibitor%2520Complex%2520at%25200.66%2520%25C3%2585%26jtitle%3DProteins%26date%3D2004%26volume%3D55%26spage%3D792%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Van Zandt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geraci, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawicki, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sredy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacot, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiCioccio, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A. D.</span><span> </span><span class="NLM_article-title">Discovery of 3-[(4,5,7-Trifluorobenzothiazol-2-yl)methyl]indole-<i>N</i>-acetic Acid (Lidorestat) and Congeners as Highly Potent and Selective Inhibitors of Aldose Reductase for Treatment of Chronic Diabetic Complications</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3141</span><span class="NLM_x">–</span> <span class="NLM_lpage">3152</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0492094" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3141-3152&author=M.+C.+Van+Zandtauthor=M.+L.+Jonesauthor=D.+E.+Gunnauthor=L.+S.+Geraciauthor=J.+H.+Jonesauthor=D.+R.+Sawickiauthor=J.+Sredyauthor=J.+L.+Jacotauthor=A.+T.+DiCioccioauthor=T.+Petrovaauthor=A.+Mitschlerauthor=A.+D.+Podjarny&title=Discovery+of+3-%5B%284%2C5%2C7-Trifluorobenzothiazol-2-yl%29methyl%5Dindole-N-acetic+Acid+%28Lidorestat%29+and+Congeners+as+Highly+Potent+and+Selective+Inhibitors+of+Aldose+Reductase+for+Treatment+of+Chronic+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Fjm0492094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0492094%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BZandt%26aufirst%3DM.%2BC.%26aulast%3DJones%26aufirst%3DM.%2BL.%26aulast%3DGunn%26aufirst%3DD.%2BE.%26aulast%3DGeraci%26aufirst%3DL.%2BS.%26aulast%3DJones%26aufirst%3DJ.%2BH.%26aulast%3DSawicki%26aufirst%3DD.%2BR.%26aulast%3DSredy%26aufirst%3DJ.%26aulast%3DJacot%26aufirst%3DJ.%2BL.%26aulast%3DDiCioccio%26aufirst%3DA.%2BT.%26aulast%3DPetrova%26aufirst%3DT.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DPodjarny%26aufirst%3DA.%2BD.%26atitle%3DDiscovery%2520of%25203-%255B%25284%252C5%252C7-Trifluorobenzothiazol-2-yl%2529methyl%255Dindole-N-acetic%2520Acid%2520%2528Lidorestat%2529%2520and%2520Congeners%2520as%2520Highly%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Aldose%2520Reductase%2520for%2520Treatment%2520of%2520Chronic%2520Diabetic%2520Complications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3141%26epage%3D3152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Van Zandt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawicki, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sredy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A. D.</span><span> </span><span class="NLM_article-title">Discovery of [3-(4,5,7-Trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-<i>b</i>]pyridin-1-yl]acetic Acids as Highly Potent and Selective Inhibitors of Aldose Reductase for Treatment of Chronic Diabetic Complications</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2006</span><span class="NLM_x">–</span> <span class="NLM_lpage">2008</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2006-2008&author=M.+C.+Van+Zandtauthor=B.+Doanauthor=D.+R.+Sawickiauthor=J.+Sredyauthor=A.+D.+Podjarny&title=Discovery+of+%5B3-%284%2C5%2C7-Trifluoro-benzothiazol-2-ylmethyl%29-pyrrolo%5B2%2C3-b%5Dpyridin-1-yl%5Dacetic+Acids+as+Highly+Potent+and+Selective+Inhibitors+of+Aldose+Reductase+for+Treatment+of+Chronic+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BZandt%26aufirst%3DM.%2BC.%26aulast%3DDoan%26aufirst%3DB.%26aulast%3DSawicki%26aufirst%3DD.%2BR.%26aulast%3DSredy%26aufirst%3DJ.%26aulast%3DPodjarny%26aufirst%3DA.%2BD.%26atitle%3DDiscovery%2520of%2520%255B3-%25284%252C5%252C7-Trifluoro-benzothiazol-2-ylmethyl%2529-pyrrolo%255B2%252C3-b%255Dpyridin-1-yl%255Dacetic%2520Acids%2520as%2520Highly%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Aldose%2520Reductase%2520for%2520Treatment%2520of%2520Chronic%2520Diabetic%2520Complications%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2006%26epage%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parveen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, B.</span><span> </span><span class="NLM_article-title">Acetic Acid Derivatives of 3,4-Dihydro-2<i>H</i>-1,2,4-benzothiadiazine 1,1-Dioxide as a Novel Class of Potent Aldose Reductase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8330</span><span class="NLM_x">–</span> <span class="NLM_lpage">8344</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100962a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8330-8344&author=X.+Chenauthor=C.+Zhuauthor=F.+Guoauthor=X.+Qiuauthor=Y.+Yangauthor=S.+Zhangauthor=M.+Heauthor=S.+Parveenauthor=C.+Jingauthor=Y.+Liauthor=B.+Ma&title=Acetic+Acid+Derivatives+of+3%2C4-Dihydro-2H-1%2C2%2C4-benzothiadiazine+1%2C1-Dioxide+as+a+Novel+Class+of+Potent+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Fjm100962a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100962a%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DParveen%26aufirst%3DS.%26aulast%3DJing%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DB.%26atitle%3DAcetic%2520Acid%2520Derivatives%2520of%25203%252C4-Dihydro-2H-1%252C2%252C4-benzothiadiazine%25201%252C1-Dioxide%2520as%2520a%2520Novel%2520Class%2520of%2520Potent%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8330%26epage%3D8344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parveen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C.</span><span> </span><span class="NLM_article-title">Effect of C7 Modifications on Benzothiadiazine-1,1-dioxide Derivatives on Their Inhibitory Activity and Selectivity toward Aldose Reductase</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">613</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1002%2Fcmdc.201200386" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=23136050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1eiu77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=603-613&author=S.+Zhangauthor=X.+Chenauthor=S.+Parveenauthor=S.+Hussainauthor=Y.+Yangauthor=C.+Jingauthor=C.+Zhu&title=Effect+of+C7+Modifications+on+Benzothiadiazine-1%2C1-dioxide+Derivatives+on+Their+Inhibitory+Activity+and+Selectivity+toward+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of C7 modifications on benzothiadiazine-1,1-dioxide derivatives on their inhibitory activity and selectivity toward aldose reductase</span></div><div class="casAuthors">Zhang, Shuzhen; Chen, Xin; Parveen, Shagufta; Hussain, Saghir; Yang, Yanchun; Jing, Chaojun; Zhu, Changjin</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">603-613</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The development and progression of chronic complications in diabetic patients, such as retinopathy, nephropathy, neuropathy, cataracts, and stroke, are related to the activation and/or overexpression of aldose reductase (ALR2), which is a member of the aldo-keto reductase superfamily.  A structure-activity relationship study focused on the C7 position of 1,2,4-benzothiadiazine-1,1-dioxide derivs. was pursued in an attempt to discover ALR2 inhibitors with enhanced potency and selectivity.  These studies led to a series of new C7-substituted compds., which were evaluated for their inhibitory activity against ALR2; they exhibited IC50 values in the range of 2.80-45.13 nM.  Two compds. with a C7-dimethylcarbamoyl and a C7-diethylcarbamoyl substituent, resp., were found to be the most active and presented excellent selectivity for ALR2 over aldehyde reductase (ALR1).  The structure-activity relationship analyses and mol. modeling studies presented herein highlight the importance of hydrophobic and bulky groups at the C7 position for inhibitory activity and selectivity toward ALR2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN53qA8uAsfbVg90H21EOLACvtfcHk0lg2uUiFqEMG1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1eiu77K&md5=23eac78354d6bca12c8487211edc7d50</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200386%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DParveen%26aufirst%3DS.%26aulast%3DHussain%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DJing%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DC.%26atitle%3DEffect%2520of%2520C7%2520Modifications%2520on%2520Benzothiadiazine-1%252C1-dioxide%2520Derivatives%2520on%2520Their%2520Inhibitory%2520Activity%2520and%2520Selectivity%2520toward%2520Aldose%2520Reductase%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D603%26epage%3D613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gui, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Potent and Selective Aldose Reductase Inhibitors Based on Pyridylthiadiazine Scaffold</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1536</span><span class="NLM_x">–</span> <span class="NLM_lpage">1544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=1536-1544&author=X.+Chenauthor=Y.+Yangauthor=B.+Maauthor=S.+Zhangauthor=M.+Heauthor=D.+Guiauthor=S.+Hussainauthor=C.+Jingauthor=C.+Zhuauthor=Q.+Yuauthor=Y.+Liu&title=Design+and+Synthesis+of+Potent+and+Selective+Aldose+Reductase+Inhibitors+Based+on+Pyridylthiadiazine+Scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DGui%26aufirst%3DD.%26aulast%3DHussain%26aufirst%3DS.%26aulast%3DJing%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Potent%2520and%2520Selective%2520Aldose%2520Reductase%2520Inhibitors%2520Based%2520on%2520Pyridylthiadiazine%2520Scaffold%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D1536%26epage%3D1544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Primofiore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simorini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavecchia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boldrini, E.</span><span> </span><span class="NLM_article-title">Naphtho[1,2-<i>d</i>]isothiazole Acetic Acid Derivatives as a Novel Class of Selective Aldose Reductase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6897</span><span class="NLM_x">–</span> <span class="NLM_lpage">6907</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050382p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6897-6907&author=F.+Da+Settimoauthor=G.+Primofioreauthor=C.+La+Mottaauthor=S.+Sartiniauthor=S.+Talianiauthor=F.+Simoriniauthor=A.+M.+Mariniauthor=A.+Lavecchiaauthor=E.+Novellinoauthor=E.+Boldrini&title=Naphtho%5B1%2C2-d%5Disothiazole+Acetic+Acid+Derivatives+as+a+Novel+Class+of+Selective+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Fjm050382p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050382p%26sid%3Dliteratum%253Aachs%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DPrimofiore%26aufirst%3DG.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DTaliani%26aufirst%3DS.%26aulast%3DSimorini%26aufirst%3DF.%26aulast%3DMarini%26aufirst%3DA.%2BM.%26aulast%3DLavecchia%26aufirst%3DA.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DBoldrini%26aufirst%3DE.%26atitle%3DNaphtho%255B1%252C2-d%255Disothiazole%2520Acetic%2520Acid%2520Derivatives%2520as%2520a%2520Novel%2520Class%2520of%2520Selective%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6897%26epage%3D6907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Steuber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zentgraf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">Evidence for a Novel Binding Site Conformer of Aldose Reductase in Ligand-Bound State</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2007&pages=186-197&author=H.+Steuberauthor=M.+Zentgrafauthor=C.+La+Mottaauthor=S.+Sartiniauthor=A.+Heineauthor=G.+Klebe&title=Evidence+for+a+Novel+Binding+Site+Conformer+of+Aldose+Reductase+in+Ligand-Bound+State"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSteuber%26aufirst%3DH.%26aulast%3DZentgraf%26aufirst%3DM.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DHeine%26aufirst%3DA.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DEvidence%2520for%2520a%2520Novel%2520Binding%2520Site%2520Conformer%2520of%2520Aldose%2520Reductase%2520in%2520Ligand-Bound%2520State%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2007%26volume%3D369%26spage%3D186%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Zentgraf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steuber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotriffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">How Reliable Are Current Docking Approaches for Structure-Based Drug Design? Lessons from Aldose Reductase</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3575</span><span class="NLM_x">–</span> <span class="NLM_lpage">3578</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=3575-3578&author=M.+Zentgrafauthor=H.+Steuberauthor=C.+Kochauthor=C.+La+Mottaauthor=S.+Sartiniauthor=C.+A.+Sotrifferauthor=G.+Klebe&title=How+Reliable+Are+Current+Docking+Approaches+for+Structure-Based+Drug+Design%3F+Lessons+from+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZentgraf%26aufirst%3DM.%26aulast%3DSteuber%26aufirst%3DH.%26aulast%3DKoch%26aufirst%3DC.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DHow%2520Reliable%2520Are%2520Current%2520Docking%2520Approaches%2520for%2520Structure-Based%2520Drug%2520Design%253F%2520Lessons%2520from%2520Aldose%2520Reductase%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D3575%26epage%3D3578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simorini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limongelli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span> </span><span class="NLM_article-title">Acetic Acid Aldose Reductase Inhibitors Bearing a Five-Membered Heterocyclic Core with Potent Topical Activity in a Visual Impairment Rat Model</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">3182</span><span class="NLM_x">–</span> <span class="NLM_lpage">3193</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701613h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3182-3193&author=C.+La+Mottaauthor=S.+Sartiniauthor=S.+Salernoauthor=F.+Simoriniauthor=S.+Talianiauthor=A.+M.+Mariniauthor=F.+Da+Settimoauthor=L.+Marinelliauthor=V.+Limongelliauthor=E.+Novellino&title=Acetic+Acid+Aldose+Reductase+Inhibitors+Bearing+a+Five-Membered+Heterocyclic+Core+with+Potent+Topical+Activity+in+a+Visual+Impairment+Rat+Model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fjm701613h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701613h%26sid%3Dliteratum%253Aachs%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DSalerno%26aufirst%3DS.%26aulast%3DSimorini%26aufirst%3DF.%26aulast%3DTaliani%26aufirst%3DS.%26aulast%3DMarini%26aufirst%3DA.%2BM.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DLimongelli%26aufirst%3DV.%26aulast%3DNovellino%26aufirst%3DE.%26atitle%3DAcetic%2520Acid%2520Aldose%2520Reductase%2520Inhibitors%2520Bearing%2520a%2520Five-Membered%2520Heterocyclic%2520Core%2520with%2520Potent%2520Topical%2520Activity%2520in%2520a%2520Visual%2520Impairment%2520Rat%2520Model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3182%26epage%3D3193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Maccari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottanà, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciurleo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigorita, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakowitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steindl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, T.</span><span> </span><span class="NLM_article-title">Evaluation of In Vitro Aldose Reductase Inhibitory Activity of 5-Arylidene-2,4-thiazolidinediones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3886</span><span class="NLM_x">–</span> <span class="NLM_lpage">3893</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3886-3893&author=R.+Maccariauthor=R.+Ottan%C3%A0author=R.+Ciurleoauthor=M.+G.+Vigoritaauthor=D.+Rakowitzauthor=T.+Steindlauthor=T.+Langer&title=Evaluation+of+In+Vitro+Aldose+Reductase+Inhibitory+Activity+of+5-Arylidene-2%2C4-thiazolidinediones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaccari%26aufirst%3DR.%26aulast%3DOttan%25C3%25A0%26aufirst%3DR.%26aulast%3DCiurleo%26aufirst%3DR.%26aulast%3DVigorita%26aufirst%3DM.%2BG.%26aulast%3DRakowitz%26aufirst%3DD.%26aulast%3DSteindl%26aufirst%3DT.%26aulast%3DLanger%26aufirst%3DT.%26atitle%3DEvaluation%2520of%2520In%2520Vitro%2520Aldose%2520Reductase%2520Inhibitory%2520Activity%2520of%25205-Arylidene-2%252C4-thiazolidinediones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3886%26epage%3D3893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Carbone, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giglio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huyton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottanà, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span> </span><span class="NLM_article-title">Structure of Aldehyde Reductase in Ternary Complex with a 5-Arylidene-2,4-thiazolidinedione Aldose Reductase Inhibitor</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1140</span><span class="NLM_x">–</span> <span class="NLM_lpage">1145</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=1140-1145&author=V.+Carboneauthor=M.+Giglioauthor=R.+Chungauthor=T.+Huytonauthor=J.+Adamsauthor=R.+Maccariauthor=R.+Ottan%C3%A0author=A.+Haraauthor=O.+El-Kabbani&title=Structure+of+Aldehyde+Reductase+in+Ternary+Complex+with+a+5-Arylidene-2%2C4-thiazolidinedione+Aldose+Reductase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarbone%26aufirst%3DV.%26aulast%3DGiglio%26aufirst%3DM.%26aulast%3DChung%26aufirst%3DR.%26aulast%3DHuyton%26aufirst%3DT.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DMaccari%26aufirst%3DR.%26aulast%3DOttan%25C3%25A0%26aufirst%3DR.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26atitle%3DStructure%2520of%2520Aldehyde%2520Reductase%2520in%2520Ternary%2520Complex%2520with%2520a%25205-Arylidene-2%252C4-thiazolidinedione%2520Aldose%2520Reductase%2520Inhibitor%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D1140%26epage%3D1145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Puppala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suryanarayana, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBarbera, D. V.</span><span> </span><span class="NLM_article-title">The Isolation and Characterization of β-Glucogallin as a Novel Aldose Reductase Inhibitor from <i>Emblica officinalis</i></span> <span class="citation_source-journal">PLoS ONE</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e31399</span><span class="refDoi"> DOI: 10.1371/journal.pone.0031399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1371%2Fjournal.pone.0031399" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e31399&author=M.+Puppalaauthor=J.+Ponderauthor=P.+Suryanarayanaauthor=G.+B.+Reddyauthor=J.+M.+Petrashauthor=D.+V.+LaBarbera&title=The+Isolation+and+Characterization+of+%CE%B2-Glucogallin+as+a+Novel+Aldose+Reductase+Inhibitor+from+Emblica+officinalis&doi=10.1371%2Fjournal.pone.0031399"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0031399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0031399%26sid%3Dliteratum%253Aachs%26aulast%3DPuppala%26aufirst%3DM.%26aulast%3DPonder%26aufirst%3DJ.%26aulast%3DSuryanarayana%26aufirst%3DP.%26aulast%3DReddy%26aufirst%3DG.%2BB.%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26aulast%3DLaBarbera%26aufirst%3DD.%2BV.%26atitle%3DThe%2520Isolation%2520and%2520Characterization%2520of%2520%25CE%25B2-Glucogallin%2520as%2520a%2520Novel%2520Aldose%2520Reductase%2520Inhibitor%2520from%2520Emblica%2520officinalis%26jtitle%3DPLoS%2520ONE%26date%3D2012%26volume%3D7%26spage%3De31399%26doi%3D10.1371%2Fjournal.pone.0031399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span> </span><span class="NLM_article-title">Discovery of New Selective Human Aldose Reductase Inhibitors through Virtual Screening Multiple Binding Pocket Conformations</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2409</span><span class="NLM_x">–</span> <span class="NLM_lpage">2422</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci400322j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFyhsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=2409-2422&author=L.+Wangauthor=Q.+Guauthor=X.+Zhengauthor=J.+Yeauthor=Z.+Liuauthor=J.+Liauthor=X.+Huauthor=A.+Haglerauthor=J.+Xu&title=Discovery+of+New+Selective+Human+Aldose+Reductase+Inhibitors+through+Virtual+Screening+Multiple+Binding+Pocket+Conformations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of New Selective Human Aldose Reductase Inhibitors through Virtual Screening Multiple Binding Pocket Conformations</span></div><div class="casAuthors">Wang, Ling; Gu, Qiong; Zheng, Xuehua; Ye, Jiming; Liu, Zhihong; Li, Jiabo; Hu, Xiaopeng; Hagler, Arnold; Xu, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2409-2422</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aldose reductase reduces glucose to sorbitol.  It plays a key role in many of the complications arising from diabetes.  Thus, aldose reductase inhibitors (ARI) have been identified as promising therapeutic agents for treating such complications of diabetes, as neuropathy, nephropathy, retinopathy, and cataracts.  In this paper, a virtual screening protocol applied to a library of compds. in house has been utilized to discover novel ARIs.  IC50's were detd. for 15 hits that inhibited ALR2 to greater than 50% at 50 μM, and ten of these have an IC50 of 10 μM or less, corresponding to a rather substantial hit rate of 14% at this level.  The specificity of these compds. relative to their cross-reactivity with human ALR1 was also assessed by inhibition assays.  This resulted in identification of novel inhibitors with IC50's comparable to the com. available drug, epalrestat, and greater than an order of magnitude better selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHO9l6GEzpULVg90H21EOLACvtfcHk0lhxGdS5LEKjMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFyhsbvE&md5=6bd1ea2c57f7199bb31ea9c167fba020</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fci400322j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci400322j%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DGu%26aufirst%3DQ.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DYe%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DHagler%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520New%2520Selective%2520Human%2520Aldose%2520Reductase%2520Inhibitors%2520through%2520Virtual%2520Screening%2520Multiple%2520Binding%2520Pocket%2520Conformations%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2013%26volume%3D53%26spage%3D2409%26epage%3D2422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Ramunno, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maglio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angiuoli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Pietra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Maro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giustiniano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span> </span><span class="NLM_article-title">Progresses in the Pursuit of Aldose Reductase Inhibitors: The Structure-Based Lead Optimization Step</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=216-226&author=A.+Ramunnoauthor=S.+Cosconatiauthor=S.+Sartiniauthor=V.+Maglioauthor=S.+Angiuoliauthor=V.+La+Pietraauthor=S.+Di+Maroauthor=M.+Giustinianoauthor=C.+La+Mottaauthor=F.+Da+Settimoauthor=L.+Marinelliauthor=E.+Novellino&title=Progresses+in+the+Pursuit+of+Aldose+Reductase+Inhibitors%3A+The+Structure-Based+Lead+Optimization+Step"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamunno%26aufirst%3DA.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DMaglio%26aufirst%3DV.%26aulast%3DAngiuoli%26aufirst%3DS.%26aulast%3DLa%2BPietra%26aufirst%3DV.%26aulast%3DDi%2BMaro%26aufirst%3DS.%26aulast%3DGiustiniano%26aufirst%3DM.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DNovellino%26aufirst%3DE.%26atitle%3DProgresses%2520in%2520the%2520Pursuit%2520of%2520Aldose%2520Reductase%2520Inhibitors%253A%2520The%2520Structure-Based%2520Lead%2520Optimization%2520Step%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D51%26spage%3D216%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Minehira, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koseki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirono, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyooka, N.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Novel (1-Thioxo-1,2,3,4-tetrahydro-β-carbolin-9-yl)acetic Acids as Selective Inhibitors for AKR1B1</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=356-367&author=D.+Minehiraauthor=D.+Takedaauthor=H.+Urataauthor=A.+Katoauthor=I.+Adachiauthor=X.+Wangauthor=Y.+Matsuyaauthor=K.+Sugimotoauthor=M.+Takemuraauthor=S.+Endoauthor=T.+Matsunagaauthor=A.+Haraauthor=J.+Kosekiauthor=K.+Narukawaauthor=S.+Hironoauthor=N.+Toyooka&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Novel+%281-Thioxo-1%2C2%2C3%2C4-tetrahydro-%CE%B2-carbolin-9-yl%29acetic+Acids+as+Selective+Inhibitors+for+AKR1B1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMinehira%26aufirst%3DD.%26aulast%3DTakeda%26aufirst%3DD.%26aulast%3DUrata%26aufirst%3DH.%26aulast%3DKato%26aufirst%3DA.%26aulast%3DAdachi%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMatsuya%26aufirst%3DY.%26aulast%3DSugimoto%26aufirst%3DK.%26aulast%3DTakemura%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DKoseki%26aufirst%3DJ.%26aulast%3DNarukawa%26aufirst%3DK.%26aulast%3DHirono%26aufirst%3DS.%26aulast%3DToyooka%26aufirst%3DN.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Novel%2520%25281-Thioxo-1%252C2%252C3%252C4-tetrahydro-%25CE%25B2-carbolin-9-yl%2529acetic%2520Acids%2520as%2520Selective%2520Inhibitors%2520for%2520AKR1B1%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D356%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrash, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBarbera, D. V.</span><span> </span><span class="NLM_article-title">Design of an Amide <i>N</i>-Glycoside Derivative of β-Glucogallin: A Stable, Potent, and Specific Inhibitor of Aldose Reductase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401311d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=71-77&author=L.+Liauthor=K.-C.+Changauthor=Y.+Zhouauthor=B.+Shiehauthor=J.+Ponderauthor=A.+D.+Abrahamauthor=H.+Aliauthor=A.+Snowauthor=J.+M.+Petrashauthor=D.+V.+LaBarbera&title=Design+of+an+Amide+N-Glycoside+Derivative+of+%CE%B2-Glucogallin%3A+A+Stable%2C+Potent%2C+and+Specific+Inhibitor+of+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Fjm401311d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401311d%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DChang%26aufirst%3DK.-C.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DShieh%26aufirst%3DB.%26aulast%3DPonder%26aufirst%3DJ.%26aulast%3DAbraham%26aufirst%3DA.%2BD.%26aulast%3DAli%26aufirst%3DH.%26aulast%3DSnow%26aufirst%3DA.%26aulast%3DPetrash%26aufirst%3DJ.%2BM.%26aulast%3DLaBarbera%26aufirst%3DD.%2BV.%26atitle%3DDesign%2520of%2520an%2520Amide%2520N-Glycoside%2520Derivative%2520of%2520%25CE%25B2-Glucogallin%253A%2520A%2520Stable%252C%2520Potent%252C%2520and%2520Specific%2520Inhibitor%2520of%2520Aldose%2520Reductase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D71%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Martin, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maser, E.</span><span> </span><span class="NLM_article-title">Role of Human Aldo-Keto-Reductase AKR1B10 in the Protection against Toxic Aldehydes</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.cbi.2008.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=19013440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFOjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2009&pages=145-150&author=H.+J.+Martinauthor=E.+Maser&title=Role+of+Human+Aldo-Keto-Reductase+AKR1B10+in+the+Protection+against+Toxic+Aldehydes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes</span></div><div class="casAuthors">Martin, Hans-Joerg; Maser, Edmund</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">145-150</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Damage of cell membranes by reactive oxygen species results in the formation of toxic lipid peroxides which may ultimately lead to cell death.  Among the best characterized intermediates of oxidative stress are the unsatd. aldehydes 4-hydroxynon-2-enal (4-HNE) and its oxidized counterpart 4-oxonon-2-enal (4-ONE).  4-HNE has been linked to various pathol. conditions including atherosclerosis, Parkinson's and Alzheimer's disease. 4-Methylpentanal (4-MP) is a side-chain cleavage product formed endogenously during steroidogenesis from cholesterol.  Like 4-HNE and 4-ONE, 4-MP is capable of binding covalently to and crosslinking of proteins.  These aldehydes are also damaging DNA by the formation of adducts.  We found that AKR1B10, a cytosolic member of the aldo-keto reductase superfamily, efficiently catalyzes the redn. of 4-HNE (Km = 0.3 mM, k cat = 43 min-1), 4-ONE (Km = 0.3 mM, k cat = 40 min-1) and 4-MP (Km = 0.05 mM, k cat = 25 min-1).  AKR1B10 catalyzed 4-MP redn. with a 30-fold increase in activity using NADPH as cofactor compared with NADH.  As was obsd. for aldose reductase (AKR1B1) 4-ONE rapidly inactivates AKR1B10, while this inactivation is not obsd. when the enzyme is preincubated with NADPH.  It was shown that cysteine 298 of aldose reductase was protected by NADPH from the α,β-unsatd. carbonyls of 4-ONE thus rendering resistance towards inactivation.  We generated a mutant AKR1B10, changing the resp. cysteine on position 299 of AKR1B10 into a serine.  This C299S mutant is still active towards 4-HNE and 4-ONE, albeit at a somewhat lower catalytic efficiency.  However, it is still inactivated by 4-ONE in the absence of NADPH.  While the best substrates for AKR1B10 are retinals, the high catalytic efficiency together with the protection from inactivation by NADPH suggests a role of AKR1B10 in the detoxification of biogenic aldehydes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsHuid09FnKLVg90H21EOLACvtfcHk0liZKlrSlZymQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFOjt7c%253D&md5=cf098515950a42eba5b68e6e6d43a1cb</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2008.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2008.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DH.%2BJ.%26aulast%3DMaser%26aufirst%3DE.%26atitle%3DRole%2520of%2520Human%2520Aldo-Keto-Reductase%2520AKR1B10%2520in%2520the%2520Protection%2520against%2520Toxic%2520Aldehydes%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2009%26volume%3D178%26spage%3D145%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Crosas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyndman, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallego, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martras, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parés, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrés, J.</span><span> </span><span class="NLM_article-title">Human Aldose Reductase and Human Small Intestine Aldose Reductase Are Efficient Retinal Reductases: Consequences for Retinoid Metabolism</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">979</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2003&pages=973-979&author=B.+Crosasauthor=D.+J.+Hyndmanauthor=O.+Gallegoauthor=S.+Martrasauthor=X.+Par%C3%A9sauthor=T.+G.+Flynnauthor=J.+Farr%C3%A9s&title=Human+Aldose+Reductase+and+Human+Small+Intestine+Aldose+Reductase+Are+Efficient+Retinal+Reductases%3A+Consequences+for+Retinoid+Metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrosas%26aufirst%3DB.%26aulast%3DHyndman%26aufirst%3DD.%2BJ.%26aulast%3DGallego%26aufirst%3DO.%26aulast%3DMartras%26aufirst%3DS.%26aulast%3DPar%25C3%25A9s%26aufirst%3DX.%26aulast%3DFlynn%26aufirst%3DT.%2BG.%26aulast%3DFarr%25C3%25A9s%26aufirst%3DJ.%26atitle%3DHuman%2520Aldose%2520Reductase%2520and%2520Human%2520Small%2520Intestine%2520Aldose%2520Reductase%2520Are%2520Efficient%2520Retinal%2520Reductases%253A%2520Consequences%2520for%2520Retinoid%2520Metabolism%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D373%26spage%3D973%26epage%3D979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitade, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Kinetic Studies of AKR1B10, Human Aldose Reductase-like Protein: Endogenous Substrates and Inhibition by Steroids</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">487</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2009&pages=1-9&author=S.+Endoauthor=T.+Matsunagaauthor=H.+Mamiyaauthor=C.+Ohtaauthor=M.+Sodaauthor=Y.+Kitadeauthor=K.+Tajimaauthor=H.-T.+Zhaoauthor=O.+El-Kabbaniauthor=A.+Hara&title=Kinetic+Studies+of+AKR1B10%2C+Human+Aldose+Reductase-like+Protein%3A+Endogenous+Substrates+and+Inhibition+by+Steroids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DMamiya%26aufirst%3DH.%26aulast%3DOhta%26aufirst%3DC.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DKitade%26aufirst%3DY.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DH.-T.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DKinetic%2520Studies%2520of%2520AKR1B10%252C%2520Human%2520Aldose%2520Reductase-like%2520Protein%253A%2520Endogenous%2520Substrates%2520and%2520Inhibition%2520by%2520Steroids%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2009%26volume%3D487%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Zhong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span> </span><span class="NLM_article-title">AKR1B10 Induces Cell Resistance to Daunorubicin and Idarubicin by Reducing C13 Ketonic Group</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.taap.2011.05.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=21640744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFKgsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=2011&pages=40-47&author=L.+Zhongauthor=H.+Shenauthor=C.+Huangauthor=H.+Jingauthor=D.+Cao&title=AKR1B10+Induces+Cell+Resistance+to+Daunorubicin+and+Idarubicin+by+Reducing+C13+Ketonic+Group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group</span></div><div class="casAuthors">Zhong, Linlin; Shen, Honglin; Huang, Chenfei; Jing, Hongwu; Cao, Deliang</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">255</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-47</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Daunorubicin, idarubicin, doxorubicin and epirubicin are anthracyclines widely used for the treatment of lymphoma, leukemia, and breast, lung, and liver cancers, but tumor resistance limits their clin. success.  Aldo-keto reductase family 1 B10 (AKR1B10) is an NADPH-dependent enzyme overexpressed in liver and lung carcinomas.  This study was aimed to det. the role of AKR1B10 in tumor resistance to anthracyclines.  AKR1B10 activity toward anthracyclines was measured using recombinant protein.  Cell resistance to anthracycline was detd. by ectopic expression of AKR1B10 or inhibition by epalrestat.  Results showed that AKR1B10 reduces C13-ketonic group on side chain of daunorubicin and idarubicin to hydroxyl forms.  In vitro, AKR1B10 converted daunorubicin to daunorubicinol at V max of 837.42 ± 81.39 nmol/mg/min, K m of 9.317 ± 2.25 mM and k cat/K m of 3.24.  AKR1B10 showed better catalytic efficiency toward idarubicin with V max at 460.23 ± 28.12 nmol/mg/min, K m at 0.461 ± 0.09 mM and k cat/K m at 35.94.  AKR1B10 was less active toward doxorubicin and epirubicin with a C14-hydroxyl group.  In living cells, AKR1B10 efficiently catalyzed redn. of daunorubicin (50 nM) and idarubicin (30 nM) to corresponding alcs.  Within 24 h, approx. 20 ± 2.7% of daunorubicin (1 μM) or 23 ± 2.3% of idarubicin (1 μM) was converted to daunorubicinol or idarubicinol in AKR1B10 expression cells compared to 7 ± 0.9% and 5 ± 1.5% in vector control.  AKR1B10 expression led to cell resistance to daunorubicin and idarubicin, but inhibitor epalrestat showed a synergistic role with these agents.  Together our data suggest that AKR1B10 participates in cellular metab. of daunorubicin and idarubicin, resulting in drug resistance.  These data are informative for the clin. use of idarubicin and daunorubicin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCCKYVvdAb7rVg90H21EOLACvtfcHk0liV9kisopdpZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFKgsbw%253D&md5=bacf54c3a864c7f868f597ca5a0b0d2e</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2011.05.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2011.05.014%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DJing%26aufirst%3DH.%26aulast%3DCao%26aufirst%3DD.%26atitle%3DAKR1B10%2520Induces%2520Cell%2520Resistance%2520to%2520Daunorubicin%2520and%2520Idarubicin%2520by%2520Reducing%2520C13%2520Ketonic%2520Group%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2011%26volume%3D255%26spage%3D40%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Selective Inhibition of the Tumor Marker AKR1B10 by Antiinflammatory <i>N</i>-Phenylanthranilic Acids and Glycyrrhetic Acid</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">886</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1248%2Fbpb.33.886" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=20460771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1Oht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=886-890&author=S.+Endoauthor=T.+Matsunagaauthor=M.+Sodaauthor=K.+Tajimaauthor=H.+T.+Zhaoauthor=O.+El-Kabbaniauthor=A.+Hara&title=Selective+Inhibition+of+the+Tumor+Marker+AKR1B10+by+Antiinflammatory+N-Phenylanthranilic+Acids+and+Glycyrrhetic+Acid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of the tumor marker AKR1B10 by antiinflammatory N-phenylanthranilic acids and glycyrrhetic acid</span></div><div class="casAuthors">Endo, Satoshi; Matsunaga, Toshiyuki; Soda, Midori; Tajima, Kazuo; Zhao, Hi-Tai; El-Kabbani, Ossama; Hara, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">886-890</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">A human aldose reductase-like protein, AKR1B10 in the aldo-keto reductase (AKR) superfamily, was recently identified as a tumor marker of several types of cancer.  Tolrestat, an aldose reductase inhibitor (ARI), is known to be the most potent inhibitor of the enzyme.  In this study, we compared the inhibitory effects of other ARIs including flavonoids on AKR1B10 and aldose reductase to evaluate their specificity.  However, ARIs showed lower inhibitory potency for AKR1B10 than for aldose reductase.  In the search for potent and selective inhibitors of AKR1B10 from other drugs used clin., we found that non-steroidal antiinflammatory N-phenylanthranilic acids, diclofenac and glycyrrhetic acid competitively inhibited AKR1B10, showing Ki values of 0.35-2.9 μM and high selectivity to this enzyme (43-57 fold vs. aldose reductase).  Mol. docking studies of mefenamic acid and glycyrrhetic acid in the AKR1B10-NADP (NADP+) complex and site-directed mutagenesis of the putative binding residues suggest that the side chain of Val301 and a hydrogen-bonding network among residues Val301, Gln114 and Ser304 are important for detg. the inhibitory potency and selectivity of the non-steroidal antiinflammatory drugs.  Thus, the potent and selective inhibition may be related to the cancer chemopreventive roles of the drugs, and their structural features may facilitate the design of new anti-cancer agents targeting AKR1B10.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDHEPGYUtiEbVg90H21EOLACvtfcHk0liV9kisopdpZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1Oht7Y%253D&md5=89b4e78d049e6bccaab07c410f541a0c</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1248%2Fbpb.33.886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.33.886%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DH.%2BT.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DSelective%2520Inhibition%2520of%2520the%2520Tumor%2520Marker%2520AKR1B10%2520by%2520Antiinflammatory%2520N-Phenylanthranilic%2520Acids%2520and%2520Glycyrrhetic%2520Acid%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2010%26volume%3D33%26spage%3D886%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Potent and Selective Inhibition of the Tumor Marker AKR1B10 by Bisdemethoxycurcumin: Probing the Active Site of the Enzyme with Molecular Modeling and Site-Directed Mutagenesis</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">389</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=389&publication_year=2009&pages=128-132&author=T.+Matsunagaauthor=S.+Endoauthor=M.+Sodaauthor=H.-T.+Zhaoauthor=O.+El-Kabbaniauthor=K.+Tajimaauthor=A.+Hara&title=Potent+and+Selective+Inhibition+of+the+Tumor+Marker+AKR1B10+by+Bisdemethoxycurcumin%3A+Probing+the+Active+Site+of+the+Enzyme+with+Molecular+Modeling+and+Site-Directed+Mutagenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DH.-T.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DPotent%2520and%2520Selective%2520Inhibition%2520of%2520the%2520Tumor%2520Marker%2520AKR1B10%2520by%2520Bisdemethoxycurcumin%253A%2520Probing%2520the%2520Active%2520Site%2520of%2520the%2520Enzyme%2520with%2520Molecular%2520Modeling%2520and%2520Site-Directed%2520Mutagenesis%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D389%26spage%3D128%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Zhao, H.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span> </span><span class="NLM_article-title">Selectivity Determinants of Inhibitor Binding to the Tumour Marker Human Aldose Reductase-like Protein (AKR1B10) Discovered from Molecular Docking and Database Screening</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4354</span><span class="NLM_x">–</span> <span class="NLM_lpage">4357</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=4354-4357&author=H.-T.+Zhaoauthor=M.+Sodaauthor=S.+Endoauthor=A.+Haraauthor=O.+El-Kabbani&title=Selectivity+Determinants+of+Inhibitor+Binding+to+the+Tumour+Marker+Human+Aldose+Reductase-like+Protein+%28AKR1B10%29+Discovered+from+Molecular+Docking+and+Database+Screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.-T.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26atitle%3DSelectivity%2520Determinants%2520of%2520Inhibitor%2520Binding%2520to%2520the%2520Tumour%2520Marker%2520Human%2520Aldose%2520Reductase-like%2520Protein%2520%2528AKR1B10%2529%2520Discovered%2520from%2520Molecular%2520Docking%2520and%2520Database%2520Screening%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D4354%26epage%3D4357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitade, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Chromene-3-carboxamide Derivatives Discovered from Virtual Screening as Potent Inhibitors of the Tumour Maker, AKR1B10</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2485</span><span class="NLM_x">–</span> <span class="NLM_lpage">2490</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=2485-2490&author=S.+Endoauthor=T.+Matsunagaauthor=K.+Kuwataauthor=H.-T.+Zhaoauthor=O.+El-Kabbaniauthor=Y.+Kitadeauthor=A.+Hara&title=Chromene-3-carboxamide+Derivatives+Discovered+from+Virtual+Screening+as+Potent+Inhibitors+of+the+Tumour+Maker%2C+AKR1B10"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DKuwata%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DH.-T.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DKitade%26aufirst%3DY.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DChromene-3-carboxamide%2520Derivatives%2520Discovered%2520from%2520Virtual%2520Screening%2520as%2520Potent%2520Inhibitors%2520of%2520the%2520Tumour%2520Maker%252C%2520AKR1B10%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D2485%26epage%3D2490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Takemura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iinuma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span> </span><span class="NLM_article-title">Selective Inhibition of the Tumor Marker Aldo-Keto Reductase Family Member 1B10 by Oleanolic Acid</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1201</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span></span><div class="citationLinks">[<a href="/doi/10.1021/np200118q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2011&pages=1201-1206&author=M.+Takemuraauthor=S.+Endoauthor=T.+Matsunagaauthor=M.+Sodaauthor=H.-T.+Zhaoauthor=O.+El-Kabbaniauthor=K.+Tajimaauthor=M.+Iinumaauthor=A.+Hara&title=Selective+Inhibition+of+the+Tumor+Marker+Aldo-Keto+Reductase+Family+Member+1B10+by+Oleanolic+Acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1021%2Fnp200118q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp200118q%26sid%3Dliteratum%253Aachs%26aulast%3DTakemura%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DMatsunaga%26aufirst%3DT.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DH.-T.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DTajima%26aufirst%3DK.%26aulast%3DIinuma%26aufirst%3DM.%26aulast%3DHara%26aufirst%3DA.%26atitle%3DSelective%2520Inhibition%2520of%2520the%2520Tumor%2520Marker%2520Aldo-Keto%2520Reductase%2520Family%2520Member%25201B10%2520by%2520Oleanolic%2520Acid%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2011%26volume%3D74%26spage%3D1201%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takemura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ifuku, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyooka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, T.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Evaluation of Caffeic Acid Phenethyl Ester-Based Inhibitors Targeting a Selectivity Pocket in the Active Site of Human Aldo-Keto Reductase 1B10</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=321-329&author=M.+Sodaauthor=D.+Huauthor=S.+Endoauthor=M.+Takemuraauthor=J.+Liauthor=R.+Wadaauthor=S.+Ifukuauthor=H.-T.+Zhaoauthor=O.+El-Kabbaniauthor=S.+Ohtaauthor=K.+Yamamuraauthor=N.+Toyookaauthor=A.+Haraauthor=T.+Matsunaga&title=Design%2C+Synthesis+and+Evaluation+of+Caffeic+Acid+Phenethyl+Ester-Based+Inhibitors+Targeting+a+Selectivity+Pocket+in+the+Active+Site+of+Human+Aldo-Keto+Reductase+1B10"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DEndo%26aufirst%3DS.%26aulast%3DTakemura%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWada%26aufirst%3DR.%26aulast%3DIfuku%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DH.-T.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26aulast%3DOhta%26aufirst%3DS.%26aulast%3DYamamura%26aufirst%3DK.%26aulast%3DToyooka%26aufirst%3DN.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DMatsunaga%26aufirst%3DT.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Evaluation%2520of%2520Caffeic%2520Acid%2520Phenethyl%2520Ester-Based%2520Inhibitors%2520Targeting%2520a%2520Selectivity%2520Pocket%2520in%2520the%2520Active%2520Site%2520of%2520Human%2520Aldo-Keto%2520Reductase%25201B10%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D48%26spage%3D321%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Ruiz, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cousido-Siah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrés, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parés, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A.</span><span> </span><span class="NLM_article-title">X-ray Structure of the V301L Aldo-Keto Reductase 1B10 Complexed with NADP<sup>+</sup> and the Potent Aldose Reductase Inhibitor Fidarestat: Implications for Inhibitor Binding and Selectivity</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.cbi.2012.12.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=23295227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1GitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2013&pages=178-185&author=F.+X.+Ruizauthor=A.+Cousido-Siahauthor=A.+Mitschlerauthor=J.+Farr%C3%A9sauthor=X.+Par%C3%A9sauthor=A.+Podjarny&title=X-ray+Structure+of+the+V301L+Aldo-Keto+Reductase+1B10+Complexed+with+NADP%2B+and+the+Potent+Aldose+Reductase+Inhibitor+Fidarestat%3A+Implications+for+Inhibitor+Binding+and+Selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP+ and the potent aldose reductase inhibitor fidarestat: Implications for inhibitor binding and selectivity</span></div><div class="casAuthors">Ruiz, Francesc Xavier; Cousido-Siah, Alexandra; Mitschler, Andre; Farres, Jaume; Pares, Xavier; Podjarny, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">178-185</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Only one crystal structure is currently available for tumor marker AKR1B10, complexed with NADP+ and tolrestat, which is an aldose reductase inhibitor (ARI) of the carboxylic acid type.  Here, the X-ray structure of the complex of the V301L substituted AKR1B10 holoenzyme with fidarestat, an ARI of the cyclic imide type, was obtained at 1.60 Å resoln. by replacement soaking of crystals contg. tolrestat.  Previously, fidarestat was found to be safe in phase III trials for diabetic neuropathy and, consistent with its low in vivo side effects, was highly selective for aldose reductase (AR or AKR1B1) vs. aldehyde reductase (AKR1A1).  Now, inhibition studies showed that fidarestat was indeed 1300-fold more selective for AR as compared to AKR1B10, while the change of Val to Leu (found in AR) caused a 20-fold decrease in the IC50 value with fidarestat.  Structural anal. of the V301L AKR1B10-fidarestat complex displayed enzyme-inhibitor interactions similar to those of the AR-fidarestat complex.  However, a close inspection of both the new crystal structure and a computer model of the wild-type AKR1B10 complex with fidarestat revealed subtle changes that could affect fidarestat binding.  In the crystal structure, a significant motion of loop A was obsd. between AR and V301L AKR1B10, linked to a Phe-122/Phe-123 side chain displacement.  This was due to the presence of the more voluminous Gln-303 side chain (Ser-302 in AR) and of a water mol. buried in a subpocket located at the base of flexible loop A.  In the wild-type AKR1B10 model, a short contact was predicted between the Val-301 side chain and fidarestat, but would not be present in AR or in V301L AKR1B10.  Overall, these changes could contribute to the difference in inhibitory potency of fidarestat between AR and AKR1B10.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpADvm7S94DbVg90H21EOLACvtfcHk0liWzsdcEHAnzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1GitL4%253D&md5=d50a893844c69c1330fdab1b3e7181ee</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2012.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2012.12.013%26sid%3Dliteratum%253Aachs%26aulast%3DRuiz%26aufirst%3DF.%2BX.%26aulast%3DCousido-Siah%26aufirst%3DA.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DFarr%25C3%25A9s%26aufirst%3DJ.%26aulast%3DPar%25C3%25A9s%26aufirst%3DX.%26aulast%3DPodjarny%26aufirst%3DA.%26atitle%3DX-ray%2520Structure%2520of%2520the%2520V301L%2520Aldo-Keto%2520Reductase%25201B10%2520Complexed%2520with%2520NADP%252B%2520and%2520the%2520Potent%2520Aldose%2520Reductase%2520Inhibitor%2520Fidarestat%253A%2520Implications%2520for%2520Inhibitor%2520Binding%2520and%2520Selectivity%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2013%26volume%3D202%26spage%3D178%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span> </span><span class="NLM_article-title">Inhibitor Selectivity between Aldo-Keto Reductase Superfamily Members AKR1B10 and AKR1B1: Role of Trp112 (Trp111)</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">587</span><span class="NLM_x">, </span> <span class="NLM_fpage">3681</span><span class="NLM_x">–</span> <span class="NLM_lpage">3686</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.febslet.2013.09.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=24100137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Wksr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=587&publication_year=2013&pages=3681-3686&author=L.+Zhangauthor=H.+Zhangauthor=Y.+Zhaoauthor=Z.+Liauthor=S.+Chenauthor=J.+Zhaiauthor=Y.+Chenauthor=W.+Xieauthor=Z.+Wangauthor=Q.+Liauthor=X.+Zhengauthor=X.+Hu&title=Inhibitor+Selectivity+between+Aldo-Keto+Reductase+Superfamily+Members+AKR1B10+and+AKR1B1%3A+Role+of+Trp112+%28Trp111%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor selectivity between aldo-keto reductase superfamily members AKR1B10 and AKR1B1: Role of Trp112 (Trp111)</span></div><div class="casAuthors">Zhang, Liping; Zhang, Hong; Zhao, Yining; Li, Zhe; Chen, Shangke; Zhai, Jing; Chen, Yunyun; Xie, Wei; Wang, Zhong; Li, Qing; Zheng, Xuehua; Hu, Xiaopeng</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">587</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3681-3686</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The antineoplastic target aldo-keto reductase family member 1B10 (AKR1B10) and the crit. polyol pathway enzyme aldose reductase (AKR1B1) share high structural similarity.  Crystal structures reported here reveal a surprising Trp112 native conformation stabilized by a specific Gln114-centered hydrogen bond network in the AKR1B10 holoenzyme, and suggest that AKR1B1 inhibitors could retain their binding affinities toward AKR1B10 by inducing Trp112 flip to result in an "AKR1B1-like" active site in AKR1B10, while selective AKR1B10 inhibitors can take advantage of the broader active site of AKR1B10 provided by the native Trp112 side-chain orientation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-ks8rD0RTSrVg90H21EOLACvtfcHk0liWzsdcEHAnzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Wksr3K&md5=a6faf542117ed3192029261dd69b514c</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2013.09.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2013.09.031%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DZhai%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DX.%26atitle%3DInhibitor%2520Selectivity%2520between%2520Aldo-Keto%2520Reductase%2520Superfamily%2520Members%2520AKR1B10%2520and%2520AKR1B1%253A%2520Role%2520of%2520Trp112%2520%2528Trp111%2529%26jtitle%3DFEBS%2520Lett.%26date%3D2013%26volume%3D587%26spage%3D3681%26epage%3D3686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span> </span><span class="NLM_article-title">Partial Inhibition of Aldose Reductase by Nitazoxanide and Its Molecular Basis</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1921</span><span class="NLM_x">–</span> <span class="NLM_lpage">1923</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1921-1923&author=X.+Zhengauthor=L.+Zhangauthor=W.+Chenauthor=Y.+Chenauthor=W.+Xieauthor=X.+Hu&title=Partial+Inhibition+of+Aldose+Reductase+by+Nitazoxanide+and+Its+Molecular+Basis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DX.%26atitle%3DPartial%2520Inhibition%2520of%2520Aldose%2520Reductase%2520by%2520Nitazoxanide%2520and%2520Its%2520Molecular%2520Basis%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1921%26epage%3D1923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Kumar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobhia, M. E.</span><span> </span><span class="NLM_article-title">Novel Insights into the Structural Requirements for the Design of Selective and Specific Aldose Reductase Inhibitors</span> <span class="citation_source-journal">J. Mol. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1791</span><span class="NLM_x">–</span> <span class="NLM_lpage">1799</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1007%2Fs00894-011-1195-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=21833829" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVais7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=1791-1799&author=H.+Kumarauthor=A.+Shahauthor=M.+E.+Sobhia&title=Novel+Insights+into+the+Structural+Requirements+for+the+Design+of+Selective+and+Specific+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Novel insights into the structural requirements for the design of selective and specific aldose reductase inhibitors</span></div><div class="casAuthors">Kumar, Hirdesh; Shah, Anup; Sobhia, M. Elizabeth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1791-1799</span>CODEN:
                <span class="NLM_cas:coden">JMMOFK</span>;
        ISSN:<span class="NLM_cas:issn">0948-5023</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aldose reductase (ALR2) plays a vital role in the etiol. of long-term diabetic microvascular complications (DMCs) such as retinopathy, nephropathy and neuropathy.  It initializes the polyol pathway and under hyperglycemic conditions, catalyzes the conversion of glucose into sorbitol in the presence of NADPH.  Many ALR2 inhibitors have been withdrawn from clin. trial studies due to their cross reactivity with other analogs enzymes or due to impairment with detoxification role of ALR2.  To address these issues we characterized the possible rationalities behind the selectivity problem assocd. with the enzyme-inhibitor interactions.  Novel mols. were designed for the induce fit cavity region of ALR2.  Docking studies were carried out using Glide to analyze the binding affinity of the designed mols. for ALR2.  The anal. showed that the designed ALR2 inhibitors are selective for ALR2 over its close analogs.  These inhibitors are also specific for the induced cavity region of ALR2 and do not interfere with the detoxification role of ALR2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPHa6bXbXzZLVg90H21EOLACvtfcHk0lhBFUL2IaqNNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVais7s%253D&md5=555968a098bc581691ac141bc7682276</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1007%2Fs00894-011-1195-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00894-011-1195-0%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DH.%26aulast%3DShah%26aufirst%3DA.%26aulast%3DSobhia%26aufirst%3DM.%2BE.%26atitle%3DNovel%2520Insights%2520into%2520the%2520Structural%2520Requirements%2520for%2520the%2520Design%2520of%2520Selective%2520and%2520Specific%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DJ.%2520Mol.%2520Model.%26date%3D2012%26volume%3D18%26spage%3D1791%26epage%3D1799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Del Corso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balestri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Bugno, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappiello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mura, U.</span><span> </span><span class="NLM_article-title">A New Approach To Control the Enigmatic Activity of Aldose Reductase</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e74076</span><span class="refDoi"> DOI: 10.1371/journal.pone.0074076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1371%2Fjournal.pone.0074076" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e74076&author=A.+Del+Corsoauthor=F.+Balestriauthor=E.+Di+Bugnoauthor=R.+Moschiniauthor=M.+Cappielloauthor=S.+Sartiniauthor=C.+La+Mottaauthor=F.+Da+Settimoauthor=U.+Mura&title=A+New+Approach+To+Control+the+Enigmatic+Activity+of+Aldose+Reductase&doi=10.1371%2Fjournal.pone.0074076"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0074076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0074076%26sid%3Dliteratum%253Aachs%26aulast%3DDel%2BCorso%26aufirst%3DA.%26aulast%3DBalestri%26aufirst%3DF.%26aulast%3DDi%2BBugno%26aufirst%3DE.%26aulast%3DMoschini%26aufirst%3DR.%26aulast%3DCappiello%26aufirst%3DM.%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DMura%26aufirst%3DU.%26atitle%3DA%2520New%2520Approach%2520To%2520Control%2520the%2520Enigmatic%2520Activity%2520of%2520Aldose%2520Reductase%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De74076%26doi%3D10.1371%2Fjournal.pone.0074076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Kim, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. S.</span><span> </span><span class="NLM_article-title">Genistein Inhibits Aldose Reductase Activity and High Glucose-Induced TGF-β2 Expression in Human Lens Epithelial Cells</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">594</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1016%2Fj.ejphar.2008.07.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Fjm500907a&amp;key=18692043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVynurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=594&publication_year=2008&pages=18-25&author=Y.+S.+Kimauthor=N.+H.+Kimauthor=D.+H.+Jungauthor=D.+S.+Jangauthor=Y.+M.+Leeauthor=J.+M.+Kimauthor=J.+S.+Kim&title=Genistein+Inhibits+Aldose+Reductase+Activity+and+High+Glucose-Induced+TGF-%CE%B22+Expression+in+Human+Lens+Epithelial+Cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Genistein inhibits aldose reductase activity and high glucose-induced TGF-β2 expression in human lens epithelial cells</span></div><div class="casAuthors">Kim, Young Sook; Kim, Nan Hee; Jung, Dong Ho; Jang, Dae Sik; Lee, Yun Mi; Kim, Jong Min; Kim, Jin Sook</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">594</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">18-25</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Aldose reductase (AR) and TGF-β have been implicated in the development of diabetic complications, such as cataracts.  In an attempt to obtain potential agents for the prevention of diabetic cataracts from natural products, we purified genistein from the roots of Pueraria lobata and investigated its inhibitory effects upon AR activity and its antioxidant effects on rat lenses.  The inhibition of AR activity by genistein increased in a dose-dependent manner and the opacities of lenses were significantly improved when treated with genistein.  In addn., we detd. the effects of genistein on mechanisms induced by exposure to high glucose in human lens epithelial (HLE-B3) cells.  We found that genistein was able to reduce the expression of TGF-β2, αB-crystallin, and fibronectin mRNAs in HLE-B3 cells that were cultured in high glucose conditions.  In addn., a redn. in glutathione (GSH) levels and thiobarbituratic acid-reactive substances was obsd.  These results show that genistein is protective against lens opacity and also inhibits high glucose-mediated toxic effects in HLE-B3 cells.  These effects are likely achieved by preventing AR and cellular oxidn.; therefore, genistein may be a potential therapeutic agent for preventing and treating complications assocd. with diabetes mellitus, such as diabetic cataracts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH434wfZMbybVg90H21EOLACvtfcHk0lhBFUL2IaqNNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVynurrI&md5=3aaece05c30cfa59e17bd2478ce76b5f</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.07.033%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DKim%26aufirst%3DN.%2BH.%26aulast%3DJung%26aufirst%3DD.%2BH.%26aulast%3DJang%26aufirst%3DD.%2BS.%26aulast%3DLee%26aufirst%3DY.%2BM.%26aulast%3DKim%26aufirst%3DJ.%2BM.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26atitle%3DGenistein%2520Inhibits%2520Aldose%2520Reductase%2520Activity%2520and%2520High%2520Glucose-Induced%2520TGF-%25CE%25B22%2520Expression%2520in%2520Human%2520Lens%2520Epithelial%2520Cells%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D594%26spage%3D18%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mugnaini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simorini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavecchia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Failli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciuffi, M.</span><span> </span><span class="NLM_article-title">Pyrido[1,2-<i>a</i>]pyrimidin-4-one Derivatives as a Novel Class of Selective Aldose Reductase. Inhibitors Exhibiting Antioxidant Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4917</span><span class="NLM_x">–</span> <span class="NLM_lpage">4927</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070398a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4917-4927&author=C.+La+Mottaauthor=S.+Sartiniauthor=L.+Mugnainiauthor=F.+Simoriniauthor=S.+Talianiauthor=S.+Salernoauthor=A.+M.+Mariniauthor=F.+Da+Settimoauthor=A.+Lavecchiaauthor=E.+Novellinoauthor=M.+Cantoreauthor=P.+Failliauthor=M.+Ciuffi&title=Pyrido%5B1%2C2-a%5Dpyrimidin-4-one+Derivatives+as+a+Novel+Class+of+Selective+Aldose+Reductase.+Inhibitors+Exhibiting+Antioxidant+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fjm070398a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070398a%26sid%3Dliteratum%253Aachs%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DMugnaini%26aufirst%3DL.%26aulast%3DSimorini%26aufirst%3DF.%26aulast%3DTaliani%26aufirst%3DS.%26aulast%3DSalerno%26aufirst%3DS.%26aulast%3DMarini%26aufirst%3DA.%2BM.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DLavecchia%26aufirst%3DA.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DCantore%26aufirst%3DM.%26aulast%3DFailli%26aufirst%3DP.%26aulast%3DCiuffi%26aufirst%3DM.%26atitle%3DPyrido%255B1%252C2-a%255Dpyrimidin-4-one%2520Derivatives%2520as%2520a%2520Novel%2520Class%2520of%2520Selective%2520Aldose%2520Reductase.%2520Inhibitors%2520Exhibiting%2520Antioxidant%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4917%26epage%3D4927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Stefek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snirc, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djoubissie, P.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majekova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demopoulos, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rackova, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezakova, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karasu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbone, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kabbani, O.</span><span> </span><span class="NLM_article-title">Carboxymethylated Pyridoindole Antioxidants as Aldose Reductase Inhibitors: Synthesis, Activity, Partitioning, and Molecular Modeling</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4908</span><span class="NLM_x">–</span> <span class="NLM_lpage">4920</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=4908-4920&author=M.+Stefekauthor=V.+Snircauthor=P.-O.+Djoubissieauthor=M.+Majekovaauthor=V.+Demopoulosauthor=L.+Rackovaauthor=Z.+Bezakovaauthor=C.+Karasuauthor=V.+Carboneauthor=O.+El-Kabbani&title=Carboxymethylated+Pyridoindole+Antioxidants+as+Aldose+Reductase+Inhibitors%3A+Synthesis%2C+Activity%2C+Partitioning%2C+and+Molecular+Modeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStefek%26aufirst%3DM.%26aulast%3DSnirc%26aufirst%3DV.%26aulast%3DDjoubissie%26aufirst%3DP.-O.%26aulast%3DMajekova%26aufirst%3DM.%26aulast%3DDemopoulos%26aufirst%3DV.%26aulast%3DRackova%26aufirst%3DL.%26aulast%3DBezakova%26aufirst%3DZ.%26aulast%3DKarasu%26aufirst%3DC.%26aulast%3DCarbone%26aufirst%3DV.%26aulast%3DEl-Kabbani%26aufirst%3DO.%26atitle%3DCarboxymethylated%2520Pyridoindole%2520Antioxidants%2520as%2520Aldose%2520Reductase%2520Inhibitors%253A%2520Synthesis%252C%2520Activity%252C%2520Partitioning%252C%2520and%2520Molecular%2520Modeling%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D4908%26epage%3D4920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Sartini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barresi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Maro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simorini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span> </span><span class="NLM_article-title">Benzofuroxane Derivatives as Multi-Effective Agents for the Treatment of Cardiovascular Diabetic Complications. Synthesis, Functional Evaluation, and Molecular Modeling Studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10523</span><span class="NLM_x">–</span> <span class="NLM_lpage">10531</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301124s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10523-10531&author=S.+Sartiniauthor=S.+Cosconatiauthor=L.+Marinelliauthor=E.+Barresiauthor=S.+Di+Maroauthor=F.+Simoriniauthor=S.+Talianiauthor=S.+Salernoauthor=A.+M.+Mariniauthor=F.+Da+Settimoauthor=E.+Novellinoauthor=C.+La+Motta&title=Benzofuroxane+Derivatives+as+Multi-Effective+Agents+for+the+Treatment+of+Cardiovascular+Diabetic+Complications.+Synthesis%2C+Functional+Evaluation%2C+and+Molecular+Modeling+Studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1021%2Fjm301124s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301124s%26sid%3Dliteratum%253Aachs%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DBarresi%26aufirst%3DE.%26aulast%3DDi%2BMaro%26aufirst%3DS.%26aulast%3DSimorini%26aufirst%3DF.%26aulast%3DTaliani%26aufirst%3DS.%26aulast%3DSalerno%26aufirst%3DS.%26aulast%3DMarini%26aufirst%3DA.%2BM.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26atitle%3DBenzofuroxane%2520Derivatives%2520as%2520Multi-Effective%2520Agents%2520for%2520the%2520Treatment%2520of%2520Cardiovascular%2520Diabetic%2520Complications.%2520Synthesis%252C%2520Functional%2520Evaluation%252C%2520and%2520Molecular%2520Modeling%2520Studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10523%26epage%3D10531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Ottanà, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giglio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Corso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappiello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mura, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span> </span><span class="NLM_article-title">Identification of 5-Arylidene-4-thiazolidinone Derivatives Endowed with Dual Activity as Aldose Reductase Inhibitors and Antioxidant Agents for the Treatment of Diabetic Complications</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2797</span><span class="NLM_x">–</span> <span class="NLM_lpage">2806</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=2797-2806&author=R.+Ottan%C3%A0author=R.+Maccariauthor=M.+Giglioauthor=A.+Del+Corsoauthor=M.+Cappielloauthor=U.+Muraauthor=S.+Cosconatiauthor=L.+Marinelliauthor=E.+Novellinoauthor=S.+Sartiniauthor=C.+La+Mottaauthor=F.+Da+Settimo&title=Identification+of+5-Arylidene-4-thiazolidinone+Derivatives+Endowed+with+Dual+Activity+as+Aldose+Reductase+Inhibitors+and+Antioxidant+Agents+for+the+Treatment+of+Diabetic+Complications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOttan%25C3%25A0%26aufirst%3DR.%26aulast%3DMaccari%26aufirst%3DR.%26aulast%3DGiglio%26aufirst%3DM.%26aulast%3DDel%2BCorso%26aufirst%3DA.%26aulast%3DCappiello%26aufirst%3DM.%26aulast%3DMura%26aufirst%3DU.%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26atitle%3DIdentification%2520of%25205-Arylidene-4-thiazolidinone%2520Derivatives%2520Endowed%2520with%2520Dual%2520Activity%2520as%2520Aldose%2520Reductase%2520Inhibitors%2520and%2520Antioxidant%2520Agents%2520for%2520the%2520Treatment%2520of%2520Diabetic%2520Complications%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D2797%26epage%3D2806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Mylari, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armento, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beebe, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coutcher, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dina, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Gorman, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhares, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oates, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tess, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withbroe, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zembrowski, W. J.</span><span> </span><span class="NLM_article-title">A Highly Selective, Non-Hydantoin, Non-Carboxylic Acid Inhibitor of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models: 6-(5-Chloro-3-methylbenzofuran-2-sulfonyl)-2-<i>H</i>-pyridazin-3-one</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2283</span><span class="NLM_x">–</span> <span class="NLM_lpage">2286</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm034065z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2283-2286&author=B.+L.+Mylariauthor=S.+J.+Armentoauthor=D.+A.+Beebeauthor=E.+L.+Connauthor=J.+B.+Coutcherauthor=M.+S.+Dinaauthor=M.+T.+O%E2%80%99Gormanauthor=M.+C.+Linharesauthor=W.+H.+Martinauthor=P.+J.+Oatesauthor=D.+A.+Tessauthor=G.+J.+Withbroeauthor=W.+J.+Zembrowski&title=A+Highly+Selective%2C+Non-Hydantoin%2C+Non-Carboxylic+Acid+Inhibitor+of+Aldose+Reductase+with+Potent+Oral+Activity+in+Diabetic+Rat+Models%3A+6-%285-Chloro-3-methylbenzofuran-2-sulfonyl%29-2-H-pyridazin-3-one"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1021%2Fjm034065z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034065z%26sid%3Dliteratum%253Aachs%26aulast%3DMylari%26aufirst%3DB.%2BL.%26aulast%3DArmento%26aufirst%3DS.%2BJ.%26aulast%3DBeebe%26aufirst%3DD.%2BA.%26aulast%3DConn%26aufirst%3DE.%2BL.%26aulast%3DCoutcher%26aufirst%3DJ.%2BB.%26aulast%3DDina%26aufirst%3DM.%2BS.%26aulast%3DO%25E2%2580%2599Gorman%26aufirst%3DM.%2BT.%26aulast%3DLinhares%26aufirst%3DM.%2BC.%26aulast%3DMartin%26aufirst%3DW.%2BH.%26aulast%3DOates%26aufirst%3DP.%2BJ.%26aulast%3DTess%26aufirst%3DD.%2BA.%26aulast%3DWithbroe%26aufirst%3DG.%2BJ.%26aulast%3DZembrowski%26aufirst%3DW.%2BJ.%26atitle%3DA%2520Highly%2520Selective%252C%2520Non-Hydantoin%252C%2520Non-Carboxylic%2520Acid%2520Inhibitor%2520of%2520Aldose%2520Reductase%2520with%2520Potent%2520Oral%2520Activity%2520in%2520Diabetic%2520Rat%2520Models%253A%25206-%25285-Chloro-3-methylbenzofuran-2-sulfonyl%2529-2-H-pyridazin-3-one%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2283%26epage%3D2286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Mylari, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armento, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beebe, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coutcher, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dina, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Gorman, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhares, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oates, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tess, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withbroe, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zembrowski, W. J.</span><span> </span><span class="NLM_article-title">A Novel Series of Non-Carboxylic Acid, Non-Hydantoin Inhibitors of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models: 6-(5-Chloro-3-methylbenzofuran-2-sulfonyl)-2<i>H</i>-pyridazin-3-one and Congeners</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6326</span><span class="NLM_x">–</span> <span class="NLM_lpage">6339</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050462t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6326-6339&author=B.+L.+Mylariauthor=S.+J.+Armentoauthor=D.+A.+Beebeauthor=E.+L.+Connauthor=J.+B.+Coutcherauthor=M.+S.+Dinaauthor=M.+T.+O%E2%80%99Gormanauthor=M.+C.+Linharesauthor=W.+H.+Martinauthor=P.+J.+Oatesauthor=D.+A.+Tessauthor=G.+J.+Withbroeauthor=W.+J.+Zembrowski&title=A+Novel+Series+of+Non-Carboxylic+Acid%2C+Non-Hydantoin+Inhibitors+of+Aldose+Reductase+with+Potent+Oral+Activity+in+Diabetic+Rat+Models%3A+6-%285-Chloro-3-methylbenzofuran-2-sulfonyl%29-2H-pyridazin-3-one+and+Congeners"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1021%2Fjm050462t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050462t%26sid%3Dliteratum%253Aachs%26aulast%3DMylari%26aufirst%3DB.%2BL.%26aulast%3DArmento%26aufirst%3DS.%2BJ.%26aulast%3DBeebe%26aufirst%3DD.%2BA.%26aulast%3DConn%26aufirst%3DE.%2BL.%26aulast%3DCoutcher%26aufirst%3DJ.%2BB.%26aulast%3DDina%26aufirst%3DM.%2BS.%26aulast%3DO%25E2%2580%2599Gorman%26aufirst%3DM.%2BT.%26aulast%3DLinhares%26aufirst%3DM.%2BC.%26aulast%3DMartin%26aufirst%3DW.%2BH.%26aulast%3DOates%26aufirst%3DP.%2BJ.%26aulast%3DTess%26aufirst%3DD.%2BA.%26aulast%3DWithbroe%26aufirst%3DG.%2BJ.%26aulast%3DZembrowski%26aufirst%3DW.%2BJ.%26atitle%3DA%2520Novel%2520Series%2520of%2520Non-Carboxylic%2520Acid%252C%2520Non-Hydantoin%2520Inhibitors%2520of%2520Aldose%2520Reductase%2520with%2520Potent%2520Oral%2520Activity%2520in%2520Diabetic%2520Rat%2520Models%253A%25206-%25285-Chloro-3-methylbenzofuran-2-sulfonyl%2529-2H-pyridazin-3-one%2520and%2520Congeners%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6326%26epage%3D6339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oates, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coutcher, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhardinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenzi, M.</span><span> </span><span class="NLM_article-title">A Selective Aldose Reductase Inhibitor of a New Structural Class Prevents or Reverses Early Retinal Abnormalities in Experimental Diabetic Retinopathy</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2757</span><span class="NLM_x">–</span> <span class="NLM_lpage">2762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2006&pages=2757-2762&author=W.+Sunauthor=P.+J.+Oatesauthor=J.+B.+Coutcherauthor=C.+Gerhardingerauthor=M.+Lorenzi&title=A+Selective+Aldose+Reductase+Inhibitor+of+a+New+Structural+Class+Prevents+or+Reverses+Early+Retinal+Abnormalities+in+Experimental+Diabetic+Retinopathy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DW.%26aulast%3DOates%26aufirst%3DP.%2BJ.%26aulast%3DCoutcher%26aufirst%3DJ.%2BB.%26aulast%3DGerhardinger%26aufirst%3DC.%26aulast%3DLorenzi%26aufirst%3DM.%26atitle%3DA%2520Selective%2520Aldose%2520Reductase%2520Inhibitor%2520of%2520a%2520New%2520Structural%2520Class%2520Prevents%2520or%2520Reverses%2520Early%2520Retinal%2520Abnormalities%2520in%2520Experimental%2520Diabetic%2520Retinopathy%26jtitle%3DDiabetes%26date%3D2006%26volume%3D55%26spage%3D2757%26epage%3D2762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Steuber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zentgraf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">High-Resolution Crystal Structure of Aldose Reductase with the Novel Sulfonyl-Pyridazinone Inhibitor Exhibiting an Alternative Active Site Anchoring Group</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">356</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2006&pages=45-56&author=H.+Steuberauthor=M.+Zentgrafauthor=S.+Podjarnyauthor=A.+Heineauthor=G.+Klebe&title=High-Resolution+Crystal+Structure+of+Aldose+Reductase+with+the+Novel+Sulfonyl-Pyridazinone+Inhibitor+Exhibiting+an+Alternative+Active+Site+Anchoring+Group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSteuber%26aufirst%3DH.%26aulast%3DZentgraf%26aufirst%3DM.%26aulast%3DPodjarny%26aufirst%3DS.%26aulast%3DHeine%26aufirst%3DA.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DHigh-Resolution%2520Crystal%2520Structure%2520of%2520Aldose%2520Reductase%2520with%2520the%2520Novel%2520Sulfonyl-Pyridazinone%2520Inhibitor%2520Exhibiting%2520an%2520Alternative%2520Active%2520Site%2520Anchoring%2520Group%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2006%26volume%3D356%26spage%3D45%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Fresneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cussac, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morand, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szymonski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tranqui, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leclerc, G.</span><span> </span><span class="NLM_article-title">Synthesis, Activity, and Molecular Modeling of New 2,4-Dioxo-5-(naphthylmethylene)-3-thiazolidineacetic Acids and 2-Thioxo Analogues as Potent Aldose Reductase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">4706</span><span class="NLM_x">–</span> <span class="NLM_lpage">4715</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9801399" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=4706-4715&author=P.+Fresneauauthor=M.+Cussacauthor=J.+M.+Morandauthor=B.+Szymonskiauthor=D.+Tranquiauthor=G.+Leclerc&title=Synthesis%2C+Activity%2C+and+Molecular+Modeling+of+New+2%2C4-Dioxo-5-%28naphthylmethylene%29-3-thiazolidineacetic+Acids+and+2-Thioxo+Analogues+as+Potent+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1021%2Fjm9801399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9801399%26sid%3Dliteratum%253Aachs%26aulast%3DFresneau%26aufirst%3DP.%26aulast%3DCussac%26aufirst%3DM.%26aulast%3DMorand%26aufirst%3DJ.%2BM.%26aulast%3DSzymonski%26aufirst%3DB.%26aulast%3DTranqui%26aufirst%3DD.%26aulast%3DLeclerc%26aufirst%3DG.%26atitle%3DSynthesis%252C%2520Activity%252C%2520and%2520Molecular%2520Modeling%2520of%2520New%25202%252C4-Dioxo-5-%2528naphthylmethylene%2529-3-thiazolidineacetic%2520Acids%2520and%25202-Thioxo%2520Analogues%2520as%2520Potent%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D4706%26epage%3D4715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Maccari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Corso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giglio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mura, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottanà, R.</span><span> </span><span class="NLM_article-title">In vitro Evaluation of 5-Arylidene-2-thioxo-4-thiazolidinones Active as Aldose Reductase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=200-203&author=R.+Maccariauthor=A.+Del+Corsoauthor=M.+Giglioauthor=R.+Moschiniauthor=U.+Muraauthor=R.+Ottan%C3%A0&title=In+vitro+Evaluation+of+5-Arylidene-2-thioxo-4-thiazolidinones+Active+as+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaccari%26aufirst%3DR.%26aulast%3DDel%2BCorso%26aufirst%3DA.%26aulast%3DGiglio%26aufirst%3DM.%26aulast%3DMoschini%26aufirst%3DR.%26aulast%3DMura%26aufirst%3DU.%26aulast%3DOttan%25C3%25A0%26aufirst%3DR.%26atitle%3DIn%2520vitro%2520Evaluation%2520of%25205-Arylidene-2-thioxo-4-thiazolidinones%2520Active%2520as%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D200%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeed, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbas, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahid, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, J.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Molecular Modelling of Novel Methyl[4-oxo-2-(aroylimino)-3-(substituted phenyl)thiazolidin-5-ylidene]acetates as Potent and Selective Aldose Reductase Inhibitors</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1428</span><span class="NLM_x">–</span> <span class="NLM_lpage">1434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Fjm500907a&amp;key=10.1039%2Fc2md20228j" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1428-1434&author=S.+Aliauthor=A.+Saeedauthor=N.+Abbasauthor=M.+Shahidauthor=M.+Bolteauthor=J.+Iqbal&title=Design%2C+Synthesis+and+Molecular+Modelling+of+Novel+Methyl%5B4-oxo-2-%28aroylimino%29-3-%28substituted+phenyl%29thiazolidin-5-ylidene%5Dacetates+as+Potent+and+Selective+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1039%2Fc2md20228j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20228j%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DS.%26aulast%3DSaeed%26aufirst%3DA.%26aulast%3DAbbas%26aufirst%3DN.%26aulast%3DShahid%26aufirst%3DM.%26aulast%3DBolte%26aufirst%3DM.%26aulast%3DIqbal%26aufirst%3DJ.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Molecular%2520Modelling%2520of%2520Novel%2520Methyl%255B4-oxo-2-%2528aroylimino%2529-3-%2528substituted%2520phenyl%2529thiazolidin-5-ylidene%255Dacetates%2520as%2520Potent%2520and%2520Selective%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2012%26volume%3D3%26spage%3D1428%26epage%3D1434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Alexiou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolaou, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demopoulos, V. J.</span><span> </span><span class="NLM_article-title">Design and Synthesis of <i>N</i>-(3,5-Difluoro-4-hydroxyphenyl)benzenesulfonamides as Aldose Reductase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3926</span><span class="NLM_x">–</span> <span class="NLM_lpage">3932</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=3926-3932&author=P.+Alexiouauthor=I.+Nicolaouauthor=M.+Stefekauthor=A.+Kristlauthor=V.+J.+Demopoulos&title=Design+and+Synthesis+of+N-%283%2C5-Difluoro-4-hydroxyphenyl%29benzenesulfonamides+as+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlexiou%26aufirst%3DP.%26aulast%3DNicolaou%26aufirst%3DI.%26aulast%3DStefek%26aufirst%3DM.%26aulast%3DKristl%26aufirst%3DA.%26aulast%3DDemopoulos%26aufirst%3DV.%2BJ.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520N-%25283%252C5-Difluoro-4-hydroxyphenyl%2529benzenesulfonamides%2520as%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D3926%26epage%3D3932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Alexiou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demopoulos, V. J.</span><span> </span><span class="NLM_article-title">A Diverse Series of Substituted Benzenesulfonamides as Aldose Reductase Inhibitors with Antioxidant Activity: Design, Synthesis, and in Vitro Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7756</span><span class="NLM_x">–</span> <span class="NLM_lpage">7766</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101008m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Fjm500907a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1KrsL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7756-7766&author=P.+Alexiouauthor=V.+J.+Demopoulos&title=A+Diverse+Series+of+Substituted+Benzenesulfonamides+as+Aldose+Reductase+Inhibitors+with+Antioxidant+Activity%3A+Design%2C+Synthesis%2C+and+in+Vitro+Activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">A Diverse Series of Substituted Benzenesulfonamides as Aldose Reductase Inhibitors with Antioxidant Activity: Design, Synthesis, and in Vitro Activity</span></div><div class="casAuthors">Alexiou, Polyxeni; Demopoulos, Vassilis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7756-7766</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Based on bioisosteric principles, 2,6-difluorophenol and tetrazole, methylsulfonylamide, and isoxazolidin-3-one phenylsulfonamide derivs. were synthesized and tested in vitro in protocols primarily related to the long-term diabetic complications.  Most of the compds. were found as aldose reductase inhibitors (ARIs) at IC50 < 100 μM, while the introduction of the 4-bromo-2-fluorobenzyl group in a phenylsulfonamidodifluorophenol structure resulted in I, presenting a submicromolar inhibitory profile.  However, the derivs. of tetrazole, methylsulfonylamine, and the (R)-enantiomer of isoxazolidin-3-one did not exhibit appreciable aldose reductase inhibitors (ARI) activity.  The selectivity of the active ARIs is also discussed.  Furthermore, the synthesized compds. exhibit potent antioxidant potential (homogeneous and heterogeneous systems).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB1NvT6auwjLVg90H21EOLACvtfcHk0ljiwFyqW0yn6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1KrsL7P&md5=563867cc9b9125eaaa603ac959f399a6</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fjm101008m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101008m%26sid%3Dliteratum%253Aachs%26aulast%3DAlexiou%26aufirst%3DP.%26aulast%3DDemopoulos%26aufirst%3DV.%2BJ.%26atitle%3DA%2520Diverse%2520Series%2520of%2520Substituted%2520Benzenesulfonamides%2520as%2520Aldose%2520Reductase%2520Inhibitors%2520with%2520Antioxidant%2520Activity%253A%2520Design%252C%2520Synthesis%252C%2520and%2520in%2520Vitro%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7756%26epage%3D7766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Chatzopoulou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamadou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juskova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koukoulitsa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolaou, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demopoulos, V. J.</span><span> </span><span class="NLM_article-title">Structure–Activity Relations on [1-(3,5-Difluoro-4-hydroxyphenyl)-1<i>H</i>-pyrrol-3-yl]phenylmethanone. The Effect of Methoxy Substitution on Aldose Reductase Inhibitory Activity and Selectivity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1426</span><span class="NLM_x">–</span> <span class="NLM_lpage">1433</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1426-1433&author=M.+Chatzopoulouauthor=E.+Mamadouauthor=M.+Juskovaauthor=C.+Koukoulitsaauthor=I.+Nicolaouauthor=M.+Stefekauthor=V.+J.+Demopoulos&title=Structure%E2%80%93Activity+Relations+on+%5B1-%283%2C5-Difluoro-4-hydroxyphenyl%29-1H-pyrrol-3-yl%5Dphenylmethanone.+The+Effect+of+Methoxy+Substitution+on+Aldose+Reductase+Inhibitory+Activity+and+Selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChatzopoulou%26aufirst%3DM.%26aulast%3DMamadou%26aufirst%3DE.%26aulast%3DJuskova%26aufirst%3DM.%26aulast%3DKoukoulitsa%26aufirst%3DC.%26aulast%3DNicolaou%26aufirst%3DI.%26aulast%3DStefek%26aufirst%3DM.%26aulast%3DDemopoulos%26aufirst%3DV.%2BJ.%26atitle%3DStructure%25E2%2580%2593Activity%2520Relations%2520on%2520%255B1-%25283%252C5-Difluoro-4-hydroxyphenyl%2529-1H-pyrrol-3-yl%255Dphenylmethanone.%2520The%2520Effect%2520of%2520Methoxy%2520Substitution%2520on%2520Aldose%2520Reductase%2520Inhibitory%2520Activity%2520and%2520Selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D1426%26epage%3D1433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Kotsampasakou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demopoulos, V. J.</span><span> </span><span class="NLM_article-title">Synthesis of Derivatives of the Keto-pyrrolyl-difluorophenol Scaffold: Some Structural Aspects for Aldose Reductase Inhibitory Activity and Selectivity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">–</span> <span class="NLM_lpage">873</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=869-873&author=E.+Kotsampasakouauthor=V.+J.+Demopoulos&title=Synthesis+of+Derivatives+of+the+Keto-pyrrolyl-difluorophenol+Scaffold%3A+Some+Structural+Aspects+for+Aldose+Reductase+Inhibitory+Activity+and+Selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKotsampasakou%26aufirst%3DE.%26aulast%3DDemopoulos%26aufirst%3DV.%2BJ.%26atitle%3DSynthesis%2520of%2520Derivatives%2520of%2520the%2520Keto-pyrrolyl-difluorophenol%2520Scaffold%253A%2520Some%2520Structural%2520Aspects%2520for%2520Aldose%2520Reductase%2520Inhibitory%2520Activity%2520and%2520Selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D869%26epage%3D873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Pegklidou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koukoulitsa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolaou, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demopoulos, V. J.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Novel Series of Pyrrole Based Chemotypes and Their Evaluation as Selective Aldose Reductase Inhibitors. A Case of Bioisosterism between a Carboxylic Acid Moiety and That of a Tetrazole</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2107</span><span class="NLM_x">–</span> <span class="NLM_lpage">2114</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=2107-2114&author=K.+Pegklidouauthor=C.+Koukoulitsaauthor=I.+Nicolaouauthor=V.+J.+Demopoulos&title=Design+and+Synthesis+of+Novel+Series+of+Pyrrole+Based+Chemotypes+and+Their+Evaluation+as+Selective+Aldose+Reductase+Inhibitors.+A+Case+of+Bioisosterism+between+a+Carboxylic+Acid+Moiety+and+That+of+a+Tetrazole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPegklidou%26aufirst%3DK.%26aulast%3DKoukoulitsa%26aufirst%3DC.%26aulast%3DNicolaou%26aufirst%3DI.%26aulast%3DDemopoulos%26aufirst%3DV.%2BJ.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Novel%2520Series%2520of%2520Pyrrole%2520Based%2520Chemotypes%2520and%2520Their%2520Evaluation%2520as%2520Selective%2520Aldose%2520Reductase%2520Inhibitors.%2520A%2520Case%2520of%2520Bioisosterism%2520between%2520a%2520Carboxylic%2520Acid%2520Moiety%2520and%2520That%2520of%2520a%2520Tetrazole%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D2107%26epage%3D2114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Papastavrou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatzopoulou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegklidou, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolaou, I.</span><span> </span><span class="NLM_article-title">1-Hydroxypyrazole as a Bioisostere of the Acetic Acid Moiety in a Series of Aldose Reductase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4951</span><span class="NLM_x">–</span> <span class="NLM_lpage">4957</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=4951-4957&author=N.+Papastavrouauthor=M.+Chatzopoulouauthor=K.+Pegklidouauthor=I.+Nicolaou&title=1-Hydroxypyrazole+as+a+Bioisostere+of+the+Acetic+Acid+Moiety+in+a+Series+of+Aldose+Reductase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPapastavrou%26aufirst%3DN.%26aulast%3DChatzopoulou%26aufirst%3DM.%26aulast%3DPegklidou%26aufirst%3DK.%26aulast%3DNicolaou%26aufirst%3DI.%26atitle%3D1-Hydroxypyrazole%2520as%2520a%2520Bioisostere%2520of%2520the%2520Acetic%2520Acid%2520Moiety%2520in%2520a%2520Series%2520of%2520Aldose%2520Reductase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D4951%26epage%3D4957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Chatzopoulou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patsilinakos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallianatou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prnova, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zakelj, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragno, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantili-Kakoulidou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demopoulos, V. J.</span><span> </span><span class="NLM_article-title">Decreasing Acidity in a Series of Aldose Reductase Inhibitors: 2-Fluoro-4-(1<i>H</i>-pyrrol-1-yl)phenol as a Scaffold for Improved Membrane Permeation</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2194</span><span class="NLM_x">–</span> <span class="NLM_lpage">2207</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=2194-2207&author=M.+Chatzopoulouauthor=A.+Patsilinakosauthor=T.+Vallianatouauthor=M.+S.+Prnovaauthor=S.+Zakeljauthor=R.+Ragnoauthor=M.+Stefekauthor=A.+Kristlauthor=A.+Tsantili-Kakoulidouauthor=V.+J.+Demopoulos&title=Decreasing+Acidity+in+a+Series+of+Aldose+Reductase+Inhibitors%3A+2-Fluoro-4-%281H-pyrrol-1-yl%29phenol+as+a+Scaffold+for+Improved+Membrane+Permeation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChatzopoulou%26aufirst%3DM.%26aulast%3DPatsilinakos%26aufirst%3DA.%26aulast%3DVallianatou%26aufirst%3DT.%26aulast%3DPrnova%26aufirst%3DM.%2BS.%26aulast%3DZakelj%26aufirst%3DS.%26aulast%3DRagno%26aufirst%3DR.%26aulast%3DStefek%26aufirst%3DM.%26aulast%3DKristl%26aufirst%3DA.%26aulast%3DTsantili-Kakoulidou%26aufirst%3DA.%26aulast%3DDemopoulos%26aufirst%3DV.%2BJ.%26atitle%3DDecreasing%2520Acidity%2520in%2520a%2520Series%2520of%2520Aldose%2520Reductase%2520Inhibitors%253A%25202-Fluoro-4-%25281H-pyrrol-1-yl%2529phenol%2520as%2520a%2520Scaffold%2520for%2520Improved%2520Membrane%2520Permeation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D2194%26epage%3D2207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Maccari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottanà, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciurleo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakowitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matuszczak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laggner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, T.</span><span> </span><span class="NLM_article-title">Synthesis, Induced-Fit Docking Investigations, and in Vitro Aldose Reductase Inhibitory Activity of Non-Carboxylic Acid Containing 2,4-Thiazolidinedione Derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5840</span><span class="NLM_x">–</span> <span class="NLM_lpage">5852</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=5840-5852&author=R.+Maccariauthor=R.+Ottan%C3%A0author=R.+Ciurleoauthor=D.+Rakowitzauthor=B.+Matuszczakauthor=C.+Laggnerauthor=T.+Langer&title=Synthesis%2C+Induced-Fit+Docking+Investigations%2C+and+in+Vitro+Aldose+Reductase+Inhibitory+Activity+of+Non-Carboxylic+Acid+Containing+2%2C4-Thiazolidinedione+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaccari%26aufirst%3DR.%26aulast%3DOttan%25C3%25A0%26aufirst%3DR.%26aulast%3DCiurleo%26aufirst%3DR.%26aulast%3DRakowitz%26aufirst%3DD.%26aulast%3DMatuszczak%26aufirst%3DB.%26aulast%3DLaggner%26aufirst%3DC.%26aulast%3DLanger%26aufirst%3DT.%26atitle%3DSynthesis%252C%2520Induced-Fit%2520Docking%2520Investigations%252C%2520and%2520in%2520Vitro%2520Aldose%2520Reductase%2520Inhibitory%2520Activity%2520of%2520Non-Carboxylic%2520Acid%2520Containing%25202%252C4-Thiazolidinedione%2520Derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D5840%26epage%3D5852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">Maccari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciurleo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giglio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappiello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Corso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mura, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottanà, R.</span><span> </span><span class="NLM_article-title">Identification of New Non-Carboxylic Acid Containing Inhibitors of Aldose Reductase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4049</span><span class="NLM_x">–</span> <span class="NLM_lpage">4055</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=4049-4055&author=R.+Maccariauthor=R.+Ciurleoauthor=M.+Giglioauthor=M.+Cappielloauthor=R.+Moschiniauthor=A.+Del+Corsoauthor=U.+Muraauthor=R.+Ottan%C3%A0&title=Identification+of+New+Non-Carboxylic+Acid+Containing+Inhibitors+of+Aldose+Reductase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaccari%26aufirst%3DR.%26aulast%3DCiurleo%26aufirst%3DR.%26aulast%3DGiglio%26aufirst%3DM.%26aulast%3DCappiello%26aufirst%3DM.%26aulast%3DMoschini%26aufirst%3DR.%26aulast%3DDel%2BCorso%26aufirst%3DA.%26aulast%3DMura%26aufirst%3DU.%26aulast%3DOttan%25C3%25A0%26aufirst%3DR.%26atitle%3DIdentification%2520of%2520New%2520Non-Carboxylic%2520Acid%2520Containing%2520Inhibitors%2520of%2520Aldose%2520Reductase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D4049%26epage%3D4055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Cosconati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Motta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Settimo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span> </span><span class="NLM_article-title">Pursuing Aldose Reductase Inhibitors through in Situ Cross-Docking and Similarity-Based Virtual Screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5578</span><span class="NLM_x">–</span> <span class="NLM_lpage">5581</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901045w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5578-5581&author=S.+Cosconatiauthor=L.+Marinelliauthor=C.+La+Mottaauthor=S.+Sartiniauthor=F.+Da+Settimoauthor=A.+J.+Olsonauthor=E.+Novellino&title=Pursuing+Aldose+Reductase+Inhibitors+through+in+Situ+Cross-Docking+and+Similarity-Based+Virtual+Screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1021%2Fjm901045w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901045w%26sid%3Dliteratum%253Aachs%26aulast%3DCosconati%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DLa%2BMotta%26aufirst%3DC.%26aulast%3DSartini%26aufirst%3DS.%26aulast%3DDa%2BSettimo%26aufirst%3DF.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26aulast%3DNovellino%26aufirst%3DE.%26atitle%3DPursuing%2520Aldose%2520Reductase%2520Inhibitors%2520through%2520in%2520Situ%2520Cross-Docking%2520and%2520Similarity-Based%2520Virtual%2520Screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5578%26epage%3D5581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MAR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MAR','PDB','1MAR'); return false;">PDB: 1MAR</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm500907a&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-5%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm500907a%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm500907a" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679984024eb72362","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
